<SEC-DOCUMENT>0000790526-23-000010.txt : 20230510
<SEC-HEADER>0000790526-23-000010.hdr.sgml : 20230510
<ACCEPTANCE-DATETIME>20230510164733
ACCESSION NUMBER:		0000790526-23-000010
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		59
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230510
DATE AS OF CHANGE:		20230510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		23907319

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>rdnt-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:b2271182-007a-4027-b874-402dbe4bcb25,g:1e66911a-3ada-4e5a-b4d0-d568e36a58ce,d:f318a573f95e4e07addbbbfb9543d1c5--><html xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:rdnt="http://www.radnet.com/20230331" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rdnt-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80L2ZyYWc6YmFlNDI0NzYxMzJkNGQ0ZTllNGI0MDI0ZGY4OGVkZTYvdGFibGU6NTcyMDEwZmM5MjZmNDA0MzlmZWZjYjkyNTA1ZGRkNDYvdGFibGVyYW5nZTo1NzIwMTBmYzkyNmY0MDQzOWZlZmNiOTI1MDVkZGQ0Nl8xLTEtMS0xLTU3MDcz_887a8092-6339-4b10-ade9-9472e9cccca3">0000790526</ix:nonNumeric><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80L2ZyYWc6YmFlNDI0NzYxMzJkNGQ0ZTllNGI0MDI0ZGY4OGVkZTYvdGFibGU6NTcyMDEwZmM5MjZmNDA0MzlmZWZjYjkyNTA1ZGRkNDYvdGFibGVyYW5nZTo1NzIwMTBmYzkyNmY0MDQzOWZlZmNiOTI1MDVkZGQ0Nl8yLTEtMS0xLTU3MDcz_ba787b22-e9eb-4974-a360-7af1a550251c">false</ix:nonNumeric><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80L2ZyYWc6YmFlNDI0NzYxMzJkNGQ0ZTllNGI0MDI0ZGY4OGVkZTYvdGFibGU6NTcyMDEwZmM5MjZmNDA0MzlmZWZjYjkyNTA1ZGRkNDYvdGFibGVyYW5nZTo1NzIwMTBmYzkyNmY0MDQzOWZlZmNiOTI1MDVkZGQ0Nl8zLTEtMS0xLTU3MDcz_9b4d48e7-bbf8-4f48-918f-dd2e9241834a">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80L2ZyYWc6YmFlNDI0NzYxMzJkNGQ0ZTllNGI0MDI0ZGY4OGVkZTYvdGFibGU6NTcyMDEwZmM5MjZmNDA0MzlmZWZjYjkyNTA1ZGRkNDYvdGFibGVyYW5nZTo1NzIwMTBmYzkyNmY0MDQzOWZlZmNiOTI1MDVkZGQ0Nl80LTEtMS0xLTU3MDcz_0d61e601-1ae0-4cf6-b9aa-a98848f1620b">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80L2ZyYWc6YmFlNDI0NzYxMzJkNGQ0ZTllNGI0MDI0ZGY4OGVkZTYvdGFibGU6NTcyMDEwZmM5MjZmNDA0MzlmZWZjYjkyNTA1ZGRkNDYvdGFibGVyYW5nZTo1NzIwMTBmYzkyNmY0MDQzOWZlZmNiOTI1MDVkZGQ0Nl81LTEtMS0xLTU3MDcz_6351cb84-54e9-43af-b6ec-5d484d68c519">2023</ix:nonNumeric><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjI1ZDk4ZTg3NTAxYTRkZWViMmE0ZTYyZGQzYTYzMjA3L3RhYmxlcmFuZ2U6MjVkOThlODc1MDFhNGRlZWIyYTRlNjJkZDNhNjMyMDdfMi00LTEtMS01NzA3Mw_82eff8fd-e435-416f-a669-f954d06a2aa7">http://fasb.org/us-gaap/2022#InterestExpenseDebt</ix:nonNumeric><ix:nonNumeric contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjllMGUxNjNhM2M3MDQ0NzA4ZGRmYzVhNDQyNjI2MmJlL3RhYmxlcmFuZ2U6OWUwZTE2M2EzYzcwNDQ3MDhkZGZjNWE0NDI2MjYyYmVfMi00LTEtMS04OTMxOA_468424d7-c562-4c21-a8d7-de7f7f9f175e">http://fasb.org/us-gaap/2022#InterestExpenseDebt</ix:nonNumeric><ix:nonNumeric contextRef="ibac46b5931104d75a9811d327fb9c53d_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODE4OTk1_66873c0e-ef14-4872-a4e6-5ee1a266aa10">P2Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rdnt-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49b54919f837402b828c88c2fb78a373_I20230504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-05-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ie931d8e47f25400f90b96046fd406a82_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i6dc177faf452405fa2bf716f25f19919_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ie6278308e0fe4e9e80559d07f63aa90e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad3e3586af214825b747d44b00364a79_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia605a6d22e64439893da71566768e2e9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb7ff594ba1c456380fafa96528d1a70_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91d4a0efd0134db0912cf424c9c05e57_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95b93de2b17549f68c2d1d19032cb451_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c5ed5063e474ba083fe5232406d387c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i468644d28f544537962de87ccfb1e608_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9479ea165b22465ab2af4cc1db0934bf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb918f8d0aad4f99a42dbf93329537ec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7aad81709c2e40bfa6d50e57ba2978f8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e0129316a1444a9a87a4f1035890d5e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ca13f2a1d6242bdbe459e60b2e0745d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i913c1e2479954386a1891ed9fbce6745_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5adf124c49f04748907d0b7a789a6104_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3adf6f8648e495e9006502147d4eae8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48b53158259a45cf99350d972b519d34_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0079ed901cd348488a81abe9066a6c27_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9f6f61fb6774fb88dfcd64fd07c4b8a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1c7d6e31a0346089303a191fa0be906_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32758e6d4de641c287fa2f616af42021_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdf0d0a31a7d4bbeab91318c3504e0e3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4127c96bf5a4ca98119ab44d3fb22df_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd187a7758714339a38596e3b8703fda_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03170300e04e4c6885da7ab306fe32fb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c6492a471c24eb79e884f0d8d9e9ef5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idab5203b536348aeb1e033a60b58d92b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78a4a63e76c7434296690fc94fa7d206_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b87a5ef08b949fd9eced9e15c7a255a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i385a0ecd81c14fc5b2842208e1659808_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7430f7620cb4b499645b1c4db111fd3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbbc7fc6774d480f8cf4ece72ee8d689_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57c8687ae4a54bc7961fd12b87f8095c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie91409c4e3ca453ca3dfd68bcfbef870_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1051455c74414445a26e00de581866c1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibddc1d75b382422a8961f98fdde6c318_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic141cdf85619420ebcf66d35adb457ca_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc0bf32b28e24d0aaab1535b72796e85_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d8fc8460d0049568d657a5449e9ce3e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i622337df6b2342b8bcf81a0bbf78cfee_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i210a11d3d8e44324b361e34bb30b96fc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c7ef23f5cc14489bb2ae2e8a17d5ac8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ec1a7c8f9b74641a09c0fc25654b909_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80882b4f5c6a453fa389846657050098_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ae3cbf23e8046c887d676fc95010311_I20230201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i875e29b29f814b69a487f86dc63c58e7_D20220120-20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceHoldingBVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e4e223d7eff48c4b6d57f718874ebf4_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceHoldingBVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06979ac32be0468ab90faae5f8a7fae6_D20220120-20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a5b65acdc4a494dad73f5d762c4bff4_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="center"><xbrli:measure>rdnt:center</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>rdnt:segment</xbrli:measure></xbrli:unit><xbrli:context id="i4d24e08a1ed346ecadd8d502b2c5e3c9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82df3264b09247118f927708d745a3e0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i780286e32ed648ff95b88393d95716a1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i52ba0462fc584809b69e0d06cebc198d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i193239544180470cbfa731378e7fcdf0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ad85707f4d64ac6a9a8091c4223b351_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i574c4913311e49879ae8136ee2d28148_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb9e5186dac3404d9c737b06211b3954_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a4072ab0edd48c8a67ccfb8f51a6290_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44ce173f477244e8b5b9d811a1911c07_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ab20d39d79f4dc98599ce2f92baa5a6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc4e3875a9e549a799c5a7ded655f868_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00746cf82a884d0881fb0a193616659f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49ac145dbb9f4ba0bc8a57932c917cba_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fa4d806c58044f58518c1759a53deb2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e3f72be824d49ff84df16d939b272c9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10301ec9313f4145901cddf7c8e67034_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67abe92a1c5140fc826b327cdcfeb0e3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:TeleradiologyandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfcabd15dd704d3592f2fedf50542f92_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:TeleradiologyandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic85c070b82f34df996b2edd5c5a6f417_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b8ceb76bd89449e9f1fdaa8aae701da_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if70ac0bb6794471fac30d72ea02c9975_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingCenterSegmentRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ab2e2f3665f40458a4bcdf95423b45a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingCenterSegmentRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0acc5172ba1c4948b09055ace900fbac_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8aa11bdde454474a9b815f584cb69e06_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5aa3078177dd4a78b72f87d219634477_D20200401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19b686e5617c4056bf4f5a81d0e86de8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50b9260334df4b2f857a1e719c97d808_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ProperyAndEquipmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f296060ae9f493f8defee2497cb5fc4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ProperyAndEquipmentNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9081293d8345436495fe616ab903e24b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i259ff7a14ab44385acf1d3dc8b32d84d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25cc54b133f44bc6867c82ea3b1d00c2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b60cc174bb1488b811b3f45e09bda82_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ArtificialIntelligenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13c7509db64a4b76a1499e8339156036_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i369ccdd58842499284be59ca42e369de_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ArtificialIntelligenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0cbe48174104f73982d4a0ca2a3857e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82d4ebf817564c7681dcb7af65622412_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ArtificialIntelligenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae3e6ed3102e4ceb8e24ea8985ea1e38_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5905542a04540b09449e8b542c285c5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if58217de99e6462f8c2e57b616294439_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93c4f1236b564f5bb1675e3e16faecef_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida57b41fb8dc4945a8405b5de4684833_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab8bcaf8f78f44d39aaba69d6770467c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie75b01796cbf464f8e6be437e129e127_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:PatentAndTrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11f4b30281c144d0ad846555d53b95ab_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:PatentAndTrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0951dd5e901c4dca8d4d713eebf12539_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedTechnologySoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id515d4eb95a4477a9767fd98d4ee59a6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedTechnologySoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f5ffc61061348a08dd5cb2414b976aa_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bc3cf8be0c742bfadeb1994780ffa21_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18f2154ea6514a0d9c02f237b9630268_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie29af3730fb445a08f77db24069ddaf2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f27bb8d1da34982b392c9596891b7ea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfc8d3dc08704d95ac2a3367f23db6ba_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4f9799f448c40938b0f4799f0dab913_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22f1eef02031411cac17b094592527ee_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1117258b4fb43f699a2f7f3415be208_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46bd0ff499564277b884f9a7be8f681c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i827b8872571a4f11aa439a07047d7c3a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:PatentAndTrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cbf83bd8a364fc4a600170db5d5f26c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:PatentAndTrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i543e313dd7ca47d3adf0f80f8df4018c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedTechnologySoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9372083139794fde97d33c195ed380f7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedTechnologySoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie74daf4e113844e9a3ae6e83d17dac2f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie55468e7e99d494d912000e2264a206a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac10bef62a4043318e0782f47e41f58d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d21764379a54e939ddab4e98c95e66a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9f162e3c0384b30924c94f3ad53ebae_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="incentiveplan"><xbrli:measure>rdnt:incentivePlan</xbrli:measure></xbrli:unit><xbrli:context id="i9099259394b94e1e889dc1476f075a27_I20210415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7309a2667674a92a4cc3eeb4825b42f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e2bb9a95d4d4802b2e4a3cc0aebe6ab_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0db9c5249a94190ac881fc140ab7671_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="agreement"><xbrli:measure>rdnt:agreement</xbrli:measure></xbrli:unit><xbrli:context id="i15eafbad7ffc4c0d940511464f11e6e8_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f647f27d1a94bd2971692b3e87ff615_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb12196c225347c6a543f74457559713_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ace4524b6974e138856ac8172419ae1_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica6e378192f34ceb847f8a3feae3fc4d_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i965b8fc567f2478dba186b27fff59b4a_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic22a4427ddba4a24b4b6ff3818dea43c_I20200701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i999c3e86ee8240ccb38c00170156728a_D20200701-20231031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1feee914475c47c19d03bc69138716ee_D20231101-20251031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2025-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i973513e4e5fe46adadaacc2b2fd7052d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8c2f246c0df4407bae5f83b9dea4895_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1c807c6ae09463bb238f4f90ec7edfa_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d0fb067263842908a465a961d0de307_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7f7fa2072f04702b6070015044cc329_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i014cf416eb05406dbacef4beed33f8c4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8290c625ae1c431faf7a99cf4dcee8ab_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d8e8b09e9574606ab6241afc0829c86_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbba037786a84b888dd30f858c80bde1_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="loan"><xbrli:measure>rdnt:loan</xbrli:measure></xbrli:unit><xbrli:context id="iee8168439bff4dcc928d2f0538a23ea5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6e9460c493149e6bd8bb71cb47a94dc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31f77a27a2e24b72a13b080caab47d8e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3d36b3137cf48c1b491cd5b202fbcdf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd948f656ced403e875b56f896581911_I20221001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bdb93152d774671850e526671c6aec3_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if10663cad4164b7d819dd600043b536c_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i066eadbb98a54c6480345b29b400d31f_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dd2d7518a4f46b4a60489e1be50cf79_D20221101-20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefc3e607700f46539886f8ce5ac3a6fe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i173b6797abf9418b9ce2d7294d426b24_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2acb391edb584f9991ed018864e62fdf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdfb2358240e4c36b0c1df5fddf49bd7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6697f341173242ddb3318ebb20797960_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie485aedb3f5a499890201c380e948451_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35969f93dd244ab9975ff3d03ff35236_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i287bda58ab4a4749bc53627ff756795d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia76a78ff4e864951a5ad37cf84296e9a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11045551fdb3449782344178a2ef73d6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93c2f0e988bf4215ba9dd9160be1bc52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51f5b3ddf736445e83e7bbca68c313c4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i058ba722d17f465ca2784c234195b2cb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d7f845cf42440e69575e47031da49f1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53894f1fe8a84432ab52b5a5b819bc93_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bb3938f8e9245c69f2103134c886ddc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f3f9c5a69554b138e8af5ee50845912_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17af87ec48d045ecb8769ad083958efe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8af6e51430bf454182807a0000e29d75_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3bfe53a05d7443eaebd569b9c1fffbb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fc55aa9a8f74f6e9d0a7f9ee6911a37_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a1961ca97b748dd97f76e81cefd372a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1cd387ced7b4e0ab675250e1043f341_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if254894b76e948059a1f851aac708545_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d9c210824bd498595db6f8ea56f2975_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idab0c26ccbb3431a83faffea0666ec73_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5324382fed8640319b97df8ad78e78da_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0f8ba61c5d04db397ce5b6e04306b7e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0eacec98a58d4cdda3f139bb7a0de027_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22e2dd058697401197f55bd60a4150ee_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i333584db5d0c4718a15a9336dd0ec38b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5422c8baca9649c8971a2171b71a5b0e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bc5a6bf23e24e448e14f910984a448e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85f996450ac44be3a585f3df56209db0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1418728f3764d51ae66362b3b005736_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e1fc62ee042414286344a73cb1100ad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b566bef11524caba9939adb72309fb2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e6a1bf96f13445c9ec8f1d1017b808f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ddcffccfdaa4e738249bb0f26ff8fd0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d7b50a32ec649b6bd1731fb1173bcf9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0fffd4237ac4587a0961b2f15478644_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5766c50c6d7461c835635f1c6343841_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bb97ef0c9bf4fecbcdce0085a7cd336_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i040b12c6fad641ae884cad957f2cfe40_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d6937e646b24c1c851fae386ba9607f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ee8e2a0aedf4e16bfc1f00854be3504_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74aaf1e8f24d470db2a98ecc203f2374_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f8b6f8b3773411ea71c13b60855758a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic66c83d188f04d7dafa027910df93466_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9fa9f6b4e3e40648840c75270131b86_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8091047fc1324ea98cd25d50961b4676_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic18ea46b2e144ce8bb4730330b274ca4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rdnt:ContingentSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f64f3acfb1b4f8d905cf0d5b3f16ff6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rdnt:ContingentSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>rdnt:security</xbrli:measure></xbrli:unit><xbrli:context id="iadfab3b66cc3465da1facc6280643211_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c812255b96e466a813bee1f44c493df_D20180201-20180201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-01</xbrli:startDate><xbrli:endDate>2018-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icff909ad5af946f582998f2b08a3332f_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i060d61245cc645109b4d1d8bb44ab6bf_I20191221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib78892651f964e84abae349ff967869b_D20191105-20191105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:WhiteRabbit.aiInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-05</xbrli:startDate><xbrli:endDate>2019-11-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="jointventure"><xbrli:measure>rdnt:jointVenture</xbrli:measure></xbrli:unit><xbrli:context id="i976bed9367284ed1a85563a07d391884_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22cb4964ff984901bd7110c2d6eecce4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97bd8c7f570042a88fd03a8a7dca61be_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a7007c50a3b4e91aede5d39ed591d0d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ec59367bdfc4e95acaca6780a70c7b4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:JointVentureInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafd6cdf3d5ab422fae40a0ba5aedb8eb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:JointVentureInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i370e4f75f34c4628af09b09b3f73bf92_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0a61645bc4e4f3e9911510a2c98ef50_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i788654bdc6144e84b022463f3c939653_I20230101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:CCDGLRSServicesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf90602139824e3f84f725fcb7a55b86_I20230101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:SouthernCaliforniaDiagnosticImagingIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf3a349f994e4b7c8b647f364de53930_I20230201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:InglewoodImagingCenterLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if677eedf1e8441f48af5d0ec930fda69_I20230201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RamapoRadiologyAssociatesPCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd669e75c1d64607a8a4a42d825b5372_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0df0cc0c59df4b2f96629acaa138268c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2afa7782c90e43af8a9291b388ae0a30_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id46e5c5dde784886904adce4e0b992aa_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ac0a47d40fa44da84be66fbe8b675c2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if935da71de9445f7a64decc4aa12e4d7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2ee49b2f311482e92604c71016505c9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c3b439894a24feb9d3346baa502e442_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62f2d5d6e38947cebfe0535e07397150_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:EquipmentNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ec02cff0bb7403d93c06ed1115db776_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:EquipmentNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff74038af72140fba140e6ea501d015f_I20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafa7ca073c27455da1ef23c17f9d1eaf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27e434031da1489c8d9bbda89a5969c6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic21b3f13e434406ba1275f4ac33a277e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bdf271a43584924822139b8fb9380b0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfa89e509e1e48328e0d64bb2910a9ae_I20230327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:OneMonthSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96f81a7f32d64009b629b9ef4859f993_I20230327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:ThreeMonthsSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42b5a1db32b749cc972364acdd9c9644_I20230327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:SixMonthsSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie71f440e2c7643508c28e8a01a00242c_I20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc1ca11c511b475ca49c7b77c92736bc_I20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7ec32e42eb944bb9330cd1cb04f945c_D20210423-20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-23</xbrli:startDate><xbrli:endDate>2021-04-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bc539faeadf438fbd7d4d1552f9881b_I20221007"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8827e76d9d944f0c83ab889ff9b40970_I20221007"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2949ad265aae416b895dc287e1c90a56_I20221007"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a4b8e05477244e69f17430f41440f40_D20221007-20221007"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-07</xbrli:startDate><xbrli:endDate>2022-10-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f4de3e0b12c4ce99436f199560d928d_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc503ebed81d4c76998b856dfa54a9b5_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5832838df87478bba175d9f9ab09d12_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb58ba96caad4ba7bb0c8651dbcd3083_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i489017a84c394ba39520152a49aa8cda_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb4c174e094d423b95626eb584086fe6_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84d7aa7a0eb0454e91b9f2219e820140_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5a73f30657642bda3a4e7fae521a479_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib440cff642614ebfb76342cdb0207f49_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7d124de1ada45beacf97bc0d67b1168_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fd2d5ebfa4446888fa605822721f229_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb2039ca234941c2af241afaa4dd085a_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaaf8454b0ae42a5825cbd6024216629_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8045fe5cfc84ac08c6a0c898079bdde_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d3c803e6a4b4fa7b9264589b4154b82_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4c088461a3c4c95a93abef9e3f00c29_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3de3948a63bb469ba713d1ada7005b41_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8335fa556c04b78865bee76634b9ff7_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i324536b68eb244a7b90b0a3ba932bb6a_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55a8765735c14513a443454a717b1110_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ba2dd225829444a8f3c676b6fd16f76_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id30c357b819f411f883897ece82a2ee9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60ee747f054f4a7fa53e6ca0d30f6fac_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida485f8e22d14a529a4301403a5a90a4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61d0d3aa77e94d1e8d2fddb57f6be350_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58b95ffabd8f4ce5a478e21bfbc7b17d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dfe80ca8754497ba1f5422326933310_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd37700473c648cbbf786d4b1f0c907d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:OneMonthSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i771d845d28a0407987c7a78f55f3c8ac_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7a1589942bf4d659b4c2a4bbeb48cb0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f1da3a1ad334f35988ca6282aa57b99_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfd92754a11641c3b9f84f0578f4bc74_D20230331-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-31</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbe38301ce1249c88966ffa550df3678_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24c9c233e2a54c57a8964647449f94d6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d5747c3ac914bc7a1e6aa46bd3d149e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i903948a537d64b37b67178fb25e84ed9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10cefc40b0c44d8cbc4372fcfb77562b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07e3281e1e824c3d97f67f8ac8a57bd4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48658f8cfbcf4487bc406a287ad83c2d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb9196414c2f47f29fa015cf40d76abc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if01c31d758364150a9bb3ce7cd850ca4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf860e6898d344c0a7a4962ee596f36d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44d10d8940d34f76ab949ea9ed5bbdc3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4bd4668c12145b1bdf1773fe1c0b99e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaae0769addc4e53bad052090529ee90_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie97a081dfdc74b2dac6dc6743edad186_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee7b9274694a4e7fbfba10c74d1e9f2b_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97202989895048c6b3682a076c3a5dc3_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i034e56b7f7854922a502eefa5771dc2a_I20210610"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if953ce5e5d654143a5f27fbf0c7a8bcf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i552d69a649564205922349013a84c526_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26ed0c3bb3bc4dfca4136d54d21385d7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ced063bc27e4d249a4e8c5f2627065c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i603724082df64ed1a5f7a54cc923b37e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebc09a78aa3040b9b0079b356035fa32_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75c6b8d0c0664a95a8cd0428ddf549df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16e7a48c2cb34748acb734708003ddda_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b2d16ac66924839910f548784911842_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idca80d4271d24fc3a40ba5927cee3bbe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8816a5b45bc14eeba46c2e754bf6809a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a719cbef35d464180bcd3fa66af85f8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4df50bb1eea438187c006139af9358d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:FutureServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3baed7f4af1344d989545d489662cec2_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="tranche"><xbrli:measure>rdnt:tranche</xbrli:measure></xbrli:unit><xbrli:context id="if430b6d648944e90a7a4d909825414d6_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic141fc5027bd4033a301df773b032bc0_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20728da098554c3492944bc24dc7bedd_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7d7b27aecc643be998969b03dbed528_D20230101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29265dd33e844d5a8bbc1d746f6353ac_D20230101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i375bf56db89c40ecb67521134911bf52_D20230101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia74217dd8ba14406bfc31c3b148192a3_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6809d4048aa4a35b513b76bacbff9df_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78302aa8284649589fadb30185381e93_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fb7ffda1bf04655ba1b20ddc4c4aab0_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a2bf0a508d6442ca467b195bdef4273_D20230101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50a36f080a554744add73eda4ce89019_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52e51b40e55a4447973325a56d0ca1aa_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibac46b5931104d75a9811d327fb9c53d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78c12519a4964a51b7deba80b2e9ae56_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cfa0f61545742ee999c634dad4b4b76_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i041f68f3d9614026814745b94c47b8c7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5b043dd93d14bad91a507a5b7da5817_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if318a573f95e4e07addbbbfb9543d1c5_1"></div><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQw_7cea45bf-859e-453b-b12a-1a6a5db99cd2">10-Q</ix:nonNumeric> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Mark One)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQ3_c00d5dde-a915-4d81-bd93-3807822f35fa">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQ_ef335a64-5003-4281-81f9-13999e835d9e">March 31, 2023</ix:nonNumeric> </span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span></div><div style="margin-bottom:10pt;margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQx_ba65a21e-17ad-406a-bb07-f1e5620fde1d">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:10pt;margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQy_a112aef3-36f0-4068-a187-1ed3de94e7f6">001-33307</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjM5_fa9edf49-f013-49c2-90b4-85f05e6ac125">RadNet, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.865%"><tr><td style="width:1.0%"></td><td style="width:26.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.322%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6N2QzYzdkOTBmZDJiNDAyNjhlZDIwMmQzZjA4NzNiODAvdGFibGVyYW5nZTo3ZDNjN2Q5MGZkMmI0MDI2OGVkMjAyZDNmMDg3M2I4MF8wLTAtMS0xLTU3MDcz_7fa5dc69-3c5e-4594-b125-49c7349fc0ef">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6N2QzYzdkOTBmZDJiNDAyNjhlZDIwMmQzZjA4NzNiODAvdGFibGVyYW5nZTo3ZDNjN2Q5MGZkMmI0MDI2OGVkMjAyZDNmMDg3M2I4MF8wLTItMS0xLTU3MDcz_48eb6980-64cf-43d5-8d17-a174b7f9deda">13-3326724</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:5pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6N2QzYzdkOTBmZDJiNDAyNjhlZDIwMmQzZjA4NzNiODAvdGFibGVyYW5nZTo3ZDNjN2Q5MGZkMmI0MDI2OGVkMjAyZDNmMDg3M2I4MF8zLTAtMS0xLTU3MDcz_4ffe3ffd-8264-426d-bf3a-611c9a8b7722">1510 Cotner Avenue</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6N2QzYzdkOTBmZDJiNDAyNjhlZDIwMmQzZjA4NzNiODAvdGFibGVyYW5nZTo3ZDNjN2Q5MGZkMmI0MDI2OGVkMjAyZDNmMDg3M2I4MF80LTAtMS0xLTU3MDcz_adabd29d-fd49-48a2-a7cd-7fa8f10d3eb7">Los Angeles,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6N2QzYzdkOTBmZDJiNDAyNjhlZDIwMmQzZjA4NzNiODAvdGFibGVyYW5nZTo3ZDNjN2Q5MGZkMmI0MDI2OGVkMjAyZDNmMDg3M2I4MF80LTEtMS0xLTU3MDcz_a341c96c-9697-496e-b52c-bf91f97573c9">California</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6N2QzYzdkOTBmZDJiNDAyNjhlZDIwMmQzZjA4NzNiODAvdGFibGVyYW5nZTo3ZDNjN2Q5MGZkMmI0MDI2OGVkMjAyZDNmMDg3M2I4MF80LTItMS0xLTU3MDcz_3702e269-d644-49ef-9f0b-2c3df85c9eb2">90025</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQz_283adce0-6f6b-4ea4-88b1-ed78703dadea">310</ix:nonNumeric>) <ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQ0_5006d701-1c1d-455a-9144-7ef6fda89a1d">478-7808</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.166%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Registered Exchange</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6MDhkZTFlYWU1ZTM0NDVlN2FkMTViYTFkMzU3OWU3NDgvdGFibGVyYW5nZTowOGRlMWVhZTVlMzQ0NWU3YWQxNWJhMWQzNTc5ZTc0OF8xLTAtMS0xLTU3MDcz_565c424d-9197-47f2-baa0-de00980edd3a">Common Stock</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6MDhkZTFlYWU1ZTM0NDVlN2FkMTViYTFkMzU3OWU3NDgvdGFibGVyYW5nZTowOGRlMWVhZTVlMzQ0NWU3YWQxNWJhMWQzNTc5ZTc0OF8xLTItMS0xLTU3MDcz_5cc08ffd-cf59-42ef-81d3-bd5ac798aff9">RDNT</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6MDhkZTFlYWU1ZTM0NDVlN2FkMTViYTFkMzU3OWU3NDgvdGFibGVyYW5nZTowOGRlMWVhZTVlMzQ0NWU3YWQxNWJhMWQzNTc5ZTc0OF8xLTQtMS0xLTU3MDcz_97fb3bd3-ca91-41ac-aba9-477c64bac39a">NASDAQ</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQ1_e7ed9400-cde6-472b-b786-67a6c063ae11">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;<ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQ2_7dc4b746-7daa-4cb4-8e5d-da6dc08d2197">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.218%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.059%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6YmQ1MzMwOWJkODYzNGE5YTk1ZTQxNmU2NTE0ZjI0ZjYvdGFibGVyYW5nZTpiZDUzMzA5YmQ4NjM0YTlhOTVlNDE2ZTY1MTRmMjRmNl8wLTAtMS0xLTU3MDcz_dff21e54-9d16-4158-8060-5cf70aff04dd">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6YmQ1MzMwOWJkODYzNGE5YTk1ZTQxNmU2NTE0ZjI0ZjYvdGFibGVyYW5nZTpiZDUzMzA5YmQ4NjM0YTlhOTVlNDE2ZTY1MTRmMjRmNl8xLTMtMS0xLTU3MDcz_77363525-789f-4fef-ba85-bb09ead3add7">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6YmQ1MzMwOWJkODYzNGE5YTk1ZTQxNmU2NTE0ZjI0ZjYvdGFibGVyYW5nZTpiZDUzMzA5YmQ4NjM0YTlhOTVlNDE2ZTY1MTRmMjRmNl8yLTMtMS0xLTU3MDcz_cab58244-eb4c-4eda-9410-9f03771769d7">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#9744;</span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)&#160;Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8zODQ4MjkwNjk5NDY1_29313771-3b69-4c77-88d8-c5d24c8ac151">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s common stock outstanding on May&#160;4, 2023 was <ix:nonFraction unitRef="shares" contextRef="i49b54919f837402b828c88c2fb78a373_I20230504" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjMw_edad0482-64b0-4d94-809f-00a8f9ef2e26">58,345,891</ix:nonFraction> shares.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="if318a573f95e4e07addbbbfb9543d1c5_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC.</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:91.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_10">PART I &#8211; FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_10">1</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_13">ITEM 1. Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_13">1</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_16">Condensed Consolidated Balance Sheets at March 31, 2023 and December 31, 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_16">1</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_19">Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_19">1</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Condensed Consolidated Statements of Comprehensive</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22"> (Loss)</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22"> Income for the Three Months Ended March 31, 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">3</a></span></div><div style="text-align:center"><span><br/></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_25">Condensed Consolidated Statement of Stockholders' Equity for the Three Months Ended March 31, 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_25">4</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_31">Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_31">5</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_34">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_34">7</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_61">ITEM 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_61">26</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_91">ITEM 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_91">39</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_94">ITEM 4. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_94">40</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_97">PART II &#8211; OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_97">41</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_100">ITEM 1.&#160;&#160;Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_100">41</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_103">ITEM 1A.&#160;&#160;Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_106">41</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_106">ITEM 2.&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_109">41</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_109">ITEM 3.&#160;&#160;Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_109">41</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_112">ITEM 4.&#160;&#160;Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_112">41</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_115">ITEM 5.&#160;&#160;Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_115">41</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ITEM 6.&#160;&#160;Exhibits</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_118">41</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_121">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_121">42</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="if318a573f95e4e07addbbbfb9543d1c5_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1 &#8211; Financial Statements</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CURRENT ASSETS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cash and cash equivalents</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNC0xLTEtMS01NzA3Mw_2cc9dd1e-ad12-41cb-80b7-46e723e37ba3">90,844</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNC0zLTEtMS01NzA3Mw_919b18e4-3a52-494e-9bc6-61cb9b993fb0">127,834</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNS0xLTEtMS01NzA3Mw_a3c5b070-11f2-46ac-98e1-606876777b16">176,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNS0zLTEtMS01NzA3Mw_53243e01-a6fb-4e7e-ba0e-565698a12522">166,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Due from affiliates</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:DueFromRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNi0xLTEtMS01NzA3Mw_ec10ad6b-c718-482d-a727-dca1a55488e3">20,387</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:DueFromRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNi0zLTEtMS01NzA3Mw_4de7004f-2dcd-4d87-852f-501024c0ea43">18,971</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNy0xLTEtMS01NzA3Mw_64ff3379-6c98-4491-99ed-ab2a0dc7472a">55,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNy0zLTEtMS01NzA3Mw_15869f87-80aa-4a0d-b092-6fb12196c3e2">54,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current assets </span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfOS0xLTEtMS01NzA3Mw_a929d5d0-15b9-4e6f-833a-1a0f553b7e29">342,685</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfOS0zLTEtMS01NzA3Mw_5b9372f5-d6cb-4f21-9e2f-e8b70412107d">367,184</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Property and equipment, net</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTEtMS0xLTEtNTcwNzM_a83c8b75-ce77-4c7c-84eb-d2669c2865f8">545,492</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTEtMy0xLTEtNTcwNzM_cf3d45a2-4fec-4bbd-90e8-4256b349e14a">565,961</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTItMS0xLTEtNTcwNzM_87cc9eaf-0564-4f22-afcd-a2a091fc025b">623,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTItMy0xLTEtNTcwNzM_6964f3e6-0ba6-477c-8a81-f09be14d8958">603,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total property, equipment and right-of-use assets</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTMtMS0xLTEtNTcwNzM_007fe57a-4c44-4285-a02e-3cc299a1742f">1,168,801</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTMtMy0xLTEtNTcwNzM_9b04f39a-5472-4253-bbbe-147cd98647dc">1,169,485</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER ASSETS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTUtMS0xLTEtNTcwNzM_5e5df33f-4db7-4403-a972-4df33b0fe2b5">687,085</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTUtMy0xLTEtNTcwNzM_f8358bc4-b91d-4dd7-bf23-d9d11fc98534">677,665</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTYtMS0xLTEtNTcwNzM_2ac58116-4526-4cef-8395-195252fd8fa9">103,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTYtMy0xLTEtNTcwNzM_593e1c38-6b2e-4ba8-904b-e162b2a9c29d">106,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred financing costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTctMS0xLTEtNTcwNzM_9e847b10-ccd7-4525-9864-e2660ebc8573">2,122</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTctMy0xLTEtNTcwNzM_d51ef516-ccde-4078-83c7-2ab670e96c42">2,280</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Investment in joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTgtMS0xLTEtNTcwNzM_7830bd2d-c825-4715-9870-866862cff27c">59,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTgtMy0xLTEtNTcwNzM_6a9c2863-c2b3-401d-bbdd-416280767f12">57,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deposits and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:DepositsAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjAtMS0xLTEtNTcwNzM_fe10e992-c907-48f4-a8f5-757f539eba00">51,052</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:DepositsAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjAtMy0xLTEtNTcwNzM_7d87b27a-cc78-4951-bf1a-7b4755ff4434">53,172</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjEtMS0xLTEtNTcwNzM_d8302c8b-982f-4bcd-bced-586454043290">2,414,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjEtMy0xLTEtNTcwNzM_56fe9b92-ffd4-46d0-8e12-3eb973514d99">2,433,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CURRENT LIABILITIES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accounts payable, accrued expenses and other</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjQtMS0xLTEtNTcwNzM_6ea57cf6-abb4-4736-b393-cc1c1aa111e0">296,727</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjQtMy0xLTEtNTcwNzM_7db3b826-1a31-4b06-9259-40d3886c51a6">369,595</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Due to affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjUtMS0xLTEtNTcwNzM_5e09d495-c425-49a6-bc82-12ce114af436">31,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjUtMy0xLTEtNTcwNzM_bffd112d-47c6-44a4-9e78-22f2a94d12eb">23,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjYtMS0xLTEtNTcwNzM_f029e480-ab21-46aa-9695-54d13b09b160">4,343</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjYtMy0xLTEtNTcwNzM_7523dc39-cc7a-4265-89c8-f836141abe96">4,021</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Current operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjgtMS0xLTEtNTcwNzM_5fac224e-272d-4786-9156-3f750baa407d">58,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjgtMy0xLTEtNTcwNzM_4d96139b-ed0c-4bb4-a1e0-5343eff518bf">57,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Current portion of notes payable</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:NotesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjktMS0xLTEtNTcwNzM_50bcf879-1555-4b58-b3a0-23ffc222f6a9">15,935</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:NotesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjktMy0xLTEtNTcwNzM_ab38e699-948b-467e-9ac4-f52e75f1aeb9">12,400</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzAtMS0xLTEtNTcwNzM_c4f981c5-f869-4209-8bee-223e386d7145">407,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzAtMy0xLTEtNTcwNzM_8c44aa8a-48f2-429d-9bbc-8177c24a25d3">466,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM LIABILITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Long-term operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzMtMS0xLTEtNTcwNzM_abacd9a5-0a63-4933-8732-707d8d405add">623,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzMtMy0xLTEtNTcwNzM_6626b9c5-d479-4c31-a4aa-9ab4f201e29d">604,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Notes payable, net of current portion</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzQtMS0xLTEtNTcwNzM_264d6339-5bbe-49ca-8c4a-dbd3b72b5af9">852,354</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzQtMy0xLTEtNTcwNzM_9fd17a19-a62d-4c93-8c1d-d106ff3f122a">839,344</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Deferred tax liability, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzUtMS0xLTEtODAzMzc_cc15e556-132e-41b0-a8bc-2a2787cfa2db">10,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzUtMy0xLTEtODAzMzc_6d96c18b-1c3a-4abd-aa0c-2bc5026956d3">9,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other non-current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzUtMS0xLTEtNTcwNzM_de04fc86-9ec7-4638-a721-e5ececcf8cad">27,523</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzUtMy0xLTEtNTcwNzM_2956f1f0-12f9-4a51-9e28-b6fc2c776d9a">23,015</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzYtMS0xLTEtNTcwNzM_34870be8-3631-4c00-a0e6-c07ed732fe73">1,920,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzYtMy0xLTEtNTcwNzM_b97bd0b6-a654-4fa0-8022-6cdf2a2a23a6">1,942,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EQUITY</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock - $<ix:nonFraction unitRef="usdPerShare" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMC0xLTEtNTcwNzMvdGV4dHJlZ2lvbjowODFlMTI0MWU0M2E0OTdmYTI2YTExMTFhMjE3M2NhM18xOQ_691553cb-7732-4231-b3b9-eceb4a84700b"><ix:nonFraction unitRef="usdPerShare" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMC0xLTEtNTcwNzMvdGV4dHJlZ2lvbjowODFlMTI0MWU0M2E0OTdmYTI2YTExMTFhMjE3M2NhM18xOQ_bf7dc29a-c3fc-4306-a7c9-fdf6c69c9ca8">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMC0xLTEtNTcwNzMvdGV4dHJlZ2lvbjowODFlMTI0MWU0M2E0OTdmYTI2YTExMTFhMjE3M2NhM18zMw_56b69b52-a43d-48b6-bcc7-912357f2f77d"><ix:nonFraction unitRef="shares" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMC0xLTEtNTcwNzMvdGV4dHJlZ2lvbjowODFlMTI0MWU0M2E0OTdmYTI2YTExMTFhMjE3M2NhM18zMw_663c734b-5a6d-4c5d-95b8-5f40777a0b4c">200,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMC0xLTEtNTcwNzMvdGV4dHJlZ2lvbjowODFlMTI0MWU0M2E0OTdmYTI2YTExMTFhMjE3M2NhM181NQ_9924a4dc-3ce1-4718-adda-a2a53f962537"><ix:nonFraction unitRef="shares" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMC0xLTEtNTcwNzMvdGV4dHJlZ2lvbjowODFlMTI0MWU0M2E0OTdmYTI2YTExMTFhMjE3M2NhM181NQ_acdb9aba-0395-4f84-9b68-c545eede61f9">58,270,290</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMC0xLTEtNTcwNzMvdGV4dHJlZ2lvbjowODFlMTI0MWU0M2E0OTdmYTI2YTExMTFhMjE3M2NhM182Mg_3c9acd77-5a39-4027-9374-68a4bc5ec842"><ix:nonFraction unitRef="shares" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMC0xLTEtNTcwNzMvdGV4dHJlZ2lvbjowODFlMTI0MWU0M2E0OTdmYTI2YTExMTFhMjE3M2NhM182Mg_f42b97bf-04b2-499a-a9a6-c7401b2ec2ea">57,723,125</ix:nonFraction></ix:nonFraction> shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMS0xLTEtNTcwNzM_a5c36b0b-d395-4d77-96f1-b9a0c319c231">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMy0xLTEtNTcwNzM_97e58089-5a10-4ab5-871d-73fae792df58">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Additional paid-in-capital</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzktMS0xLTEtNTcwNzM_54b0d90c-450e-40f2-8ce2-f2a45d71d31c">448,522</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzktMy0xLTEtNTcwNzM_8069d9a1-a33c-4193-9869-2cd63ad4b862">436,288</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDAtMS0xLTEtNTcwNzM_555dac9d-5a04-49cd-844b-84f8e3a0f5e3">16,978</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDAtMy0xLTEtNTcwNzM_9005680d-f2af-4526-95ec-7ee5b6080129">20,677</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accumulated deficit</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDEtMS0xLTEtNTcwNzM_86faeeec-ce44-459d-9c0f-4282c8b78f2c">103,628</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDEtMy0xLTEtNTcwNzM_1a22bc68-2129-4ef9-b69e-c2719d2d6f2d">82,622</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total RadNet, Inc.'s stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDItMS0xLTEtNTcwNzM_b77ff2ec-1a40-487a-936b-11ae731f7a21">327,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDItMy0xLTEtNTcwNzM_5ded9e9a-c45c-4e2c-b4d2-4ef0ad06dc72">332,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDMtMS0xLTEtNTcwNzM_faff1971-1811-403b-ba65-1f32c804245a">165,179</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDMtMy0xLTEtNTcwNzM_b7c9da44-c439-4a93-ab7d-09887e5548ae">158,457</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDQtMS0xLTEtNTcwNzM_5d448d4a-12b3-4f36-900c-eb0e92ffda9f">493,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDQtMy0xLTEtNTcwNzM_25250923-be78-48c7-bd4c-b7ed3fa9d298">491,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and equity</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDUtMS0xLTEtNTcwNzM_f91d4e90-6954-4455-af26-86562ed85e40">2,414,069</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDUtMy0xLTEtNTcwNzM_1482a19f-2318-4896-87db-f8abc116ed95">2,433,907</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_19"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.584%"><tr><td style="width:1.0%"></td><td style="width:66.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.770%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REVENUE</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Service fee revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6278308e0fe4e9e80559d07f63aa90e_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMy0xLTEtMS01NzA3Mw_73ed309e-71b2-42e3-9bcb-21b14ae6870c">352,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3e3586af214825b747d44b00364a79_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMy0zLTEtMS01NzA3Mw_8865b6ed-03ce-476a-a613-2e8e6e7aaf9e">303,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia605a6d22e64439893da71566768e2e9_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfNC0xLTEtMS01NzA3Mw_aef52ab1-b0bb-4521-8fd2-48e06edd5ae8">38,144</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb7ff594ba1c456380fafa96528d1a70_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfNC0zLTEtMS01NzA3Mw_c640f261-1819-4c80-8b07-4df899b90092">38,491</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfNS0xLTEtMS01NzA3Mw_f0745dce-620a-46e8-8b21-08e5ca26a5bc">390,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfNS0zLTEtMS01NzA3Mw_55ebc513-9368-4491-9282-6fb98ed37667">341,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING EXPENSES</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cost of operations, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="rdnt:OperatingExpensesExcludingDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfOC0xLTEtMS01NzA3Mw_8a4ed7b0-9a8f-46e0-9e62-cf6548b976dd">351,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="rdnt:OperatingExpensesExcludingDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfOC0zLTEtMS01NzA3Mw_eb315de5-f8cb-4d3c-9899-5defeba926ce">315,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfOS0xLTEtMS01NzA3Mw_adab325c-84c5-4874-8fe0-b1766d5468ef">31,315</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfOS0zLTEtMS01NzA3Mw_dfe2acd7-6c9b-4632-ab36-06104a097091">27,118</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Loss on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTAtMS0xLTEtNTcwNzM_f518c1b1-672f-4333-80b1-52af33157315">579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTAtMy0xLTEtNTcwNzM_258f9e77-a485-494f-9fff-510a4e385363">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Severance costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTEtMS0xLTEtNTcwNzM_2539df92-633c-4f1e-8b5f-561aeec51daf">134</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTEtMy0xLTEtNTcwNzM_392122a3-afd1-4d86-8bbe-ed4da965ac9f">201</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTItMS0xLTEtNTcwNzM_dc77313a-8a53-4dc3-8559-dc3760cafbb8">383,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTItMy0xLTEtNTcwNzM_3373f9af-c20e-48b1-9a39-a55476fad2a6">343,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;INCOME (LOSS)  FROM OPERATIONS</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTMtMS0xLTEtNTcwNzM_676aadf2-e4e3-4bc7-aa38-9737ffce3ebe">6,671</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTMtMy0xLTEtNTcwNzM_0972d1fd-013f-4ed9-95d4-35fa313ef9c6">1,719</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME AND EXPENSES</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTYtMS0xLTEtNTcwNzM_b188af0d-79af-40f2-9c38-ee4a7d89db22">15,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTYtMy0xLTEtNTcwNzM_8246996d-d091-4d93-8222-ccd2eeda4213">11,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Equity in earnings of joint ventures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTctMS0xLTEtNTcwNzM_7f569d6d-7452-405e-ba5e-2a4c6ee070d2">1,428</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTctMy0xLTEtNTcwNzM_26a3fa49-651d-43de-ac75-3e0a10ee4ba1">2,517</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTgtMS0xLTEtNTcwNzM_09bfc23e-5c0b-4141-a777-b9749774bb77">4,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTgtMy0xLTEtNTcwNzM_419be03b-d64e-42cb-b3ab-5a4a0a65ae38">20,819</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjAtMS0xLTEtNTcwNzM_ab177296-883e-4333-8e8d-2ded1e44453e">1,432</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjAtMy0xLTEtNTcwNzM_5d2a67ab-7f1b-421f-a48c-2f4284677452">165</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense (income)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjEtMS0xLTEtNTcwNzM_6329c906-d47b-49c9-ad26-eefdb69a442f">19,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjEtMy0xLTEtNTcwNzM_328bf53e-bea5-4173-a9bf-7d2cfb09d8fc">11,578</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(LOSS) INCOME BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjItMS0xLTEtNTcwNzM_b98d10e9-e389-49a5-9328-82777c9232da">13,148</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjItMy0xLTEtNTcwNzM_077a7574-e96e-43da-aa23-13d34f49db8a">9,859</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjMtMS0xLTEtNTcwNzM_868847ea-de4b-41d7-8af8-94676e25ddbb">1,135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjMtMy0xLTEtNTcwNzM_f5816733-bf2f-4bda-a821-19d240058909">1,496</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET (LOSS) INCOME</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjQtMS0xLTEtNTcwNzM_7eddd20c-3ad3-46b8-8dc3-a84bdee4c359">14,283</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjQtMy0xLTEtNTcwNzM_ac0873e6-e864-4b35-af93-23c53f27c3dc">8,363</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjUtMS0xLTEtNTcwNzM_8fedd0f0-1544-4a5a-bd02-f53e642a9e0b">6,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjUtMy0xLTEtNTcwNzM_a8d6b28c-18a2-4fac-8fc0-d30da80487c6">5,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjYtMS0xLTEtNTcwNzM_7652df12-08b0-4235-af04-4033c6a0776f">21,005</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjYtMy0xLTEtNTcwNzM_1e6abe0e-c0d4-4e58-a01b-7600c0c72030">3,013</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjgtMS0xLTEtNTcwNzM_8f9748b8-4c46-4eb1-86d4-4e0d6cd0fdd2">0.36</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjgtMy0xLTEtNTcwNzM_7779acd1-5afa-43e9-8047-f6519e834879">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMzAtMS0xLTEtNTcwNzM_f1bdc465-3372-47c4-8177-f9880c464a14">0.36</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMzAtMy0xLTEtNTcwNzM_9c515850-056f-47fd-bfc6-2a06eb847a68">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WEIGHTED AVERAGE SHARES OUTSTANDING</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMzItMS0xLTEtNTcwNzM_9a4895d3-645d-4f61-b48d-e159533c22c8">57,701,439</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMzItMy0xLTEtNTcwNzM_aa8a4049-48c1-4839-abd7-97952bf83f3a">55,303,007</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMzMtMS0xLTEtNTcwNzM_ae8d27aa-8b95-4010-9619-81ced9ca506f">57,701,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMzMtMy0xLTEtNTcwNzM_da8085fe-3484-4028-bef8-06e1582443af">56,362,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="if318a573f95e4e07addbbbfb9543d1c5_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"><tr><td style="width:1.0%"></td><td style="width:69.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.243%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET (LOSS) INCOME</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfMi0xLTEtMS01NzA3Mw_74622a58-1c04-42ba-888c-2a6a56543ed5">14,283</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfMi0zLTEtMS01NzA3Mw_d327628e-fdf1-4a80-9116-3dc6307f2906">8,363</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Foreign currency translation adjustments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfMy0xLTEtMS01NzA3Mw_9a95495e-a48f-4580-afc2-e07355eed176">2,777</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfMy0zLTEtMS01NzA3Mw_75e89b97-a8de-4da8-8569-69604d1690b1">1,264</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfNS0xLTEtMS01NzA3Mw_ceb09a19-aec8-4df4-a233-1a510bd41b53">922</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfNS0zLTEtMS01NzA3Mw_57d0f977-07e2-44af-a373-71e3159c897c">923</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPREHENSIVE (LOSS) INCOME</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfNi0xLTEtMS01NzA3Mw_5ed6ca93-a200-4ac5-8df6-6beec0c1b5ad">10,584</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfNi0zLTEtMS01NzA3Mw_0915ad55-6e22-4ae2-b53e-7b700bfae505">8,022</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Less comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfNy0xLTEtMS01NzA3Mw_57d5c249-1760-4751-aa5e-c18e583bcabc">6,722</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfNy0zLTEtMS01NzA3Mw_cd492cf4-df9c-4be8-8562-6d47956c3e0f">5,350</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfOS0xLTEtMS01NzA3Mw_50e545bb-b203-409e-8fd8-5ee9bfe24018">17,306</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfOS0zLTEtMS01NzA3Mw_9582a636-d117-4f7c-977b-5330e59efc4b">2,672</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="if318a573f95e4e07addbbbfb9543d1c5_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE DATA)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in the Company&#8217;s consolidated stockholders' equity, including noncontrolling interest, during the three months ended March&#160;31, 2023 and March&#160;31, 2022.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.458%"><tr><td style="width:1.0%"></td><td style="width:28.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.454%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.888%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other<br/>Comprehensive<br/>&#160;Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Radnet, Inc.'s<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE - JANUARY 1, 2023</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91d4a0efd0134db0912cf424c9c05e57_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMi0xLTEtMS01NzA3Mw_d288a3ba-378f-4649-a832-b330aab807e3">57,723,125</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d4a0efd0134db0912cf424c9c05e57_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMi0zLTEtMS01NzA3Mw_605f163a-7331-478f-a54c-95fdc5e08b0b">6</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95b93de2b17549f68c2d1d19032cb451_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMi01LTEtMS01NzA3Mw_f52cbec6-dd99-4f87-8686-f0c68fef56d1">436,288</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c5ed5063e474ba083fe5232406d387c_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMi03LTEtMS01NzA3Mw_c1c9c9ac-7bc0-4f54-a237-ed2da95d2eac">20,677</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i468644d28f544537962de87ccfb1e608_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMi05LTEtMS01NzA3Mw_f988179d-e22d-43a3-b8ad-f54adbc72f94">82,622</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9479ea165b22465ab2af4cc1db0934bf_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMi0xMS0xLTEtNTcwNzM_a74c37d4-c739-49f8-90b7-dff7919b05ba">332,995</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb918f8d0aad4f99a42dbf93329537ec_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMi0xMy0xLTEtNTcwNzM_85eb6a27-4d37-4b5a-b4ce-dd56df369e50">158,457</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMi0xNS0xLTEtNTcwNzM_713ecb95-0aa9-4dd1-ba60-7f8810e57798">491,452</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of options</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7aad81709c2e40bfa6d50e57ba2978f8_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNC0xLTEtMS01NzA3Mw_ba2f800f-c7f7-44d7-a049-a876e5956aad">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0129316a1444a9a87a4f1035890d5e_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNC01LTEtMS01NzA3Mw_5db16ba1-67fc-4df1-b28b-b033177f431f">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca13f2a1d6242bdbe459e60b2e0745d_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNC0xMS0xLTEtNTcwNzM_b6ae02a7-53cf-47eb-b5c1-0dba44266da2">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNC0xNS0xLTEtNTcwNzM_1715f181-1872-4ef5-943c-4c29808c2df8">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under the equity compensation plan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7aad81709c2e40bfa6d50e57ba2978f8_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNS0xLTEtMS01NzA3Mw_11ea695e-62c7-443a-8718-146dc663114a">527,692</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under the DeepHealth equity compensation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i913c1e2479954386a1891ed9fbce6745_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNi0xLTEtMS01NzA3Mw_6022174f-cd11-48c1-ae83-9eee00d2d7eb">14,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0129316a1444a9a87a4f1035890d5e_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNy01LTEtMS01NzA3Mw_09898e5e-678d-4c2e-b963-a6d22ba53802">12,185</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca13f2a1d6242bdbe459e60b2e0745d_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNy0xMS0xLTEtNTcwNzM_ecf958f5-213f-480a-9989-98b31b06651d">12,185</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNy0xNS0xLTEtNTcwNzM_593c4724-3072-41f3-9dce-4fbea966b8f9">12,185</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5adf124c49f04748907d0b7a789a6104_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMTctNy0xLTEtNTcwNzM_8c8d9c14-4110-4d73-87ce-b5b756532cb4">2,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca13f2a1d6242bdbe459e60b2e0745d_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMTctMTEtMS0xLTU3MDcz_b3ba4db8-de7b-4750-b49f-0d2eb568a792">2,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMTctMTUtMS0xLTU3MDcz_2d576f71-62c9-4d47-afd0-a2e1e1ce2561">2,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5adf124c49f04748907d0b7a789a6104_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMTktNy0xLTEtNTcwNzM_27eea0c9-be65-4b3a-8766-52248260d3aa">922</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca13f2a1d6242bdbe459e60b2e0745d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMTktMTEtMS0xLTU3MDcz_1633853d-2bb1-4a28-b24d-3b6dc038f8d4">922</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMTktMTUtMS0xLTU3MDcz_da0a0630-a1f2-4e36-90f8-98a2cc3f76a2">922</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e0129316a1444a9a87a4f1035890d5e_D20230101-20230331" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjAtNS0xLTEtNTcwNzM_627334f8-4c98-4a9f-9141-5f2fa6916299">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3adf6f8648e495e9006502147d4eae8_D20230101-20230331" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjAtOS0xLTEtNTcwNzM_71b76cc5-03a8-4118-a2d8-f19acaf201c5">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca13f2a1d6242bdbe459e60b2e0745d_D20230101-20230331" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjAtMTEtMS0xLTU3MDcz_09fb8e50-ea28-400b-bf95-8cc317236e2f">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjAtMTUtMS0xLTU3MDcz_afa609c2-317d-447d-a43d-5ed079897925">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3adf6f8648e495e9006502147d4eae8_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjEtOS0xLTEtNTcwNzM_7cbf1038-5094-41fe-be1e-71e8d4288ba9">21,005</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca13f2a1d6242bdbe459e60b2e0745d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjEtMTEtMS0xLTU3MDcz_d1bececd-33c8-49c5-a51e-13d399cc5c19">21,005</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48b53158259a45cf99350d972b519d34_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjEtMTMtMS0xLTU3MDcz_4def42ea-6d82-4d95-b3ec-34a52488e08a">6,722</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjEtMTUtMS0xLTU3MDcz_fcaa6826-e0f7-48ed-9621-2fea8824ac8c">14,283</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE-MARCH 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0079ed901cd348488a81abe9066a6c27_I20230331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjItMS0xLTEtNTcwNzM_8e01aa0b-a9a3-420e-a7f2-74e31dafe3e3">58,270,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0079ed901cd348488a81abe9066a6c27_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjItMy0xLTEtNTcwNzM_4734d8b2-1b5d-4701-bcf9-a6e245e22596">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9f6f61fb6774fb88dfcd64fd07c4b8a_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjItNS0xLTEtNTcwNzM_93816d7e-2106-45bc-acb9-77f7e656a047">448,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1c7d6e31a0346089303a191fa0be906_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjItNy0xLTEtNTcwNzM_b8c82857-354d-4fdf-8ba2-d5b5a09c0b68">16,978</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32758e6d4de641c287fa2f616af42021_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjItOS0xLTEtNTcwNzM_4e6419b0-2710-4815-8878-dc5ea62336b1">103,628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf0d0a31a7d4bbeab91318c3504e0e3_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjItMTEtMS0xLTU3MDcz_aad57889-6c2d-4c05-b3f9-85f9b062f340">327,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4127c96bf5a4ca98119ab44d3fb22df_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjItMTMtMS0xLTU3MDcz_2faabb96-6092-4780-94c7-2a31b57db502">165,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjItMTUtMS0xLTU3MDcz_fcea62f2-13c5-4096-bb7c-d7098b2453dd">493,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE - JANUARY 1, 2022</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icd187a7758714339a38596e3b8703fda_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjQtMS0xLTEtNTcwNzM_c053b8f9-5916-4f8a-b492-65febdb11190">53,548,227</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd187a7758714339a38596e3b8703fda_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjQtMy0xLTEtNTcwNzM_78a369f1-bed4-4408-9a1f-d0d3207bbc76">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03170300e04e4c6885da7ab306fe32fb_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjQtNS0xLTEtNTcwNzM_939e4dc0-e4e4-41e5-a583-029b2fe15a72">342,592</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c6492a471c24eb79e884f0d8d9e9ef5_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjQtNy0xLTEtNTcwNzM_44444bd6-14d3-4d4f-bd16-5d193ba581e4">20,421</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idab5203b536348aeb1e033a60b58d92b_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjQtOS0xLTEtNTcwNzM_c1eee391-6294-4354-aba5-bd047e380bf3">93,272</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a4a63e76c7434296690fc94fa7d206_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjQtMTEtMS0xLTU3MDcz_8cc6cd87-e477-4113-8472-d282fa8603b8">228,904</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b87a5ef08b949fd9eced9e15c7a255a_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjQtMTMtMS0xLTU3MDcz_d1a0f0da-7d59-4207-b0ed-7ddca72e9e02">117,253</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i385a0ecd81c14fc5b2842208e1659808_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjQtMTUtMS0xLTU3MDcz_36e74b1c-1adc-4fff-acc8-02ba0924f9dd">346,157</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under the equity compensation plan</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7430f7620cb4b499645b1c4db111fd3_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjYtMS0xLTEtNTcwNzM_81a0531e-632f-49cf-ac67-ec0f5439de28">530,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under the DeepHealth equity compensation plan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbbc7fc6774d480f8cf4ece72ee8d689_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjctMS0xLTEtNTcwNzM_74a9b0c9-52a5-4b5a-adca-84a1b8bd3db8">13,119</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57c8687ae4a54bc7961fd12b87f8095c_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjgtNS0xLTEtNTcwNzM_7085cd73-3c0f-4a29-bead-31ed2136be87">10,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91409c4e3ca453ca3dfd68bcfbef870_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjgtMTEtMS0xLTU3MDcz_79f8b490-6463-4d16-bee7-74740b339698">10,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjgtMTUtMS0xLTU3MDcz_2efb7dad-ff6b-4b10-b177-3e116c1ae295">10,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for acquisitions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7430f7620cb4b499645b1c4db111fd3_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjktMS0xLTEtNTcwNzM_3a19915b-93aa-44e0-b9a1-aa0d6181ce57">2,106,292</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57c8687ae4a54bc7961fd12b87f8095c_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjktNS0xLTEtNTcwNzM_736d193b-3b2f-4856-a61c-b525791b5aff">56,470</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91409c4e3ca453ca3dfd68bcfbef870_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjktMTEtMS0xLTU3MDcz_ea86e2dd-9ca5-41bd-bda8-9f706f49e534">56,470</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjktMTUtMS0xLTU3MDcz_bdb017a1-7130-4c25-969e-afd8a1b7e052">56,470</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1051455c74414445a26e00de581866c1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzQtNy0xLTEtNTcwNzM_dc7a2f9f-d562-4130-81fa-4de9e8fab4d3">1,264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie91409c4e3ca453ca3dfd68bcfbef870_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzQtMTEtMS0xLTU3MDcz_85c14c41-89ac-4de5-86d5-2f1f53846ca8">1,264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzQtMTUtMS0xLTU3MDcz_30c0e9da-1f0e-451f-8c01-29050c0a1750">1,264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1051455c74414445a26e00de581866c1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzYtNy0xLTEtNTcwNzM_a778b517-21d2-4d31-92cb-28686a65a0e3">923</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91409c4e3ca453ca3dfd68bcfbef870_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzYtMTEtMS0xLTU3MDcz_1e880271-6f36-4588-bb53-58d2550164fa">923</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzYtMTUtMS0xLTU3MDcz_b4f16907-39ba-453a-8191-3e8f023c1de9">923</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1051455c74414445a26e00de581866c1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzctNy0xLTEtNTcwNzM_2976eec6-42a0-40c3-93e9-fb9e0818ab55">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibddc1d75b382422a8961f98fdde6c318_D20220101-20220331" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzctOS0xLTEtNTcwNzM_4d449fb4-8284-429e-85c9-56f1b242a1fc">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91409c4e3ca453ca3dfd68bcfbef870_D20220101-20220331" decimals="-3" name="us-gaap:StockholdersEquityOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzctMTEtMS0xLTU3MDcz_85403b7c-adb3-4a65-9c67-9a6e07120faa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:StockholdersEquityOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzctMTUtMS0xLTU3MDcz_85cb1163-b7b2-46b0-a84d-1147981ac5b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibddc1d75b382422a8961f98fdde6c318_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzgtOS0xLTEtNTcwNzM_ac52d9b6-3e37-433f-baf8-bc23e31bc7a8">3,013</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91409c4e3ca453ca3dfd68bcfbef870_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzgtMTEtMS0xLTU3MDcz_87b01e86-aae7-440d-9e94-916c9fae7b20">3,013</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic141cdf85619420ebcf66d35adb457ca_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzgtMTMtMS0xLTU3MDcz_77143f66-b5ef-433a-b290-1b58b271802b">5,350</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzgtMTUtMS0xLTU3MDcz_7452029e-077c-4370-b080-ba6e8a29679d">8,363</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE-MARCH 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc0bf32b28e24d0aaab1535b72796e85_I20220331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzktMS0xLTEtNTcwNzM_c086254f-43f1-4550-9fca-20223de8f746">56,197,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc0bf32b28e24d0aaab1535b72796e85_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzktMy0xLTEtNTcwNzM_2f967b59-9c1c-4fae-8e4b-7a63fa869caa">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8fc8460d0049568d657a5449e9ce3e_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzktNS0xLTEtNTcwNzM_71c13ac5-e3c6-4792-8854-60cdf9ea498b">409,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i622337df6b2342b8bcf81a0bbf78cfee_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzktNy0xLTEtNTcwNzM_8f168e64-8be5-4285-ba4d-8f6abc6e7aba">20,761</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i210a11d3d8e44324b361e34bb30b96fc_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzktOS0xLTEtNTcwNzM_28c2f8ef-a13f-4db1-bea3-2d179e00695e">90,260</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7ef23f5cc14489bb2ae2e8a17d5ac8_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzktMTEtMS0xLTU3MDcz_97d2284d-ed2d-4107-bcaa-337af5eaf57a">298,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec1a7c8f9b74641a09c0fc25654b909_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzktMTMtMS0xLTU3MDcz_f2d8ffe7-474d-40a7-8ac7-3b495dbf9e07">122,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80882b4f5c6a453fa389846657050098_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzktMTUtMS0xLTU3MDcz_1dbdcda6-d174-4264-84bd-e874cd231492">421,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="if318a573f95e4e07addbbbfb9543d1c5_31"></div><hr style="page-break-after:always"/><div style="min-height:24.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.218%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMy0xLTEtMS01NzA3Mw_42d381ef-13c0-4a50-a075-502df63ccd10">14,283</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMy0zLTEtMS01NzA3Mw_0e892015-0a67-412f-9452-a14a44254d64">8,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNS0xLTEtMS01NzA3Mw_a0ddd216-4c3c-405f-8189-a9cf8d8c0a88">31,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNS0zLTEtMS01NzA3Mw_a71dd938-b0dc-435a-94df-3bfc6839a223">27,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNi0xLTEtMS01NzA3Mw_7df9202e-21cd-4b72-be56-04d4db26692f">15,699</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNi0zLTEtMS01NzA3Mw_dbc9fee8-df4b-4d2e-a9d1-a56784431a83">16,802</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in earnings of joint ventures, net of dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNy0xLTEtMS01NzA3Mw_9ca22123-0987-4e58-b9bf-a51d6884dc03">1,835</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNy0zLTEtMS01NzA3Mw_c29edb9a-14d3-4b33-831f-ca75cd5aaede">2,517</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of deferred financing costs and loan discount</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfOS0xLTEtMS01NzA3Mw_e1f21564-3e10-489e-bfc8-954a88ff2bca">746</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfOS0zLTEtMS01NzA3Mw_97e8ca3c-2b6f-4a18-be2b-cd575df2c77b">648</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTAtMS0xLTEtNTcwNzM_f12ce7e6-806d-4205-ba0e-c86c13333cc6">579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTAtMy0xLTEtNTcwNzM_8f27e1b7-066a-4e79-bec1-2826cce44c11">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of cash flow hedge, net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTItMS0xLTEtNTcwNzM_a924267e-0156-40f1-a09e-3c156c36be01">922</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTItMy0xLTEtNTcwNzM_10e09b41-1b28-48c3-a508-07a737fb0d40">923</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTMtMS0xLTEtNTcwNzM_a66f1429-ad99-4d1b-bccf-df809234641e">4,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTMtMy0xLTEtNTcwNzM_6d3cc379-6ac2-4e17-a562-44bd2b5decbd">20,819</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTQtMS0xLTEtNTcwNzM_5bdde31b-e8eb-402e-b31c-c7d173535afa">12,185</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTQtMy0xLTEtNTcwNzM_dc530ec8-9e29-48fe-bd83-8859e654bd80">11,102</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTYtMS0xLTEtNTcwNzM_8e9db33b-8d7d-4f3c-b1e0-ec9fdc529ba9">2,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTYtMy0xLTEtNTcwNzM_fae2950e-3919-447e-809b-bda8ccface8b">501</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTgtMS0xLTEtNTcwNzM_419c52b8-8514-44e0-aedf-d1e1cac27d44">9,997</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTgtMy0xLTEtNTcwNzM_146b17dc-9a35-42e2-91c3-39a03540f38a">23,904</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTktMS0xLTEtNTcwNzM_8f075d8c-3023-4ffa-874f-fc65898da9a6">1,691</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTktMy0xLTEtNTcwNzM_1ea5e45c-328b-4ef2-b085-8e4f3eb9f98f">4,065</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjAtMS0xLTEtNTcwNzM_18456ba3-1a64-4825-aba7-09eedbf82342">2,726</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjAtMy0xLTEtNTcwNzM_d55b61f8-cea1-48f7-89fa-855a157fcc62">1,417</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjEtMS0xLTEtNTcwNzM_ba332966-1ee6-454e-b624-3c41b9b9ade2">942</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjEtMy0xLTEtNTcwNzM_051700fb-903d-43da-a726-5ae1d48b592f">1,387</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjItMS0xLTEtNTcwNzM_f499e08c-83db-4e95-abec-ae11623d19ce">15,080</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjItMy0xLTEtNTcwNzM_b39c7652-9150-40bf-86eb-0825e8a9486d">15,859</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjMtMS0xLTEtNTcwNzM_1794adda-76c4-4e4f-a1af-6036393e31e5">335</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjMtMy0xLTEtNTcwNzM_5e38f59a-0177-4fc3-a7d5-6b41ae695f38">4,519</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjQtMS0xLTEtNTcwNzM_42426260-90ec-47ca-b058-c4fe9bef6c34">9,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjQtMy0xLTEtNTcwNzM_5e899d98-3dfd-425e-963f-9313a1ed417c">7,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjUtMS0xLTEtNTcwNzM_236b1678-faa3-4890-a337-534a4ac28319">32,616</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjUtMy0xLTEtNTcwNzM_02986aa6-65a4-424f-beb0-f128b942053c">901</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of imaging centers and other acquisitions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireBuildings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjctMS0xLTEtNTcwNzM_a1258b01-39d2-47cc-985d-abfaab350ce7">9,644</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireBuildings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjctMy0xLTEtNTcwNzM_2fa05887-3c29-414d-bf36-911636ca3c53">25,123</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjktMS0xLTEtNTcwNzM_7e2c1646-dbcf-44f4-9852-d8dd2374079d">55,915</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjktMy0xLTEtNTcwNzM_95843963-fb45-4e76-af7e-a6d24edbb9be">36,558</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMzAtMS0xLTEtNTcwNzM_f360544b-94fd-4418-af26-0c8048949b26">3</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMzAtMy0xLTEtNTcwNzM_7be47a5c-cf5f-4828-8957-40c4a81881df">117</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMzQtMS0xLTEtNTcwNzM_9539c72f-b0b9-4cd6-a744-5a11a6a11c07">65,556</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMzQtMy0xLTEtNTcwNzM_838395dd-9976-46dd-992d-c5016b26b0ca">61,564</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal payments on notes and leases payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMzYtMS0xLTEtNTcwNzM_48a36a82-7057-4a1d-8459-68771e467eb1">184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMzYtMy0xLTEtNTcwNzM_3214b62b-31e1-49d9-aa47-5cc0c5fad797">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on term loan debt</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMzctMS0xLTEtNTcwNzM_57fd9484-ded0-4df3-8de3-28eefa4debe2">3,688</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMzctMy0xLTEtNTcwNzM_5dfa6c8b-252c-4ae9-a2d9-5fd02db34afa">3,313</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock upon exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNDctMS0xLTEtNTcwNzM_557defb3-507b-438c-8f8f-8f1324854b81">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNDctMy0xLTEtNTcwNzM_ee3af9c9-5206-4c53-acfd-f17f41c373a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNDgtMS0xLTEtNTcwNzM_46ec427e-10bf-4d14-ab6b-4056d7ad4d59">3,821</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNDgtMy0xLTEtNTcwNzM_41c7cf8b-4b7a-4255-b03c-e38a5f37292b">3,313</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EFFECT OF EXCHANGE RATE CHANGES ON CASH</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNDktMS0xLTEtNTcwNzM_e3cc8acd-c8c6-4866-8181-6a6b5a0d6cfe">229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNDktMy0xLTEtNTcwNzM_a6a02731-5ae7-4c26-96ec-ba8285c65f87">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET DECREASE IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTAtMS0xLTEtNTcwNzM_364dfe5f-aeb7-49d6-b4be-24cb00f331af">36,990</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTAtMy0xLTEtNTcwNzM_63429bd2-4585-4a93-ba68-995a76c4d358">63,893</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTEtMS0xLTEtNTcwNzM_5df9b6ae-bb40-4949-8cc0-a2e70a6d31b2">127,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i385a0ecd81c14fc5b2842208e1659808_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTEtMy0xLTEtNTcwNzM_88ed137b-7e2e-4e39-99f6-c4a466b04f80">134,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH AND CASH EQUIVALENTS, end of period</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTItMS0xLTEtNTcwNzM_dbe1199f-9bbf-4003-bd34-03aaaddda5ab">90,844</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80882b4f5c6a453fa389846657050098_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTItMy0xLTEtNTcwNzM_90878777-898c-4252-a5ae-e32c86a479f1">70,713</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid during the period for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTUtMS0xLTEtNTcwNzM_3e3c9c0a-ad0f-408f-96a6-ae9c97359a8c">21,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTUtMy0xLTEtNTcwNzM_c4637d05-296b-4d51-aa64-765991201ccc">7,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid during the period for income taxes</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTYtMS0xLTEtNTcwNzM_2c86db76-e7e0-4166-b262-3ab3951a7c62">40</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTYtMy0xLTEtNTcwNzM_317d7a99-617e-4e09-ab47-25e9f49e9343">34</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:24.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Schedule of Non-Cash Investing and Financing Activities</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired equipment and certain leasehold improvements for approximately $<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-5" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RleHRyZWdpb246NWUwNDRjY2ExZGM1NDMyZjhhMjg2MjEyZDgxZWFmMDZfNDMz_156afbc5-0d53-4c2e-bfcb-bdb9a7008339">40.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-5" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RleHRyZWdpb246NWUwNDRjY2ExZGM1NDMyZjhhMjg2MjEyZDgxZWFmMDZfNDQw_5a46d6d4-f041-43ca-8bff-01312e381ffb">42.2</ix:nonFraction> million during the three months ended March&#160;31, 2023 and 2022, respectively, which were not paid for as of March&#160;31, 2023 and 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> respectively. The offsetting amounts due were recorded in our condensed consolidated balance sheet under accounts payable, accrued expenses and other.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2023, we issued a promissory note in the amount of $<ix:nonFraction unitRef="usd" contextRef="i7ae3cbf23e8046c887d676fc95010311_I20230201" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RleHRyZWdpb246NWUwNDRjY2ExZGM1NDMyZjhhMjg2MjEyZDgxZWFmMDZfNTQ5NzU1ODE1ODM3_083dfb92-e0af-4cc0-bbed-024900e71583">19.8</ix:nonFraction> million to acquire radiology equipment previously leased under operating leases.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we issued <ix:nonFraction unitRef="shares" contextRef="i875e29b29f814b69a487f86dc63c58e7_D20220120-20220120" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RleHRyZWdpb246NWUwNDRjY2ExZGM1NDMyZjhhMjg2MjEyZDgxZWFmMDZfNzE4_e9350570-06e1-4cce-ba7e-0fe03750584d">1,141,234</ix:nonFraction> shares of our common stock to complete our purchase of Aidence Holding B.V..The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="i8e4e223d7eff48c4b6d57f718874ebf4_I20220120" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RleHRyZWdpb246NWUwNDRjY2ExZGM1NDMyZjhhMjg2MjEyZDgxZWFmMDZfODMz_65838e77-9c67-49fe-a078-3c7fe41f5b61">30.6</ix:nonFraction> million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we issued <ix:nonFraction unitRef="shares" contextRef="i06979ac32be0468ab90faae5f8a7fae6_D20220120-20220120" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RleHRyZWdpb246NWUwNDRjY2ExZGM1NDMyZjhhMjg2MjEyZDgxZWFmMDZfODY4_0a598e9d-737b-40f9-b684-52a240dc43f9">965,058</ix:nonFraction> shares to complete our purchase of Quantib B.V..  The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="i2a5b65acdc4a494dad73f5d762c4bff4_I20220120" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RleHRyZWdpb246NWUwNDRjY2ExZGM1NDMyZjhhMjg2MjEyZDgxZWFmMDZfOTU3_c5b99c97-8fb7-4680-b615-4815e41a94a0">25.9</ix:nonFraction> million.</span></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="if318a573f95e4e07addbbbfb9543d1c5_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1 &#8211; <ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfODIxOA_43ec0ef8-4bd0-4dd4-97df-fcb58b2cbb13" continuedAt="i29755549d6a148e68be04330a3928221" escape="true">NATURE OF BUSINESS AND BASIS OF PRESENTATION</ix:nonNumeric></span></div><ix:continuation id="i29755549d6a148e68be04330a3928221" continuedAt="ifdc5452e29644deb98b5d77ba2c53774"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At March&#160;31, 2023, we operated directly or indirectly through joint ventures with hospitals, <ix:nonFraction unitRef="center" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="INF" name="rdnt:NumberOfCenters" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfMjU2_c588018a-2adb-48c5-873c-09862abd3659">363</ix:nonFraction> centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  In addition to our center operations, we have certain other subsidiaries that develop Artificial Intelligence ("AI") products and solutions that are designed to enhance interpretation of radiographic images. Our operations comprise <ix:nonFraction unitRef="segment" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfMTIxOQ_f119ec67-82f8-47ec-9ea3-9ab053f45fee">two</ix:nonFraction> segments for financial reporting purposes for this reporting period, Imaging Centers and Artificial Intelligence. For further financial information about these segments, see Note 5, Segment Reporting.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of RadNet, Inc as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#8220;RadNet&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221; in this report</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#8220;VIE&#8221;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#8217;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management and provide professional medical services for centers in Arizona, California, Delaware, Maryland, New Jersey and New York.  These VIEs are collectively referred to as the consolidated medical group ("the Group").  RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity.  Substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.  The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of the Group. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group on a combined basis recognized $<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNDY3MA_72bac9b6-dbff-4748-9d1f-220b95688040">48.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNDY3Nw_5bd3f972-f2b8-46b7-a580-2740c0672480">45.7</ix:nonFraction> million of revenue, net of management services fees to RadNet, for the three months ended March&#160;31, 2023 and 2022, respectively and $<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNDc5MA_a492d6ee-55d1-46b1-8c9b-65ca6cc045c2">48.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNDc5Nw_9312aced-9048-4f3e-8152-22e5b6f1a00f">45.7</ix:nonFraction> million of operating expenses for the three months ended March&#160;31, 2023 and 2022, respectively.  RadNet recognized $<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNDg5Mw_4d1c12b3-28fc-4afd-bff7-57062e8ed903">207.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNDkwMA_4b2ca43d-03e7-4a93-ba2e-0bca0e1f3fcf">191.0</ix:nonFraction> million of total billed net service fee revenue for the three months ended March&#160;31, 2023, and 2022, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flows of the Group are included in the accompanying condensed consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022, we have included approximately $<ix:nonFraction unitRef="usd" contextRef="i4d24e08a1ed346ecadd8d502b2c5e3c9_I20230331" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNTM4OA_56c61090-b614-482b-80b2-e075c505be60">103.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i82df3264b09247118f927708d745a3e0_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNTM5NQ_9f419f6c-d048-4fef-8b93-c596c982ce31">100.4</ix:nonFraction> million, respectively, of accounts receivable and approximately $<ix:nonFraction unitRef="usd" contextRef="i4d24e08a1ed346ecadd8d502b2c5e3c9_I20230331" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNTQ1NA_6c67a264-b6b1-4c20-9292-d5e3458848a8">18.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i82df3264b09247118f927708d745a3e0_I20221231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNTQ2MQ_f2c8eca4-a17e-43e8-b6c9-028ab31ee3d5">16.9</ix:nonFraction> million of accounts payable and accrued liabilities related to the Group, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="ifdc5452e29644deb98b5d77ba2c53774"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At all of our centers not serviced by the Group we have entered into long-term contracts with medical groups to provide professional services at those centers, including supervision and interpretation of diagnostic imaging procedures. The medical groups maintain full control over the physicians they employ. Through our management agreements, we make available to the medical groups the imaging centers, including all furniture, fixtures and medical equipment therein.  The medical groups are compensated for their services from the professional component of the global net service fee revenue and after deducting management service fees paid to us, we have no economic controlling interest in these medical groups. As such, the financial results of these groups are not consolidated in our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also own a <ix:nonFraction unitRef="number" contextRef="i780286e32ed648ff95b88393d95716a1_I20230331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNjM3NA_49c49538-1a41-4679-bbaa-bfca91f38bce">49</ix:nonFraction>% economic interest in ScriptSender, LLC, which provides secure data transmission services of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender, LLC is dependent on RadNet to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.  We have continued to finance ScriptSender during it's development phase and our maximum exposure to loss is $<ix:nonFraction unitRef="usd" contextRef="i780286e32ed648ff95b88393d95716a1_I20230331" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNzAwMw_df6b89fa-6860-4c28-964e-29159da8b8a8">3.1</ix:nonFraction>&#160;million, which represents our receivable balance from the entity.  Maximum exposure to loss is the loss that we would absorb in the event that all of the assets of ScriptSender are deemed worthless.  We paid operating expenses for the venture of $<ix:nonFraction unitRef="usd" contextRef="i52ba0462fc584809b69e0d06cebc198d_D20230101-20230331" decimals="-5" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNzI0NA_3352c7cf-0cc4-4fe3-92f4-62a404585ff5">0.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i193239544180470cbfa731378e7fcdf0_D20220101-20220331" decimals="-5" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNzI1MQ_c41c0f13-e176-48aa-b698-7b86c3207481">0.4</ix:nonFraction>&#160;million for the three months ended March 31, 2023, and March&#160;31, 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended March&#160;31, 2023 and 2022 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December&#160;31, 2022.</span></div></ix:continuation><div id="if318a573f95e4e07addbbbfb9543d1c5_40"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2 - <ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMTE_b13739a6-c927-4be4-b7bc-d52b2ab2f7b2" continuedAt="i2815cff53c4840d384e0b3a6692ee6e0" escape="true">SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i2815cff53c4840d384e0b3a6692ee6e0" continuedAt="i626479b423ba493c9d649c94e99b310d"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period covered in this report, there have been no material changes to the significant accounting policies we use and have explained, in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2022. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2022.</span></div><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMTI_14c61b80-40b8-44ff-be9c-37976dbd99f8" continuedAt="i443d3a3eae7a4ae6b20290d0a6b62187" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES  - Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><ix:continuation id="i626479b423ba493c9d649c94e99b310d" continuedAt="i369e7aff322245cd91d12bf972c58679"><ix:continuation id="i443d3a3eae7a4ae6b20290d0a6b62187"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div></ix:continuation><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwODQ_8450e587-be9a-4d50-89f5-36c9ab7c0854" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service revenues during the three months ended March&#160;31, 2023 and 2022 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.707%"><tr><td style="width:1.0%"></td><td style="width:65.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.781%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ad85707f4d64ac6a9a8091c4223b351_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMi0xLTEtMS01NzA3Mw_6e3fd41b-5097-4411-ad51-a47046791748">217,209</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i574c4913311e49879ae8136ee2d28148_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMi0zLTEtMS01NzA3Mw_fc85a281-fbfe-4007-a24a-01e7414ae639">188,465</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb9e5186dac3404d9c737b06211b3954_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMy0xLTEtMS01NzA3Mw_7fa6a431-57be-49e7-b0ad-f38251507616">86,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a4072ab0edd48c8a67ccfb8f51a6290_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMy0zLTEtMS01NzA3Mw_9e9a7e89-cc64-486d-b685-dc2162e289f0">70,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44ce173f477244e8b5b9d811a1911c07_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfNC0xLTEtMS01NzA3Mw_5a616eb4-49f8-44e4-aeb7-45bcfd18244d">10,153</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ab20d39d79f4dc98599ce2f92baa5a6_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfNC0zLTEtMS01NzA3Mw_0c9631e5-d9ee-48dd-a4da-f5e74c221058">9,087</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc4e3875a9e549a799c5a7ded655f868_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfNS0xLTEtMS01NzA3Mw_4b182cf9-464e-41a3-a9e1-bda8207417c2">12,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00746cf82a884d0881fb0a193616659f_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfNS0zLTEtMS01NzA3Mw_2eda7c0e-271f-446f-934d-1e2e2ffa8939">12,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49ac145dbb9f4ba0bc8a57932c917cba_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfNi0xLTEtMS01NzA3Mw_d5f012fb-882b-40ab-896b-df7541aa0536">9,745</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa4d806c58044f58518c1759a53deb2_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfNi0zLTEtMS01NzA3Mw_918cdd2e-0074-4968-b1cc-4cb8bc77a654">7,123</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e3f72be824d49ff84df16d939b272c9_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfNy0xLTEtMS01NzA3Mw_19df1694-cb04-4957-a20c-10cc7acfd77a">4,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10301ec9313f4145901cddf7c8e67034_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfNy0zLTEtMS01NzA3Mw_79ba4e85-4ccb-4f08-9d4a-1f80c0cee19a">5,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teleradiology and Software revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67abe92a1c5140fc826b327cdcfeb0e3_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfOC0xLTEtMS01NzA3Mw_be47d98f-d8c8-4597-add1-8f143785b0db">4,333</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfcabd15dd704d3592f2fedf50542f92_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfOC0zLTEtMS01NzA3Mw_3db6156c-4beb-47e5-ae87-528366f1d75a">3,399</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic85c070b82f34df996b2edd5c5a6f417_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfOS0xLTEtMS01NzA3Mw_ad0579fb-cb6a-4e77-b448-ccd26e712b64">5,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8ceb76bd89449e9f1fdaa8aae701da_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfOS0zLTEtMS01NzA3Mw_5eadf0de-9645-4c1d-aa48-785d28be8a95">5,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia605a6d22e64439893da71566768e2e9_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMTAtMS0xLTEtNTcwNzM_6183171d-59e8-4eb1-8d52-f8a378292423">38,144</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb7ff594ba1c456380fafa96528d1a70_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMTAtMy0xLTEtNTcwNzM_0d12aa03-bcd2-46e8-839d-0a5292cb685c">38,491</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Center Segment Revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70ac0bb6794471fac30d72ea02c9975_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMTEtMS0xLTEtNTcwNzM_2e67808a-46bc-4331-9f9b-2aa00ecb4af9">388,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ab2e2f3665f40458a4bcdf95423b45a_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMTEtMy0xLTEtNTcwNzM_7d35861a-fce1-4019-adfe-0dd88d53ba7f">341,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI Segment Revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0acc5172ba1c4948b09055ace900fbac_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMTItMS0xLTEtNTcwNzM_0389fee4-f416-492b-8b73-f759f5687929">2,133</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa11bdde454474a9b815f584cb69e06_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMTItMy0xLTEtNTcwNzM_888f71f5-333e-4cdc-971e-6970f0f91834">599</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMTMtMS0xLTEtNTcwNzM_f251ef97-bc12-40d3-aa34-6d4b8cf54283">390,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMTMtMy0xLTEtNTcwNzM_33001949-3ba0-402f-84d2-d16c2049ab87">341,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">GOVERNMENT ASSISTANCE: COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  To aid businesses and stimulate the national economy, Congress passed The Coronavirus Aid, Relief, and Economic Security ("CARES") Act, which was signed in to law on March 27, 2020.  As part of the CARES act, we received $<ix:nonFraction unitRef="usd" contextRef="i5aa3078177dd4a78b72f87d219634477_D20200401-20220331" decimals="-5" name="rdnt:AdvanceMedicarePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNDQwNw_d2d190ce-34a1-42ed-a8f9-5789e520a475">39.6</ix:nonFraction> million total of accelerated Medicare payments which were recorded to deferred revenue in our consolidated balance sheet and are being applied to revenue as services are performed.  Through the three months ended March 31, 2023, $<ix:nonFraction unitRef="usd" contextRef="i19b686e5617c4056bf4f5a81d0e86de8_D20230101-20230331" decimals="-5" name="rdnt:RepaymentOfAdvanceMedicarePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTA4NA_1d8a9072-3984-4073-bf2a-be9f004cc3e1">38.6</ix:nonFraction> million of the accelerated Medicare payments have been applied to revenue. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNjY_9a93121e-1764-47c6-a636-ec881f864de5" continuedAt="i7238305be7e8475dbe2413331e0266ad" escape="true">ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7238305be7e8475dbe2413331e0266ad" continuedAt="icbab30aa59004bb7a4bbdfc90414665c">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.</ix:continuation>  Amounts remaining to be collected on these agreements were $<ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-5" name="rdnt:ContractsReceivableFactoringReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNzM3Mw_9fb61f4c-1566-4e3b-ba3c-dab1dce9bc87">15.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-5" name="rdnt:ContractsReceivableFactoringReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNzM4MA_e329e285-af33-4873-a4e5-643e92013133">15.4</ix:nonFraction> million at March&#160;31, 2023 and December&#160;31, 2022, respectively. <ix:continuation id="icbab30aa59004bb7a4bbdfc90414665c">We do not utilize factoring arrangements as an integral part of our financing for working capital and assess the party's ability to pay upfront at the inception of the notes receivable and subsequently by reviewing their financial statements annually and reassessing any insolvency risk on a periodic basis.</ix:continuation></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:DeferredChargesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwOTk_746c7f8e-2661-415c-99e1-ee99bfa77a30" escape="true">DEFERRED FINANCING COSTS - Costs of financing are deferred and amortized using the effective interest rate method and are related to our revolving credit facilities.</ix:nonNumeric> Deferred financing costs, net of accumulated amortization, were $<ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNzg5OA_6a1fc5a4-b44c-40e9-9294-8f829245241d">2.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNzkwNQ_2f099931-9072-4240-8ed4-ddd2184c3813">2.3</ix:nonFraction> million, as of March&#160;31, 2023 and December&#160;31, 2022, respectively.  See Note 6, Credit Facilities and Notes Payable for more information.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><ix:continuation id="i369e7aff322245cd91d12bf972c58679" continuedAt="ib54a5634fdf5472da24acb2219d1a8a5"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMTc_166ad8aa-28e3-4486-9fb9-3ecca2e8cdb3" escape="true">PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation of property and equipment is performed using the straight-line method over the estimated useful lives of the assets acquired, which range from <ix:nonNumeric contextRef="i50b9260334df4b2f857a1e719c97d808_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfODMzNw_02bcc413-965e-4110-9d94-047952c87f6e">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i6f296060ae9f493f8defee2497cb5fc4_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfODM0Mw_20127ff9-c7ad-426b-abf5-5100fe9e43b8">15</ix:nonNumeric> years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from <ix:nonNumeric contextRef="i9081293d8345436495fe616ab903e24b_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfODQ2Mg_eb3db0de-7acc-42bc-b7d8-a76fa35fb42c">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i259ff7a14ab44385acf1d3dc8b32d84d_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfODQ2OA_3e5fe1d3-e164-4eeb-a44d-7ab25515ec18">15</ix:nonNumeric> years. Maintenance and repairs are charged to expense as incurred.</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNjE_61d5a1da-90fa-4821-a29b-f57e378bf305" escape="true">BUSINESS COMBINATION  -  When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNjg_27b25dc8-0e08-49c5-80ab-51d27ac03ac2" continuedAt="i47dda7eedbec4ae9af61261178f6093d" escape="true">GOODWILL</ix:nonNumeric> - Goodwill at March&#160;31, 2023 totaled $<ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfOTY4MA_0cd14def-15c2-4db6-ad60-5c80d792fe4a">687.1</ix:nonFraction> million.   <ix:continuation id="i47dda7eedbec4ae9af61261178f6093d">Goodwill is recorded as a result of business combinations. When we determine the carrying value of reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  We tested goodwill and indefinite lived intangibles for impairment on October 1, 2022, noting no impairment.</ix:continuation>  <ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNzQ_50b749c0-b196-4267-b629-f3121f0880cd" continuedAt="ic542d41eb4e3430ab30d5da5a108eaa5" escape="true">Activity in goodwill for the three months ended March&#160;31, 2023 is provided below (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ic542d41eb4e3430ab30d5da5a108eaa5"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.531%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Center</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Artificial Intelligence</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25cc54b133f44bc6867c82ea3b1d00c2_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMS0xLTEtMS04MTAxNA_e794b7d6-881b-4681-a865-1d248eee6407">606,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b60cc174bb1488b811b3f45e09bda82_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMS0zLTEtMS04MTAxOA_2e7a6d9c-6b72-4b97-ab4d-15ee8ccc40d9">71,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMC0xLTEtMS01NzA3Mw_7b027977-1d8b-4334-81a0-6b5a0c76ddf7">677,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill from acquisitions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMi0xLTEtMS04MTAyOQ_a77f0abf-db25-425c-9e3a-6ede7293e755">6,174</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369ccdd58842499284be59ca42e369de_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMi0zLTEtMS04MTAzOQ_d9d15d8f-cec6-4b47-be04-339600216ac3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMS0xLTEtMS01NzA3Mw_7f89fe42-b0f4-4fb4-91d1-b10e6b3e8452">6,174</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMy0xLTEtMS04MTAyOQ_6fe91c47-041c-47b4-aa2b-dff2f13e113a">1,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369ccdd58842499284be59ca42e369de_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMy0zLTEtMS04MTAzOQ_4623f7d7-661e-4e8a-9d4f-8e5044546eef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMi0xLTEtMS01NzA3Mw_0bbfa6f8-08cb-4966-8c62-db932f45ad2b">1,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfNC0xLTEtMS04MTAyOQ_493db7b6-29d6-4dda-8f31-6b62aae78714">576</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369ccdd58842499284be59ca42e369de_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfNC0zLTEtMS04MTAzOQ_fd6c3f43-7b23-47c3-8385-73efae820cb4">1,067</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMy0xLTEtMS01NzA3Mw_47f95ba8-9814-435f-b8d3-3dd9f29a94bd">1,643</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0cbe48174104f73982d4a0ca2a3857e_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMTUtMS0xLTEtODEwMzM_8c9a304c-32f8-48fe-870b-6839750370be">614,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82d4ebf817564c7681dcb7af65622412_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMTUtMy0xLTEtODEwNDc_9db94213-fe24-4f0f-8906-c6134a69afbb">72,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMTQtMS0xLTEtNTcwNzM_3b7cfdcd-7b62-4871-85cd-eaa34ed1c22c">687,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INTANGIBLE ASSETS - The components of intangible assets, both finite and indefinite, along with annual amortization expense that will be recorded over the next five years at March&#160;31, 2023 and December&#160;31, 2022 are as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMzg0ODI5MDc0MzQ4OQ_42ba37c6-e922-45d5-84b8-27d6c42bc467" continuedAt="i691cfccf4d0a4958a7d082e554d73d8f" escape="true"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023:</span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:22.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.332%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">*</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae3e6ed3102e4ceb8e24ea8985ea1e38_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMS0xLTEtMS04NzgyNA_9b3048c8-6635-4346-9258-58c4a4aa0f71">1,717</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae3e6ed3102e4ceb8e24ea8985ea1e38_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMS0zLTEtMS04NzgyNA_bd6605bc-f748-429b-bc99-c80170a8e18e">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae3e6ed3102e4ceb8e24ea8985ea1e38_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMS01LTEtMS04NzgyNA_01b11ed2-af2f-42ba-a4bd-a0c4f3cac91c">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae3e6ed3102e4ceb8e24ea8985ea1e38_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMS03LTEtMS04NzgyNA_a1a4f997-6d25-49fa-97cd-088778db2966">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae3e6ed3102e4ceb8e24ea8985ea1e38_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMS05LTEtMS04NzgyNA_dadbf4b6-89de-4309-a952-fe2889a9262c">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae3e6ed3102e4ceb8e24ea8985ea1e38_I20230331" decimals="-3" name="rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMS0xMS0xLTEtODc4MjQ_07e225a1-0b67-4d90-a7a8-3106ae889fe1">8,959</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae3e6ed3102e4ceb8e24ea8985ea1e38_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMS0xMy0xLTEtODc4MjQ_6afd11da-5bca-4931-a241-e487b23c829c">19,824</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5905542a04540b09449e8b542c285c5_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMS0xNS0xLTEtODc4MjQ_defe8a1a-8690-4931-aae9-91b52fa30a34">8.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if58217de99e6462f8c2e57b616294439_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMi0xLTEtMS04NzgyNA_c83bf82d-a87e-4f41-8f99-87f061091e6b">1,013</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if58217de99e6462f8c2e57b616294439_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMi0zLTEtMS04NzgyNA_31967218-9e0e-426b-9271-fb62c59d2389">941</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if58217de99e6462f8c2e57b616294439_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMi01LTEtMS04NzgyNA_1eb0a9d5-ea37-42c9-822f-19e4228ec32b">692</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if58217de99e6462f8c2e57b616294439_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMi03LTEtMS04NzgyNA_9e71b696-af5c-4960-b4cb-62896eb5f47b">406</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if58217de99e6462f8c2e57b616294439_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMi05LTEtMS04NzgyNA_9b771b35-866d-4061-a19f-834cbb23c154">122</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if58217de99e6462f8c2e57b616294439_I20230331" decimals="-3" name="rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMi0xMS0xLTEtODc4MjQ_49b1443a-685b-44cd-89b3-a1d1560bfb57">41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if58217de99e6462f8c2e57b616294439_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMi0xMy0xLTEtODc4MjQ_6e04896e-4d3c-4534-be09-f8a07f7d0008">3,215</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i93c4f1236b564f5bb1675e3e16faecef_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMi0xNS0xLTEtODc4MjQ_344715e0-9ed4-44c7-9ad7-6937743e28fe">3.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer Relationships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida57b41fb8dc4945a8405b5de4684833_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMy0xLTEtMS04NzgyNA_e6c9a8e4-0546-4739-ae78-bc06e686360c">924</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida57b41fb8dc4945a8405b5de4684833_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMy0zLTEtMS04NzgyNA_78e49eec-ff0b-401a-a698-22772853d30f">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida57b41fb8dc4945a8405b5de4684833_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMy01LTEtMS04NzgyNA_e0597db6-c752-4d44-aaeb-196e2630bc7f">1,088</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida57b41fb8dc4945a8405b5de4684833_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMy03LTEtMS04NzgyNA_6f46e65f-4da8-4395-846a-6026ba5dd5b0">966</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida57b41fb8dc4945a8405b5de4684833_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMy05LTEtMS04NzgyNA_58044f41-956e-4d6a-812b-81d8ba555c8f">767</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida57b41fb8dc4945a8405b5de4684833_I20230331" decimals="-3" name="rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMy0xMS0xLTEtODc4MjQ_fe5ab6d1-ac58-46a1-b656-104382936fb6">10,984</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida57b41fb8dc4945a8405b5de4684833_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMy0xMy0xLTEtODc4MjQ_1d7e3687-1ba5-402c-89db-20d6bb4325fb">15,948</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab8bcaf8f78f44d39aaba69d6770467c_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMy0xNS0xLTEtODc4MjQ_8e150473-9593-4ff4-9786-0840c453a380">18.1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patent and Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75b01796cbf464f8e6be437e129e127_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNC0xLTEtMS04NzgyNA_efc5d741-8c6c-4423-82b9-3a114a99ad34">280</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75b01796cbf464f8e6be437e129e127_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNC0zLTEtMS04NzgyNA_5f697f8a-52b6-47aa-a6e0-657d58c40877">313</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75b01796cbf464f8e6be437e129e127_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNC01LTEtMS04NzgyNA_355c6f74-4885-42ea-a6b7-86b56a76dbcd">313</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75b01796cbf464f8e6be437e129e127_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNC03LTEtMS04NzgyNA_10f6d826-4dca-4ecb-bc12-e13a9169cd2b">313</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75b01796cbf464f8e6be437e129e127_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNC05LTEtMS04NzgyNA_f9f52a6f-6808-4468-93fb-c9c31e66c4cc">313</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75b01796cbf464f8e6be437e129e127_I20230331" decimals="-3" name="rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNC0xMS0xLTEtODc4MjQ_eddbe744-17d6-4d06-a119-a050d01ba936">399</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75b01796cbf464f8e6be437e129e127_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNC0xMy0xLTEtODc4MjQ_9ee951ba-01e3-4368-9e44-aa32397da3cc">1,931</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i11f4b30281c144d0ad846555d53b95ab_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNC0xNS0xLTEtODc4MjQ_1c4766af-08c1-47b5-9b08-a18ac2d6eb72">6.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology &amp; Software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0951dd5e901c4dca8d4d713eebf12539_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNS0xLTEtMS04NzgyNA_3e29099d-ab14-4c4a-bc25-7df684b56382">5,810</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0951dd5e901c4dca8d4d713eebf12539_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNS0zLTEtMS04NzgyNA_f7e80f2d-2a72-463a-8b8f-d1f88daa5d4a">6,657</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0951dd5e901c4dca8d4d713eebf12539_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNS01LTEtMS04NzgyNA_bac0a61f-df58-46fd-86f6-a3b7102308e9">6,657</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0951dd5e901c4dca8d4d713eebf12539_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNS03LTEtMS04NzgyNA_d9d4520d-1bd3-4932-9dcb-eb60a158ad4f">6,617</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0951dd5e901c4dca8d4d713eebf12539_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNS05LTEtMS04NzgyNA_d270c677-44dd-4f25-9f9c-88f643ce751d">6,083</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0951dd5e901c4dca8d4d713eebf12539_I20230331" decimals="-3" name="rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNS0xMS0xLTEtODc4MjQ_1be0ac00-884f-4b2d-a58e-ff86c2cb3c03">5,392</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0951dd5e901c4dca8d4d713eebf12539_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNS0xMy0xLTEtODc4MjQ_633fa7c5-ff90-4d50-a549-dff9b4adba98">37,216</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id515d4eb95a4477a9767fd98d4ee59a6_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNS0xNS0xLTEtODc4MjQ_88c32a1b-dc89-4ed3-bc0e-017e1f94484b">6.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5ffc61061348a08dd5cb2414b976aa_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNi0xLTEtMS04NzgyNA_0889be76-571f-4f9e-9daf-25b88e3b9b27">208</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5ffc61061348a08dd5cb2414b976aa_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNi0zLTEtMS04NzgyNA_e191dda9-a8d1-4d4c-b2e7-d968a0b0d8c1">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5ffc61061348a08dd5cb2414b976aa_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNi01LTEtMS04NzgyNA_9b8acdee-6eb3-4df5-bae8-16496bcde155">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5ffc61061348a08dd5cb2414b976aa_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNi03LTEtMS04NzgyNA_4e6ef73f-4fa1-45f2-948d-f390c3509369">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5ffc61061348a08dd5cb2414b976aa_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNi05LTEtMS04NzgyNA_6c37b8e4-b81e-490e-a89c-2a6ff0d827d4">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5ffc61061348a08dd5cb2414b976aa_I20230331" decimals="-3" name="rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNi0xMS0xLTEtODc4MjQ_b0d1237a-8123-474b-a44e-7555fa7da3e8">89</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5ffc61061348a08dd5cb2414b976aa_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNi0xMy0xLTEtODc4MjQ_53408469-41bc-4962-9041-b8d3e296955c">605</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5bc3cf8be0c742bfadeb1994780ffa21_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNi0xNS0xLTEtODc4MjQ_41c06222-0dc2-4272-9e02-25a05668cabf">4.6</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f2154ea6514a0d9c02f237b9630268_I20230331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNy0xMS0xLTEtODc4MjQ_5125d2d5-34c3-4173-ab26-0e35a0abeb2b">7,100</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f2154ea6514a0d9c02f237b9630268_I20230331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNy0xMy0xLTEtODc4MjQ_840cac81-6e36-4053-9487-3591bab92193">7,100</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie29af3730fb445a08f77db24069ddaf2_I20230331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOC0xMS0xLTEtODc4MjQ_967675bf-cf78-4122-a1a3-88f0bdc75f5f">17,164</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie29af3730fb445a08f77db24069ddaf2_I20230331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOC0xMy0xLTEtODc4MjQ_0a7872bd-6121-4548-bf2f-b8902fd1b6bf">17,164</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOS0xLTEtMS04NzgyNA_325379a4-4130-4f3d-8dc7-8ec0bb120968">9,952</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOS0zLTEtMS04NzgyNA_67825113-2805-4988-bca4-9e0123e94ad6">11,494</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOS01LTEtMS04NzgyNA_cd995e2c-6ed6-4895-bea0-0ecad40d3b75">11,114</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOS03LTEtMS04NzgyNA_b03a7c71-bf59-4e0c-9dc6-4709d915fd47">10,666</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOS05LTEtMS04NzgyNA_c60d77d3-c5e0-43be-9631-558ecb878d98">9,649</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOS0xMS0xLTEtODc4MjQ_ac070538-1c55-4bdc-8471-ed61f627e495">50,128</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOS0xMy0xLTEtODc4MjQ_1324e028-e013-4d0b-9fee-087de7e38ca6">103,003</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Excluding the three months ended March 31, 2023</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><ix:continuation id="ib54a5634fdf5472da24acb2219d1a8a5" continuedAt="i3b4cdd7d05ad4b91a75e6617e4d1fc81"><ix:continuation id="i691cfccf4d0a4958a7d082e554d73d8f"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:22.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.332%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f27bb8d1da34982b392c9596891b7ea_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMS0xLTEtMS04NzY4Mw_fe588d01-13a2-42c2-8f18-5fc5d65ad741">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f27bb8d1da34982b392c9596891b7ea_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMS0zLTEtMS04NzY4Mw_62cd29c3-36a0-4a54-b624-afde996e9c54">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f27bb8d1da34982b392c9596891b7ea_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMS01LTEtMS04NzY4Mw_6f644be0-6af4-4e9f-a3aa-0358698548ef">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f27bb8d1da34982b392c9596891b7ea_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMS03LTEtMS04NzY4Mw_683956ed-568d-4803-9412-bb0bc651bed1">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f27bb8d1da34982b392c9596891b7ea_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMS05LTEtMS04NzY4Mw_0e57f400-d182-46f1-9746-8e4944007619">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f27bb8d1da34982b392c9596891b7ea_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMS0xMS0xLTEtODc2ODM_3416909e-0570-4512-857b-a66050f790a8">8,958</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f27bb8d1da34982b392c9596891b7ea_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMS0xMy0xLTEtODc2ODM_4a06242b-9a98-4930-a299-0603d32d50ee">20,393</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icfc8d3dc08704d95ac2a3367f23db6ba_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMS0xNS0xLTEtODc2ODM_c6a6edb0-f25a-4150-8039-cc29eaff70b7">8.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f9799f448c40938b0f4799f0dab913_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMi0xLTEtMS04NzY4Mw_aec19933-09f4-4335-8ba0-b4c8b8af3a4f">1,319</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f9799f448c40938b0f4799f0dab913_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMi0zLTEtMS04NzY4Mw_2d7f34d6-bc00-405f-8a7f-72e1502594ab">891</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f9799f448c40938b0f4799f0dab913_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMi01LTEtMS04NzY4Mw_17d049c8-9934-4447-bde1-11270aa2c82d">642</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f9799f448c40938b0f4799f0dab913_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMi03LTEtMS04NzY4Mw_81959a83-7dd3-4bb8-9ed5-f29ba519f703">356</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f9799f448c40938b0f4799f0dab913_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMi05LTEtMS04NzY4Mw_229e0f4c-ae14-4d66-b010-781c50776cbc">72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f9799f448c40938b0f4799f0dab913_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMi0xMS0xLTEtODc2ODM_31ca812f-0a9c-4a5e-855e-5ceaa53b1e2d">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f9799f448c40938b0f4799f0dab913_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMi0xMy0xLTEtODc2ODM_6615174f-d0ce-4985-9fd7-51509ac2fe01">3,320</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i22f1eef02031411cac17b094592527ee_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMi0xNS0xLTEtODc2ODM_96103d0b-f4dd-41d4-9f9d-51c63655095d">3.1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer Relationships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1117258b4fb43f699a2f7f3415be208_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMy0xLTEtMS04NzY4Mw_69303be7-956a-4265-a8ea-67cabe4c79ca">1,244</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1117258b4fb43f699a2f7f3415be208_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMy0zLTEtMS04NzY4Mw_ace87b67-e9b7-46db-9433-690104bf8010">1,244</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1117258b4fb43f699a2f7f3415be208_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMy01LTEtMS04NzY4Mw_d64631a4-1e1d-4916-a84d-0e261a5c77ee">1,112</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1117258b4fb43f699a2f7f3415be208_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMy03LTEtMS04NzY4Mw_1af0c7cf-7c01-4bee-85d4-c2b636697546">991</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1117258b4fb43f699a2f7f3415be208_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMy05LTEtMS04NzY4Mw_12216279-175b-451f-8ada-c03d5595a9c7">816</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1117258b4fb43f699a2f7f3415be208_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMy0xMS0xLTEtODc2ODM_678c337c-7596-4a60-a99e-3478a289ccf0">12,396</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1117258b4fb43f699a2f7f3415be208_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMy0xMy0xLTEtODc2ODM_4ae3c10c-07e2-45b7-ae71-04e80cfedbf7">17,803</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i46bd0ff499564277b884f9a7be8f681c_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMy0xNS0xLTEtODc2ODM_7b98149d-ea74-4b49-8779-ace9b4644d4b">18.6</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patent and Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i827b8872571a4f11aa439a07047d7c3a_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNC0xLTEtMS04NzY4Mw_fa3c0b26-8c24-45fe-9bdb-ffdbeda93495">298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i827b8872571a4f11aa439a07047d7c3a_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNC0zLTEtMS04NzY4Mw_84248e6c-b59b-4055-9e78-9e5a0c8ed941">298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i827b8872571a4f11aa439a07047d7c3a_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNC01LTEtMS04NzY4Mw_a656ce3a-7cb2-406a-b8e8-e1a755a4f84d">298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i827b8872571a4f11aa439a07047d7c3a_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNC03LTEtMS04NzY4Mw_58ad9fd0-5ff2-40ff-9a7a-b2675c8c16e1">298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i827b8872571a4f11aa439a07047d7c3a_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNC05LTEtMS04NzY4Mw_31a49ebf-cb18-4094-96a8-4fcb5eba6a2f">298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i827b8872571a4f11aa439a07047d7c3a_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNC0xMS0xLTEtODc2ODM_d1fb0251-9c76-43ab-9c49-fedfa9b483bd">322</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i827b8872571a4f11aa439a07047d7c3a_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNC0xMy0xLTEtODc2ODM_4983493f-6e1f-4179-9de6-dd0c0a2fb5d0">1,812</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1cbf83bd8a364fc4a600170db5d5f26c_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNC0xNS0xLTEtODc2ODM_336a7c6c-adb3-4126-8dae-b439b55a522b">6.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology &amp; Software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i543e313dd7ca47d3adf0f80f8df4018c_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNS0xLTEtMS04NzY4Mw_1230c018-6091-4413-975c-117ba9273b18">6,297</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i543e313dd7ca47d3adf0f80f8df4018c_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNS0zLTEtMS04NzY4Mw_79a1a6d0-652f-4768-952e-ce25952e5a71">6,297</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i543e313dd7ca47d3adf0f80f8df4018c_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNS01LTEtMS04NzY4Mw_c42a50fe-a724-48dd-8d5a-31f9289fee94">6,297</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i543e313dd7ca47d3adf0f80f8df4018c_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNS03LTEtMS04NzY4Mw_465a2a3e-007a-4cfe-a15d-0315de081290">6,257</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i543e313dd7ca47d3adf0f80f8df4018c_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNS05LTEtMS04NzY4Mw_9a2e4ba7-a334-4b10-91eb-7236ad5c2d8a">5,722</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i543e313dd7ca47d3adf0f80f8df4018c_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNS0xMS0xLTEtODc2ODM_67129d06-f0af-46b5-9409-35cb240fc71d">7,196</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i543e313dd7ca47d3adf0f80f8df4018c_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNS0xMy0xLTEtODc2ODM_66f04797-6956-48fd-9203-2d7f279707e9">38,066</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9372083139794fde97d33c195ed380f7_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNS0xNS0xLTEtODc2ODM_23f46b07-5e2a-400b-ab97-523b6e48f4ba">6.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie74daf4e113844e9a3ae6e83d17dac2f_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNi0xLTEtMS04NzY4Mw_a79aadc0-0897-429f-84e1-699de1d6c4d9">305</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie74daf4e113844e9a3ae6e83d17dac2f_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNi0zLTEtMS04NzY4Mw_994c4c50-55b6-4753-81bf-a6172b4aa19f">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie74daf4e113844e9a3ae6e83d17dac2f_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNi01LTEtMS04NzY4Mw_d85daa88-ae7a-4a01-944a-eba9f8a905cd">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie74daf4e113844e9a3ae6e83d17dac2f_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNi03LTEtMS04NzY4Mw_6a6892b5-ea5c-43c3-b5d4-2a2991a5ccba">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie74daf4e113844e9a3ae6e83d17dac2f_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNi05LTEtMS04NzY4Mw_709dc4c2-85b5-4084-b46f-7f18290a58bb">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie74daf4e113844e9a3ae6e83d17dac2f_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNi0xMS0xLTEtODc2ODM_87ce8670-d0c7-4c25-b9a6-98ee75cb21f3">89</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie74daf4e113844e9a3ae6e83d17dac2f_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNi0xMy0xLTEtODc2ODM_68492968-cd3c-4fa7-bcd2-c1672bd65ebf">702</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie55468e7e99d494d912000e2264a206a_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNi0xNS0xLTEtODc2ODM_eddd56fc-45d4-45f9-9c43-dd9b678e63ab">4.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac10bef62a4043318e0782f47e41f58d_I20221231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNy0xMS0xLTEtODc2ODM_f3905514-157f-4cb9-9e25-5e380a9df17b">7,100</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac10bef62a4043318e0782f47e41f58d_I20221231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNy0xMy0xLTEtODc2ODM_40affe34-6d12-487e-958c-b2d9005aae39">7,100</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d21764379a54e939ddab4e98c95e66a_I20221231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOC0xMS0xLTEtODc2ODM_0e973fb4-bde6-4719-8ae8-3c42e223fcd8">17,032</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d21764379a54e939ddab4e98c95e66a_I20221231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOC0xMy0xLTEtODc2ODM_b9ce9f93-af14-4298-9a9f-85415fa3b46e">17,032</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOS0xLTEtMS04NzY4Mw_d75efbc8-cd91-4f6f-bace-7bbfe60e0eb9">11,750</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOS0zLTEtMS04NzY4Mw_da2ded4e-e4a5-48d0-bf84-8c8bfbb30259">11,094</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOS01LTEtMS04NzY4Mw_e103c8c7-2777-4c3a-8f95-2beff408f73f">10,713</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOS03LTEtMS04NzY4Mw_d8882800-0da1-43ac-8aee-549098226e92">10,266</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOS05LTEtMS04NzY4Mw_917ba9cb-f44b-4a65-9806-2e798d757ea9">9,272</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOS0xMS0xLTEtODc2ODM_399b02be-940a-40d2-ae53-0bbfb8fc5dd4">53,133</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOS0xMy0xLTEtODc2ODM_0f932791-2ec5-4bc9-9c4d-b065e18953e3">106,228</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:continuation><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible asset amortization expense was $<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODYyMTA4_71ae9c40-1f7a-4c81-9e39-33ec7f41681d">3.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODYyMTE2_2fa707d8-b1a1-4912-bd21-fb1bb30f00c8">2.1</ix:nonFraction> million for the three months ended March&#160;31, 2023 and March&#160;31, 2022, respectively.  Intangible assets are amortized using the straight-line method over their useful life determined at acquisition. Management service agreements are amortized over <ix:nonNumeric contextRef="if5905542a04540b09449e8b542c285c5_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODY0MDI3_093c5cdb-4e34-46ca-b9ec-5c7e9c8c5d12">25</ix:nonNumeric> years using the straight line method.  Software development is capitalized and amortized over the useful life of the software when placed into service.  Trade names are reviewed annually for impairment.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMTM_57b0ed4f-c993-4280-ac96-7c862d894330" continuedAt="iabab9fa84ce24920b9a42dccdc0d7bd7" escape="true">INCOME TAXES -  Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized.</ix:nonNumeric> </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a provision to income taxes of $<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTE1NTk_d8ded35d-9780-4b0e-873e-1472cbb1bf3a">1.1</ix:nonFraction> million, or an effective tax rate of (<ix:nonFraction unitRef="number" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTE1OTE_b26ce420-aee2-416d-b350-787d30f1768c">8.6</ix:nonFraction>)%, for the three months ended March 31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="ib9f162e3c0384b30924c94f3ad53ebae_D20210101-20210331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTE2NDA_688f003a-a35b-43c2-8325-73eef72d451a">1.5</ix:nonFraction> million, or an effective tax rate of <ix:nonFraction unitRef="number" contextRef="ib9f162e3c0384b30924c94f3ad53ebae_D20210101-20210331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTE2NzI_9cef98c4-994c-4a9b-b4b6-1c5ed1b0041b">15.2</ix:nonFraction>% for the three months ended March 31, 2022.  The income tax rates for the three months ended March&#160;31, 2023 diverge from the federal statutory rate due to (i) noncontrolling interests due to the controlled partnerships; (ii) effects of state income taxes (iii) effects of foreign income taxes; and (iv) excess tax benefits attributable to share-based compensation.  <ix:continuation id="iabab9fa84ce24920b9a42dccdc0d7bd7">We believe no significant changes in the unrecognized tax benefits will occur within the next 12 months.</ix:continuation></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMTU_52d73107-6e0b-41a5-b06c-55fc79a4e355" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable.  We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tested for impairment if circumstances suggest that the carrying amount may not be recoverable.  Our ROU assets consist of facility and equipment assets on operating leases.  No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of March&#160;31, 2023.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities.  We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances.  Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><ix:continuation id="i3b4cdd7d05ad4b91a75e6617e4d1fc81" continuedAt="i990b9bcd6b9e49ff820a89fdec4f1ca3"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMDg_13915843-0bcd-46fa-a663-ca9d9db41737" escape="true">EQUITY BASED COMPENSATION &#8211; We have <ix:nonFraction unitRef="incentiveplan" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTQ1MTI_59a98dfb-8b7f-4156-b5bc-2fdf0eec3709">one</ix:nonFraction> long-term incentive plan that we adopted in 2006 and which we have amended and restated at various points in time: first on April 20, 2015, second on March 9, 2017, and currently as of April 15, 2021 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved <ix:nonFraction unitRef="shares" contextRef="i9099259394b94e1e889dc1476f075a27_I20210415" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTQ4NTk_6bc5c9bf-fcb7-4539-8f16-00f130815ce5">16,500,000</ix:nonFraction> shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric.  We evaluate performance-based awards to determine if it is probable that the vesting conditions will be met. We also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period.  Stock options generally vest over <ix:nonNumeric contextRef="if7309a2667674a92a4cc3eeb4825b42f_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTU1NDk_2e060629-248f-47d7-acc2-58a52942b14d">three years</ix:nonNumeric> to <ix:nonNumeric contextRef="i7e2bb9a95d4d4802b2e4a3cc0aebe6ab_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTU1NTU_a7261e27-1b73-4233-9c51-fbdf52154938">five years</ix:nonNumeric> and expire <ix:nonNumeric contextRef="if7309a2667674a92a4cc3eeb4825b42f_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTU1Njk_53c2c32d-cf24-4aca-afdf-314adb0ee6c0">five years</ix:nonNumeric> to <ix:nonNumeric contextRef="i7e2bb9a95d4d4802b2e4a3cc0aebe6ab_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTU1NzU_230e1db4-f802-42db-83a6-d257ebdbb909">ten years</ix:nonNumeric> from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 7, Stock-Based Compensation, for more information.</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwODk_d7990858-c22d-4eaf-90fd-7ecef313fa84" escape="true">COMPREHENSIVE (LOSS) INCOME - Accounting guidance establishes rules for reporting and displaying other comprehensive (loss) income and its components. Our foreign currency translation adjustments, changes in the fair value of cash flow hedges, and the amortization of balances associated with derivatives previously classified as cash flow hedges are included in other comprehensive (loss) income. The components of other comprehensive (loss) income for the twelve month periods ended March&#160;31, 2023 and March&#160;31, 2022 are included in the consolidated statements of comprehensive (loss) income.</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNTc_492f7847-834d-4750-9c78-6c0c36b39dc3" escape="true">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNTg_84f4abb0-55b7-40a0-92ad-53c72e9ae410" continuedAt="i196f30d33c2a4385bb54c1c458c364d8" escape="true">DERIVATIVE INSTRUMENTS</ix:nonNumeric> - In the second quarter of 2019, we entered into <ix:nonFraction unitRef="agreement" contextRef="if0db9c5249a94190ac881fc140ab7671_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTgwMDA_203065b5-e91c-4b65-af81-e890df526eb8">four</ix:nonFraction> forward interest rate agreements ("2019 Swaps").  The 2019 Swaps have total notional amounts of $<ix:nonFraction unitRef="usd" contextRef="if0db9c5249a94190ac881fc140ab7671_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTgwOTk_260b36c9-2900-48a4-88c8-b143422ab954">500,000,000</ix:nonFraction>, consisting of <ix:nonFraction unitRef="agreement" contextRef="i15eafbad7ffc4c0d940511464f11e6e8_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTgxMTc_d42bdee4-a5af-4a0c-8a8a-e64c0c348701">two</ix:nonFraction> agreements of $<ix:nonFraction unitRef="usd" contextRef="i15eafbad7ffc4c0d940511464f11e6e8_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTgxMzQ_a1120eeb-b400-450d-ac5e-2342be423c65">50,000,000</ix:nonFraction> each and <ix:nonFraction unitRef="agreement" contextRef="i2f647f27d1a94bd2971692b3e87ff615_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTgxNDY_10c2b381-9bf4-4a3e-998f-25bf8dba2c28">two</ix:nonFraction> agreements of  $<ix:nonFraction unitRef="usd" contextRef="i2f647f27d1a94bd2971692b3e87ff615_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTgxNjQ_252f88c7-bc86-41dc-85e5-9451261ca310">200,000,000</ix:nonFraction> each.  <ix:continuation id="i196f30d33c2a4385bb54c1c458c364d8" continuedAt="i762d8fec9bba46d4902ae5381db37698">The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional.</ix:continuation> Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at <ix:nonFraction unitRef="number" contextRef="ifb12196c225347c6a543f74457559713_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTg1MjE_cb5593e6-6198-43b3-825a-83168f8b8864">1.96</ix:nonFraction>% for the $<ix:nonFraction unitRef="usd" contextRef="i9ace4524b6974e138856ac8172419ae1_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTg1MzI_43c4edce-cd15-443e-9570-060789bf13f2">100,000,000</ix:nonFraction> notional and at <ix:nonFraction unitRef="number" contextRef="ica6e378192f34ceb847f8a3feae3fc4d_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTg1NTE_94b17eff-37eb-40a0-994d-050872dac6fa">2.05</ix:nonFraction>% for the $<ix:nonFraction unitRef="usd" contextRef="i965b8fc567f2478dba186b27fff59b4a_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTg1NjI_c8fe0cdc-3792-4232-861f-01c76fb5e3cc">400,000,000</ix:nonFraction> notional.  <ix:continuation id="i762d8fec9bba46d4902ae5381db37698" continuedAt="i1173b29e5d004519ba0e8fd4e44d3c2c">As of the effective date, we are liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates are above the arranged rates.</ix:continuation></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1173b29e5d004519ba0e8fd4e44d3c2c">At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive gain or loss in the consolidated statement of equity.</ix:continuation>  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $<ix:nonFraction unitRef="usd" contextRef="i965b8fc567f2478dba186b27fff59b4a_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTkyODI_c8fe0cdc-3792-4232-861f-01c76fb5e3cc">400,000,000</ix:nonFraction> notional interest rate swap contract locked in at <ix:nonFraction unitRef="number" contextRef="ica6e378192f34ceb847f8a3feae3fc4d_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTkzMzU_94b17eff-37eb-40a0-994d-050872dac6fa">2.05</ix:nonFraction>% due October 2025 and our $<ix:nonFraction unitRef="usd" contextRef="i9ace4524b6974e138856ac8172419ae1_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTkzNjM_43c4edce-cd15-443e-9570-060789bf13f2">100,000,000</ix:nonFraction> notional interest rate swap contract locked in at <ix:nonFraction unitRef="number" contextRef="ifb12196c225347c6a543f74457559713_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTk0MTY_cb5593e6-6198-43b3-825a-83168f8b8864">1.96</ix:nonFraction>% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $<ix:nonFraction unitRef="usd" contextRef="i965b8fc567f2478dba186b27fff59b4a_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTk2MzU_c8fe0cdc-3792-4232-861f-01c76fb5e3cc">400,000,000</ix:nonFraction> notional and after July 1, 2020 for the $<ix:nonFraction unitRef="usd" contextRef="i9ace4524b6974e138856ac8172419ae1_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTk2Nzg_43c4edce-cd15-443e-9570-060789bf13f2">100,000,000</ix:nonFraction> notional are being recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $<ix:nonFraction unitRef="usd" contextRef="ic22a4427ddba4a24b4b6ff3818dea43c_I20200701" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTk4NTA_560bb138-f93d-430a-aeb6-2062aad047dd">24.4</ix:nonFraction> million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $<ix:nonFraction unitRef="usd" contextRef="i999c3e86ee8240ccb38c00170156728a_D20200701-20231031" decimals="-5" name="rdnt:MonthlyAmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTk5NTc_041ad0b6-23cc-4e11-a713-c7f45175258e">0.4</ix:nonFraction> million per month and continuing at approximately $<ix:nonFraction unitRef="usd" contextRef="i1feee914475c47c19d03bc69138716ee_D20231101-20251031" decimals="-5" name="rdnt:MonthlyAmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjAwMDI_9e6c1c09-a2ae-4959-82bb-6e5ae80e03d0">0.3</ix:nonFraction> million through October 2025.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNjc_0ebe75ee-3bf3-4cda-b836-14f10eecdcd3" continuedAt="i6cb3e951cc1b4b3cb58e254e736c6085" escape="true">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><ix:continuation id="i990b9bcd6b9e49ff820a89fdec4f1ca3" continuedAt="i41715da84d784206a5942c15ece46ab8"><ix:continuation id="i6cb3e951cc1b4b3cb58e254e736c6085"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:36.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.229%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.217%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.534%"></td><td style="width:0.1%"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i973513e4e5fe46adadaacc2b2fd7052d_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjhiMjU3YzM1Yzk3NTQ4NTRhNTdmNTdhZjA1MzYyMjYzL3RhYmxlcmFuZ2U6OGIyNTdjMzVjOTc1NDg1NGE1N2Y1N2FmMDUzNjIyNjNfMi0yLTEtMS01NzA3Mw_33943de7-2f60-427f-9573-770e92824af9">15,201</ix:nonFraction>)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie8c2f246c0df4407bae5f83b9dea4895_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjhiMjU3YzM1Yzk3NTQ4NTRhNTdmNTdhZjA1MzYyMjYzL3RhYmxlcmFuZ2U6OGIyNTdjMzVjOTc1NDg1NGE1N2Y1N2FmMDUzNjIyNjNfMi00LTEtMS01NzA3Mw_4fa8ffeb-83fe-4148-876f-7989b6b9031b">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie8c2f246c0df4407bae5f83b9dea4895_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjhiMjU3YzM1Yzk3NTQ4NTRhNTdmNTdhZjA1MzYyMjYzL3RhYmxlcmFuZ2U6OGIyNTdjMzVjOTc1NDg1NGE1N2Y1N2FmMDUzNjIyNjNfMi02LTEtMS01NzA3Mw_92bd4fe8-f968-4014-8d48-58b466a8a2bf">922</ix:nonFraction></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="ia1c807c6ae09463bb238f4f90ec7edfa_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjhiMjU3YzM1Yzk3NTQ4NTRhNTdmNTdhZjA1MzYyMjYzL3RhYmxlcmFuZ2U6OGIyNTdjMzVjOTc1NDg1NGE1N2Y1N2FmMDUzNjIyNjNfMi04LTEtMS01NzA3Mw_14b49962-ad26-4e9a-9854-a6d9f021c712">14,279</ix:nonFraction>)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:36.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.229%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.217%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.534%"></td><td style="width:0.1%"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i3d0fb067263842908a465a961d0de307_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmI2YzVhNTgxODMyYjQyMTY4NmJhMDRhMjc1ZDUwOGUxL3RhYmxlcmFuZ2U6YjZjNWE1ODE4MzJiNDIxNjg2YmEwNGEyNzVkNTA4ZTFfMi0yLTEtMS04OTU4NA_bcdfe8ba-e388-4ac0-ba2a-a82335c3073b">18,887</ix:nonFraction>)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie7f7fa2072f04702b6070015044cc329_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmI2YzVhNTgxODMyYjQyMTY4NmJhMDRhMjc1ZDUwOGUxL3RhYmxlcmFuZ2U6YjZjNWE1ODE4MzJiNDIxNjg2YmEwNGEyNzVkNTA4ZTFfMi00LTEtMS04OTY0Mw_2bc242a3-e29b-4cd3-8e01-31b82b4fa764">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie7f7fa2072f04702b6070015044cc329_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmI2YzVhNTgxODMyYjQyMTY4NmJhMDRhMjc1ZDUwOGUxL3RhYmxlcmFuZ2U6YjZjNWE1ODE4MzJiNDIxNjg2YmEwNGEyNzVkNTA4ZTFfMi02LTEtMS04OTYwMA_3596ea41-e3cd-41e0-aa4a-d48cec149e3d">924</ix:nonFraction></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i014cf416eb05406dbacef4beed33f8c4_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmI2YzVhNTgxODMyYjQyMTY4NmJhMDRhMjc1ZDUwOGUxL3RhYmxlcmFuZ2U6YjZjNWE1ODE4MzJiNDIxNjg2YmEwNGEyNzVkNTA4ZTFfMi04LTEtMS04OTYwNg_cf9adf19-fa6d-4146-a3f9-7e98085fed29">17,963</ix:nonFraction>)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:23.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.114%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ineffective interest rate swap</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8c2f246c0df4407bae5f83b9dea4895_D20230101-20230331" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjI1ZDk4ZTg3NTAxYTRkZWViMmE0ZTYyZGQzYTYzMjA3L3RhYmxlcmFuZ2U6MjVkOThlODc1MDFhNGRlZWIyYTRlNjJkZDNhNjMyMDdfMi0yLTEtMS01NzA3Mw_7b564b29-e4b2-4887-af36-c43edcdc2349">4,093</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjI1ZDk4ZTg3NTAxYTRkZWViMmE0ZTYyZGQzYTYzMjA3L3RhYmxlcmFuZ2U6MjVkOThlODc1MDFhNGRlZWIyYTRlNjJkZDNhNjMyMDdfMi00LTEtMS01NzA3Mw_82eff8fd-e435-416f-a669-f954d06a2aa7">Other income (expense)</span></span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8290c625ae1c431faf7a99cf4dcee8ab_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjI1ZDk4ZTg3NTAxYTRkZWViMmE0ZTYyZGQzYTYzMjA3L3RhYmxlcmFuZ2U6MjVkOThlODc1MDFhNGRlZWIyYTRlNjJkZDNhNjMyMDdfMi02LTEtMS01NzA3Mw_1a581119-ef78-4cf2-8147-009f614864d1">922</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:23.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.114%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ineffective interest rate swap</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7f7fa2072f04702b6070015044cc329_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjllMGUxNjNhM2M3MDQ0NzA4ZGRmYzVhNDQyNjI2MmJlL3RhYmxlcmFuZ2U6OWUwZTE2M2EzYzcwNDQ3MDhkZGZjNWE0NDI2MjYyYmVfMi0yLTEtMS04OTMwMg_6667482f-9c38-411b-af7e-8af1b156951b">20,819</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjllMGUxNjNhM2M3MDQ0NzA4ZGRmYzVhNDQyNjI2MmJlL3RhYmxlcmFuZ2U6OWUwZTE2M2EzYzcwNDQ3MDhkZGZjNWE0NDI2MjYyYmVfMi00LTEtMS04OTMxOA_468424d7-c562-4c21-a8d7-de7f7f9f175e">Other income (expense)</span></span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8e8b09e9574606ab6241afc0829c86_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjllMGUxNjNhM2M3MDQ0NzA4ZGRmYzVhNDQyNjI2MmJlL3RhYmxlcmFuZ2U6OWUwZTE2M2EzYzcwNDQ3MDhkZGZjNWE0NDI2MjYyYmVfMi02LTEtMS04OTMxMA_91b7e446-f5d6-4593-97bb-3641867d7faf">923</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr></table></div></ix:continuation><div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Fair Value Measurements section below for the fair value of the 2019 Swaps at March&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONTINGENT CONSIDERATION - </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Aidence Holding B.V.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise centered on lung cancer screening.  As part of the purchase agreement, we will pay up to $<ix:nonFraction unitRef="usd" contextRef="icbba037786a84b888dd30f858c80bde1_I20220120" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUxMTgx_026a49dd-1dc7-48f5-b4a8-d9909190d8e4">10.0</ix:nonFraction> million consideration upon the completion of <ix:nonFraction unitRef="loan" contextRef="icbba037786a84b888dd30f858c80bde1_I20220120" decimals="INF" name="rdnt:BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" format="ixt-sec:numwordsen" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUxMTg3_fd8873ec-c0d5-4486-9c9b-d245c941e258">two</ix:nonFraction> identified milestones in RadNet common shares or cash at our election.  This </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><ix:continuation id="i41715da84d784206a5942c15ece46ab8" continuedAt="ie9ae8b9817784b498bf40bb78003c831"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contingency had a value of approximately $<ix:nonFraction unitRef="usd" contextRef="iee8168439bff4dcc928d2f0538a23ea5_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUxMTky_d794a12a-14c6-4cf0-92bc-3cc24c777d5a">7.3</ix:nonFraction> million on March&#160;31, 2023. The amount is reviewed quarterly and adjusted to fair value based on the yield rate of S&amp;P B-rated corporate bonds and the probability of FDA approval, which has been currently determined by management to be <ix:nonFraction unitRef="number" contextRef="icbba037786a84b888dd30f858c80bde1_I20220120" decimals="INF" name="rdnt:BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMDUy_90d9d163-3e0f-476d-ba37-0522e0bd86de">80</ix:nonFraction>% for milestone one and <ix:nonFraction unitRef="number" contextRef="icbba037786a84b888dd30f858c80bde1_I20220120" decimals="INF" name="rdnt:BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMDU2_988aff8f-ded0-46d8-85ac-80573c4b307e">70</ix:nonFraction>% for milestone two.  In addition, there is a remaining general holdback of $<ix:nonFraction unitRef="usd" contextRef="ib6e9460c493149e6bd8bb71cb47a94dc_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMDYw_d7d3fc1f-0790-457b-b03c-8ac7940c36e1">4.0</ix:nonFraction> million to be issued in shares of our common stock subject to adjustment for any indemnification claims.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantib B.V.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening.  As part of the purchase agreement, we will issue <ix:nonNumeric contextRef="i06979ac32be0468ab90faae5f8a7fae6_D20220120-20220120" name="rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMDcy_645acb7e-d3ee-4488-b113-6bf94fd55d6e">18</ix:nonNumeric> months after acquisition, <ix:nonFraction unitRef="shares" contextRef="i2a5b65acdc4a494dad73f5d762c4bff4_I20220120" decimals="INF" name="rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMDc2_06979715-8fef-4dee-a84d-9f95072065aa">113,303</ix:nonFraction> shares of our common stock with an initial fair value at the date of close of $<ix:nonFraction unitRef="usd" contextRef="i2a5b65acdc4a494dad73f5d762c4bff4_I20220120" decimals="-5" name="rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMDgw_17b25050-54b5-4d81-aa4e-09996819b39a">3.0</ix:nonFraction> million subject to adjustment for any indemnification claims and will be adjusted to fair value in subsequent periods. This contingency had a value of approximately $<ix:nonFraction unitRef="usd" contextRef="i31f77a27a2e24b72a13b080caab47d8e_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMDg3_6120a800-8080-450e-a46a-95f0badafa8c">2.8</ix:nonFraction> million as of March&#160;31, 2023. In addition, there is a general holdback of $<ix:nonFraction unitRef="usd" contextRef="ie3d36b3137cf48c1b491cd5b202fbcdf_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMDk5_772e2b7a-636d-49dc-9355-8b559c337888">1.6</ix:nonFraction> million to be issued in cash subject to adjustment for any indemnification claims.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Montclair</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2022, we completed our acquisition of Montclair Radiological Associates. As part of the purchase agreement, we recorded $<ix:nonFraction unitRef="usd" contextRef="ibd948f656ced403e875b56f896581911_I20221001" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMTA2_acd33478-f20c-4241-badd-a9c32c0c5efd">1.2</ix:nonFraction> million in contingent consideration to be determined by obtaining specific EBITDA targets within a defined time frame.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Heart and Lung Imaging Limited</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we completed our acquisition of <ix:nonFraction unitRef="number" contextRef="i0bdb93152d774671850e526671c6aec3_I20221101" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMTEz_be14074d-a9a3-4eb3-88a2-9a690f6f4b4c">75</ix:nonFraction>% of the equity interests of Heart and Lung Imaging Limited. The purchase included $<ix:nonFraction unitRef="usd" contextRef="if10663cad4164b7d819dd600043b536c_I20221101" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMTE3_aac189c5-5226-47ac-9bc2-a1a9402e76c4">10.2</ix:nonFraction> million in contingent milestone consideration and cash holdback of $<ix:nonFraction unitRef="usd" contextRef="i066eadbb98a54c6480345b29b400d31f_I20221101" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMTI0_6efcae21-c439-4800-b59b-aaf695d03803">0.6</ix:nonFraction> million to be issued <ix:nonNumeric contextRef="i0dd2d7518a4f46b4a60489e1be50cf79_D20221101-20221101" name="rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMTMx_d9dd7412-0464-4f96-89df-efd2f28a7a84">24</ix:nonNumeric> months after acquisition subject to adjustment for any indemnification claims, which will be adjusted to fair value in subsequent periods.  The milestone contingency had a value of approximately $<ix:nonFraction unitRef="usd" contextRef="iefc3e607700f46539886f8ce5ac3a6fe_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMTM1_d75c5f03-ba01-4b79-8862-179fef3166a6">13.1</ix:nonFraction> million as of March&#160;31, 2023.   The contingent consideration is determined by the achievement of a specific number of physician reads.</span></div><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMzg0ODI5MDczMjEwMA_c3573792-e043-4faf-bef6-80d3c0ffae19" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular rollforward of contingent consideration is as follows (amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"></td><td style="width:12.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.485%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issuance of contingent consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in valuation of Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023  Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173b6797abf9418b9ce2d7294d426b24_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfMi00LTEtMS04MDgzOQ_84df4d6a-2b8d-4f15-bfca-5f3b924aaf4a">11,158</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2acb391edb584f9991ed018864e62fdf_D20230101-20230331" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfMi02LTEtMS04MDgzOQ_f2c918f1-60f9-45a7-973e-928e8334359b">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2acb391edb584f9991ed018864e62fdf_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfMi04LTEtMS04MDgzOQ_9c1c66f4-fb2c-4bb9-9189-f2e0e8273ab6">158</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2acb391edb584f9991ed018864e62fdf_D20230101-20230331" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfMi0xMC0xLTEtODA4Mzk_7c5b91dc-76bc-4d28-a077-0de6b0941b70">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdfb2358240e4c36b0c1df5fddf49bd7_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfMi0xMi0xLTEtODA4Mzk_31bd98d3-5474-464c-94a4-0689758280ac">11,316</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6697f341173242ddb3318ebb20797960_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNC00LTEtMS04MDgzOQ_8726de3f-38a7-4917-86cc-e5d1f54ca55a">3,709</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie485aedb3f5a499890201c380e948451_D20230101-20230331" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNC02LTEtMS04MDgzOQ_33e8e094-490e-4bb9-b8ea-7c70c5ab675d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie485aedb3f5a499890201c380e948451_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNC04LTEtMS04MDgzOQ_3390abb1-c3fc-4e4c-8c09-fcfcd2f61765">702</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie485aedb3f5a499890201c380e948451_D20230101-20230331" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNC0xMC0xLTEtODA4Mzk_95f2ca79-0b37-46cf-a027-1a570c40cb5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35969f93dd244ab9975ff3d03ff35236_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNC0xMi0xLTEtODA4Mzk_3335d43a-20bc-4a04-a3e2-df119a06edfa">4,411</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i287bda58ab4a4749bc53627ff756795d_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNi00LTEtMS04MDgzOQ_c2ccb510-0498-48b8-84c5-a2ad90f6119f">1,200</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia76a78ff4e864951a5ad37cf84296e9a_D20230101-20230331" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNi02LTEtMS04MDgzOQ_15f9b992-8f30-4fd9-a385-e7f993e524a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia76a78ff4e864951a5ad37cf84296e9a_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNi04LTEtMS04MDgzOQ_669a634e-63ee-44ca-9ffd-7c11bbbf7231">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia76a78ff4e864951a5ad37cf84296e9a_D20230101-20230331" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNi0xMC0xLTEtODA4Mzk_1ca430be-7dc1-47a2-a2bc-0874f367da49">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11045551fdb3449782344178a2ef73d6_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNi0xMi0xLTEtODA4Mzk_286c3d12-715e-41b5-8974-c9b4cbcd1d4d">1,200</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Limited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93c2f0e988bf4215ba9dd9160be1bc52_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNy00LTEtMS04MDgzOQ_8a580348-e0cb-42e2-b092-1b2983aaa53a">11,656</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f5b3ddf736445e83e7bbca68c313c4_D20230101-20230331" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNy02LTEtMS04MDgzOQ_5f5a77b1-03ff-4022-a7fe-20b75fbbfc89">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f5b3ddf736445e83e7bbca68c313c4_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNy04LTEtMS04MDgzOQ_c75a8d42-ca2e-4fe9-b6cd-fcbf188bb5db">1,124</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f5b3ddf736445e83e7bbca68c313c4_D20230101-20230331" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNy0xMC0xLTEtODA4Mzk_c2859cf2-f301-42ec-a494-a4a82a8ec7a0">350</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i058ba722d17f465ca2784c234195b2cb_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNy0xMi0xLTEtODA4Mzk_a9ac0830-96c6-4384-8f39-be45a8e11def">13,130</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Fair Value Measurements section below for the fair value of contingent consideration at March&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMDY_42510688-7dfd-497a-8c3b-8c5328ea89d2" continuedAt="ic538ce407b4c4c349d39e36711ae71f7" escape="true">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair </ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><ix:continuation id="ie9ae8b9817784b498bf40bb78003c831" continuedAt="i2aa12276a7514d28896b32920e948371"><ix:continuation id="ic538ce407b4c4c349d39e36711ae71f7" continuedAt="i6269f492830a4794ac6fa0fe236c87d2"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives:</span></div><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwODY_b0f45d45-1e5c-4f75-a28d-7903ea607c04" continuedAt="i625226cfe8364a94ad38607ca7f3a0b9" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term assets</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Swaps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d7f845cf42440e69575e47031da49f1_I20230331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmM3YmE1NWUwZWVmODQwYTRiNmU2MzFlZmQ0MzhhMzZjL3RhYmxlcmFuZ2U6YzdiYTU1ZTBlZWY4NDBhNGI2ZTYzMWVmZDQzOGEzNmNfNC0xLTEtMS01NzA3Mw_ee6f3bc7-db9a-4307-b078-46ac83712b20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53894f1fe8a84432ab52b5a5b819bc93_I20230331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmM3YmE1NWUwZWVmODQwYTRiNmU2MzFlZmQ0MzhhMzZjL3RhYmxlcmFuZ2U6YzdiYTU1ZTBlZWY4NDBhNGI2ZTYzMWVmZDQzOGEzNmNfNC0zLTEtMS01NzA3Mw_73f2bb8d-a747-4d0e-97f3-a312226142f1">19,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb3938f8e9245c69f2103134c886ddc_I20230331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmM3YmE1NWUwZWVmODQwYTRiNmU2MzFlZmQ0MzhhMzZjL3RhYmxlcmFuZ2U6YzdiYTU1ZTBlZWY4NDBhNGI2ZTYzMWVmZDQzOGEzNmNfNC01LTEtMS01NzA3Mw_8e06a831-cf2e-4b45-a227-43640b85736d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f3f9c5a69554b138e8af5ee50845912_I20230331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmM3YmE1NWUwZWVmODQwYTRiNmU2MzFlZmQ0MzhhMzZjL3RhYmxlcmFuZ2U6YzdiYTU1ZTBlZWY4NDBhNGI2ZTYzMWVmZDQzOGEzNmNfNC03LTEtMS01NzA3Mw_56e80780-7c25-42f5-9386-bb7338cdae32">19,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term assets</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Swaps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17af87ec48d045ecb8769ad083958efe_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmMzZjFkMDY4YTVmNTQ1YmE5NGVhNmQxNDU5N2QzNjg2L3RhYmxlcmFuZ2U6YzNmMWQwNjhhNWY1NDViYTk0ZWE2ZDE0NTk3ZDM2ODZfNC0xLTEtMS01NzA3Mw_21a67260-85e5-4db9-9d64-9e0c2c6f58fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af6e51430bf454182807a0000e29d75_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmMzZjFkMDY4YTVmNTQ1YmE5NGVhNmQxNDU5N2QzNjg2L3RhYmxlcmFuZ2U6YzNmMWQwNjhhNWY1NDViYTk0ZWE2ZDE0NTk3ZDM2ODZfNC0zLTEtMS01NzA3Mw_7c346562-1b48-4072-9cc4-575487279661">23,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfe53a05d7443eaebd569b9c1fffbb_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmMzZjFkMDY4YTVmNTQ1YmE5NGVhNmQxNDU5N2QzNjg2L3RhYmxlcmFuZ2U6YzNmMWQwNjhhNWY1NDViYTk0ZWE2ZDE0NTk3ZDM2ODZfNC01LTEtMS01NzA3Mw_fbf2c339-ef17-47d6-bfa7-7700a33b5d36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc55aa9a8f74f6e9d0a7f9ee6911a37_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmMzZjFkMDY4YTVmNTQ1YmE5NGVhNmQxNDU5N2QzNjg2L3RhYmxlcmFuZ2U6YzNmMWQwNjhhNWY1NDViYTk0ZWE2ZDE0NTk3ZDM2ODZfNC03LTEtMS01NzA3Mw_8328ba9d-595f-459e-a314-2d39a84f2061">23,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6269f492830a4794ac6fa0fe236c87d2" continuedAt="ib2af1576b0874ff3a160b0e524f47ce1">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.</ix:continuation></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration:</span></div><ix:continuation id="i625226cfe8364a94ad38607ca7f3a0b9" continuedAt="i7be598e606804cc3ac60de40f07ca369"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of contingencies and holdback relating to our Aidence Holding B.V. and Quantib B.V. acquisitions on January 20, 2022, the Montclair Radiological Associates acquisition on October 1, 2022 and the Heart and Lung Imaging Limited acquisition on November 1, 2022 that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence Holding B.V. milestone consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a1961ca97b748dd97f76e81cefd372a_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfMy0xLTEtMS04MDg0Nw_0ff65fee-c3b1-4cab-be4a-dadcb13a0dcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1cd387ced7b4e0ab675250e1043f341_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfMy0zLTEtMS04MDg0Nw_8b294ae3-262f-4ef4-9883-4a1fa20eaea3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if254894b76e948059a1f851aac708545_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfMy01LTEtMS04MDg0Nw_bd57a15f-7ed3-495b-8bd3-95bf0607c16a">11,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9c210824bd498595db6f8ea56f2975_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfMy03LTEtMS04MDg0Nw_f3584c9b-ff63-4a8f-9b9c-b6de63d6bbb4">11,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib B.V. holdback of <ix:nonFraction unitRef="shares" contextRef="i2a5b65acdc4a494dad73f5d762c4bff4_I20220120" decimals="INF" name="rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNC0wLTEtMS04MDg0Ny90ZXh0cmVnaW9uOmZiYTA0NTYxMmZkNzQ3NWVhMjQ3MTg1YjdmNTY4ZTNkXzMw_380da2c7-9b49-43a7-b762-e7897980a6b6">113,303</ix:nonFraction> shares of RadNet common stock</span></div></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idab0c26ccbb3431a83faffea0666ec73_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNC0xLTEtMS04MDg0Nw_978b934d-4613-4148-97ef-7a9bfedf7bef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5324382fed8640319b97df8ad78e78da_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNC0zLTEtMS04MDg0Nw_c4594b85-ec31-4c92-8cb8-c09580fec29f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0f8ba61c5d04db397ce5b6e04306b7e_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNC01LTEtMS04MDg0Nw_1ca862a8-a6da-4c3e-ab7f-cfdcd74f3b7b">4,411</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eacec98a58d4cdda3f139bb7a0de027_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNC03LTEtMS04MDg0Nw_13d82772-b40e-470d-b207-43dd949a0b94">4,411</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e2dd058697401197f55bd60a4150ee_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNS0xLTEtMS04MDg0Nw_17362d70-0686-458c-ab21-7c7d53647598">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i333584db5d0c4718a15a9336dd0ec38b_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNS0zLTEtMS04MDg0Nw_4aa0ecd0-917e-49b4-8e9e-ae47a354dc7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5422c8baca9649c8971a2171b71a5b0e_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNS01LTEtMS04MDg0Nw_be6bdd4d-cb27-43a8-a4d4-9a278a899211">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc5a6bf23e24e448e14f910984a448e_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNS03LTEtMS04MDg0Nw_ca35cd28-32a7-47b7-ac9a-32b877534096">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Imaging Limited</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f996450ac44be3a585f3df56209db0_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNi0xLTEtMS04MDg0Nw_80ffaa50-1a9a-412e-8c5a-a5b3dc24a3c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1418728f3764d51ae66362b3b005736_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNi0zLTEtMS04MDg0Nw_22ce3448-3b44-4af2-a013-08a4af5ae567">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e1fc62ee042414286344a73cb1100ad_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNi01LTEtMS04MDg0Nw_2062bbb1-ffed-48f6-b673-a9c2df300da9">13,130</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b566bef11524caba9939adb72309fb2_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNi03LTEtMS04MDg0Nw_b67cb8f2-0994-4a2e-b47e-ac6ebfd59e3d">13,130</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these liabilities was determined using Level 3 inputs.  For Aidence Holding B.V., the  milestone contingent liability was adjusted to fair value based on the yield rate of S&amp;P B-rated corporate bonds and the probability of FDA approval.  For the Quantib B.V holdback shares, the fair value was determined by calculating the value of estimated shares issuable as of the reporting date (which was $<ix:nonFraction unitRef="usdPerShare" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODU2NDcz_a62c7555-4b5e-4403-a900-a0decb09de2d">25.03</ix:nonFraction>) at March&#160;31, 2023, the time period related to the contractual settlement term, and the probability of issuing the shares.  For Montclair Radiological Associates the contingent consideration is determined by obtaining specific EBITDA targets within a defined time frame.  For Heart Lung Imaging Limited the contingent consideration is determined by the achievement of a specific number of physician reads.  As significant </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><ix:continuation id="i2aa12276a7514d28896b32920e948371" continuedAt="icdc6fed5ba644a128aa78e70f62dc66f"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">inputs for the contingent consideration of Aidence B.V., Quantib B.V., Montclair Radiological Associates and Heart Lung Imaging Limited are not observable and cannot be corroborated by observable market data they are classified as Level 3.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long Term Debt:</span></div><ix:continuation id="i7be598e606804cc3ac60de40f07ca369"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and Truist Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e6a1bf96f13445c9ec8f1d1017b808f_I20230331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjRjMjM4Y2Q2OGU5MjRiZmRhNWY2ZmU5MzM2YzUyNWU3L3RhYmxlcmFuZ2U6NGMyMzhjZDY4ZTkyNGJmZGE1ZjZmZTkzMzZjNTI1ZTdfMi0xLTEtMS01NzA3Mw_d079ad6e-b73c-4cf0-be56-cabd669e7ef0">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ddcffccfdaa4e738249bb0f26ff8fd0_I20230331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjRjMjM4Y2Q2OGU5MjRiZmRhNWY2ZmU5MzM2YzUyNWU3L3RhYmxlcmFuZ2U6NGMyMzhjZDY4ZTkyNGJmZGE1ZjZmZTkzMzZjNTI1ZTdfMi0zLTEtMS01NzA3Mw_2308e843-da0d-4b70-8bd9-00e78a25dda5">856,876</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7b50a32ec649b6bd1731fb1173bcf9_I20230331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjRjMjM4Y2Q2OGU5MjRiZmRhNWY2ZmU5MzM2YzUyNWU3L3RhYmxlcmFuZ2U6NGMyMzhjZDY4ZTkyNGJmZGE1ZjZmZTkzMzZjNTI1ZTdfMi01LTEtMS01NzA3Mw_d4ae14a9-5ab5-4dab-8eb9-02abd0912cb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0fffd4237ac4587a0961b2f15478644_I20230331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjRjMjM4Y2Q2OGU5MjRiZmRhNWY2ZmU5MzM2YzUyNWU3L3RhYmxlcmFuZ2U6NGMyMzhjZDY4ZTkyNGJmZGE1ZjZmZTkzMzZjNTI1ZTdfMi03LTEtMS01NzA3Mw_5379b560-df27-41c2-a50b-e02f8535441a">856,876</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjRjMjM4Y2Q2OGU5MjRiZmRhNWY2ZmU5MzM2YzUyNWU3L3RhYmxlcmFuZ2U6NGMyMzhjZDY4ZTkyNGJmZGE1ZjZmZTkzMzZjNTI1ZTdfMi05LTEtMS01NzA3Mw_11de9004-66c2-48a8-81f5-3faf0f440596">860,438</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and Truist Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5766c50c6d7461c835635f1c6343841_I20221231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdiOTA1YmM5YjNlYTRmMmM4NGM2YjE1YTVjZmEzZjg5L3RhYmxlcmFuZ2U6N2I5MDViYzliM2VhNGYyYzg0YzZiMTVhNWNmYTNmODlfMi0xLTEtMS01NzA3Mw_f3f6ecee-044f-4a5c-9b9b-b3811af3288b">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb97ef0c9bf4fecbcdce0085a7cd336_I20221231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdiOTA1YmM5YjNlYTRmMmM4NGM2YjE1YTVjZmEzZjg5L3RhYmxlcmFuZ2U6N2I5MDViYzliM2VhNGYyYzg0YzZiMTVhNWNmYTNmODlfMi0zLTEtMS01NzA3Mw_e2716d1a-f98e-456e-9800-00a7ca83e517">843,594</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040b12c6fad641ae884cad957f2cfe40_I20221231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdiOTA1YmM5YjNlYTRmMmM4NGM2YjE1YTVjZmEzZjg5L3RhYmxlcmFuZ2U6N2I5MDViYzliM2VhNGYyYzg0YzZiMTVhNWNmYTNmODlfMi01LTEtMS01NzA3Mw_d9d736f4-cd8a-4222-93d4-4c52e823f040">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d6937e646b24c1c851fae386ba9607f_I20221231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdiOTA1YmM5YjNlYTRmMmM4NGM2YjE1YTVjZmEzZjg5L3RhYmxlcmFuZ2U6N2I5MDViYzliM2VhNGYyYzg0YzZiMTVhNWNmYTNmODlfMi03LTEtMS01NzA3Mw_6ee42494-7205-4e9f-b853-e025dcbc2d25">843,594</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdiOTA1YmM5YjNlYTRmMmM4NGM2YjE1YTVjZmEzZjg5L3RhYmxlcmFuZ2U6N2I5MDViYzliM2VhNGYyYzg0YzZiMTVhNWNmYTNmODlfMi05LTEtMS01NzA3Mw_7cf8e027-0634-4f40-85a2-28bfd0d2e063">864,125</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and at December&#160;31, 2022 our Barclays revolving credit facility had <ix:nonFraction unitRef="usd" contextRef="i5ee8e2a0aedf4e16bfc1f00854be3504_I20221231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjQzNjQ_097f275a-4147-4081-a140-88fa280d0cf8"><ix:nonFraction unitRef="usd" contextRef="i74aaf1e8f24d470db2a98ecc203f2374_I20230331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjQzNjQ_fa8c1588-64de-4109-9606-65fd9bb89e8b">no</ix:nonFraction></ix:nonFraction> balance outstanding. Our Truist revolving credit facility relating to our consolidated subsidiary The New Jersey Imaging Network ("NJIN"), had <ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjQ1MTI_a2bf9b56-43b8-4ccd-8eea-26f49e2dc786"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjQ1MTI_b032d066-9449-488e-8b5b-488ec2c39277">no</ix:nonFraction></ix:nonFraction> principal amount outstanding at March&#160;31, 2023 and at December&#160;31, 2022.</span></div><ix:continuation id="ib2af1576b0874ff3a160b0e524f47ce1"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our long-term debt, which is discussed in Note 6, Credit Facilities and Notes Payable, was determined using Level 2 inputs primarily related to comparable market prices.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMTk_c0886962-9438-48c6-8be5-94706ee0c7fc" escape="true">EARNINGS PER SHARE - <ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNzE_9dcc4004-624a-4cac-a428-aeadad28bc63" continuedAt="i5da31938e4d04d8285384acf53ad4a16" escape="true">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</ix:nonNumeric></ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><ix:continuation id="icdc6fed5ba644a128aa78e70f62dc66f" continuedAt="i886af7eab3d24305baae46b0b9baeec6"><ix:continuation id="i5da31938e4d04d8285384acf53ad4a16"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.584%"><tr><td style="width:1.0%"></td><td style="width:67.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.768%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income  attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMi0xLTEtMS01NzA3Mw_a9faa0e4-972f-485d-8850-79c6c009c078">21,005</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMi0zLTEtMS01NzA3Mw_cb85e7ca-cbf5-487e-81b5-c5aaa3fc75f6">3,013</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfNS0xLTEtMS01NzA3Mw_882f42d9-62e2-42b2-b720-2fd9a6de51c9">57,701,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfNS0zLTEtMS01NzA3Mw_efd42770-7080-4f29-bdb2-c60af3c9b773">55,303,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfNi0xLTEtMS01NzA3Mw_e9ce6493-045e-49f3-b5f5-b27b6b3feb16">0.36</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfNi0zLTEtMS01NzA3Mw_e6f08b19-e5fa-4f75-9a9d-f5749c752a7b">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfOS0xLTEtMS01NzA3Mw_38e7b4c1-157b-4295-a325-dc23087aa171">57,701,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfOS0zLTEtMS01NzA3Mw_acda0f3f-9f68-49f2-86b7-1177afad695e">55,303,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTAtMS0xLTEtNTcwNzM_3449dc90-9c5f-4f1f-b279-5dd21114ffab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTAtMy0xLTEtNTcwNzM_9319ad07-e08c-47bf-ae34-6dfc13c1ec0b">197,911</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and contingently issuable shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTEtMS0xLTEtNTcwNzM_9bbad6a3-9648-404c-975a-5329fd22a64c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTEtMy0xLTEtNTcwNzM_be33a43a-41f5-42f4-b5cc-f396b014214e">861,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTItMS0xLTEtNTcwNzM_0ef6828e-85f4-4fdf-ba4c-9c836aae4e4a">57,701,439</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTItMy0xLTEtNTcwNzM_d3672d54-c046-43cd-a6c8-4075b2a4ac09">56,362,193</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTMtMS0xLTEtNTcwNzM_29491451-dfb7-4c4f-9c87-b96a906c49be">0.36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTMtMy0xLTEtNTcwNzM_4ad84d28-ae73-4cc2-ad2f-f906dfdf9f0f">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value change for contingently issuable shares excluded from the computation of diluted per share amounts as its effect would be antidilutive</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="rdnt:FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTUtMS0xLTEtODgxODg_9a7c7884-e38d-4842-b919-065a2fc2c8e8">769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="rdnt:FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTUtMy0xLTEtODgyMzI_e9d0f0c8-a731-4e41-b92e-9e8deb3934d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f8b6f8b3773411ea71c13b60855758a_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTYtMS0xLTEtNTcwNzM_64f72dc9-6bf3-4f48-b964-8a5811dae4c7">594,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic66c83d188f04d7dafa027910df93466_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTYtMy0xLTEtNTcwNzM_ece392aa-e738-4953-b4cc-4e5ac1c85d18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9fa9f6b4e3e40648840c75270131b86_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTctMS0xLTEtNTcwNzM_db3bde55-ea55-455b-8e51-f7d7fc7f122a">750,075</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8091047fc1324ea98cd25d50961b4676_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTctMy0xLTEtNTcwNzM_d53b4d82-95a9-419f-acb5-da32c7634cdd">46,912</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently issuable shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic18ea46b2e144ce8bb4730330b274ca4_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTgtMS0xLTEtODczMjk_9b7eb0e7-6eef-41c4-a08e-fe2d515e7fb0">273,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f64f3acfb1b4f8d905cf0d5b3f16ff6_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTgtMy0xLTEtODczMzc_30543e12-7322-4a12-aee0-bd58a3f4bcd0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023  we excluded all outstanding options, restricted stock awards and other requisite shares in the calculation of diluted earnings per share because their effect would be antidilutive.</span></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwODg_22e72f2b-2ec7-4059-9134-ceedcac328b7" escape="true">INVESTMENTS IN EQUITY SECURITIES&#8211;Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income.</ix:nonNumeric> </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we have <ix:nonFraction unitRef="security" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="INF" name="rdnt:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjU5NTQ_93130d09-3757-4c49-ad53-28b4f9a65e4f">three</ix:nonFraction> equity investments for which a fair value is not readily determinable and therefore the total amounts invested are recognized at cost as follows:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  Our investment of $<ix:nonFraction unitRef="usd" contextRef="iadfab3b66cc3465da1facc6280643211_I20230331" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjYzMTY_ce9fecd6-50fd-44ed-b752-1bb08dc7340c">1.2</ix:nonFraction> million  represents a <ix:nonFraction unitRef="number" contextRef="iadfab3b66cc3465da1facc6280643211_I20230331" decimals="4" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjYzMzM_e9f818f9-e50a-4bc6-b35a-27fdf26e999f">14.21</ix:nonFraction>% equity interest in the company.  No observable price changes or impairment in our investment was identified as of March&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed.  On February 1, 2018, we purchased <ix:nonFraction unitRef="shares" contextRef="i7c812255b96e466a813bee1f44c493df_D20180201-20180201" decimals="-5" name="rdnt:EquityMethodInvestmentSharesPurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODU4MjE4_595e62a6-7ba5-4e5b-97a5-07a3c3dd7ac2">2.1</ix:nonFraction>&#160;million preferred shares in Turner Imaging Systems for $<ix:nonFraction unitRef="usd" contextRef="i7c812255b96e466a813bee1f44c493df_D20180201-20180201" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODU4MjIy_c78275c9-e9fd-4ecb-8a7e-b0d3e74c738d">2.0</ix:nonFraction> million. On January 1, 2019 we funded a convertible promissory note in </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><ix:continuation id="i886af7eab3d24305baae46b0b9baeec6"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the amount of $<ix:nonFraction unitRef="usd" contextRef="icff909ad5af946f582998f2b08a3332f_I20190101" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODU4MjQy_1a73bab7-107d-4053-aca7-37761489f67c">0.1</ix:nonFraction> million that converted to an additional <ix:nonFraction unitRef="shares" contextRef="i060d61245cc645109b4d1d8bb44ab6bf_I20191221" decimals="-3" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODU4MjYy_63785148-705e-4f56-a899-e3c9cfa496f7">80,000</ix:nonFraction> preferred shares on October 11, 2019.No observable price changes or impairment in our investment was identified as of March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $<ix:nonFraction unitRef="usd" contextRef="ib78892651f964e84abae349ff967869b_D20191105-20191105" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjcwMDA_0a30dc79-41cc-40ca-9dac-f48db35eab7b">1.0</ix:nonFraction> million and also loaned the company $<ix:nonFraction unitRef="usd" contextRef="ib78892651f964e84abae349ff967869b_D20191105-20191105" decimals="-5" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjcwMzE_e15af5d1-5310-400a-a818-0645ad7e841f">2.5</ix:nonFraction> million in support of its operations.  No observable price changes, impairment in our investment or impairment of the loan receivable was identified as of March&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMDQ_b41e3fa7-70a0-49ab-b186-f98c78beb70f" escape="true">INVESTMENT IN JOINT VENTURES &#8211; We have <ix:nonFraction unitRef="jointventure" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="INF" name="rdnt:NumberofUnconsolidatedJointVentures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjcyMjQ_cae394fc-9f5a-4921-b13b-b69f01513cab">13</ix:nonFraction> unconsolidated joint ventures with ownership interests ranging from <ix:nonFraction unitRef="number" contextRef="i976bed9367284ed1a85563a07d391884_D20230101-20230331" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjcyOTU_aa9ce8fc-df2b-4385-bcb3-25334ebc63bf">35</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i22cb4964ff984901bd7110c2d6eecce4_D20230101-20230331" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjczMDE_358377c5-7db8-4c87-8615-8a4148a1a3dd">55</ix:nonFraction>%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;Our investment in these joint ventures is accounted for under the equity method, since RadNet does not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of March&#160;31, 2023.</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment and financial information</span></div><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNjQ_d15dfb7b-060a-426b-91b1-5e2fe75dd22f" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the three months ended March 31, 2023 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:87.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmRkM2Y4N2UzYmQ0ZjRmNzg5MmNlMjc3ZjNlYmExMjE1L3RhYmxlcmFuZ2U6ZGQzZjg3ZTNiZDRmNGY3ODkyY2UyNzdmM2ViYTEyMTVfMC0xLTEtMS01NzA3Mw_bd62b305-53da-4450-80d7-19dac528a83d">57,893</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmRkM2Y4N2UzYmQ0ZjRmNzg5MmNlMjc3ZjNlYmExMjE1L3RhYmxlcmFuZ2U6ZGQzZjg3ZTNiZDRmNGY3ODkyY2UyNzdmM2ViYTEyMTVfMS0xLTEtMS01NzA3Mw_64fbf57e-0ee0-45e2-8a73-405c2a0654b2">1,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmRkM2Y4N2UzYmQ0ZjRmNzg5MmNlMjc3ZjNlYmExMjE1L3RhYmxlcmFuZ2U6ZGQzZjg3ZTNiZDRmNGY3ODkyY2UyNzdmM2ViYTEyMTVfNy0xLTEtMS01NzA3Mw_4b5922c4-07b8-4fc3-affc-6234defa3485">59,321</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately $<ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-5" name="rdnt:ManagementServiceFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjg4MzE_b86b1b59-5b1c-48d1-8703-1f6d7c058a11">4.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-5" name="rdnt:ManagementServiceFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjg4Mzg_ef820130-6aca-4d0f-97ea-49ef929f6562">5.5</ix:nonFraction> million for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNjM_9126db1a-cbc6-4819-bf94-31298980f362" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data for these joint ventures as of March&#160;31, 2023 and December&#160;31, 2022 and income statement data for the three months ended March 31, 2023 and 2022 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97bd8c7f570042a88fd03a8a7dca61be_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfMS0xLTEtMS01NzA3Mw_125bbcc0-9852-4849-949f-a5c14544431c">49,091</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a7007c50a3b4e91aede5d39ed591d0d_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfMS0zLTEtMS01NzA3Mw_06eea465-7e01-4877-b0ca-1b79924fe799">39,304</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97bd8c7f570042a88fd03a8a7dca61be_I20230331" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfMi0xLTEtMS01NzA3Mw_4f99c516-6634-4950-86aa-f8cf6c6f8e20">142,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a7007c50a3b4e91aede5d39ed591d0d_I20221231" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfMi0zLTEtMS01NzA3Mw_b7dcedaa-41de-42f6-a976-d803df470c12">134,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97bd8c7f570042a88fd03a8a7dca61be_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfMy0xLTEtMS01NzA3Mw_32e93139-d6e2-41e3-a301-0846a89fd767">32,995</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a7007c50a3b4e91aede5d39ed591d0d_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfMy0zLTEtMS01NzA3Mw_8a8db139-4678-4a86-a2f4-42668adc1f1a">29,588</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97bd8c7f570042a88fd03a8a7dca61be_I20230331" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfNC0xLTEtMS01NzA3Mw_616da740-1bd4-4d08-9572-59de32fa1c90">48,872</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a7007c50a3b4e91aede5d39ed591d0d_I20221231" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfNC0zLTEtMS01NzA3Mw_3fe6bc4c-040c-4ec6-98dd-f315060d22e6">37,952</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec59367bdfc4e95acaca6780a70c7b4_I20230331" decimals="-3" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfNS0xLTEtMS01NzA3Mw_299351b8-0d60-4ca1-a500-8b0bb3c7518c">109,368</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd6cdf3d5ab422fae40a0ba5aedb8eb_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfNS0zLTEtMS01NzA3Mw_e6aaae2e-885b-4525-b2ab-15612198ed1a">106,458</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec59367bdfc4e95acaca6780a70c7b4_I20230331" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfNy0xLTEtMS01NzA3Mw_d38590fb-2c72-414f-8725-d64c30e9bfde">50,754</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd6cdf3d5ab422fae40a0ba5aedb8eb_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfNy0zLTEtMS01NzA3Mw_1e5ad868-bbd5-4be9-8d45-643fcafd5091">49,564</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec59367bdfc4e95acaca6780a70c7b4_I20230331" decimals="-3" name="us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfOC0xLTEtMS01NzA3Mw_12c7f235-13df-49b2-aa08-ff02a8f0f6bd">8,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd6cdf3d5ab422fae40a0ba5aedb8eb_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfOC0zLTEtMS01NzA3Mw_c62c4900-7f40-47dc-b483-85489b8c7a9a">8,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec59367bdfc4e95acaca6780a70c7b4_I20230331" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfOS0xLTEtMS01NzA3Mw_cdf28c4e-eb59-4274-99b5-311d44c7e51c">59,321</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd6cdf3d5ab422fae40a0ba5aedb8eb_I20221231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfOS0zLTEtMS01NzA3Mw_42b8c7fd-beda-4658-81ab-795325c1cc8c">57,893</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement data for the three months ended March 31,</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i370e4f75f34c4628af09b09b3f73bf92_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmMzNTZmMjk5Y2NjOTQyZWJhMjhkZGY5ZDY2Y2JjODljL3RhYmxlcmFuZ2U6YzM1NmYyOTljY2M5NDJlYmEyOGRkZjlkNjZjYmM4OWNfMS0xLTEtMS01NzA3Mw_36328d30-798a-41bc-a914-9a89f0bcb304">42,086</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0a61645bc4e4f3e9911510a2c98ef50_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmMzNTZmMjk5Y2NjOTQyZWJhMjhkZGY5ZDY2Y2JjODljL3RhYmxlcmFuZ2U6YzM1NmYyOTljY2M5NDJlYmEyOGRkZjlkNjZjYmM4OWNfMS0zLTEtMS01NzA3Mw_a679a288-3676-49b3-b006-e8bbef7da02f">34,411</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i370e4f75f34c4628af09b09b3f73bf92_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmMzNTZmMjk5Y2NjOTQyZWJhMjhkZGY5ZDY2Y2JjODljL3RhYmxlcmFuZ2U6YzM1NmYyOTljY2M5NDJlYmEyOGRkZjlkNjZjYmM4OWNfMi0xLTEtMS01NzA3Mw_a0a1be58-b94a-42f0-9d56-4503f5e8bdaf">2,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0a61645bc4e4f3e9911510a2c98ef50_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmMzNTZmMjk5Y2NjOTQyZWJhMjhkZGY5ZDY2Y2JjODljL3RhYmxlcmFuZ2U6YzM1NmYyOTljY2M5NDJlYmEyOGRkZjlkNjZjYmM4OWNfMi0zLTEtMS01NzA3Mw_72749eb4-7c5f-4cf0-ad73-63aac9ca9f56">5,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_43"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3 &#8211; <ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80My9mcmFnOmNlMDI2OTEwYTZiZjRmYWE4ZGM3NjhjMWM2YWIwMjlkL3RleHRyZWdpb246Y2UwMjY5MTBhNmJmNGZhYThkYzc2OGMxYzZhYjAyOWRfMjcyNw_6dbf0f81-2919-4519-8d0a-4955afd33083" continuedAt="i33de8a02e8e24f2ba8104b587808e0f2" escape="true">RECENT ACCOUNTING AND REPORTING STANDARDS</ix:nonNumeric></span></div><div style="margin-top:10pt"><span><br/></span></div><ix:continuation id="i33de8a02e8e24f2ba8104b587808e0f2"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80My9mcmFnOmNlMDI2OTEwYTZiZjRmYWE4ZGM3NjhjMWM2YWIwMjlkL3RleHRyZWdpb246Y2UwMjY5MTBhNmJmNGZhYThkYzc2OGMxYzZhYjAyOWRfMjcyNg_1a614777-17fa-455c-aee4-a6ddb9a2a5b1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor new accounting pronouncements issued by the FASB and do not believe any accounting pronouncements issued through the date of this report will have a material impact on our financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_46"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> NOTE 4 &#8211; <ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RleHRyZWdpb246NWQ1YzBlNDQyMDU3NGFjMTkwYTZmODAzMTJhNThkMGZfMzY0NA_4971f8a2-c1ba-4a5e-9b6b-4587bd0313ef" continuedAt="i30a091a932f8441cb2464b1d361d45ed" escape="true">BUSINESS COMBINATIONS AND RELATED ACTIVITY</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="i30a091a932f8441cb2464b1d361d45ed"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center Segment</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the California and New York markets.  These acquisitions are reported as part of our Imaging Center segment.  <ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RleHRyZWdpb246NWQ1YzBlNDQyMDU3NGFjMTkwYTZmODAzMTJhNThkMGZfMzY0Nw_c428affe-e7e8-4328-b6dc-af33732db2d2" continuedAt="i1b3503084a634600be21f103739e1605" escape="true">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i1b3503084a634600be21f103739e1605"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.286%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.267%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C.C.D.G.L.R. &amp; S Services Inc.</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i788654bdc6144e84b022463f3c939653_I20230101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMS0yLTEtMS01NzA3Mw_c75ea00e-887b-434c-8b66-3115e9206407">3,500</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i788654bdc6144e84b022463f3c939653_I20230101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMS0zLTEtMS01NzA3Mw_4501f442-2e80-4dd7-a389-dc847c0d04b1">435</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i788654bdc6144e84b022463f3c939653_I20230101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMS00LTEtMS01NzA3Mw_902f680a-b9e4-4fe0-ac7e-4ecca83725e9">1,689</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i788654bdc6144e84b022463f3c939653_I20230101" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMS01LTEtMS01NzA3Mw_26fac19d-9ea9-44a7-82fb-1bba5d5b3645">3,015</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i788654bdc6144e84b022463f3c939653_I20230101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMS02LTEtMS01NzA3Mw_7da56d30-f689-4040-893d-237d5164aa93">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i788654bdc6144e84b022463f3c939653_I20230101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMS03LTEtMS01NzA3Mw_8f0c24e8-639b-4e18-b800-1e1b26b8c9df">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i788654bdc6144e84b022463f3c939653_I20230101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMS04LTEtMS01NzA3Mw_d4fc0470-ccc3-4c80-9e2b-afd68fbd6281">1,689</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southern California Diagnostic Imaging, Inc. </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf90602139824e3f84f725fcb7a55b86_I20230101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi0yLTEtMS04MjExNg_76fa2022-92e7-48e1-9e01-1f36495074c0">1,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf90602139824e3f84f725fcb7a55b86_I20230101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi0zLTEtMS04MjExNg_2018a461-b293-414a-8a77-83d2c97fc029">466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf90602139824e3f84f725fcb7a55b86_I20230101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi00LTEtMS04MjExNg_f10ec512-69a9-4f62-bc58-022ea9573885">1,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf90602139824e3f84f725fcb7a55b86_I20230101" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi01LTEtMS04MjExNg_00b50735-6526-4960-88b9-8ef487d81393">1,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf90602139824e3f84f725fcb7a55b86_I20230101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi02LTEtMS04MjExNg_2706fbdc-e580-4ff4-9139-21f659fccf92">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf90602139824e3f84f725fcb7a55b86_I20230101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi03LTEtMS04MjExNg_89d06bb5-555b-44e2-a99d-0bd353a1b079">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf90602139824e3f84f725fcb7a55b86_I20230101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi04LTEtMS04MjExNg_19eb9f06-50d8-4034-bda3-10881562631d">1,184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inglewood Imaging Center, LLC</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf3a349f994e4b7c8b647f364de53930_I20230201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi0yLTEtMS01NzA3Mw_3f1bf62b-a199-48da-b6c2-bda430fe6b83">2,600</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf3a349f994e4b7c8b647f364de53930_I20230201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi0zLTEtMS01NzA3Mw_f95302f9-2b4d-4325-bc0e-d6ea2c4e00df">877</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf3a349f994e4b7c8b647f364de53930_I20230201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi00LTEtMS01NzA3Mw_dd942e78-9dfb-4ec8-86c9-d41f93b3b13a">1,188</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf3a349f994e4b7c8b647f364de53930_I20230201" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi01LTEtMS01NzA3Mw_0ddab062-5efe-4df3-bae0-4d9bf23e513d">1,658</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf3a349f994e4b7c8b647f364de53930_I20230201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi02LTEtMS01NzA3Mw_f625fe66-069b-4a5c-b4cc-c2841a80fc2c">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf3a349f994e4b7c8b647f364de53930_I20230201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi03LTEtMS01NzA3Mw_631caf65-b8ee-4944-8b9f-da0e2b0ecd7d">15</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf3a349f994e4b7c8b647f364de53930_I20230201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi04LTEtMS01NzA3Mw_b39423c9-5974-4362-b53d-8ad0c6431aa1">1,188</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ramapo Radiology Associates, P.C.</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2023</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if677eedf1e8441f48af5d0ec930fda69_I20230201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfNC0yLTEtMS04MjEzMw_8de7d36e-06ff-4e55-ba87-9e30c36fc8d9">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if677eedf1e8441f48af5d0ec930fda69_I20230201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfNC0zLTEtMS04MjEzMw_80307b71-17dc-45a6-8482-fe6f4f61aa7a">1,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if677eedf1e8441f48af5d0ec930fda69_I20230201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfNC00LTEtMS04MjEzMw_88ec6329-b14d-48f4-952d-3d878320c4de">3,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if677eedf1e8441f48af5d0ec930fda69_I20230201" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfNC01LTEtMS04MjEzMw_afccfb76-63f0-445a-a7ce-a95482e4611c">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if677eedf1e8441f48af5d0ec930fda69_I20230201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfNC02LTEtMS04MjEzMw_00681db9-47cf-4f3e-9c83-b74a04b97fef">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if677eedf1e8441f48af5d0ec930fda69_I20230201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfNC03LTEtMS04MjEzMw_77aa9743-62ac-4e95-a105-abfaa12fb41f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if677eedf1e8441f48af5d0ec930fda69_I20230201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfNC04LTEtMS04MjEzMw_48027b5e-ca3c-49d1-8395-e2a9d8d0416f">3,775</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd669e75c1d64607a8a4a42d825b5372_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMy0yLTEtMS01NzA3Mw_0d106d97-ce99-45d8-b730-10f33c081aaf">9,915</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd669e75c1d64607a8a4a42d825b5372_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMy0zLTEtMS01NzA3Mw_9ca4dae6-616a-4bf5-85c6-d4f9b9989a06">3,441</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd669e75c1d64607a8a4a42d825b5372_I20230331" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMy00LTEtMS01NzA3Mw_9fbee11b-6abc-4c28-ac5f-aa923a08f12b">7,836</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd669e75c1d64607a8a4a42d825b5372_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMy01LTEtMS01NzA3Mw_cf39cfc6-0040-49c8-a499-c8995053b12f">6,174</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd669e75c1d64607a8a4a42d825b5372_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMy02LTEtMS01NzA3Mw_541bead3-49aa-49b7-a051-2cb5b1641c97">250</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd669e75c1d64607a8a4a42d825b5372_I20230331" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMy03LTEtMS01NzA3Mw_7343d327-2cd8-41c3-a2f9-aff93ae36e0c">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd669e75c1d64607a8a4a42d825b5372_I20230331" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMy04LTEtMS01NzA3Mw_d2153471-f6ce-4822-b64b-8bfc2d7c8d70">7,836</ix:nonFraction>)</span></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_49"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> NOTE 5 &#8211; <ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RleHRyZWdpb246OWIyMzQ5YmVjNTJmNGFmNjk4YTc5ZDgwMmVlZDQ0NmJfMTkzNw_f0eb28a8-91c2-404b-a636-f6591eb7504a" continuedAt="i0d464206554241d0b2974f31183c148f" escape="true">SEGMENT REPORTING</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0d464206554241d0b2974f31183c148f" continuedAt="i1fc769dca0054a2c8613e067dfe961a4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reportable segments are described below:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a strategy that diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  Included in the segment is our eRad subsidiary, which designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence ("AI")</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our chief operating decision maker ("CODM"), who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit and loss statements prepared on a basis not consistent with GAAP.  We do not report balance sheet information by segment since it is not reviewed by our CODM.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RleHRyZWdpb246OWIyMzQ5YmVjNTJmNGFmNjk4YTc5ZDgwMmVlZDQ0NmJfMTkzNg_476b00ed-4c0d-4175-aad4-e03059034681" continuedAt="i2c10b55410864b5ba65f56125bfc9754" escape="true">The table below presents segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="text-indent:36pt"><ix:continuation id="i1fc769dca0054a2c8613e067dfe961a4"><ix:continuation id="i2c10b55410864b5ba65f56125bfc9754"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.198%"><tr><td style="width:1.0%"></td><td style="width:51.672%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.103%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.104%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2023</span></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMy0xLTEtMS01NzA3Mw_39186d0e-ed4f-48c5-aa3b-50ff08469443">388,431</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0df0cc0c59df4b2f96629acaa138268c_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMy0zLTEtMS01NzA3Mw_d155283b-8365-4212-b50a-cbbbebd76eb9">341,168</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2afa7782c90e43af8a9291b388ae0a30_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfNC0xLTEtMS01NzA3Mw_9516d27f-9afb-49d5-b855-87066a046b15">2,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id46e5c5dde784886904adce4e0b992aa_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfNC0zLTEtMS01NzA3Mw_bf320fb0-e832-40ec-8163-bff4e87d3af3">599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfNS0xLTEtMS01NzA3Mw_eb23c5af-9b73-40fc-8830-814c27af3f9e">390,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfNS0zLTEtMS01NzA3Mw_ba73d841-56fd-47df-86de-116681f45996">341,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cost of Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfOC0xLTEtMS01NzA3Mw_c1d339b5-abb7-4997-ba16-098e7d78c98b">344,580</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0df0cc0c59df4b2f96629acaa138268c_D20220101-20220331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfOC0zLTEtMS01NzA3Mw_4ad255de-1917-4a5a-b56f-a01880b9a8ca">310,110</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2afa7782c90e43af8a9291b388ae0a30_D20230101-20230331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfOS0xLTEtMS01NzA3Mw_1d6165e7-c3e6-4100-bc78-28163b29a0a2">7,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id46e5c5dde784886904adce4e0b992aa_D20220101-20220331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfOS0zLTEtMS01NzA3Mw_8b95de97-9bce-4d58-985a-abf1ac6bd53d">4,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cost of operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTAtMS0xLTEtNTcwNzM_a90ce823-8ff6-4943-896d-a17b0bef7a94">351,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTAtMy0xLTEtNTcwNzM_13caebae-4e22-4e98-8537-8de6eb5ea16f">315,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Depreciation and Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTMtMS0xLTEtNTcwNzM_9514653e-dde6-45a9-894f-68380459d87e">29,591</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0df0cc0c59df4b2f96629acaa138268c_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTMtMy0xLTEtNTcwNzM_cb411d05-91e9-49f6-864c-d5d54a194ae6">25,805</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2afa7782c90e43af8a9291b388ae0a30_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTQtMS0xLTEtNTcwNzM_4ebc247a-b817-46c4-ba9f-4f4721cb0627">1,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id46e5c5dde784886904adce4e0b992aa_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTQtMy0xLTEtNTcwNzM_f06f1b39-ef2d-4e34-a158-b6614a156d18">1,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTUtMS0xLTEtNTcwNzM_f09122f8-d041-435b-8c51-561ce8f82ca4">31,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTUtMy0xLTEtNTcwNzM_8b85cacd-f79f-49cd-bbc0-e09a19a02d2e">27,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Loss on Disposal of Equipment:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTgtMS0xLTEtNTcwNzM_2cf98561-cb0c-4667-9c31-a436b4c33c29">577</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0df0cc0c59df4b2f96629acaa138268c_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTgtMy0xLTEtNTcwNzM_d2b7097e-12f1-4220-8d0a-79566d5f7e47">1,154</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2afa7782c90e43af8a9291b388ae0a30_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTktMS0xLTEtNTcwNzM_4a4c5aa4-5706-4ccd-9739-9602a36c687c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="id46e5c5dde784886904adce4e0b992aa_D20220101-20220331" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTktMy0xLTEtNTcwNzM_3f7a5035-7cff-460d-a76a-952391e0b169">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total loss on disposal of equipment</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjAtMS0xLTEtNTcwNzM_3a2e277e-c039-4af0-add1-94fb9075901d">579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjAtMy0xLTEtNTcwNzM_bc010214-ea48-441f-8237-368101186f20">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Severance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjMtMS0xLTEtNTcwNzM_59c46b8b-4bad-4b82-8fe9-2bdaeeef10d6">122</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0df0cc0c59df4b2f96629acaa138268c_D20220101-20220331" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjMtMy0xLTEtNTcwNzM_52ee0597-cba7-4df8-9dff-c70f03d03c18">201</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2afa7782c90e43af8a9291b388ae0a30_D20230101-20230331" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjQtMS0xLTEtNTcwNzM_32153614-713d-4cb2-ab3d-3ff23bac44b4">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id46e5c5dde784886904adce4e0b992aa_D20220101-20220331" decimals="-3" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjQtMy0xLTEtNTcwNzM_2dfc4c93-2300-4ba1-bca7-a8433d634ce6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total severance</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjUtMS0xLTEtNTcwNzM_56d05b7f-ccdf-4b51-bc90-5e469b6f806f">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjUtMy0xLTEtNTcwNzM_753170f5-cdcc-44c7-b981-6594131df15e">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;Income (Loss) from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjgtMS0xLTEtNTcwNzM_9120541e-d3a8-46e6-8e86-54235e4ec44b">13,561</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0df0cc0c59df4b2f96629acaa138268c_D20220101-20220331" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjgtMy0xLTEtNTcwNzM_d69f217c-8ccf-4bdb-a352-30ba2daf2ada">3,898</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i2afa7782c90e43af8a9291b388ae0a30_D20230101-20230331" decimals="-3" sign="-" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjktMS0xLTEtNTcwNzM_d47fd23c-6b04-4db2-9fdc-21e3dc944ccc">6,890</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="id46e5c5dde784886904adce4e0b992aa_D20220101-20220331" decimals="-3" sign="-" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjktMy0xLTEtNTcwNzM_45c2b1a6-7dcb-4c7d-acd0-c82df721485d">5,617</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total income (loss) from operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMzAtMS0xLTEtNTcwNzM_02718a3b-5c87-494d-8714-5c1604ab02db">6,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331" decimals="-3" sign="-" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMzAtMy0xLTEtNTcwNzM_c0e4e659-07bc-44b7-9f16-6fc82a9fe420">1,719</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></ix:continuation></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="if318a573f95e4e07addbbbfb9543d1c5_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6 &#8211; <ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfODE0NQ_708ab15b-cebe-45f4-8bf3-45d909ec7aab" continuedAt="ifc41dfe857664bdba52600fbe1201b8b" escape="true">CREDIT FACILITIES AND NOTES PAYABLE</ix:nonNumeric></span></div><ix:continuation id="ifc41dfe857664bdba52600fbe1201b8b" continuedAt="ie44fcec61e7940fb9fdac2bcfd75b638"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfODE0Ng_b21ed4e5-7710-4c7c-8a23-4f6f8134fc03" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022 our term loan debt and other obligations are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:74.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.841%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ac0a47d40fa44da84be66fbe8b675c2_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfMi0xLTEtMS01NzA3Mw_e2d9eb79-0ba3-4fa0-b03a-dd16b73af35f">712,313</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if935da71de9445f7a64decc4aa12e4d7_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfMi0zLTEtMS01NzA3Mw_52939de4-ab53-4a43-991d-eb14975c85f5">714,125</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ac0a47d40fa44da84be66fbe8b675c2_I20230331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfMy0xLTEtMS01NzA3Mw_a6bdcb91-95e0-4946-ad29-b467b06f4fb4">10,606</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if935da71de9445f7a64decc4aa12e4d7_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfMy0zLTEtMS01NzA3Mw_70e43cb6-da40-4e16-a9ea-0bcdad1515e6">11,127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2ee49b2f311482e92604c71016505c9_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfNC0xLTEtMS01NzA3Mw_f95b24ff-3c67-4b5e-8ca4-df00508a1469">148,125</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c3b439894a24feb9d3346baa502e442_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfNC0zLTEtMS01NzA3Mw_35456db9-7626-4936-9411-b8189e1dc213">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on NJIN Term Loan Agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2ee49b2f311482e92604c71016505c9_I20230331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfNS0xLTEtMS04MTY1OA_b995ecc5-4c68-4f4b-afbe-e3dd3f6ed361">1,188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c3b439894a24feb9d3346baa502e442_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfNS0zLTEtMS04MTY2Ng_b26a62be-1c72-44c1-847b-90f24db98174">1,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment notes payable at <ix:nonFraction unitRef="number" contextRef="i62f2d5d6e38947cebfe0535e07397150_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfNy0wLTEtMS01NzA3My90ZXh0cmVnaW9uOjc1MDA0NmQ2MjQ4ZDQ0MDU5MDExYTA4Y2EzYmFlMDNiXzE2NDkyNjc0NDE3NTg_705f69c6-27d0-4e83-83da-56638adc0806">6.0</ix:nonFraction>%, due 2028, collateralized by medical equipment</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f2d5d6e38947cebfe0535e07397150_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfNy0xLTEtMS04MTY3NA_1bbf9029-074e-45cd-92c2-64404348cc9c">19,645</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ec02cff0bb7403d93c06ed1115db776_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfNy0zLTEtMS04MTY3NA_9de01fff-09e1-408f-955b-2c2c3f6c0106">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfOC0xLTEtMS01NzA3Mw_2c93b2cb-5f9d-41c5-a5a2-3f5531040ee7">868,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfOC0zLTEtMS01NzA3Mw_bb247c59-ecef-4f4b-beea-8d721eda1453">851,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfOS0xLTEtMS01NzA3Mw_fb7faa46-8ac3-4888-9568-687c762a1332">15,935</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfOS0zLTEtMS01NzA3Mw_51548384-3c6e-422a-86b5-73e0983dfa0d">12,400</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term portion debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfMTAtMS0xLTEtNTcwNzM_31fd693c-6529-4c3d-8d21-e22128b21130">852,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfMTAtMy0xLTEtNTcwNzM_cc15fd79-7a1b-48de-910b-ecec42cea585">839,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="usd" contextRef="i5ee8e2a0aedf4e16bfc1f00854be3504_I20221231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMTM3_097f275a-4147-4081-a140-88fa280d0cf8"><ix:nonFraction unitRef="usd" contextRef="i74aaf1e8f24d470db2a98ecc203f2374_I20230331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMTM3_fa8c1588-64de-4109-9606-65fd9bb89e8b">no</ix:nonFraction></ix:nonFraction> outstanding balance under our $<ix:nonFraction unitRef="usd" contextRef="iff74038af72140fba140e6ea501d015f_I20210423" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMTcw_2214944d-f71d-443a-960d-d2ec2dbed877">195.0</ix:nonFraction> million Barclays Revolving Credit Facility at March&#160;31, 2023 and have reserved $<ix:nonFraction unitRef="usd" contextRef="iafa7ca073c27455da1ef23c17f9d1eaf_I20230331" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMjMy_bb42b153-f194-4104-b534-7a012888253f">7.6</ix:nonFraction> million for certain letters of credit. The remaining $<ix:nonFraction unitRef="usd" contextRef="i27e434031da1489c8d9bbda89a5969c6_I20230331" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMjgw_60638824-c522-400c-9bb4-4a02144e484e">187.4</ix:nonFraction> million of our Barclays Revolving Credit Facility was available to draw upon as of March&#160;31, 2023.  We also had <ix:nonFraction unitRef="usd" contextRef="ic21b3f13e434406ba1275f4ac33a277e_I20230331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMzcw_a72522ec-f0ec-416c-955a-0cc2bd2e0677">no</ix:nonFraction> balance under our $<ix:nonFraction unitRef="usd" contextRef="i5bdf271a43584924822139b8fb9380b0_I20230331" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNDAz_7226fb1f-e455-4f2d-85c0-d4ae78452461">50.0</ix:nonFraction> million Truist Revolving Credit Facility related to our consolidated subsidiary NJIN at March&#160;31, 2023, and with no letters of credit reserved against the facility, the full amount was available to draw upon.  At March&#160;31, 2023, we were in compliance with all covenants under our credit facilities.  On February 1, 2023, we issued a promissory note in the amount of $<ix:nonFraction unitRef="usd" contextRef="i7ae3cbf23e8046c887d676fc95010311_I20230201" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQyOTE4_083dfb92-e0af-4cc0-bbed-024900e71583">19.8</ix:nonFraction> million to acquire radiology equipment previously leased under operating leases.</span></div><div style="margin-top:5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments to Credit Facilities</span></div><div style="margin-top:10pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays: First Amendment to Second Amended and Restated First Lien Credit and Guaranty Agreement</span></div><div style="margin-top:10pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2023, we entered into the First Amendment to Second Amended and Restated First Lien Credit and Guaranty Agreement (the &#8220;Amendment&#8221;). The Amendment replaces the interest rate benchmark, from the London Interbank Offered Rate (&#8220;LIBOR&#8221;) to the Secured Overnight Financing Rate (&#8220;SOFR&#8221;) and includes applicable credit spread adjustments of <ix:nonFraction unitRef="number" contextRef="idfa89e509e1e48328e0d64bb2910a9ae_I20230327" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxNzMw_ce8d5d85-a10a-4b32-b2bb-4fbb5ed9a7ea">0.11448</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i96f81a7f32d64009b629b9ef4859f993_I20230327" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxNzM0_3211cf21-aedf-4a9e-bba1-d6f548687088">0.26161</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i42b5a1db32b749cc972364acdd9c9644_I20230327" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxNzM4_7de905da-c1c8-40b7-a734-b260ec27d275">0.42826</ix:nonFraction>% for interest periods of one month, three months, and six months, respectively. The replacement of LIBOR with SOFR and the credit spread adjustments shall be effective as of March 31, 2023, which is the last day of the last-ending existing interest period of currently outstanding loans bearing interest at LIBOR. Other than the foregoing, the material terms of the Credit Agreement remain unchanged.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays: Second Amended and Restated First Lien Credit and Guaranty Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2021, we entered into the Second Amended and Restated First Lien Credit and Guaranty Agreement (the  "Restated Credit Agreement") which provides for $<ix:nonFraction unitRef="usd" contextRef="ie71f440e2c7643508c28e8a01a00242c_I20210423" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNzYw_a80b8eac-0690-438a-abfe-d13b36340f65">725.0</ix:nonFraction> million of senior secured first lien term loans (the "First Lien Term Loans") and a $<ix:nonFraction unitRef="usd" contextRef="iff74038af72140fba140e6ea501d015f_I20210423" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfODM5_2214944d-f71d-443a-960d-d2ec2dbed877">195.0</ix:nonFraction> million senior secured revolving credit facility (the "Barclays Revolving Credit Facility"). The proceeds of the First Lien Term Loans were used to refinance loans outstanding under our prior first lien credit agreement and provide funding for current and future operations. Total costs of the Restated Credit Agreement amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="icc1ca11c511b475ca49c7b77c92736bc_I20210423" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMTE4MA_70d31960-392e-4d42-8ecd-4374625e9f15">14.9</ix:nonFraction> million segregated as follows: $<ix:nonFraction unitRef="usd" contextRef="icc1ca11c511b475ca49c7b77c92736bc_I20210423" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMTIwNg_40da806a-04d4-4dc9-8b09-1fb6d445b5c0">8.8</ix:nonFraction> million capitalized to discount and deferred finance cost, $<ix:nonFraction unitRef="usd" contextRef="icc1ca11c511b475ca49c7b77c92736bc_I20210423" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMTI2MA_ce9135f1-1499-4f53-8254-ad9dac17fea4">4.5</ix:nonFraction> million expensed to debt restructuring costs, $<ix:nonFraction unitRef="usd" contextRef="if7ec32e42eb944bb9330cd1cb04f945c_D20210423-20210423" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMTMwMg_96a4a443-57eb-4332-a0f4-d6fc9060c12c">1.5</ix:nonFraction> million charged to loss on early extinguishment of debt and $<ix:nonFraction unitRef="usd" contextRef="if7ec32e42eb944bb9330cd1cb04f945c_D20210423-20210423" decimals="-5" name="us-gaap:AmortizationOfDeferredCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMTM1Nw_283a8d1c-1876-4f3c-8fc8-0361f209ec8e">0.1</ix:nonFraction> million written off to interest expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist: Second Amended and Restated Revolving Credit and Term Loan Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 7, 2022, we entered into the Second Amended and Restated Revolving Credit and Term Loan Agreement (the "Restated Credit and Term Loan Agreement") which provides for a $<ix:nonFraction unitRef="usd" contextRef="i3bc539faeadf438fbd7d4d1552f9881b_I20221007" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODM1_d2d000cf-887a-47ab-8860-1da8e1313515">150.0</ix:nonFraction> million of a secured term loan (the "Truist Term Loan") and a $<ix:nonFraction unitRef="usd" contextRef="i8827e76d9d944f0c83ab889ff9b40970_I20221007" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODQy_79e87fca-d7cb-4f17-9d5e-68413e071c71">50.0</ix:nonFraction> million secured revolving credit facility (the "Truist Revolving Credit Facility").  Both loans were secured by our simultaneous entry into the Second Amended and Restated Guaranty and Security Agreement on the same date.  The proceeds were were used to refinance the outstanding balance under our prior term loan agreement and provide funding for current and future operations. Total costs of the Restated Credit and Term Loan Agreement amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i2949ad265aae416b895dc287e1c90a56_I20221007" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODQ3_f2f2fdaa-949c-48a2-97ec-5a693393808c">2.7</ix:nonFraction> million segregated as follows: $<ix:nonFraction unitRef="usd" contextRef="i2949ad265aae416b895dc287e1c90a56_I20221007" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODU0_46d4ff77-41c2-4a6a-b7e7-c537819642b6">2.0</ix:nonFraction> million capitalized to discount and deferred finance cost and $<ix:nonFraction unitRef="usd" contextRef="i4a4b8e05477244e69f17430f41440f40_D20221007-20221007" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODYx_4e3ab33e-f2d2-4fcc-90e3-fcdb988f46a4">0.7</ix:nonFraction> million expensed to loss </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><ix:continuation id="ie44fcec61e7940fb9fdac2bcfd75b638" continuedAt="i2ff923d945314d6483fada4beb34be87"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on extinguishment of debt and related expenses in other expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit and Term Loan Agreement.</span></div><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="rdnt:ScheduleOfLeverageRatioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMzg0ODI5MDcyMjEyMg_94ef51f8-0aca-4106-8cfc-ee50080f08bd" continuedAt="ia4c2e8ac8cdb4b46ad8e87b6858b5f7a" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All obligations under the Second Amended and Restated Credit and Term Loan Agreement bear interest at either a SOFR or a Base Rate (each as defined in the Restated Credit and Term Loan Agreement), plus an applicable margin according to the following schedule:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for SOFR Loans</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to <ix:nonFraction unitRef="number" contextRef="i6f4de3e0b12c4ce99436f199560d928d_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMS0xLTEtMS04MTc1OC90ZXh0cmVnaW9uOmY2MmE1YTM5OTMxYzQ0ODY4YjBjOGE0MDE0OGYyNzkzXzI5_5ce8faab-d4b8-43da-afad-874843bc7997">3.00</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc503ebed81d4c76998b856dfa54a9b5_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMS0yLTEtMS04MTc1OC90ZXh0cmVnaW9uOjNhNmQ3NWNiMzk4ZjQ5MzFhZTNlMDY4Y2IyZGE1ZmU0XzU_0df3dbef-4dfc-4834-8779-2502293c9b3a">2.50</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie5832838df87478bba175d9f9ab09d12_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMS0zLTEtMS04MTc1OC90ZXh0cmVnaW9uOmRmNDAyMWVlZDRiMDQ4YjQ5MjRiODZhZmExN2FjMmRkXzU_0942dd05-e7d8-4da7-86fc-854f0ee71592">1.50</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb58ba96caad4ba7bb0c8651dbcd3083_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMS00LTEtMS04MTc1OC90ZXh0cmVnaW9uOmQ3ZDYwZmI3OWVjMTQ3N2Q5ZjRlYTdlY2JmYjYyODU5XzU_d56a12fe-6e46-432b-b8cd-a38285b14f1a">2.50</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb58ba96caad4ba7bb0c8651dbcd3083_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMS01LTEtMS04MTc1OC90ZXh0cmVnaW9uOjc2Mjg1YmQyNWQ0ZDQwNTQ5NTU2YzY4N2IzZWZiNTQ0XzU_7450925d-b8b8-4b94-8bd0-3d6c9daeed8f">0.45</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="i489017a84c394ba39520152a49aa8cda_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMi0xLTEtMS04MTc1OC90ZXh0cmVnaW9uOmQxZGE0Njk4MmQ2OTRkZTZhZTNkNjRjNTcwYjM3MGExXzE0_fba54fce-6d33-4781-b27d-f6034f78ec06">3.00</ix:nonFraction>:1.00 but greater than or equal to <ix:nonFraction unitRef="number" contextRef="i489017a84c394ba39520152a49aa8cda_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMi0xLTEtMS04MTc1OC90ZXh0cmVnaW9uOmQxZGE0Njk4MmQ2OTRkZTZhZTNkNjRjNTcwYjM3MGExXzUx_a5194395-fcb5-409f-a5e0-0853d50c82b0">2.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icb4c174e094d423b95626eb584086fe6_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMi0yLTEtMS04MTc1OC90ZXh0cmVnaW9uOmQ3YjZkMTBlZDRhYzQ2Yzc4MzEyMGQ5NzhhNDcxZjU5XzU_6937795d-3c00-42c9-8bcf-e289b24e8f81">2.25</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84d7aa7a0eb0454e91b9f2219e820140_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMi0zLTEtMS04MTc1OC90ZXh0cmVnaW9uOjdhOWVmZDk1ZDYxYTRmMjNiYjhlODM5Y2VhNTBlYjE0XzU_cd158ceb-132f-4672-be7f-88534befd83c">1.25</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie5a73f30657642bda3a4e7fae521a479_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMi00LTEtMS04MTc1OC90ZXh0cmVnaW9uOmNkYmQwYTQwYWUxNDQ2NTY5NmY1MDcwYWE3OGIxNThhXzU_37091c8e-2212-44a5-bdde-473aa3122214">2.25</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie5a73f30657642bda3a4e7fae521a479_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMi01LTEtMS04MTc1OC90ZXh0cmVnaW9uOmM0ZGQzYzRhMTg2MTRkOTVhNDZkNzVhZGQzNmNkNGRkXzU_021f9fe1-d416-4df9-99be-bb7fc27463a7">0.40</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="ib440cff642614ebfb76342cdb0207f49_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMy0xLTEtMS04MTc1OC90ZXh0cmVnaW9uOmI2MThlYWZmZjMwNTQ2ZTE4N2UxM2VmZjQyY2QxMmYxXzE1_6cea3405-0aee-4763-9777-ac3d46a39918">2.50</ix:nonFraction>:1.00 but greater than or equal to</span></div><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib440cff642614ebfb76342cdb0207f49_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMy0xLTEtMS04MTc1OC90ZXh0cmVnaW9uOmI2MThlYWZmZjMwNTQ2ZTE4N2UxM2VmZjQyY2QxMmYxXzUy_0d730a0e-984f-4637-b9b6-bb920724cf50">2.00</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7d124de1ada45beacf97bc0d67b1168_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMy0yLTEtMS04MTc1OC90ZXh0cmVnaW9uOmFjMDQwODk4MjQxZjRkMmRiODI3MmI0ODBlMjA1ZWM5XzU_8d8ea284-5b8e-4bf9-aa5c-eb673116dfa3">2.00</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5fd2d5ebfa4446888fa605822721f229_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMy0zLTEtMS04MTc1OC90ZXh0cmVnaW9uOjJiYTBhYjM0ZDk4YzRiYmQ5ODlmYjFiYTE5MWEyMjA3XzU_331f017a-b4ff-43a7-80b7-6422b1e28e40">1.00</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb2039ca234941c2af241afaa4dd085a_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMy00LTEtMS04MTc1OC90ZXh0cmVnaW9uOjFmNDRmNzYzMjAyYzQ1ZWQ4OWE5ZmNhNjQyNTUyYTA4XzU_e3d01780-0b56-47ea-8ab9-824aa448119c">2.00</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb2039ca234941c2af241afaa4dd085a_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMy01LTEtMS04MTc1OC90ZXh0cmVnaW9uOjJkYjM2Yjg3YTk0NzQ3OTZiNTBhMjM1NzA0ZmQyZDUzXzU_fd6c5323-072c-40de-b13a-4a88aef62129">0.35</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="icaaf8454b0ae42a5825cbd6024216629_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNC0xLTEtMS04MTc1OC90ZXh0cmVnaW9uOjk1OTk5MTFmNWQ1MjQ2MWRiNGU4NTgzYTEwNTIxOWExXzE0_18b2b243-953c-443e-bf2e-8622fcf8d0df">2.00</ix:nonFraction>:1.00 but greater than or equal to <ix:nonFraction unitRef="number" contextRef="icaaf8454b0ae42a5825cbd6024216629_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNC0xLTEtMS04MTc1OC90ZXh0cmVnaW9uOjk1OTk5MTFmNWQ1MjQ2MWRiNGU4NTgzYTEwNTIxOWExXzUx_43ab5146-afbe-470c-972a-d6e1c53aaa52">1.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia8045fe5cfc84ac08c6a0c898079bdde_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNC0yLTEtMS04MTc1OC90ZXh0cmVnaW9uOmIyODAwYTFkM2M0NzQxMzFhMGU3YjM2N2M4NTk0ZjkzXzU_5bca1d7b-35a6-4a78-9e55-66a6f3c674ae">1.75</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d3c803e6a4b4fa7b9264589b4154b82_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNC0zLTEtMS04MTc1OC90ZXh0cmVnaW9uOmU4NmE0MDU4YWRmYTRiOGJhZTI1MjVhNTI2NjRiNzgxXzU_834fe680-fe15-4132-99d1-c215bd809113">0.75</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia4c088461a3c4c95a93abef9e3f00c29_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNC00LTEtMS04MTc1OC90ZXh0cmVnaW9uOmYxZTBjODBkZmE1ZDRmZjFhMzc0ZDcyZGVmYWMzYWMwXzU_20dfbaf9-952c-464e-8f25-58d8a459f537">1.75</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia4c088461a3c4c95a93abef9e3f00c29_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNC01LTEtMS04MTc1OC90ZXh0cmVnaW9uOjYyY2VjZjBhZTZjYjQxYzdhZWNiOWQ5NWFlNTQyOTM1XzU_98444397-aed2-4662-9a3a-e3ecc8f72064">0.30</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="i3de3948a63bb469ba713d1ada7005b41_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNS0xLTEtMS04MTc1OC90ZXh0cmVnaW9uOjZkYjdhZjkzODE5OTRiYjhiOTU3MmNmYWMwZDg0NDBlXzE0_641f85ef-103d-4ef3-9d09-463289ff29c0">1.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia8335fa556c04b78865bee76634b9ff7_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNS0yLTEtMS04MTc1OC90ZXh0cmVnaW9uOjk3NTJkMjE0ZDJjNjQ3ZTNhMzQyY2M3YTJiZTA4NGRlXzU_9b763439-e160-4935-a282-ea95606ecdad">1.50</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i324536b68eb244a7b90b0a3ba932bb6a_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNS0zLTEtMS04MTc1OC90ZXh0cmVnaW9uOjZiYWMwOGI2ZGExMzQyOGNhMWI4MmIyZTI0YWQ3Y2ZhXzU_c6478d42-0b08-420d-8e85-82addb186cdd">0.50</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55a8765735c14513a443454a717b1110_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNS00LTEtMS04MTc1OC90ZXh0cmVnaW9uOmYwZTUyYzIyZTdkZDRhZjE4NjdjN2Q0ODc4YTAyODFiXzU_b5a85d35-a03a-4bff-8c45-2c0278755b8b">1.50</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55a8765735c14513a443454a717b1110_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNS01LTEtMS04MTc1OC90ZXh0cmVnaW9uOjAyMzI0MzAwODljYTQ0OWY5YTllNjBiNzc4ZmQ0YzNhXzU_e8738c88-8ae2-4c63-83c0-9129c05667e0">0.30</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Secured Credit Facilities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">First Lien Term Loans:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through March 31, 2023, the First Lien Term Loans under the Restated Credit Agreement bore interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement), plus an applicable margin.  The applicable margin for Eurodollar Rate and Alternate Base Rate First Lien Term Loans under the Restated Credit Agreement was <ix:nonFraction unitRef="number" contextRef="i3ba2dd225829444a8f3c676b6fd16f76_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM3MzAw_68350ed2-19a5-4848-802c-50c99ca57f4a">3.00</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="id30c357b819f411f883897ece82a2ee9_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM3MzA4_0d0650f2-cd36-4c84-8d9e-123f97f9eb16">2.00</ix:nonFraction>%, respectively, with an effective Eurodollar Rate and the Alternate Base Rate of <ix:nonFraction unitRef="number" contextRef="i60ee747f054f4a7fa53e6ca0d30f6fac_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMjI3OQ_dfe413b2-be9b-4f00-beb1-59cbf4681252">4.63</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ida485f8e22d14a529a4301403a5a90a4_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMjI4Ng_96863042-3b99-45c8-9049-f81a785556e8">8.00</ix:nonFraction>%, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amendment, effective March 31, 2023, the First Lien Term Loans under the Restated Credit Agreement will bear interest either at a SOFR or an Alternate Base Rate (in each case, as defined in the Amendment) plus an applicable margin.  The applicable margin for the SOFR and Alternate Base Rate First Lien Term Loans under the Amendment is <ix:nonFraction unitRef="number" contextRef="i61d0d3aa77e94d1e8d2fddb57f6be350_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxNzU5_a35b601c-f7e9-4f8c-977b-f79d3b6876aa">3.00</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i58b95ffabd8f4ce5a478e21bfbc7b17d_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxNzYz_5aff89bb-0629-4317-be69-0b6c8b416012">2.00</ix:nonFraction>%, respectively.  At March 31, 2023, we have an effective SOFR of <ix:nonFraction unitRef="number" contextRef="i7dfe80ca8754497ba1f5422326933310_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxNzUx_3263fd4e-b946-4eb9-99e1-0d35e026ea1d">7.81</ix:nonFraction>% ,with an applicable credit spread adjustment of <ix:nonFraction unitRef="number" contextRef="ifd37700473c648cbbf786d4b1f0c907d_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxNzU1_a0bb0e7a-9aab-4ee4-895f-486eb7846d52">0.11448</ix:nonFraction>%, and an Alternate Base Rate of <ix:nonFraction unitRef="number" contextRef="i771d845d28a0407987c7a78f55f3c8ac_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxNzY3_dc4d295d-c1ab-402e-a674-7f15453601f8">10</ix:nonFraction>%, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Credit Agreement provides for quarterly payments of principal for the First Lien Term Loan in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="ia7a1589942bf4d659b4c2a4bbeb48cb0_D20230101-20230331" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMjYwMA_71ed41ad-2017-4d87-8b44-58337ee4193e">1.8</ix:nonFraction> million.  The  First Lien Term Loan will mature on April 23, 2028 unless otherwise accelerated under the terms of the Restated Credit Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist Term Loan:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Truist Term Loan currently bears interest at a three month SOFR election of <ix:nonFraction unitRef="number" contextRef="i1f1da3a1ad334f35988ca6282aa57b99_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODkx_b933c934-7343-4ad9-a545-8aab4131a83a">4.69</ix:nonFraction>% plus an applicable margin and fees based on Pricing Level III described above.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled amortization of the Truist Term Loan begins March 31, 2023 with quarterly payments of $<ix:nonFraction unitRef="usd" contextRef="idfd92754a11641c3b9f84f0578f4bc74_D20230331-20230331" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODcy_b03cf41b-0d6a-484c-a4c9-667fe256f923">1.9</ix:nonFraction> million, representing <ix:nonFraction unitRef="number" contextRef="idfd92754a11641c3b9f84f0578f4bc74_D20230331-20230331" decimals="INF" name="rdnt:DebtInstrumentPeriodicPaymentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODgw_03a10b11-a47c-479d-961d-96a85749bd4f">1.00</ix:nonFraction>% of the original principal balance. At scheduled intervals, the quarterly amortization increases by $<ix:nonFraction unitRef="usd" contextRef="ifbe38301ce1249c88966ffa550df3678_I20230331" decimals="-5" name="rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODg0_a0c4faa9-e3e5-46ee-9774-8d4fc96ee055">0.9</ix:nonFraction> million, with the remaining balance to be paid at maturity.  The Truist Term Loan will mature on October 10, 2027 unless otherwise accelerated under the terms of the  Credit Agreement.</span></div><div><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Credit Facilities</span></div></ix:continuation><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><ix:continuation id="i2ff923d945314d6483fada4beb34be87"><div style="padding-left:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Associated with both the Barclays and Truist Revolving Credit Facilities are deferred financing costs, net of accumulated amortization, of $<ix:nonFraction unitRef="usd" contextRef="i27e434031da1489c8d9bbda89a5969c6_I20230331" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQzMjQ5_ab896daf-148e-40c8-8497-3623dc60e083">2.1</ix:nonFraction> million at March&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Revolving Credit Facility</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Barclays Revolving Credit Facility under the Restated Credit Agreement is a $<ix:nonFraction unitRef="usd" contextRef="iff74038af72140fba140e6ea501d015f_I20210423" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNDQwNA_2214944d-f71d-443a-960d-d2ec2dbed877">195.0</ix:nonFraction> million senior secured revolving credit facility. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia4c2e8ac8cdb4b46ad8e87b6858b5f7a" continuedAt="i63a5cca4b2b6477b98cbe2cff222bcd8">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a SOFR or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:</ix:continuation></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="i63a5cca4b2b6477b98cbe2cff222bcd8"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"><tr><td style="width:1.0%"></td><td style="width:31.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Net Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term SOFR Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Alternate Base Rate Spread</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; <ix:nonFraction unitRef="number" contextRef="i24c9c233e2a54c57a8964647449f94d6_I20230331" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMS0wLTEtMS01NzA3My90ZXh0cmVnaW9uOmUxMGRhZmU3YTg5ZDQyZmNiM2E0MTgxZjE1NDEzNjBhXzY_a3ecc5c2-02c2-4738-8191-621edd6fb173">3.50</ix:nonFraction>x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7d5747c3ac914bc7a1e6aa46bd3d149e_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMS0xLTEtMS01NzA3Mw_aeeff00c-894d-4a44-8ecb-52d1a171314a">3.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i903948a537d64b37b67178fb25e84ed9_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMS0yLTEtMS01NzA3Mw_30dcd8e7-2b00-4d9f-b9ae-4e9deb28d818">2.25</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; <ix:nonFraction unitRef="number" contextRef="i10cefc40b0c44d8cbc4372fcfb77562b_I20230331" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMi0wLTEtMS01NzA3My90ZXh0cmVnaW9uOjM3MmU0OGFkZjA5YzQyZTE4NmMxZmQwN2Q1ZjVkZTE5XzY_dce67bfe-ef2b-4cd1-8c26-b80ccfeec6ab">3.00</ix:nonFraction>x but &#8804; <ix:nonFraction unitRef="number" contextRef="i07e3281e1e824c3d97f67f8ac8a57bd4_I20230331" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMi0wLTEtMS01NzA3My90ZXh0cmVnaW9uOjM3MmU0OGFkZjA5YzQyZTE4NmMxZmQwN2Q1ZjVkZTE5XzE2_d956eb06-8c54-44d2-b2ef-0aeda57f8058">3.50</ix:nonFraction>x</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48658f8cfbcf4487bc406a287ad83c2d_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMi0xLTEtMS01NzA3Mw_eefc6ccb-3311-4067-b35f-0974eda155f0">3.00</ix:nonFraction>%</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icb9196414c2f47f29fa015cf40d76abc_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMi0yLTEtMS01NzA3Mw_1bc82936-ef3d-49ff-84e6-be07989fa216">2.00</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; <ix:nonFraction unitRef="number" contextRef="if01c31d758364150a9bb3ce7cd850ca4_I20230331" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMy0wLTEtMS01NzA3My90ZXh0cmVnaW9uOjFmNzQ2ODgzMjIwYjQ5OGZiZTQ4NjBmYTk1YjI4NmZmXzY_b164a027-f255-460e-89de-186c206502b3">3.00</ix:nonFraction>x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibf860e6898d344c0a7a4962ee596f36d_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMy0xLTEtMS01NzA3Mw_e14edd37-0316-4ce9-bc3f-759b13581796">2.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i44d10d8940d34f76ab949ea9ed5bbdc3_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMy0yLTEtMS01NzA3Mw_b3cc33a9-b8d3-41f6-ba17-111dd3562e84">1.75</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the effective interest rate payable on revolving loans under the Barclays Revolving Credit Facility was <ix:nonFraction unitRef="number" contextRef="iafa7ca073c27455da1ef23c17f9d1eaf_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTAyMg_9d0ff1bb-41df-4701-8f82-71d8a706820d">5.25</ix:nonFraction>%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for Eurodollar rate revolving loans which is currently <ix:nonFraction unitRef="number" contextRef="ic4bd4668c12145b1bdf1773fe1c0b99e_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTIxMQ_6336e8b5-88c6-472f-9c8c-98af7949173a">2.75</ix:nonFraction>% and fronting fees accrue at <ix:nonFraction unitRef="number" contextRef="iaaae0769addc4e53bad052090529ee90_D20230101-20230331" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTI0Mg_09b42e1c-bac9-4f21-a232-818ccebff557">0.125</ix:nonFraction>% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the Restated Credit Agreement. In addition, a commitment fee of <ix:nonFraction unitRef="number" contextRef="iaaae0769addc4e53bad052090529ee90_D20230101-20230331" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ0Mg_0eba1e16-74d4-4d86-9522-1d27bc03b5c8">0.50</ix:nonFraction>% per annum accrues on the unused revolver commitments under the Barclays Revolving Credit Facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Barclays Revolving Credit Facility will terminate on April 23, 2026 unless otherwise accelerated in accordance with the terms of the Restated Credit Agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist Revolving Credit Facility:</span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Associated with the Truist Revolving Credit Facility of $<ix:nonFraction unitRef="usd" contextRef="i8827e76d9d944f0c83ab889ff9b40970_I20221007" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQwNDc2_911c570c-f791-49ef-9985-bb2484f0f0e6">50.0</ix:nonFraction> million are deferred financing costs, net of accumulated amortization, of  $<ix:nonFraction unitRef="usd" contextRef="ie97a081dfdc74b2dac6dc6743edad186_I20230331" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQwNDgz_6d105f3e-fa9f-41e5-beea-b3a0e2d2877f">0.6</ix:nonFraction> million at March&#160;31, 2023.  As of March&#160;31, 2023, NJIN had no borrowings under the Truist Revolving Credit Facility. </span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Truist Revolving Credit Facility bears interest with different margins based on types of borrowings at a Pricing Level III as noted in the pricing grid above.  The Truist Revolving Credit Facility terminates on the earliest of (i) October 7, 2027, (ii) the date on which the Revolving Commitments are terminated pursuant to Section 2.8 of the Truist Restated Credit Agreement, or (iii) the date on which all amounts outstanding under the Truist Restated Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  </span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent prior amendments to prior credit facilities:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">Truist Credit Facilities:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 31, 2018, under the Amended and Restated Revolving Credit and Term Loan Agreement, NJIN secured a term loan commitment of $<ix:nonFraction unitRef="usd" contextRef="iee7b9274694a4e7fbfba10c74d1e9f2b_I20180831" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxMzE5_ef631c0f-a766-4e7b-8b94-af8eba2566bf">60.0</ix:nonFraction> million and established revolving credit facility of $<ix:nonFraction unitRef="usd" contextRef="i97202989895048c6b3682a076c3a5dc3_I20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxMzI2_19222527-899c-4bce-bee3-1cadf8825044">30.0</ix:nonFraction> million.  The agreement had a maturity date of August 31, 2023 and was refinanced on October 10, 2022 by the Second Amended and Restated Revolving Credit and Term Loan Agreement.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_55"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7 &#8211; <ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNDQzNg_97ed5616-f22c-4a88-855b-7f1da83e7712" continuedAt="i9669c9c7fbb44891910a34e8ba553f67" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="i9669c9c7fbb44891910a34e8ba553f67" continuedAt="i9341b3d14cca4dee956b36a4affa4072"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Incentive Plans</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have <ix:nonFraction unitRef="incentiveplan" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNjk_4b84adf9-c59f-4d63-b285-f1be0e7b8f7c">one</ix:nonFraction> long-term equity incentive plan, the RadNet, Inc. Equity Incentive Plan, which we first amended and restated April 20, 2015, again on March 9, 2017 and currently as of April 15, 2021  (the "Restated Plan&#8221;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved for issuance under the Restated Plan <ix:nonFraction unitRef="shares" contextRef="i034e56b7f7854922a502eefa5771dc2a_I20210610" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNDUx_f3d0368c-9b73-463b-8de1-2de2d7a09aac">16,500,000</ix:nonFraction> shares of common stock. We can issue options (incentive and nonstatutory), </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><ix:continuation id="i9341b3d14cca4dee956b36a4affa4072" continuedAt="ib8642a86f1c64a24af023b9c806720bb"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance based options, stock awards (restricted or unrestricted), stock units, performance based stock units, and stock appreciation rights under the Restated Plan.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations.  Stock options generally vest over <ix:nonNumeric contextRef="if7309a2667674a92a4cc3eeb4825b42f_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNzgy_d6c99485-5905-48e9-8c21-5a5d78ba2d0d">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i7e2bb9a95d4d4802b2e4a3cc0aebe6ab_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNzg4_9dfe42fc-759f-41de-8ed0-3d18987a484e">5</ix:nonNumeric> years and expire <ix:nonNumeric contextRef="if7309a2667674a92a4cc3eeb4825b42f_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfODA4_b564b912-7337-40b3-a096-2e56eafcb795">5</ix:nonNumeric> to <ix:nonNumeric contextRef="i7e2bb9a95d4d4802b2e4a3cc0aebe6ab_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfODE0_30602ca9-f384-41bf-8aa3-87607150cbb1">10</ix:nonNumeric> years from the date of grant.</span></div><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNDQzMw_327ce299-ca81-48f3-bd5a-5a1ef9ddda85" continuedAt="i79419c6d388e4cbea82a0a695b21eefd" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes all of our option transactions for the three months ended March&#160;31, 2023:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:48.973%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfMS0yLTEtMS01NzA3Mw_96071d04-a59c-467c-8dbc-1909246347dd">678,914</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfMS00LTEtMS01NzA3Mw_b3b85013-eb78-4bb2-a9bb-eb3425bf7d86">15.72</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfMi0yLTEtMS01NzA3Mw_d1046536-ef4c-4a04-bcc9-de2da526f62e">261,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfMi00LTEtMS01NzA3Mw_ede86d22-ca21-4886-a9bc-a001190bf55c">18.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfMy0yLTEtMS01NzA3Mw_86188b86-231a-4064-8913-3e1c65c4ca0e">5,000</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfMy00LTEtMS01NzA3Mw_1b1b68a5-86d7-445a-9c4d-956d417309db">10.10</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfNS0yLTEtMS01NzA3Mw_27191567-f936-4da7-8f6f-1d57bd4c2412">935,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfNS00LTEtMS01NzA3Mw_ab2d5591-69ed-443e-86f1-cfff9fdf61f3">16.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfNS02LTEtMS01NzA3Mw_e93e03c1-1471-49db-bab7-21a4cab4f71b">6.96</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfNS04LTEtMS01NzA3Mw_933b193f-8f17-4943-b68e-0ce71121a4fe">8,840,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2023</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfNi0yLTEtMS01NzA3Mw_e28dc79b-0a83-4179-9612-75812077fc68">672,538</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfNi00LTEtMS01NzA3Mw_340014a7-ddbc-406a-813a-bbb586b750db">14.70</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfNi02LTEtMS01NzA3Mw_e79ca1a4-87b8-4421-a4cb-7d0004d7312c">5.98</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfNi04LTEtMS01NzA3Mw_3c6edc2e-2040-4a60-99a5-b0823c1f6274">7,568,342</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on March&#160;31, 2023 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on March&#160;31, 2023.  As of March&#160;31, 2023, total unrecognized stock-based compensation expense related to non-vested employee awards was $<ix:nonFraction unitRef="usd" contextRef="if953ce5e5d654143a5f27fbf0c7a8bcf_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMTgwMA_645d49dc-0e20-49f4-8911-342083284648">2.5</ix:nonFraction> million, which is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="i552d69a649564205922349013a84c526_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMTg4Nw_83c722da-2107-47d3-bbb5-de0649c19acf">2.11</ix:nonNumeric> years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">DeepHealth Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted options to acquire&#160;<ix:nonFraction unitRef="shares" contextRef="i26ed0c3bb3bc4dfca4136d54d21385d7_D20200401-20200630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMjA0Nw_3b369f31-653c-4025-8dc7-40e70756e52f">412,434</ix:nonFraction>&#160;shares at a grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8ced063bc27e4d249a4e8c5f2627065c_D20200401-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMjA4Nw_6abce8ae-1bd0-4627-8d01-1171f458e438">16.93</ix:nonFraction>&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of March&#160;31, 2023, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $<ix:nonFraction unitRef="usd" contextRef="i603724082df64ed1a5f7a54cc923b37e_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMjMzNQ_bca4f629-f794-4c21-8c89-6940716fb32e">0.3</ix:nonFraction> million, which is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="iebc09a78aa3040b9b0079b356035fa32_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMjQyMg_c2f15b22-8928-449c-8ba9-a96014a1cb99">0.60</ix:nonNumeric> years</span></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><ix:continuation id="i79419c6d388e4cbea82a0a695b21eefd"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:48.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75c6b8d0c0664a95a8cd0428ddf549df_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfMS0yLTEtMS01NzA3Mw_e8c46b1b-35ed-4f42-85b9-cf98d501e616">116,982</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i75c6b8d0c0664a95a8cd0428ddf549df_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfMS00LTEtMS01NzA3Mw_8502e9e9-7af6-48a5-8786-a59bb9010ad3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i16e7a48c2cb34748acb734708003ddda_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfMi0yLTEtMS01NzA3Mw_2cc7cb07-71c1-4514-84e6-0db2bd31470d">14,473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i16e7a48c2cb34748acb734708003ddda_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfMi00LTEtMS01NzA3Mw_969c07a0-e19f-4ea0-b037-b46ae42913f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1b2d16ac66924839910f548784911842_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfMy0yLTEtMS01NzA3Mw_f89fbbdf-5bc7-4a74-b6b9-6748a8d75bcd">102,509</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b2d16ac66924839910f548784911842_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfMy00LTEtMS01NzA3Mw_8d4d0302-90ae-43df-836b-bba801efbede">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i16e7a48c2cb34748acb734708003ddda_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfMy02LTEtMS01NzA3Mw_a22ff3bb-2b68-4ab9-8866-fd4501dd026b">6.55</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b2d16ac66924839910f548784911842_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfMy04LTEtMS01NzA3Mw_2238241d-913b-4ed4-8693-6eb1e5ac393e">2,565,800</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1b2d16ac66924839910f548784911842_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfNC0yLTEtMS01NzA3Mw_4df9ec8c-5086-4efa-8d86-748a68daa2c3">77,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b2d16ac66924839910f548784911842_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfNC00LTEtMS01NzA3Mw_8e96a14e-e875-4d3e-b89d-d9ea55d153e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i16e7a48c2cb34748acb734708003ddda_D20230101-20230331" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfNC02LTEtMS01NzA3Mw_3538a15a-0593-4b05-9f0e-c817dfb3f729">6.55</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b2d16ac66924839910f548784911842_I20230331" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfNC04LTEtMS01NzA3Mw_1d2f5e98-e161-42ba-b031-37c9d4eaa7cb">1,940,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options issued in replacement of original DeepHealth options as a result of our acquisition are not included in the share count under the Restated Plan.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards ("RSAs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNDQzNA_0408449e-84c9-4eeb-a968-f3d1b6b45c2e" continuedAt="i57ef54fd686241709e69213effb3cee6" escape="true">The Restated Plan permits the award of RSAs and the following summarizes all unvested RSA&#8217;s activities during the three months ended March&#160;31, 2023:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><ix:continuation id="ib8642a86f1c64a24af023b9c806720bb" continuedAt="i1a9f1565b1f147e485a3e01df869ab56"><div style="margin-top:5pt"><ix:continuation id="i57ef54fd686241709e69213effb3cee6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSAs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idca80d4271d24fc3a40ba5927cee3bbe_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfMS0xLTEtMS01NzA3Mw_b1218a40-55e3-4d33-8154-fddf98888b3c">536,767</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idca80d4271d24fc3a40ba5927cee3bbe_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfMS01LTEtMS01NzA3Mw_2f984b6c-b4ac-418e-ad79-85057e8fc68d">23.84</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8816a5b45bc14eeba46c2e754bf6809a_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfMy0xLTEtMS01NzA3Mw_a800f8f6-29fd-4383-a81e-01493b97ab74">694,324</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8816a5b45bc14eeba46c2e754bf6809a_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfMy01LTEtMS01NzA3Mw_201419bc-061b-4cd0-8271-15988af09993">19.77</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8816a5b45bc14eeba46c2e754bf6809a_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfNC0xLTEtMS01NzA3Mw_e09e5e76-601c-4547-ae4f-1a08d96be9fd">704,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8816a5b45bc14eeba46c2e754bf6809a_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfNC01LTEtMS01NzA3Mw_8bc75fe8-ffe5-4c9b-afe3-8b3440ab5fb8">21.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Canceled</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8816a5b45bc14eeba46c2e754bf6809a_D20230101-20230331" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfNS0xLTEtMS01NzA3Mw_261888b5-b27c-4c8b-8927-1c6cbd6e5ea7">667</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8816a5b45bc14eeba46c2e754bf6809a_D20230101-20230331" decimals="2" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfNS01LTEtMS01NzA3Mw_185f779c-073a-4437-bc6c-66f536fdeb99">22.80</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs unvested at March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a719cbef35d464180bcd3fa66af85f8_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfNi0xLTEtMS01NzA3Mw_85554af2-b76b-4120-a649-01d296988d0d">526,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8816a5b45bc14eeba46c2e754bf6809a_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfNi0zLTEtMS01NzA3Mw_ad1f6804-6f48-430a-917d-b124d228deeb">1.51</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6a719cbef35d464180bcd3fa66af85f8_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfNi01LTEtMS01NzA3Mw_12adb4f6-1805-4ead-b648-568fffae0d57">20.77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of all RSAs based on the closing price of our common stock on the award date.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other stock bonus awards</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan also permits share awards not subject to any future service period. These are valued and expensed based on the closing price of our common stock on the date of award. During the three months ended March&#160;31, 2023, <ix:nonFraction unitRef="shares" contextRef="ic4df50bb1eea438187c006139af9358d_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIwOTkx_1fe9f83e-833e-4f60-ac23-3a16d42d5a2f">10,765</ix:nonFraction> shares were issued with a value of $<ix:nonFraction unitRef="usd" contextRef="ic4df50bb1eea438187c006139af9358d_D20230101-20230331" decimals="-5" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIxMDU2_1fe54f08-4cc4-4e83-9abd-fae72f239bd8">0.2</ix:nonFraction> million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance based stock units ("PSUs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we granted certain employees PSUs with a target award of <ix:nonFraction unitRef="shares" contextRef="i3baed7f4af1344d989545d489662cec2_D20220101-20220131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMzM0Mw_d1c0d8a6-93e4-4233-8531-23f8cc6a9bb2">25,683</ix:nonFraction> shares of our common stock. The PSUs will vest in <ix:nonFraction unitRef="tranche" contextRef="i3baed7f4af1344d989545d489662cec2_D20220101-20220131" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIzNzYw_99be3500-5bc2-4409-a034-0c5c050ede32">two</ix:nonFraction> equal parts, starting <ix:nonNumeric contextRef="i3baed7f4af1344d989545d489662cec2_D20220101-20220131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIzNzgx_27320cc7-2e94-4b3f-8bf5-da861e19086b">three years</ix:nonNumeric> from the grant date based on continuous service, with the number of shares earned (<ix:nonFraction unitRef="number" contextRef="if430b6d648944e90a7a4d909825414d6_D20220101-20220131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMzUxNw_70bc2835-46e1-4bf0-ba82-592ca7111059">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ic141fc5027bd4033a301df773b032bc0_D20220101-20220131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMzUyMw_bc57aff6-cc68-4c6e-8121-4b64553dea12">200</ix:nonFraction>% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022.  In January of 2023, based on the performance condition achieved, the board of directors issued <ix:nonFraction unitRef="shares" contextRef="i20728da098554c3492944bc24dc7bedd_I20230131" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODE5NDU0_834577a7-a8b5-47e3-a451-5c990a75c1d4">12,843</ix:nonFraction> units with a fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i20728da098554c3492944bc24dc7bedd_I20230131" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODE5NDU3_d90ce0c2-2ab0-4e20-aca3-e7fd85733c0e">29.44</ix:nonFraction> per unit.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, the we granted certain employees PSUs with a target award of <ix:nonFraction unitRef="shares" contextRef="ib7d7b27aecc643be998969b03dbed528_D20230101-20230131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIwODIz_5d76f440-5e39-4824-97bb-265a714aeb7e">60,685</ix:nonFraction> shares of our common stock. The PSUs will vest in <ix:nonFraction unitRef="tranche" contextRef="ib7d7b27aecc643be998969b03dbed528_D20230101-20230131" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIzNzg4_f9d6d941-0aab-4e0b-bce2-685811b297e8">two</ix:nonFraction> equal parts, starting <ix:nonNumeric contextRef="ib7d7b27aecc643be998969b03dbed528_D20230101-20230131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODI0Njc5_84b1cae2-192b-4152-bf76-4c0eaa833dda">three years</ix:nonNumeric> from the grant date based on continuous service, with the number of shares earned (<ix:nonFraction unitRef="number" contextRef="i29265dd33e844d5a8bbc1d746f6353ac_D20230101-20230131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIwODI3_5e78ae0b-7acb-464d-9f8e-b999f175b78b">&#8212;</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i375bf56db89c40ecb67521134911bf52_D20230101-20230131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIwODMx_233d81c8-a5c0-4465-ad31-1b8439b087e8">200</ix:nonFraction>% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2023 through December 31, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance based stock options ("PSOs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we granted certain employees PSOs with a potential to option a maximum of <ix:nonFraction unitRef="shares" contextRef="ia74217dd8ba14406bfc31c3b148192a3_D20220101-20220131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMzg2Mg_9a0d9728-f361-44b8-bf9b-dee8f433eb30">111,925</ix:nonFraction> shares of our common stock. The PSOs will vest in <ix:nonFraction unitRef="tranche" contextRef="ia74217dd8ba14406bfc31c3b148192a3_D20220101-20220131" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODI0NzEy_7d51b0ba-e27f-488e-994f-ab1fea78faa3">three</ix:nonFraction> equal parts, starting <ix:nonNumeric contextRef="ia74217dd8ba14406bfc31c3b148192a3_D20220101-20220131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODI0NzI4_a562f1e4-fe6f-4f50-9cdf-0c55461f8c38">three years</ix:nonNumeric> from the grant date based on continuous service, with the number of shares earned (<ix:nonFraction unitRef="shares" contextRef="ie6809d4048aa4a35b513b76bacbff9df_I20220131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNDAzOA_628210d2-02f6-4550-b955-5c4e04d4e4c5">0</ix:nonFraction> shares to <ix:nonFraction unitRef="shares" contextRef="i78302aa8284649589fadb30185381e93_I20220131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNDA1MQ_74a59cc3-5a1a-4230-8817-b523efec74e8">111,925</ix:nonFraction> shares) depending upon the extent to which we achieve a performance condition as determined the board of directors over the period from January 1, 2022 through December 31, 2022.  In January of 2023, based on the performance condition achieved, the board of directors issued <ix:nonFraction unitRef="shares" contextRef="i3fb7ffda1bf04655ba1b20ddc4c4aab0_I20230131" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODE5NzAw_44558586-8018-40ea-bcc2-20bf3dd15030">27,981</ix:nonFraction> options with a strike price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i3fb7ffda1bf04655ba1b20ddc4c4aab0_I20230131" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODE5NzQ3_8f818157-da8c-4d44-8c10-51dfbd125a3c">29.44</ix:nonFraction> per share.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, we granted certain employees PSOs with a potential to option a maximum of <ix:nonFraction unitRef="shares" contextRef="i4a2bf0a508d6442ca467b195bdef4273_D20230101-20230131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIwODEx_9dbf2a5b-5201-4ff8-a3a3-adbfc4920bd2">235,227</ix:nonFraction> shares of our common stock. The PSOs will vest in <ix:nonFraction unitRef="tranche" contextRef="i4a2bf0a508d6442ca467b195bdef4273_D20230101-20230131" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODI0NzU1_61f4675b-d5b9-4cbc-b878-709fcd127aa8">three</ix:nonFraction> equal parts, starting <ix:nonNumeric contextRef="i4a2bf0a508d6442ca467b195bdef4273_D20230101-20230131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODI0NzU5_d9af1859-2693-4818-b2aa-26e8a71d0f3b">three years</ix:nonNumeric> from the grant date based on continuous service, with the number of shares earned (<ix:nonFraction unitRef="shares" contextRef="i50a36f080a554744add73eda4ce89019_I20230131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIwODE5_68492b1d-8db9-4811-bee9-b672b454a94a">0</ix:nonFraction> shares to <ix:nonFraction unitRef="shares" contextRef="i52e51b40e55a4447973325a56d0ca1aa_I20230131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIwODE1_a98d3076-0f5a-409f-a1cd-848563ff12e9">235,227</ix:nonFraction> shares) depending upon the extent to which we achieve a performance condition as determined the board of directors over the period from January 1, 2023 through December 31, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long Term Incentive Plan shares ("LTIPs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we issue stock-based compensation to certain employees in our AI segment in the form of Stock Units and Restricted Stock Awards, subject to certain restrictions. The awards represent a form of long term incentive and are reflective of a general practice within the software industry.  The units and shares vest ratably over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODE4OTk1_66873c0e-ef14-4872-a4e6-5ee1a266aa10">two</span> to <ix:nonNumeric contextRef="i78c12519a4964a51b7deba80b2e9ae56_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMzg0ODI5MDcwMjUyNw_b496d805-9bc9-405e-b985-faae78d39c88">four year</ix:nonNumeric> period, conditioned on continued employment through the vesting periods. We determine the fair value of all LTIPs based on the closing price of our common stock on the award date.  <ix:nonNumeric contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMzg0ODI5MDcwMjUyMQ_d7422a2b-4670-4ff1-883a-023724a81280" continuedAt="ic14ec05512d14efdafec9549940bda7c" escape="true">The following summarizes all unvested LTIPs activities during the three months ended March 31, 2023:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><ix:continuation id="i1a9f1565b1f147e485a3e01df869ab56"><div style="margin-top:10pt;text-align:justify"><ix:continuation id="ic14ec05512d14efdafec9549940bda7c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LTIPs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1cfa0f61545742ee999c634dad4b4b76_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfMS0xLTEtMS04MDEyNQ_8ab0c34e-fa5a-440f-a1e9-39604e3cebfd">169,471</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1cfa0f61545742ee999c634dad4b4b76_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfMS01LTEtMS04MDE3Ng_bb287f14-a56f-45a7-a0ee-a317f0923860">19.56</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i041f68f3d9614026814745b94c47b8c7_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfMy0xLTEtMS04MDEzMw_081b8105-d8f7-499a-bd52-2830f47566e4">209,643</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i041f68f3d9614026814745b94c47b8c7_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfMy01LTEtMS04MDE3Ng_f6cc7eab-ba37-4fa5-8244-586ce1ee1a7e">20.03</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i041f68f3d9614026814745b94c47b8c7_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfNC0xLTEtMS04MDEzMw_65b19fbc-aaf1-4a26-9cd1-40d04f75c28e">48,395</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i041f68f3d9614026814745b94c47b8c7_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfNC01LTEtMS04MDE3Ng_eb56dcd8-bc0b-4788-b36d-34e6b8b08ea7">19.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Canceled</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i041f68f3d9614026814745b94c47b8c7_D20230101-20230331" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfNS0xLTEtMS04MDEzMw_a46add22-f520-4b3f-a46a-7b51bc4dfef1">13,476</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i041f68f3d9614026814745b94c47b8c7_D20230101-20230331" decimals="2" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfNS01LTEtMS04MDE3Ng_78b579bc-9924-44a5-8343-cef18bf617cf">19.72</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia5b043dd93d14bad91a507a5b7da5817_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfNi0xLTEtMS04MDE0MQ_c4116acf-074d-48f6-8d7f-2773485575ae">317,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i041f68f3d9614026814745b94c47b8c7_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfNi0zLTEtMS04MDE2MQ_04d6dc63-553e-45ed-aa0b-29b6f2bc1b17">3.43</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b043dd93d14bad91a507a5b7da5817_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfNi01LTEtMS04MDE3Ng_9b1b3521-6d2f-453d-91f5-68d11ef7eca9">19.87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restated Plan summary</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, of the <ix:nonFraction unitRef="shares" contextRef="i034e56b7f7854922a502eefa5771dc2a_I20210610" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNDI3NA_f3d0368c-9b73-463b-8de1-2de2d7a09aac">16,500,000</ix:nonFraction> shares of common stock reserved for issuance under the Restated Plan, at March&#160;31, 2023, there remain approximately <ix:nonFraction unitRef="shares" contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331" decimals="-3" name="us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNDM2Nw_b3b5f196-562e-4ba2-9417-cbed90efa94b">740,000</ix:nonFraction> shares available under the Restated Plan for future issuance.</span></div></ix:continuation><div id="if318a573f95e4e07addbbbfb9543d1c5_61"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our unaudited condensed consolidated financial statements and notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10-Q and with our audited consolidated financial statements and notes thereto for the year ended December 31, 2022 included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed with the U.S. Securities and Exchange Commission (SEC) on March 1, 2023.</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_64"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This quarterly report on Form 10-Q contains &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect current views about future events and are based on our currently available financial, economic and competitive data and on current business plans. Actual events or results may differ materially depending on risks and uncertainties that may affect our operations, markets, services, prices and other factors.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;assumption&#8221; or the negative of these terms or other comparable terminology. Forward-looking statements in this quarterly report include, among others, statements we make regarding:</span></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">anticipated trends in our revenues, operating expenses or capital expenditures, and our financial guidance;</span></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">expected future market acceptance for our products or services, and the anticipated protection afforded by our competitive strengths in the markets we serve;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">potential timing and impact of changes in regulations impacting our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the ongoing impact on our business, suppliers, payors, customers, referral sources, partners, patients and employees of the COVID-19 pandemic; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the anticipated effect of the measures we are taking to respond to the COVID-19 pandemic;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to successfully acquire and integrate new imaging operations; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">cost savings, efficiencies and improvements anticipated from our investments in artificial intelligence and machine learning products and services; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our future liquidity and our continuing ability to service and remain in compliance with applicable debt covenants or refinance our current indebtedness.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are neither historical facts nor assurances of future performance.  Because forward-looking statements relate to the future, they are inherently subject to known and unknown risks, uncertainties and other factors </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that are difficult to predict and out of our control.  Our actual results, level of activity, performance or achievements may be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.  Important factors that could cause our actual results to differ materially from those indicated or implied in our forward-looking statements include the factors included in &#8220;Risk Factors,&#8221; in our annual report on Form 10-K for the fiscal year ended December 31, 2022 or supplemented by the information in Part II&#8211; Item 1A below. You should consider the inherent limitations on, and risks associated with, forward-looking statements and not unduly rely on the accuracy of predictions contained in such forward-looking statements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any forward-looking statement in this quarterly report is based on information currently available to us and speaks only as of the date of this report.  We do not undertake any responsibility to release publicly any revisions to these forward-looking statements to take into account events or circumstances that occur after the date of this quarterly report or any unanticipated events which may cause actual results to differ from those expressed or implied by the forward-looking statements contained in this report, except as required by law.</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_67"></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of diagnostic imaging services in the United States. At March&#160;31, 2023, we operated directly or indirectly through joint ventures with hospitals, 363 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our operations comprise two segments for financial reporting purposes for this reporting period, Imaging Centers and Artificial Intelligence. For further financial information about these segments, see Note 5, Segment Reporting, in the notes accompanying our consolidated financial statements included in this report.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often reducing the cost and amount of care for patients. Integral to the imaging center business is our software arm headed by eRAD, Inc., which sells computerized systems that distribute, display, store and retrieve digital images. Internationally, our subsidiary Heart and Lung Imaging LLC, provides teleradiology services for remote interpretation of images on behalf of providers within the framework of the United Kingdom's National Health Service.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also established an Artificial Intelligence ("AI") division, that develops and deploys AI suites to enhance radiologist interpretations of breast, lung and prostate images. The division is led by DeepHealth, and includes our acquisitions of Aidence Holding B.V. and Quantib B.V., both based in The Netherlands.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows our centers in operation and revenues for the three months ended March&#160;31, 2023 and March&#160;31, 2022:</span></div><div style="margin-top:5pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.421%"><tr><td style="width:1.0%"></td><td style="width:64.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.325%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centers in operation</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues (millions)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is derived from a diverse mix of payors, including private, managed care capitated and government payors. We believe our payor diversity mitigates our exposure to possible unfavorable reimbursement trends within any one payor class. Our total service fee revenue, net of contractual allowances and discounts, and implicit price concessions for the three months ended March&#160;31, 2023 and 2022 is summarized in the following table (in thousands):</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,209&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,465&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,153&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,087&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,745&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,123&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teleradiology and Software revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,333&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,399&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,144&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,491&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Center Segment Revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388,431&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,168&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI Segment Revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,133&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,564&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,767&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As 2023 begins, we continue to have strong growth in our procedure volumes, which have increased 14% in the same period over the prior year on an overall basis, and we have opened 10 new advanced imaging centers.  In December of 2022, our subsidiary DeepHealth, Inc, received FDA clearance of its mammography density assessment software that assists radiologists in interpreting visual images.  In February of 2023, we launched our Enhanced Breast Cancer Detection service, powered by DeepHealth AI, which provides patients an advanced screening mammography service along with a life time risk assessment for breast cancer and post mammography support. Initial locations for this service are in Florida, New Jersey and New York.</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_70"></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions, Equity Investments and Joint Venture Activity</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion summarizes certain details concerning our acquisition or disposition of centers, our equity investment and our joint venture transaction. See Note 4, Business Combinations and Related Activity and Note 2, Summary of Significant Accounting Policies to our consolidated financial statements included in this quarterly report on Form 10-Q for further information.  The information below updates our activity of such matters contained in our annual report on Form 10-K for the year ended December&#160;31, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the California and New York markets.  These acquisitions are reported as part of our Imaging Center segment.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C.C.D.G.L.R. &amp; S Services Inc.</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,689</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,689)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southern California Diagnostic Imaging, Inc. </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,184)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inglewood Imaging Center, LLC</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,658</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,188)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ramapo Radiology Associates, P.C.</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,775</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,775)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,915</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,441</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,836</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,174</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">250</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,836)</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Investments</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we have three equity investments for which a fair value is not readily determinable and therefore the total amounts invested are recognized at cost as follows:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision Imaging Solutions Ltd., based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  Our investment of $1.2 million  represents a 14.21% equity interest in the company.  No observable price changes or impairment in our investment was identified as of March&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased 2.1 million preferred shares in Turner Imaging Systems for $2.0 million. On January 1, 2019 we funded a convertible promissory note in the amount of $0.1 million that converted into an additional 80,000 shares effective December 21, 2019.  No observable price changes or impairment in our investment was identified as of March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million in support of it operations.  No observable price changes,  impairment in our investment or impairment of the loan receivable was identified as of March&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint Venture Activity</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the three months ended March 31, 2023 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:87.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,893&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,321&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately $4.2 million and $5.5 million for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data for these joint ventures as of March&#160;31, 2023 and December&#160;31, 2022 and income statement data for the three months ended March 31, 2023 and 2022 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,091&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,304&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,144&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,995)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,588)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,872)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,952)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,368&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,458&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,754&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,564&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,567&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,329&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,321&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,893&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement data for the three months ended March 31,</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,086&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,411&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,909&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,035&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="if318a573f95e4e07addbbbfb9543d1c5_73"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Securities and Exchange Commission defines critical accounting estimates as those that are both most important to the portrayal of a company&#8217;s financial condition and results of operations and require management&#8217;s most difficult, subjective or complex judgment, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods.&#160;In Note 2 to our consolidated financial statements in this quarterly report and in our annual report on Form 10-K for the year ended December&#160;31, 2022, we discuss our significant accounting policies, including those that do not require management to make difficult, subjective or complex judgments or estimates. The most significant areas involving management&#8217;s judgments and estimates are described below.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements were prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues generally relate to net patient fees received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations, changes in business and economic conditions, and the frequent changes in managed care contractual terms resulting from contract re-negotiations and renewals.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon our management's estimate of amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under Medicare, Medicaid, managed care and commercial insurance plans are based upon historical collection experience of the payments received from such payors in accordance with the underlying contractual agreements. Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have price concessions applied. We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.  Our estimates and assumptions related to revenue recognition did not change materially for the quarter ended March&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients.&#160;Services are generally provided pursuant to one-year contracts with healthcare providers. Receivables generally are collected within industry norms for third-party payors.&#160;We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.  Our estimates and assumptions for allowances on our account receivable did not change materially during the quarter ended March&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combination</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate all acquisitions under the framework Clarifying the Definition of a Business in the accounting guidance. Once a purchase has been determined to be the acquisition of a business, we are required to recognize the assets acquired and the liabilities assumed at their acquisition date fair values. Any portion of the purchase consideration transferred in excess of the net of the acquisition date fair values of the assets acquired and the liabilities assumed, is allocated to goodwill.  The allocation requires our management to make estimates of the value of various assets acquired and liabilities assumed.  While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Indefinite Lived Intangibles</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill at March&#160;31, 2023 totaled $687.1 million.  Indefinite Lived Intangible Assets at March&#160;31, 2023 were $24.3 million and are associated with the value of certain trade name intangibles and in process research and development (IPR&amp;D). Goodwill, trade name intangibles and IPR&amp;D are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our annual test of goodwill, trade name and IPR&amp;D noted no impairment as of October 1, 2022, and we have not identified any indicators of impairment through March&#160;31, 2023.</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_76"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Standards</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_7">Table of Contents</a></span></div></div><div style="margin-bottom:10pt;margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 3, Recent Accounting and Reporting Standards to the financial statements included in this report for further information.</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_79"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, for the three months ended March&#160;31, 2023 and 2022, the percentage that certain items in the statements of operations bears to total service revenue, inclusive of revenue under capitation contracts.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE DATA)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.853%"><tr><td style="width:1.0%"></td><td style="width:66.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.526%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REVENUE</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Service fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING EXPENSES</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cost of operations, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Loss on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Severance costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;INCOME (LOSS)  FROM OPERATIONS</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME AND EXPENSES</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Equity in earnings of joint ventures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense (income)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(LOSS) INCOME BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET (LOSS) INCOME</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center Segment</span></div><div style="margin-top:1pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed our medical imaging centers segment through a combination of organic growth, equity investments, acquisitions and joint venture formations.  We have segregated some of our information to demonstrate which is attributable to centers that were in operation through the entirety of the comparison period, and which is attributable to those that were acquired or disposed of during the period.  The discussion below shows a breakdown and analysis of revenue and expenses for the three months ended March&#160;31, 2023 and 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended March 31, 2023 Compared to the Three Months Ended March 31, 2022 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$388,431</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$341,168</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$47,263</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center Revenue</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$361,273</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$337,157</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24,116</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$27,158</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,011</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We experienced an overall same center total procedure volume growth of 8.4% over the same period in the prior year, which resulted in an upswing in revenue through a combination of increased capitation contract rates, a 7.9% rise in same center routine imaging procedures and same center advanced radiology procedures of CT, MRI, PET and Nuclear Medicine expanding by 10.3%.  Excluded amounts refer to revenue contributions for the three month periods ending March 31, 2023 and March 31, 2022, respectively, from centers that were acquired or divested between January 1, 2022 through March 31, 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses for the three months ended March 31, 2023 increased approximately $37.6 million, or 11.1%, from $337.3 million for the three months ended March 31, 2022 to $374.9 million for the three months ended March 31, 2023. The following table sets forth a breakdown of our cost of operations and total operating expenses for the three months ended March&#160;31, 2023 and 2022 (in thousands):&#160;</span></div><div style="margin-top:5pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:74.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and professional reading fees, excluding stock-based compensation</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,512&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,962&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and equipment rental</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,951&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,623&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical supplies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">*</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,454&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,611&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344,580&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,870&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337,271&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes billing fees, office supplies, repairs and maintenance, insurance, business tax and license, outside services, telecom, utilities, marketing, travel and other expenses.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion below provides additional information and analysis on changes in our various operating expenses for the three months ended March&#160;31, 2023 and 2022 (in thousands): </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Salaries and professional reading fees, excluding stock-based compensation and severance</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and Professional Fees</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Salaries</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$216,512</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$196,962</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19,550</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center Salaries</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$203,294</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$193,194</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10,100</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13,218</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,768</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Stemming from the higher procedure volumes noted above, our staffing levels were adjusted to support the influx of patients seeking radiology procedures.  Similar to other businesses, we still face inflation in employee cost as we compete for talent in the marketplace.  Excluded amounts refer to salaries and professional reading fees for the three month periods ending March 31, 2023 and March 31, 2022, respectively, from centers that were acquired or divested between January 1, 2022 through March 31, 2023.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based compensation</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation rose $1.2 million, or 11.3% to approximately $11.5 million for the three months ended March 31, 2023 compared to $10.4 million for three months ended March 31, 2022. Although the fair value of stock awarded and vested in the first quarter of 2023 was lower as compared to stock awarded and vested in the prior year, the higher amount of shares granted over the same period in the prior year spurred the increase. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Building and equipment rental</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building &amp; Equipment Rental</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$28,951</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29,623</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(672)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,793</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$28,263</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(2,470)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded Sites</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,158</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,360</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in building and equipment rental expense relates to reduced equipment rental relating to operating lease contracts which ended or were bought out during 2022. Excluded amounts refer to building and equipment rental for the three month periods ending March 31, 2023 and March 31, 2022, respectively, from centers that were acquired or divested between January 1, 2022 through March 31, 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical supplies</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Supplies Expense</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20,134</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15,557</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,577</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18,814</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15,158</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,656</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded Sites</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,320</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$399</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The increase in medical supplies expense was driven by higher patient volume combined with price increases for contrasting agents used in advanced radiology procedures. In addition, we had a high utilization rate of a specialty isotope PYLARIFY which is used in our PSMA study of prostate cancer, for which we are ultimately reimbursed on a cost plus margin basis that exceeds our initial expense outlay.  Excluded amounts refer to medical supplies expense for the three month periods ending March 31, 2023 and March 31, 2022, respectively, from centers that were acquired or divested between January 1, 2022 through March 31, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other operating expenses</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Operating Expenses</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$67,454</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$57,611</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,843</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$62,611</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$55,850</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,761</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded Sites</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,843</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,761</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rise in other operating expenses was experienced across all of our major categories to support the increase in volumes at inflated prices compared to the same period in the prior year.  Excluded amounts refer to other operating expenses for the three month periods ending March 31, 2023 and March 31, 2022, respectively, from centers that were acquired or divested between January 1, 2022 through March 31, 2023.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional segment operating and non operating expenses:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.040%"><tr><td style="width:1.0%"></td><td style="width:48.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29,591</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,806</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,785</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of equipment and other</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$577</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,154</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(577)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,093</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($20,819)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,912</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$730</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$661</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$69</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$122</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$201</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(79)</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3%</span></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nm= not meaningful</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.684%"><tr><td style="width:1.0%"></td><td style="width:41.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Interest Expense</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15,722</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11,601</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,121</span></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="background-color:#eeeeee;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Paid for Interest</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21,471</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7,448</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14,023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The rise in total interest expense is attributable to a higher overall loan balances in combination with increased variable interest rates paid on those balances compared to the same period in the prior year. The change in cash paid for interest relates to timing of interest rate elections, as our interest payment in the first quarter included interest charged to our term loan balances in 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During 2022 we refinanced our Truist term loan which added an additional $108.0 million in obligations to our balance sheet in the fourth quarter. Based on recent increases in global interests rates, we expect the effective interest rates on our senior credit facilities, and our related interest expense, to continue to rise in the near term. See &#8220;Liquidity and Capital Resources&#8221; below for more details on our credit facilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To mitigate our future interest expense exposure we have entered into certain interest rate swap agreements.  During the three months ended March&#160;31, 2023, we received cash payments from our swap agreements of approximately $3.0 million, which served to reduce our overall interest expense.  See the Derivative Instruments section of Note 2, Significant Accounting Policies, to the condensed consolidated financial statements included in this report for more details on our derivative transactions. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in earnings from unconsolidated joint ventures</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023 we recognized equity in earnings from unconsolidated joint ventures in the amount of $1.4 million and for three months ended March 31, 2022 we recognized equity in earnings from unconsolidated joint ventures of $2.5 million, an decrease of $1.1 million or 43.3%.  The decrease was mainly related to the equity in earnings received from our venture operations in Arizona.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AI Segment</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.  We are developing our AI segment initially through acquisition activity.  The breakdown of revenue and expenses of the segment for the three months ended March&#160;31, 2023 and 2022 are as follows:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.111%"><tr><td style="width:1.0%"></td><td style="width:28.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.558%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Change</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Statement of Operations</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,133</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$599</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,534</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">256.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Salaries and Wages</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,131</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,284</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,847</span></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.2&#160;</span></td><td style="background-color:#eeeeee;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock Compensation</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.8)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other operating</span></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.3&#160;</span></td><td style="background-color:#eeeeee;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation &amp; Amort.</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,724</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other operating loss (gain)</span></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107.7)</span></td><td style="background-color:#eeeeee;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Severance</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,023</span></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,216</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,807</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from Operations</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,890)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,617)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,273)</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">703</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(504)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,207</span></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">239.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,593)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,113)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,480)</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(667)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">667</span></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(100.0)</span></td><td style="background-color:#eeeeee;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net loss</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,593)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($4,446)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($3,147)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for AI segment increased over the prior year as our Enhance Brest Caner Detection program powered by DeepHealth AI has been introduced in the Florida, New Jersey and New York markets.  As we ramp up this program and develop additional products for other types of cancers, our expenses have also risen accordingly. Segment growth will seen long term through the commercialization of our AI products and expansion of our various cancer detection programs.</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_85"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use both GAAP and non-GAAP metrics to measure our financial results.  We believe that, in addition to GAAP metrics, certain non-GAAP metrics, such as Adjusted EBITDA assist us in measuring our business performance, cash generated from operations, leverage capacity and ability to service our debt obligations.  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Adjusted EBITDA metric removes non-cash and non-recurring charges that occur in the affected period and provides a basis for measuring the Company&#8217;s core financial performance against other periods.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, as adjusted to exclude losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishment, bargain purchase gains, loss on de-consolidation of joint ventures and non-cash equity compensation.  Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted for non-cash or one-time events that take place during the period.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is a non-GAAP financial measure used as an analytical indicator by us and the healthcare industry to assess business performance, and is a measure of leverage capacity and ability to service debt. Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation and this metric, as presented, may not be comparable to other similarly titled measures of other companies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of GAAP net income attributable to RadNet, Inc. common stockholders to Adjusted EBITDA for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"><tr><td style="width:1.0%"></td><td style="width:58.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.831%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income income attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,005)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,013&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,722&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,593&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,315&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,118&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash employee stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,819)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustment to joint venture investment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent Consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non operational rent expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA including losses from AI Segment &amp; Provider Relief Funding</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48,165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38,132</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA including losses from AI Segment and excluding benefit from Provider Relief Funding</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48,165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38,132</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA Losses from AI Segment</span></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,496&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,585&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA excluding losses from AI Segment &amp; Provider Relief Funding</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52,661</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,717</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of GAAP net income for our AI Segment to Adjusted EBITDA for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"><tr><td style="width:1.0%"></td><td style="width:58.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.831%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net loss</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,593)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,446)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation &amp; Amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,724&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(496)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(667)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA including losses from AI Segment &amp; Provider Relief Funding</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,496)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,585)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="if318a573f95e4e07addbbbfb9543d1c5_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes key balance sheet data related to our liquidity as of March&#160;31, 2023 and December&#160;31, 2022 and income statement data for the three months ended March&#160;31, 2023 and 2022 (in thousands):</span></div><div style="margin-top:5pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:68.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.676%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,844&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,834&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,357&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital (exclusive of current operating lease liabilities)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,868)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,932)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders' equity</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,452&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:68.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.950%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.410%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement data for the three months ended March 31,</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,564&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,767&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income  attributable to RadNet common stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,005)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,013&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations.&#160;In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging centers, the acquisition of additional centers and new diagnostic imaging equipment.&#160;Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties to fund our working capital requirements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have credit available from our current credit facilities and borrowing under those facilities is subject to continued compliance with lending covenants.  We currently meet those requirements, and expect that we will continue to do so for the foreseeable future, but substantial and sustained operating losses could impact our ability to borrow under those facilities.  If we are not able to meet such requirements, we may be required to seek additional financing and there can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our subsidiaries or affiliates may from time to time, in our sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sources and Uses of Cash</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes key components of our sources and uses of cash (in thousands) for the three months ended:</span></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.497%"><tr><td style="width:1.0%"></td><td style="width:66.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by operating activities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,616&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,556)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,564)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used in financing activities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,821)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,313)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash provided by operating activities for the three months ended March&#160;31, 2022 was affected by the non-cash change in fair value of our interest rate hedge of $20.8 million.  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities for the three months ended March&#160;31, 2023, included purchases of property and equipment for approximately $55.9 million and the acquisition of imaging business and other assets for $9.6 million.  As part of our business operations we continually evaluate investment opportunities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in financing activities of $3.8 million  for the three months ended March&#160;31, 2023, was due to payment on our term loan obligations and equipment notes. Please see Note 6, Credit Facilities and Notes Payable in the notes to consolidated financials statements included in this report for more information.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Secured Credit Facilities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain secured credit facilities with Barclays Bank PLC and with Truist Bank.  The Barclays credit facilities are comprised of first lien term loans and a revolving credit facility of $195.0 million.  The Truist credit facilities are comprised of a term loan and a revolving credit facility of $50.0 million. As of March&#160;31, 2023, we were in compliance with all covenants under our credit facilities.  Deferred financing costs at March&#160;31, 2023, net of accumulated amortization, were $2.1 million and are specifically related to our revolving credit facilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our condensed consolidated balance sheets at March&#160;31, 2023 are $860.4 million of total term loan debt (exclusive of unamortized discounts of  $11.8 million) in thousands: </span></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.543%"><tr><td style="width:1.0%"></td><td style="width:58.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712,313&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,606)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701,707&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Truist Term Loan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,188)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,937&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Term Loans</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860,438&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,794)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848,644&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, we had no borrowings under our Barclays or Truist revolving credit facilities.  After reserves for outstanding letters of credit of $7.6 million, we have $187.4 million available for borrowing under our Barclays Credit Facility and $50.0 million available under our Truist Revolving Credit Facility.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our existing capital resources, anticipated cash from operations and our borrowing capacity under our credit facilities will be sufficient to sustain our operations for the next twelve months and the foreseeable future.  Please see Note 6, Credit Facilities and Notes Payable in the notes to consolidated financials statements included in this report for more information on our secured credit facilities.</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_91"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We receive payment for our imaging services exclusively in United States dollars. As a result, our financial results are unlikely to be affected by factors such as changes in foreign currency, exchange rates or weak economic conditions in foreign markets.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to foreign exchange risk with respect to revenues and expenses denominated in the Euro, Canadian Dollar and Hungarian Forint and Pound Sterling. We have Artificial Intelligence operations in the Netherlands, radiology services in the United Kingdom, and maintain research and development centers in Canada and Hungary.  At the present time, we do not have any foreign currency exchange contracts to mitigate this risk. At March&#160;31, 2023, a hypothetical 1% decline in the currency exchange rates between the U.S. dollar against these currencies, would have resulted in an annual increase of approximately $0.3 million in operating expenses.&#160;</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Sensitivity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We pay interest on various types of debt instruments to our suppliers and lending institutions. The agreements entail either fixed or variable interest rates.&#160; Instruments which have fixed rates are mainly leases on radiology equipment. Variable rate interest obligations relate primarily to amounts borrowed under our outstanding credit facilities.&#160;Accordingly, our interest expense and consequently, our earnings, are affected by changes in short term interest rates. However due to our purchase of caps, described below, the effects of interest rate changes are limited.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We can elect SOFR or Alternative Base Rate interest options on amounts outstanding under the First Lien Term Loans.  At March&#160;31, 2023, we had $712.3 million outstanding subject to a SOFR election on First Lien Term Loans and our effective rate plus applicable margin was 7.92%. A hypothetical 1% increase in the adjusted Eurodollar rates under the Restated Credit Agreement over the current SOFR rate would result in an increase of $2.1 million in annual interest expense and a corresponding decrease in income before taxes, as interest rates are above arranged rates on our 2019 Swaps.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, we had $148.1 million outstanding subject to an adjusted SOFR election on the Truist Restated Credit and Agreement. We can elect SOFR or Base Rate interest rate options on amounts outstanding under the Truist Restated Credit and Term Loan Agreement.  At March&#160;31, 2023, our effective SOFR rate plus applicable margin was 6.79%.  A </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hypothetical 1% increase in the adjusted Eurodollar rates under the Truist Restated Credit Agreement would result in an increase of approximately $1.5 million in annual interest expense and a corresponding decrease in income before taxes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 Swaps").  The 2019 Swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional. Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05%  for the $400,000,000 notional.  As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive payments under the 2019 Swaps if interest rates rise above the arranged rates.</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_94"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Controls and Procedures</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain controls and procedures designed to ensure that we are able to collect the information we are required to disclose in the reports we file with the SEC, and to process, summarize and disclose this information within the time periods specified in the rules of the SEC. Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has conducted an evaluation of the design and operation of our &#8220;disclosure controls and procedures&#8221; as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report  for the purposes set forth above.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> been no change in our internal control over financial reporting during three months ended March 31, 2023 that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="if318a573f95e4e07addbbbfb9543d1c5_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_100"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;Legal Proceedings</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time we are engaged legal proceedings that arise in the ordinary course of our business. We do not believe that the outcome of any of our current legal proceedings will have a material adverse impact on our business, financial condition and results of operations. </span></div><div><span><br/></span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_103"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;Risk Factors</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information about the risks and uncertainties related to our business, please see the risk factors described in our annual report on Form 10-K for the year ended December 31, 2022. The risks described in our Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_106"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_109"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;Defaults Upon Senior Securities</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_112"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;Mine Safety Disclosures</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_115"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;Other Information</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_118"></div><div style="-sec-extract:summary;margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. Exhibits</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if318a573f95e4e07addbbbfb9543d1c5_7">Table of Contents</a></span></div></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002122/radnet_ex1001.htm">First Amendment to Second Amended and Restated First Lien Credit Guaranty Agreement dated March dated March 27, 2023 among RadNet Management, Inc., as borrower, RadNet, Inc. and certain of its subsidiaries, as guarantors, the lenders and issuing banks party thereto and Barclays Bank PLC, as administrative agent and collateral agent.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q12023exhibit311.htm">Certification of Howard G. Berger, M.D. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q12023exhibit312.htm">Certification of Mark D. Stolper pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q12023exhibit321.htm">Certification of Howard G. Berger, M.D. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. *</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q12023exhibit322.htm">Certification of Mark D. Stolper pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. *</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following financial information from RadNet, Inc.'s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 formatted in Inline XBRL (Extensible Business Reporting Language) includes: (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Comprehensive Loss, (iv) the Condensed Consolidated Statements of Changes in Stockholders Equity, (v) the Condensed Consolidated Statements of Cash Flows, and (vi) Notes to the Condensed Consolidated Financial Statements.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. 1350, and is not being filed for purposes of Section 18 of the Exchange Act and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</span></div><div id="if318a573f95e4e07addbbbfb9543d1c5_121"></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RADNET, INC.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 10, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Howard G. Berger, M.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Howard G. Berger, M.D., President and Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 10, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mark D. Stolper</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark D. Stolper, Chief Financial Officer<br/>(Principal Financial and Accounting Officer)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>q12023exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i649b0368a6af4d2493bdca0cd5d3336f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Howard G. Berger, M.D., certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this report on Form 10-Q of RadNet, Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; May&#160;10, 2023 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President, Chief Executive Officer and Chairman of the Board of Directors</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>q12023exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i0165089e90bd4bfebcad4375a25e5885_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mark D. Stolper, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">I have reviewed this report on Form 10-Q of RadNet, Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.      Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.      Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.    The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; May&#160;10, 2023 </font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">and Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>q12023exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="idc17711e057a4d52b7b49c5059123a2c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of RadNet, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarterly period ended March 31, 2023, as filed with the Securities and Exchange Commission on May 10, 2023 (the &#8220;Report&#8221;), I, Howard G. Berger, M.D., Chairman of the Board of Directors and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2023</font></td></tr></table></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>q12023exhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id580278dd9374d37bee506097dd3915f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of RadNet, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarterly period ended March 31, 2023, as filed with the Securities and Exchange Commission on May 10, 2023 (the &#8220;Report&#8221;), I, Mark D. Stolper, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2023</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>rdnt-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b2271182-007a-4027-b874-402dbe4bcb25,g:1e66911a-3ada-4e5a-b4d0-d568e36a58ce-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rdnt="http://www.radnet.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.radnet.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.radnet.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical">
        <link:definition>0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFBUSINESSANDBASISOFPRESENTATION" roleURI="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION">
        <link:definition>0000009 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECENTACCOUNTINGANDREPORTINGSTANDARD" roleURI="http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARD">
        <link:definition>0000011 - Disclosure - RECENT ACCOUNTING AND REPORTING STANDARD</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITY" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY">
        <link:definition>0000012 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTREPORTING" roleURI="http://www.radnet.com/role/SEGMENTREPORTING">
        <link:definition>0000013 - Disclosure - SEGMENT REPORTING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLE" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE">
        <link:definition>0000014 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>0000015 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0000016 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>0000017 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables">
        <link:definition>0000018 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTREPORTINGTables" roleURI="http://www.radnet.com/role/SEGMENTREPORTINGTables">
        <link:definition>0000019 - Disclosure - SEGMENT REPORTING (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLETables" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables">
        <link:definition>0000020 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>0000021 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails" roleURI="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails">
        <link:definition>0000022 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
        <link:definition>0000023 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails">
        <link:definition>0000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Service Fee Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails">
        <link:definition>0000025 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails">
        <link:definition>0000026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Annual Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails">
        <link:definition>0000027 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Effect of Derivative Instruments on Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails">
        <link:definition>0000028 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Business Acquisitions by Acquisition, Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails">
        <link:definition>0000029 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value of Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails">
        <link:definition>0000030 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESScheduleofInvestmentinJointVenturesDetails" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofInvestmentinJointVenturesDetails">
        <link:definition>0000031 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Investment in Joint Ventures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails">
        <link:definition>0000032 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Joint Venture Investment and Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails">
        <link:definition>0000033 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTREPORTINGDetails" roleURI="http://www.radnet.com/role/SEGMENTREPORTINGDetails">
        <link:definition>0000034 - Disclosure - SEGMENT REPORTING (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails">
        <link:definition>0000035 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Term Loan Debt Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLENarrativeDetails" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails">
        <link:definition>0000036 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails">
        <link:definition>0000037 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Leverage Ratio (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails">
        <link:definition>0000038 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Margin Spread Based on Leverage Ratio (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONNarrativeDetails" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>0000039 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails">
        <link:definition>0000040 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails">
        <link:definition>0000041 - Disclosure - STOCK-BASED COMPENSATION - Schedule of RSA Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails">
        <link:definition>0000042 - Disclosure - STOCK-BASED COMPENSATION - Schedule of LTIPs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" abstract="false" name="ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_NumberofUnconsolidatedJointVentures" abstract="false" name="NumberofUnconsolidatedJointVentures" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_OperatingExpensesExcludingDepreciationAndAmortization" abstract="false" name="OperatingExpensesExcludingDepreciationAndAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentSharesPurchased" abstract="false" name="EquityMethodInvestmentSharesPurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" abstract="true" name="BusinessCombinationContingentConsiderationLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember" abstract="true" name="OneMonthSecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_RamapoRadiologyAssociatesPCMember" abstract="true" name="RamapoRadiologyAssociatesPCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_WorkersCompensationPersonalInjury1Member" abstract="true" name="WorkersCompensationPersonalInjury1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_CapitationArrangementsMember" abstract="true" name="CapitationArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_HealthCareManagementServiceMember" abstract="true" name="HealthCareManagementServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PricingLevelVMember" abstract="true" name="PricingLevelVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_RestatedAgreementMember" abstract="true" name="RestatedAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_DebtInstrumentLeverageRatio" abstract="false" name="DebtInstrumentLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" abstract="false" name="JointVentureInvestmentAndFinancialInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted" abstract="false" name="FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="rdnt_PricingLevelIMember" abstract="true" name="PricingLevelIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" abstract="false" name="DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_MedicVisionMember" abstract="false" name="MedicVisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionsMember" abstract="true" name="BusinessAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_October2023Member" abstract="true" name="October2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioTwoMember" abstract="true" name="LeverageRatioTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_COVID19PandemicMember" abstract="true" name="COVID19PandemicMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_QuantibMember" abstract="true" name="QuantibMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ContingentSharesMember" abstract="true" name="ContingentSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ScriptSenderLlcMember" abstract="false" name="ScriptSenderLlcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_HealthCarePatientServiceOtherMember" abstract="true" name="HealthCarePatientServiceOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_WhiteRabbit.aiInc.Member" abstract="true" name="WhiteRabbit.aiInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_TruistMember" abstract="true" name="TruistMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ImagingCentersMember" abstract="true" name="ImagingCentersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember" abstract="true" name="ThreeMonthsSecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_SouthernCaliforniaDiagnosticImagingIncMember" abstract="true" name="SouthernCaliforniaDiagnosticImagingIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" abstract="false" name="DebtInstrumentCovenantLiquidityRatioRequiredMinimum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_TeleradiologyandSoftwareMember" abstract="true" name="TeleradiologyandSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ContractsReceivableFactoringReceivable" abstract="false" name="ContractsReceivableFactoringReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ProperyAndEquipmentNetMember" abstract="false" name="ProperyAndEquipmentNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_InglewoodImagingCenterLLCMember" abstract="true" name="InglewoodImagingCenterLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DeepHealthInc.Member" abstract="true" name="DeepHealthInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" abstract="false" name="BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_AidenceMember" abstract="true" name="AidenceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember" abstract="true" name="SixMonthsSecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AidenceHoldingBVMember" abstract="true" name="AidenceHoldingBVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" abstract="false" name="PropertyPlantandEquipmentNetIncludingRightofUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_RestatedPlanMember" abstract="false" name="RestatedPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AIMember" abstract="true" name="AIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_GlendaleAdvancedImagingMember" abstract="true" name="GlendaleAdvancedImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementSixthAmendmentMember" abstract="true" name="FirstLienCreditAgreementSixthAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DignityHealthMember" abstract="true" name="DignityHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioDomain" abstract="true" name="LeverageRatioDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_CovenantNotToCompeteMember" abstract="true" name="CovenantNotToCompeteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_October2025Member" abstract="true" name="October2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FutureServiceMember" abstract="true" name="FutureServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_JointVentureInterestMember" abstract="true" name="JointVentureInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIIIMember" abstract="true" name="PricingLevelIIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_A2019SWAPS1Member" abstract="true" name="A2019SWAPS1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_A2019SWAPSMember" abstract="true" name="A2019SWAPSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_Medicare1Member" abstract="true" name="Medicare1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementSeventhAmendmentMember" abstract="true" name="FirstLienCreditAgreementSeventhAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_WeightedAverageRemainingContractualLife" abstract="true" name="WeightedAverageRemainingContractualLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_CommercialInsurance1Member" abstract="true" name="CommercialInsurance1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_TurnerImagingSystemsMember" abstract="true" name="TurnerImagingSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AggregateIntrinsicValue" abstract="true" name="AggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_PerformanceBasedStockOptionsMember" abstract="true" name="PerformanceBasedStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentCovenantLeverageRatioMaximum" abstract="false" name="DebtInstrumentCovenantLeverageRatioMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_ArtificialIntelligenceMember" abstract="true" name="ArtificialIntelligenceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" abstract="false" name="BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_CashHoldbackMember" abstract="true" name="CashHoldbackMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_MontclairMember" abstract="true" name="MontclairMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ManagementServiceFees" abstract="false" name="ManagementServiceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ImagingCenterSegmentRevenueMember" abstract="true" name="ImagingCenterSegmentRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioThreeMember" abstract="true" name="LeverageRatioThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ScheduleOfLeverageRatioTableTextBlock" abstract="false" name="ScheduleOfLeverageRatioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rdnt_RepaymentOfAdvanceMedicarePayments" abstract="false" name="RepaymentOfAdvanceMedicarePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_Medicaid1Member" abstract="true" name="Medicaid1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_MonthlyAmortizationOfDeferredHedgeGains" abstract="false" name="MonthlyAmortizationOfDeferredHedgeGains" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_FirstLienTermLoanMember" abstract="false" name="FirstLienTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIIMember" abstract="true" name="PricingLevelIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementMember" abstract="true" name="FirstLienCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DebtInstrumentPeriodicPaymentPercent" abstract="false" name="DebtInstrumentPeriodicPaymentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rdnt_DeepHealthIncMember" abstract="true" name="DeepHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_HeartAndLungImagingLimitedMember" abstract="true" name="HeartAndLungImagingLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioFourMember" abstract="true" name="LeverageRatioFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PatentAndTrademarksMember" abstract="true" name="PatentAndTrademarksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_OperatingIncomeLossExcludingReliefFunding" abstract="false" name="OperatingIncomeLossExcludingReliefFunding" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_EquipmentAcquiredAndLeaseholdImprovements" abstract="false" name="EquipmentAcquiredAndLeaseholdImprovements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" abstract="true" name="InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_AdvanceMedicarePayments" abstract="false" name="AdvanceMedicarePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rdnt_BarclaysMember" abstract="true" name="BarclaysMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_LeverageRatioOneMember" abstract="true" name="LeverageRatioOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LongTermIncentivePlanSharesMember" abstract="true" name="LongTermIncentivePlanSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ManagementServiceContractsMember" abstract="true" name="ManagementServiceContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_JointVentureMember" abstract="true" name="JointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_PerformanceBasedStockUnitsMember" abstract="true" name="PerformanceBasedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_CCDGLRSServicesIncMember" abstract="true" name="CCDGLRSServicesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_NumberOfCenters" abstract="false" name="NumberOfCenters" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_DevelopedTechnologySoftwareMember" abstract="true" name="DevelopedTechnologySoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rdnt_LeverageRatioAxis" abstract="true" name="LeverageRatioAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" abstract="false" name="BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_EarningPerShareBasicAndDilutedAbstract" abstract="true" name="EarningPerShareBasicAndDilutedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_EquipmentNotesPayableMember" abstract="true" name="EquipmentNotesPayableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIVMember" abstract="true" name="PricingLevelIVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ContingentMilestoneConsiderationMember" abstract="true" name="ContingentMilestoneConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementEighthAmendmentMember" abstract="true" name="FirstLienCreditAgreementEighthAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>rdnt-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b2271182-007a-4027-b874-402dbe4bcb25,g:1e66911a-3ada-4e5a-b4d0-d568e36a58ce-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_3dadd9d1-997f-455c-a550-7d5424ce285d" xlink:href="rdnt-20230331.xsd#rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_94cb6b1f-3c89-4edf-96fa-c58f6f65de14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_3dadd9d1-997f-455c-a550-7d5424ce285d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_94cb6b1f-3c89-4edf-96fa-c58f6f65de14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c8cc108f-5214-48c0-9457-2c9bcc99e13a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_3dadd9d1-997f-455c-a550-7d5424ce285d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c8cc108f-5214-48c0-9457-2c9bcc99e13a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c49abcd0-9fab-4028-9cb4-e6176ae20c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_4d0df0ff-1a85-4b54-bf8a-8228d6b365f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c49abcd0-9fab-4028-9cb4-e6176ae20c80" xlink:to="loc_us-gaap_DueToAffiliateCurrent_4d0df0ff-1a85-4b54-bf8a-8228d6b365f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_93c2b29c-771c-45ca-ba2f-ac400befe94f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c49abcd0-9fab-4028-9cb4-e6176ae20c80" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_93c2b29c-771c-45ca-ba2f-ac400befe94f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_ef38204e-649d-4ce9-af4c-cbab2fcb4bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c49abcd0-9fab-4028-9cb4-e6176ae20c80" xlink:to="loc_us-gaap_NotesPayableCurrent_ef38204e-649d-4ce9-af4c-cbab2fcb4bd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_8ef1f0b1-5d1a-4b26-a9d3-a6bd1e8d5fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c49abcd0-9fab-4028-9cb4-e6176ae20c80" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_8ef1f0b1-5d1a-4b26-a9d3-a6bd1e8d5fcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_09654585-d16c-4969-a19f-6b000bedda37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c49abcd0-9fab-4028-9cb4-e6176ae20c80" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_09654585-d16c-4969-a19f-6b000bedda37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e70c6c9a-a25a-40a6-9b05-8d4b73b6ee82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8ba8a6a2-faf0-44b4-8332-6359eeb0d84c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e70c6c9a-a25a-40a6-9b05-8d4b73b6ee82" xlink:to="loc_us-gaap_StockholdersEquity_8ba8a6a2-faf0-44b4-8332-6359eeb0d84c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_b36c1af9-1d3c-4968-a58c-7e97ed2c80c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e70c6c9a-a25a-40a6-9b05-8d4b73b6ee82" xlink:to="loc_us-gaap_MinorityInterest_b36c1af9-1d3c-4968-a58c-7e97ed2c80c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8252fa0f-ba43-41ef-8950-4bd814324067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3e7a2d23-27d8-4460-b6bf-8072d5fffa28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8252fa0f-ba43-41ef-8950-4bd814324067" xlink:to="loc_us-gaap_CommonStockValue_3e7a2d23-27d8-4460-b6bf-8072d5fffa28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_e153bf5e-9156-48b6-9bf0-fa7f9063abe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8252fa0f-ba43-41ef-8950-4bd814324067" xlink:to="loc_us-gaap_AdditionalPaidInCapital_e153bf5e-9156-48b6-9bf0-fa7f9063abe7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_17fc8443-ba4b-461f-9afd-a88295c31dab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8252fa0f-ba43-41ef-8950-4bd814324067" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_17fc8443-ba4b-461f-9afd-a88295c31dab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fd19a802-95f0-43a3-bc75-5d20964a5dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8252fa0f-ba43-41ef-8950-4bd814324067" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fd19a802-95f0-43a3-bc75-5d20964a5dc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_32f0a535-3a35-45c2-8109-b92bde9a03e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4abcde7b-f81b-4f32-99ab-cb90efdebd91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_32f0a535-3a35-45c2-8109-b92bde9a03e1" xlink:to="loc_us-gaap_Goodwill_4abcde7b-f81b-4f32-99ab-cb90efdebd91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_96467149-3c04-4620-ac1c-c1715bcb487a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_32f0a535-3a35-45c2-8109-b92bde9a03e1" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_96467149-3c04-4620-ac1c-c1715bcb487a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets_a0b8e927-26c2-4eae-8df5-ebf90e7d563f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_32f0a535-3a35-45c2-8109-b92bde9a03e1" xlink:to="loc_us-gaap_DepositsAssets_a0b8e927-26c2-4eae-8df5-ebf90e7d563f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_c6515952-e862-432a-8da0-43f0fd5c72f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_32f0a535-3a35-45c2-8109-b92bde9a03e1" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_c6515952-e862-432a-8da0-43f0fd5c72f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_b6818bea-ffc4-4f66-a617-7ab747ff8dab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_32f0a535-3a35-45c2-8109-b92bde9a03e1" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_b6818bea-ffc4-4f66-a617-7ab747ff8dab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_5aa107bb-1d3a-4af8-8ba7-74814ed4cb7c" xlink:href="rdnt-20230331.xsd#rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_32f0a535-3a35-45c2-8109-b92bde9a03e1" xlink:to="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_5aa107bb-1d3a-4af8-8ba7-74814ed4cb7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_137050f9-3e78-4244-9cfa-2ca6b21e3419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_32f0a535-3a35-45c2-8109-b92bde9a03e1" xlink:to="loc_us-gaap_AssetsCurrent_137050f9-3e78-4244-9cfa-2ca6b21e3419" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_23f48520-febd-4845-88ef-0a86df65c24e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_77837a93-444a-4c5f-9113-0619343a3060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_23f48520-febd-4845-88ef-0a86df65c24e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_77837a93-444a-4c5f-9113-0619343a3060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_6e144c5d-14d4-4d66-9d7d-bb6c5044224b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_23f48520-febd-4845-88ef-0a86df65c24e" xlink:to="loc_us-gaap_LongTermNotesPayable_6e144c5d-14d4-4d66-9d7d-bb6c5044224b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4c897e21-c16f-41ca-8a04-a32ed7ef2057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_23f48520-febd-4845-88ef-0a86df65c24e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_4c897e21-c16f-41ca-8a04-a32ed7ef2057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_700334b4-8be4-4303-bbba-7f4d56d6b04a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_23f48520-febd-4845-88ef-0a86df65c24e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_700334b4-8be4-4303-bbba-7f4d56d6b04a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_590c3c44-c84a-478a-9e3a-3ce95d345e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_23f48520-febd-4845-88ef-0a86df65c24e" xlink:to="loc_us-gaap_LiabilitiesCurrent_590c3c44-c84a-478a-9e3a-3ce95d345e0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c3b7d151-96db-4791-8832-0f1d7d70a7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d482cfb3-9c73-40a5-87a3-8850016f20d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c3b7d151-96db-4791-8832-0f1d7d70a7f4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d482cfb3-9c73-40a5-87a3-8850016f20d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a92e7f7c-8cf0-4d5f-88ea-7a94dd5933bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c3b7d151-96db-4791-8832-0f1d7d70a7f4" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_a92e7f7c-8cf0-4d5f-88ea-7a94dd5933bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_2df740a5-b109-4e64-a85a-42ef7ddc3209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c3b7d151-96db-4791-8832-0f1d7d70a7f4" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_2df740a5-b109-4e64-a85a-42ef7ddc3209" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e48d4ffe-f013-4e9f-9705-0924a380dfe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c3b7d151-96db-4791-8832-0f1d7d70a7f4" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e48d4ffe-f013-4e9f-9705-0924a380dfe1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_319f740d-6817-4a92-be2d-49863c2e1cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_81207b92-267d-49fe-b772-b75bc2cc7b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_319f740d-6817-4a92-be2d-49863c2e1cf8" xlink:to="loc_us-gaap_Liabilities_81207b92-267d-49fe-b772-b75bc2cc7b25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ea43d2e9-352d-4cec-aacd-50506055356d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_319f740d-6817-4a92-be2d-49863c2e1cf8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ea43d2e9-352d-4cec-aacd-50506055356d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d368aabb-47d4-4188-a318-b1f08ace0b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_700d293e-607d-4626-a7a2-0e629cbfedb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d368aabb-47d4-4188-a318-b1f08ace0b30" xlink:to="loc_us-gaap_SeveranceCosts1_700d293e-607d-4626-a7a2-0e629cbfedb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_10dd3737-ca46-4cd6-8ee1-f4bc9eaa9cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d368aabb-47d4-4188-a318-b1f08ace0b30" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_10dd3737-ca46-4cd6-8ee1-f4bc9eaa9cbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_8cfe5564-4f0e-4d16-aee5-e5e30d73f505" xlink:href="rdnt-20230331.xsd#rdnt_OperatingExpensesExcludingDepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d368aabb-47d4-4188-a318-b1f08ace0b30" xlink:to="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_8cfe5564-4f0e-4d16-aee5-e5e30d73f505" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e19c2588-1467-4f23-a552-3c2e3ad23689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d368aabb-47d4-4188-a318-b1f08ace0b30" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e19c2588-1467-4f23-a552-3c2e3ad23689" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_aebce01b-75a0-4419-9135-2b178f52eacc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_010884f4-ee20-45f8-8f8a-6e4fb6b5ffa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_aebce01b-75a0-4419-9135-2b178f52eacc" xlink:to="loc_us-gaap_OperatingExpenses_010884f4-ee20-45f8-8f8a-6e4fb6b5ffa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bb109e24-89ad-400c-b07a-df7de81a4001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_aebce01b-75a0-4419-9135-2b178f52eacc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bb109e24-89ad-400c-b07a-df7de81a4001" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_e8dde666-64d9-432c-b4b5-cd29a03df1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_25980737-e745-4d0f-b785-e3812b7b5efc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e8dde666-64d9-432c-b4b5-cd29a03df1d4" xlink:to="loc_us-gaap_InterestExpenseDebt_25980737-e745-4d0f-b785-e3812b7b5efc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e4c74082-3dd5-4419-ac81-657617e6ef71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e8dde666-64d9-432c-b4b5-cd29a03df1d4" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e4c74082-3dd5-4419-ac81-657617e6ef71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a5566a85-f85b-48f0-bace-2a5c4aa4d50d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e8dde666-64d9-432c-b4b5-cd29a03df1d4" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a5566a85-f85b-48f0-bace-2a5c4aa4d50d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_c6588e98-f5ce-49d8-ba93-4c88647211f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e8dde666-64d9-432c-b4b5-cd29a03df1d4" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_c6588e98-f5ce-49d8-ba93-4c88647211f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d8d7a824-e0d6-472b-ac2e-b4928714d2da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d3ff920-d501-4908-bcdc-21f751e713bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_d8d7a824-e0d6-472b-ac2e-b4928714d2da" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d3ff920-d501-4908-bcdc-21f751e713bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7a2e77a8-fd0d-4579-9b31-97314ca84c92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_d8d7a824-e0d6-472b-ac2e-b4928714d2da" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7a2e77a8-fd0d-4579-9b31-97314ca84c92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_299de62a-f776-4187-b3af-104e4aee8fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6971f1ed-f6f9-4813-97f6-80914fe2b0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_299de62a-f776-4187-b3af-104e4aee8fc5" xlink:to="loc_us-gaap_ProfitLoss_6971f1ed-f6f9-4813-97f6-80914fe2b0d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_244ef2c4-410f-4c9f-b536-beaf660ba45a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_299de62a-f776-4187-b3af-104e4aee8fc5" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_244ef2c4-410f-4c9f-b536-beaf660ba45a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5f931db5-b163-4022-9f0e-50777c4d1bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_06bfd16a-33a1-47ea-b8c1-378e9a2c87f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5f931db5-b163-4022-9f0e-50777c4d1bd0" xlink:to="loc_us-gaap_OperatingIncomeLoss_06bfd16a-33a1-47ea-b8c1-378e9a2c87f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_009cdf01-e85a-421d-b095-20e77b88222c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5f931db5-b163-4022-9f0e-50777c4d1bd0" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_009cdf01-e85a-421d-b095-20e77b88222c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b5d995c3-2571-4074-b231-a5ca0cae9ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a6915ea6-4835-4651-bc81-33b8145b1ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b5d995c3-2571-4074-b231-a5ca0cae9ca5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a6915ea6-4835-4651-bc81-33b8145b1ea0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a1b9c6c9-4f52-4937-9af9-56d2da225047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b5d995c3-2571-4074-b231-a5ca0cae9ca5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a1b9c6c9-4f52-4937-9af9-56d2da225047" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_66af28c0-bee4-40dd-88b4-ff6e0d062642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b8a13cf3-85b8-4aea-b543-800194652acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_66af28c0-bee4-40dd-88b4-ff6e0d062642" xlink:to="loc_us-gaap_ProfitLoss_b8a13cf3-85b8-4aea-b543-800194652acc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_49dd0c15-154f-4bb8-baca-3df2c5809f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_66af28c0-bee4-40dd-88b4-ff6e0d062642" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_49dd0c15-154f-4bb8-baca-3df2c5809f8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_9641d5a9-965d-44f2-8549-ccf80b11d37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_66af28c0-bee4-40dd-88b4-ff6e0d062642" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_9641d5a9-965d-44f2-8549-ccf80b11d37d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d65ac831-0cc8-4403-b184-b3d039a73061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_ProfitLoss_d65ac831-0cc8-4403-b184-b3d039a73061" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_bb04ac78-5f56-4ecf-b14c-9609f08a9d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_bb04ac78-5f56-4ecf-b14c-9609f08a9d13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_88ffdd55-58da-4329-8a1d-7f490c1aa661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_88ffdd55-58da-4329-8a1d-7f490c1aa661" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_8550d676-0623-4015-a5c3-2e729b954e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_8550d676-0623-4015-a5c3-2e729b954e68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_45ccb21a-c60b-4971-bc04-c746f660d1ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_45ccb21a-c60b-4971-bc04-c746f660d1ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_0b4be609-43a8-4666-bb8a-f5df2a9085c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_0b4be609-43a8-4666-bb8a-f5df2a9085c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_bfb91560-70d3-4a67-ac94-5ce95da77661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_bfb91560-70d3-4a67-ac94-5ce95da77661" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_fe575ade-b166-47cf-b58c-9c5af5f57c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_ShareBasedCompensation_fe575ade-b166-47cf-b58c-9c5af5f57c2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_56264202-d9fe-44c8-924e-4b060ca307ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_56264202-d9fe-44c8-924e-4b060ca307ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_301e13df-7606-47a4-a220-2b88d52d0b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_301e13df-7606-47a4-a220-2b88d52d0b73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_3736c008-e4f5-48a9-b0fc-72b0f0e735b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_3736c008-e4f5-48a9-b0fc-72b0f0e735b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_468242aa-fb79-4266-9a1d-e6a898e1850d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_468242aa-fb79-4266-9a1d-e6a898e1850d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_c70b324e-b52d-4a6b-b59b-0b0735de8e26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_c70b324e-b52d-4a6b-b59b-0b0735de8e26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2d4f70b3-bef8-48c0-8148-4d694715749f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2d4f70b3-bef8-48c0-8148-4d694715749f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_339a7617-335d-48f5-bf0a-905729db483d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_339a7617-335d-48f5-bf0a-905729db483d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_60af883e-baf2-460a-b7aa-8f8b87b5d45f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_60af883e-baf2-460a-b7aa-8f8b87b5d45f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_6f1710c7-411c-4b77-af83-3686d709e7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5203f5db-9867-40be-8cc7-e8ed725faea8" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_6f1710c7-411c-4b77-af83-3686d709e7eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b40dee0b-4088-46e8-9e52-5c16d8cc0f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_b8938010-e7d9-45eb-b4ca-600799c37a29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b40dee0b-4088-46e8-9e52-5c16d8cc0f89" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_b8938010-e7d9-45eb-b4ca-600799c37a29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_83961efd-23d1-4201-a1f5-a0a2bd26d8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b40dee0b-4088-46e8-9e52-5c16d8cc0f89" xlink:to="loc_us-gaap_RepaymentsOfDebt_83961efd-23d1-4201-a1f5-a0a2bd26d8bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a5acadc6-1e3b-4e1d-91ce-66ba3302ec10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b40dee0b-4088-46e8-9e52-5c16d8cc0f89" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a5acadc6-1e3b-4e1d-91ce-66ba3302ec10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_172c5e64-e78d-49ef-9f35-6ec56cbe5db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings_31907574-1fc2-4c16-804b-c559fc5832f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_172c5e64-e78d-49ef-9f35-6ec56cbe5db4" xlink:to="loc_us-gaap_PaymentsToAcquireBuildings_31907574-1fc2-4c16-804b-c559fc5832f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_eb754681-5892-4a82-ba9c-a65ab9c5367d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_172c5e64-e78d-49ef-9f35-6ec56cbe5db4" xlink:to="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_eb754681-5892-4a82-ba9c-a65ab9c5367d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_9d9add90-4b86-44d8-9634-d9d6b1efab21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_172c5e64-e78d-49ef-9f35-6ec56cbe5db4" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_9d9add90-4b86-44d8-9634-d9d6b1efab21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5a215e4e-8836-472e-a492-22acf5e54fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24b83edf-e56a-4fa5-8ecd-ea3d4978b02e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5a215e4e-8836-472e-a492-22acf5e54fca" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24b83edf-e56a-4fa5-8ecd-ea3d4978b02e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a384fd66-d53b-4867-9324-0e92bf6d036c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5a215e4e-8836-472e-a492-22acf5e54fca" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a384fd66-d53b-4867-9324-0e92bf6d036c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7115e89-73e4-4384-a1f9-8da3eeb434fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5a215e4e-8836-472e-a492-22acf5e54fca" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7115e89-73e4-4384-a1f9-8da3eeb434fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c6699f5b-dff1-4a2c-b91e-081b5ad84265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5a215e4e-8836-472e-a492-22acf5e54fca" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c6699f5b-dff1-4a2c-b91e-081b5ad84265" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_008b8912-7f7f-4378-b142-1f6559a034a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_40d39a86-256c-4450-93ed-f682b7dd6679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_008b8912-7f7f-4378-b142-1f6559a034a4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_40d39a86-256c-4450-93ed-f682b7dd6679" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_5f27943b-cd8d-4326-8bf4-4c6d068eaef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_008b8912-7f7f-4378-b142-1f6559a034a4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_5f27943b-cd8d-4326-8bf4-4c6d068eaef8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_05b6e93e-7c48-489b-9f37-a032004216a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_008b8912-7f7f-4378-b142-1f6559a034a4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_05b6e93e-7c48-489b-9f37-a032004216a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ef43cbb3-d91f-4e02-9813-409cd2fa20e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_008b8912-7f7f-4378-b142-1f6559a034a4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ef43cbb3-d91f-4e02-9813-409cd2fa20e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2ae0c6f5-1126-499a-9073-882493ca8ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_008b8912-7f7f-4378-b142-1f6559a034a4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2ae0c6f5-1126-499a-9073-882493ca8ecb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_04dfb6c5-891e-470b-b3f3-d860fc075c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_008b8912-7f7f-4378-b142-1f6559a034a4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_04dfb6c5-891e-470b-b3f3-d860fc075c86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_738ce773-45b7-421f-98be-99ac1c6c0595" xlink:href="rdnt-20230331.xsd#rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_008b8912-7f7f-4378-b142-1f6559a034a4" xlink:to="loc_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_738ce773-45b7-421f-98be-99ac1c6c0595" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_7018bb07-8316-4fa4-98a4-a0cb4eabf799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_008b8912-7f7f-4378-b142-1f6559a034a4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_7018bb07-8316-4fa4-98a4-a0cb4eabf799" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2f2b9286-e3b4-49c6-8cc8-25006330d26d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d83169f1-f25d-45ab-81de-10f0b4fdfaba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2f2b9286-e3b4-49c6-8cc8-25006330d26d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d83169f1-f25d-45ab-81de-10f0b4fdfaba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d998e095-2a2b-44a1-b2be-aa9cc76e0387" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2f2b9286-e3b4-49c6-8cc8-25006330d26d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d998e095-2a2b-44a1-b2be-aa9cc76e0387" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_01aa3717-5428-44d1-81e5-bb76b5bacc39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_467d5841-169f-4486-b386-50dd09c635bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_01aa3717-5428-44d1-81e5-bb76b5bacc39" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_467d5841-169f-4486-b386-50dd09c635bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_e1d04b35-d193-423d-88e9-e04601eba2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_01aa3717-5428-44d1-81e5-bb76b5bacc39" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_e1d04b35-d193-423d-88e9-e04601eba2fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2ca52617-e060-4214-a7b5-21d8746e2326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_01aa3717-5428-44d1-81e5-bb76b5bacc39" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2ca52617-e060-4214-a7b5-21d8746e2326" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_e161cdfe-5cc6-4abc-989a-07737718f165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_09c157bc-f6ae-46f7-8bfb-2cc18b7c3d06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_e161cdfe-5cc6-4abc-989a-07737718f165" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_09c157bc-f6ae-46f7-8bfb-2cc18b7c3d06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2be8b1c0-d6d2-4d45-8b4f-5ad31d197d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_e161cdfe-5cc6-4abc-989a-07737718f165" xlink:to="loc_us-gaap_LiabilitiesCurrent_2be8b1c0-d6d2-4d45-8b4f-5ad31d197d0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_71ee1e9d-05fd-4b44-a756-246d8376e4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_e161cdfe-5cc6-4abc-989a-07737718f165" xlink:to="loc_us-gaap_AssetsCurrent_71ee1e9d-05fd-4b44-a756-246d8376e4ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_42bcc34b-8a63-4716-a35c-3956971c2eed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_e161cdfe-5cc6-4abc-989a-07737718f165" xlink:to="loc_us-gaap_AssetsNoncurrent_42bcc34b-8a63-4716-a35c-3956971c2eed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_3465f0c9-dc13-4f6a-a987-ec458f39d65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_84cef217-d109-4a20-b1b5-5f270d862f64" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_3465f0c9-dc13-4f6a-a987-ec458f39d65b" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_84cef217-d109-4a20-b1b5-5f270d862f64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_744ea559-713c-4039-a5e9-2dd41b6d6936" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_3465f0c9-dc13-4f6a-a987-ec458f39d65b" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_744ea559-713c-4039-a5e9-2dd41b6d6936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e4af9058-6008-4865-bd09-856076d63eda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_3465f0c9-dc13-4f6a-a987-ec458f39d65b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e4af9058-6008-4865-bd09-856076d63eda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_bd55f8bb-54c6-4dfd-aeb3-3d398d2b5b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_3465f0c9-dc13-4f6a-a987-ec458f39d65b" xlink:to="loc_us-gaap_Goodwill_bd55f8bb-54c6-4dfd-aeb3-3d398d2b5b9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_e1a42830-319d-473a-b293-de7522a83c5f" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_3465f0c9-dc13-4f6a-a987-ec458f39d65b" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_e1a42830-319d-473a-b293-de7522a83c5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_cbe51df4-8878-4b13-a53e-983e8f6d4bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_3465f0c9-dc13-4f6a-a987-ec458f39d65b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_cbe51df4-8878-4b13-a53e-983e8f6d4bde" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_dc2d1227-090a-4014-af6a-2b66de80d375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_2094f587-eb01-457c-ada3-6deb60a46874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_dc2d1227-090a-4014-af6a-2b66de80d375" xlink:to="loc_us-gaap_LongTermDebtCurrent_2094f587-eb01-457c-ada3-6deb60a46874" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_1d5dd664-c6d9-463f-9919-ca3fc54ad7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_dc2d1227-090a-4014-af6a-2b66de80d375" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_1d5dd664-c6d9-463f-9919-ca3fc54ad7a9" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>rdnt-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b2271182-007a-4027-b874-402dbe4bcb25,g:1e66911a-3ada-4e5a-b4d0-d568e36a58ce-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="ia39a55179af5434f93e98e8a9a3ba3de_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_57e1755b-5e09-42d8-97b5-d06bb2445541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_RevenuesAbstract_57e1755b-5e09-42d8-97b5-d06bb2445541" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28b7fdd7-9860-4457-8f10-2810e818332f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_57e1755b-5e09-42d8-97b5-d06bb2445541" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28b7fdd7-9860-4457-8f10-2810e818332f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_3c7c4c68-7a75-4085-81df-55d5479ba523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_OperatingExpensesAbstract_3c7c4c68-7a75-4085-81df-55d5479ba523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_d413b4dd-8306-477c-84b0-ad9edff60c53" xlink:href="rdnt-20230331.xsd#rdnt_OperatingExpensesExcludingDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3c7c4c68-7a75-4085-81df-55d5479ba523" xlink:to="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_d413b4dd-8306-477c-84b0-ad9edff60c53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_cfce07b9-2c08-4bc6-a2ea-cd4196f9988a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3c7c4c68-7a75-4085-81df-55d5479ba523" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_cfce07b9-2c08-4bc6-a2ea-cd4196f9988a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_3ce99357-7431-4071-ac83-9e5e8a10b74b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3c7c4c68-7a75-4085-81df-55d5479ba523" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_3ce99357-7431-4071-ac83-9e5e8a10b74b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_ec477b59-53c9-4c0b-a624-848ade5f9d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3c7c4c68-7a75-4085-81df-55d5479ba523" xlink:to="loc_us-gaap_SeveranceCosts1_ec477b59-53c9-4c0b-a624-848ade5f9d62" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f351fdc3-e7b1-4a01-8361-2629ab90c99e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3c7c4c68-7a75-4085-81df-55d5479ba523" xlink:to="loc_us-gaap_OperatingExpenses_f351fdc3-e7b1-4a01-8361-2629ab90c99e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a0f4259b-8cd2-491c-a545-7a9879e821de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_OperatingIncomeLoss_a0f4259b-8cd2-491c-a545-7a9879e821de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract_54c550c1-f9a5-4a63-ab07-1a20ac83dd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_OtherExpensesAbstract_54c550c1-f9a5-4a63-ab07-1a20ac83dd7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_e27eddc7-71bc-43cf-b3ee-1c5cf7e4af81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_54c550c1-f9a5-4a63-ab07-1a20ac83dd7e" xlink:to="loc_us-gaap_InterestExpenseDebt_e27eddc7-71bc-43cf-b3ee-1c5cf7e4af81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_43256aa5-452b-476f-935a-70fb1c515926" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_54c550c1-f9a5-4a63-ab07-1a20ac83dd7e" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_43256aa5-452b-476f-935a-70fb1c515926" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_764fbc08-096b-41e9-800b-2ddf12563dff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_54c550c1-f9a5-4a63-ab07-1a20ac83dd7e" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_764fbc08-096b-41e9-800b-2ddf12563dff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4fe62b37-c1a8-4fec-a586-cccab6b76b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_54c550c1-f9a5-4a63-ab07-1a20ac83dd7e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4fe62b37-c1a8-4fec-a586-cccab6b76b31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b6a6b650-2584-474c-8e08-fcf04dac9982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_54c550c1-f9a5-4a63-ab07-1a20ac83dd7e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b6a6b650-2584-474c-8e08-fcf04dac9982" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4db32984-8691-42b1-8860-7d0393ce787c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4db32984-8691-42b1-8860-7d0393ce787c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_588f3d0a-1eda-48c5-9f5a-747de178fc7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_588f3d0a-1eda-48c5-9f5a-747de178fc7d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3fb7e3b5-8fe7-4be5-ac32-d5ec3ea8d4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_ProfitLoss_3fb7e3b5-8fe7-4be5-ac32-d5ec3ea8d4ca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8ab2e088-7ec7-4f06-ae93-c6f27d75bf92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8ab2e088-7ec7-4f06-ae93-c6f27d75bf92" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4847dfcc-fb80-411d-93f6-d14a27abcb69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_NetIncomeLoss_4847dfcc-fb80-411d-93f6-d14a27abcb69" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2cfeba7d-ce24-42f6-8f49-c86c65e4e270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_EarningsPerShareBasic_2cfeba7d-ce24-42f6-8f49-c86c65e4e270" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_aa84a78d-fa82-4d1c-a2d1-462d477f18ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_aa84a78d-fa82-4d1c-a2d1-462d477f18ea" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_2d574159-6065-44b0-a864-74061817520a" xlink:href="rdnt-20230331.xsd#rdnt_EarningPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_2d574159-6065-44b0-a864-74061817520a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_685fbcef-31c2-4826-8793-289e8793b915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_2d574159-6065-44b0-a864-74061817520a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_685fbcef-31c2-4826-8793-289e8793b915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_94b00ded-3736-4375-aee5-2a41c0f1bda6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_2d574159-6065-44b0-a864-74061817520a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_94b00ded-3736-4375-aee5-2a41c0f1bda6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_185f6380-404d-4776-8acc-6313922fdab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_StatementTable_185f6380-404d-4776-8acc-6313922fdab3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c4c07bee-bb04-44cb-87f3-d0ecd716c598" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_185f6380-404d-4776-8acc-6313922fdab3" xlink:to="loc_srt_ProductOrServiceAxis_c4c07bee-bb04-44cb-87f3-d0ecd716c598" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c4c07bee-bb04-44cb-87f3-d0ecd716c598_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c4c07bee-bb04-44cb-87f3-d0ecd716c598" xlink:to="loc_srt_ProductsAndServicesDomain_c4c07bee-bb04-44cb-87f3-d0ecd716c598_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e70ef1bc-4c23-4fbb-bd9a-a781a3e40c64" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c4c07bee-bb04-44cb-87f3-d0ecd716c598" xlink:to="loc_srt_ProductsAndServicesDomain_e70ef1bc-4c23-4fbb-bd9a-a781a3e40c64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_1077b7e1-18f3-45a2-8623-415d125a775d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e70ef1bc-4c23-4fbb-bd9a-a781a3e40c64" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_1077b7e1-18f3-45a2-8623-415d125a775d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_85c20dfc-c207-40a3-a1b8-8dffcc333fd2" xlink:href="rdnt-20230331.xsd#rdnt_CapitationArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e70ef1bc-4c23-4fbb-bd9a-a781a3e40c64" xlink:to="loc_rdnt_CapitationArrangementsMember_85c20dfc-c207-40a3-a1b8-8dffcc333fd2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i68bd1f95e1d54444a5d567dd65cedd1b_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_45469ef2-09e5-459b-910e-d674ce18ea52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_45469ef2-09e5-459b-910e-d674ce18ea52" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1eac11a5-844d-4c84-88e7-8b8fc2adc63a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1eac11a5-844d-4c84-88e7-8b8fc2adc63a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7150046b-cb9b-4fce-82f3-2a3463b594f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7150046b-cb9b-4fce-82f3-2a3463b594f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e9ad5ec7-3b82-43fe-b809-e9d5a4e7c0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e9ad5ec7-3b82-43fe-b809-e9d5a4e7c0a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0537d4ca-fde5-49c5-b1cc-2c6549667cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0537d4ca-fde5-49c5-b1cc-2c6549667cc4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b70ef053-fd8d-4eb4-be65-da007bde5b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b70ef053-fd8d-4eb4-be65-da007bde5b29" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ee8e23cb-1c07-487a-afc3-741155c1e4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ee8e23cb-1c07-487a-afc3-741155c1e4a7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f1e00425-6bf4-4997-80b7-4dc468f5e9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f1e00425-6bf4-4997-80b7-4dc468f5e9a0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_f2a8e359-e924-41a0-bbe3-98e808fa08e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_f2a8e359-e924-41a0-bbe3-98e808fa08e4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_e64d18d5-2590-4f91-92bf-2003e699ffc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_e64d18d5-2590-4f91-92bf-2003e699ffc8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_a11fe186-2150-4e83-a538-2d35c5f90b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_a11fe186-2150-4e83-a538-2d35c5f90b26" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_b90bb7dc-0aa9-4348-8850-10b82fbb7135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_StockholdersEquityOther_b90bb7dc-0aa9-4348-8850-10b82fbb7135" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2cf39696-840a-4596-a3d1-a732bfdacb54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_ProfitLoss_2cf39696-840a-4596-a3d1-a732bfdacb54" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e5270e66-03df-4320-9411-f92924f6e990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3872537c-bf9b-43a2-a4c8-fb8a9ab472cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cae15494-c534-4c76-ba8a-a9d1b34eea8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_45469ef2-09e5-459b-910e-d674ce18ea52" xlink:to="loc_us-gaap_StatementTable_cae15494-c534-4c76-ba8a-a9d1b34eea8c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9b162555-6ac8-4d78-9eaf-c255d4a2d097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_cae15494-c534-4c76-ba8a-a9d1b34eea8c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9b162555-6ac8-4d78-9eaf-c255d4a2d097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9b162555-6ac8-4d78-9eaf-c255d4a2d097_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9b162555-6ac8-4d78-9eaf-c255d4a2d097" xlink:to="loc_us-gaap_EquityComponentDomain_9b162555-6ac8-4d78-9eaf-c255d4a2d097_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ffd4ca16-4613-459e-a39d-89d7cdf5c51e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9b162555-6ac8-4d78-9eaf-c255d4a2d097" xlink:to="loc_us-gaap_EquityComponentDomain_ffd4ca16-4613-459e-a39d-89d7cdf5c51e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_c9be554e-c527-4d72-a5c6-b548d4576e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ffd4ca16-4613-459e-a39d-89d7cdf5c51e" xlink:to="loc_us-gaap_ParentMember_c9be554e-c527-4d72-a5c6-b548d4576e29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7e8f9a73-6ffd-4e59-9584-e39d76b2e908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_c9be554e-c527-4d72-a5c6-b548d4576e29" xlink:to="loc_us-gaap_CommonStockMember_7e8f9a73-6ffd-4e59-9584-e39d76b2e908" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9ef235a9-4aee-48fb-9dab-074849971ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_c9be554e-c527-4d72-a5c6-b548d4576e29" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9ef235a9-4aee-48fb-9dab-074849971ceb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5b2101e1-d939-40ac-b9be-d3871e9d4ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_c9be554e-c527-4d72-a5c6-b548d4576e29" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5b2101e1-d939-40ac-b9be-d3871e9d4ef9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cb7b780a-5457-41b5-a2d8-4699009cf249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_c9be554e-c527-4d72-a5c6-b548d4576e29" xlink:to="loc_us-gaap_RetainedEarningsMember_cb7b780a-5457-41b5-a2d8-4699009cf249" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_bea1bfd5-7c18-4caa-80c4-928446ea7127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ffd4ca16-4613-459e-a39d-89d7cdf5c51e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_bea1bfd5-7c18-4caa-80c4-928446ea7127" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_eae5b8c8-69fc-4737-871b-05d935cfe66c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_cae15494-c534-4c76-ba8a-a9d1b34eea8c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_eae5b8c8-69fc-4737-871b-05d935cfe66c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eae5b8c8-69fc-4737-871b-05d935cfe66c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_eae5b8c8-69fc-4737-871b-05d935cfe66c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eae5b8c8-69fc-4737-871b-05d935cfe66c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06af2517-42e6-4615-a6f1-69a288aa3b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_eae5b8c8-69fc-4737-871b-05d935cfe66c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06af2517-42e6-4615-a6f1-69a288aa3b3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_f643b98c-0f3a-4227-ada2-a285ad9d274d" xlink:href="rdnt-20230331.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06af2517-42e6-4615-a6f1-69a288aa3b3e" xlink:to="loc_rdnt_DeepHealthInc.Member_f643b98c-0f3a-4227-ada2-a285ad9d274d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="extended" id="icff2b36d7432482f99310d2ab02f29a9_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8d202e73-d7d3-4a16-964e-6ca08e544a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7100697f-a5c4-4819-ae3c-cd446973221f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d202e73-d7d3-4a16-964e-6ca08e544a6f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7100697f-a5c4-4819-ae3c-cd446973221f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_7a66b68d-4bbc-48f5-a72b-2b3491bce315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d202e73-d7d3-4a16-964e-6ca08e544a6f" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_7a66b68d-4bbc-48f5-a72b-2b3491bce315" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_c8847807-0c73-4d59-9353-595368c55c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d202e73-d7d3-4a16-964e-6ca08e544a6f" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_c8847807-0c73-4d59-9353-595368c55c79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0da96016-f9d9-471b-a9f3-f2863ebf8eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8d202e73-d7d3-4a16-964e-6ca08e544a6f" xlink:to="loc_us-gaap_StatementTable_0da96016-f9d9-471b-a9f3-f2863ebf8eaa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6969ba22-27d9-470b-8b33-2771746c0cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0da96016-f9d9-471b-a9f3-f2863ebf8eaa" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6969ba22-27d9-470b-8b33-2771746c0cc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6969ba22-27d9-470b-8b33-2771746c0cc4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6969ba22-27d9-470b-8b33-2771746c0cc4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6969ba22-27d9-470b-8b33-2771746c0cc4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9a87748-da6c-4137-8486-90d9de9103c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6969ba22-27d9-470b-8b33-2771746c0cc4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9a87748-da6c-4137-8486-90d9de9103c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVMember_93f29e73-16f1-474e-99d2-0353173e4f05" xlink:href="rdnt-20230331.xsd#rdnt_AidenceHoldingBVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9a87748-da6c-4137-8486-90d9de9103c8" xlink:to="loc_rdnt_AidenceHoldingBVMember_93f29e73-16f1-474e-99d2-0353173e4f05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_3fab5fde-300e-44cf-b4cb-74a60829848c" xlink:href="rdnt-20230331.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9a87748-da6c-4137-8486-90d9de9103c8" xlink:to="loc_rdnt_QuantibMember_3fab5fde-300e-44cf-b4cb-74a60829848c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e52ece5b-6b8c-435c-9b24-604817e4d6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0da96016-f9d9-471b-a9f3-f2863ebf8eaa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e52ece5b-6b8c-435c-9b24-604817e4d6e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e52ece5b-6b8c-435c-9b24-604817e4d6e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e52ece5b-6b8c-435c-9b24-604817e4d6e5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e52ece5b-6b8c-435c-9b24-604817e4d6e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b7584174-3326-4ba9-bafa-059063011333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e52ece5b-6b8c-435c-9b24-604817e4d6e5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b7584174-3326-4ba9-bafa-059063011333" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_c4b5c89b-c4b8-43fb-b7d4-ac99297f1f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b7584174-3326-4ba9-bafa-059063011333" xlink:to="loc_us-gaap_UnsecuredDebtMember_c4b5c89b-c4b8-43fb-b7d4-ac99297f1f3c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails" xlink:type="extended" id="i2cac2a7f810149af9df733682416e116_NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters_c7c0d557-5d62-4c70-8029-caf5e0d79349" xlink:href="rdnt-20230331.xsd#rdnt_NumberOfCenters"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_rdnt_NumberOfCenters_c7c0d557-5d62-4c70-8029-caf5e0d79349" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_9219e4a8-85ab-4ff9-a201-af0526231775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_NumberOfReportableSegments_9219e4a8-85ab-4ff9-a201-af0526231775" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_27877a71-c210-4ecd-b4b1-a5d6eb2b3f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_27877a71-c210-4ecd-b4b1-a5d6eb2b3f10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_2a07ec55-8e45-4e27-87d2-4911c66dbaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_2a07ec55-8e45-4e27-87d2-4911c66dbaaf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_1b8f72ee-f81e-4dbc-ba9c-f79606ae1550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_1b8f72ee-f81e-4dbc-ba9c-f79606ae1550" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_415c6009-6f0d-4baf-befc-ac86251b993d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_Assets_415c6009-6f0d-4baf-befc-ac86251b993d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3275fbaf-bb8f-412a-beac-beee82732953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_Liabilities_3275fbaf-bb8f-412a-beac-beee82732953" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_e3c837a1-eb83-4592-a684-5772cd995a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_e3c837a1-eb83-4592-a684-5772cd995a37" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_a81331e8-3341-4e31-9d7c-d6cd7aee894f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_EquityMethodInvestments_a81331e8-3341-4e31-9d7c-d6cd7aee894f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_c9eb91ec-6213-404e-89cc-54df2e643829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_c9eb91ec-6213-404e-89cc-54df2e643829" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c049629-e2b3-4051-b659-cb643ca23844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c049629-e2b3-4051-b659-cb643ca23844" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_6d0c19e0-e3a1-4009-874d-ab7a6dec9366" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c049629-e2b3-4051-b659-cb643ca23844" xlink:to="loc_srt_ConsolidatedEntitiesAxis_6d0c19e0-e3a1-4009-874d-ab7a6dec9366" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_6d0c19e0-e3a1-4009-874d-ab7a6dec9366_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6d0c19e0-e3a1-4009-874d-ab7a6dec9366" xlink:to="loc_srt_ConsolidatedEntitiesDomain_6d0c19e0-e3a1-4009-874d-ab7a6dec9366_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_26768716-a4bc-470e-9d83-2ea16d115bf6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6d0c19e0-e3a1-4009-874d-ab7a6dec9366" xlink:to="loc_srt_ConsolidatedEntitiesDomain_26768716-a4bc-470e-9d83-2ea16d115bf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_17c15ddd-cc0c-4c54-8d26-ebded77e7531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_26768716-a4bc-470e-9d83-2ea16d115bf6" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_17c15ddd-cc0c-4c54-8d26-ebded77e7531" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_eeba7f18-22a5-4c49-8124-757ecd19c653" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c049629-e2b3-4051-b659-cb643ca23844" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_eeba7f18-22a5-4c49-8124-757ecd19c653" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_eeba7f18-22a5-4c49-8124-757ecd19c653_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_eeba7f18-22a5-4c49-8124-757ecd19c653" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_eeba7f18-22a5-4c49-8124-757ecd19c653_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7766a5af-c8ed-42ef-a0a5-e3167a1c4069" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_eeba7f18-22a5-4c49-8124-757ecd19c653" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7766a5af-c8ed-42ef-a0a5-e3167a1c4069" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderLlcMember_c3443b4f-4e40-4972-ba19-dcfc5024ee22" xlink:href="rdnt-20230331.xsd#rdnt_ScriptSenderLlcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7766a5af-c8ed-42ef-a0a5-e3167a1c4069" xlink:to="loc_rdnt_ScriptSenderLlcMember_c3443b4f-4e40-4972-ba19-dcfc5024ee22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_37553ee1-0674-4bd6-b308-91d2488e0125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c049629-e2b3-4051-b659-cb643ca23844" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_37553ee1-0674-4bd6-b308-91d2488e0125" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_37553ee1-0674-4bd6-b308-91d2488e0125_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_37553ee1-0674-4bd6-b308-91d2488e0125" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_37553ee1-0674-4bd6-b308-91d2488e0125_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_b9ffb196-8d49-4606-868e-d64b76e9a063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_37553ee1-0674-4bd6-b308-91d2488e0125" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_b9ffb196-8d49-4606-868e-d64b76e9a063" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_38146a91-c3a7-454f-a72a-6b1ed18bad1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_b9ffb196-8d49-4606-868e-d64b76e9a063" xlink:to="loc_us-gaap_OperatingExpenseMember_38146a91-c3a7-454f-a72a-6b1ed18bad1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_51acd03a-6224-4733-a690-af03626c1384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c049629-e2b3-4051-b659-cb643ca23844" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_51acd03a-6224-4733-a690-af03626c1384" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_51acd03a-6224-4733-a690-af03626c1384_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_51acd03a-6224-4733-a690-af03626c1384" xlink:to="loc_us-gaap_RelatedPartyDomain_51acd03a-6224-4733-a690-af03626c1384_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4d56868c-60c6-46a4-b3d0-8502d3a28c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_51acd03a-6224-4733-a690-af03626c1384" xlink:to="loc_us-gaap_RelatedPartyDomain_4d56868c-60c6-46a4-b3d0-8502d3a28c79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_d5e0d57c-29d3-4854-9185-1b8ba94b2e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4d56868c-60c6-46a4-b3d0-8502d3a28c79" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_d5e0d57c-29d3-4854-9185-1b8ba94b2e3a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended" id="id9fbbd86cdb249a4b261966b1a597946_SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments_a822460b-28d8-4a65-8361-ceb274c64cb5" xlink:href="rdnt-20230331.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_AdvanceMedicarePayments_a822460b-28d8-4a65-8361-ceb274c64cb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfAdvanceMedicarePayments_2801532f-c2a6-4f37-ba28-9747d93bf25f" xlink:href="rdnt-20230331.xsd#rdnt_RepaymentOfAdvanceMedicarePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_RepaymentOfAdvanceMedicarePayments_2801532f-c2a6-4f37-ba28-9747d93bf25f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable_be60cdfc-b33c-4244-88d7-4a73d3c75cc3" xlink:href="rdnt-20230331.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_ContractsReceivableFactoringReceivable_be60cdfc-b33c-4244-88d7-4a73d3c75cc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_891426a0-8da2-430d-8fd2-2ffd30f1d3db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_891426a0-8da2-430d-8fd2-2ffd30f1d3db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e14a18a9-83e7-45a2-b7a7-49a1e6d32fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e14a18a9-83e7-45a2-b7a7-49a1e6d32fa7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b3e37406-3e17-41f8-a785-9b4fb1c27d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_Goodwill_b3e37406-3e17-41f8-a785-9b4fb1c27d23" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2cc64a54-5010-4f49-a2d1-6e3f9be9bd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2cc64a54-5010-4f49-a2d1-6e3f9be9bd5c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_29e5402c-85a5-413a-aec1-aa2263b35b48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_29e5402c-85a5-413a-aec1-aa2263b35b48" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_10b1c262-e595-4c5c-ba8f-29d34de96786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_10b1c262-e595-4c5c-ba8f-29d34de96786" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8101774a-78a8-4e12-802c-b41d28b31ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8101774a-78a8-4e12-802c-b41d28b31ac2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_3ea159d7-6344-4b62-9960-10987dd4439a" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_3ea159d7-6344-4b62-9960-10987dd4439a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9f6a2afe-2379-4cea-85fa-c7fac7ee8756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9f6a2afe-2379-4cea-85fa-c7fac7ee8756" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ea8f983f-3033-4a54-9a86-27aa0fcd5347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ea8f983f-3033-4a54-9a86-27aa0fcd5347" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f0512a8b-cbe0-47e8-ac53-c042691e2006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f0512a8b-cbe0-47e8-ac53-c042691e2006" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_be63bebf-04bf-4aa5-a544-c169eab510a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_be63bebf-04bf-4aa5-a544-c169eab510a1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_dae36329-5e84-448e-885e-ab97ca659343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_dae36329-5e84-448e-885e-ab97ca659343" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_64ff0dc4-0fe5-4916-a94d-df3e4501c594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_64ff0dc4-0fe5-4916-a94d-df3e4501c594" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f460c3dd-e29e-44d5-ac81-c4b25e8c98f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_StockholdersEquity_f460c3dd-e29e-44d5-ac81-c4b25e8c98f9" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_b7f083a4-6d2c-4253-8692-1660233c33b5" xlink:href="rdnt-20230331.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_b7f083a4-6d2c-4253-8692-1660233c33b5" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e1189e9e-3bf2-45b8-9f60-8066a6d65ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e1189e9e-3bf2-45b8-9f60-8066a6d65ffc" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_bd7dc6a2-9582-41c9-9570-d382373ac970" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_bd7dc6a2-9582-41c9-9570-d382373ac970" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_aede298f-730a-458c-b486-070d9f46773e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_aede298f-730a-458c-b486-070d9f46773e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne_d9b44e4b-f667-40f1-bd28-2bff24cb33b1" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne_d9b44e4b-f667-40f1-bd28-2bff24cb33b1" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo_127740bc-71b5-440b-a4e4-a6f1165d9960" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo_127740bc-71b5-440b-a4e4-a6f1165d9960" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_6c6be953-e7e8-4560-85bb-46dcdc6c94c2" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_6c6be953-e7e8-4560-85bb-46dcdc6c94c2" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_37427e9c-9b94-4fdd-8ea0-a2205ad79669" xlink:href="rdnt-20230331.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_37427e9c-9b94-4fdd-8ea0-a2205ad79669" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_ac1f9495-32d7-4761-9715-b6fa31e8f123" xlink:href="rdnt-20230331.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_ac1f9495-32d7-4761-9715-b6fa31e8f123" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_a4a0b424-5677-4c23-bf93-bc9ff03500c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_a4a0b424-5677-4c23-bf93-bc9ff03500c4" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_9b774ea8-d331-4919-a50b-4763c6c1a9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_SharePrice_9b774ea8-d331-4919-a50b-4763c6c1a9e5" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_979dc378-9dc3-4642-b487-0e2dd3156ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_LineOfCredit_979dc378-9dc3-4642-b487-0e2dd3156ad7" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities_29bc0b97-58c6-4e38-be07-f7939ead7f43" xlink:href="rdnt-20230331.xsd#rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities_29bc0b97-58c6-4e38-be07-f7939ead7f43" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_0290220f-cc85-4d18-928c-4b8556b38365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_0290220f-cc85-4d18-928c-4b8556b38365" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_b670b1ea-11c3-4c40-bbe2-dc5a009bddb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_b670b1ea-11c3-4c40-bbe2-dc5a009bddb7" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased_d02a0ca5-4eef-402b-ba2c-6de965595c39" xlink:href="rdnt-20230331.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_EquityMethodInvestmentSharesPurchased_d02a0ca5-4eef-402b-ba2c-6de965595c39" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_bbdf6ff2-58b8-4723-8c1a-af37aaf97d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_bbdf6ff2-58b8-4723-8c1a-af37aaf97d54" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_d25f63bf-e849-4ea5-bc4b-c2e9cfbd7cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_ShortTermBorrowings_d25f63bf-e849-4ea5-bc4b-c2e9cfbd7cd1" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_8d56ae52-bcd9-4a70-a451-947eace8c435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_8d56ae52-bcd9-4a70-a451-947eace8c435" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_2c09559e-5714-471c-9571-fb2d993b200d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_2c09559e-5714-471c-9571-fb2d993b200d" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures_6c368893-89c4-4a48-8252-4ac3721ec116" xlink:href="rdnt-20230331.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_NumberofUnconsolidatedJointVentures_6c368893-89c4-4a48-8252-4ac3721ec116" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_a434799f-3989-4171-b4de-b7c9bea4339b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_a434799f-3989-4171-b4de-b7c9bea4339b" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees_35aa7a9c-3510-4276-9d55-2a4d89c9bf29" xlink:href="rdnt-20230331.xsd#rdnt_ManagementServiceFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_ManagementServiceFees_35aa7a9c-3510-4276-9d55-2a4d89c9bf29" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_9f19ab0f-47e9-4b70-af00-eebb71cee9df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_9f19ab0f-47e9-4b70-af00-eebb71cee9df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_9f19ab0f-47e9-4b70-af00-eebb71cee9df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_9f19ab0f-47e9-4b70-af00-eebb71cee9df" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_9f19ab0f-47e9-4b70-af00-eebb71cee9df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_b73ab347-272c-403b-b2f3-31d9b98b6753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_9f19ab0f-47e9-4b70-af00-eebb71cee9df" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_b73ab347-272c-403b-b2f3-31d9b98b6753" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_1f22f309-cffc-4098-9656-5c3dee9c8f02" xlink:href="rdnt-20230331.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_b73ab347-272c-403b-b2f3-31d9b98b6753" xlink:to="loc_rdnt_COVID19PandemicMember_1f22f309-cffc-4098-9656-5c3dee9c8f02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_99cb712d-5963-4f09-9747-5a553b424d02" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_srt_RangeAxis_99cb712d-5963-4f09-9747-5a553b424d02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_99cb712d-5963-4f09-9747-5a553b424d02_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_99cb712d-5963-4f09-9747-5a553b424d02" xlink:to="loc_srt_RangeMember_99cb712d-5963-4f09-9747-5a553b424d02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3b146b2a-f277-4f22-a560-6b7d5804dafd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_99cb712d-5963-4f09-9747-5a553b424d02" xlink:to="loc_srt_RangeMember_3b146b2a-f277-4f22-a560-6b7d5804dafd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_af27a598-a0a8-4317-98af-9cfb97998035" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3b146b2a-f277-4f22-a560-6b7d5804dafd" xlink:to="loc_srt_MinimumMember_af27a598-a0a8-4317-98af-9cfb97998035" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ab76556a-a9e3-4528-a0e8-b1394e2a51a4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3b146b2a-f277-4f22-a560-6b7d5804dafd" xlink:to="loc_srt_MaximumMember_ab76556a-a9e3-4528-a0e8-b1394e2a51a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1cfda76e-cbcf-4277-9654-07f6ea19de48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1cfda76e-cbcf-4277-9654-07f6ea19de48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1cfda76e-cbcf-4277-9654-07f6ea19de48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1cfda76e-cbcf-4277-9654-07f6ea19de48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1cfda76e-cbcf-4277-9654-07f6ea19de48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8656a46f-9d72-454b-9988-06d558128637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1cfda76e-cbcf-4277-9654-07f6ea19de48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8656a46f-9d72-454b-9988-06d558128637" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProperyAndEquipmentNetMember_c8c4d96c-ff95-40bc-be50-8e7ba1adcc3d" xlink:href="rdnt-20230331.xsd#rdnt_ProperyAndEquipmentNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8656a46f-9d72-454b-9988-06d558128637" xlink:to="loc_rdnt_ProperyAndEquipmentNetMember_c8c4d96c-ff95-40bc-be50-8e7ba1adcc3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_6bb78cbd-7df0-4804-9bc6-5bdbead2cab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8656a46f-9d72-454b-9988-06d558128637" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_6bb78cbd-7df0-4804-9bc6-5bdbead2cab9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bb82c46f-b2ad-46a8-bdf3-65bfe8cf7c07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bb82c46f-b2ad-46a8-bdf3-65bfe8cf7c07" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bb82c46f-b2ad-46a8-bdf3-65bfe8cf7c07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bb82c46f-b2ad-46a8-bdf3-65bfe8cf7c07" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bb82c46f-b2ad-46a8-bdf3-65bfe8cf7c07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f225fae-e0e0-4947-9d68-c6a6046f2451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bb82c46f-b2ad-46a8-bdf3-65bfe8cf7c07" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f225fae-e0e0-4947-9d68-c6a6046f2451" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_d1f4fefb-5d53-4415-ab98-c307c7b2873e" xlink:href="rdnt-20230331.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f225fae-e0e0-4947-9d68-c6a6046f2451" xlink:to="loc_rdnt_ManagementServiceContractsMember_d1f4fefb-5d53-4415-ab98-c307c7b2873e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_49572e78-fa04-41fd-8690-8fa91cf785d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_PlanNameAxis_49572e78-fa04-41fd-8690-8fa91cf785d7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_49572e78-fa04-41fd-8690-8fa91cf785d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_49572e78-fa04-41fd-8690-8fa91cf785d7" xlink:to="loc_us-gaap_PlanNameDomain_49572e78-fa04-41fd-8690-8fa91cf785d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_2a772d60-bba9-45f9-9d94-2bdc0ef4be20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_49572e78-fa04-41fd-8690-8fa91cf785d7" xlink:to="loc_us-gaap_PlanNameDomain_2a772d60-bba9-45f9-9d94-2bdc0ef4be20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_c75a7ccb-0101-4031-9ddc-e752934c71ae" xlink:href="rdnt-20230331.xsd#rdnt_RestatedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_2a772d60-bba9-45f9-9d94-2bdc0ef4be20" xlink:to="loc_rdnt_RestatedPlanMember_c75a7ccb-0101-4031-9ddc-e752934c71ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_0312adf6-6ef4-4852-b906-f6a8f413b7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_0312adf6-6ef4-4852-b906-f6a8f413b7d4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_0312adf6-6ef4-4852-b906-f6a8f413b7d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_0312adf6-6ef4-4852-b906-f6a8f413b7d4" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_0312adf6-6ef4-4852-b906-f6a8f413b7d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ea0620cb-8dba-4935-91c1-f219153a1c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_0312adf6-6ef4-4852-b906-f6a8f413b7d4" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ea0620cb-8dba-4935-91c1-f219153a1c8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember_e5f94dbe-40c0-41a2-99ce-ed0096cfac12" xlink:href="rdnt-20230331.xsd#rdnt_A2019SWAPSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ea0620cb-8dba-4935-91c1-f219153a1c8d" xlink:to="loc_rdnt_A2019SWAPSMember_e5f94dbe-40c0-41a2-99ce-ed0096cfac12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member_f0c3c4b4-80c9-4865-826f-72ff3d63c22d" xlink:href="rdnt-20230331.xsd#rdnt_A2019SWAPS1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ea0620cb-8dba-4935-91c1-f219153a1c8d" xlink:to="loc_rdnt_A2019SWAPS1Member_f0c3c4b4-80c9-4865-826f-72ff3d63c22d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis_56d4076f-bd3b-4bb9-8606-b6ae8d4b6152" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_CreditDerivativesByContractTypeAxis_56d4076f-bd3b-4bb9-8606-b6ae8d4b6152" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_56d4076f-bd3b-4bb9-8606-b6ae8d4b6152_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_56d4076f-bd3b-4bb9-8606-b6ae8d4b6152" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_56d4076f-bd3b-4bb9-8606-b6ae8d4b6152_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_2fa52575-969d-41ec-a10b-36a5c19bb412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_56d4076f-bd3b-4bb9-8606-b6ae8d4b6152" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_2fa52575-969d-41ec-a10b-36a5c19bb412" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member_b7569477-bcb1-4859-ad33-683112b3e537" xlink:href="rdnt-20230331.xsd#rdnt_October2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_2fa52575-969d-41ec-a10b-36a5c19bb412" xlink:to="loc_rdnt_October2023Member_b7569477-bcb1-4859-ad33-683112b3e537" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member_26bef44a-9650-4134-8fe2-aa48010b2e60" xlink:href="rdnt-20230331.xsd#rdnt_October2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_2fa52575-969d-41ec-a10b-36a5c19bb412" xlink:to="loc_rdnt_October2025Member_26bef44a-9650-4134-8fe2-aa48010b2e60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e9222bc8-c24c-4c5b-bbd7-75b91d749a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e9222bc8-c24c-4c5b-bbd7-75b91d749a75" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e9222bc8-c24c-4c5b-bbd7-75b91d749a75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e9222bc8-c24c-4c5b-bbd7-75b91d749a75" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e9222bc8-c24c-4c5b-bbd7-75b91d749a75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2ea6f2ba-86fa-4eb8-9542-4cedeacbc590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e9222bc8-c24c-4c5b-bbd7-75b91d749a75" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2ea6f2ba-86fa-4eb8-9542-4cedeacbc590" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ef088199-4dea-4322-ba9e-5105908bde4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2ea6f2ba-86fa-4eb8-9542-4cedeacbc590" xlink:to="loc_us-gaap_InterestRateSwapMember_ef088199-4dea-4322-ba9e-5105908bde4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d9f98bec-9289-459e-9acb-28cf6c8ddb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_VariableRateAxis_d9f98bec-9289-459e-9acb-28cf6c8ddb8c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d9f98bec-9289-459e-9acb-28cf6c8ddb8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_d9f98bec-9289-459e-9acb-28cf6c8ddb8c" xlink:to="loc_us-gaap_VariableRateDomain_d9f98bec-9289-459e-9acb-28cf6c8ddb8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_143e14de-58cf-4008-ab24-b1b5fc503ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_d9f98bec-9289-459e-9acb-28cf6c8ddb8c" xlink:to="loc_us-gaap_VariableRateDomain_143e14de-58cf-4008-ab24-b1b5fc503ab8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2e8d3a2b-fdb6-483a-8338-74a67f49d0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_143e14de-58cf-4008-ab24-b1b5fc503ab8" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2e8d3a2b-fdb6-483a-8338-74a67f49d0ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_404ebbf0-4a71-4db8-ae20-b486fa7fd41e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_404ebbf0-4a71-4db8-ae20-b486fa7fd41e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_404ebbf0-4a71-4db8-ae20-b486fa7fd41e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_404ebbf0-4a71-4db8-ae20-b486fa7fd41e" xlink:to="loc_us-gaap_EquityComponentDomain_404ebbf0-4a71-4db8-ae20-b486fa7fd41e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fd11f440-9267-4cd7-8f62-261bf6a9e873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_404ebbf0-4a71-4db8-ae20-b486fa7fd41e" xlink:to="loc_us-gaap_EquityComponentDomain_fd11f440-9267-4cd7-8f62-261bf6a9e873" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_872b3661-4a1b-400b-a999-51b143c9fa25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fd11f440-9267-4cd7-8f62-261bf6a9e873" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_872b3661-4a1b-400b-a999-51b143c9fa25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_073ea855-8a45-41f1-8943-8c019b17f4b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_srt_StatementScenarioAxis_073ea855-8a45-41f1-8943-8c019b17f4b9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_073ea855-8a45-41f1-8943-8c019b17f4b9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_073ea855-8a45-41f1-8943-8c019b17f4b9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_073ea855-8a45-41f1-8943-8c019b17f4b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ad5fe446-e961-4bdf-8009-4c7b67ae30a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_073ea855-8a45-41f1-8943-8c019b17f4b9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ad5fe446-e961-4bdf-8009-4c7b67ae30a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_bd285eed-4e1e-4441-877f-0f409903a504" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_ad5fe446-e961-4bdf-8009-4c7b67ae30a7" xlink:to="loc_srt_ScenarioForecastMember_bd285eed-4e1e-4441-877f-0f409903a504" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_04390c1e-1bc4-4dcb-ac3f-eb8cd72be53b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_04390c1e-1bc4-4dcb-ac3f-eb8cd72be53b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04390c1e-1bc4-4dcb-ac3f-eb8cd72be53b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_04390c1e-1bc4-4dcb-ac3f-eb8cd72be53b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04390c1e-1bc4-4dcb-ac3f-eb8cd72be53b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_436b6de0-ad8f-43a9-b908-b88c3aa40ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_04390c1e-1bc4-4dcb-ac3f-eb8cd72be53b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_436b6de0-ad8f-43a9-b908-b88c3aa40ae4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_958f67e4-b0d6-43fa-9a22-a6bba931ec0c" xlink:href="rdnt-20230331.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_436b6de0-ad8f-43a9-b908-b88c3aa40ae4" xlink:to="loc_rdnt_AidenceMember_958f67e4-b0d6-43fa-9a22-a6bba931ec0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_29f350ac-2dc1-48fe-8f13-b573d37bb668" xlink:href="rdnt-20230331.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_436b6de0-ad8f-43a9-b908-b88c3aa40ae4" xlink:to="loc_rdnt_QuantibMember_29f350ac-2dc1-48fe-8f13-b573d37bb668" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_87571a31-aeff-4c23-b98b-9c8a69444c3a" xlink:href="rdnt-20230331.xsd#rdnt_MontclairMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_436b6de0-ad8f-43a9-b908-b88c3aa40ae4" xlink:to="loc_rdnt_MontclairMember_87571a31-aeff-4c23-b98b-9c8a69444c3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_6896f143-b471-4d39-a89c-03df67197dda" xlink:href="rdnt-20230331.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_436b6de0-ad8f-43a9-b908-b88c3aa40ae4" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_6896f143-b471-4d39-a89c-03df67197dda" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_063a409d-b72e-4b20-ac15-c2bdd77c8500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_063a409d-b72e-4b20-ac15-c2bdd77c8500" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_063a409d-b72e-4b20-ac15-c2bdd77c8500_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_063a409d-b72e-4b20-ac15-c2bdd77c8500" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_063a409d-b72e-4b20-ac15-c2bdd77c8500_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_cfd0466b-01b7-424d-8004-41e6bed9eaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_063a409d-b72e-4b20-ac15-c2bdd77c8500" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_cfd0466b-01b7-424d-8004-41e6bed9eaf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentMilestoneConsiderationMember_2750d28d-bd56-47ef-a706-313405d26c09" xlink:href="rdnt-20230331.xsd#rdnt_ContingentMilestoneConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_cfd0466b-01b7-424d-8004-41e6bed9eaf7" xlink:to="loc_rdnt_ContingentMilestoneConsiderationMember_2750d28d-bd56-47ef-a706-313405d26c09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember_83e8eda6-a2ff-420e-8a2b-91aa5fb19092" xlink:href="rdnt-20230331.xsd#rdnt_CashHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_cfd0466b-01b7-424d-8004-41e6bed9eaf7" xlink:to="loc_rdnt_CashHoldbackMember_83e8eda6-a2ff-420e-8a2b-91aa5fb19092" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ca54633f-47cb-4874-aee8-4e9ed340bc78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_CreditFacilityAxis_ca54633f-47cb-4874-aee8-4e9ed340bc78" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ca54633f-47cb-4874-aee8-4e9ed340bc78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_ca54633f-47cb-4874-aee8-4e9ed340bc78" xlink:to="loc_us-gaap_CreditFacilityDomain_ca54633f-47cb-4874-aee8-4e9ed340bc78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8594d058-68cf-4513-b28d-a8c67ae4707b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_ca54633f-47cb-4874-aee8-4e9ed340bc78" xlink:to="loc_us-gaap_CreditFacilityDomain_8594d058-68cf-4513-b28d-a8c67ae4707b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_da9416e4-c5a5-4279-bd45-4ceb4716bd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_8594d058-68cf-4513-b28d-a8c67ae4707b" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_da9416e4-c5a5-4279-bd45-4ceb4716bd7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_57cc7adc-6c9a-4690-a7dc-1589beed2706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_DebtInstrumentAxis_57cc7adc-6c9a-4690-a7dc-1589beed2706" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_57cc7adc-6c9a-4690-a7dc-1589beed2706_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_57cc7adc-6c9a-4690-a7dc-1589beed2706" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_57cc7adc-6c9a-4690-a7dc-1589beed2706_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_60592fe0-e746-40eb-afe9-83543bd107a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_57cc7adc-6c9a-4690-a7dc-1589beed2706" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_60592fe0-e746-40eb-afe9-83543bd107a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_d17510bb-9f08-41a7-86ce-ea2c38903556" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60592fe0-e746-40eb-afe9-83543bd107a2" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_d17510bb-9f08-41a7-86ce-ea2c38903556" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_80abcf5d-7264-4c57-b3a5-910e1b35085a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_80abcf5d-7264-4c57-b3a5-910e1b35085a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_80abcf5d-7264-4c57-b3a5-910e1b35085a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_80abcf5d-7264-4c57-b3a5-910e1b35085a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_80abcf5d-7264-4c57-b3a5-910e1b35085a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_e8d5c2a2-2224-4649-86e3-f5c303b934f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_80abcf5d-7264-4c57-b3a5-910e1b35085a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_e8d5c2a2-2224-4649-86e3-f5c303b934f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_dd4176ba-c39d-45b8-bb20-b0ed76254611" xlink:href="rdnt-20230331.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_e8d5c2a2-2224-4649-86e3-f5c303b934f0" xlink:to="loc_rdnt_BarclaysMember_dd4176ba-c39d-45b8-bb20-b0ed76254611" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a86de0a3-2b08-4e35-a0a3-4ed56f7db10a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a86de0a3-2b08-4e35-a0a3-4ed56f7db10a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a86de0a3-2b08-4e35-a0a3-4ed56f7db10a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a86de0a3-2b08-4e35-a0a3-4ed56f7db10a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a86de0a3-2b08-4e35-a0a3-4ed56f7db10a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fbafb7f5-ff69-4640-9e40-7d7c5b419234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a86de0a3-2b08-4e35-a0a3-4ed56f7db10a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fbafb7f5-ff69-4640-9e40-7d7c5b419234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_f79c8574-7678-40ea-a39c-dce1ad97fd20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fbafb7f5-ff69-4640-9e40-7d7c5b419234" xlink:to="loc_us-gaap_LineOfCreditMember_f79c8574-7678-40ea-a39c-dce1ad97fd20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a7cb8787-3913-4aa6-b767-f5e2d1083ab0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a7cb8787-3913-4aa6-b767-f5e2d1083ab0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a7cb8787-3913-4aa6-b767-f5e2d1083ab0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a7cb8787-3913-4aa6-b767-f5e2d1083ab0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a7cb8787-3913-4aa6-b767-f5e2d1083ab0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a0b0bdf4-e1ae-4ba7-8ca0-3fc6974a0033" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a7cb8787-3913-4aa6-b767-f5e2d1083ab0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a0b0bdf4-e1ae-4ba7-8ca0-3fc6974a0033" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember_5e82a0b0-a067-4edc-94c8-17acc25cab0d" xlink:href="rdnt-20230331.xsd#rdnt_MedicVisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a0b0bdf4-e1ae-4ba7-8ca0-3fc6974a0033" xlink:to="loc_rdnt_MedicVisionMember_5e82a0b0-a067-4edc-94c8-17acc25cab0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember_d45abcbb-8d80-4c48-a6d3-1cfbc5ebc954" xlink:href="rdnt-20230331.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a0b0bdf4-e1ae-4ba7-8ca0-3fc6974a0033" xlink:to="loc_rdnt_TurnerImagingSystemsMember_d45abcbb-8d80-4c48-a6d3-1cfbc5ebc954" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbit.aiInc.Member_60506dad-0811-4713-8230-13ec0c6458f2" xlink:href="rdnt-20230331.xsd#rdnt_WhiteRabbit.aiInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a0b0bdf4-e1ae-4ba7-8ca0-3fc6974a0033" xlink:to="loc_rdnt_WhiteRabbit.aiInc.Member_60506dad-0811-4713-8230-13ec0c6458f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_60d80869-472f-4eab-89a8-052eb31452af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_srt_CounterpartyNameAxis_60d80869-472f-4eab-89a8-052eb31452af" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_60d80869-472f-4eab-89a8-052eb31452af_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_60d80869-472f-4eab-89a8-052eb31452af" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_60d80869-472f-4eab-89a8-052eb31452af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fc4f8da5-cf4c-4ed2-a553-a8e7fa06f1d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_60d80869-472f-4eab-89a8-052eb31452af" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fc4f8da5-cf4c-4ed2-a553-a8e7fa06f1d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_113610aa-6f1b-4c86-be64-25e6d962cb79" xlink:href="rdnt-20230331.xsd#rdnt_DignityHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fc4f8da5-cf4c-4ed2-a553-a8e7fa06f1d7" xlink:to="loc_rdnt_DignityHealthMember_113610aa-6f1b-4c86-be64-25e6d962cb79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_a2707a32-068a-4a75-9859-9cd4411a926f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_a2707a32-068a-4a75-9859-9cd4411a926f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_a2707a32-068a-4a75-9859-9cd4411a926f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_a2707a32-068a-4a75-9859-9cd4411a926f" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_a2707a32-068a-4a75-9859-9cd4411a926f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_f275caeb-224b-4b84-9293-b798c837d694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_a2707a32-068a-4a75-9859-9cd4411a926f" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_f275caeb-224b-4b84-9293-b798c837d694" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember_441e7532-01b4-4edd-9bd1-4ed98a58f40b" xlink:href="rdnt-20230331.xsd#rdnt_JointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_f275caeb-224b-4b84-9293-b798c837d694" xlink:to="loc_rdnt_JointVentureMember_441e7532-01b4-4edd-9bd1-4ed98a58f40b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_489d767b-6c3a-4a59-9c58-11a617b78988" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_dei_LegalEntityAxis_489d767b-6c3a-4a59-9c58-11a617b78988" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_489d767b-6c3a-4a59-9c58-11a617b78988_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_489d767b-6c3a-4a59-9c58-11a617b78988" xlink:to="loc_dei_EntityDomain_489d767b-6c3a-4a59-9c58-11a617b78988_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6acd3e9a-2f4e-4f18-886b-c60a04000624" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_489d767b-6c3a-4a59-9c58-11a617b78988" xlink:to="loc_dei_EntityDomain_6acd3e9a-2f4e-4f18-886b-c60a04000624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember_6bd125c9-dfae-4e2a-bcd0-13e9d1c12fef" xlink:href="rdnt-20230331.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_6acd3e9a-2f4e-4f18-886b-c60a04000624" xlink:to="loc_rdnt_GlendaleAdvancedImagingMember_6bd125c9-dfae-4e2a-bcd0-13e9d1c12fef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_0bc3bd99-bc47-4674-8f39-da4f09312075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_0bc3bd99-bc47-4674-8f39-da4f09312075" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_0bc3bd99-bc47-4674-8f39-da4f09312075_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_0bc3bd99-bc47-4674-8f39-da4f09312075" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_0bc3bd99-bc47-4674-8f39-da4f09312075_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_f3c5aae2-5aca-4d05-aa5f-bc7b292286d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_0bc3bd99-bc47-4674-8f39-da4f09312075" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_f3c5aae2-5aca-4d05-aa5f-bc7b292286d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_bc31e099-b37c-4f7e-896b-85ed10554d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_f3c5aae2-5aca-4d05-aa5f-bc7b292286d8" xlink:to="loc_us-gaap_CommercialPaperMember_bc31e099-b37c-4f7e-896b-85ed10554d98" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails" xlink:type="extended" id="i8ab393b5b28744c2b4a71c9c0b9b4188_SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_6e9ae276-3cb6-4ff3-8686-c2cc1fe17674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1e02dc1d-86a2-420a-a2a9-4cf315f13d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_6e9ae276-3cb6-4ff3-8686-c2cc1fe17674" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1e02dc1d-86a2-420a-a2a9-4cf315f13d73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_8c26d6eb-c9a1-43f2-b9a3-764373d1236c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_6e9ae276-3cb6-4ff3-8686-c2cc1fe17674" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_8c26d6eb-c9a1-43f2-b9a3-764373d1236c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_86122684-4da8-42ce-a320-ffef18b5be7a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_8c26d6eb-c9a1-43f2-b9a3-764373d1236c" xlink:to="loc_srt_ProductOrServiceAxis_86122684-4da8-42ce-a320-ffef18b5be7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_86122684-4da8-42ce-a320-ffef18b5be7a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_86122684-4da8-42ce-a320-ffef18b5be7a" xlink:to="loc_srt_ProductsAndServicesDomain_86122684-4da8-42ce-a320-ffef18b5be7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1f6b95d2-9e69-4e93-8daf-9ab14be2c548" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_86122684-4da8-42ce-a320-ffef18b5be7a" xlink:to="loc_srt_ProductsAndServicesDomain_1f6b95d2-9e69-4e93-8daf-9ab14be2c548" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:href="rdnt-20230331.xsd#rdnt_ImagingCenterSegmentRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1f6b95d2-9e69-4e93-8daf-9ab14be2c548" xlink:to="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member_807ddfac-5c0b-4729-ad6f-70c05cf89e97" xlink:href="rdnt-20230331.xsd#rdnt_CommercialInsurance1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_rdnt_CommercialInsurance1Member_807ddfac-5c0b-4729-ad6f-70c05cf89e97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member_35bd3637-138b-4784-a4a7-3f7372300c79" xlink:href="rdnt-20230331.xsd#rdnt_Medicare1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_rdnt_Medicare1Member_35bd3637-138b-4784-a4a7-3f7372300c79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member_e4febdff-d2b7-46d2-8259-3121af53505e" xlink:href="rdnt-20230331.xsd#rdnt_Medicaid1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_rdnt_Medicaid1Member_e4febdff-d2b7-46d2-8259-3121af53505e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member_e7d61826-1cc9-44bf-95ef-96292635a8da" xlink:href="rdnt-20230331.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_rdnt_WorkersCompensationPersonalInjury1Member_e7d61826-1cc9-44bf-95ef-96292635a8da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember_fc5dac77-4fc1-4f07-b317-e9a70fa4adb7" xlink:href="rdnt-20230331.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_rdnt_HealthCarePatientServiceOtherMember_fc5dac77-4fc1-4f07-b317-e9a70fa4adb7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember_ad803c16-b97f-4ef3-b6d6-34206fd951b9" xlink:href="rdnt-20230331.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_rdnt_HealthCareManagementServiceMember_ad803c16-b97f-4ef3-b6d6-34206fd951b9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TeleradiologyandSoftwareMember_59cf8c31-7263-41ee-87ef-a0546fdd4826" xlink:href="rdnt-20230331.xsd#rdnt_TeleradiologyandSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_rdnt_TeleradiologyandSoftwareMember_59cf8c31-7263-41ee-87ef-a0546fdd4826" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_88945e9b-cc4e-49c9-8968-ece205713f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_us-gaap_HealthCareOtherMember_88945e9b-cc4e-49c9-8968-ece205713f8f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_9f270abe-c908-42f7-b2d9-167cdef6ec88" xlink:href="rdnt-20230331.xsd#rdnt_CapitationArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_rdnt_CapitationArrangementsMember_9f270abe-c908-42f7-b2d9-167cdef6ec88" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_2ee50593-1cf9-42f8-9729-43bc8f0bdca0" xlink:href="rdnt-20230331.xsd#rdnt_AIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1f6b95d2-9e69-4e93-8daf-9ab14be2c548" xlink:to="loc_rdnt_AIMember_2ee50593-1cf9-42f8-9729-43bc8f0bdca0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails" xlink:type="extended" id="i2bd753f70e4e4134ae1ca3a6560fd6af_SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_bfdd9eec-cf19-4f2e-a086-848a6ecd7ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_7eff52c8-e9fc-486f-bc81-38aeb312113a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_bfdd9eec-cf19-4f2e-a086-848a6ecd7ebb" xlink:to="loc_us-gaap_GoodwillRollForward_7eff52c8-e9fc-486f-bc81-38aeb312113a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_14e7b50d-8f04-4293-a866-5a93da07a7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7eff52c8-e9fc-486f-bc81-38aeb312113a" xlink:to="loc_us-gaap_Goodwill_14e7b50d-8f04-4293-a866-5a93da07a7ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_7a9ee334-401e-42bd-a247-b8f49a93f9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7eff52c8-e9fc-486f-bc81-38aeb312113a" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_7a9ee334-401e-42bd-a247-b8f49a93f9a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_900cf43c-6cc8-41fc-80b6-a934eb11d456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7eff52c8-e9fc-486f-bc81-38aeb312113a" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_900cf43c-6cc8-41fc-80b6-a934eb11d456" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9a6fb803-8bb1-430b-b93c-f85936092204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7eff52c8-e9fc-486f-bc81-38aeb312113a" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9a6fb803-8bb1-430b-b93c-f85936092204" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4ad14150-1f4c-4098-97d4-db0b72c72942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_f4cb2259-ffd7-4cab-a7fa-38ac32f0c8db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_bfdd9eec-cf19-4f2e-a086-848a6ecd7ebb" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_f4cb2259-ffd7-4cab-a7fa-38ac32f0c8db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d50b0366-1086-4e2e-b9f9-e01591a17f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f4cb2259-ffd7-4cab-a7fa-38ac32f0c8db" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d50b0366-1086-4e2e-b9f9-e01591a17f7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d50b0366-1086-4e2e-b9f9-e01591a17f7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d50b0366-1086-4e2e-b9f9-e01591a17f7d" xlink:to="loc_us-gaap_SegmentDomain_d50b0366-1086-4e2e-b9f9-e01591a17f7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_50e6e124-0e5b-4d75-a550-00a6e7b153f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d50b0366-1086-4e2e-b9f9-e01591a17f7d" xlink:to="loc_us-gaap_SegmentDomain_50e6e124-0e5b-4d75-a550-00a6e7b153f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_401f62a5-d432-4518-ab70-e6ae5cdd1019" xlink:href="rdnt-20230331.xsd#rdnt_ImagingCentersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_50e6e124-0e5b-4d75-a550-00a6e7b153f2" xlink:to="loc_rdnt_ImagingCentersMember_401f62a5-d432-4518-ab70-e6ae5cdd1019" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArtificialIntelligenceMember_14c41981-1f3c-41e6-9a6d-43f487fbd7e6" xlink:href="rdnt-20230331.xsd#rdnt_ArtificialIntelligenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_50e6e124-0e5b-4d75-a550-00a6e7b153f2" xlink:to="loc_rdnt_ArtificialIntelligenceMember_14c41981-1f3c-41e6-9a6d-43f487fbd7e6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails" xlink:type="extended" id="ic5c46fe6bbfa4441886c587748fee0e2_SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_cc2fd0ca-47ba-4694-aab7-9e492e32c035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_cc2fd0ca-47ba-4694-aab7-9e492e32c035" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_cce04d4b-02d8-4980-baad-d0200a790c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_cce04d4b-02d8-4980-baad-d0200a790c9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c35ca295-8946-47d8-87af-9e9cbdceed03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c35ca295-8946-47d8-87af-9e9cbdceed03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_16620ce6-5912-4bdb-bd8c-5eaf7d83ea64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_16620ce6-5912-4bdb-bd8c-5eaf7d83ea64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5af9db26-a622-44ac-851d-a8c383fde522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5af9db26-a622-44ac-851d-a8c383fde522" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_aa9d76cd-2e36-4ab0-8807-cc9b764ec50c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_aa9d76cd-2e36-4ab0-8807-cc9b764ec50c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_da28ce43-b0fa-421b-9139-50f13ea4063c" xlink:href="rdnt-20230331.xsd#rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_da28ce43-b0fa-421b-9139-50f13ea4063c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e04fc81c-fd41-42d3-94d8-6403fe2de636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e04fc81c-fd41-42d3-94d8-6403fe2de636" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8d9f5685-9184-4b89-8865-c9bd5f478954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8d9f5685-9184-4b89-8865-c9bd5f478954" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_4a457f3c-b9ec-45cd-9b35-df9baf0adaa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_4a457f3c-b9ec-45cd-9b35-df9baf0adaa1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7f068243-6f01-4087-a719-287bbd4459a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7f068243-6f01-4087-a719-287bbd4459a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d41c257-27a4-4623-b33e-4e1f725c8f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7f068243-6f01-4087-a719-287bbd4459a8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d41c257-27a4-4623-b33e-4e1f725c8f73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2d41c257-27a4-4623-b33e-4e1f725c8f73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d41c257-27a4-4623-b33e-4e1f725c8f73" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2d41c257-27a4-4623-b33e-4e1f725c8f73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb6ee89-5663-4194-b2b3-0cb3ff40bd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d41c257-27a4-4623-b33e-4e1f725c8f73" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb6ee89-5663-4194-b2b3-0cb3ff40bd3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_37e7bd81-3246-4a61-8e86-0f65d8643d6c" xlink:href="rdnt-20230331.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb6ee89-5663-4194-b2b3-0cb3ff40bd3a" xlink:to="loc_rdnt_ManagementServiceContractsMember_37e7bd81-3246-4a61-8e86-0f65d8643d6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CovenantNotToCompeteMember_d35c02fc-3fcd-4aaa-8fdd-9ec0cedaf24c" xlink:href="rdnt-20230331.xsd#rdnt_CovenantNotToCompeteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb6ee89-5663-4194-b2b3-0cb3ff40bd3a" xlink:to="loc_rdnt_CovenantNotToCompeteMember_d35c02fc-3fcd-4aaa-8fdd-9ec0cedaf24c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_06cfd30b-431b-41e0-a7b3-a5750eb86f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb6ee89-5663-4194-b2b3-0cb3ff40bd3a" xlink:to="loc_us-gaap_CustomerRelationshipsMember_06cfd30b-431b-41e0-a7b3-a5750eb86f75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatentAndTrademarksMember_5e6aab41-e531-4d49-b1d0-79705c4e0ba5" xlink:href="rdnt-20230331.xsd#rdnt_PatentAndTrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb6ee89-5663-4194-b2b3-0cb3ff40bd3a" xlink:to="loc_rdnt_PatentAndTrademarksMember_5e6aab41-e531-4d49-b1d0-79705c4e0ba5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DevelopedTechnologySoftwareMember_5d70b1d1-ded9-427f-9929-8308068a227c" xlink:href="rdnt-20230331.xsd#rdnt_DevelopedTechnologySoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb6ee89-5663-4194-b2b3-0cb3ff40bd3a" xlink:to="loc_rdnt_DevelopedTechnologySoftwareMember_5d70b1d1-ded9-427f-9929-8308068a227c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_92ef5a68-ab8f-4da9-9331-146c166368a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb6ee89-5663-4194-b2b3-0cb3ff40bd3a" xlink:to="loc_us-gaap_TradeNamesMember_92ef5a68-ab8f-4da9-9331-146c166368a9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_d950627d-8ec8-40c5-93ab-f25468c07404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d7a91c7f-0493-4fa4-b722-d815a65d5357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_d950627d-8ec8-40c5-93ab-f25468c07404" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d7a91c7f-0493-4fa4-b722-d815a65d5357" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_d6719e07-d2ea-42bf-8e90-944464a2bcb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_d950627d-8ec8-40c5-93ab-f25468c07404" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_d6719e07-d2ea-42bf-8e90-944464a2bcb9" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7a58a580-ba8b-45fb-b264-0871e61d45d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_d6719e07-d2ea-42bf-8e90-944464a2bcb9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7a58a580-ba8b-45fb-b264-0871e61d45d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7a58a580-ba8b-45fb-b264-0871e61d45d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7a58a580-ba8b-45fb-b264-0871e61d45d1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7a58a580-ba8b-45fb-b264-0871e61d45d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_12ce433c-420d-41c3-b5c5-61768466a925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7a58a580-ba8b-45fb-b264-0871e61d45d1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_12ce433c-420d-41c3-b5c5-61768466a925" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_5b4414df-6cd7-4b24-9e7c-ece7e8a6ea14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_12ce433c-420d-41c3-b5c5-61768466a925" xlink:to="loc_us-gaap_TradeNamesMember_5b4414df-6cd7-4b24-9e7c-ece7e8a6ea14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_2dfb05e9-8217-4b4c-8c92-d08fb371ab31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_12ce433c-420d-41c3-b5c5-61768466a925" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_2dfb05e9-8217-4b4c-8c92-d08fb371ab31" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails" xlink:type="extended" id="i1faa8147d97143dd83877deaed6b9b33_SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_b4d7200f-f951-49f6-8f99-b6b250123f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_114abfbe-d0de-41fd-87a8-b67f027dd3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_b4d7200f-f951-49f6-8f99-b6b250123f6a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_114abfbe-d0de-41fd-87a8-b67f027dd3b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_977420d2-a980-4e0e-95da-0058a636b1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_b4d7200f-f951-49f6-8f99-b6b250123f6a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_977420d2-a980-4e0e-95da-0058a636b1c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_81b9a73d-a064-4e45-8168-935d7c87a8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_b4d7200f-f951-49f6-8f99-b6b250123f6a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_81b9a73d-a064-4e45-8168-935d7c87a8cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b042d6b5-925e-43a3-8da5-7321cd20ed50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_85eed947-8660-4f5a-b45a-8c37deaaf935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_b4d7200f-f951-49f6-8f99-b6b250123f6a" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_85eed947-8660-4f5a-b45a-8c37deaaf935" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_19a6a20b-3dde-4882-ad7c-28acc6de8b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_b4d7200f-f951-49f6-8f99-b6b250123f6a" xlink:to="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_19a6a20b-3dde-4882-ad7c-28acc6de8b1c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_a9091106-f724-42f3-8c65-8c130c5b9d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_b4d7200f-f951-49f6-8f99-b6b250123f6a" xlink:to="loc_us-gaap_OffsettingAssetsTable_a9091106-f724-42f3-8c65-8c130c5b9d43" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_268761e3-724c-42ed-b081-e503bfc27565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_a9091106-f724-42f3-8c65-8c130c5b9d43" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_268761e3-724c-42ed-b081-e503bfc27565" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_268761e3-724c-42ed-b081-e503bfc27565_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_268761e3-724c-42ed-b081-e503bfc27565" xlink:to="loc_us-gaap_EquityComponentDomain_268761e3-724c-42ed-b081-e503bfc27565_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_29bc6482-e107-48e6-bf96-9a4c8d8b98df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_268761e3-724c-42ed-b081-e503bfc27565" xlink:to="loc_us-gaap_EquityComponentDomain_29bc6482-e107-48e6-bf96-9a4c8d8b98df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5c251156-9972-4db4-b817-ccb02081d0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_29bc6482-e107-48e6-bf96-9a4c8d8b98df" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5c251156-9972-4db4-b817-ccb02081d0a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_43438f85-0958-42eb-9504-ce7492d55a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_a9091106-f724-42f3-8c65-8c130c5b9d43" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_43438f85-0958-42eb-9504-ce7492d55a5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_43438f85-0958-42eb-9504-ce7492d55a5a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_43438f85-0958-42eb-9504-ce7492d55a5a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_43438f85-0958-42eb-9504-ce7492d55a5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ef259b8e-615c-44d9-9e51-1a235b630c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_43438f85-0958-42eb-9504-ce7492d55a5a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ef259b8e-615c-44d9-9e51-1a235b630c11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_fc142af6-2b16-4ce8-8062-1659e67fe2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ef259b8e-615c-44d9-9e51-1a235b630c11" xlink:to="loc_us-gaap_InterestExpenseMember_fc142af6-2b16-4ce8-8062-1659e67fe2a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f3996ed0-e48e-4522-8270-4e5070c0f3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_a9091106-f724-42f3-8c65-8c130c5b9d43" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f3996ed0-e48e-4522-8270-4e5070c0f3b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f3996ed0-e48e-4522-8270-4e5070c0f3b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f3996ed0-e48e-4522-8270-4e5070c0f3b1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f3996ed0-e48e-4522-8270-4e5070c0f3b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ac853b82-3e16-4cbf-85f6-f4e668a45b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f3996ed0-e48e-4522-8270-4e5070c0f3b1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ac853b82-3e16-4cbf-85f6-f4e668a45b30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_bd1a7816-017e-4197-a4e4-493d1a9b45be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac853b82-3e16-4cbf-85f6-f4e668a45b30" xlink:to="loc_us-gaap_InterestRateSwapMember_bd1a7816-017e-4197-a4e4-493d1a9b45be" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails" xlink:type="extended" id="ib2b6b339c9704c2fad7a418f1e384375_SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_83856aba-60ca-46b7-8335-63f7304423a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_1be016c7-410a-400f-897c-aab8ff846ddc" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_83856aba-60ca-46b7-8335-63f7304423a0" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_1be016c7-410a-400f-897c-aab8ff846ddc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a714e129-1287-46cf-9a8b-927bb2572ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_1be016c7-410a-400f-897c-aab8ff846ddc" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a714e129-1287-46cf-9a8b-927bb2572ee1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration_bdf35737-c0a9-4d19-a5d2-3a6709b7c26c" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_1be016c7-410a-400f-897c-aab8ff846ddc" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration_bdf35737-c0a9-4d19-a5d2-3a6709b7c26c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_aea6b0c3-d082-4f6b-b159-abe4f181e322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_1be016c7-410a-400f-897c-aab8ff846ddc" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_aea6b0c3-d082-4f6b-b159-abe4f181e322" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_cb3adc45-70e3-431f-ab94-dbfe241717be" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_1be016c7-410a-400f-897c-aab8ff846ddc" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_cb3adc45-70e3-431f-ab94-dbfe241717be" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2c96d9c0-7015-421a-9c13-2281def4c7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_076a342f-7a5c-4677-acd5-2ea54af4aba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_83856aba-60ca-46b7-8335-63f7304423a0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_076a342f-7a5c-4677-acd5-2ea54af4aba5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_21420c79-80a5-4f7e-92e5-a52b1f6ec48b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_076a342f-7a5c-4677-acd5-2ea54af4aba5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_21420c79-80a5-4f7e-92e5-a52b1f6ec48b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21420c79-80a5-4f7e-92e5-a52b1f6ec48b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_21420c79-80a5-4f7e-92e5-a52b1f6ec48b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21420c79-80a5-4f7e-92e5-a52b1f6ec48b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6a1dcf1-f49e-4fab-af2b-34507ed10911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_21420c79-80a5-4f7e-92e5-a52b1f6ec48b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6a1dcf1-f49e-4fab-af2b-34507ed10911" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_5b30f56e-db8e-47b7-b903-4c44c0693130" xlink:href="rdnt-20230331.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6a1dcf1-f49e-4fab-af2b-34507ed10911" xlink:to="loc_rdnt_AidenceMember_5b30f56e-db8e-47b7-b903-4c44c0693130" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_4b827a40-3b0f-4d05-a168-f3317bee7512" xlink:href="rdnt-20230331.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6a1dcf1-f49e-4fab-af2b-34507ed10911" xlink:to="loc_rdnt_QuantibMember_4b827a40-3b0f-4d05-a168-f3317bee7512" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_693c7366-1b72-41a0-b698-afe0a2e053f7" xlink:href="rdnt-20230331.xsd#rdnt_MontclairMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6a1dcf1-f49e-4fab-af2b-34507ed10911" xlink:to="loc_rdnt_MontclairMember_693c7366-1b72-41a0-b698-afe0a2e053f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_8b821e50-ee7e-4e4b-b908-5ce7a6dd15b0" xlink:href="rdnt-20230331.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6a1dcf1-f49e-4fab-af2b-34507ed10911" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_8b821e50-ee7e-4e4b-b908-5ce7a6dd15b0" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails" xlink:type="extended" id="i8a97785f61e3467bbf1e0815063bf93a_SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d3a9c4ae-866a-460a-bece-f82e1b61b9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_74022ee4-9e00-426f-8c7f-1057b120b872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d3a9c4ae-866a-460a-bece-f82e1b61b9e8" xlink:to="loc_us-gaap_DerivativeAssets_74022ee4-9e00-426f-8c7f-1057b120b872" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_4a2884a8-2000-4790-b419-957330824113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d3a9c4ae-866a-460a-bece-f82e1b61b9e8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_4a2884a8-2000-4790-b419-957330824113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_3fabcaab-073a-4755-ba46-9f823bd83d38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d3a9c4ae-866a-460a-bece-f82e1b61b9e8" xlink:to="loc_us-gaap_DebtInstrumentFairValue_3fabcaab-073a-4755-ba46-9f823bd83d38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_d5d9b197-b82b-4adc-b813-a854b4f537e7" xlink:href="rdnt-20230331.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d3a9c4ae-866a-460a-bece-f82e1b61b9e8" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_d5d9b197-b82b-4adc-b813-a854b4f537e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a0f618d8-4d31-4774-85e2-c56fdd5026ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d3a9c4ae-866a-460a-bece-f82e1b61b9e8" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a0f618d8-4d31-4774-85e2-c56fdd5026ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c7a4259b-ff72-494d-b2ac-4d1584d0c855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a0f618d8-4d31-4774-85e2-c56fdd5026ad" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c7a4259b-ff72-494d-b2ac-4d1584d0c855" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c7a4259b-ff72-494d-b2ac-4d1584d0c855_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c7a4259b-ff72-494d-b2ac-4d1584d0c855" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c7a4259b-ff72-494d-b2ac-4d1584d0c855_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5f31ec04-325f-43f2-b48d-78f576d3434c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c7a4259b-ff72-494d-b2ac-4d1584d0c855" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5f31ec04-325f-43f2-b48d-78f576d3434c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6cea72b0-ed89-441f-bf3d-a5989dbbaf6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5f31ec04-325f-43f2-b48d-78f576d3434c" xlink:to="loc_us-gaap_InterestRateSwapMember_6cea72b0-ed89-441f-bf3d-a5989dbbaf6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_a3ce00f5-cad0-46c2-81f9-f3d02622a8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a0f618d8-4d31-4774-85e2-c56fdd5026ad" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_a3ce00f5-cad0-46c2-81f9-f3d02622a8d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a3ce00f5-cad0-46c2-81f9-f3d02622a8d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_a3ce00f5-cad0-46c2-81f9-f3d02622a8d1" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a3ce00f5-cad0-46c2-81f9-f3d02622a8d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6425413b-3009-4b6c-89d4-abd8a0913d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_a3ce00f5-cad0-46c2-81f9-f3d02622a8d1" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6425413b-3009-4b6c-89d4-abd8a0913d54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_073de062-27c3-4f63-b6db-bdb101ecbf1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6425413b-3009-4b6c-89d4-abd8a0913d54" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_073de062-27c3-4f63-b6db-bdb101ecbf1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_78157b8d-2189-4637-882f-3d97df6ad46b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_073de062-27c3-4f63-b6db-bdb101ecbf1d" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_78157b8d-2189-4637-882f-3d97df6ad46b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_92380c74-41e5-4d35-8874-d33a3b55eeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a0f618d8-4d31-4774-85e2-c56fdd5026ad" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_92380c74-41e5-4d35-8874-d33a3b55eeb7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92380c74-41e5-4d35-8874-d33a3b55eeb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_92380c74-41e5-4d35-8874-d33a3b55eeb7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92380c74-41e5-4d35-8874-d33a3b55eeb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b15945c8-919e-4e67-a10a-f9836a710cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_92380c74-41e5-4d35-8874-d33a3b55eeb7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b15945c8-919e-4e67-a10a-f9836a710cac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_761f155b-97a2-4b6f-abd6-0caf6117dd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b15945c8-919e-4e67-a10a-f9836a710cac" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_761f155b-97a2-4b6f-abd6-0caf6117dd7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f790b538-72fb-481e-8a89-c35f492380d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b15945c8-919e-4e67-a10a-f9836a710cac" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f790b538-72fb-481e-8a89-c35f492380d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0e7a1081-66ab-4273-882b-23cdda6ba2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b15945c8-919e-4e67-a10a-f9836a710cac" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0e7a1081-66ab-4273-882b-23cdda6ba2d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_46d35f69-815a-46cc-80a4-fffc4c0c817e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a0f618d8-4d31-4774-85e2-c56fdd5026ad" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_46d35f69-815a-46cc-80a4-fffc4c0c817e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_46d35f69-815a-46cc-80a4-fffc4c0c817e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_46d35f69-815a-46cc-80a4-fffc4c0c817e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_46d35f69-815a-46cc-80a4-fffc4c0c817e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45fe3462-5e75-4033-a3a8-82dd1ebea3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_46d35f69-815a-46cc-80a4-fffc4c0c817e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45fe3462-5e75-4033-a3a8-82dd1ebea3b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_36c5a491-c70b-4b78-b6fa-4cb074363fe1" xlink:href="rdnt-20230331.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45fe3462-5e75-4033-a3a8-82dd1ebea3b5" xlink:to="loc_rdnt_QuantibMember_36c5a491-c70b-4b78-b6fa-4cb074363fe1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_30855b14-416c-49bc-a502-70935a0a8280" xlink:href="rdnt-20230331.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45fe3462-5e75-4033-a3a8-82dd1ebea3b5" xlink:to="loc_rdnt_AidenceMember_30855b14-416c-49bc-a502-70935a0a8280" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_b706b797-48e0-4bad-87b8-b55b7ba0f2b3" xlink:href="rdnt-20230331.xsd#rdnt_MontclairMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45fe3462-5e75-4033-a3a8-82dd1ebea3b5" xlink:to="loc_rdnt_MontclairMember_b706b797-48e0-4bad-87b8-b55b7ba0f2b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_2f18d955-1a0e-492f-992f-a8922caab945" xlink:href="rdnt-20230331.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45fe3462-5e75-4033-a3a8-82dd1ebea3b5" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_2f18d955-1a0e-492f-992f-a8922caab945" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails" xlink:type="extended" id="i53d9842f0d7d4957a8b6c81a2f7ea03f_SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f57b5121-6237-442b-8735-63b78dce2eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_75077ce1-de5b-4101-929c-3314a6935213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f57b5121-6237-442b-8735-63b78dce2eb6" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_75077ce1-de5b-4101-929c-3314a6935213" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fdaddcbe-392c-4cbb-99ff-6d8dced8903d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_75077ce1-de5b-4101-929c-3314a6935213" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fdaddcbe-392c-4cbb-99ff-6d8dced8903d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9a457f5f-39dd-42cc-9f1f-62e85ba64d60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f57b5121-6237-442b-8735-63b78dce2eb6" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9a457f5f-39dd-42cc-9f1f-62e85ba64d60" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b838c240-c9b0-4cf1-8bcd-bbfbf2aedb97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9a457f5f-39dd-42cc-9f1f-62e85ba64d60" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b838c240-c9b0-4cf1-8bcd-bbfbf2aedb97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b838c240-c9b0-4cf1-8bcd-bbfbf2aedb97_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b838c240-c9b0-4cf1-8bcd-bbfbf2aedb97" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b838c240-c9b0-4cf1-8bcd-bbfbf2aedb97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_608aadc8-dc5c-4be3-ade7-af0d2f127938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b838c240-c9b0-4cf1-8bcd-bbfbf2aedb97" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_608aadc8-dc5c-4be3-ade7-af0d2f127938" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_1d84e14a-62ec-4366-b514-fb4611639cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_608aadc8-dc5c-4be3-ade7-af0d2f127938" xlink:to="loc_us-gaap_RestrictedStockMember_1d84e14a-62ec-4366-b514-fb4611639cd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_20d02f1d-0e6d-4a24-90a5-b4ce1a9afd56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_608aadc8-dc5c-4be3-ade7-af0d2f127938" xlink:to="loc_us-gaap_EmployeeStockOptionMember_20d02f1d-0e6d-4a24-90a5-b4ce1a9afd56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentSharesMember_830d885c-0b3a-4786-a060-4f769a812d31" xlink:href="rdnt-20230331.xsd#rdnt_ContingentSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_608aadc8-dc5c-4be3-ade7-af0d2f127938" xlink:to="loc_rdnt_ContingentSharesMember_830d885c-0b3a-4786-a060-4f769a812d31" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails" xlink:type="extended" id="ie1c62bc985f240c3afd7c753749f7f34_SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7ba34029-23ee-4e82-8a1a-d2783b27a2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_AssetsCurrent_7ba34029-23ee-4e82-8a1a-d2783b27a2a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_602dbf51-a841-4b6b-81f2-ca203165661e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_AssetsNoncurrent_602dbf51-a841-4b6b-81f2-ca203165661e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_71329727-ad01-4b79-999d-07ad3960f686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_LiabilitiesCurrent_71329727-ad01-4b79-999d-07ad3960f686" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_97454b9b-99cc-4930-8d46-e413596c092a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_97454b9b-99cc-4930-8d46-e413596c092a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_fa260b6e-1e4f-4808-92bd-ea3a057cd5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_fa260b6e-1e4f-4808-92bd-ea3a057cd5e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_39ce04ce-3736-448a-98d5-37496abc3c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_EquityMethodInvestments_39ce04ce-3736-448a-98d5-37496abc3c39" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_fae5478d-44b7-4e1d-ad04-592dfb391be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_fae5478d-44b7-4e1d-ad04-592dfb391be1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_38e5d27e-e40f-40cb-a1a1-f2eabbd616ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_38e5d27e-e40f-40cb-a1a1-f2eabbd616ba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6ab244b3-ede1-49cd-bd0c-de2a48eaa1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_Revenues_6ab244b3-ede1-49cd-bd0c-de2a48eaa1af" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_be106396-f3dc-4b5b-8863-3022ec6745f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_ProfitLoss_be106396-f3dc-4b5b-8863-3022ec6745f9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fa252340-d3db-4dfd-a47a-811e8471948f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fa252340-d3db-4dfd-a47a-811e8471948f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_6d4a6c09-dbe6-4a65-999b-11450f9f98a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fa252340-d3db-4dfd-a47a-811e8471948f" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_6d4a6c09-dbe6-4a65-999b-11450f9f98a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_6d4a6c09-dbe6-4a65-999b-11450f9f98a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_6d4a6c09-dbe6-4a65-999b-11450f9f98a5" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_6d4a6c09-dbe6-4a65-999b-11450f9f98a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_bb22990b-6e01-4c28-a33f-bb871d0cb0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_6d4a6c09-dbe6-4a65-999b-11450f9f98a5" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_bb22990b-6e01-4c28-a33f-bb871d0cb0a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_1a391de4-960e-4a15-9506-a49add7381b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_bb22990b-6e01-4c28-a33f-bb871d0cb0a3" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_1a391de4-960e-4a15-9506-a49add7381b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_697d3a81-036b-470b-9282-4ff8b27c4168" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fa252340-d3db-4dfd-a47a-811e8471948f" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_697d3a81-036b-470b-9282-4ff8b27c4168" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_697d3a81-036b-470b-9282-4ff8b27c4168_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_697d3a81-036b-470b-9282-4ff8b27c4168" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_697d3a81-036b-470b-9282-4ff8b27c4168_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4b0bd4ec-2433-4cda-bfb1-e3bb6a2eed46" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_697d3a81-036b-470b-9282-4ff8b27c4168" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4b0bd4ec-2433-4cda-bfb1-e3bb6a2eed46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInterestMember_c02d0fbc-086a-4737-b341-5dd80d7038a3" xlink:href="rdnt-20230331.xsd#rdnt_JointVentureInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4b0bd4ec-2433-4cda-bfb1-e3bb6a2eed46" xlink:to="loc_rdnt_JointVentureInterestMember_c02d0fbc-086a-4737-b341-5dd80d7038a3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails" xlink:type="extended" id="ie3617d65e85c4c14af4e14c1c879f2f6_BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8c980dea-daf6-422a-a07d-10a77aa0173e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8c980dea-daf6-422a-a07d-10a77aa0173e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_91e12df8-2f34-44e6-aec1-5f437a212f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_91e12df8-2f34-44e6-aec1-5f437a212f8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_e2558acd-89ae-4de9-9349-ea5a6f31c858" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_e2558acd-89ae-4de9-9349-ea5a6f31c858" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_eda227e9-f78b-4cf6-b234-22756d97e88c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:to="loc_us-gaap_Goodwill_eda227e9-f78b-4cf6-b234-22756d97e88c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_153aeefb-ce03-4bf7-9b43-a087971a5906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_153aeefb-ce03-4bf7-9b43-a087971a5906" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_a35cf22c-f721-4eb6-8f94-2c00cd97ed23" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_a35cf22c-f721-4eb6-8f94-2c00cd97ed23" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_41317a60-8771-4a57-b9c9-7e7c09b3317c" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_41317a60-8771-4a57-b9c9-7e7c09b3317c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b7dcc39b-66df-4f86-8e41-e3a8cea5962e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b7dcc39b-66df-4f86-8e41-e3a8cea5962e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bdadf370-6308-4240-8815-132b20b0c970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b7dcc39b-66df-4f86-8e41-e3a8cea5962e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bdadf370-6308-4240-8815-132b20b0c970" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bdadf370-6308-4240-8815-132b20b0c970_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bdadf370-6308-4240-8815-132b20b0c970" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bdadf370-6308-4240-8815-132b20b0c970_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2923a1c3-c178-4d80-8332-f607a828436b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bdadf370-6308-4240-8815-132b20b0c970" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2923a1c3-c178-4d80-8332-f607a828436b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionsMember_808ed8ec-1cd7-4eaf-8363-659e4154d073" xlink:href="rdnt-20230331.xsd#rdnt_BusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2923a1c3-c178-4d80-8332-f607a828436b" xlink:to="loc_rdnt_BusinessAcquisitionsMember_808ed8ec-1cd7-4eaf-8363-659e4154d073" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CCDGLRSServicesIncMember_c1723d32-090c-4c87-8146-e60be050141d" xlink:href="rdnt-20230331.xsd#rdnt_CCDGLRSServicesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_BusinessAcquisitionsMember_808ed8ec-1cd7-4eaf-8363-659e4154d073" xlink:to="loc_rdnt_CCDGLRSServicesIncMember_c1723d32-090c-4c87-8146-e60be050141d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SouthernCaliforniaDiagnosticImagingIncMember_829abb7c-00ce-4ad5-9b30-b720a27d4c4c" xlink:href="rdnt-20230331.xsd#rdnt_SouthernCaliforniaDiagnosticImagingIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_BusinessAcquisitionsMember_808ed8ec-1cd7-4eaf-8363-659e4154d073" xlink:to="loc_rdnt_SouthernCaliforniaDiagnosticImagingIncMember_829abb7c-00ce-4ad5-9b30-b720a27d4c4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InglewoodImagingCenterLLCMember_0f10b1c5-e93d-4f27-ae6f-f50941f2dd14" xlink:href="rdnt-20230331.xsd#rdnt_InglewoodImagingCenterLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_BusinessAcquisitionsMember_808ed8ec-1cd7-4eaf-8363-659e4154d073" xlink:to="loc_rdnt_InglewoodImagingCenterLLCMember_0f10b1c5-e93d-4f27-ae6f-f50941f2dd14" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RamapoRadiologyAssociatesPCMember_46fc7fd3-be9d-446c-ae8a-39eb86971335" xlink:href="rdnt-20230331.xsd#rdnt_RamapoRadiologyAssociatesPCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_BusinessAcquisitionsMember_808ed8ec-1cd7-4eaf-8363-659e4154d073" xlink:to="loc_rdnt_RamapoRadiologyAssociatesPCMember_46fc7fd3-be9d-446c-ae8a-39eb86971335" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SEGMENTREPORTINGDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SEGMENTREPORTINGDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SEGMENTREPORTINGDetails" xlink:type="extended" id="id4c126bf8ff3460182687fcfdc6fb966_SEGMENTREPORTINGDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b6ebaa4e-f916-4c9c-803f-5d8f0a819a45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9316a756-345d-48d6-8cfd-9b1720bbc955" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b6ebaa4e-f916-4c9c-803f-5d8f0a819a45" xlink:to="loc_us-gaap_Revenues_9316a756-345d-48d6-8cfd-9b1720bbc955" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_ef34c1a4-4536-4482-9c72-bdc3c87975e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b6ebaa4e-f916-4c9c-803f-5d8f0a819a45" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_ef34c1a4-4536-4482-9c72-bdc3c87975e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1a743e32-d5aa-40ac-b239-39db0579e3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b6ebaa4e-f916-4c9c-803f-5d8f0a819a45" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1a743e32-d5aa-40ac-b239-39db0579e3f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_aecf63a5-9632-40b7-b32d-b733f191d3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b6ebaa4e-f916-4c9c-803f-5d8f0a819a45" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_aecf63a5-9632-40b7-b32d-b733f191d3d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_9cab03a3-5316-4429-8ced-dda3735beb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b6ebaa4e-f916-4c9c-803f-5d8f0a819a45" xlink:to="loc_us-gaap_SeveranceCosts1_9cab03a3-5316-4429-8ced-dda3735beb5a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingIncomeLossExcludingReliefFunding_f4ed4627-7036-48e5-8511-a557e51623a2" xlink:href="rdnt-20230331.xsd#rdnt_OperatingIncomeLossExcludingReliefFunding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b6ebaa4e-f916-4c9c-803f-5d8f0a819a45" xlink:to="loc_rdnt_OperatingIncomeLossExcludingReliefFunding_f4ed4627-7036-48e5-8511-a557e51623a2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9ca4caa2-f82d-466f-8892-6040d2a5478f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b6ebaa4e-f916-4c9c-803f-5d8f0a819a45" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9ca4caa2-f82d-466f-8892-6040d2a5478f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ccdc72da-7032-4d86-8969-9e6e3d4f1a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9ca4caa2-f82d-466f-8892-6040d2a5478f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ccdc72da-7032-4d86-8969-9e6e3d4f1a33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ccdc72da-7032-4d86-8969-9e6e3d4f1a33_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ccdc72da-7032-4d86-8969-9e6e3d4f1a33" xlink:to="loc_us-gaap_SegmentDomain_ccdc72da-7032-4d86-8969-9e6e3d4f1a33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_251ea636-f5e7-448f-957f-e096fd076947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ccdc72da-7032-4d86-8969-9e6e3d4f1a33" xlink:to="loc_us-gaap_SegmentDomain_251ea636-f5e7-448f-957f-e096fd076947" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_d813222f-1c82-40c0-baba-697dcd20fe1e" xlink:href="rdnt-20230331.xsd#rdnt_ImagingCentersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_251ea636-f5e7-448f-957f-e096fd076947" xlink:to="loc_rdnt_ImagingCentersMember_d813222f-1c82-40c0-baba-697dcd20fe1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_0a0ae6fd-5ba5-4775-997b-50a3ee3ed20d" xlink:href="rdnt-20230331.xsd#rdnt_AIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_251ea636-f5e7-448f-957f-e096fd076947" xlink:to="loc_rdnt_AIMember_0a0ae6fd-5ba5-4775-997b-50a3ee3ed20d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails" xlink:type="extended" id="ie7f15acfe5e740f88bc337c8551df091_CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f9c7f506-9d54-4247-9f3b-7c939dc06caf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2e07a4cb-868f-41b0-ab19-5cc536f424b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9c7f506-9d54-4247-9f3b-7c939dc06caf" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2e07a4cb-868f-41b0-ab19-5cc536f424b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_268eb908-1abd-4db6-a4f4-682dd44985c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9c7f506-9d54-4247-9f3b-7c939dc06caf" xlink:to="loc_us-gaap_LongTermDebt_268eb908-1abd-4db6-a4f4-682dd44985c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_4be723a6-097e-43f9-92ae-712d10bb6fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9c7f506-9d54-4247-9f3b-7c939dc06caf" xlink:to="loc_us-gaap_LongTermDebtCurrent_4be723a6-097e-43f9-92ae-712d10bb6fa9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4b2dcde2-0070-4398-b03b-54d9d28b278c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9c7f506-9d54-4247-9f3b-7c939dc06caf" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4b2dcde2-0070-4398-b03b-54d9d28b278c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_73c79fa1-b8ba-47dc-bdc5-4b7b84ceb340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9c7f506-9d54-4247-9f3b-7c939dc06caf" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_73c79fa1-b8ba-47dc-bdc5-4b7b84ceb340" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9ee1386b-1c18-428f-abdf-dc64e6781295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9c7f506-9d54-4247-9f3b-7c939dc06caf" xlink:to="loc_us-gaap_DebtInstrumentTable_9ee1386b-1c18-428f-abdf-dc64e6781295" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cb50170a-222a-44b0-9050-0f2db6215316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9ee1386b-1c18-428f-abdf-dc64e6781295" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cb50170a-222a-44b0-9050-0f2db6215316" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cb50170a-222a-44b0-9050-0f2db6215316_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cb50170a-222a-44b0-9050-0f2db6215316" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cb50170a-222a-44b0-9050-0f2db6215316_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_46f0a781-7736-4007-b21a-f1ecb20a1edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cb50170a-222a-44b0-9050-0f2db6215316" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_46f0a781-7736-4007-b21a-f1ecb20a1edb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_eba6c9ba-74e6-4494-adf9-7dfacaf653d7" xlink:href="rdnt-20230331.xsd#rdnt_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_46f0a781-7736-4007-b21a-f1ecb20a1edb" xlink:to="loc_rdnt_TermLoanMember_eba6c9ba-74e6-4494-adf9-7dfacaf653d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b9b6c741-6fcb-48ca-890b-455278f2f9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9ee1386b-1c18-428f-abdf-dc64e6781295" xlink:to="loc_us-gaap_DebtInstrumentAxis_b9b6c741-6fcb-48ca-890b-455278f2f9f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b9b6c741-6fcb-48ca-890b-455278f2f9f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b9b6c741-6fcb-48ca-890b-455278f2f9f2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b9b6c741-6fcb-48ca-890b-455278f2f9f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3bb49ddd-4767-4bb6-9b77-5bd2a5ccc8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b9b6c741-6fcb-48ca-890b-455278f2f9f2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3bb49ddd-4767-4bb6-9b77-5bd2a5ccc8ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_bb90e23f-b903-492e-9b8b-16e61cd26a13" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3bb49ddd-4767-4bb6-9b77-5bd2a5ccc8ca" xlink:to="loc_rdnt_FirstLienTermLoanMember_bb90e23f-b903-492e-9b8b-16e61cd26a13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_421c7aa7-a127-481d-ab7a-42dc92e77ccf" xlink:href="rdnt-20230331.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3bb49ddd-4767-4bb6-9b77-5bd2a5ccc8ca" xlink:to="loc_rdnt_RestatedAgreementMember_421c7aa7-a127-481d-ab7a-42dc92e77ccf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentNotesPayableMember_52ecaae2-2629-4401-a586-9beff99d19be" xlink:href="rdnt-20230331.xsd#rdnt_EquipmentNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3bb49ddd-4767-4bb6-9b77-5bd2a5ccc8ca" xlink:to="loc_rdnt_EquipmentNotesPayableMember_52ecaae2-2629-4401-a586-9beff99d19be" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails" xlink:type="extended" id="i79c039490ffe4b1fb169432d9b749ae2_CREDITFACILITIESANDNOTESPAYABLENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_5f7acba2-2f4a-4727-be06-74649cf99aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_LineOfCredit_5f7acba2-2f4a-4727-be06-74649cf99aa9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_eef8cf4a-cb16-4390-864e-d9d89579ca57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_eef8cf4a-cb16-4390-864e-d9d89579ca57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_0836d788-5ea1-4328-b0d4-157c8b0063db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_0836d788-5ea1-4328-b0d4-157c8b0063db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_7f01daad-e692-4d49-9db9-633603380c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_7f01daad-e692-4d49-9db9-633603380c18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b148be4f-7629-40bc-9b72-0ee3f5a053ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b148be4f-7629-40bc-9b72-0ee3f5a053ca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_af2fe28e-ec9b-4b5a-a9fd-973bcc503dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_af2fe28e-ec9b-4b5a-a9fd-973bcc503dcd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_0f546512-d625-41a1-806d-eba92c2eba59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_0f546512-d625-41a1-806d-eba92c2eba59" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_7390255a-810f-4c4e-baa0-e22528f1cdc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_7390255a-810f-4c4e-baa0-e22528f1cdc2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d90f20c9-c1e3-46ce-a2d4-27d89f6598b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d90f20c9-c1e3-46ce-a2d4-27d89f6598b1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges_655872e8-ef6f-44be-874e-1a1464dccbad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_AmortizationOfDeferredCharges_655872e8-ef6f-44be-874e-1a1464dccbad" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d2156d12-4319-4b77-8977-d0b782e7ba04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d2156d12-4319-4b77-8977-d0b782e7ba04" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_2743f23e-9690-4dfe-9a7b-18bdbdf3ae68" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_2743f23e-9690-4dfe-9a7b-18bdbdf3ae68" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d27af323-ace4-4ec8-9466-1a9ad7f54d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d27af323-ace4-4ec8-9466-1a9ad7f54d27" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_6c8f36c0-9925-461c-abd4-c07b821511a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_6c8f36c0-9925-461c-abd4-c07b821511a3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_99b7ba25-4a1b-40be-9819-1cc8009f2594" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_99b7ba25-4a1b-40be-9819-1cc8009f2594" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_c86513ea-6553-4424-b4f9-8c8ed018bb9e" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_c86513ea-6553-4424-b4f9-8c8ed018bb9e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_dbbcddf0-1bc6-473f-bcd5-0900268d11ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_dbbcddf0-1bc6-473f-bcd5-0900268d11ab" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_f4f07837-0c2b-4b93-b788-24fb8858d749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_f4f07837-0c2b-4b93-b788-24fb8858d749" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_80342e54-9d2e-41ae-beb3-022376f0bb91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_80342e54-9d2e-41ae-beb3-022376f0bb91" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a54baf27-c6b6-4920-bf44-cdefaf06e086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a54baf27-c6b6-4920-bf44-cdefaf06e086" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_639848b6-316a-4bab-8f86-fdcf530ee8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:to="loc_us-gaap_CreditFacilityAxis_639848b6-316a-4bab-8f86-fdcf530ee8ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_639848b6-316a-4bab-8f86-fdcf530ee8ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_639848b6-316a-4bab-8f86-fdcf530ee8ff" xlink:to="loc_us-gaap_CreditFacilityDomain_639848b6-316a-4bab-8f86-fdcf530ee8ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a0108fe6-d28f-405c-9ae0-d64ff55edc34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_639848b6-316a-4bab-8f86-fdcf530ee8ff" xlink:to="loc_us-gaap_CreditFacilityDomain_a0108fe6-d28f-405c-9ae0-d64ff55edc34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_f4f1771d-f2cd-4514-a4ec-7b0750488eed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a0108fe6-d28f-405c-9ae0-d64ff55edc34" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_f4f1771d-f2cd-4514-a4ec-7b0750488eed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_ccbc92c6-dfb2-429d-b0c9-11186f119c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a0108fe6-d28f-405c-9ae0-d64ff55edc34" xlink:to="loc_us-gaap_LetterOfCreditMember_ccbc92c6-dfb2-429d-b0c9-11186f119c53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0108aec5-79ef-497f-b7b0-b8b7bc322b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:to="loc_us-gaap_DebtInstrumentAxis_0108aec5-79ef-497f-b7b0-b8b7bc322b2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0108aec5-79ef-497f-b7b0-b8b7bc322b2d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0108aec5-79ef-497f-b7b0-b8b7bc322b2d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0108aec5-79ef-497f-b7b0-b8b7bc322b2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1995afc7-360f-4a6a-9128-048e6bf64ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0108aec5-79ef-497f-b7b0-b8b7bc322b2d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1995afc7-360f-4a6a-9128-048e6bf64ed8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_a039ed2c-92dd-4cfd-8833-21c46fc00599" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1995afc7-360f-4a6a-9128-048e6bf64ed8" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_a039ed2c-92dd-4cfd-8833-21c46fc00599" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_60075133-21d3-46ef-bcce-036aeb2412ec" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1995afc7-360f-4a6a-9128-048e6bf64ed8" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_60075133-21d3-46ef-bcce-036aeb2412ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_0c6b2b0f-dc8c-4198-a52c-625adc00ccca" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1995afc7-360f-4a6a-9128-048e6bf64ed8" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_0c6b2b0f-dc8c-4198-a52c-625adc00ccca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_d62fa24b-2553-4b50-8f47-b85fb5366c9f" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1995afc7-360f-4a6a-9128-048e6bf64ed8" xlink:to="loc_rdnt_FirstLienTermLoanMember_d62fa24b-2553-4b50-8f47-b85fb5366c9f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_3ec76a95-6573-4884-91db-2f2ddbb5f430" xlink:href="rdnt-20230331.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1995afc7-360f-4a6a-9128-048e6bf64ed8" xlink:to="loc_rdnt_RestatedAgreementMember_3ec76a95-6573-4884-91db-2f2ddbb5f430" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_4d15eff2-f3c5-4497-98b2-a07dbe28c12f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_4d15eff2-f3c5-4497-98b2-a07dbe28c12f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_4d15eff2-f3c5-4497-98b2-a07dbe28c12f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_4d15eff2-f3c5-4497-98b2-a07dbe28c12f" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_4d15eff2-f3c5-4497-98b2-a07dbe28c12f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_4a181a5e-72ca-4d96-ad90-d3d89795a045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_4d15eff2-f3c5-4497-98b2-a07dbe28c12f" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_4a181a5e-72ca-4d96-ad90-d3d89795a045" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_72479e13-0da7-42bc-a1ca-9a809e0d62da" xlink:href="rdnt-20230331.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_4a181a5e-72ca-4d96-ad90-d3d89795a045" xlink:to="loc_rdnt_BarclaysMember_72479e13-0da7-42bc-a1ca-9a809e0d62da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_15ba2e8c-6aa4-4ede-82ec-d003da6806bb" xlink:href="rdnt-20230331.xsd#rdnt_TruistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_4a181a5e-72ca-4d96-ad90-d3d89795a045" xlink:to="loc_rdnt_TruistMember_15ba2e8c-6aa4-4ede-82ec-d003da6806bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_03156458-b2de-4713-838d-5af71fdc768d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_03156458-b2de-4713-838d-5af71fdc768d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_03156458-b2de-4713-838d-5af71fdc768d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_03156458-b2de-4713-838d-5af71fdc768d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_03156458-b2de-4713-838d-5af71fdc768d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0fdff532-5832-4f50-bdb3-9cdf67a713a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_03156458-b2de-4713-838d-5af71fdc768d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0fdff532-5832-4f50-bdb3-9cdf67a713a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_eaed57ec-335c-44ec-aa45-b0ad09e740b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0fdff532-5832-4f50-bdb3-9cdf67a713a7" xlink:to="loc_us-gaap_LineOfCreditMember_eaed57ec-335c-44ec-aa45-b0ad09e740b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_32cfe316-d60c-4d38-8f84-854a922353d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0fdff532-5832-4f50-bdb3-9cdf67a713a7" xlink:to="loc_us-gaap_MediumTermNotesMember_32cfe316-d60c-4d38-8f84-854a922353d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_71f45071-f661-4ef0-9abe-becf39bf92e3" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0fdff532-5832-4f50-bdb3-9cdf67a713a7" xlink:to="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_71f45071-f661-4ef0-9abe-becf39bf92e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_9217a2cb-5db6-47d6-b882-607b19f4a276" xlink:href="rdnt-20230331.xsd#rdnt_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0fdff532-5832-4f50-bdb3-9cdf67a713a7" xlink:to="loc_rdnt_TermLoanMember_9217a2cb-5db6-47d6-b882-607b19f4a276" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_d153f198-63bc-4c48-833d-3ca433299e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0fdff532-5832-4f50-bdb3-9cdf67a713a7" xlink:to="loc_us-gaap_LetterOfCreditMember_d153f198-63bc-4c48-833d-3ca433299e1b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_5d0186ce-5fb3-4976-b148-0127676e15ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:to="loc_us-gaap_VariableRateAxis_5d0186ce-5fb3-4976-b148-0127676e15ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_5d0186ce-5fb3-4976-b148-0127676e15ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_5d0186ce-5fb3-4976-b148-0127676e15ca" xlink:to="loc_us-gaap_VariableRateDomain_5d0186ce-5fb3-4976-b148-0127676e15ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8ecc61e5-d113-42aa-a614-63de08c9439f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_5d0186ce-5fb3-4976-b148-0127676e15ca" xlink:to="loc_us-gaap_VariableRateDomain_8ecc61e5-d113-42aa-a614-63de08c9439f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_fa871f76-1f43-4572-865b-c7d98da5c2db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_8ecc61e5-d113-42aa-a614-63de08c9439f" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_fa871f76-1f43-4572-865b-c7d98da5c2db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_74092077-99ef-4fc9-9ee5-4ef1c51175cd" xlink:href="rdnt-20230331.xsd#rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_fa871f76-1f43-4572-865b-c7d98da5c2db" xlink:to="loc_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_74092077-99ef-4fc9-9ee5-4ef1c51175cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember_5f938329-51e8-4bc3-a4b0-9c2f22392af6" xlink:href="rdnt-20230331.xsd#rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_fa871f76-1f43-4572-865b-c7d98da5c2db" xlink:to="loc_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember_5f938329-51e8-4bc3-a4b0-9c2f22392af6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember_665217de-c276-492d-a059-f937d965a008" xlink:href="rdnt-20230331.xsd#rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_fa871f76-1f43-4572-865b-c7d98da5c2db" xlink:to="loc_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember_665217de-c276-492d-a059-f937d965a008" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_c266cf19-7657-4098-abe2-3a4de4997d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_8ecc61e5-d113-42aa-a614-63de08c9439f" xlink:to="loc_us-gaap_EurodollarMember_c266cf19-7657-4098-abe2-3a4de4997d3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_fd778ca1-0ff1-41c5-8697-d51ab98b48ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_8ecc61e5-d113-42aa-a614-63de08c9439f" xlink:to="loc_us-gaap_BaseRateMember_fd778ca1-0ff1-41c5-8697-d51ab98b48ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_b0a9b072-1fb5-436e-b6ff-74d7d3c35434" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:to="loc_rdnt_LeverageRatioAxis_b0a9b072-1fb5-436e-b6ff-74d7d3c35434" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_b0a9b072-1fb5-436e-b6ff-74d7d3c35434_default" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_b0a9b072-1fb5-436e-b6ff-74d7d3c35434" xlink:to="loc_rdnt_LeverageRatioDomain_b0a9b072-1fb5-436e-b6ff-74d7d3c35434_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_c72d50cc-54ab-465d-afed-1f84b5254dcb" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_b0a9b072-1fb5-436e-b6ff-74d7d3c35434" xlink:to="loc_rdnt_LeverageRatioDomain_c72d50cc-54ab-465d-afed-1f84b5254dcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_70181ceb-56e4-4c39-a5aa-6940e649246b" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_c72d50cc-54ab-465d-afed-1f84b5254dcb" xlink:to="loc_rdnt_LeverageRatioThreeMember_70181ceb-56e4-4c39-a5aa-6940e649246b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_511eba9a-9079-428e-9ab7-32e370cf23cc" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelIIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_c72d50cc-54ab-465d-afed-1f84b5254dcb" xlink:to="loc_rdnt_PricingLevelIIIMember_511eba9a-9079-428e-9ab7-32e370cf23cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember_1e8c1265-cb8b-4277-8214-44923cadf1f2" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelIVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_c72d50cc-54ab-465d-afed-1f84b5254dcb" xlink:to="loc_rdnt_PricingLevelIVMember_1e8c1265-cb8b-4277-8214-44923cadf1f2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails" xlink:type="extended" id="icd7cf23d82654d3fa0d03767a4ae9a9d_CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7075f75a-b127-45a0-9e3d-225b918523fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_bf3585a4-8109-46a7-a6c7-26608588465f" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7075f75a-b127-45a0-9e3d-225b918523fc" xlink:to="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_bf3585a4-8109-46a7-a6c7-26608588465f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_e06ae685-6856-443a-9f51-d4b83eef28fa" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7075f75a-b127-45a0-9e3d-225b918523fc" xlink:to="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_e06ae685-6856-443a-9f51-d4b83eef28fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f5652742-b544-4ee7-a052-838735132391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7075f75a-b127-45a0-9e3d-225b918523fc" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f5652742-b544-4ee7-a052-838735132391" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_d15d4b5f-b4ce-47b0-b064-019f3ba82b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7075f75a-b127-45a0-9e3d-225b918523fc" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_d15d4b5f-b4ce-47b0-b064-019f3ba82b1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_9ae4dcee-1847-45bb-aa79-a1de9d587a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7075f75a-b127-45a0-9e3d-225b918523fc" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_9ae4dcee-1847-45bb-aa79-a1de9d587a76" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c0bef3a3-2206-45d5-a396-32ee7a9b4f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7075f75a-b127-45a0-9e3d-225b918523fc" xlink:to="loc_us-gaap_DebtInstrumentTable_c0bef3a3-2206-45d5-a396-32ee7a9b4f8a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cc8d78df-3584-45dd-a866-def53f0ad4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c0bef3a3-2206-45d5-a396-32ee7a9b4f8a" xlink:to="loc_us-gaap_DebtInstrumentAxis_cc8d78df-3584-45dd-a866-def53f0ad4f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cc8d78df-3584-45dd-a866-def53f0ad4f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cc8d78df-3584-45dd-a866-def53f0ad4f7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cc8d78df-3584-45dd-a866-def53f0ad4f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3510e7a9-fb78-4e7d-8812-efcf8bb6fd52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cc8d78df-3584-45dd-a866-def53f0ad4f7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3510e7a9-fb78-4e7d-8812-efcf8bb6fd52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_b07d46af-e9a8-4c5b-acd5-313920655aee" xlink:href="rdnt-20230331.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3510e7a9-fb78-4e7d-8812-efcf8bb6fd52" xlink:to="loc_rdnt_RestatedAgreementMember_b07d46af-e9a8-4c5b-acd5-313920655aee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f0e09b8d-27cc-4051-b1fb-e3da1b5a09df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c0bef3a3-2206-45d5-a396-32ee7a9b4f8a" xlink:to="loc_us-gaap_CreditFacilityAxis_f0e09b8d-27cc-4051-b1fb-e3da1b5a09df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f0e09b8d-27cc-4051-b1fb-e3da1b5a09df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f0e09b8d-27cc-4051-b1fb-e3da1b5a09df" xlink:to="loc_us-gaap_CreditFacilityDomain_f0e09b8d-27cc-4051-b1fb-e3da1b5a09df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e1f5be2b-0436-47c2-a99d-61a2841c68a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f0e09b8d-27cc-4051-b1fb-e3da1b5a09df" xlink:to="loc_us-gaap_CreditFacilityDomain_e1f5be2b-0436-47c2-a99d-61a2841c68a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8326a677-dc63-4395-a954-c1541a962743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_e1f5be2b-0436-47c2-a99d-61a2841c68a3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8326a677-dc63-4395-a954-c1541a962743" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ebab47b9-7579-4640-b54d-a7a32e3a104b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c0bef3a3-2206-45d5-a396-32ee7a9b4f8a" xlink:to="loc_us-gaap_VariableRateAxis_ebab47b9-7579-4640-b54d-a7a32e3a104b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ebab47b9-7579-4640-b54d-a7a32e3a104b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_ebab47b9-7579-4640-b54d-a7a32e3a104b" xlink:to="loc_us-gaap_VariableRateDomain_ebab47b9-7579-4640-b54d-a7a32e3a104b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6d055b19-4773-449a-be81-6f5b6e2f71df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_ebab47b9-7579-4640-b54d-a7a32e3a104b" xlink:to="loc_us-gaap_VariableRateDomain_6d055b19-4773-449a-be81-6f5b6e2f71df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_337583fb-4cd7-495f-aff4-7247e8a0596f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_6d055b19-4773-449a-be81-6f5b6e2f71df" xlink:to="loc_us-gaap_EurodollarMember_337583fb-4cd7-495f-aff4-7247e8a0596f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_9b2763b2-d33f-4eb9-9d3c-6497ca1a8570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_6d055b19-4773-449a-be81-6f5b6e2f71df" xlink:to="loc_us-gaap_BaseRateMember_9b2763b2-d33f-4eb9-9d3c-6497ca1a8570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_214072f0-7fa8-41c5-abc5-83559754e500" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c0bef3a3-2206-45d5-a396-32ee7a9b4f8a" xlink:to="loc_rdnt_LeverageRatioAxis_214072f0-7fa8-41c5-abc5-83559754e500" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_214072f0-7fa8-41c5-abc5-83559754e500_default" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_214072f0-7fa8-41c5-abc5-83559754e500" xlink:to="loc_rdnt_LeverageRatioDomain_214072f0-7fa8-41c5-abc5-83559754e500_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_ac85a20f-5e44-4e77-9315-910ed5a9402f" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_214072f0-7fa8-41c5-abc5-83559754e500" xlink:to="loc_rdnt_LeverageRatioDomain_ac85a20f-5e44-4e77-9315-910ed5a9402f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember_d8c230d5-defd-4088-8825-8a8b8fa0a7f1" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_ac85a20f-5e44-4e77-9315-910ed5a9402f" xlink:to="loc_rdnt_PricingLevelIMember_d8c230d5-defd-4088-8825-8a8b8fa0a7f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember_b279f75d-6562-4df4-bb04-7c66433639af" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_ac85a20f-5e44-4e77-9315-910ed5a9402f" xlink:to="loc_rdnt_PricingLevelIIMember_b279f75d-6562-4df4-bb04-7c66433639af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_ac2ec92f-3124-4866-8541-4f41bca58c36" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelIIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_ac85a20f-5e44-4e77-9315-910ed5a9402f" xlink:to="loc_rdnt_PricingLevelIIIMember_ac2ec92f-3124-4866-8541-4f41bca58c36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember_5078e097-b31b-4fb2-87cc-2bd12fb6d9b8" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelIVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_ac85a20f-5e44-4e77-9315-910ed5a9402f" xlink:to="loc_rdnt_PricingLevelIVMember_5078e097-b31b-4fb2-87cc-2bd12fb6d9b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember_5cfce4d7-de21-4526-a924-f92a2d7d12e9" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_ac85a20f-5e44-4e77-9315-910ed5a9402f" xlink:to="loc_rdnt_PricingLevelVMember_5cfce4d7-de21-4526-a924-f92a2d7d12e9" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails" xlink:type="extended" id="id445b516c3f24219a207eb0e36ae16e0_CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e6298be2-79da-4f11-ae66-84ed43324abe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_18108e4c-d6af-499a-b4a1-acb7cf559192" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e6298be2-79da-4f11-ae66-84ed43324abe" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_18108e4c-d6af-499a-b4a1-acb7cf559192" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_6024e698-6e2a-4d72-bd31-2e46e9c6480b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e6298be2-79da-4f11-ae66-84ed43324abe" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_6024e698-6e2a-4d72-bd31-2e46e9c6480b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e6298be2-79da-4f11-ae66-84ed43324abe" xlink:to="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_261fbcf8-594e-4874-9101-b04c9afea43b" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:to="loc_rdnt_LeverageRatioAxis_261fbcf8-594e-4874-9101-b04c9afea43b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_261fbcf8-594e-4874-9101-b04c9afea43b_default" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_261fbcf8-594e-4874-9101-b04c9afea43b" xlink:to="loc_rdnt_LeverageRatioDomain_261fbcf8-594e-4874-9101-b04c9afea43b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_b75a557b-396e-49f5-aa54-00e55d77956a" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_261fbcf8-594e-4874-9101-b04c9afea43b" xlink:to="loc_rdnt_LeverageRatioDomain_b75a557b-396e-49f5-aa54-00e55d77956a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_3be8c792-c56b-4891-8af3-e2336ca7bd3c" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_b75a557b-396e-49f5-aa54-00e55d77956a" xlink:to="loc_rdnt_LeverageRatioOneMember_3be8c792-c56b-4891-8af3-e2336ca7bd3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember_b408f798-3092-4844-b8f8-e8edeaef32b6" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_b75a557b-396e-49f5-aa54-00e55d77956a" xlink:to="loc_rdnt_LeverageRatioTwoMember_b408f798-3092-4844-b8f8-e8edeaef32b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFourMember_020d1cfb-2956-4d34-acf0-1613cf31d969" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_b75a557b-396e-49f5-aa54-00e55d77956a" xlink:to="loc_rdnt_LeverageRatioFourMember_020d1cfb-2956-4d34-acf0-1613cf31d969" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_cbaa4043-dacc-456c-a624-e18da5508263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:to="loc_us-gaap_CreditFacilityAxis_cbaa4043-dacc-456c-a624-e18da5508263" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cbaa4043-dacc-456c-a624-e18da5508263_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_cbaa4043-dacc-456c-a624-e18da5508263" xlink:to="loc_us-gaap_CreditFacilityDomain_cbaa4043-dacc-456c-a624-e18da5508263_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_dd0a612e-3966-4874-b43a-43a05042436a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_cbaa4043-dacc-456c-a624-e18da5508263" xlink:to="loc_us-gaap_CreditFacilityDomain_dd0a612e-3966-4874-b43a-43a05042436a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8e221803-b056-45d5-ab3f-64ae9e12cd68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_dd0a612e-3966-4874-b43a-43a05042436a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8e221803-b056-45d5-ab3f-64ae9e12cd68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_69f403fc-3c6c-4a73-bc89-af3eab1866b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:to="loc_us-gaap_DebtInstrumentAxis_69f403fc-3c6c-4a73-bc89-af3eab1866b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_69f403fc-3c6c-4a73-bc89-af3eab1866b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_69f403fc-3c6c-4a73-bc89-af3eab1866b3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_69f403fc-3c6c-4a73-bc89-af3eab1866b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_35845b71-eb8a-4c8d-9f32-40e16b181413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_69f403fc-3c6c-4a73-bc89-af3eab1866b3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_35845b71-eb8a-4c8d-9f32-40e16b181413" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_81d87089-3738-4598-8e5e-2911d4a88a46" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35845b71-eb8a-4c8d-9f32-40e16b181413" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_81d87089-3738-4598-8e5e-2911d4a88a46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e7c7625a-bf8a-473c-b679-5c5667650eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e7c7625a-bf8a-473c-b679-5c5667650eff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e7c7625a-bf8a-473c-b679-5c5667650eff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e7c7625a-bf8a-473c-b679-5c5667650eff" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e7c7625a-bf8a-473c-b679-5c5667650eff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0a8383a7-d430-47c7-8365-5c74474de737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e7c7625a-bf8a-473c-b679-5c5667650eff" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0a8383a7-d430-47c7-8365-5c74474de737" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_6361b311-e2dc-4638-9c27-66abf32d96bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0a8383a7-d430-47c7-8365-5c74474de737" xlink:to="loc_us-gaap_LineOfCreditMember_6361b311-e2dc-4638-9c27-66abf32d96bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9a3f7c20-6493-46e5-b4cb-7ee33f241533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:to="loc_us-gaap_VariableRateAxis_9a3f7c20-6493-46e5-b4cb-7ee33f241533" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9a3f7c20-6493-46e5-b4cb-7ee33f241533_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_9a3f7c20-6493-46e5-b4cb-7ee33f241533" xlink:to="loc_us-gaap_VariableRateDomain_9a3f7c20-6493-46e5-b4cb-7ee33f241533_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3a589d3e-289d-4a5c-91d1-dff75cbb4528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_9a3f7c20-6493-46e5-b4cb-7ee33f241533" xlink:to="loc_us-gaap_VariableRateDomain_3a589d3e-289d-4a5c-91d1-dff75cbb4528" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_ea9252a7-b42d-4e2d-816a-52cef4d6b6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_3a589d3e-289d-4a5c-91d1-dff75cbb4528" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_ea9252a7-b42d-4e2d-816a-52cef4d6b6e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_67c6a4c6-70a5-4faf-a374-fc4be140597a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_3a589d3e-289d-4a5c-91d1-dff75cbb4528" xlink:to="loc_us-gaap_BaseRateMember_67c6a4c6-70a5-4faf-a374-fc4be140597a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f2e9ea25-2d2d-4f2b-bd0d-570f9e0b722b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:to="loc_srt_RangeAxis_f2e9ea25-2d2d-4f2b-bd0d-570f9e0b722b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f2e9ea25-2d2d-4f2b-bd0d-570f9e0b722b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f2e9ea25-2d2d-4f2b-bd0d-570f9e0b722b" xlink:to="loc_srt_RangeMember_f2e9ea25-2d2d-4f2b-bd0d-570f9e0b722b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_84ca7c00-b365-4165-926d-e0caf302b292" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f2e9ea25-2d2d-4f2b-bd0d-570f9e0b722b" xlink:to="loc_srt_RangeMember_84ca7c00-b365-4165-926d-e0caf302b292" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ae136869-8789-4d2a-84bc-87c1f1c439ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_84ca7c00-b365-4165-926d-e0caf302b292" xlink:to="loc_srt_MaximumMember_ae136869-8789-4d2a-84bc-87c1f1c439ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_040b9bb7-fe1b-4e23-9d3f-5711ef85e018" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_84ca7c00-b365-4165-926d-e0caf302b292" xlink:to="loc_srt_MinimumMember_040b9bb7-fe1b-4e23-9d3f-5711ef85e018" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended" id="i6d794065b4624809b665668faea7b8bc_STOCKBASEDCOMPENSATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_8f06f4ae-b1d6-4463-9861-5c4aaedfd9b9" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_8f06f4ae-b1d6-4463-9861-5c4aaedfd9b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a126fd82-1f2d-40c8-b75d-8451c3fadbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a126fd82-1f2d-40c8-b75d-8451c3fadbb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c9f202bb-975c-4bca-b46b-76c66431849a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c9f202bb-975c-4bca-b46b-76c66431849a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c6928a8d-c3c7-419e-be46-9e456f66944d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c6928a8d-c3c7-419e-be46-9e456f66944d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8a887084-e1e5-4b94-985c-a4ab8e2e43d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8a887084-e1e5-4b94-985c-a4ab8e2e43d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8820c6ba-2396-4ec3-900d-b7497dc570d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8820c6ba-2396-4ec3-900d-b7497dc570d1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0ac085a9-72b4-4ee7-b662-bb93c022baec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0ac085a9-72b4-4ee7-b662-bb93c022baec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e92b6aef-9b0e-4173-ac95-7ce670e4db9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e92b6aef-9b0e-4173-ac95-7ce670e4db9f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_99bce166-3271-4342-afce-0b55ac9c4a40" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_99bce166-3271-4342-afce-0b55ac9c4a40" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_21a7a5a8-3517-47eb-a12e-f207e6c046ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_21a7a5a8-3517-47eb-a12e-f207e6c046ff" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_4e4e9334-a0ad-44e0-9b2b-79504852fc7d" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_4e4e9334-a0ad-44e0-9b2b-79504852fc7d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_46d09979-854d-4c7e-b303-a5979ad61695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_46d09979-854d-4c7e-b303-a5979ad61695" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_e5671fd2-d326-481c-a299-7f959f16ae43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_SharesIssued_e5671fd2-d326-481c-a299-7f959f16ae43" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_9215f8ff-cdac-4f3c-a615-3b2d04ba1cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_9215f8ff-cdac-4f3c-a615-3b2d04ba1cc7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_85e38891-8f88-454a-b54c-14f1128a5a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_85e38891-8f88-454a-b54c-14f1128a5a0d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_802dc245-b5a3-48ac-9248-a341425a28b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_802dc245-b5a3-48ac-9248-a341425a28b4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a45917c-5b4b-4a18-905e-f68feb24958d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a45917c-5b4b-4a18-905e-f68feb24958d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_61c61895-6515-41dc-8f12-5265d08148e8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a45917c-5b4b-4a18-905e-f68feb24958d" xlink:to="loc_srt_RangeAxis_61c61895-6515-41dc-8f12-5265d08148e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_61c61895-6515-41dc-8f12-5265d08148e8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_61c61895-6515-41dc-8f12-5265d08148e8" xlink:to="loc_srt_RangeMember_61c61895-6515-41dc-8f12-5265d08148e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b84a87a5-5dc4-4d77-ba98-70a29acd1bab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_61c61895-6515-41dc-8f12-5265d08148e8" xlink:to="loc_srt_RangeMember_b84a87a5-5dc4-4d77-ba98-70a29acd1bab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c131d596-3390-4ffd-b74a-2c9f8bf1dff0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b84a87a5-5dc4-4d77-ba98-70a29acd1bab" xlink:to="loc_srt_MinimumMember_c131d596-3390-4ffd-b74a-2c9f8bf1dff0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f65063cb-e303-46f2-9db3-51cea8f81eb3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b84a87a5-5dc4-4d77-ba98-70a29acd1bab" xlink:to="loc_srt_MaximumMember_f65063cb-e303-46f2-9db3-51cea8f81eb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_17472c26-b72b-4bfa-ac29-e6e7066aa5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a45917c-5b4b-4a18-905e-f68feb24958d" xlink:to="loc_us-gaap_AwardTypeAxis_17472c26-b72b-4bfa-ac29-e6e7066aa5f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_17472c26-b72b-4bfa-ac29-e6e7066aa5f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_17472c26-b72b-4bfa-ac29-e6e7066aa5f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_17472c26-b72b-4bfa-ac29-e6e7066aa5f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f05500a6-965f-412e-a4d7-4b1fae2580d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_17472c26-b72b-4bfa-ac29-e6e7066aa5f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f05500a6-965f-412e-a4d7-4b1fae2580d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ab19dc79-bcd9-4f94-9ba4-97200f3ba45f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f05500a6-965f-412e-a4d7-4b1fae2580d3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ab19dc79-bcd9-4f94-9ba4-97200f3ba45f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember_b3641cf7-dd16-4c83-a0b2-3137909d5d79" xlink:href="rdnt-20230331.xsd#rdnt_FutureServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f05500a6-965f-412e-a4d7-4b1fae2580d3" xlink:to="loc_rdnt_FutureServiceMember_b3641cf7-dd16-4c83-a0b2-3137909d5d79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockUnitsMember_e153823d-f1c7-4c2f-846a-eae6acf67645" xlink:href="rdnt-20230331.xsd#rdnt_PerformanceBasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f05500a6-965f-412e-a4d7-4b1fae2580d3" xlink:to="loc_rdnt_PerformanceBasedStockUnitsMember_e153823d-f1c7-4c2f-846a-eae6acf67645" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember_8c286a5a-4393-4bc2-b7d3-d2ab76b08257" xlink:href="rdnt-20230331.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f05500a6-965f-412e-a4d7-4b1fae2580d3" xlink:to="loc_rdnt_PerformanceBasedStockOptionsMember_8c286a5a-4393-4bc2-b7d3-d2ab76b08257" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember_712cf069-02b1-4729-97b7-7669c93e2fca" xlink:href="rdnt-20230331.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f05500a6-965f-412e-a4d7-4b1fae2580d3" xlink:to="loc_rdnt_LongTermIncentivePlanSharesMember_712cf069-02b1-4729-97b7-7669c93e2fca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c2a5488f-354a-4f2e-9440-966552ab42a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a45917c-5b4b-4a18-905e-f68feb24958d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c2a5488f-354a-4f2e-9440-966552ab42a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c2a5488f-354a-4f2e-9440-966552ab42a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c2a5488f-354a-4f2e-9440-966552ab42a5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c2a5488f-354a-4f2e-9440-966552ab42a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e51a44b-e53f-4812-a83a-0d05f0c14294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c2a5488f-354a-4f2e-9440-966552ab42a5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e51a44b-e53f-4812-a83a-0d05f0c14294" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_08c3f954-1e02-4b42-911c-d4d736fd6943" xlink:href="rdnt-20230331.xsd#rdnt_DeepHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e51a44b-e53f-4812-a83a-0d05f0c14294" xlink:to="loc_rdnt_DeepHealthIncMember_08c3f954-1e02-4b42-911c-d4d736fd6943" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_b6c15554-28a0-4268-964f-7c90fc01c092" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a45917c-5b4b-4a18-905e-f68feb24958d" xlink:to="loc_srt_TitleOfIndividualAxis_b6c15554-28a0-4268-964f-7c90fc01c092" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_b6c15554-28a0-4268-964f-7c90fc01c092_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_b6c15554-28a0-4268-964f-7c90fc01c092" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_b6c15554-28a0-4268-964f-7c90fc01c092_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32b055cb-6db2-45d0-a5f6-f93a6547ce36" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_b6c15554-28a0-4268-964f-7c90fc01c092" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32b055cb-6db2-45d0-a5f6-f93a6547ce36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_f1f5c478-2a7c-447d-a578-72628dcd9e42" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32b055cb-6db2-45d0-a5f6-f93a6547ce36" xlink:to="loc_srt_DirectorMember_f1f5c478-2a7c-447d-a578-72628dcd9e42" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails" xlink:type="extended" id="i0352bfd7b31a45cdaa0895c19d34dfb4_STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd407f93-b43c-496b-9af9-e9dd0fd08948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_28bd567b-dddc-48be-b314-95fd376abe54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd407f93-b43c-496b-9af9-e9dd0fd08948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_28bd567b-dddc-48be-b314-95fd376abe54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d1537fed-b068-4be6-92a5-5ec546b7942d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_28bd567b-dddc-48be-b314-95fd376abe54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d1537fed-b068-4be6-92a5-5ec546b7942d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a172e903-225a-4f47-80bf-2a694b582833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_28bd567b-dddc-48be-b314-95fd376abe54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a172e903-225a-4f47-80bf-2a694b582833" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d3bc34f6-747a-43db-9473-1e680440661a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_28bd567b-dddc-48be-b314-95fd376abe54" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d3bc34f6-747a-43db-9473-1e680440661a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fc44c9ec-e2de-4251-af97-83bbc650673a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a045d65e-ef6f-4ead-9155-5546e8c627c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd407f93-b43c-496b-9af9-e9dd0fd08948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a045d65e-ef6f-4ead-9155-5546e8c627c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a30b11de-b05c-49ea-b3fe-f267cf0749f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd407f93-b43c-496b-9af9-e9dd0fd08948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a30b11de-b05c-49ea-b3fe-f267cf0749f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_011e5ad5-b589-490a-8a99-0ec3c1c68080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a30b11de-b05c-49ea-b3fe-f267cf0749f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_011e5ad5-b589-490a-8a99-0ec3c1c68080" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0568f8d5-2815-4df0-a254-83b1bc429e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a30b11de-b05c-49ea-b3fe-f267cf0749f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0568f8d5-2815-4df0-a254-83b1bc429e87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8353ced3-c67b-497c-9926-50c5b2f15f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a30b11de-b05c-49ea-b3fe-f267cf0749f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8353ced3-c67b-497c-9926-50c5b2f15f7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_64e115da-e485-452b-922f-deb878d72987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_75c8232b-069f-42bf-b948-11a36ce706f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd407f93-b43c-496b-9af9-e9dd0fd08948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_75c8232b-069f-42bf-b948-11a36ce706f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife_66a64abc-6b66-4fa8-afb9-fdceff7e7a8c" xlink:href="rdnt-20230331.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd407f93-b43c-496b-9af9-e9dd0fd08948" xlink:to="loc_rdnt_WeightedAverageRemainingContractualLife_66a64abc-6b66-4fa8-afb9-fdceff7e7a8c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_605d3265-c8e8-46fb-89ec-b166b46231bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_66a64abc-6b66-4fa8-afb9-fdceff7e7a8c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_605d3265-c8e8-46fb-89ec-b166b46231bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_b21ef353-cd2e-4eaa-b64e-a6cfe42182bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_66a64abc-6b66-4fa8-afb9-fdceff7e7a8c" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_b21ef353-cd2e-4eaa-b64e-a6cfe42182bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue_df6acaf1-8b0f-4b05-8e16-c7f78be66978" xlink:href="rdnt-20230331.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd407f93-b43c-496b-9af9-e9dd0fd08948" xlink:to="loc_rdnt_AggregateIntrinsicValue_df6acaf1-8b0f-4b05-8e16-c7f78be66978" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_80762664-0d08-4f48-8e9b-f99611d85d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AggregateIntrinsicValue_df6acaf1-8b0f-4b05-8e16-c7f78be66978" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_80762664-0d08-4f48-8e9b-f99611d85d3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4a865882-a7e1-47c8-adcc-7b5aa02a8fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AggregateIntrinsicValue_df6acaf1-8b0f-4b05-8e16-c7f78be66978" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4a865882-a7e1-47c8-adcc-7b5aa02a8fb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6a10f2ec-084a-46c9-a789-7f87fe11ce29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd407f93-b43c-496b-9af9-e9dd0fd08948" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6a10f2ec-084a-46c9-a789-7f87fe11ce29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_185a8b6d-a6a5-4784-80ca-0c0a321f7213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6a10f2ec-084a-46c9-a789-7f87fe11ce29" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_185a8b6d-a6a5-4784-80ca-0c0a321f7213" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_185a8b6d-a6a5-4784-80ca-0c0a321f7213_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_185a8b6d-a6a5-4784-80ca-0c0a321f7213" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_185a8b6d-a6a5-4784-80ca-0c0a321f7213_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0277fcc7-964b-4ccd-9782-e4bfe59b7a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_185a8b6d-a6a5-4784-80ca-0c0a321f7213" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0277fcc7-964b-4ccd-9782-e4bfe59b7a4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_36fc14b1-6b1b-40c5-903c-3837e065957f" xlink:href="rdnt-20230331.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0277fcc7-964b-4ccd-9782-e4bfe59b7a4f" xlink:to="loc_rdnt_DeepHealthInc.Member_36fc14b1-6b1b-40c5-903c-3837e065957f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails" xlink:type="extended" id="i966bbcbf299f4cae84b9a0cfd0c0b2e2_STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9bd1c4d-85d3-4592-b91f-a3b23075fcee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_f5ea7609-ae94-4dc7-a955-6bde9468da85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9bd1c4d-85d3-4592-b91f-a3b23075fcee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_f5ea7609-ae94-4dc7-a955-6bde9468da85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6880c82d-9eb9-4847-96d3-aa84a7479c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_f5ea7609-ae94-4dc7-a955-6bde9468da85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6880c82d-9eb9-4847-96d3-aa84a7479c8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fabbe754-c7e3-474c-8233-903a2e739ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_f5ea7609-ae94-4dc7-a955-6bde9468da85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fabbe754-c7e3-474c-8233-903a2e739ab6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a82a4154-2d9d-40bf-a3f7-f1900362bf6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_f5ea7609-ae94-4dc7-a955-6bde9468da85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a82a4154-2d9d-40bf-a3f7-f1900362bf6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_8c373b86-8c72-44d8-b956-0f3dbe1fd06f" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_f5ea7609-ae94-4dc7-a955-6bde9468da85" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_8c373b86-8c72-44d8-b956-0f3dbe1fd06f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_09a4bc28-c4b5-40df-9811-8601f6028a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_16345a62-b296-412f-9a1c-5269130dee2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9bd1c4d-85d3-4592-b91f-a3b23075fcee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_16345a62-b296-412f-9a1c-5269130dee2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c721abe2-b482-46a0-a4f8-0e125380448b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9bd1c4d-85d3-4592-b91f-a3b23075fcee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c721abe2-b482-46a0-a4f8-0e125380448b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_850fee9a-8c64-468f-89ac-14850027570a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c721abe2-b482-46a0-a4f8-0e125380448b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_850fee9a-8c64-468f-89ac-14850027570a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dda0ba19-9abe-4d24-8d61-4bf626b05bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c721abe2-b482-46a0-a4f8-0e125380448b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dda0ba19-9abe-4d24-8d61-4bf626b05bdb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_70101a94-bdea-4ff8-8386-32095e314332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c721abe2-b482-46a0-a4f8-0e125380448b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_70101a94-bdea-4ff8-8386-32095e314332" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_bdc43a16-743c-45b1-9219-330bd16ed95d" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c721abe2-b482-46a0-a4f8-0e125380448b" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_bdc43a16-743c-45b1-9219-330bd16ed95d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5eccabff-ce98-4c85-be3a-7cf9685e5546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_548c139e-6305-4aa3-9361-20794d3f37b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9bd1c4d-85d3-4592-b91f-a3b23075fcee" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_548c139e-6305-4aa3-9361-20794d3f37b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1ff2cebb-432a-4ad0-8d74-7fefee30ad4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_548c139e-6305-4aa3-9361-20794d3f37b2" xlink:to="loc_us-gaap_AwardTypeAxis_1ff2cebb-432a-4ad0-8d74-7fefee30ad4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff2cebb-432a-4ad0-8d74-7fefee30ad4a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1ff2cebb-432a-4ad0-8d74-7fefee30ad4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff2cebb-432a-4ad0-8d74-7fefee30ad4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c01d0a4f-eae5-414e-ab76-eeff9fba4d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1ff2cebb-432a-4ad0-8d74-7fefee30ad4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c01d0a4f-eae5-414e-ab76-eeff9fba4d20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_96965714-7e91-483b-aa0d-7df2683d9ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c01d0a4f-eae5-414e-ab76-eeff9fba4d20" xlink:to="loc_us-gaap_RestrictedStockMember_96965714-7e91-483b-aa0d-7df2683d9ef3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails" xlink:type="extended" id="iea87a969626448babc12720e8be3c834_STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02c36076-ca73-45b9-94f2-15df566218c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0975bc6f-9ef7-41f7-b593-df8cf84fa19c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02c36076-ca73-45b9-94f2-15df566218c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0975bc6f-9ef7-41f7-b593-df8cf84fa19c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9964fda4-37e1-4bd2-aba4-c8cd4559c12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0975bc6f-9ef7-41f7-b593-df8cf84fa19c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9964fda4-37e1-4bd2-aba4-c8cd4559c12e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_bd870af1-b5e1-4d36-8f66-6bb89d658013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0975bc6f-9ef7-41f7-b593-df8cf84fa19c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_bd870af1-b5e1-4d36-8f66-6bb89d658013" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_02b9cc34-a873-421d-bad8-5e51ee7165ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0975bc6f-9ef7-41f7-b593-df8cf84fa19c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_02b9cc34-a873-421d-bad8-5e51ee7165ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_e3c80664-d220-4da4-a964-bc08b9e9b9a8" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0975bc6f-9ef7-41f7-b593-df8cf84fa19c" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_e3c80664-d220-4da4-a964-bc08b9e9b9a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6ec2ee3f-b24a-43b2-a431-64f067628867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_63a4e1b1-673f-4910-befd-12fda2497d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02c36076-ca73-45b9-94f2-15df566218c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_63a4e1b1-673f-4910-befd-12fda2497d3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8bdd8eec-7760-43f2-8df2-a037ecae81d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02c36076-ca73-45b9-94f2-15df566218c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8bdd8eec-7760-43f2-8df2-a037ecae81d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_46d74c9b-827d-42d1-ada8-043fd5f43ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8bdd8eec-7760-43f2-8df2-a037ecae81d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_46d74c9b-827d-42d1-ada8-043fd5f43ac7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_72d3cf90-8fd3-4006-8889-d82cd50d6554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8bdd8eec-7760-43f2-8df2-a037ecae81d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_72d3cf90-8fd3-4006-8889-d82cd50d6554" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8cf7ab2c-08d6-41f1-97fa-7fb2697b9194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8bdd8eec-7760-43f2-8df2-a037ecae81d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8cf7ab2c-08d6-41f1-97fa-7fb2697b9194" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_5d4fa3eb-bea4-4461-85f3-7fff3e572153" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8bdd8eec-7760-43f2-8df2-a037ecae81d0" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_5d4fa3eb-bea4-4461-85f3-7fff3e572153" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_860e7fd4-d59e-441e-94ff-0c6bf806a5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_133af644-dd09-4c7c-9852-74a1b3dfad01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02c36076-ca73-45b9-94f2-15df566218c7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_133af644-dd09-4c7c-9852-74a1b3dfad01" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c78f9526-e69c-49f0-ab1e-2bee8a101845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_133af644-dd09-4c7c-9852-74a1b3dfad01" xlink:to="loc_us-gaap_AwardTypeAxis_c78f9526-e69c-49f0-ab1e-2bee8a101845" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c78f9526-e69c-49f0-ab1e-2bee8a101845_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c78f9526-e69c-49f0-ab1e-2bee8a101845" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c78f9526-e69c-49f0-ab1e-2bee8a101845_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_40e21a25-db15-4aea-a059-6222d07172a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c78f9526-e69c-49f0-ab1e-2bee8a101845" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_40e21a25-db15-4aea-a059-6222d07172a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember_82a2f1f8-c281-41d4-8212-51232a73d94c" xlink:href="rdnt-20230331.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_40e21a25-db15-4aea-a059-6222d07172a9" xlink:to="loc_rdnt_LongTermIncentivePlanSharesMember_82a2f1f8-c281-41d4-8212-51232a73d94c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>rdnt-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b2271182-007a-4027-b874-402dbe4bcb25,g:1e66911a-3ada-4e5a-b4d0-d568e36a58ce-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_a60ff355-3dbf-4000-8329-5dab14a1ae21_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_1d570a18-2104-4e81-b565-2536af157b84_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIIMember_60b0e987-df46-4b9b-aa68-022e650435b6_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II</link:label>
    <link:label id="lab_rdnt_PricingLevelIIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIIMember" xlink:to="lab_rdnt_PricingLevelIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_5bd379ff-8b3e-4373-87e0-294d7d52264b_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, liability, period</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Period</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b7e6c1af-85df-4724-87a4-d5f03d8186f7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_7ffa471d-ada5-47fd-8790-7113bc400f9a_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET (LOSS) INCOME</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_dda077a9-2778-4583-8191-88ba046c4daf_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET (LOSS) INCOME</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_fe888a72-9c3f-4377-a4c5-f2be72cb9bd0_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_d1a1b5d8-8784-406a-a1dc-3ec37eb2cae1_netLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureInterestMember_fbb3a947-c61b-49cd-882f-6b7f1e77ab87_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Interest</link:label>
    <link:label id="lab_rdnt_JointVentureInterestMember_label_en-US" xlink:label="lab_rdnt_JointVentureInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Interest [Member]</link:label>
    <link:label id="lab_rdnt_JointVentureInterestMember_documentation_en-US" xlink:label="lab_rdnt_JointVentureInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInterestMember" xlink:href="rdnt-20230331.xsd#rdnt_JointVentureInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureInterestMember" xlink:to="lab_rdnt_JointVentureInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_44cc2bca-98f9-4750-97a0-d3e582cf6f1d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_1635e7f8-e022-4e45-acc0-96d78990005d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_379052d9-9d97-484f-8e0a-2382e0410962_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of additional shares issued after execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:href="rdnt-20230331.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_98db0fef-47b5-45e3-9aa7-d65a69685c01_terseLabel_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</link:label>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_label_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</link:label>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_documentation_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:href="rdnt-20230331.xsd#rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:to="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_dd467fd3-79a7-41ea-a756-fdeab6829c24_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATION</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_78f3a2d5-9525-491f-aee8-344ee39f0361_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_ff0cb1c6-d18d-468d-82f3-535a48792cda_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability [Roll Forward]</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability [Roll Forward]</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ee95ff48-b23f-44cb-b392-05a8e4f75177_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_4017663a-0fab-4f7e-8e3a-015bc3881cb6_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_ebc9d32f-dce4-422e-8fb3-7e1dfa5758ec_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Term Loans and Truist Term Loan</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EarningPerShareBasicAndDilutedAbstract_a307d896-761b-4780-8a09-17f2d56fa160_terseLabel_en-US" xlink:label="lab_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEIGHTED AVERAGE SHARES OUTSTANDING</link:label>
    <link:label id="lab_rdnt_EarningPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earning Per Share, Basic and Diluted [Abstract]</link:label>
    <link:label id="lab_rdnt_EarningPerShareBasicAndDilutedAbstract_documentation_en-US" xlink:label="lab_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earning Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:href="rdnt-20230331.xsd#rdnt_EarningPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:to="lab_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_d8f19fe6-f6c6-4c46-8be0-2b264eb9575e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_ef11fcab-d229-44ed-9cf6-e04c734625e9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_14dfb658-8c92-4c78-9f95-3cb132d6bd42_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_689dd24a-d0bd-4fe1-9e68-2c03e2a2558c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1e1a9ac1-d0bf-41ec-8d21-9b84beb243b8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_4f2e18a8-124b-4822-a3e5-78ac5e8fe50a_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2030e94e-f547-4eb6-88b1-b70a5a05c62d_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_eb1150e1-703c-40f4-8ed5-7d5bddd75d0a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0bbb2f53-5b71-45a5-9682-ada54d4303d9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1f4764b1-52e9-4154-92a2-b630fa280a5a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PerformanceBasedStockOptionsMember_3419469d-3887-4f49-b86a-f760e3d309a7_terseLabel_en-US" xlink:label="lab_rdnt_PerformanceBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Options ("PSOs")</link:label>
    <link:label id="lab_rdnt_PerformanceBasedStockOptionsMember_label_en-US" xlink:label="lab_rdnt_PerformanceBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Options [Member]</link:label>
    <link:label id="lab_rdnt_PerformanceBasedStockOptionsMember_documentation_en-US" xlink:label="lab_rdnt_PerformanceBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember" xlink:href="rdnt-20230331.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PerformanceBasedStockOptionsMember" xlink:to="lab_rdnt_PerformanceBasedStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_8689ded5-18d4-4c2a-9cb4-b74ee748ca90_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_d1aa8d37-d72b-4f42-9768-ef9b7357dc20_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_6aea5506-c204-4b8a-a793-8f6c6ddd437f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_cdde57a2-e630-4d22-83e2-6aeac2b1ece1_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b353285-7dd5-4d57-8df1-33cc155171e8_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_a52da448-8b43-4958-ae96-7673d50c06f6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_7d67f3a9-f4de-4f83-8df9-6f546f2c9f02_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for acquisitions (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TurnerImagingSystemsMember_80afb12b-4c83-477d-b1d6-1b7c511430f7_terseLabel_en-US" xlink:label="lab_rdnt_TurnerImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging Systems</link:label>
    <link:label id="lab_rdnt_TurnerImagingSystemsMember_label_en-US" xlink:label="lab_rdnt_TurnerImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging Systems [Member]</link:label>
    <link:label id="lab_rdnt_TurnerImagingSystemsMember_documentation_en-US" xlink:label="lab_rdnt_TurnerImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging Systems</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember" xlink:href="rdnt-20230331.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TurnerImagingSystemsMember" xlink:to="lab_rdnt_TurnerImagingSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_c6e61e76-e6f8-450b-ba2c-241c0279d03a_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on term loan debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_dfd46b02-cf2d-4017-a74e-88be463631b4_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_86916749-245d-41f2-be5c-b07caea5d7b4_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to RadNet, Inc.'s common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_8c4020df-8903-47d9-a349-4de927ea984e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7bff1c0f-c0d4-4e50-abfd-b42c6304d0da_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_ffe39fbb-e6ee-4318-b461-a6fbdfb18f7b_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_84b1c298-11e1-48d1-bc4a-3baf24bed977_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of forward interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_52deec3d-038d-4950-8bc8-a14d2d543f82_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of cash flow hedge, net of taxes</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Hedge Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:to="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_483be540-6058-407c-8586-ca09fcc1766f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TruistMember_cf395459-bed7-49e3-8253-99ce0bfb9741_terseLabel_en-US" xlink:label="lab_rdnt_TruistMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Truist</link:label>
    <link:label id="lab_rdnt_TruistMember_label_en-US" xlink:label="lab_rdnt_TruistMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Truist [Member]</link:label>
    <link:label id="lab_rdnt_TruistMember_documentation_en-US" xlink:label="lab_rdnt_TruistMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Truist</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember" xlink:href="rdnt-20230331.xsd#rdnt_TruistMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TruistMember" xlink:to="lab_rdnt_TruistMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TermLoanMember_dde61d62-339a-4227-a517-51095c315063_terseLabel_en-US" xlink:label="lab_rdnt_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loans</link:label>
    <link:label id="lab_rdnt_TermLoanMember_label_en-US" xlink:label="lab_rdnt_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember" xlink:href="rdnt-20230331.xsd#rdnt_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TermLoanMember" xlink:to="lab_rdnt_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_7cd0133f-22b4-498f-adba-86a7883a64cf_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_709ddea0-fe5c-4a9b-a3f6-ee28a9ab4623_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_27f0a94e-077d-4c27-a2a1-b6f763211290_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting rights, percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_b824c0d7-941f-4eeb-b94a-341971a72b61_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Medicaid1Member_e66318d9-f571-441f-8407-81a161c439e5_terseLabel_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid</link:label>
    <link:label id="lab_rdnt_Medicaid1Member_label_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid1 [Member]</link:label>
    <link:label id="lab_rdnt_Medicaid1Member_documentation_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member" xlink:href="rdnt-20230331.xsd#rdnt_Medicaid1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Medicaid1Member" xlink:to="lab_rdnt_Medicaid1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_d0ec9533-d74e-43f1-9cf0-b94c0fefe566_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_e0b90142-dda8-47d6-b98c-ebceadaa9514_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_db04d88f-6191-410a-b497-47bd693bc815_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeepHealthInc.Member_aa23770a-1c2a-4fdd-84dc-e9efc97b09e6_terseLabel_en-US" xlink:label="lab_rdnt_DeepHealthInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc.</link:label>
    <link:label id="lab_rdnt_DeepHealthInc.Member_label_en-US" xlink:label="lab_rdnt_DeepHealthInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc. [Member]</link:label>
    <link:label id="lab_rdnt_DeepHealthInc.Member_documentation_en-US" xlink:label="lab_rdnt_DeepHealthInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member" xlink:href="rdnt-20230331.xsd#rdnt_DeepHealthInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeepHealthInc.Member" xlink:to="lab_rdnt_DeepHealthInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RestatedAgreementMember_fb631241-5e03-4537-a0d6-5e14d65c790c_verboseLabel_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NJIN Term Loan Agreement</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_fcc5eaf0-0697-4c0c-8b56-5f3787a0202f_terseLabel_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_label_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement [Member]</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_documentation_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember" xlink:href="rdnt-20230331.xsd#rdnt_RestatedAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RestatedAgreementMember" xlink:to="lab_rdnt_RestatedAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpensesAbstract_ec9dabb9-b650-47cc-9b65-a3ccd0d2fe7b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER INCOME AND EXPENSES</link:label>
    <link:label id="lab_us-gaap_OtherExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpensesAbstract" xlink:to="lab_us-gaap_OtherExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_9c8a34ee-c0e6-489d-b2bf-290947e0d5a4_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_aeb20df9-77db-4b26-be05-77b3d2986616_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CovenantNotToCompeteMember_10a4b988-e346-46ff-b7aa-1401fed25313_terseLabel_en-US" xlink:label="lab_rdnt_CovenantNotToCompeteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant not to compete and other contracts</link:label>
    <link:label id="lab_rdnt_CovenantNotToCompeteMember_label_en-US" xlink:label="lab_rdnt_CovenantNotToCompeteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant Not To Compete [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CovenantNotToCompeteMember" xlink:href="rdnt-20230331.xsd#rdnt_CovenantNotToCompeteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CovenantNotToCompeteMember" xlink:to="lab_rdnt_CovenantNotToCompeteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_21338230-3318-4d2d-a168-7d1b2a38f488_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_05d42c6a-3f7b-466d-bf08-80559565c605_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_d0fa790b-38ba-4a07-8305-6b50567d98cb_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_cb7380f8-d239-43be-aeba-7cefc48feb89_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_6ba98efa-6fc5-403e-a082-60defe0c4e15_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facilities outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_2be696f2-9e71-4b18-8bfc-346eaa17858e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total credit facilities outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_47c34ba4-a0d7-4f1e-beca-68a4abd31611_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_f61e42e0-aa01-48da-a618-53cc7e8882ca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOtherMember_0a583538-d6a5-4602-aed1-794061ced38b_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_HealthCareOtherMember_label_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOtherMember" xlink:to="lab_us-gaap_HealthCareOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HeartAndLungImagingLimitedMember_1f6903c3-2d58-4c27-8576-56a16108d430_terseLabel_en-US" xlink:label="lab_rdnt_HeartAndLungImagingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heart and Lung Limited</link:label>
    <link:label id="lab_rdnt_HeartAndLungImagingLimitedMember_label_en-US" xlink:label="lab_rdnt_HeartAndLungImagingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heart and Lung Imaging Limited [Member]</link:label>
    <link:label id="lab_rdnt_HeartAndLungImagingLimitedMember_documentation_en-US" xlink:label="lab_rdnt_HeartAndLungImagingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heart and Lung Imaging Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember" xlink:href="rdnt-20230331.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HeartAndLungImagingLimitedMember" xlink:to="lab_rdnt_HeartAndLungImagingLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_a71f1d3b-73af-435b-b58f-dc16d11f2352_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_5f7d4729-6825-4217-a171-b5530d06f8d1_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_76e65198-3c8d-4813-9cf6-db1a390ecc9c_terseLabel_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly amortization of deferred hedge gains</link:label>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_label_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly Amortization Of Deferred Hedge Gains</link:label>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_documentation_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly Amortization Of Deferred Hedge Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:href="rdnt-20230331.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:to="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_76db3d2c-5c6c-4b47-90b5-b9c78f7bb94f_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&gt; 3.00x but &#8804; 3.50x</link:label>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Two [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioTwoMember" xlink:to="lab_rdnt_LeverageRatioTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_ec9ad489-eadf-475f-b651-32d048c57be2_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_97ea21d8-c208-44af-928e-9e24b6c3864c_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_be8105cd-382d-4d65-916a-9bf75b0452f0_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment amortization increase</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_label_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Amortization Increase</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Amortization Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:to="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_cf6204af-fd59-49a0-ae7a-0e3f2a0ba93c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_e7be0c50-b9fa-49b4-b6a8-eb80ad44f155_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_bbf8a96d-a20f-42f4-941b-e7955e46d5b0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current and long term assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A2019SWAPSMember_e3fd091b-f791-4554-9698-5859b9456ffd_terseLabel_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS</link:label>
    <link:label id="lab_rdnt_A2019SWAPSMember_label_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS [Member]</link:label>
    <link:label id="lab_rdnt_A2019SWAPSMember_documentation_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember" xlink:href="rdnt-20230331.xsd#rdnt_A2019SWAPSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A2019SWAPSMember" xlink:to="lab_rdnt_A2019SWAPSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_b968001b-b76e-4dd2-a217-fce093211c8e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management services provided to BRMG and NY Groups</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Income or Loss before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_0c0f578a-f5ff-471f-8d82-776cde499e93_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_48917aa9-ab16-4551-a5d3-91b9c2fe5f35_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo_a4077d16-7d60-4633-a4ce-dc69d27227b9_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of FDA approval and payout, milestone two</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone Two</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_2a46635d-3399-4c26-9477-db3ed2adef66_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioAxis_4690d9fb-f343-47e3-b5fc-56e02f90dfa1_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:label id="lab_rdnt_LeverageRatioAxis_label_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:label id="lab_rdnt_LeverageRatioAxis_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioAxis" xlink:to="lab_rdnt_LeverageRatioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5d06abd4-08ce-43d5-82a4-a3a3011dca2e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_94419f63-a76d-4b79-bbed-6f262cb4d0e6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property &amp; Equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_37526617-99e2-4631-ac7c-a6c0f1038279_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_fd620255-7cf9-4e61-96ee-1edcc947dff1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term portion debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_c33ac146-1bca-4e5d-b034-2db4125e5e1b_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Arrangements Change In Currency Translation</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Arrangements Change In Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_240a27a2-018a-4a93-9b16-51d1ee639a09_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_535c866c-3783-450f-ad76-9fb5595edda3_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups accounts payable</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ee9c99fb-678b-458d-bc05-5ceaed77e160_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_5ef20c78-bb2c-49be-b747-539034599d89_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation adjustment</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2228040a-52c8-4065-a25e-28a048c0dc1a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_3c938cb0-5af8-4341-a016-d1ee6ff19bdf_terseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or Canceled (in dollars per share)</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited Or Cancelled Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited Or Cancelled Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:to="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_00a64422-dbc4-417c-b5bc-61ddb797fe62_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, percentage of voting interests acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AIMember_f4e97ade-600e-4f11-9fe2-f0070ab93c71_verboseLabel_en-US" xlink:label="lab_rdnt_AIMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI Segment Revenue</link:label>
    <link:label id="lab_rdnt_AIMember_3bf9fb82-f354-4bc3-9ab2-b6a52892fc5d_terseLabel_en-US" xlink:label="lab_rdnt_AIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI</link:label>
    <link:label id="lab_rdnt_AIMember_label_en-US" xlink:label="lab_rdnt_AIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI [Member]</link:label>
    <link:label id="lab_rdnt_AIMember_documentation_en-US" xlink:label="lab_rdnt_AIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember" xlink:href="rdnt-20230331.xsd#rdnt_AIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AIMember" xlink:to="lab_rdnt_AIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PatentAndTrademarksMember_6ae7783c-8b76-4da1-907e-1621a924159a_terseLabel_en-US" xlink:label="lab_rdnt_PatentAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent and Trademarks</link:label>
    <link:label id="lab_rdnt_PatentAndTrademarksMember_label_en-US" xlink:label="lab_rdnt_PatentAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent and Trademarks [Member]</link:label>
    <link:label id="lab_rdnt_PatentAndTrademarksMember_documentation_en-US" xlink:label="lab_rdnt_PatentAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent and Trademarks</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatentAndTrademarksMember" xlink:href="rdnt-20230331.xsd#rdnt_PatentAndTrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PatentAndTrademarksMember" xlink:to="lab_rdnt_PatentAndTrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_2269e152-322e-436f-86b5-ecfb4305b273_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e68f81e8-117b-4316-b458-e4a35d6fb091_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_f5c637a9-18b8-49fc-9f9e-c5aa8a442a85_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_adba0634-dcdc-4353-adc4-cfd713c06634_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_e3ed895c-1428-4772-b2ec-3a3b25d5200e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4c4ecfe2-02c9-4844-a80b-5d38c907cc03_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise price Per Common Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_f52a2093-fb3e-4c6d-8bd7-f4a418b21991_verboseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFR</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_cacec065-d59f-4c79-b752-e129ecf4d4c9_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term SOFR Loans</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_2d031053-d97d-47ff-9025-b27447f679ba_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPE estimated useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_11e39059-a541-49a0-8e76-4429ee135d3a_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne_1c10ab72-13b1-48d4-a366-09d13c111e75_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of FDA approval and payout, milestone one</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone One</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_f9aaa76c-0dbe-428a-a781-3e478fa1c9dd_terseLabel_en-US" xlink:label="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of operations, excluding depreciation and amortization</link:label>
    <link:label id="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_label_en-US" xlink:label="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Excluding Depreciation And Amortization</link:label>
    <link:label id="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_documentation_en-US" xlink:label="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Excluding Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:href="rdnt-20230331.xsd#rdnt_OperatingExpensesExcludingDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:to="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b5d4ae2-7bf2-45fb-b777-b47b8f0a9101_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_a314cedf-c495-4bff-a1f6-7b5ea2ae7289_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_9ba20b70-3bf4-441f-9d4b-a7c36421582c_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7a566a9a-a7e6-475a-bb22-4f62766485ea_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a9747b05-c995-4518-a9a3-b6f88820f94d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_5c2a6f1c-d3e9-4867-8630-b21659c27b99_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_0d0280b9-4dba-4dfe-b195-f7e2a372069f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CREDIT FACILITIES AND NOTES PAYABLE</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_1731fe6b-43d8-4c6a-96b0-0d8772c34dce_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_c117312d-6d82-4945-89fa-ff9eadf65f8d_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_3b83a4f5-0cda-43a4-bbdb-7e90362772e8_terseLabel_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts receivable, factoring receivable</link:label>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_label_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Factoring Receivable</link:label>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_documentation_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Factoring Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable" xlink:href="rdnt-20230331.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContractsReceivableFactoringReceivable" xlink:to="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_84c5b9b6-4418-46ba-93b5-31f07b1c73eb_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ab3b13e3-80bc-431c-bb6c-e40b674504ba_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_a4bc2acd-6d9a-4ad6-ae3a-38db3ef90e57_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2023Member_75a844c1-5b8d-42bb-ae28-a13cae0f17b4_terseLabel_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023</link:label>
    <link:label id="lab_rdnt_October2023Member_label_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 [Member]</link:label>
    <link:label id="lab_rdnt_October2023Member_documentation_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member" xlink:href="rdnt-20230331.xsd#rdnt_October2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2023Member" xlink:to="lab_rdnt_October2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_a316f4db-e271-4573-834a-4f984cc91bb2_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_6e5bbc83-88a3-4aaa-8d81-2e52714ff4c3_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ScriptSenderLlcMember_1205705b-ebd2-42d4-bb98-956f2ca4df02_terseLabel_en-US" xlink:label="lab_rdnt_ScriptSenderLlcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScriptSender LLC</link:label>
    <link:label id="lab_rdnt_ScriptSenderLlcMember_label_en-US" xlink:label="lab_rdnt_ScriptSenderLlcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScriptSender LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderLlcMember" xlink:href="rdnt-20230331.xsd#rdnt_ScriptSenderLlcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ScriptSenderLlcMember" xlink:to="lab_rdnt_ScriptSenderLlcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_e70b05dc-bdee-40f6-9dda-a4dbb6113337_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_b93d55e4-c87b-4950-90bc-98b29ca143df_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups accounts receivable</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FutureServiceMember_d54cc9e8-ef35-4176-81e7-3748d65bb742_terseLabel_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Stock Bonus Awards</link:label>
    <link:label id="lab_rdnt_FutureServiceMember_label_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Service [Member]</link:label>
    <link:label id="lab_rdnt_FutureServiceMember_documentation_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember" xlink:href="rdnt-20230331.xsd#rdnt_FutureServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FutureServiceMember" xlink:to="lab_rdnt_FutureServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_728b9dbc-17f3-47ac-b3dd-b57c2bd2c4af_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_4fc9390c-2c13-4de2-8107-8cf96126f5e8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_42afd8ce-72b8-4aa1-86f1-094229cc2c53_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_8d2ffce8-4e12-45ca-8f14-54b06b729b35_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_16490386-dcbf-420e-a6eb-b86a9d068443_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Swaps - Interest Rate Contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_508edbbb-5392-441e-acfc-defb5a966954_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_7bea7a9a-4604-46ae-ac42-e6e84a590797_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIIIMember_6da1c86a-2e24-4e27-b91a-217d3cccea4c_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III</link:label>
    <link:label id="lab_rdnt_PricingLevelIIIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIIIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelIIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIIIMember" xlink:to="lab_rdnt_PricingLevelIIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_4847b042-8830-417d-b67f-b43103188b5e_negatedLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5953bb81-1d7e-4b00-9934-194277a61c3e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_QuantibMember_14c802f5-48ae-4bca-8e97-fb3697d5859a_terseLabel_en-US" xlink:label="lab_rdnt_QuantibMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib</link:label>
    <link:label id="lab_rdnt_QuantibMember_label_en-US" xlink:label="lab_rdnt_QuantibMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib [Member]</link:label>
    <link:label id="lab_rdnt_QuantibMember_documentation_en-US" xlink:label="lab_rdnt_QuantibMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember" xlink:href="rdnt-20230331.xsd#rdnt_QuantibMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_QuantibMember" xlink:to="lab_rdnt_QuantibMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_e88a001a-add1-4bd3-901f-28c39df6179d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_d05fa615-6eb7-4b3f-9fdc-c6f81e9f90ca_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_b7138f4f-1de0-4c36-bea6-fdfe959764a3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_64d26868-b5ef-4394-a767-a13270aa6edc_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0e4afa4f-4540-41ed-bdda-6a2ca4bdd392_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(LOSS) INCOME BEFORE INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_37cf970f-a4fc-4b4c-9f2c-03558b04eb12_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6fa74622-72df-4751-acbe-089e606e85a2_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_62586832-a098-4db2-9710-356475893b26_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_7ae3331d-6b5e-496b-8e34-c75dcf381021_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_200a3487-d627-4f87-a095-c846122a85b2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest issued, value assigned</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_8b3f960e-626b-4934-ae52-4d718d6498fd_terseLabel_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Leverage Ratio</link:label>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_label_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leverage Ratio [Table Text Block]</link:label>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leverage Ratio [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:href="rdnt-20230331.xsd#rdnt_ScheduleOfLeverageRatioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:to="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_8cd8b2c3-ed51-4fe4-8a2f-eec87be43c14_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add additional shares issuable upon exercise of stock options and contingently issuable shares (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_f5b28ae4-f38f-4516-9013-0af0d81e77cd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ef6b895a-4923-4319-998d-359217eac9d5_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE (LOSS) INCOME</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6491fdbe-09c9-4e40-8298-7bb7a08ec2b7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8cc398eb-7c31-4f98-8ee7-772c67baf7c6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized expense weighted average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_4ec2ba7f-c268-430c-80ea-f7a88c3bb532_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt restructuring and extinguishment expenses</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_22483029-40ea-46bf-91ce-3f7546324138_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCOUNTS RECEIVABLE</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_b9e87b55-f937-4d65-92a0-d1bb25a42ca7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_0a05bd66-22a4-44b4-bc5e-362a104c016d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ffb5820c-fefd-4329-8221-2044c3dad0c6_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TeleradiologyandSoftwareMember_33a799db-3ff3-4b80-8e75-8e5257a31615_terseLabel_en-US" xlink:label="lab_rdnt_TeleradiologyandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teleradiology and Software revenue</link:label>
    <link:label id="lab_rdnt_TeleradiologyandSoftwareMember_label_en-US" xlink:label="lab_rdnt_TeleradiologyandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teleradiology and Software [Member]</link:label>
    <link:label id="lab_rdnt_TeleradiologyandSoftwareMember_documentation_en-US" xlink:label="lab_rdnt_TeleradiologyandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teleradiology and Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TeleradiologyandSoftwareMember" xlink:href="rdnt-20230331.xsd#rdnt_TeleradiologyandSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TeleradiologyandSoftwareMember" xlink:to="lab_rdnt_TeleradiologyandSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_c3d84932-ee49-4b7a-8a7f-077a3377b814_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_a1511476-bd0a-416a-ab5a-45985abbad24_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_25bce7c1-5f23-43f3-bc08-aec415add34f_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsLineItems" xlink:to="lab_us-gaap_OffsettingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_dbdd2af0-ac47-4c55-98fe-eb3df7413db3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureMember_4c73c2ee-7ffa-4092-bf76-20705e6a1f33_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture</link:label>
    <link:label id="lab_rdnt_JointVentureMember_label_en-US" xlink:label="lab_rdnt_JointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember" xlink:href="rdnt-20230331.xsd#rdnt_JointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureMember" xlink:to="lab_rdnt_JointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_5f131400-79ef-4caa-b582-0d67a03319a6_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_398cb445-270e-4c17-9a17-170d81961877_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_c5edb381-5611-4ff9-85e1-e463c29c81e5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss, net of taxes</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_5b8aa5c4-753f-4b85-9b1d-5dcdc3dbc10f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING EXPENSES</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e3e38a78-07fe-4232-a086-a54815973b6a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ef18ba7c-94cd-4dc5-9493-a0eead9db5b2_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_31d340b4-a728-4b8b-8bcf-648217fd236d_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_aedcae63-e8e9-4dcf-946c-a97bf54e3cd7_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration_caad3180-676f-4f59-9033-b5e01f49408d_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of contingent consideration</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Issuance Of Contingent Consideration</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Issuance Of Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_336ed433-adfb-40af-bf03-b9c911848573_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_ebb82945-aba4-42c6-9b52-3cc5adb40442_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_01b56dba-a6ee-4fe4-95f3-05bfe774adbe_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_9f45d142-7699-43f4-b24a-4da01fe35d26_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioDomain_6dd27d3a-1915-44b2-a72d-7f09ca4e1976_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Domain]</link:label>
    <link:label id="lab_rdnt_LeverageRatioDomain_label_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Domain]</link:label>
    <link:label id="lab_rdnt_LeverageRatioDomain_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Leverage Ratio [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioDomain" xlink:to="lab_rdnt_LeverageRatioDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_282d96ad-ddd5-47f4-b262-ce2bd89d1d6a_netLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of comprehensive loss recognized on derivative net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionsMember_2b7a8606-7506-4ec5-a6e2-0c7a922a1b16_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionsMember_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions [Member]</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionsMember_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionsMember" xlink:href="rdnt-20230331.xsd#rdnt_BusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionsMember" xlink:to="lab_rdnt_BusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBuildings_a068d1c5-55a5-42fd-a739-80cfb9407fcb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBuildings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of imaging centers and other acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBuildings_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBuildings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Buildings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBuildings" xlink:to="lab_us-gaap_PaymentsToAcquireBuildings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b32a6415-2a69-48f0-a3c3-c8255fd2bae8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_c23d5161-2fa4-497a-8f64-58f2ed109a95_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash change in fair value of interest rate hedge</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioFourMember_1760226c-f8a4-4839-9331-0fa41d9b4984_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#8804; 3.00x</link:label>
    <link:label id="lab_rdnt_LeverageRatioFourMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Four [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioFourMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFourMember" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioFourMember" xlink:to="lab_rdnt_LeverageRatioFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_6c8f90e4-64f9-4c13-b483-9176f9f8a795_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs, net of accumulated amortization</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8bbb1d36-18a2-4889-b885-5adc03bede19_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionAxis_201e6f7f-58b1-4832-8747-fdf26443a9b1_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionAxis_label_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5566c76e-6046-49b7-bbb3-9d56404c6a96_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_5c4eff53-2d67-4da7-8036-1e8098b8d69a_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_d84af2c4-a0f1-4d33-a6db-a8730f3788b8_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_863374b3-5e21-49a9-8b17-5708ea37dad1_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GlendaleAdvancedImagingMember_dc4affcd-f7f1-4b49-a959-1222f93acd2f_terseLabel_en-US" xlink:label="lab_rdnt_GlendaleAdvancedImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glendale Advanced Imaging</link:label>
    <link:label id="lab_rdnt_GlendaleAdvancedImagingMember_label_en-US" xlink:label="lab_rdnt_GlendaleAdvancedImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glendale Advanced Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember" xlink:href="rdnt-20230331.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GlendaleAdvancedImagingMember" xlink:to="lab_rdnt_GlendaleAdvancedImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_11d2437b-cd78-469e-b9c6-5badedca1aca_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year four</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_bcee55cc-fc2c-46f7-b199-08d853933f6f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment, principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CCDGLRSServicesIncMember_f8e331d6-b597-44e3-81c0-0f7247d76465_terseLabel_en-US" xlink:label="lab_rdnt_CCDGLRSServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C.C.D.G.L.R. &amp; S Services Inc.</link:label>
    <link:label id="lab_rdnt_CCDGLRSServicesIncMember_label_en-US" xlink:label="lab_rdnt_CCDGLRSServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C.C.D.G.L.R. &amp; S Services Inc. [Member]</link:label>
    <link:label id="lab_rdnt_CCDGLRSServicesIncMember_documentation_en-US" xlink:label="lab_rdnt_CCDGLRSServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C.C.D.G.L.R. &amp; S Services Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CCDGLRSServicesIncMember" xlink:href="rdnt-20230331.xsd#rdnt_CCDGLRSServicesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CCDGLRSServicesIncMember" xlink:to="lab_rdnt_CCDGLRSServicesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_97e14e6d-8d7a-46e6-b9b1-f858307fba40_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DevelopedTechnologySoftwareMember_45942d10-2c3b-4fbb-9965-e7f04cc2adce_terseLabel_en-US" xlink:label="lab_rdnt_DevelopedTechnologySoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology &amp; Software</link:label>
    <link:label id="lab_rdnt_DevelopedTechnologySoftwareMember_label_en-US" xlink:label="lab_rdnt_DevelopedTechnologySoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology &amp; Software [Member]</link:label>
    <link:label id="lab_rdnt_DevelopedTechnologySoftwareMember_documentation_en-US" xlink:label="lab_rdnt_DevelopedTechnologySoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DevelopedTechnologySoftwareMember" xlink:href="rdnt-20230331.xsd#rdnt_DevelopedTechnologySoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DevelopedTechnologySoftwareMember" xlink:to="lab_rdnt_DevelopedTechnologySoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_0d7d92b8-393f-474e-a402-2e6d48e268dc_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_661b0982-264e-4dfd-9842-26a955953342_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_f7e92ebe-3a05-4be8-9a9f-d8f680b77d31_terseLabel_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life (in years)</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_label_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_documentation_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life abstract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife" xlink:href="rdnt-20230331.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife" xlink:to="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_995e456f-7a66-42a8-919a-7b3b0b288593_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f5887125-434a-4209-b8e4-cf416147fe8a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_8bf66a86-bcf7-4b06-a01b-d55edc621bbc_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from affiliates</link:label>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:to="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_096856a8-58ff-404e-aa31-c1386c943eb3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATIONS AND RELATED ACTIVITY</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_3517f442-fd4e-4c5f-9995-8dacef4c65c3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Service Fee Revenue</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Principal Transactions Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:to="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ac17c096-c338-445d-ae7d-9ddd96d23a17_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_6411cc35-0e89-4752-853d-59af8990c0ff_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_d9ba046c-7b58-4a87-96f5-22958abc0936_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_713c8cce-2d88-4edf-aa34-b2e2950d7fb7_netLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c7cb1b8d-a6fb-4df8-a075-1faaa8dfaf69_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_3d17f4d6-66b6-4073-84e4-335b0c5ac483_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, periodic payment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_75aefc01-5450-4249-b36f-30a303542d77_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingIncomeLossExcludingReliefFunding_e8df6be0-f402-4c5d-87af-a0007fdf5ff0_terseLabel_en-US" xlink:label="lab_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Operations</link:label>
    <link:label id="lab_rdnt_OperatingIncomeLossExcludingReliefFunding_label_en-US" xlink:label="lab_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Excluding Relief Funding</link:label>
    <link:label id="lab_rdnt_OperatingIncomeLossExcludingReliefFunding_documentation_en-US" xlink:label="lab_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Excluding Relief Funding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:href="rdnt-20230331.xsd#rdnt_OperatingIncomeLossExcludingReliefFunding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:to="lab_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_139d45fe-d126-4481-a645-0067f1e7f4fc_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_a16ca5ed-7bc5-4913-9e9f-6f043703dba3_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Operations</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_6f80f781-cd30-4707-b69a-e6df7ce53ce9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d4133976-9f4d-4a5d-93d5-6f6767e80428_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_bafe1351-2b3b-4f4a-86ba-3d01b559095c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9128bdf8-b084-4570-846c-573cc9526f0a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_59285eb6-4912-4526-82b4-2f8f2616224a_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d6617c44-d600-405c-be36-1c58c83c4364_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_34797778-4577-4098-a4a7-ab21185bbf60_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total RadNet, Inc.'s stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_618139ed-2c57-4fa3-990a-d406a7c99d25_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss recognized in income on derivative (current period ineffective portion)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_44bae3a3-b852-49c3-b210-85ce3aa44923_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board of Directors</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_3dcdfae6-3a78-4ff7-be10-786f8dce3051_terseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to affiliates</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_label_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Affiliate, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToAffiliateCurrent" xlink:to="lab_us-gaap_DueToAffiliateCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_1854c833-eafe-4dd2-9597-5804ef96f104_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_5f38e17c-d67a-40ac-ba6d-6e57cdf0c02d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ce20aa2e-cc50-44a9-b619-c724d5aa068d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4d267e3b-0ce2-477b-9b40-a88ca549e457_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year three</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_68e84853-a69e-4f54-942c-b455bbb80fda_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_20c2dbe7-facf-4ee0-b1d9-5ae1d5cfc770_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8cc5fa50-66ba-4667-a8a7-3c2bd68905a0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_ff42e931-6a5e-4e66-8223-c4d4792b7fa2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CashHoldbackMember_32ed261d-c1d0-414b-98eb-600c7feca4c1_terseLabel_en-US" xlink:label="lab_rdnt_CashHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Holdback</link:label>
    <link:label id="lab_rdnt_CashHoldbackMember_label_en-US" xlink:label="lab_rdnt_CashHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Holdback [Member]</link:label>
    <link:label id="lab_rdnt_CashHoldbackMember_documentation_en-US" xlink:label="lab_rdnt_CashHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember" xlink:href="rdnt-20230331.xsd#rdnt_CashHoldbackMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CashHoldbackMember" xlink:to="lab_rdnt_CashHoldbackMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_6b09f636-63af-47f3-bc65-7badd7ab8bc5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_1bee61da-7f2b-43ab-ba1d-824a3aa74e83_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_dc37c308-b5c7-4a5c-92d3-318fff15a650_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available in grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_d8803577-c31b-4151-b255-4b8764492e7f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_b8e9f52c-1761-4ccd-930c-4cd25afc4fca_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses at the beginning</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_9fd1ea27-86fe-4bba-929f-1ea54b0a9a5a_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses at the end</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_e70247c0-827f-41ee-9e97-5ad9729acd62_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of RSA Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_b7773141-4016-46ae-9ea4-e186a6682140_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_9976621a-96ea-4904-815c-5409c648b259_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_f24c59ba-f5c6-4cd3-9850-be78f40ec464_terseLabel_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_label_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_documentation_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue" xlink:href="rdnt-20230331.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AggregateIntrinsicValue" xlink:to="lab_rdnt_AggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_f6beb108-1ec1-460c-a83d-3fe6cef1a0ac_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_386f6c7c-ae91-43b5-981f-0f780b3f334a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_49e25b5c-5e5e-4715-8481-ef3cc64c3aeb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_0a270ea8-13d4-4d62-bae5-cf7f132926ee_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ImagingCentersMember_2aa0c58a-9180-45df-b07c-a4e6fb870d28_verboseLabel_en-US" xlink:label="lab_rdnt_ImagingCentersMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Center</link:label>
    <link:label id="lab_rdnt_ImagingCentersMember_3a2b2701-18fa-4f3a-8cee-de88d045fdb1_terseLabel_en-US" xlink:label="lab_rdnt_ImagingCentersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Centers</link:label>
    <link:label id="lab_rdnt_ImagingCentersMember_label_en-US" xlink:label="lab_rdnt_ImagingCentersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Centers [Member]</link:label>
    <link:label id="lab_rdnt_ImagingCentersMember_documentation_en-US" xlink:label="lab_rdnt_ImagingCentersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Centers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember" xlink:href="rdnt-20230331.xsd#rdnt_ImagingCentersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ImagingCentersMember" xlink:to="lab_rdnt_ImagingCentersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfCenters_233acffe-4fba-46ee-b93a-18bd9d405fe9_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of centers</link:label>
    <link:label id="lab_rdnt_NumberOfCenters_label_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers</link:label>
    <link:label id="lab_rdnt_NumberOfCenters_documentation_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters" xlink:href="rdnt-20230331.xsd#rdnt_NumberOfCenters"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfCenters" xlink:to="lab_rdnt_NumberOfCenters" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_a09c5c27-2b22-4e4d-9fad-f036af0b5063_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_0307ca55-62f0-4020-a308-ed5a21f4357f_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_e6839079-724b-4bba-bd03-d83119d88c21_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_64b80750-04fe-4eae-a375-8332a5d99742_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_6a31a27e-ec81-43f7-a52e-2371646c564e_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_3a9cfdbf-f9ba-4ff2-b25e-18826d9ffe4b_terseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of vesting traches</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Vesting Tranches</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Vesting Tranches</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:to="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8cc98772-7c51-4a62-bda4-3cbda454f465_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_da8992f0-d171-4bb0-9665-b94d8dd47720_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_680f9514-d009-4601-9dff-f55c274d7250_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_271f1ba0-a420-498a-9947-a5ca70c7e4cc_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_40186baa-61c3-4097-9344-82206af39f8f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_4567725d-8bc5-461c-b22b-497159fae3d6_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued upon conversion (in shares)</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_fca8bfb4-b33c-443f-a203-9285354164f9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_93db94fd-e365-4de5-8032-54667087fd32_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_dd999064-9047-4b81-a415-7fdb44a3294e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_1f2c6700-788d-4e5a-af17-4d8f8a757ecf_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_332fd61d-2646-490e-9bf0-66ec7eba13d2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price Per Common Share, Exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_1ea093a5-b469-4099-ad5f-dad70c676f33_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE (LOSS) INCOME</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIMember_ed3cb319-8192-4a8e-92c3-3bfed5166366_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I</link:label>
    <link:label id="lab_rdnt_PricingLevelIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIMember" xlink:to="lab_rdnt_PricingLevelIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_dde01f65-be4e-4290-b50e-15122be1f8e4_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MontclairMember_2f9bbeb9-1cb8-481b-b51b-94d787d3bc7c_terseLabel_en-US" xlink:label="lab_rdnt_MontclairMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Montclair</link:label>
    <link:label id="lab_rdnt_MontclairMember_label_en-US" xlink:label="lab_rdnt_MontclairMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Montclair [Member]</link:label>
    <link:label id="lab_rdnt_MontclairMember_documentation_en-US" xlink:label="lab_rdnt_MontclairMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Montclair</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember" xlink:href="rdnt-20230331.xsd#rdnt_MontclairMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MontclairMember" xlink:to="lab_rdnt_MontclairMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fae911f6-058c-4fd1-b6f2-75511c8f1201_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_ca85d2b8-3268-4db4-a140-66e1762ef502_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_28417cc8-e7b4-4f8f-95d4-a249c4102eae_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of joint ventures, net of dividends</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Net of Dividends or Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_05a0958b-95a5-409f-9678-0ae61c24c7f4_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b22e8be2-f832-4c72-a632-3a72fb98e0ce_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_81ecd6f8-923c-48c1-bdff-5ed90cf8a559_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_bf31e74d-62a5-4574-a407-e10db8979cad_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEFERRED FINANCING COSTS</link:label>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:to="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_37c9b146-65ef-41c8-925a-d7084b560dc0_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense (income)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_de5d5a32-e23a-48c3-97a9-f6bfaa21f823_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienTermLoanMember_3e79ccfa-a7e2-4cf5-859c-c67996ea8934_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Term Loan</link:label>
    <link:label id="lab_rdnt_FirstLienTermLoanMember_label_en-US" xlink:label="lab_rdnt_FirstLienTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienTermLoanMember" xlink:to="lab_rdnt_FirstLienTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_48f05820-cde0-41f4-b73e-09b9f7d5398d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ManagementServiceFees_a5293e38-4045-4ef0-844f-1b8ec3aa9ade_terseLabel_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees</link:label>
    <link:label id="lab_rdnt_ManagementServiceFees_label_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Service Fees</link:label>
    <link:label id="lab_rdnt_ManagementServiceFees_documentation_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees" xlink:href="rdnt-20230331.xsd#rdnt_ManagementServiceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ManagementServiceFees" xlink:to="lab_rdnt_ManagementServiceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_aa32c2ce-1e48-46b4-8842-76b4cb47701b_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENT ACCOUNTING AND REPORTING STANDARD</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_add20ec9-6822-433f-b8df-8531bbf02da4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6b7e53f0-e4c0-445c-825a-5a3bf14faaf4_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation of Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_500a152d-32d2-4ff3-b2d5-1cdc4b9df2cd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_d8f920eb-ff4b-423e-b821-af125f223b46_negatedTerseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of Use Liabilities</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_811fe80c-eb14-4608-b985-51ffb680bc62_terseLabel_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unconsolidated joint ventures</link:label>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_label_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Unconsolidated Joint Ventures</link:label>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_documentation_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Unconsolidated Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures" xlink:href="rdnt-20230331.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberofUnconsolidatedJointVentures" xlink:to="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4fbc63fd-b004-46c2-91bc-641042e2729e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ImagingCenterSegmentRevenueMember_d50fa1c9-4b59-4aa4-868d-96444fd6ed20_terseLabel_en-US" xlink:label="lab_rdnt_ImagingCenterSegmentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Center Segment Revenue</link:label>
    <link:label id="lab_rdnt_ImagingCenterSegmentRevenueMember_label_en-US" xlink:label="lab_rdnt_ImagingCenterSegmentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Center Segment Revenue [Member]</link:label>
    <link:label id="lab_rdnt_ImagingCenterSegmentRevenueMember_documentation_en-US" xlink:label="lab_rdnt_ImagingCenterSegmentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Center Segment Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCenterSegmentRevenueMember" xlink:href="rdnt-20230331.xsd#rdnt_ImagingCenterSegmentRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember" xlink:to="lab_rdnt_ImagingCenterSegmentRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_3da08d68-4d78-47a7-befe-0c69e6c8e71e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_7cee2081-b786-4b24-a05e-6f3059080451_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b57f4616-93e3-4865-8f95-cbefe6a806a3_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6823f54d-c966-4222-9b93-57c6bf97fdf2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_29239a31-49b7-43bc-a6c7-79cff83f5fcd_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME (LOSS) FROM OPERATIONS</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1bf53b8d-eeee-43f4-add7-c6b6e7c9d4a7_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENT ACCOUNTING AND REPORTING STANDARDS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_779d27d4-cc1c-458c-80f3-8cfd23ea53e1_negatedTerseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or Canceled (in shares)</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited Or Cancelled In Period</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited Or Cancelled In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:to="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_48f86b42-91f4-4479-9e43-681fceedbd5a_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of identified milestones</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Number Of Identified Milestones</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Number Of Identified Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RepaymentOfAdvanceMedicarePayments_3fbbb901-1d6e-4c36-87b4-d70a0a91b5e5_terseLabel_en-US" xlink:label="lab_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of advance medicare payments</link:label>
    <link:label id="lab_rdnt_RepaymentOfAdvanceMedicarePayments_label_en-US" xlink:label="lab_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment Of Advance Medicare Payments</link:label>
    <link:label id="lab_rdnt_RepaymentOfAdvanceMedicarePayments_documentation_en-US" xlink:label="lab_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment Of Advance Medicare Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:href="rdnt-20230331.xsd#rdnt_RepaymentOfAdvanceMedicarePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:to="lab_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements_18b1e50c-04d6-4523-8681-dd6e65276be8_terseLabel_en-US" xlink:label="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment acquired and leasehold improvements</link:label>
    <link:label id="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements_label_en-US" xlink:label="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Acquired and Leasehold Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:href="rdnt-20230331.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:to="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LongTermIncentivePlanSharesMember_8f39f01b-465f-4735-bf66-cef1ead40089_terseLabel_en-US" xlink:label="lab_rdnt_LongTermIncentivePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Incentive Plan Shares</link:label>
    <link:label id="lab_rdnt_LongTermIncentivePlanSharesMember_label_en-US" xlink:label="lab_rdnt_LongTermIncentivePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Incentive Plan Shares [Member]</link:label>
    <link:label id="lab_rdnt_LongTermIncentivePlanSharesMember_documentation_en-US" xlink:label="lab_rdnt_LongTermIncentivePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Incentive Plan Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember" xlink:href="rdnt-20230331.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LongTermIncentivePlanSharesMember" xlink:to="lab_rdnt_LongTermIncentivePlanSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_80f9ab08-c516-4199-a2d8-7f72dc951b61_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_74e861b1-6ab5-48bb-8c56-07457b7f93f1_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_b705b5cd-57cb-4af0-8c0d-5c7c270e9b8c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_5108ea27-9e19-42ae-ac65-f1b34d0e5949_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in joint ventures</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_d20991dc-500d-4eca-a091-82a31e5b441f_periodStartLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_6a1f3d14-6a81-48c6-8987-3948765aea84_periodEndLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_a1807577-5839-45bc-83c0-c14d8f925cc0_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_0500ca64-0dfc-48e7-9e51-26aa6de3cab9_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_6fe1aa3b-e031-49fe-b6d7-1b1fb8e30e66_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_c6eb93a8-aa00-46a2-9e85-a41446bb776d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d6035f60-ce3b-4a76-8192-aced9c95ca57_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BarclaysMember_8cdb09d1-7dc9-431a-ba82-b482264e01dc_terseLabel_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays</link:label>
    <link:label id="lab_rdnt_BarclaysMember_label_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays [Member]</link:label>
    <link:label id="lab_rdnt_BarclaysMember_documentation_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember" xlink:href="rdnt-20230331.xsd#rdnt_BarclaysMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BarclaysMember" xlink:to="lab_rdnt_BarclaysMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_eecffceb-9b0a-496c-83bc-6ee1d820b9b9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvesteeMember" xlink:to="lab_us-gaap_EquityMethodInvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_780b846f-48e9-4a9d-a954-b1da9a8c67aa_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_fb41a8eb-f796-454d-b4ea-37e1d0835978_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_8f3f2dad-fa71-4b32-bc2a-b5bc9c60596a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_99f4b3f0-98ba-4050-aff6-256e023eba2d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_0e466047-d2ae-4748-8f15-6dc334cf7050_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_7394a028-ab64-41ff-b862-112177e9e35a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4f3ab783-85ce-4dbd-abcd-67a994df9109_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_bc0db4a6-e19e-4799-be9d-226f4320ddf1_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e3019bdf-0e41-404a-be4e-f57fed82753d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_b11bd937-b291-4349-bd3a-14f8767636cd_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_63cbfc76-2dce-4e7c-804b-2803dd8b0065_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7b5b252b-c2de-40db-8108-843350c360f1_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_72883ce7-a9cf-49b4-a1e7-b01087af7fbf_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares used in calculating diluted net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableCurrent_b8305762-047e-4a95-9693-2bb3bec109c7_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_c653b1ed-109a-4247-97c9-b529eec878bc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_805490e3-97c4-4f79-b625-a2e7525048f9_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternate Base Rate Spread</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_f9541e0e-9518-400d-9b75-069644834eb4_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssets_37f94024-6de6-459a-8ded-c1e21075c988_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits and other</link:label>
    <link:label id="lab_us-gaap_DepositsAssets_label_en-US" xlink:label="lab_us-gaap_DepositsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssets" xlink:to="lab_us-gaap_DepositsAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_f28fa4a4-14d0-420d-88da-637881c16586_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - $0.0001 par value, 200,000,000 shares authorized; 58,270,290 and 57,723,125 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities_5506e135-bca2-40a3-a241-0a451f1758c2_terseLabel_en-US" xlink:label="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of securities without readily determinable fair value</link:label>
    <link:label id="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities_label_en-US" xlink:label="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Securities</link:label>
    <link:label id="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities_documentation_en-US" xlink:label="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" xlink:href="rdnt-20230331.xsd#rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" xlink:to="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeepHealthIncMember_f89547a4-ed7f-4bbb-8674-29d4cb0128f0_terseLabel_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth Inc.</link:label>
    <link:label id="lab_rdnt_DeepHealthIncMember_label_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deep Health Inc [Member]</link:label>
    <link:label id="lab_rdnt_DeepHealthIncMember_documentation_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deep Health, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember" xlink:href="rdnt-20230331.xsd#rdnt_DeepHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeepHealthIncMember" xlink:to="lab_rdnt_DeepHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_b25724ee-ba92-43ad-9225-195121a0fed3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContingentMilestoneConsiderationMember_04fe3cd7-9d6c-4070-ab7f-803108bcb1d8_terseLabel_en-US" xlink:label="lab_rdnt_ContingentMilestoneConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Milestone Consideration</link:label>
    <link:label id="lab_rdnt_ContingentMilestoneConsiderationMember_label_en-US" xlink:label="lab_rdnt_ContingentMilestoneConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Milestone Consideration [Member]</link:label>
    <link:label id="lab_rdnt_ContingentMilestoneConsiderationMember_documentation_en-US" xlink:label="lab_rdnt_ContingentMilestoneConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Milestone Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentMilestoneConsiderationMember" xlink:href="rdnt-20230331.xsd#rdnt_ContingentMilestoneConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContingentMilestoneConsiderationMember" xlink:to="lab_rdnt_ContingentMilestoneConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_73bfe4a4-fd8d-404c-bf9a-b4a08a6ee5ce_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_ab987172-b4d9-4d5d-ad44-488858e96a5c_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio, greater than</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_label_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:to="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7a410de6-0127-4298-bf9a-84968e7cefb3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditDerivativesContractTypeDomain_28fdd45c-fcf9-466d-ac42-0d2bd44043ff_terseLabel_en-US" xlink:label="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditDerivativesContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain" xlink:to="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_46d72cc9-47a1-427f-be4b-1cde1f53d173_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_efb54d1a-2e81-4d57-afc4-112e7ac4214f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Derivative Instruments on Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_dd662731-c666-4122-8598-fde373083339_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash change in fair value of interest rate hedge</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value of Hedged Item in Interest Rate Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:to="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_48ef516b-b3b5-46bb-b5f1-0765c4cc0815_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate value exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain_eebb0a1f-e197-4cdd-b320-2469e77d0d82_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain_label_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_451ae8cf-14e6-4692-8d37-30e76c954369_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e23d9f8d-51bb-4172-9211-20698dc7dee9_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4977055a-6665-484e-8ea2-3a091605afcf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Medicare1Member_2f90b298-62f3-41b1-92e4-5480f312fe05_terseLabel_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_rdnt_Medicare1Member_label_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare1 [Member]</link:label>
    <link:label id="lab_rdnt_Medicare1Member_documentation_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member" xlink:href="rdnt-20230331.xsd#rdnt_Medicare1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Medicare1Member" xlink:to="lab_rdnt_Medicare1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e3280639-fe32-4ccc-a5d0-6c609846ff78_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_60abe3a3-d5da-4ec7-b0af-98c8d5f09ce4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_f50f2449-ad11-4266-a033-cc9c4ed23692_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment in Joint Ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_8ef7d3b4-bc7b-4371-810d-f50d1a678947_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_2bc8c03f-2af7-4091-be3b-6864b5f3c497_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book value of RadNet joint venture interests</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_4d5401fe-20f0-45af-8721-010e76492d4b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementMember_b2cbce77-a0b7-4e2c-95d9-ecee6fee73ae_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementMember" xlink:to="lab_rdnt_FirstLienCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_07b4ed3e-63f1-4665-a903-700926d658a1_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Radnet, Inc.'s Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_482455e1-2ebb-4abd-9734-70f8fc43cb43_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_c3c188c0-8053-41d7-9d6f-5c1fb8db9772_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_22ecc7a8-2113-4851-886c-ab483fa249c1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_ffed21c8-fd87-4c72-ac3a-ec9d0408080a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:to="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_04644688-438c-443f-943b-b21b99862235_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_30e54e1e-dd0c-4ff4-864a-4e74ad6c10fb_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_5cf410fb-55bb-4614-909f-fd42f2171baa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument face value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioOneMember_fd84b05c-20fe-46c7-bb9c-9b8e35ef5c7a_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&gt; 3.50x</link:label>
    <link:label id="lab_rdnt_LeverageRatioOneMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio One [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioOneMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioOneMember" xlink:to="lab_rdnt_LeverageRatioOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_0bb8abea-a6df-46ca-898f-2fea579174df_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average amortization period remaining in years</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_42e1d50e-c32e-492f-8de1-657b9d170dd7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTMENTS IN JOINT VENTURES</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_c6a8e8fe-193e-4c17-b5dc-157fb38466c4_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_ff895590-7225-41dd-a047-1678b345df92_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill from acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_aab15b95-4aaf-45a5-9510-abecdd3f7724_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock upon exercise of options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_d3e7fdc4-1b72-4d7b-bbf5-f3d9c12965a9_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment, percent</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_label_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Percent</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:to="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_1b21cd28-c857-4c10-a725-bcf37a3a37a9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_d80189fd-43a2-4734-8e09-923e5c4af64d_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Current</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_1567f025-effe-4d67-96f0-31b5a102a395_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1603cdf2-b7ce-405e-84fe-da6c2d767d21_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable Shares at the end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_COVID19PandemicMember_0e96c7a6-89a3-4a05-afd5-59d0b427900d_terseLabel_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic</link:label>
    <link:label id="lab_rdnt_COVID19PandemicMember_label_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic [Member]</link:label>
    <link:label id="lab_rdnt_COVID19PandemicMember_documentation_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember" xlink:href="rdnt-20230331.xsd#rdnt_COVID19PandemicMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_COVID19PandemicMember" xlink:to="lab_rdnt_COVID19PandemicMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SouthernCaliforniaDiagnosticImagingIncMember_a297e9da-0c32-4bf6-8ba5-bf38b734628e_terseLabel_en-US" xlink:label="lab_rdnt_SouthernCaliforniaDiagnosticImagingIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Southern California Diagnostic Imaging, Inc.</link:label>
    <link:label id="lab_rdnt_SouthernCaliforniaDiagnosticImagingIncMember_label_en-US" xlink:label="lab_rdnt_SouthernCaliforniaDiagnosticImagingIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Southern California Diagnostic Imaging, Inc. [Member]</link:label>
    <link:label id="lab_rdnt_SouthernCaliforniaDiagnosticImagingIncMember_documentation_en-US" xlink:label="lab_rdnt_SouthernCaliforniaDiagnosticImagingIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Southern California Diagnostic Imaging, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SouthernCaliforniaDiagnosticImagingIncMember" xlink:href="rdnt-20230331.xsd#rdnt_SouthernCaliforniaDiagnosticImagingIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SouthernCaliforniaDiagnosticImagingIncMember" xlink:to="lab_rdnt_SouthernCaliforniaDiagnosticImagingIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_d37c841d-61df-4a73-8b40-e0410466a2ee_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_ac568b75-31bc-48a7-8ee0-9930548b56b4_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_5b27c83a-c623-4144-b251-6371d5bc6cda_netLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and Amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_05f77aff-136b-428b-b88c-90db10b5ee1e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused capacity, commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PerformanceBasedStockUnitsMember_5888a182-df59-4f19-8c76-db4d9126cdbf_terseLabel_en-US" xlink:label="lab_rdnt_PerformanceBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Units ("PSUs")</link:label>
    <link:label id="lab_rdnt_PerformanceBasedStockUnitsMember_label_en-US" xlink:label="lab_rdnt_PerformanceBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Units [Member]</link:label>
    <link:label id="lab_rdnt_PerformanceBasedStockUnitsMember_documentation_en-US" xlink:label="lab_rdnt_PerformanceBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockUnitsMember" xlink:href="rdnt-20230331.xsd#rdnt_PerformanceBasedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PerformanceBasedStockUnitsMember" xlink:to="lab_rdnt_PerformanceBasedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_05b6d55d-e559-44cd-a3d0-5eca5a700946_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_257fb70e-3084-4d27-801e-a40f59e15c28_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net, Including and Excluding Capital Leased Asset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_3da31554-b890-46ab-9b92-990ace1cd479_terseLabel_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' compensation/personal injury</link:label>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_label_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation/Personal Injury1 [Member]</link:label>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_documentation_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation/Personal Injury1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member" xlink:href="rdnt-20230331.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WorkersCompensationPersonalInjury1Member" xlink:to="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_f8e788b5-4498-495b-a033-da84f8b124f7_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_37804fcf-1e2e-4722-8709-7b281769c567_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional number of shares issued (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:href="rdnt-20230331.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_94e68d5d-74b2-4648-a7a4-5f7339dcbf8b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e1774e53-c974-4451-8308-d8a4413eacce_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b9c6c83e-fc28-4377-ab6a-6b0ae23c430d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_2077a713-afde-408d-bf9f-50088324c0ed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_98887d55-78bf-4ada-a7d0-85c99bc2d50d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSAs</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_776966a9-6038-49f7-b53a-6572ff970d03_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LTIPs</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2faf2260-15c4-455b-844c-c79ec956cb5b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EFFECT OF EXCHANGE RATE CHANGES ON CASH</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_2a38068f-70d3-4150-8653-4f97247a35fe_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_c1edd55f-338f-4920-af11-ac0826e90fe3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Annual Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_0b0a63a4-952c-4d83-8b29-8436933cd12a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_da1a7ea9-4ecc-4b96-9b65-3c00c599397c_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_c2fdf4b5-5177-4560-ab32-d17eb711cb27_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issuable upon the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_19c69ab5-8507-4924-9fdb-6f9563e4c51b_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issuable Upon the Exercise of Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_029e188e-1044-4624-a4a7-df4a28991cef_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_4fcd5143-6aac-4477-abb5-3b1be7ab8b73_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_2ce98c0f-c7e5-4df3-a26f-4a7514e08ae1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of outcomes (upto)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2025Member_c70ed182-8b63-4d1c-bfe2-38ff3fa397f9_terseLabel_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025</link:label>
    <link:label id="lab_rdnt_October2025Member_label_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025 [Member]</link:label>
    <link:label id="lab_rdnt_October2025Member_documentation_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member" xlink:href="rdnt-20230331.xsd#rdnt_October2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2025Member" xlink:to="lab_rdnt_October2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_507d0063-35a2-4843-8998-ed20e655d8de_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_dfaadc9f-d725-4273-aa5e-310318a18cbd_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_35cc531c-d183-49b8-a33b-0b8cac44b938_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expenses</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_ab2bbc66-1ba5-4573-b3dc-64fc11542b92_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_ea7e9f31-4c6d-4215-8359-730a86c2199e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ba39a574-9e63-4f7f-8560-2dc46e8545b8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_79cac8f8-8811-4d2d-a7d9-02ffb5b01bf9_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_af352f1c-9992-4577-8dd1-cf9c57a038ef_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_21187c5a-0871-432e-9380-d50a6ee6a537_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_7eef2fb3-372e-4d66-914a-3ae6cc82c2b0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER ASSETS</link:label>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsAbstract" xlink:to="lab_us-gaap_OtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_0f7a0b6e-0161-4701-ad1c-5beee7993f1d_terseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plans</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:to="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_775bb48b-97b3-47da-914a-75e9c0ca3611_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_4690372b-373c-4117-8ac0-76d4a03195a6_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_679bb961-9d0e-42a6-93e3-d46828bd78c3_verboseLabel_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service fee revenue</link:label>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_label_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCarePatientServiceMember" xlink:to="lab_us-gaap_HealthCarePatientServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_b68776b4-853d-4b60-ab76-eb9dff9c1c1b_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_f366106b-b241-4657-ad23-8f9ca4e621e6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicVisionMember_ce1b28de-a079-46ad-a166-2d2760236a32_terseLabel_en-US" xlink:label="lab_rdnt_MedicVisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medic Vision</link:label>
    <link:label id="lab_rdnt_MedicVisionMember_label_en-US" xlink:label="lab_rdnt_MedicVisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medic Vision [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember" xlink:href="rdnt-20230331.xsd#rdnt_MedicVisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicVisionMember" xlink:to="lab_rdnt_MedicVisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_e87cbc2d-10e8-449a-9f6b-953fdb8e4520_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_5df27845-d348-46fa-9c25-fbb8ca46eb1a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_b47a9e39-a21d-4066-81d1-5a586c05f9d2_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_efb5a948-25da-4e7e-97ae-b6478f064a01_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_56a1a331-4cf4-4f7e-bbc9-d10207acdf99_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_f2df806a-9bf4-4995-b122-5fca0bc01abb_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_d41234ff-4694-4d40-9df5-1fd9a88c247c_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortiztion total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_d00b7bb3-07d2-4a21-b960-29375f7bbe3d_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_ca79aefc-9864-4ae9-a71c-d2bc6c553d55_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_2c3c201c-dcb7-4fe2-9f13-3e5aec5929b1_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of Use Assets</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_99caeaf0-1911-4c68-b42e-24320e2a2f11_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_16274a42-2a9d-4409-aa7e-924b2065b46a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_cbe12113-2cac-4e9e-969b-368d95362e6c_terseLabel_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fee revenue</link:label>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_label_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Management Service [Member]</link:label>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_documentation_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Management Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember" xlink:href="rdnt-20230331.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HealthCareManagementServiceMember" xlink:to="lab_rdnt_HealthCareManagementServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_aeb96f9a-b2f6-4e9f-9d5b-1de03f2e1b44_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate value outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_14dfefd1-8900-4551-babc-e8f4a21b1875_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_07e387c3-fd18-40e5-8262-5962bac74bb9_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_44d9df09-0337-45b9-b091-db83fb355c83_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_ba23e4ca-a973-4b13-a43d-7ad829066c94_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_f9efb118-0dbb-4a2b-b419-98fbc14325c3_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_78101d4e-53c0-4b3a-9330-3c1caf3f92d2_totalLabel_en-US" xlink:label="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, equipment and right-of-use assets</link:label>
    <link:label id="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_label_en-US" xlink:label="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Plant and Equipment Net Including Right of Use Assets</link:label>
    <link:label id="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_documentation_en-US" xlink:label="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Plant and Equipment Net Including Right of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:href="rdnt-20230331.xsd#rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:to="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_948c9ccf-51cd-4759-afd3-920afe871a7f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a5389f5d-0db5-43b4-8771-3f344485edad_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under the equity compensation plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_91eeba6d-f9a6-46d8-bd97-2768d5376e35_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT REPORTING</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_7c80f9d5-235e-45e6-821a-421a9524ae3f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_e232f02e-23b9-4359-868d-7f3cf403d274_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_faa8017b-8119-4132-8ba4-a06beb1147de_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss recognized in income on derivative (current period ineffective portion)</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_34d29594-43e5-4249-8aad-170919a82e03_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year two</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_489346c7-979a-43ce-95b8-3813a1601659_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_eb10a901-2ff1-49d6-965e-4503765f8d2c_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_652a0f67-5976-40c6-948a-a2c4c14a714c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_ee237e15-8b7a-4b8b-8370-517f1a92d071_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee or Group of Investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_8f4b83d2-84e8-4e2e-96a9-152e4c1367cc_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale and disposal of equipment and other</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_8bdab63c-d66e-42e4-b0f8-a07643662596_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale and disposal of equipment and other</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_dcad5296-e7bb-4053-b784-96f5809ebd7f_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount on First Lien Term Loans</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_fe36e2a7-c2fb-49d5-9464-945b9084429f_terseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of options</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:to="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_835dadf1-a335-4fd0-9ce1-f7fb096fc219_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsTable" xlink:to="lab_us-gaap_OffsettingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_11186638-fa7b-4308-962d-09c9d8d12692_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares purchased (in shares)</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Shares Purchased</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Shares Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased" xlink:href="rdnt-20230331.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentSharesPurchased" xlink:to="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_26e6a6b8-6785-4a0d-8d36-74c9b459433b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested restricted stock subject only to service vesting (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_f64112c5-b2fd-4dce-83bc-5d199d083dd0_terseLabel_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other patient revenue</link:label>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_label_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service Other [Member]</link:label>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_documentation_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember" xlink:href="rdnt-20230331.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HealthCarePatientServiceOtherMember" xlink:to="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_4f3d644d-2a1e-418c-b2fa-d05be41307c8_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RestatedPlanMember_03d1c1be-332d-42f5-9dae-c3df34795533_terseLabel_en-US" xlink:label="lab_rdnt_RestatedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Plan</link:label>
    <link:label id="lab_rdnt_RestatedPlanMember_label_en-US" xlink:label="lab_rdnt_RestatedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember" xlink:href="rdnt-20230331.xsd#rdnt_RestatedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RestatedPlanMember" xlink:to="lab_rdnt_RestatedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3e73f427-fbbf-4f85-83e7-c145ac8075f8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cbe1427e-2ce8-402c-9c0e-e42d64a8d47b_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding during the period (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WhiteRabbit.aiInc.Member_91b09a18-e933-4c76-a357-45a025ee7d99_terseLabel_en-US" xlink:label="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc.</link:label>
    <link:label id="lab_rdnt_WhiteRabbit.aiInc.Member_label_en-US" xlink:label="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc. [Member]</link:label>
    <link:label id="lab_rdnt_WhiteRabbit.aiInc.Member_documentation_en-US" xlink:label="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbit.aiInc.Member" xlink:href="rdnt-20230331.xsd#rdnt_WhiteRabbit.aiInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WhiteRabbit.aiInc.Member" xlink:to="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentLeverageRatio_b5044b00-89c5-4eea-8560-4d6cff6ec8d6_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio</link:label>
    <link:label id="lab_rdnt_DebtInstrumentLeverageRatio_label_en-US" xlink:label="lab_rdnt_DebtInstrumentLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Leverage Ratio</link:label>
    <link:label id="lab_rdnt_DebtInstrumentLeverageRatio_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentLeverageRatio" xlink:to="lab_rdnt_DebtInstrumentLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_5a1e2c84-95d4-416b-ac43-89a050fc8af7_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio, less than</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_label_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:to="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_f8735b61-eba4-4e5f-bc07-68dbf4885ba4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_018e89d4-a6d3-40dc-9c76-ee19ecdb07e8_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_669f7a65-bc90-448e-8d61-eb8d52bf6325_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3ffa0b0c-3f16-4123-a9ec-febb3e62e72d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b28246a6-98b7-4178-8772-2933949127b5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_ba4afcef-fdd7-4a63-b7b8-ec25fc531d4e_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6640c9a8-d241-489d-986b-0b70dc097095_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_f24ae97d-2644-4fc4-9fb3-cce6ec0a4d9a_negatedNetLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredCharges_80a5fddb-cc00-4831-a475-d5dbd18b3292_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredCharges" xlink:to="lab_us-gaap_AmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_1e74a6e8-fa5c-47b4-8242-7c7466e1d144_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_27b9b8a8-0571-4656-b6cc-0a9279768dfd_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested restricted stock subject to service vesting</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_38413086-acba-481c-bbdc-0285c3165df8_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_ca0316f0-0b0a-4c8a-b64a-8c531a582738_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_45ea76dc-badd-4078-a93e-d2cff4d066db_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups revenues</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_b6e9f843-3459-47c7-93cb-e8a27353257a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Term Loan Debt Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_97baf123-47a9-4fcf-ad92-add366d3319d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ManagementServiceContractsMember_5a8acaaf-dfa5-444d-a189-52a127aa5378_terseLabel_en-US" xlink:label="lab_rdnt_ManagementServiceContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Service Contracts</link:label>
    <link:label id="lab_rdnt_ManagementServiceContractsMember_label_en-US" xlink:label="lab_rdnt_ManagementServiceContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Service Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember" xlink:href="rdnt-20230331.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ManagementServiceContractsMember" xlink:to="lab_rdnt_ManagementServiceContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e716d4d0-6570-4ea1-848b-84f534fc4897_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total service revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5b2346a0-67f3-4ac0-a94b-34a62645be20_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_1d3b345c-254e-403e-aab2-5767ec9d51c7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-TERM LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_da63d55d-7a0c-4019-aa0c-a27d61d36174_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_ab31f41c-b03f-42eb-ba78-f7c38200714b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DignityHealthMember_4e6bd75e-a299-4d66-8818-9088ec97d810_terseLabel_en-US" xlink:label="lab_rdnt_DignityHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health</link:label>
    <link:label id="lab_rdnt_DignityHealthMember_label_en-US" xlink:label="lab_rdnt_DignityHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember" xlink:href="rdnt-20230331.xsd#rdnt_DignityHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DignityHealthMember" xlink:to="lab_rdnt_DignityHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_0269c395-e66f-4656-ac54-0703e0b27edc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_f9ab1f76-e3a0-4755-8d58-7b43be119194_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_7b844d9a-def4-47c7-8be3-28754a401e72_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_20de2762-e83a-4589-b78e-2ab07b25ed67_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_2d06e763-d155-4846-88b1-d6237f5c10f9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_09b88abf-e554-49c8-8089-e6d376cc018f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_009b05fc-fad9-4211-8589-c441aeed5add_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_dbf99acb-f78a-4f7a-b984-d9badef01558_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_352737a8-bdec-4833-948c-7a1b6d7ea031_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenseMember_e1693786-a803-4c59-ace8-4cd719fa1e5d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense</link:label>
    <link:label id="lab_us-gaap_OperatingExpenseMember_label_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenseMember" xlink:to="lab_us-gaap_OperatingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EurodollarMember_ac4743a9-6099-415f-8ea3-9b7eb2f195cd_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term SOFR Loans</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_label_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember" xlink:to="lab_us-gaap_EurodollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AidenceMember_a52bc27a-6998-4371-8561-b654c032697e_terseLabel_en-US" xlink:label="lab_rdnt_AidenceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence</link:label>
    <link:label id="lab_rdnt_AidenceMember_label_en-US" xlink:label="lab_rdnt_AidenceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence [Member]</link:label>
    <link:label id="lab_rdnt_AidenceMember_documentation_en-US" xlink:label="lab_rdnt_AidenceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember" xlink:href="rdnt-20230331.xsd#rdnt_AidenceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AidenceMember" xlink:to="lab_rdnt_AidenceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_7d67b446-67f6-45c6-8d4e-530aaf995f56_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred financing costs and loan discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_d10d76f7-5db3-4725-95db-f6b161facbe8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ArtificialIntelligenceMember_0247dd75-4065-49a4-8f11-562fc11a9b18_terseLabel_en-US" xlink:label="lab_rdnt_ArtificialIntelligenceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Artificial Intelligence</link:label>
    <link:label id="lab_rdnt_ArtificialIntelligenceMember_label_en-US" xlink:label="lab_rdnt_ArtificialIntelligenceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Artificial Intelligence [Member]</link:label>
    <link:label id="lab_rdnt_ArtificialIntelligenceMember_documentation_en-US" xlink:label="lab_rdnt_ArtificialIntelligenceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Artificial Intelligence</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArtificialIntelligenceMember" xlink:href="rdnt-20230331.xsd#rdnt_ArtificialIntelligenceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ArtificialIntelligenceMember" xlink:to="lab_rdnt_ArtificialIntelligenceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_59d1987d-0034-4de2-aaa6-344999928e53_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_6dedf2f9-b021-464d-8a6b-eae43d9675a5_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_86f10eca-fc04-4719-94e2-e23bdce61af7_terseLabel_en-US" xlink:label="lab_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month SOFR</link:label>
    <link:label id="lab_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember" xlink:href="rdnt-20230331.xsd#rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember" xlink:to="lab_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f2bfe3d2-4d45-4d6f-9a89-5a9b41b48f4a_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContingentSharesMember_5eec9a38-888f-4ced-81b8-ccd494673985_terseLabel_en-US" xlink:label="lab_rdnt_ContingentSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingently issuable shares</link:label>
    <link:label id="lab_rdnt_ContingentSharesMember_label_en-US" xlink:label="lab_rdnt_ContingentSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Shares [Member]</link:label>
    <link:label id="lab_rdnt_ContingentSharesMember_documentation_en-US" xlink:label="lab_rdnt_ContingentSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentSharesMember" xlink:href="rdnt-20230331.xsd#rdnt_ContingentSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContingentSharesMember" xlink:to="lab_rdnt_ContingentSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_d3c47c59-2263-4c30-bab6-809a0975f352_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_d8debd7c-2c35-4526-b824-9d077a135e62_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups operating expenses</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_c0fb01a6-6b94-4c7b-842b-b9a9b5bd4b46_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_67e14df3-b1e2-4197-93a1-80f9c9f778ee_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5dacede4-5f1e-44cb-bf11-24252c2e3246_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_89e57ae6-2c3e-431c-9f98-1da5dc4a5d6b_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_2a1c3ca7-b328-4fcc-8c30-bc3a1cc4ec85_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_652bd0db-3a8c-439c-b99e-89af840abcaf_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIVMember_5e35c35f-16e0-48da-99b2-06873366794c_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV</link:label>
    <link:label id="lab_rdnt_PricingLevelIVMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIVMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelIVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIVMember" xlink:to="lab_rdnt_PricingLevelIVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d63dc05b-1d9f-4da2-87df-ba2c59d775ed_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_994e5dc5-8bb3-461d-bb5d-1a3f68ac9826_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment award, award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_868932ed-32e5-43fe-b2ba-df2f7e31a648_negatedNetLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Disposal of Equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_047ba928-171a-4d4b-bc4e-e6eac4581a70_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_5ca70efc-2c64-45a3-9b07-1edea8be0970_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_3ae2f16b-64d9-49b0-a249-1e91d443bd73_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProperyAndEquipmentNetMember_afc45306-222f-46bd-a065-fa0a68d1c6c0_terseLabel_en-US" xlink:label="lab_rdnt_ProperyAndEquipmentNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Returned to Property and Equipment</link:label>
    <link:label id="lab_rdnt_ProperyAndEquipmentNetMember_label_en-US" xlink:label="lab_rdnt_ProperyAndEquipmentNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Propery and Equipment, Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProperyAndEquipmentNetMember" xlink:href="rdnt-20230331.xsd#rdnt_ProperyAndEquipmentNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProperyAndEquipmentNetMember" xlink:to="lab_rdnt_ProperyAndEquipmentNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_f7b0ff30-f040-4641-a7f5-e01bd5041cda_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_10ad3b06-dd42-465e-a3a7-a1914fa20939_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_InglewoodImagingCenterLLCMember_5a107a28-19dc-4db6-8f00-c4129b89e94d_terseLabel_en-US" xlink:label="lab_rdnt_InglewoodImagingCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inglewood Imaging Center, LLC</link:label>
    <link:label id="lab_rdnt_InglewoodImagingCenterLLCMember_label_en-US" xlink:label="lab_rdnt_InglewoodImagingCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inglewood Imaging Center, LLC [Member]</link:label>
    <link:label id="lab_rdnt_InglewoodImagingCenterLLCMember_documentation_en-US" xlink:label="lab_rdnt_InglewoodImagingCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inglewood Imaging Center, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InglewoodImagingCenterLLCMember" xlink:href="rdnt-20230331.xsd#rdnt_InglewoodImagingCenterLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_InglewoodImagingCenterLLCMember" xlink:to="lab_rdnt_InglewoodImagingCenterLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_22b28728-e889-4f3a-997f-096a4e065211_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment award, expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_f071328a-da00-4f35-81d6-a5e314af3cfc_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember_486d0818-f777-4a2a-9e1c-0de7745a89c1_terseLabel_en-US" xlink:label="lab_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Months SOFR</link:label>
    <link:label id="lab_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Months Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Months Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember" xlink:href="rdnt-20230331.xsd#rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember" xlink:to="lab_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_d7da65b3-2920-43e0-84f5-d1a560309c0f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CommercialInsurance1Member_29227e9f-92a3-4154-9daf-2a9e3393c2d8_terseLabel_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial insurance</link:label>
    <link:label id="lab_rdnt_CommercialInsurance1Member_label_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Insurance1 [Member]</link:label>
    <link:label id="lab_rdnt_CommercialInsurance1Member_documentation_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Insurance1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member" xlink:href="rdnt-20230331.xsd#rdnt_CommercialInsurance1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CommercialInsurance1Member" xlink:to="lab_rdnt_CommercialInsurance1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_1b3718b0-29a9-48d9-ad31-9c7278458822_terseLabel_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance medicare payments</link:label>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_label_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Medicare Payments</link:label>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_documentation_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Medicare Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments" xlink:href="rdnt-20230331.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdvanceMedicarePayments" xlink:to="lab_rdnt_AdvanceMedicarePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_a1c6deb1-a0d6-49dd-a2f0-d2c121191590_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_12a1a160-7e28-4112-9c93-947e15759cc4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, remaining borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_0477351e-9a5e-4742-bd01-09da21aa929d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to fund loan to related parties</link:label>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Fund Long-Term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_38335c99-141d-4bbf-bc77-4afc8b96d726_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on notes and leases payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_545205f3-db54-41cf-9f5d-ccd7e69a1359_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names amortized</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_8740ca74-c7ae-4a14-a0cc-a5f0ed09bade_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names indefinite life</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_63c5d961-d8ca-422c-be9b-fdbf6dd67f5e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTMENTS IN EQUITY SECURITIES</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_dc090b08-9950-4d43-8803-38456e5116c1_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted_7727e61a-bd1b-41a3-b0ab-768e3911f567_terseLabel_en-US" xlink:label="lab_rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value change for contingently issuable shares excluded from the computation of diluted per share amounts as its effect would be antidilutive</link:label>
    <link:label id="lab_rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted_label_en-US" xlink:label="lab_rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Change for Contingently Available Shares Excluded From Computation Of Diluted</link:label>
    <link:label id="lab_rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted_documentation_en-US" xlink:label="lab_rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Change for Contingently Available Shares Excluded From Computation Of Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted" xlink:href="rdnt-20230331.xsd#rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted" xlink:to="lab_rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_71cb8d48-dd90-4bea-a017-3042268231e0_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Three</link:label>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Three [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioThreeMember" xlink:to="lab_rdnt_LeverageRatioThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_5cd265eb-9120-4e70-bdbd-b405e9d35ad9_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement, Sixth Amendment</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Sixth Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Sixth Amendment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5675c130-9fad-42b0-8d09-7652b89e4b02_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_fdda2c28-6809-46e7-8d26-7f8fd917dd1e_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ad34d27b-5421-49c9-952e-e2e33764b9f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_1d8844b4-b103-45a7-b677-edf36c3ff832_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Joint Venture Investment and Financial Information</link:label>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Investment And Financial Information [Table Text Block]</link:label>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Investment And Financial Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:href="rdnt-20230331.xsd#rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:to="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_34e1afcd-4ce1-4982-8ae3-277b81a8ee37_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of LTIPs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_0dd001fa-0d23-4f82-be71-d946c9657277_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember_fd29e12b-023b-4fe6-a416-09e821717c6a_terseLabel_en-US" xlink:label="lab_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Months SOFR</link:label>
    <link:label id="lab_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Months Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Months Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember" xlink:href="rdnt-20230331.xsd#rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember" xlink:to="lab_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_017f0eda-e4db-4a14-bfe3-b2918c28c4ef_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reminder of fiscal amortization year</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_64aef12f-33a4-44cc-9a06-1e6f8f55b063_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_2896ef89-4063-4808-87bf-ac6e2693fd7c_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest entity, ownership percentage</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2abe7f01-da8e-4c33-a121-dbf09371b028_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET DECREASE IN CASH AND CASH EQUIVALENTS</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditDerivativesByContractTypeAxis_2e943693-c429-4d0c-8ec0-1f7f95a2adbf_terseLabel_en-US" xlink:label="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditDerivativesByContractTypeAxis_label_en-US" xlink:label="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis" xlink:to="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_f79c949c-af6d-4246-b841-73454f267c46_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promissory Note</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_f4074611-116a-4fab-bd8a-36b76c936b5b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_0439e02e-dbe5-4a71-8a91-b1bb0a0e0915_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_fb5a7f35-0ca1-4e89-8645-d7f79c43fd4a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RamapoRadiologyAssociatesPCMember_ba3ac86a-c12d-4475-9731-98561c279c5e_terseLabel_en-US" xlink:label="lab_rdnt_RamapoRadiologyAssociatesPCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ramapo Radiology Associates, P.C.</link:label>
    <link:label id="lab_rdnt_RamapoRadiologyAssociatesPCMember_label_en-US" xlink:label="lab_rdnt_RamapoRadiologyAssociatesPCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ramapo Radiology Associates, P.C. [Member]</link:label>
    <link:label id="lab_rdnt_RamapoRadiologyAssociatesPCMember_documentation_en-US" xlink:label="lab_rdnt_RamapoRadiologyAssociatesPCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ramapo Radiology Associates, P.C.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RamapoRadiologyAssociatesPCMember" xlink:href="rdnt-20230331.xsd#rdnt_RamapoRadiologyAssociatesPCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RamapoRadiologyAssociatesPCMember" xlink:to="lab_rdnt_RamapoRadiologyAssociatesPCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_097b0675-9883-49b7-90f2-8042badf2974_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_64882b47-aebf-451c-87de-d5bd00907c2a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_181ce218-0476-40b3-9590-389377e93ce5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_636e8bc0-4c0d-422a-b0f7-55639068139c_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelVMember_ef408bd8-3480-44a5-a9ae-02b8523b5848_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V</link:label>
    <link:label id="lab_rdnt_PricingLevelVMember_label_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelVMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelVMember" xlink:to="lab_rdnt_PricingLevelVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_3fbf18a0-d1e4-4396-956c-fb3357c9bb1c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_4eeaefc3-a693-48b9-83ae-bd1d189aa67a_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_b2e04f6f-b172-404a-84e3-61de89ae11a6_terseLabel_en-US" xlink:label="lab_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:label id="lab_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="rdnt-20230331.xsd#rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_4292b837-8b36-45d2-8a68-082b1ecafbed_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_51e0e4ac-4c00-466c-b6f6-9df536baab4e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_e657662f-a876-4ffc-8576-e05a8976b15b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_518b342a-0ac4-4a57-9d4e-7ffdb8f2765f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AidenceHoldingBVMember_54a95c15-a970-4fa6-975f-751217c3b831_terseLabel_en-US" xlink:label="lab_rdnt_AidenceHoldingBVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence</link:label>
    <link:label id="lab_rdnt_AidenceHoldingBVMember_label_en-US" xlink:label="lab_rdnt_AidenceHoldingBVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence Holding B.V. [Member]</link:label>
    <link:label id="lab_rdnt_AidenceHoldingBVMember_documentation_en-US" xlink:label="lab_rdnt_AidenceHoldingBVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence Holding B.V.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVMember" xlink:href="rdnt-20230331.xsd#rdnt_AidenceHoldingBVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AidenceHoldingBVMember" xlink:to="lab_rdnt_AidenceHoldingBVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_341fd422-7299-43f6-9278-eed89b6eabcd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CapitationArrangementsMember_15aa5d30-756d-4358-86ed-66071eb541e0_verboseLabel_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue under capitation arrangements</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_b62e3ca9-6f80-4c92-bf54-0c4eae36693b_terseLabel_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue under capitation arrangements</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_label_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation Arrangements [Member]</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_documentation_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember" xlink:href="rdnt-20230331.xsd#rdnt_CapitationArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CapitationArrangementsMember" xlink:to="lab_rdnt_CapitationArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_686e12a3-75cf-4c0b-b98e-61903eea6485_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_dd514099-fe7e-47e0-b5f2-7844b9f1d26a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in cumulative foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_c9e05a79-38d6-4b57-84d9-046d9d976f59_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ad150e30-f91d-4250-843a-fb31f56c416a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_88dfd385-ed01-484f-8b50-5bc40d47846a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity method investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1a0a5264-33c3-41ac-8147-1ae0176eb7fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_32a47a20-bf94-4a94-aded-71a3d5cf4933_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost in excess of book value of acquired joint venture interests and other</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Underlying Equity in Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:to="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A2019SWAPS1Member_39fdbd3e-2984-4c35-9003-127c24772738_terseLabel_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS-1</link:label>
    <link:label id="lab_rdnt_A2019SWAPS1Member_label_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1 [Member]</link:label>
    <link:label id="lab_rdnt_A2019SWAPS1Member_documentation_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member" xlink:href="rdnt-20230331.xsd#rdnt_A2019SWAPS1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A2019SWAPS1Member" xlink:to="lab_rdnt_A2019SWAPS1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_1ac79158-c9f5-41ca-8a83-aec783e6b499_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_7fadf6d2-3431-4af8-8bcf-4296b373e7c3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_7d6e1cc5-0dc1-4be2-a1ee-83f5c88c83cf_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_ae056762-e93f-4476-946e-944b54dc6b26_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings in these joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_29076d47-c1a8-4c09-a9b6-78ae2913d00b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_79652159-89a2-40a8-81e1-d9772606fa42_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year one</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5eb40806-ebd0-491d-b2f0-f31e86465820_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_fbffe8b7-623c-4b76-a7eb-376416e57af2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_c6a4e419-3510-4449-931c-3e077f3fb22f_totalLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquipmentNotesPayableMember_9b75b4bf-66af-4b55-98c2-4c89242170dc_terseLabel_en-US" xlink:label="lab_rdnt_EquipmentNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment notes payable at 6.0%, due 2028, collateralized by medical equipment</link:label>
    <link:label id="lab_rdnt_EquipmentNotesPayableMember_label_en-US" xlink:label="lab_rdnt_EquipmentNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Notes Payable [Member]</link:label>
    <link:label id="lab_rdnt_EquipmentNotesPayableMember_documentation_en-US" xlink:label="lab_rdnt_EquipmentNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentNotesPayableMember" xlink:href="rdnt-20230331.xsd#rdnt_EquipmentNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquipmentNotesPayableMember" xlink:to="lab_rdnt_EquipmentNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_805a1ad1-65e3-4050-acf9-a1fecff70a13_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NATURE OF BUSINESS AND BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_27282ea5-a2fc-44a0-a54b-d8f564861144_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets (Liabilities), Other</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets (Liabilities), Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>rdnt-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b2271182-007a-4027-b874-402dbe4bcb25,g:1e66911a-3ada-4e5a-b4d0-d568e36a58ce-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.radnet.com/role/CoverPage" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f77b97d5-9056-48b6-98ba-b43c9114b8ab" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_DocumentType_f77b97d5-9056-48b6-98ba-b43c9114b8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_cba3a5f0-99de-425e-a576-a4275fa6d2f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_DocumentQuarterlyReport_cba3a5f0-99de-425e-a576-a4275fa6d2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_451550d2-4cca-44bb-92f9-64db2c7b9b09" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_DocumentPeriodEndDate_451550d2-4cca-44bb-92f9-64db2c7b9b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_8d7e6ff3-0248-49f4-a26d-23f6d314f628" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_DocumentTransitionReport_8d7e6ff3-0248-49f4-a26d-23f6d314f628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_1d1b641e-6686-46ba-acfa-63aa55b85356" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_EntityFileNumber_1d1b641e-6686-46ba-acfa-63aa55b85356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c999cd0d-ade9-44e0-8ea4-874cbeb5bacc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_EntityRegistrantName_c999cd0d-ade9-44e0-8ea4-874cbeb5bacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d795f282-780c-4b94-a655-f254ee3e55f5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d795f282-780c-4b94-a655-f254ee3e55f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_bf9d262b-f3b6-4900-a9eb-864298bd7fd6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_EntityTaxIdentificationNumber_bf9d262b-f3b6-4900-a9eb-864298bd7fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e97b81c7-ed93-415c-8f79-fba9611a89f9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_EntityAddressAddressLine1_e97b81c7-ed93-415c-8f79-fba9611a89f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_cb9a18e4-82a7-4628-b5b5-eb93102f73cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_EntityAddressCityOrTown_cb9a18e4-82a7-4628-b5b5-eb93102f73cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_e7ca9a38-997f-47f9-bc29-2c3d6c17033e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_EntityAddressStateOrProvince_e7ca9a38-997f-47f9-bc29-2c3d6c17033e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4005a277-b8d3-4c4f-9a5d-1bc0906270a3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_EntityAddressPostalZipCode_4005a277-b8d3-4c4f-9a5d-1bc0906270a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b9069a23-af61-4c0c-a97b-633b71fa9189" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_CityAreaCode_b9069a23-af61-4c0c-a97b-633b71fa9189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_d0689b51-d15a-4a0a-b94f-d3d1feca925e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_LocalPhoneNumber_d0689b51-d15a-4a0a-b94f-d3d1feca925e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_07ce2301-2fac-4b19-bada-b3d74bd4b300" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_Security12bTitle_07ce2301-2fac-4b19-bada-b3d74bd4b300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d905a32a-d431-420a-8c29-e96f2a95ca71" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_TradingSymbol_d905a32a-d431-420a-8c29-e96f2a95ca71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_526d5dff-0801-4472-9ba4-30642d083256" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_SecurityExchangeName_526d5dff-0801-4472-9ba4-30642d083256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_6df7bb5b-3462-4f2f-8d06-45911dd95511" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_EntityCurrentReportingStatus_6df7bb5b-3462-4f2f-8d06-45911dd95511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_5d3d3b3b-05de-4273-af9c-5de459a9f779" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_EntityInteractiveDataCurrent_5d3d3b3b-05de-4273-af9c-5de459a9f779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_894a54f2-e7c0-4512-99dd-78c6e6f44277" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_EntityFilerCategory_894a54f2-e7c0-4512-99dd-78c6e6f44277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_b9db2cfc-5052-4820-8852-ba8a65f0bfe9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_EntitySmallBusiness_b9db2cfc-5052-4820-8852-ba8a65f0bfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_df78456b-2ac7-4673-9a70-881053f0abc0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_EntityEmergingGrowthCompany_df78456b-2ac7-4673-9a70-881053f0abc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_94389521-9b21-43d3-aa77-1c4bd91ff60c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_EntityShellCompany_94389521-9b21-43d3-aa77-1c4bd91ff60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_51ec62ec-0dac-46be-bc0a-d03281495878" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_51ec62ec-0dac-46be-bc0a-d03281495878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5a8d7a6d-564f-4fcb-a5c0-893e49ec34cf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_EntityCentralIndexKey_5a8d7a6d-564f-4fcb-a5c0-893e49ec34cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_7a2b651e-1f92-4b60-b33d-2ae7a027e33e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_AmendmentFlag_7a2b651e-1f92-4b60-b33d-2ae7a027e33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_d55f6e94-7fc4-4e7b-acb1-009ca79341a9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_CurrentFiscalYearEndDate_d55f6e94-7fc4-4e7b-acb1-009ca79341a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4c8fb2ba-9144-4514-91fe-6e11145427a4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4c8fb2ba-9144-4514-91fe-6e11145427a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_0e02ec2c-e209-49bc-ad8c-aaf14c95240f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1c29d93d-07a0-4c04-ac98-7e4ee03cd22b" xlink:to="loc_dei_DocumentFiscalYearFocus_0e02ec2c-e209-49bc-ad8c-aaf14c95240f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ef565306-5ed7-41ac-959a-3211ca272971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_3658d1b1-caa6-4d52-893e-3b2233707609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ef565306-5ed7-41ac-959a-3211ca272971" xlink:to="loc_us-gaap_AssetsAbstract_3658d1b1-caa6-4d52-893e-3b2233707609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_87f92c3d-d355-4e81-8e47-72c8d19ba88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3658d1b1-caa6-4d52-893e-3b2233707609" xlink:to="loc_us-gaap_AssetsCurrentAbstract_87f92c3d-d355-4e81-8e47-72c8d19ba88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b66f4d62-76ca-4f14-91dc-baff39ce24a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_87f92c3d-d355-4e81-8e47-72c8d19ba88d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b66f4d62-76ca-4f14-91dc-baff39ce24a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6e4d83d2-7d57-4e0f-8a5e-1035834fd0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_87f92c3d-d355-4e81-8e47-72c8d19ba88d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_6e4d83d2-7d57-4e0f-8a5e-1035834fd0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_bf8e24fc-9d54-45ff-ba72-a1cb0781402c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_87f92c3d-d355-4e81-8e47-72c8d19ba88d" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_bf8e24fc-9d54-45ff-ba72-a1cb0781402c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f3607569-fa2c-4ac0-8d5d-04e77ea70002" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_87f92c3d-d355-4e81-8e47-72c8d19ba88d" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f3607569-fa2c-4ac0-8d5d-04e77ea70002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_71c2b264-ed98-4790-8c5d-6b436b3c700b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_87f92c3d-d355-4e81-8e47-72c8d19ba88d" xlink:to="loc_us-gaap_AssetsCurrent_71c2b264-ed98-4790-8c5d-6b436b3c700b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_028afa9a-38af-4769-81e0-3df0080f8575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3658d1b1-caa6-4d52-893e-3b2233707609" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_028afa9a-38af-4769-81e0-3df0080f8575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e7344286-20c2-433b-b982-67103c36aa88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_028afa9a-38af-4769-81e0-3df0080f8575" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e7344286-20c2-433b-b982-67103c36aa88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_425796c0-c57c-4359-9e22-321b8a4c7365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_028afa9a-38af-4769-81e0-3df0080f8575" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_425796c0-c57c-4359-9e22-321b8a4c7365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_7234e822-6073-4e06-9373-1975ea828437" xlink:href="rdnt-20230331.xsd#rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_028afa9a-38af-4769-81e0-3df0080f8575" xlink:to="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_7234e822-6073-4e06-9373-1975ea828437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_75eafc28-7a6d-42e4-a1a6-dd8989a1f6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3658d1b1-caa6-4d52-893e-3b2233707609" xlink:to="loc_us-gaap_OtherAssetsAbstract_75eafc28-7a6d-42e4-a1a6-dd8989a1f6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cf5a2874-9de1-4142-a21c-c9c7d7422401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_75eafc28-7a6d-42e4-a1a6-dd8989a1f6d1" xlink:to="loc_us-gaap_Goodwill_cf5a2874-9de1-4142-a21c-c9c7d7422401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_fae6dc34-d053-4d11-8629-59390f518f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_75eafc28-7a6d-42e4-a1a6-dd8989a1f6d1" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_fae6dc34-d053-4d11-8629-59390f518f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_8070014d-8f34-4534-855e-ba085a423f57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_75eafc28-7a6d-42e4-a1a6-dd8989a1f6d1" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_8070014d-8f34-4534-855e-ba085a423f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_156be34c-5158-4132-9a5c-d454307671b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_75eafc28-7a6d-42e4-a1a6-dd8989a1f6d1" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_156be34c-5158-4132-9a5c-d454307671b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets_e95ebb03-5062-4e47-be5a-c0f7b15012b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_75eafc28-7a6d-42e4-a1a6-dd8989a1f6d1" xlink:to="loc_us-gaap_DepositsAssets_e95ebb03-5062-4e47-be5a-c0f7b15012b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a63df9fd-b627-4761-bad2-9df66f1703b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3658d1b1-caa6-4d52-893e-3b2233707609" xlink:to="loc_us-gaap_Assets_a63df9fd-b627-4761-bad2-9df66f1703b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1029038e-a1ad-4812-8745-6184b92e24fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ef565306-5ed7-41ac-959a-3211ca272971" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1029038e-a1ad-4812-8745-6184b92e24fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3e1efc82-ffcf-4f22-ad9c-0c4ba32990e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1029038e-a1ad-4812-8745-6184b92e24fa" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_3e1efc82-ffcf-4f22-ad9c-0c4ba32990e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_7a06f658-54d2-435b-9ce5-20bd081766a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3e1efc82-ffcf-4f22-ad9c-0c4ba32990e0" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_7a06f658-54d2-435b-9ce5-20bd081766a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_043a209f-9886-427d-8ba2-2ff705bc5a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3e1efc82-ffcf-4f22-ad9c-0c4ba32990e0" xlink:to="loc_us-gaap_DueToAffiliateCurrent_043a209f-9886-427d-8ba2-2ff705bc5a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_168437d8-0dae-4234-bbc7-6e934bffb52d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3e1efc82-ffcf-4f22-ad9c-0c4ba32990e0" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_168437d8-0dae-4234-bbc7-6e934bffb52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9bb4c49d-a290-4401-85c1-fac5fd1e92ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3e1efc82-ffcf-4f22-ad9c-0c4ba32990e0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9bb4c49d-a290-4401-85c1-fac5fd1e92ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_64863906-0ef3-4fad-b688-bdd3cc512ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3e1efc82-ffcf-4f22-ad9c-0c4ba32990e0" xlink:to="loc_us-gaap_NotesPayableCurrent_64863906-0ef3-4fad-b688-bdd3cc512ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_906e9fcb-8787-414e-bc39-1ac4ed0b6cde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3e1efc82-ffcf-4f22-ad9c-0c4ba32990e0" xlink:to="loc_us-gaap_LiabilitiesCurrent_906e9fcb-8787-414e-bc39-1ac4ed0b6cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_dc11086e-33e5-4d7a-90da-c3b0897b75f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1029038e-a1ad-4812-8745-6184b92e24fa" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_dc11086e-33e5-4d7a-90da-c3b0897b75f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_03467fc8-f964-44fb-9c41-390630cb2a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_dc11086e-33e5-4d7a-90da-c3b0897b75f9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_03467fc8-f964-44fb-9c41-390630cb2a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_e6ebc28e-468b-4041-a15c-781ff4010ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_dc11086e-33e5-4d7a-90da-c3b0897b75f9" xlink:to="loc_us-gaap_LongTermNotesPayable_e6ebc28e-468b-4041-a15c-781ff4010ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_86c229c0-b18d-4089-bcbc-50fa31451eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_dc11086e-33e5-4d7a-90da-c3b0897b75f9" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_86c229c0-b18d-4089-bcbc-50fa31451eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2c61b14c-4342-4a5f-bc93-2e625fb8e5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_dc11086e-33e5-4d7a-90da-c3b0897b75f9" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2c61b14c-4342-4a5f-bc93-2e625fb8e5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0f6833ae-896f-4fd7-b36b-5b2e789c151c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_dc11086e-33e5-4d7a-90da-c3b0897b75f9" xlink:to="loc_us-gaap_Liabilities_0f6833ae-896f-4fd7-b36b-5b2e789c151c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_c646b299-93f3-4395-9f7d-19e25eca2bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1029038e-a1ad-4812-8745-6184b92e24fa" xlink:to="loc_us-gaap_StockholdersEquityAbstract_c646b299-93f3-4395-9f7d-19e25eca2bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9be0d4d4-c158-44c7-8ca2-8901ee9a00db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c646b299-93f3-4395-9f7d-19e25eca2bca" xlink:to="loc_us-gaap_CommonStockValue_9be0d4d4-c158-44c7-8ca2-8901ee9a00db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_0b51544f-7f6d-420e-92bd-5dc5d0845dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c646b299-93f3-4395-9f7d-19e25eca2bca" xlink:to="loc_us-gaap_AdditionalPaidInCapital_0b51544f-7f6d-420e-92bd-5dc5d0845dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_136d1ad8-978d-4f0b-9b00-c7e2740e6ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c646b299-93f3-4395-9f7d-19e25eca2bca" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_136d1ad8-978d-4f0b-9b00-c7e2740e6ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7a0437d2-56ca-470f-aabb-e10818325c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c646b299-93f3-4395-9f7d-19e25eca2bca" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7a0437d2-56ca-470f-aabb-e10818325c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f26f3685-2f10-4ba7-ba8e-537bb00775a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c646b299-93f3-4395-9f7d-19e25eca2bca" xlink:to="loc_us-gaap_StockholdersEquity_f26f3685-2f10-4ba7-ba8e-537bb00775a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_4901c36a-ca30-4959-8d2b-d42af7011429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c646b299-93f3-4395-9f7d-19e25eca2bca" xlink:to="loc_us-gaap_MinorityInterest_4901c36a-ca30-4959-8d2b-d42af7011429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1a9cace2-80b4-4367-a9a5-a5e15765fc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c646b299-93f3-4395-9f7d-19e25eca2bca" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1a9cace2-80b4-4367-a9a5-a5e15765fc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9e5f1d1e-67d8-49f4-baf5-576da0761127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1029038e-a1ad-4812-8745-6184b92e24fa" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_9e5f1d1e-67d8-49f4-baf5-576da0761127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_8622c8db-2ee1-4c3b-9b8c-ac55f1fd3581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ffb5b868-8192-45b7-826b-22fa73b96bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8622c8db-2ee1-4c3b-9b8c-ac55f1fd3581" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ffb5b868-8192-45b7-826b-22fa73b96bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b7be687c-51ec-424f-901c-02239130e3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8622c8db-2ee1-4c3b-9b8c-ac55f1fd3581" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b7be687c-51ec-424f-901c-02239130e3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_899dae8b-f84c-477a-baf9-91e59facb1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8622c8db-2ee1-4c3b-9b8c-ac55f1fd3581" xlink:to="loc_us-gaap_CommonStockSharesIssued_899dae8b-f84c-477a-baf9-91e59facb1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_baa9dea8-da14-46f5-8392-ae52406d6dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8622c8db-2ee1-4c3b-9b8c-ac55f1fd3581" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_baa9dea8-da14-46f5-8392-ae52406d6dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_b9f95eab-9505-4717-8850-930abf56f971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_185f6380-404d-4776-8acc-6313922fdab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b9f95eab-9505-4717-8850-930abf56f971" xlink:to="loc_us-gaap_StatementTable_185f6380-404d-4776-8acc-6313922fdab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c4c07bee-bb04-44cb-87f3-d0ecd716c598" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_185f6380-404d-4776-8acc-6313922fdab3" xlink:to="loc_srt_ProductOrServiceAxis_c4c07bee-bb04-44cb-87f3-d0ecd716c598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e70ef1bc-4c23-4fbb-bd9a-a781a3e40c64" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c4c07bee-bb04-44cb-87f3-d0ecd716c598" xlink:to="loc_srt_ProductsAndServicesDomain_e70ef1bc-4c23-4fbb-bd9a-a781a3e40c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_1077b7e1-18f3-45a2-8623-415d125a775d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e70ef1bc-4c23-4fbb-bd9a-a781a3e40c64" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_1077b7e1-18f3-45a2-8623-415d125a775d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_85c20dfc-c207-40a3-a1b8-8dffcc333fd2" xlink:href="rdnt-20230331.xsd#rdnt_CapitationArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e70ef1bc-4c23-4fbb-bd9a-a781a3e40c64" xlink:to="loc_rdnt_CapitationArrangementsMember_85c20dfc-c207-40a3-a1b8-8dffcc333fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_185f6380-404d-4776-8acc-6313922fdab3" xlink:to="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_57e1755b-5e09-42d8-97b5-d06bb2445541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_RevenuesAbstract_57e1755b-5e09-42d8-97b5-d06bb2445541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28b7fdd7-9860-4457-8f10-2810e818332f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_57e1755b-5e09-42d8-97b5-d06bb2445541" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28b7fdd7-9860-4457-8f10-2810e818332f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_3c7c4c68-7a75-4085-81df-55d5479ba523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_OperatingExpensesAbstract_3c7c4c68-7a75-4085-81df-55d5479ba523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_d413b4dd-8306-477c-84b0-ad9edff60c53" xlink:href="rdnt-20230331.xsd#rdnt_OperatingExpensesExcludingDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3c7c4c68-7a75-4085-81df-55d5479ba523" xlink:to="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_d413b4dd-8306-477c-84b0-ad9edff60c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_cfce07b9-2c08-4bc6-a2ea-cd4196f9988a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3c7c4c68-7a75-4085-81df-55d5479ba523" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_cfce07b9-2c08-4bc6-a2ea-cd4196f9988a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_3ce99357-7431-4071-ac83-9e5e8a10b74b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3c7c4c68-7a75-4085-81df-55d5479ba523" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_3ce99357-7431-4071-ac83-9e5e8a10b74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_ec477b59-53c9-4c0b-a624-848ade5f9d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3c7c4c68-7a75-4085-81df-55d5479ba523" xlink:to="loc_us-gaap_SeveranceCosts1_ec477b59-53c9-4c0b-a624-848ade5f9d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f351fdc3-e7b1-4a01-8361-2629ab90c99e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3c7c4c68-7a75-4085-81df-55d5479ba523" xlink:to="loc_us-gaap_OperatingExpenses_f351fdc3-e7b1-4a01-8361-2629ab90c99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a0f4259b-8cd2-491c-a545-7a9879e821de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_OperatingIncomeLoss_a0f4259b-8cd2-491c-a545-7a9879e821de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract_54c550c1-f9a5-4a63-ab07-1a20ac83dd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_OtherExpensesAbstract_54c550c1-f9a5-4a63-ab07-1a20ac83dd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_e27eddc7-71bc-43cf-b3ee-1c5cf7e4af81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_54c550c1-f9a5-4a63-ab07-1a20ac83dd7e" xlink:to="loc_us-gaap_InterestExpenseDebt_e27eddc7-71bc-43cf-b3ee-1c5cf7e4af81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_43256aa5-452b-476f-935a-70fb1c515926" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_54c550c1-f9a5-4a63-ab07-1a20ac83dd7e" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_43256aa5-452b-476f-935a-70fb1c515926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_764fbc08-096b-41e9-800b-2ddf12563dff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_54c550c1-f9a5-4a63-ab07-1a20ac83dd7e" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_764fbc08-096b-41e9-800b-2ddf12563dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4fe62b37-c1a8-4fec-a586-cccab6b76b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_54c550c1-f9a5-4a63-ab07-1a20ac83dd7e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4fe62b37-c1a8-4fec-a586-cccab6b76b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b6a6b650-2584-474c-8e08-fcf04dac9982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_54c550c1-f9a5-4a63-ab07-1a20ac83dd7e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b6a6b650-2584-474c-8e08-fcf04dac9982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4db32984-8691-42b1-8860-7d0393ce787c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4db32984-8691-42b1-8860-7d0393ce787c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_588f3d0a-1eda-48c5-9f5a-747de178fc7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_588f3d0a-1eda-48c5-9f5a-747de178fc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3fb7e3b5-8fe7-4be5-ac32-d5ec3ea8d4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_ProfitLoss_3fb7e3b5-8fe7-4be5-ac32-d5ec3ea8d4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8ab2e088-7ec7-4f06-ae93-c6f27d75bf92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8ab2e088-7ec7-4f06-ae93-c6f27d75bf92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4847dfcc-fb80-411d-93f6-d14a27abcb69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_NetIncomeLoss_4847dfcc-fb80-411d-93f6-d14a27abcb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2cfeba7d-ce24-42f6-8f49-c86c65e4e270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_EarningsPerShareBasic_2cfeba7d-ce24-42f6-8f49-c86c65e4e270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_aa84a78d-fa82-4d1c-a2d1-462d477f18ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_aa84a78d-fa82-4d1c-a2d1-462d477f18ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_2d574159-6065-44b0-a864-74061817520a" xlink:href="rdnt-20230331.xsd#rdnt_EarningPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3cccc79b-b149-4d5a-82f3-5c3c2d94843a" xlink:to="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_2d574159-6065-44b0-a864-74061817520a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_685fbcef-31c2-4826-8793-289e8793b915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_2d574159-6065-44b0-a864-74061817520a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_685fbcef-31c2-4826-8793-289e8793b915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_94b00ded-3736-4375-aee5-2a41c0f1bda6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_2d574159-6065-44b0-a864-74061817520a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_94b00ded-3736-4375-aee5-2a41c0f1bda6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f08ccbf9-e40e-478a-9b5d-d8ca150b642c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9943b2c5-f0d6-40b4-b8a6-f89d74dfb152" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f08ccbf9-e40e-478a-9b5d-d8ca150b642c" xlink:to="loc_us-gaap_ProfitLoss_9943b2c5-f0d6-40b4-b8a6-f89d74dfb152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b246db0c-9039-4c36-9233-532a740a48be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f08ccbf9-e40e-478a-9b5d-d8ca150b642c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b246db0c-9039-4c36-9233-532a740a48be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8c698ee5-99ea-46bc-b67d-a841f27e4659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f08ccbf9-e40e-478a-9b5d-d8ca150b642c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8c698ee5-99ea-46bc-b67d-a841f27e4659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7ad4af92-5a6b-4c51-a452-7afb4fa54201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f08ccbf9-e40e-478a-9b5d-d8ca150b642c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7ad4af92-5a6b-4c51-a452-7afb4fa54201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2052bff9-e63d-4f5f-bc4f-cec47cbe6bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f08ccbf9-e40e-478a-9b5d-d8ca150b642c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2052bff9-e63d-4f5f-bc4f-cec47cbe6bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_287223ca-01dc-4c78-a88e-c01e5aea4502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f08ccbf9-e40e-478a-9b5d-d8ca150b642c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_287223ca-01dc-4c78-a88e-c01e5aea4502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_15065a43-0212-446b-9477-1e1c611be51a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cae15494-c534-4c76-ba8a-a9d1b34eea8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_15065a43-0212-446b-9477-1e1c611be51a" xlink:to="loc_us-gaap_StatementTable_cae15494-c534-4c76-ba8a-a9d1b34eea8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9b162555-6ac8-4d78-9eaf-c255d4a2d097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cae15494-c534-4c76-ba8a-a9d1b34eea8c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9b162555-6ac8-4d78-9eaf-c255d4a2d097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ffd4ca16-4613-459e-a39d-89d7cdf5c51e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9b162555-6ac8-4d78-9eaf-c255d4a2d097" xlink:to="loc_us-gaap_EquityComponentDomain_ffd4ca16-4613-459e-a39d-89d7cdf5c51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_c9be554e-c527-4d72-a5c6-b548d4576e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ffd4ca16-4613-459e-a39d-89d7cdf5c51e" xlink:to="loc_us-gaap_ParentMember_c9be554e-c527-4d72-a5c6-b548d4576e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7e8f9a73-6ffd-4e59-9584-e39d76b2e908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_c9be554e-c527-4d72-a5c6-b548d4576e29" xlink:to="loc_us-gaap_CommonStockMember_7e8f9a73-6ffd-4e59-9584-e39d76b2e908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9ef235a9-4aee-48fb-9dab-074849971ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_c9be554e-c527-4d72-a5c6-b548d4576e29" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9ef235a9-4aee-48fb-9dab-074849971ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5b2101e1-d939-40ac-b9be-d3871e9d4ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_c9be554e-c527-4d72-a5c6-b548d4576e29" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5b2101e1-d939-40ac-b9be-d3871e9d4ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cb7b780a-5457-41b5-a2d8-4699009cf249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_c9be554e-c527-4d72-a5c6-b548d4576e29" xlink:to="loc_us-gaap_RetainedEarningsMember_cb7b780a-5457-41b5-a2d8-4699009cf249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_bea1bfd5-7c18-4caa-80c4-928446ea7127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ffd4ca16-4613-459e-a39d-89d7cdf5c51e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_bea1bfd5-7c18-4caa-80c4-928446ea7127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_eae5b8c8-69fc-4737-871b-05d935cfe66c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cae15494-c534-4c76-ba8a-a9d1b34eea8c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_eae5b8c8-69fc-4737-871b-05d935cfe66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06af2517-42e6-4615-a6f1-69a288aa3b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_eae5b8c8-69fc-4737-871b-05d935cfe66c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06af2517-42e6-4615-a6f1-69a288aa3b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_f643b98c-0f3a-4227-ada2-a285ad9d274d" xlink:href="rdnt-20230331.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06af2517-42e6-4615-a6f1-69a288aa3b3e" xlink:to="loc_rdnt_DeepHealthInc.Member_f643b98c-0f3a-4227-ada2-a285ad9d274d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_45469ef2-09e5-459b-910e-d674ce18ea52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cae15494-c534-4c76-ba8a-a9d1b34eea8c" xlink:to="loc_us-gaap_StatementLineItems_45469ef2-09e5-459b-910e-d674ce18ea52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_45469ef2-09e5-459b-910e-d674ce18ea52" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1eac11a5-844d-4c84-88e7-8b8fc2adc63a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1eac11a5-844d-4c84-88e7-8b8fc2adc63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7150046b-cb9b-4fce-82f3-2a3463b594f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7150046b-cb9b-4fce-82f3-2a3463b594f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e9ad5ec7-3b82-43fe-b809-e9d5a4e7c0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e9ad5ec7-3b82-43fe-b809-e9d5a4e7c0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0537d4ca-fde5-49c5-b1cc-2c6549667cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0537d4ca-fde5-49c5-b1cc-2c6549667cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b70ef053-fd8d-4eb4-be65-da007bde5b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b70ef053-fd8d-4eb4-be65-da007bde5b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ee8e23cb-1c07-487a-afc3-741155c1e4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ee8e23cb-1c07-487a-afc3-741155c1e4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f1e00425-6bf4-4997-80b7-4dc468f5e9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f1e00425-6bf4-4997-80b7-4dc468f5e9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_f2a8e359-e924-41a0-bbe3-98e808fa08e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_f2a8e359-e924-41a0-bbe3-98e808fa08e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_e64d18d5-2590-4f91-92bf-2003e699ffc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_e64d18d5-2590-4f91-92bf-2003e699ffc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_a11fe186-2150-4e83-a538-2d35c5f90b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_a11fe186-2150-4e83-a538-2d35c5f90b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_b90bb7dc-0aa9-4348-8850-10b82fbb7135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_StockholdersEquityOther_b90bb7dc-0aa9-4348-8850-10b82fbb7135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2cf39696-840a-4596-a3d1-a732bfdacb54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_ProfitLoss_2cf39696-840a-4596-a3d1-a732bfdacb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e5270e66-03df-4320-9411-f92924f6e990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e5270e66-03df-4320-9411-f92924f6e990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3872537c-bf9b-43a2-a4c8-fb8a9ab472cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c07643dc-66fe-4931-8469-4c81d31a74e3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3872537c-bf9b-43a2-a4c8-fb8a9ab472cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1d2b4cf3-1dde-4402-853b-e5d6f2c3575d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c42c4e2b-4481-463b-9ea6-1fd1b6b330a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1d2b4cf3-1dde-4402-853b-e5d6f2c3575d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c42c4e2b-4481-463b-9ea6-1fd1b6b330a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b3ebf038-093c-483a-a2b7-199ad9a05438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c42c4e2b-4481-463b-9ea6-1fd1b6b330a7" xlink:to="loc_us-gaap_ProfitLoss_b3ebf038-093c-483a-a2b7-199ad9a05438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c5637347-61e9-42ca-88c3-cfe1998ab980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c42c4e2b-4481-463b-9ea6-1fd1b6b330a7" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c5637347-61e9-42ca-88c3-cfe1998ab980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ef6eda9e-87e3-4fd2-8874-6f98faaac35a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c5637347-61e9-42ca-88c3-cfe1998ab980" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ef6eda9e-87e3-4fd2-8874-6f98faaac35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_09011e95-9bd2-4373-946b-fbb37cf5c161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c5637347-61e9-42ca-88c3-cfe1998ab980" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_09011e95-9bd2-4373-946b-fbb37cf5c161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_98d2cc4c-4f28-49cb-83f8-63d6f6603dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c5637347-61e9-42ca-88c3-cfe1998ab980" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_98d2cc4c-4f28-49cb-83f8-63d6f6603dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_7659758d-7f52-42ec-b865-447af1aea76c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c5637347-61e9-42ca-88c3-cfe1998ab980" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_7659758d-7f52-42ec-b865-447af1aea76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_55963028-6af4-4ed5-b64b-91c08cc7d93a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c5637347-61e9-42ca-88c3-cfe1998ab980" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_55963028-6af4-4ed5-b64b-91c08cc7d93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_242cb5ae-afe1-4f0d-bde1-2ecec8d35559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c5637347-61e9-42ca-88c3-cfe1998ab980" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_242cb5ae-afe1-4f0d-bde1-2ecec8d35559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_d512530b-9d25-44c2-8c3d-95bee4508cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c5637347-61e9-42ca-88c3-cfe1998ab980" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_d512530b-9d25-44c2-8c3d-95bee4508cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_76042a5d-d80d-4cfb-89f9-7798d501e9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c5637347-61e9-42ca-88c3-cfe1998ab980" xlink:to="loc_us-gaap_ShareBasedCompensation_76042a5d-d80d-4cfb-89f9-7798d501e9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1230cd6d-a29b-48c5-bc9b-b789871eb9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c5637347-61e9-42ca-88c3-cfe1998ab980" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1230cd6d-a29b-48c5-bc9b-b789871eb9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_879410f5-5a93-449c-a9a6-b498b17e359b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c5637347-61e9-42ca-88c3-cfe1998ab980" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_879410f5-5a93-449c-a9a6-b498b17e359b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_086e3e74-12e0-4dbd-a8e0-a1cccc4a9893" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_879410f5-5a93-449c-a9a6-b498b17e359b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_086e3e74-12e0-4dbd-a8e0-a1cccc4a9893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_09d92970-7b6e-4a08-be43-8104cc62b6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_879410f5-5a93-449c-a9a6-b498b17e359b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_09d92970-7b6e-4a08-be43-8104cc62b6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_44795073-f585-4d30-8c69-acf0e45a93c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_879410f5-5a93-449c-a9a6-b498b17e359b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_44795073-f585-4d30-8c69-acf0e45a93c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_76ed2558-7cc9-4770-b46d-04d5510ca519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_879410f5-5a93-449c-a9a6-b498b17e359b" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_76ed2558-7cc9-4770-b46d-04d5510ca519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4ae8aa8d-267b-4c88-958a-d471aca24419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_879410f5-5a93-449c-a9a6-b498b17e359b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4ae8aa8d-267b-4c88-958a-d471aca24419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_8b9f03ef-42f9-48b2-bad4-05cb508424cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_879410f5-5a93-449c-a9a6-b498b17e359b" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_8b9f03ef-42f9-48b2-bad4-05cb508424cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c7de9ba6-cb62-4e56-a970-902589ba2bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_879410f5-5a93-449c-a9a6-b498b17e359b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c7de9ba6-cb62-4e56-a970-902589ba2bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444653dd-4543-4c86-87d1-6b363b31e10d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c42c4e2b-4481-463b-9ea6-1fd1b6b330a7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444653dd-4543-4c86-87d1-6b363b31e10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_38a6bacc-5710-454e-b326-5f39380faf92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1d2b4cf3-1dde-4402-853b-e5d6f2c3575d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_38a6bacc-5710-454e-b326-5f39380faf92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings_bb00df46-5cc7-4aed-9b67-f143f64e176b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_38a6bacc-5710-454e-b326-5f39380faf92" xlink:to="loc_us-gaap_PaymentsToAcquireBuildings_bb00df46-5cc7-4aed-9b67-f143f64e176b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_8fced0c5-3e34-4689-89f5-2b14df795521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_38a6bacc-5710-454e-b326-5f39380faf92" xlink:to="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_8fced0c5-3e34-4689-89f5-2b14df795521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a9d437e1-d77a-43cc-932d-9e7b4bf26b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_38a6bacc-5710-454e-b326-5f39380faf92" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a9d437e1-d77a-43cc-932d-9e7b4bf26b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b624ea28-6e6f-44f7-afda-098965f182df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_38a6bacc-5710-454e-b326-5f39380faf92" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b624ea28-6e6f-44f7-afda-098965f182df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_59aff7f4-56d7-4716-9c87-55899f6e6f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1d2b4cf3-1dde-4402-853b-e5d6f2c3575d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_59aff7f4-56d7-4716-9c87-55899f6e6f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_387f8374-6b3a-4dd3-942b-6f036d30edeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_59aff7f4-56d7-4716-9c87-55899f6e6f4f" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_387f8374-6b3a-4dd3-942b-6f036d30edeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_798b7c1d-2a6c-4972-a123-abde9a0c6b81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_59aff7f4-56d7-4716-9c87-55899f6e6f4f" xlink:to="loc_us-gaap_RepaymentsOfDebt_798b7c1d-2a6c-4972-a123-abde9a0c6b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_7449eacd-b41d-433a-8a96-f6274f89b287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_59aff7f4-56d7-4716-9c87-55899f6e6f4f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_7449eacd-b41d-433a-8a96-f6274f89b287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cfcaf320-1a15-44bc-bc96-579c3ac9c862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_59aff7f4-56d7-4716-9c87-55899f6e6f4f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cfcaf320-1a15-44bc-bc96-579c3ac9c862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9aa1e778-c274-4c90-b009-363811620156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1d2b4cf3-1dde-4402-853b-e5d6f2c3575d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9aa1e778-c274-4c90-b009-363811620156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9accbc24-4b20-4177-bddb-4abc3c9d9c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1d2b4cf3-1dde-4402-853b-e5d6f2c3575d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9accbc24-4b20-4177-bddb-4abc3c9d9c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_83354ed1-1c0f-4d20-ab10-358d248c216d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1d2b4cf3-1dde-4402-853b-e5d6f2c3575d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_83354ed1-1c0f-4d20-ab10-358d248c216d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e3c1491b-16d5-4c78-bb27-1494dcddbc71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1d2b4cf3-1dde-4402-853b-e5d6f2c3575d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e3c1491b-16d5-4c78-bb27-1494dcddbc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_443a6c46-b7d9-4856-9bce-8f2c77e6ec33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1d2b4cf3-1dde-4402-853b-e5d6f2c3575d" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_443a6c46-b7d9-4856-9bce-8f2c77e6ec33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_b708a12b-bb95-4cac-b3f8-0d6a35490a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_443a6c46-b7d9-4856-9bce-8f2c77e6ec33" xlink:to="loc_us-gaap_InterestPaidNet_b708a12b-bb95-4cac-b3f8-0d6a35490a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_a1528d85-d849-47e6-a6f1-d2375070b535" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_443a6c46-b7d9-4856-9bce-8f2c77e6ec33" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_a1528d85-d849-47e6-a6f1-d2375070b535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_8055f233-2bdf-4d3d-ab46-f06e89c0894a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_57cbcae6-b6bc-4ad6-a23e-aa12b5ee76f9" xlink:href="rdnt-20230331.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8055f233-2bdf-4d3d-ab46-f06e89c0894a" xlink:to="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_57cbcae6-b6bc-4ad6-a23e-aa12b5ee76f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0da96016-f9d9-471b-a9f3-f2863ebf8eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8055f233-2bdf-4d3d-ab46-f06e89c0894a" xlink:to="loc_us-gaap_StatementTable_0da96016-f9d9-471b-a9f3-f2863ebf8eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6969ba22-27d9-470b-8b33-2771746c0cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0da96016-f9d9-471b-a9f3-f2863ebf8eaa" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6969ba22-27d9-470b-8b33-2771746c0cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9a87748-da6c-4137-8486-90d9de9103c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6969ba22-27d9-470b-8b33-2771746c0cc4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9a87748-da6c-4137-8486-90d9de9103c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVMember_93f29e73-16f1-474e-99d2-0353173e4f05" xlink:href="rdnt-20230331.xsd#rdnt_AidenceHoldingBVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9a87748-da6c-4137-8486-90d9de9103c8" xlink:to="loc_rdnt_AidenceHoldingBVMember_93f29e73-16f1-474e-99d2-0353173e4f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_3fab5fde-300e-44cf-b4cb-74a60829848c" xlink:href="rdnt-20230331.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9a87748-da6c-4137-8486-90d9de9103c8" xlink:to="loc_rdnt_QuantibMember_3fab5fde-300e-44cf-b4cb-74a60829848c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e52ece5b-6b8c-435c-9b24-604817e4d6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0da96016-f9d9-471b-a9f3-f2863ebf8eaa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e52ece5b-6b8c-435c-9b24-604817e4d6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b7584174-3326-4ba9-bafa-059063011333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e52ece5b-6b8c-435c-9b24-604817e4d6e5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b7584174-3326-4ba9-bafa-059063011333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_c4b5c89b-c4b8-43fb-b7d4-ac99297f1f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b7584174-3326-4ba9-bafa-059063011333" xlink:to="loc_us-gaap_UnsecuredDebtMember_c4b5c89b-c4b8-43fb-b7d4-ac99297f1f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8d202e73-d7d3-4a16-964e-6ca08e544a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0da96016-f9d9-471b-a9f3-f2863ebf8eaa" xlink:to="loc_us-gaap_StatementLineItems_8d202e73-d7d3-4a16-964e-6ca08e544a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7100697f-a5c4-4819-ae3c-cd446973221f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d202e73-d7d3-4a16-964e-6ca08e544a6f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7100697f-a5c4-4819-ae3c-cd446973221f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_7a66b68d-4bbc-48f5-a72b-2b3491bce315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d202e73-d7d3-4a16-964e-6ca08e544a6f" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_7a66b68d-4bbc-48f5-a72b-2b3491bce315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_c8847807-0c73-4d59-9353-595368c55c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d202e73-d7d3-4a16-964e-6ca08e544a6f" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_c8847807-0c73-4d59-9353-595368c55c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION" xlink:type="simple" xlink:href="rdnt-20230331.xsd#NATUREOFBUSINESSANDBASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e5a094a4-ebd9-4095-934b-4260e271ffd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_623c2c2c-c505-4efd-89f6-798b14fe24be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e5a094a4-ebd9-4095-934b-4260e271ffd6" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_623c2c2c-c505-4efd-89f6-798b14fe24be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7e3d45b3-9327-4dac-8d66-011c17278e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_30ea5dff-2f9e-446d-85a1-13dad5132d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7e3d45b3-9327-4dac-8d66-011c17278e49" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_30ea5dff-2f9e-446d-85a1-13dad5132d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARD" xlink:type="simple" xlink:href="rdnt-20230331.xsd#RECENTACCOUNTINGANDREPORTINGSTANDARD"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARD" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_62188818-e5a8-4afa-8884-f92b01b93e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_ee783540-beaf-4c21-ae83-40a459d2571b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_62188818-e5a8-4afa-8884-f92b01b93e8e" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_ee783540-beaf-4c21-ae83-40a459d2571b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY" xlink:type="simple" xlink:href="rdnt-20230331.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITY"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_8f34ad77-a80b-4600-aa7f-e439ed15b090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_8d98bd17-85f8-4f98-8359-c11fcc4f227c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_8f34ad77-a80b-4600-aa7f-e439ed15b090" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_8d98bd17-85f8-4f98-8359-c11fcc4f227c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SEGMENTREPORTING" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SEGMENTREPORTING"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SEGMENTREPORTING" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f6b96ad5-6272-4fa9-b7ba-eca0441d9f99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_d69cab5f-7010-4c22-8953-343ce3a6c7fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f6b96ad5-6272-4fa9-b7ba-eca0441d9f99" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_d69cab5f-7010-4c22-8953-343ce3a6c7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CREDITFACILITIESANDNOTESPAYABLE"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cce6278a-8838-4eeb-b3b4-6e3c408af182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_703f8ad5-e553-44bb-b5ab-94c9a40da9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cce6278a-8838-4eeb-b3b4-6e3c408af182" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_703f8ad5-e553-44bb-b5ab-94c9a40da9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="rdnt-20230331.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_48af1e6d-e9b0-4f1a-b181-0528a7959bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_86168a9b-0100-428f-92ca-5445d28b709a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_48af1e6d-e9b0-4f1a-b181-0528a7959bea" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_86168a9b-0100-428f-92ca-5445d28b709a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_bc5e96fd-8b10-45c2-b18a-2381da5b0a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_bc5e96fd-8b10-45c2-b18a-2381da5b0a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_f0816f51-f39b-4498-b824-5b0e3642146e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_f0816f51-f39b-4498-b824-5b0e3642146e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock_c62abf3a-049d-42fb-bb1f-1f691d7cafe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_DeferredChargesPolicyTextBlock_c62abf3a-049d-42fb-bb1f-1f691d7cafe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_21afcaad-75a9-4a09-b02c-d8ede2dae6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_21afcaad-75a9-4a09-b02c-d8ede2dae6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_f7a9245c-636f-40e7-b654-7a43de606100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_f7a9245c-636f-40e7-b654-7a43de606100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_11ed4718-b838-4c07-9804-48f35e26da97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_11ed4718-b838-4c07-9804-48f35e26da97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_52c2c99c-7d2a-4838-9d18-8a02ab46da50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_52c2c99c-7d2a-4838-9d18-8a02ab46da50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_37924130-a09b-4a33-93ad-9e4cfb860531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_37924130-a09b-4a33-93ad-9e4cfb860531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_6c3e9029-4f7c-4bf8-8ce6-3297927fd6b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_6c3e9029-4f7c-4bf8-8ce6-3297927fd6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_2d9f7123-3331-4437-8afb-f03fb0fccb84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_2d9f7123-3331-4437-8afb-f03fb0fccb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_f3ee4c40-a641-4863-b530-c561fc228949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_f3ee4c40-a641-4863-b530-c561fc228949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_54d56c9c-c139-49aa-8c12-1f85acf475a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_54d56c9c-c139-49aa-8c12-1f85acf475a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9b482123-3706-47d0-98de-2ee27de86b76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9b482123-3706-47d0-98de-2ee27de86b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_91da118e-5131-4b7b-b23a-c31a2dcefede" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_91da118e-5131-4b7b-b23a-c31a2dcefede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_8066ea06-889a-4723-b1f6-7a44a15caeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_8066ea06-889a-4723-b1f6-7a44a15caeb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_c6e8f85f-34cf-48ea-82c2-bd6be012a681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_c6e8f85f-34cf-48ea-82c2-bd6be012a681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6ce16718-c5fd-4c84-ba5c-1c40fe578d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d814a668-873c-4df2-8659-8860d7f5785b" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6ce16718-c5fd-4c84-ba5c-1c40fe578d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b7bafe1f-21cb-49cc-a2d7-d463e72710d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_2c2e8c11-1b36-41dd-a04b-9f42673216ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b7bafe1f-21cb-49cc-a2d7-d463e72710d9" xlink:to="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_2c2e8c11-1b36-41dd-a04b-9f42673216ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_3958594a-249f-47ed-a237-bb7b131532bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b7bafe1f-21cb-49cc-a2d7-d463e72710d9" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_3958594a-249f-47ed-a237-bb7b131532bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_27eeb518-613c-442c-a3bd-49ceeaec7764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b7bafe1f-21cb-49cc-a2d7-d463e72710d9" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_27eeb518-613c-442c-a3bd-49ceeaec7764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_aaa3cd3d-403b-4f03-b6ed-89e52d4516ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b7bafe1f-21cb-49cc-a2d7-d463e72710d9" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_aaa3cd3d-403b-4f03-b6ed-89e52d4516ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_88b2ca85-c2c4-44b2-93df-a6e8eb8a974f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b7bafe1f-21cb-49cc-a2d7-d463e72710d9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_88b2ca85-c2c4-44b2-93df-a6e8eb8a974f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_1c020911-b077-47df-9808-b836eee0aeca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b7bafe1f-21cb-49cc-a2d7-d463e72710d9" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_1c020911-b077-47df-9808-b836eee0aeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c780a732-065a-41be-9077-fa3b7ab0607b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b7bafe1f-21cb-49cc-a2d7-d463e72710d9" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c780a732-065a-41be-9077-fa3b7ab0607b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_b2b5b818-2255-4a43-83ba-997eae3b6ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b7bafe1f-21cb-49cc-a2d7-d463e72710d9" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_b2b5b818-2255-4a43-83ba-997eae3b6ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_6e952414-c578-4a47-a11b-b77c24b47551" xlink:href="rdnt-20230331.xsd#rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b7bafe1f-21cb-49cc-a2d7-d463e72710d9" xlink:to="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_6e952414-c578-4a47-a11b-b77c24b47551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables" xlink:type="simple" xlink:href="rdnt-20230331.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6f77c3bd-a1c4-4ee4-a974-2a728cc93387" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_81207574-5a9a-4dab-9c67-ca1b54554c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6f77c3bd-a1c4-4ee4-a974-2a728cc93387" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_81207574-5a9a-4dab-9c67-ca1b54554c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SEGMENTREPORTINGTables" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SEGMENTREPORTINGTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SEGMENTREPORTINGTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_12af4a6d-afae-4f71-9649-0e5e234c053d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_bc4e54f4-4684-4de8-8877-b9a8b8d373a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_12af4a6d-afae-4f71-9649-0e5e234c053d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_bc4e54f4-4684-4de8-8877-b9a8b8d373a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CREDITFACILITIESANDNOTESPAYABLETables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ba60662f-45c3-4eab-916d-4be548e330a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_7399883b-d1ed-4399-abd7-219b67ba888e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ba60662f-45c3-4eab-916d-4be548e330a6" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_7399883b-d1ed-4399-abd7-219b67ba888e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock_d7ed4ccf-5114-4b2c-9813-66236b21ff00" xlink:href="rdnt-20230331.xsd#rdnt_ScheduleOfLeverageRatioTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ba60662f-45c3-4eab-916d-4be548e330a6" xlink:to="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock_d7ed4ccf-5114-4b2c-9813-66236b21ff00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="rdnt-20230331.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f5b6bed5-b734-4ee7-95f6-9f93313d4491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_b3e59c0c-f9bd-4486-953b-0c20cdc2f061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f5b6bed5-b734-4ee7-95f6-9f93313d4491" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_b3e59c0c-f9bd-4486-953b-0c20cdc2f061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_3c596c31-2fe8-49c6-8d17-9fb610ab73ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f5b6bed5-b734-4ee7-95f6-9f93313d4491" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_3c596c31-2fe8-49c6-8d17-9fb610ab73ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_e047e799-7ad3-4a35-8af7-251a2e6e27d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f5b6bed5-b734-4ee7-95f6-9f93313d4491" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_e047e799-7ad3-4a35-8af7-251a2e6e27d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e5547c1a-36d6-4342-930e-47b94ae2eec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c049629-e2b3-4051-b659-cb643ca23844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e5547c1a-36d6-4342-930e-47b94ae2eec7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c049629-e2b3-4051-b659-cb643ca23844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_6d0c19e0-e3a1-4009-874d-ab7a6dec9366" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c049629-e2b3-4051-b659-cb643ca23844" xlink:to="loc_srt_ConsolidatedEntitiesAxis_6d0c19e0-e3a1-4009-874d-ab7a6dec9366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_26768716-a4bc-470e-9d83-2ea16d115bf6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6d0c19e0-e3a1-4009-874d-ab7a6dec9366" xlink:to="loc_srt_ConsolidatedEntitiesDomain_26768716-a4bc-470e-9d83-2ea16d115bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_17c15ddd-cc0c-4c54-8d26-ebded77e7531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_26768716-a4bc-470e-9d83-2ea16d115bf6" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_17c15ddd-cc0c-4c54-8d26-ebded77e7531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_eeba7f18-22a5-4c49-8124-757ecd19c653" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c049629-e2b3-4051-b659-cb643ca23844" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_eeba7f18-22a5-4c49-8124-757ecd19c653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7766a5af-c8ed-42ef-a0a5-e3167a1c4069" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_eeba7f18-22a5-4c49-8124-757ecd19c653" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7766a5af-c8ed-42ef-a0a5-e3167a1c4069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderLlcMember_c3443b4f-4e40-4972-ba19-dcfc5024ee22" xlink:href="rdnt-20230331.xsd#rdnt_ScriptSenderLlcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7766a5af-c8ed-42ef-a0a5-e3167a1c4069" xlink:to="loc_rdnt_ScriptSenderLlcMember_c3443b4f-4e40-4972-ba19-dcfc5024ee22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_37553ee1-0674-4bd6-b308-91d2488e0125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c049629-e2b3-4051-b659-cb643ca23844" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_37553ee1-0674-4bd6-b308-91d2488e0125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_b9ffb196-8d49-4606-868e-d64b76e9a063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_37553ee1-0674-4bd6-b308-91d2488e0125" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_b9ffb196-8d49-4606-868e-d64b76e9a063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_38146a91-c3a7-454f-a72a-6b1ed18bad1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_b9ffb196-8d49-4606-868e-d64b76e9a063" xlink:to="loc_us-gaap_OperatingExpenseMember_38146a91-c3a7-454f-a72a-6b1ed18bad1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_51acd03a-6224-4733-a690-af03626c1384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c049629-e2b3-4051-b659-cb643ca23844" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_51acd03a-6224-4733-a690-af03626c1384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4d56868c-60c6-46a4-b3d0-8502d3a28c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_51acd03a-6224-4733-a690-af03626c1384" xlink:to="loc_us-gaap_RelatedPartyDomain_4d56868c-60c6-46a4-b3d0-8502d3a28c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_d5e0d57c-29d3-4854-9185-1b8ba94b2e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4d56868c-60c6-46a4-b3d0-8502d3a28c79" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_d5e0d57c-29d3-4854-9185-1b8ba94b2e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c049629-e2b3-4051-b659-cb643ca23844" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters_c7c0d557-5d62-4c70-8029-caf5e0d79349" xlink:href="rdnt-20230331.xsd#rdnt_NumberOfCenters"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_rdnt_NumberOfCenters_c7c0d557-5d62-4c70-8029-caf5e0d79349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_9219e4a8-85ab-4ff9-a201-af0526231775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_NumberOfReportableSegments_9219e4a8-85ab-4ff9-a201-af0526231775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_27877a71-c210-4ecd-b4b1-a5d6eb2b3f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_27877a71-c210-4ecd-b4b1-a5d6eb2b3f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_2a07ec55-8e45-4e27-87d2-4911c66dbaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_2a07ec55-8e45-4e27-87d2-4911c66dbaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_1b8f72ee-f81e-4dbc-ba9c-f79606ae1550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_1b8f72ee-f81e-4dbc-ba9c-f79606ae1550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_415c6009-6f0d-4baf-befc-ac86251b993d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_Assets_415c6009-6f0d-4baf-befc-ac86251b993d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3275fbaf-bb8f-412a-beac-beee82732953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_Liabilities_3275fbaf-bb8f-412a-beac-beee82732953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_e3c837a1-eb83-4592-a684-5772cd995a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_e3c837a1-eb83-4592-a684-5772cd995a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_a81331e8-3341-4e31-9d7c-d6cd7aee894f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_EquityMethodInvestments_a81331e8-3341-4e31-9d7c-d6cd7aee894f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_c9eb91ec-6213-404e-89cc-54df2e643829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f53dcaa6-3ef0-4971-9b50-ce8bb97d2984" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_c9eb91ec-6213-404e-89cc-54df2e643829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_42eb843a-39ec-4a89-81fe-918d390da166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_42eb843a-39ec-4a89-81fe-918d390da166" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_9f19ab0f-47e9-4b70-af00-eebb71cee9df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_9f19ab0f-47e9-4b70-af00-eebb71cee9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_b73ab347-272c-403b-b2f3-31d9b98b6753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_9f19ab0f-47e9-4b70-af00-eebb71cee9df" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_b73ab347-272c-403b-b2f3-31d9b98b6753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_1f22f309-cffc-4098-9656-5c3dee9c8f02" xlink:href="rdnt-20230331.xsd#rdnt_COVID19PandemicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_b73ab347-272c-403b-b2f3-31d9b98b6753" xlink:to="loc_rdnt_COVID19PandemicMember_1f22f309-cffc-4098-9656-5c3dee9c8f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_99cb712d-5963-4f09-9747-5a553b424d02" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_srt_RangeAxis_99cb712d-5963-4f09-9747-5a553b424d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3b146b2a-f277-4f22-a560-6b7d5804dafd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_99cb712d-5963-4f09-9747-5a553b424d02" xlink:to="loc_srt_RangeMember_3b146b2a-f277-4f22-a560-6b7d5804dafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_af27a598-a0a8-4317-98af-9cfb97998035" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3b146b2a-f277-4f22-a560-6b7d5804dafd" xlink:to="loc_srt_MinimumMember_af27a598-a0a8-4317-98af-9cfb97998035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ab76556a-a9e3-4528-a0e8-b1394e2a51a4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3b146b2a-f277-4f22-a560-6b7d5804dafd" xlink:to="loc_srt_MaximumMember_ab76556a-a9e3-4528-a0e8-b1394e2a51a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1cfda76e-cbcf-4277-9654-07f6ea19de48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1cfda76e-cbcf-4277-9654-07f6ea19de48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8656a46f-9d72-454b-9988-06d558128637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1cfda76e-cbcf-4277-9654-07f6ea19de48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8656a46f-9d72-454b-9988-06d558128637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProperyAndEquipmentNetMember_c8c4d96c-ff95-40bc-be50-8e7ba1adcc3d" xlink:href="rdnt-20230331.xsd#rdnt_ProperyAndEquipmentNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8656a46f-9d72-454b-9988-06d558128637" xlink:to="loc_rdnt_ProperyAndEquipmentNetMember_c8c4d96c-ff95-40bc-be50-8e7ba1adcc3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_6bb78cbd-7df0-4804-9bc6-5bdbead2cab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8656a46f-9d72-454b-9988-06d558128637" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_6bb78cbd-7df0-4804-9bc6-5bdbead2cab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bb82c46f-b2ad-46a8-bdf3-65bfe8cf7c07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bb82c46f-b2ad-46a8-bdf3-65bfe8cf7c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f225fae-e0e0-4947-9d68-c6a6046f2451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bb82c46f-b2ad-46a8-bdf3-65bfe8cf7c07" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f225fae-e0e0-4947-9d68-c6a6046f2451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_d1f4fefb-5d53-4415-ab98-c307c7b2873e" xlink:href="rdnt-20230331.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f225fae-e0e0-4947-9d68-c6a6046f2451" xlink:to="loc_rdnt_ManagementServiceContractsMember_d1f4fefb-5d53-4415-ab98-c307c7b2873e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_49572e78-fa04-41fd-8690-8fa91cf785d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_PlanNameAxis_49572e78-fa04-41fd-8690-8fa91cf785d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_2a772d60-bba9-45f9-9d94-2bdc0ef4be20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_49572e78-fa04-41fd-8690-8fa91cf785d7" xlink:to="loc_us-gaap_PlanNameDomain_2a772d60-bba9-45f9-9d94-2bdc0ef4be20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_c75a7ccb-0101-4031-9ddc-e752934c71ae" xlink:href="rdnt-20230331.xsd#rdnt_RestatedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_2a772d60-bba9-45f9-9d94-2bdc0ef4be20" xlink:to="loc_rdnt_RestatedPlanMember_c75a7ccb-0101-4031-9ddc-e752934c71ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_0312adf6-6ef4-4852-b906-f6a8f413b7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_0312adf6-6ef4-4852-b906-f6a8f413b7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ea0620cb-8dba-4935-91c1-f219153a1c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_0312adf6-6ef4-4852-b906-f6a8f413b7d4" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ea0620cb-8dba-4935-91c1-f219153a1c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember_e5f94dbe-40c0-41a2-99ce-ed0096cfac12" xlink:href="rdnt-20230331.xsd#rdnt_A2019SWAPSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ea0620cb-8dba-4935-91c1-f219153a1c8d" xlink:to="loc_rdnt_A2019SWAPSMember_e5f94dbe-40c0-41a2-99ce-ed0096cfac12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member_f0c3c4b4-80c9-4865-826f-72ff3d63c22d" xlink:href="rdnt-20230331.xsd#rdnt_A2019SWAPS1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ea0620cb-8dba-4935-91c1-f219153a1c8d" xlink:to="loc_rdnt_A2019SWAPS1Member_f0c3c4b4-80c9-4865-826f-72ff3d63c22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis_56d4076f-bd3b-4bb9-8606-b6ae8d4b6152" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_CreditDerivativesByContractTypeAxis_56d4076f-bd3b-4bb9-8606-b6ae8d4b6152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_2fa52575-969d-41ec-a10b-36a5c19bb412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_56d4076f-bd3b-4bb9-8606-b6ae8d4b6152" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_2fa52575-969d-41ec-a10b-36a5c19bb412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member_b7569477-bcb1-4859-ad33-683112b3e537" xlink:href="rdnt-20230331.xsd#rdnt_October2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_2fa52575-969d-41ec-a10b-36a5c19bb412" xlink:to="loc_rdnt_October2023Member_b7569477-bcb1-4859-ad33-683112b3e537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member_26bef44a-9650-4134-8fe2-aa48010b2e60" xlink:href="rdnt-20230331.xsd#rdnt_October2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_2fa52575-969d-41ec-a10b-36a5c19bb412" xlink:to="loc_rdnt_October2025Member_26bef44a-9650-4134-8fe2-aa48010b2e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e9222bc8-c24c-4c5b-bbd7-75b91d749a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e9222bc8-c24c-4c5b-bbd7-75b91d749a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2ea6f2ba-86fa-4eb8-9542-4cedeacbc590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e9222bc8-c24c-4c5b-bbd7-75b91d749a75" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2ea6f2ba-86fa-4eb8-9542-4cedeacbc590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ef088199-4dea-4322-ba9e-5105908bde4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2ea6f2ba-86fa-4eb8-9542-4cedeacbc590" xlink:to="loc_us-gaap_InterestRateSwapMember_ef088199-4dea-4322-ba9e-5105908bde4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d9f98bec-9289-459e-9acb-28cf6c8ddb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_VariableRateAxis_d9f98bec-9289-459e-9acb-28cf6c8ddb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_143e14de-58cf-4008-ab24-b1b5fc503ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_d9f98bec-9289-459e-9acb-28cf6c8ddb8c" xlink:to="loc_us-gaap_VariableRateDomain_143e14de-58cf-4008-ab24-b1b5fc503ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2e8d3a2b-fdb6-483a-8338-74a67f49d0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_143e14de-58cf-4008-ab24-b1b5fc503ab8" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2e8d3a2b-fdb6-483a-8338-74a67f49d0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_404ebbf0-4a71-4db8-ae20-b486fa7fd41e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_404ebbf0-4a71-4db8-ae20-b486fa7fd41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fd11f440-9267-4cd7-8f62-261bf6a9e873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_404ebbf0-4a71-4db8-ae20-b486fa7fd41e" xlink:to="loc_us-gaap_EquityComponentDomain_fd11f440-9267-4cd7-8f62-261bf6a9e873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_872b3661-4a1b-400b-a999-51b143c9fa25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fd11f440-9267-4cd7-8f62-261bf6a9e873" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_872b3661-4a1b-400b-a999-51b143c9fa25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_073ea855-8a45-41f1-8943-8c019b17f4b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_srt_StatementScenarioAxis_073ea855-8a45-41f1-8943-8c019b17f4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ad5fe446-e961-4bdf-8009-4c7b67ae30a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_073ea855-8a45-41f1-8943-8c019b17f4b9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ad5fe446-e961-4bdf-8009-4c7b67ae30a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_bd285eed-4e1e-4441-877f-0f409903a504" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_ad5fe446-e961-4bdf-8009-4c7b67ae30a7" xlink:to="loc_srt_ScenarioForecastMember_bd285eed-4e1e-4441-877f-0f409903a504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_04390c1e-1bc4-4dcb-ac3f-eb8cd72be53b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_04390c1e-1bc4-4dcb-ac3f-eb8cd72be53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_436b6de0-ad8f-43a9-b908-b88c3aa40ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_04390c1e-1bc4-4dcb-ac3f-eb8cd72be53b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_436b6de0-ad8f-43a9-b908-b88c3aa40ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_958f67e4-b0d6-43fa-9a22-a6bba931ec0c" xlink:href="rdnt-20230331.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_436b6de0-ad8f-43a9-b908-b88c3aa40ae4" xlink:to="loc_rdnt_AidenceMember_958f67e4-b0d6-43fa-9a22-a6bba931ec0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_29f350ac-2dc1-48fe-8f13-b573d37bb668" xlink:href="rdnt-20230331.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_436b6de0-ad8f-43a9-b908-b88c3aa40ae4" xlink:to="loc_rdnt_QuantibMember_29f350ac-2dc1-48fe-8f13-b573d37bb668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_87571a31-aeff-4c23-b98b-9c8a69444c3a" xlink:href="rdnt-20230331.xsd#rdnt_MontclairMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_436b6de0-ad8f-43a9-b908-b88c3aa40ae4" xlink:to="loc_rdnt_MontclairMember_87571a31-aeff-4c23-b98b-9c8a69444c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_6896f143-b471-4d39-a89c-03df67197dda" xlink:href="rdnt-20230331.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_436b6de0-ad8f-43a9-b908-b88c3aa40ae4" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_6896f143-b471-4d39-a89c-03df67197dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_063a409d-b72e-4b20-ac15-c2bdd77c8500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_063a409d-b72e-4b20-ac15-c2bdd77c8500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_cfd0466b-01b7-424d-8004-41e6bed9eaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_063a409d-b72e-4b20-ac15-c2bdd77c8500" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_cfd0466b-01b7-424d-8004-41e6bed9eaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentMilestoneConsiderationMember_2750d28d-bd56-47ef-a706-313405d26c09" xlink:href="rdnt-20230331.xsd#rdnt_ContingentMilestoneConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_cfd0466b-01b7-424d-8004-41e6bed9eaf7" xlink:to="loc_rdnt_ContingentMilestoneConsiderationMember_2750d28d-bd56-47ef-a706-313405d26c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember_83e8eda6-a2ff-420e-8a2b-91aa5fb19092" xlink:href="rdnt-20230331.xsd#rdnt_CashHoldbackMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_cfd0466b-01b7-424d-8004-41e6bed9eaf7" xlink:to="loc_rdnt_CashHoldbackMember_83e8eda6-a2ff-420e-8a2b-91aa5fb19092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ca54633f-47cb-4874-aee8-4e9ed340bc78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_CreditFacilityAxis_ca54633f-47cb-4874-aee8-4e9ed340bc78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8594d058-68cf-4513-b28d-a8c67ae4707b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_ca54633f-47cb-4874-aee8-4e9ed340bc78" xlink:to="loc_us-gaap_CreditFacilityDomain_8594d058-68cf-4513-b28d-a8c67ae4707b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_da9416e4-c5a5-4279-bd45-4ceb4716bd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_8594d058-68cf-4513-b28d-a8c67ae4707b" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_da9416e4-c5a5-4279-bd45-4ceb4716bd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_57cc7adc-6c9a-4690-a7dc-1589beed2706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_DebtInstrumentAxis_57cc7adc-6c9a-4690-a7dc-1589beed2706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_60592fe0-e746-40eb-afe9-83543bd107a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_57cc7adc-6c9a-4690-a7dc-1589beed2706" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_60592fe0-e746-40eb-afe9-83543bd107a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_d17510bb-9f08-41a7-86ce-ea2c38903556" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60592fe0-e746-40eb-afe9-83543bd107a2" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_d17510bb-9f08-41a7-86ce-ea2c38903556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_80abcf5d-7264-4c57-b3a5-910e1b35085a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_80abcf5d-7264-4c57-b3a5-910e1b35085a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_e8d5c2a2-2224-4649-86e3-f5c303b934f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_80abcf5d-7264-4c57-b3a5-910e1b35085a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_e8d5c2a2-2224-4649-86e3-f5c303b934f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_dd4176ba-c39d-45b8-bb20-b0ed76254611" xlink:href="rdnt-20230331.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_e8d5c2a2-2224-4649-86e3-f5c303b934f0" xlink:to="loc_rdnt_BarclaysMember_dd4176ba-c39d-45b8-bb20-b0ed76254611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a86de0a3-2b08-4e35-a0a3-4ed56f7db10a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a86de0a3-2b08-4e35-a0a3-4ed56f7db10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fbafb7f5-ff69-4640-9e40-7d7c5b419234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a86de0a3-2b08-4e35-a0a3-4ed56f7db10a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fbafb7f5-ff69-4640-9e40-7d7c5b419234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_f79c8574-7678-40ea-a39c-dce1ad97fd20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fbafb7f5-ff69-4640-9e40-7d7c5b419234" xlink:to="loc_us-gaap_LineOfCreditMember_f79c8574-7678-40ea-a39c-dce1ad97fd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a7cb8787-3913-4aa6-b767-f5e2d1083ab0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a7cb8787-3913-4aa6-b767-f5e2d1083ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a0b0bdf4-e1ae-4ba7-8ca0-3fc6974a0033" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a7cb8787-3913-4aa6-b767-f5e2d1083ab0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a0b0bdf4-e1ae-4ba7-8ca0-3fc6974a0033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember_5e82a0b0-a067-4edc-94c8-17acc25cab0d" xlink:href="rdnt-20230331.xsd#rdnt_MedicVisionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a0b0bdf4-e1ae-4ba7-8ca0-3fc6974a0033" xlink:to="loc_rdnt_MedicVisionMember_5e82a0b0-a067-4edc-94c8-17acc25cab0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember_d45abcbb-8d80-4c48-a6d3-1cfbc5ebc954" xlink:href="rdnt-20230331.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a0b0bdf4-e1ae-4ba7-8ca0-3fc6974a0033" xlink:to="loc_rdnt_TurnerImagingSystemsMember_d45abcbb-8d80-4c48-a6d3-1cfbc5ebc954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbit.aiInc.Member_60506dad-0811-4713-8230-13ec0c6458f2" xlink:href="rdnt-20230331.xsd#rdnt_WhiteRabbit.aiInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a0b0bdf4-e1ae-4ba7-8ca0-3fc6974a0033" xlink:to="loc_rdnt_WhiteRabbit.aiInc.Member_60506dad-0811-4713-8230-13ec0c6458f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_60d80869-472f-4eab-89a8-052eb31452af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_srt_CounterpartyNameAxis_60d80869-472f-4eab-89a8-052eb31452af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fc4f8da5-cf4c-4ed2-a553-a8e7fa06f1d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_60d80869-472f-4eab-89a8-052eb31452af" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fc4f8da5-cf4c-4ed2-a553-a8e7fa06f1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_113610aa-6f1b-4c86-be64-25e6d962cb79" xlink:href="rdnt-20230331.xsd#rdnt_DignityHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fc4f8da5-cf4c-4ed2-a553-a8e7fa06f1d7" xlink:to="loc_rdnt_DignityHealthMember_113610aa-6f1b-4c86-be64-25e6d962cb79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_a2707a32-068a-4a75-9859-9cd4411a926f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_a2707a32-068a-4a75-9859-9cd4411a926f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_f275caeb-224b-4b84-9293-b798c837d694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_a2707a32-068a-4a75-9859-9cd4411a926f" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_f275caeb-224b-4b84-9293-b798c837d694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember_441e7532-01b4-4edd-9bd1-4ed98a58f40b" xlink:href="rdnt-20230331.xsd#rdnt_JointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_f275caeb-224b-4b84-9293-b798c837d694" xlink:to="loc_rdnt_JointVentureMember_441e7532-01b4-4edd-9bd1-4ed98a58f40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_489d767b-6c3a-4a59-9c58-11a617b78988" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_dei_LegalEntityAxis_489d767b-6c3a-4a59-9c58-11a617b78988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6acd3e9a-2f4e-4f18-886b-c60a04000624" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_489d767b-6c3a-4a59-9c58-11a617b78988" xlink:to="loc_dei_EntityDomain_6acd3e9a-2f4e-4f18-886b-c60a04000624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember_6bd125c9-dfae-4e2a-bcd0-13e9d1c12fef" xlink:href="rdnt-20230331.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_6acd3e9a-2f4e-4f18-886b-c60a04000624" xlink:to="loc_rdnt_GlendaleAdvancedImagingMember_6bd125c9-dfae-4e2a-bcd0-13e9d1c12fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_0bc3bd99-bc47-4674-8f39-da4f09312075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_0bc3bd99-bc47-4674-8f39-da4f09312075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_f3c5aae2-5aca-4d05-aa5f-bc7b292286d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_0bc3bd99-bc47-4674-8f39-da4f09312075" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_f3c5aae2-5aca-4d05-aa5f-bc7b292286d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_bc31e099-b37c-4f7e-896b-85ed10554d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_f3c5aae2-5aca-4d05-aa5f-bc7b292286d8" xlink:to="loc_us-gaap_CommercialPaperMember_bc31e099-b37c-4f7e-896b-85ed10554d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b4b865d-126c-409e-aeb6-52f487a2bf96" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments_a822460b-28d8-4a65-8361-ceb274c64cb5" xlink:href="rdnt-20230331.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_AdvanceMedicarePayments_a822460b-28d8-4a65-8361-ceb274c64cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfAdvanceMedicarePayments_2801532f-c2a6-4f37-ba28-9747d93bf25f" xlink:href="rdnt-20230331.xsd#rdnt_RepaymentOfAdvanceMedicarePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_RepaymentOfAdvanceMedicarePayments_2801532f-c2a6-4f37-ba28-9747d93bf25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable_be60cdfc-b33c-4244-88d7-4a73d3c75cc3" xlink:href="rdnt-20230331.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_ContractsReceivableFactoringReceivable_be60cdfc-b33c-4244-88d7-4a73d3c75cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_891426a0-8da2-430d-8fd2-2ffd30f1d3db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_891426a0-8da2-430d-8fd2-2ffd30f1d3db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e14a18a9-83e7-45a2-b7a7-49a1e6d32fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e14a18a9-83e7-45a2-b7a7-49a1e6d32fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b3e37406-3e17-41f8-a785-9b4fb1c27d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_Goodwill_b3e37406-3e17-41f8-a785-9b4fb1c27d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2cc64a54-5010-4f49-a2d1-6e3f9be9bd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2cc64a54-5010-4f49-a2d1-6e3f9be9bd5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_29e5402c-85a5-413a-aec1-aa2263b35b48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_29e5402c-85a5-413a-aec1-aa2263b35b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_10b1c262-e595-4c5c-ba8f-29d34de96786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_10b1c262-e595-4c5c-ba8f-29d34de96786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8101774a-78a8-4e12-802c-b41d28b31ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8101774a-78a8-4e12-802c-b41d28b31ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_3ea159d7-6344-4b62-9960-10987dd4439a" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_3ea159d7-6344-4b62-9960-10987dd4439a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9f6a2afe-2379-4cea-85fa-c7fac7ee8756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9f6a2afe-2379-4cea-85fa-c7fac7ee8756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ea8f983f-3033-4a54-9a86-27aa0fcd5347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ea8f983f-3033-4a54-9a86-27aa0fcd5347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f0512a8b-cbe0-47e8-ac53-c042691e2006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f0512a8b-cbe0-47e8-ac53-c042691e2006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_be63bebf-04bf-4aa5-a544-c169eab510a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_be63bebf-04bf-4aa5-a544-c169eab510a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_dae36329-5e84-448e-885e-ab97ca659343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_dae36329-5e84-448e-885e-ab97ca659343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_64ff0dc4-0fe5-4916-a94d-df3e4501c594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_64ff0dc4-0fe5-4916-a94d-df3e4501c594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f460c3dd-e29e-44d5-ac81-c4b25e8c98f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_StockholdersEquity_f460c3dd-e29e-44d5-ac81-c4b25e8c98f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_b7f083a4-6d2c-4253-8692-1660233c33b5" xlink:href="rdnt-20230331.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_b7f083a4-6d2c-4253-8692-1660233c33b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e1189e9e-3bf2-45b8-9f60-8066a6d65ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e1189e9e-3bf2-45b8-9f60-8066a6d65ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_bd7dc6a2-9582-41c9-9570-d382373ac970" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_bd7dc6a2-9582-41c9-9570-d382373ac970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_aede298f-730a-458c-b486-070d9f46773e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_aede298f-730a-458c-b486-070d9f46773e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne_d9b44e4b-f667-40f1-bd28-2bff24cb33b1" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne_d9b44e4b-f667-40f1-bd28-2bff24cb33b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo_127740bc-71b5-440b-a4e4-a6f1165d9960" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo_127740bc-71b5-440b-a4e4-a6f1165d9960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_6c6be953-e7e8-4560-85bb-46dcdc6c94c2" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_6c6be953-e7e8-4560-85bb-46dcdc6c94c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_37427e9c-9b94-4fdd-8ea0-a2205ad79669" xlink:href="rdnt-20230331.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_37427e9c-9b94-4fdd-8ea0-a2205ad79669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_ac1f9495-32d7-4761-9715-b6fa31e8f123" xlink:href="rdnt-20230331.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_ac1f9495-32d7-4761-9715-b6fa31e8f123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_a4a0b424-5677-4c23-bf93-bc9ff03500c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_a4a0b424-5677-4c23-bf93-bc9ff03500c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_9b774ea8-d331-4919-a50b-4763c6c1a9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_SharePrice_9b774ea8-d331-4919-a50b-4763c6c1a9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_979dc378-9dc3-4642-b487-0e2dd3156ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_LineOfCredit_979dc378-9dc3-4642-b487-0e2dd3156ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities_29bc0b97-58c6-4e38-be07-f7939ead7f43" xlink:href="rdnt-20230331.xsd#rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities_29bc0b97-58c6-4e38-be07-f7939ead7f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_0290220f-cc85-4d18-928c-4b8556b38365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_0290220f-cc85-4d18-928c-4b8556b38365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_b670b1ea-11c3-4c40-bbe2-dc5a009bddb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_b670b1ea-11c3-4c40-bbe2-dc5a009bddb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased_d02a0ca5-4eef-402b-ba2c-6de965595c39" xlink:href="rdnt-20230331.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_EquityMethodInvestmentSharesPurchased_d02a0ca5-4eef-402b-ba2c-6de965595c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_bbdf6ff2-58b8-4723-8c1a-af37aaf97d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_bbdf6ff2-58b8-4723-8c1a-af37aaf97d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_d25f63bf-e849-4ea5-bc4b-c2e9cfbd7cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_ShortTermBorrowings_d25f63bf-e849-4ea5-bc4b-c2e9cfbd7cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_8d56ae52-bcd9-4a70-a451-947eace8c435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_8d56ae52-bcd9-4a70-a451-947eace8c435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_2c09559e-5714-471c-9571-fb2d993b200d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_2c09559e-5714-471c-9571-fb2d993b200d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures_6c368893-89c4-4a48-8252-4ac3721ec116" xlink:href="rdnt-20230331.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_NumberofUnconsolidatedJointVentures_6c368893-89c4-4a48-8252-4ac3721ec116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_a434799f-3989-4171-b4de-b7c9bea4339b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_a434799f-3989-4171-b4de-b7c9bea4339b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees_35aa7a9c-3510-4276-9d55-2a4d89c9bf29" xlink:href="rdnt-20230331.xsd#rdnt_ManagementServiceFees"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_604fc50d-2f36-4862-b2a3-822eb0ef7811" xlink:to="loc_rdnt_ManagementServiceFees_35aa7a9c-3510-4276-9d55-2a4d89c9bf29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4bb82ab2-bf2c-4755-be9c-48c8f30a80cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_8c26d6eb-c9a1-43f2-b9a3-764373d1236c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4bb82ab2-bf2c-4755-be9c-48c8f30a80cf" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_8c26d6eb-c9a1-43f2-b9a3-764373d1236c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_86122684-4da8-42ce-a320-ffef18b5be7a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_8c26d6eb-c9a1-43f2-b9a3-764373d1236c" xlink:to="loc_srt_ProductOrServiceAxis_86122684-4da8-42ce-a320-ffef18b5be7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1f6b95d2-9e69-4e93-8daf-9ab14be2c548" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_86122684-4da8-42ce-a320-ffef18b5be7a" xlink:to="loc_srt_ProductsAndServicesDomain_1f6b95d2-9e69-4e93-8daf-9ab14be2c548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:href="rdnt-20230331.xsd#rdnt_ImagingCenterSegmentRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1f6b95d2-9e69-4e93-8daf-9ab14be2c548" xlink:to="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member_807ddfac-5c0b-4729-ad6f-70c05cf89e97" xlink:href="rdnt-20230331.xsd#rdnt_CommercialInsurance1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_rdnt_CommercialInsurance1Member_807ddfac-5c0b-4729-ad6f-70c05cf89e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member_35bd3637-138b-4784-a4a7-3f7372300c79" xlink:href="rdnt-20230331.xsd#rdnt_Medicare1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_rdnt_Medicare1Member_35bd3637-138b-4784-a4a7-3f7372300c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member_e4febdff-d2b7-46d2-8259-3121af53505e" xlink:href="rdnt-20230331.xsd#rdnt_Medicaid1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_rdnt_Medicaid1Member_e4febdff-d2b7-46d2-8259-3121af53505e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member_e7d61826-1cc9-44bf-95ef-96292635a8da" xlink:href="rdnt-20230331.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_rdnt_WorkersCompensationPersonalInjury1Member_e7d61826-1cc9-44bf-95ef-96292635a8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember_fc5dac77-4fc1-4f07-b317-e9a70fa4adb7" xlink:href="rdnt-20230331.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_rdnt_HealthCarePatientServiceOtherMember_fc5dac77-4fc1-4f07-b317-e9a70fa4adb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember_ad803c16-b97f-4ef3-b6d6-34206fd951b9" xlink:href="rdnt-20230331.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_rdnt_HealthCareManagementServiceMember_ad803c16-b97f-4ef3-b6d6-34206fd951b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TeleradiologyandSoftwareMember_59cf8c31-7263-41ee-87ef-a0546fdd4826" xlink:href="rdnt-20230331.xsd#rdnt_TeleradiologyandSoftwareMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_rdnt_TeleradiologyandSoftwareMember_59cf8c31-7263-41ee-87ef-a0546fdd4826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_88945e9b-cc4e-49c9-8968-ece205713f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOtherMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_us-gaap_HealthCareOtherMember_88945e9b-cc4e-49c9-8968-ece205713f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_9f270abe-c908-42f7-b2d9-167cdef6ec88" xlink:href="rdnt-20230331.xsd#rdnt_CapitationArrangementsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_dc20b0a8-f913-431f-82d2-eefd5ee00fb2" xlink:to="loc_rdnt_CapitationArrangementsMember_9f270abe-c908-42f7-b2d9-167cdef6ec88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_2ee50593-1cf9-42f8-9729-43bc8f0bdca0" xlink:href="rdnt-20230331.xsd#rdnt_AIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1f6b95d2-9e69-4e93-8daf-9ab14be2c548" xlink:to="loc_rdnt_AIMember_2ee50593-1cf9-42f8-9729-43bc8f0bdca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_6e9ae276-3cb6-4ff3-8686-c2cc1fe17674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_8c26d6eb-c9a1-43f2-b9a3-764373d1236c" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_6e9ae276-3cb6-4ff3-8686-c2cc1fe17674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1e02dc1d-86a2-420a-a2a9-4cf315f13d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_6e9ae276-3cb6-4ff3-8686-c2cc1fe17674" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1e02dc1d-86a2-420a-a2a9-4cf315f13d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9f5a5484-37ec-4ad2-94d7-1565761359b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_f4cb2259-ffd7-4cab-a7fa-38ac32f0c8db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9f5a5484-37ec-4ad2-94d7-1565761359b9" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_f4cb2259-ffd7-4cab-a7fa-38ac32f0c8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d50b0366-1086-4e2e-b9f9-e01591a17f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f4cb2259-ffd7-4cab-a7fa-38ac32f0c8db" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d50b0366-1086-4e2e-b9f9-e01591a17f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_50e6e124-0e5b-4d75-a550-00a6e7b153f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d50b0366-1086-4e2e-b9f9-e01591a17f7d" xlink:to="loc_us-gaap_SegmentDomain_50e6e124-0e5b-4d75-a550-00a6e7b153f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_401f62a5-d432-4518-ab70-e6ae5cdd1019" xlink:href="rdnt-20230331.xsd#rdnt_ImagingCentersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_50e6e124-0e5b-4d75-a550-00a6e7b153f2" xlink:to="loc_rdnt_ImagingCentersMember_401f62a5-d432-4518-ab70-e6ae5cdd1019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArtificialIntelligenceMember_14c41981-1f3c-41e6-9a6d-43f487fbd7e6" xlink:href="rdnt-20230331.xsd#rdnt_ArtificialIntelligenceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_50e6e124-0e5b-4d75-a550-00a6e7b153f2" xlink:to="loc_rdnt_ArtificialIntelligenceMember_14c41981-1f3c-41e6-9a6d-43f487fbd7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_bfdd9eec-cf19-4f2e-a086-848a6ecd7ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f4cb2259-ffd7-4cab-a7fa-38ac32f0c8db" xlink:to="loc_us-gaap_GoodwillLineItems_bfdd9eec-cf19-4f2e-a086-848a6ecd7ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_7eff52c8-e9fc-486f-bc81-38aeb312113a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_bfdd9eec-cf19-4f2e-a086-848a6ecd7ebb" xlink:to="loc_us-gaap_GoodwillRollForward_7eff52c8-e9fc-486f-bc81-38aeb312113a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_14e7b50d-8f04-4293-a866-5a93da07a7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7eff52c8-e9fc-486f-bc81-38aeb312113a" xlink:to="loc_us-gaap_Goodwill_14e7b50d-8f04-4293-a866-5a93da07a7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_7a9ee334-401e-42bd-a247-b8f49a93f9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7eff52c8-e9fc-486f-bc81-38aeb312113a" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_7a9ee334-401e-42bd-a247-b8f49a93f9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_900cf43c-6cc8-41fc-80b6-a934eb11d456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7eff52c8-e9fc-486f-bc81-38aeb312113a" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_900cf43c-6cc8-41fc-80b6-a934eb11d456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9a6fb803-8bb1-430b-b93c-f85936092204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7eff52c8-e9fc-486f-bc81-38aeb312113a" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9a6fb803-8bb1-430b-b93c-f85936092204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4ad14150-1f4c-4098-97d4-db0b72c72942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7eff52c8-e9fc-486f-bc81-38aeb312113a" xlink:to="loc_us-gaap_Goodwill_4ad14150-1f4c-4098-97d4-db0b72c72942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0f155959-d25f-4161-89f0-e9a8656dfba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7f068243-6f01-4087-a719-287bbd4459a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0f155959-d25f-4161-89f0-e9a8656dfba9" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7f068243-6f01-4087-a719-287bbd4459a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d41c257-27a4-4623-b33e-4e1f725c8f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7f068243-6f01-4087-a719-287bbd4459a8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d41c257-27a4-4623-b33e-4e1f725c8f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb6ee89-5663-4194-b2b3-0cb3ff40bd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d41c257-27a4-4623-b33e-4e1f725c8f73" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb6ee89-5663-4194-b2b3-0cb3ff40bd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_37e7bd81-3246-4a61-8e86-0f65d8643d6c" xlink:href="rdnt-20230331.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb6ee89-5663-4194-b2b3-0cb3ff40bd3a" xlink:to="loc_rdnt_ManagementServiceContractsMember_37e7bd81-3246-4a61-8e86-0f65d8643d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CovenantNotToCompeteMember_d35c02fc-3fcd-4aaa-8fdd-9ec0cedaf24c" xlink:href="rdnt-20230331.xsd#rdnt_CovenantNotToCompeteMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb6ee89-5663-4194-b2b3-0cb3ff40bd3a" xlink:to="loc_rdnt_CovenantNotToCompeteMember_d35c02fc-3fcd-4aaa-8fdd-9ec0cedaf24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_06cfd30b-431b-41e0-a7b3-a5750eb86f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb6ee89-5663-4194-b2b3-0cb3ff40bd3a" xlink:to="loc_us-gaap_CustomerRelationshipsMember_06cfd30b-431b-41e0-a7b3-a5750eb86f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatentAndTrademarksMember_5e6aab41-e531-4d49-b1d0-79705c4e0ba5" xlink:href="rdnt-20230331.xsd#rdnt_PatentAndTrademarksMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb6ee89-5663-4194-b2b3-0cb3ff40bd3a" xlink:to="loc_rdnt_PatentAndTrademarksMember_5e6aab41-e531-4d49-b1d0-79705c4e0ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DevelopedTechnologySoftwareMember_5d70b1d1-ded9-427f-9929-8308068a227c" xlink:href="rdnt-20230331.xsd#rdnt_DevelopedTechnologySoftwareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb6ee89-5663-4194-b2b3-0cb3ff40bd3a" xlink:to="loc_rdnt_DevelopedTechnologySoftwareMember_5d70b1d1-ded9-427f-9929-8308068a227c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_92ef5a68-ab8f-4da9-9331-146c166368a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb6ee89-5663-4194-b2b3-0cb3ff40bd3a" xlink:to="loc_us-gaap_TradeNamesMember_92ef5a68-ab8f-4da9-9331-146c166368a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7f068243-6f01-4087-a719-287bbd4459a8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_cc2fd0ca-47ba-4694-aab7-9e492e32c035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_cc2fd0ca-47ba-4694-aab7-9e492e32c035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_cce04d4b-02d8-4980-baad-d0200a790c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_cce04d4b-02d8-4980-baad-d0200a790c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c35ca295-8946-47d8-87af-9e9cbdceed03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c35ca295-8946-47d8-87af-9e9cbdceed03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_16620ce6-5912-4bdb-bd8c-5eaf7d83ea64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_16620ce6-5912-4bdb-bd8c-5eaf7d83ea64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5af9db26-a622-44ac-851d-a8c383fde522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5af9db26-a622-44ac-851d-a8c383fde522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_aa9d76cd-2e36-4ab0-8807-cc9b764ec50c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_aa9d76cd-2e36-4ab0-8807-cc9b764ec50c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_da28ce43-b0fa-421b-9139-50f13ea4063c" xlink:href="rdnt-20230331.xsd#rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_da28ce43-b0fa-421b-9139-50f13ea4063c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e04fc81c-fd41-42d3-94d8-6403fe2de636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e04fc81c-fd41-42d3-94d8-6403fe2de636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8d9f5685-9184-4b89-8865-c9bd5f478954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8d9f5685-9184-4b89-8865-c9bd5f478954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_4a457f3c-b9ec-45cd-9b35-df9baf0adaa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d7cb9a3b-4a56-48d7-8c80-daa19045a89a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_4a457f3c-b9ec-45cd-9b35-df9baf0adaa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_d6719e07-d2ea-42bf-8e90-944464a2bcb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0f155959-d25f-4161-89f0-e9a8656dfba9" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_d6719e07-d2ea-42bf-8e90-944464a2bcb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7a58a580-ba8b-45fb-b264-0871e61d45d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_d6719e07-d2ea-42bf-8e90-944464a2bcb9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7a58a580-ba8b-45fb-b264-0871e61d45d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_12ce433c-420d-41c3-b5c5-61768466a925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7a58a580-ba8b-45fb-b264-0871e61d45d1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_12ce433c-420d-41c3-b5c5-61768466a925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_5b4414df-6cd7-4b24-9e7c-ece7e8a6ea14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_12ce433c-420d-41c3-b5c5-61768466a925" xlink:to="loc_us-gaap_TradeNamesMember_5b4414df-6cd7-4b24-9e7c-ece7e8a6ea14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_2dfb05e9-8217-4b4c-8c92-d08fb371ab31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_12ce433c-420d-41c3-b5c5-61768466a925" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_2dfb05e9-8217-4b4c-8c92-d08fb371ab31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_d950627d-8ec8-40c5-93ab-f25468c07404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_d6719e07-d2ea-42bf-8e90-944464a2bcb9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_d950627d-8ec8-40c5-93ab-f25468c07404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d7a91c7f-0493-4fa4-b722-d815a65d5357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_d950627d-8ec8-40c5-93ab-f25468c07404" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d7a91c7f-0493-4fa4-b722-d815a65d5357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_85b246b6-15cc-469f-9322-4b1086678988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0f155959-d25f-4161-89f0-e9a8656dfba9" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_85b246b6-15cc-469f-9322-4b1086678988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_377e5ae2-f736-4dc3-b6cd-a36b41896c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_a9091106-f724-42f3-8c65-8c130c5b9d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_377e5ae2-f736-4dc3-b6cd-a36b41896c3b" xlink:to="loc_us-gaap_OffsettingAssetsTable_a9091106-f724-42f3-8c65-8c130c5b9d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_268761e3-724c-42ed-b081-e503bfc27565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_a9091106-f724-42f3-8c65-8c130c5b9d43" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_268761e3-724c-42ed-b081-e503bfc27565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_29bc6482-e107-48e6-bf96-9a4c8d8b98df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_268761e3-724c-42ed-b081-e503bfc27565" xlink:to="loc_us-gaap_EquityComponentDomain_29bc6482-e107-48e6-bf96-9a4c8d8b98df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5c251156-9972-4db4-b817-ccb02081d0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_29bc6482-e107-48e6-bf96-9a4c8d8b98df" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5c251156-9972-4db4-b817-ccb02081d0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_43438f85-0958-42eb-9504-ce7492d55a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_a9091106-f724-42f3-8c65-8c130c5b9d43" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_43438f85-0958-42eb-9504-ce7492d55a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ef259b8e-615c-44d9-9e51-1a235b630c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_43438f85-0958-42eb-9504-ce7492d55a5a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ef259b8e-615c-44d9-9e51-1a235b630c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_fc142af6-2b16-4ce8-8062-1659e67fe2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ef259b8e-615c-44d9-9e51-1a235b630c11" xlink:to="loc_us-gaap_InterestExpenseMember_fc142af6-2b16-4ce8-8062-1659e67fe2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f3996ed0-e48e-4522-8270-4e5070c0f3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_a9091106-f724-42f3-8c65-8c130c5b9d43" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f3996ed0-e48e-4522-8270-4e5070c0f3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ac853b82-3e16-4cbf-85f6-f4e668a45b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f3996ed0-e48e-4522-8270-4e5070c0f3b1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ac853b82-3e16-4cbf-85f6-f4e668a45b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_bd1a7816-017e-4197-a4e4-493d1a9b45be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac853b82-3e16-4cbf-85f6-f4e668a45b30" xlink:to="loc_us-gaap_InterestRateSwapMember_bd1a7816-017e-4197-a4e4-493d1a9b45be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_b4d7200f-f951-49f6-8f99-b6b250123f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_a9091106-f724-42f3-8c65-8c130c5b9d43" xlink:to="loc_us-gaap_OffsettingAssetsLineItems_b4d7200f-f951-49f6-8f99-b6b250123f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_114abfbe-d0de-41fd-87a8-b67f027dd3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_b4d7200f-f951-49f6-8f99-b6b250123f6a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_114abfbe-d0de-41fd-87a8-b67f027dd3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_977420d2-a980-4e0e-95da-0058a636b1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_b4d7200f-f951-49f6-8f99-b6b250123f6a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_977420d2-a980-4e0e-95da-0058a636b1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_81b9a73d-a064-4e45-8168-935d7c87a8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_b4d7200f-f951-49f6-8f99-b6b250123f6a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_81b9a73d-a064-4e45-8168-935d7c87a8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b042d6b5-925e-43a3-8da5-7321cd20ed50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_b4d7200f-f951-49f6-8f99-b6b250123f6a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b042d6b5-925e-43a3-8da5-7321cd20ed50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_85eed947-8660-4f5a-b45a-8c37deaaf935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_b4d7200f-f951-49f6-8f99-b6b250123f6a" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_85eed947-8660-4f5a-b45a-8c37deaaf935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_19a6a20b-3dde-4882-ad7c-28acc6de8b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_b4d7200f-f951-49f6-8f99-b6b250123f6a" xlink:to="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_19a6a20b-3dde-4882-ad7c-28acc6de8b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_695e63fe-8518-4dc0-bc03-6f436a5d8285" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_076a342f-7a5c-4677-acd5-2ea54af4aba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_695e63fe-8518-4dc0-bc03-6f436a5d8285" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_076a342f-7a5c-4677-acd5-2ea54af4aba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_21420c79-80a5-4f7e-92e5-a52b1f6ec48b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_076a342f-7a5c-4677-acd5-2ea54af4aba5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_21420c79-80a5-4f7e-92e5-a52b1f6ec48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6a1dcf1-f49e-4fab-af2b-34507ed10911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_21420c79-80a5-4f7e-92e5-a52b1f6ec48b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6a1dcf1-f49e-4fab-af2b-34507ed10911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_5b30f56e-db8e-47b7-b903-4c44c0693130" xlink:href="rdnt-20230331.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6a1dcf1-f49e-4fab-af2b-34507ed10911" xlink:to="loc_rdnt_AidenceMember_5b30f56e-db8e-47b7-b903-4c44c0693130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_4b827a40-3b0f-4d05-a168-f3317bee7512" xlink:href="rdnt-20230331.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6a1dcf1-f49e-4fab-af2b-34507ed10911" xlink:to="loc_rdnt_QuantibMember_4b827a40-3b0f-4d05-a168-f3317bee7512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_693c7366-1b72-41a0-b698-afe0a2e053f7" xlink:href="rdnt-20230331.xsd#rdnt_MontclairMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6a1dcf1-f49e-4fab-af2b-34507ed10911" xlink:to="loc_rdnt_MontclairMember_693c7366-1b72-41a0-b698-afe0a2e053f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_8b821e50-ee7e-4e4b-b908-5ce7a6dd15b0" xlink:href="rdnt-20230331.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6a1dcf1-f49e-4fab-af2b-34507ed10911" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_8b821e50-ee7e-4e4b-b908-5ce7a6dd15b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_83856aba-60ca-46b7-8335-63f7304423a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_076a342f-7a5c-4677-acd5-2ea54af4aba5" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_83856aba-60ca-46b7-8335-63f7304423a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_1be016c7-410a-400f-897c-aab8ff846ddc" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_83856aba-60ca-46b7-8335-63f7304423a0" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_1be016c7-410a-400f-897c-aab8ff846ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a714e129-1287-46cf-9a8b-927bb2572ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_1be016c7-410a-400f-897c-aab8ff846ddc" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a714e129-1287-46cf-9a8b-927bb2572ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration_bdf35737-c0a9-4d19-a5d2-3a6709b7c26c" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_1be016c7-410a-400f-897c-aab8ff846ddc" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration_bdf35737-c0a9-4d19-a5d2-3a6709b7c26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_aea6b0c3-d082-4f6b-b159-abe4f181e322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_1be016c7-410a-400f-897c-aab8ff846ddc" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_aea6b0c3-d082-4f6b-b159-abe4f181e322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_cb3adc45-70e3-431f-ab94-dbfe241717be" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_1be016c7-410a-400f-897c-aab8ff846ddc" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_cb3adc45-70e3-431f-ab94-dbfe241717be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2c96d9c0-7015-421a-9c13-2281def4c7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_1be016c7-410a-400f-897c-aab8ff846ddc" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2c96d9c0-7015-421a-9c13-2281def4c7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f216270b-42d7-4968-97b3-bc0c301d9dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a0f618d8-4d31-4774-85e2-c56fdd5026ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f216270b-42d7-4968-97b3-bc0c301d9dc0" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a0f618d8-4d31-4774-85e2-c56fdd5026ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c7a4259b-ff72-494d-b2ac-4d1584d0c855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a0f618d8-4d31-4774-85e2-c56fdd5026ad" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c7a4259b-ff72-494d-b2ac-4d1584d0c855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5f31ec04-325f-43f2-b48d-78f576d3434c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c7a4259b-ff72-494d-b2ac-4d1584d0c855" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5f31ec04-325f-43f2-b48d-78f576d3434c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6cea72b0-ed89-441f-bf3d-a5989dbbaf6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5f31ec04-325f-43f2-b48d-78f576d3434c" xlink:to="loc_us-gaap_InterestRateSwapMember_6cea72b0-ed89-441f-bf3d-a5989dbbaf6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_a3ce00f5-cad0-46c2-81f9-f3d02622a8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a0f618d8-4d31-4774-85e2-c56fdd5026ad" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_a3ce00f5-cad0-46c2-81f9-f3d02622a8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6425413b-3009-4b6c-89d4-abd8a0913d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_a3ce00f5-cad0-46c2-81f9-f3d02622a8d1" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6425413b-3009-4b6c-89d4-abd8a0913d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_073de062-27c3-4f63-b6db-bdb101ecbf1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6425413b-3009-4b6c-89d4-abd8a0913d54" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_073de062-27c3-4f63-b6db-bdb101ecbf1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_78157b8d-2189-4637-882f-3d97df6ad46b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_073de062-27c3-4f63-b6db-bdb101ecbf1d" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_78157b8d-2189-4637-882f-3d97df6ad46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_92380c74-41e5-4d35-8874-d33a3b55eeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a0f618d8-4d31-4774-85e2-c56fdd5026ad" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_92380c74-41e5-4d35-8874-d33a3b55eeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b15945c8-919e-4e67-a10a-f9836a710cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_92380c74-41e5-4d35-8874-d33a3b55eeb7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b15945c8-919e-4e67-a10a-f9836a710cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_761f155b-97a2-4b6f-abd6-0caf6117dd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b15945c8-919e-4e67-a10a-f9836a710cac" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_761f155b-97a2-4b6f-abd6-0caf6117dd7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f790b538-72fb-481e-8a89-c35f492380d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b15945c8-919e-4e67-a10a-f9836a710cac" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f790b538-72fb-481e-8a89-c35f492380d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0e7a1081-66ab-4273-882b-23cdda6ba2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b15945c8-919e-4e67-a10a-f9836a710cac" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0e7a1081-66ab-4273-882b-23cdda6ba2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_46d35f69-815a-46cc-80a4-fffc4c0c817e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a0f618d8-4d31-4774-85e2-c56fdd5026ad" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_46d35f69-815a-46cc-80a4-fffc4c0c817e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45fe3462-5e75-4033-a3a8-82dd1ebea3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_46d35f69-815a-46cc-80a4-fffc4c0c817e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45fe3462-5e75-4033-a3a8-82dd1ebea3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_36c5a491-c70b-4b78-b6fa-4cb074363fe1" xlink:href="rdnt-20230331.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45fe3462-5e75-4033-a3a8-82dd1ebea3b5" xlink:to="loc_rdnt_QuantibMember_36c5a491-c70b-4b78-b6fa-4cb074363fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_30855b14-416c-49bc-a502-70935a0a8280" xlink:href="rdnt-20230331.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45fe3462-5e75-4033-a3a8-82dd1ebea3b5" xlink:to="loc_rdnt_AidenceMember_30855b14-416c-49bc-a502-70935a0a8280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_b706b797-48e0-4bad-87b8-b55b7ba0f2b3" xlink:href="rdnt-20230331.xsd#rdnt_MontclairMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45fe3462-5e75-4033-a3a8-82dd1ebea3b5" xlink:to="loc_rdnt_MontclairMember_b706b797-48e0-4bad-87b8-b55b7ba0f2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_2f18d955-1a0e-492f-992f-a8922caab945" xlink:href="rdnt-20230331.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45fe3462-5e75-4033-a3a8-82dd1ebea3b5" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_2f18d955-1a0e-492f-992f-a8922caab945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d3a9c4ae-866a-460a-bece-f82e1b61b9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a0f618d8-4d31-4774-85e2-c56fdd5026ad" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d3a9c4ae-866a-460a-bece-f82e1b61b9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_74022ee4-9e00-426f-8c7f-1057b120b872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d3a9c4ae-866a-460a-bece-f82e1b61b9e8" xlink:to="loc_us-gaap_DerivativeAssets_74022ee4-9e00-426f-8c7f-1057b120b872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_4a2884a8-2000-4790-b419-957330824113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d3a9c4ae-866a-460a-bece-f82e1b61b9e8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_4a2884a8-2000-4790-b419-957330824113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_3fabcaab-073a-4755-ba46-9f823bd83d38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d3a9c4ae-866a-460a-bece-f82e1b61b9e8" xlink:to="loc_us-gaap_DebtInstrumentFairValue_3fabcaab-073a-4755-ba46-9f823bd83d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_d5d9b197-b82b-4adc-b813-a854b4f537e7" xlink:href="rdnt-20230331.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d3a9c4ae-866a-460a-bece-f82e1b61b9e8" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_d5d9b197-b82b-4adc-b813-a854b4f537e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1c574675-457d-469e-bed3-82df9731170c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_81b92d49-8024-49e2-9de7-92aec9c2a1ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1c574675-457d-469e-bed3-82df9731170c" xlink:to="loc_us-gaap_NetIncomeLoss_81b92d49-8024-49e2-9de7-92aec9c2a1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_0bcfeeca-d2ab-435e-a961-2ba5e8ceb120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1c574675-457d-469e-bed3-82df9731170c" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_0bcfeeca-d2ab-435e-a961-2ba5e8ceb120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a38ba43b-f23a-49d9-9d0c-51f7576203a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_0bcfeeca-d2ab-435e-a961-2ba5e8ceb120" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a38ba43b-f23a-49d9-9d0c-51f7576203a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0532024b-483b-4d12-b132-03071a93a984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_0bcfeeca-d2ab-435e-a961-2ba5e8ceb120" xlink:to="loc_us-gaap_EarningsPerShareBasic_0532024b-483b-4d12-b132-03071a93a984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_057216d5-79fb-4a1d-ac57-2cb9f21a4149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_0bcfeeca-d2ab-435e-a961-2ba5e8ceb120" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_057216d5-79fb-4a1d-ac57-2cb9f21a4149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_40cd9827-7eb1-4c81-9603-f6187aeaad8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_0bcfeeca-d2ab-435e-a961-2ba5e8ceb120" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_40cd9827-7eb1-4c81-9603-f6187aeaad8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8e2023cf-d065-4243-b407-7f9b3ff381d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_0bcfeeca-d2ab-435e-a961-2ba5e8ceb120" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8e2023cf-d065-4243-b407-7f9b3ff381d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c9e09442-af72-4844-a84d-fc7d4195d2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_0bcfeeca-d2ab-435e-a961-2ba5e8ceb120" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c9e09442-af72-4844-a84d-fc7d4195d2b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted_4ef831a0-06b3-44b8-b7f4-0f3e8e104c16" xlink:href="rdnt-20230331.xsd#rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_0bcfeeca-d2ab-435e-a961-2ba5e8ceb120" xlink:to="loc_rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted_4ef831a0-06b3-44b8-b7f4-0f3e8e104c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9a457f5f-39dd-42cc-9f1f-62e85ba64d60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1c574675-457d-469e-bed3-82df9731170c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9a457f5f-39dd-42cc-9f1f-62e85ba64d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b838c240-c9b0-4cf1-8bcd-bbfbf2aedb97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9a457f5f-39dd-42cc-9f1f-62e85ba64d60" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b838c240-c9b0-4cf1-8bcd-bbfbf2aedb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_608aadc8-dc5c-4be3-ade7-af0d2f127938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b838c240-c9b0-4cf1-8bcd-bbfbf2aedb97" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_608aadc8-dc5c-4be3-ade7-af0d2f127938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_1d84e14a-62ec-4366-b514-fb4611639cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_608aadc8-dc5c-4be3-ade7-af0d2f127938" xlink:to="loc_us-gaap_RestrictedStockMember_1d84e14a-62ec-4366-b514-fb4611639cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_20d02f1d-0e6d-4a24-90a5-b4ce1a9afd56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_608aadc8-dc5c-4be3-ade7-af0d2f127938" xlink:to="loc_us-gaap_EmployeeStockOptionMember_20d02f1d-0e6d-4a24-90a5-b4ce1a9afd56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentSharesMember_830d885c-0b3a-4786-a060-4f769a812d31" xlink:href="rdnt-20230331.xsd#rdnt_ContingentSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_608aadc8-dc5c-4be3-ade7-af0d2f127938" xlink:to="loc_rdnt_ContingentSharesMember_830d885c-0b3a-4786-a060-4f769a812d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f57b5121-6237-442b-8735-63b78dce2eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9a457f5f-39dd-42cc-9f1f-62e85ba64d60" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f57b5121-6237-442b-8735-63b78dce2eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_75077ce1-de5b-4101-929c-3314a6935213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f57b5121-6237-442b-8735-63b78dce2eb6" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_75077ce1-de5b-4101-929c-3314a6935213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fdaddcbe-392c-4cbb-99ff-6d8dced8903d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_75077ce1-de5b-4101-929c-3314a6935213" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fdaddcbe-392c-4cbb-99ff-6d8dced8903d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofInvestmentinJointVenturesDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofInvestmentinJointVenturesDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofInvestmentinJointVenturesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6f91e6ab-bf71-4fca-9e14-fe361173304f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_2e84434c-b5b3-4b38-ac19-e684c920b0ca" xlink:href="rdnt-20230331.xsd#rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6f91e6ab-bf71-4fca-9e14-fe361173304f" xlink:to="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_2e84434c-b5b3-4b38-ac19-e684c920b0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_14cca3c6-7efc-42ff-93fd-e913b048ab1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_2e84434c-b5b3-4b38-ac19-e684c920b0ca" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_14cca3c6-7efc-42ff-93fd-e913b048ab1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b2853dbb-f574-46b5-8bde-e71283d157b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_2e84434c-b5b3-4b38-ac19-e684c920b0ca" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b2853dbb-f574-46b5-8bde-e71283d157b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_22bd1530-5256-4a7e-8b67-e154b61f5d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_2e84434c-b5b3-4b38-ac19-e684c920b0ca" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_22bd1530-5256-4a7e-8b67-e154b61f5d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6e0d88b7-dce3-4c39-b285-f38a7a300559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fa252340-d3db-4dfd-a47a-811e8471948f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6e0d88b7-dce3-4c39-b285-f38a7a300559" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fa252340-d3db-4dfd-a47a-811e8471948f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_6d4a6c09-dbe6-4a65-999b-11450f9f98a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fa252340-d3db-4dfd-a47a-811e8471948f" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_6d4a6c09-dbe6-4a65-999b-11450f9f98a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_bb22990b-6e01-4c28-a33f-bb871d0cb0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_6d4a6c09-dbe6-4a65-999b-11450f9f98a5" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_bb22990b-6e01-4c28-a33f-bb871d0cb0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_1a391de4-960e-4a15-9506-a49add7381b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_bb22990b-6e01-4c28-a33f-bb871d0cb0a3" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_1a391de4-960e-4a15-9506-a49add7381b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_697d3a81-036b-470b-9282-4ff8b27c4168" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fa252340-d3db-4dfd-a47a-811e8471948f" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_697d3a81-036b-470b-9282-4ff8b27c4168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4b0bd4ec-2433-4cda-bfb1-e3bb6a2eed46" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_697d3a81-036b-470b-9282-4ff8b27c4168" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4b0bd4ec-2433-4cda-bfb1-e3bb6a2eed46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInterestMember_c02d0fbc-086a-4737-b341-5dd80d7038a3" xlink:href="rdnt-20230331.xsd#rdnt_JointVentureInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4b0bd4ec-2433-4cda-bfb1-e3bb6a2eed46" xlink:to="loc_rdnt_JointVentureInterestMember_c02d0fbc-086a-4737-b341-5dd80d7038a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fa252340-d3db-4dfd-a47a-811e8471948f" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7ba34029-23ee-4e82-8a1a-d2783b27a2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_AssetsCurrent_7ba34029-23ee-4e82-8a1a-d2783b27a2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_602dbf51-a841-4b6b-81f2-ca203165661e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_AssetsNoncurrent_602dbf51-a841-4b6b-81f2-ca203165661e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_71329727-ad01-4b79-999d-07ad3960f686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_LiabilitiesCurrent_71329727-ad01-4b79-999d-07ad3960f686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_97454b9b-99cc-4930-8d46-e413596c092a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_97454b9b-99cc-4930-8d46-e413596c092a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_fa260b6e-1e4f-4808-92bd-ea3a057cd5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_fa260b6e-1e4f-4808-92bd-ea3a057cd5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_39ce04ce-3736-448a-98d5-37496abc3c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_EquityMethodInvestments_39ce04ce-3736-448a-98d5-37496abc3c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_fae5478d-44b7-4e1d-ad04-592dfb391be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_fae5478d-44b7-4e1d-ad04-592dfb391be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_38e5d27e-e40f-40cb-a1a1-f2eabbd616ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_38e5d27e-e40f-40cb-a1a1-f2eabbd616ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6ab244b3-ede1-49cd-bd0c-de2a48eaa1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_Revenues_6ab244b3-ede1-49cd-bd0c-de2a48eaa1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_be106396-f3dc-4b5b-8863-3022ec6745f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e19d73ca-766f-4e2b-9f4e-5ecc24f0a7df" xlink:to="loc_us-gaap_ProfitLoss_be106396-f3dc-4b5b-8863-3022ec6745f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a9c7dd2c-ca47-4007-8d38-598cbc5e93d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b7dcc39b-66df-4f86-8e41-e3a8cea5962e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a9c7dd2c-ca47-4007-8d38-598cbc5e93d4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b7dcc39b-66df-4f86-8e41-e3a8cea5962e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bdadf370-6308-4240-8815-132b20b0c970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b7dcc39b-66df-4f86-8e41-e3a8cea5962e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bdadf370-6308-4240-8815-132b20b0c970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2923a1c3-c178-4d80-8332-f607a828436b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bdadf370-6308-4240-8815-132b20b0c970" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2923a1c3-c178-4d80-8332-f607a828436b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionsMember_808ed8ec-1cd7-4eaf-8363-659e4154d073" xlink:href="rdnt-20230331.xsd#rdnt_BusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2923a1c3-c178-4d80-8332-f607a828436b" xlink:to="loc_rdnt_BusinessAcquisitionsMember_808ed8ec-1cd7-4eaf-8363-659e4154d073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CCDGLRSServicesIncMember_c1723d32-090c-4c87-8146-e60be050141d" xlink:href="rdnt-20230331.xsd#rdnt_CCDGLRSServicesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessAcquisitionsMember_808ed8ec-1cd7-4eaf-8363-659e4154d073" xlink:to="loc_rdnt_CCDGLRSServicesIncMember_c1723d32-090c-4c87-8146-e60be050141d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SouthernCaliforniaDiagnosticImagingIncMember_829abb7c-00ce-4ad5-9b30-b720a27d4c4c" xlink:href="rdnt-20230331.xsd#rdnt_SouthernCaliforniaDiagnosticImagingIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessAcquisitionsMember_808ed8ec-1cd7-4eaf-8363-659e4154d073" xlink:to="loc_rdnt_SouthernCaliforniaDiagnosticImagingIncMember_829abb7c-00ce-4ad5-9b30-b720a27d4c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InglewoodImagingCenterLLCMember_0f10b1c5-e93d-4f27-ae6f-f50941f2dd14" xlink:href="rdnt-20230331.xsd#rdnt_InglewoodImagingCenterLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessAcquisitionsMember_808ed8ec-1cd7-4eaf-8363-659e4154d073" xlink:to="loc_rdnt_InglewoodImagingCenterLLCMember_0f10b1c5-e93d-4f27-ae6f-f50941f2dd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RamapoRadiologyAssociatesPCMember_46fc7fd3-be9d-446c-ae8a-39eb86971335" xlink:href="rdnt-20230331.xsd#rdnt_RamapoRadiologyAssociatesPCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessAcquisitionsMember_808ed8ec-1cd7-4eaf-8363-659e4154d073" xlink:to="loc_rdnt_RamapoRadiologyAssociatesPCMember_46fc7fd3-be9d-446c-ae8a-39eb86971335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b7dcc39b-66df-4f86-8e41-e3a8cea5962e" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8c980dea-daf6-422a-a07d-10a77aa0173e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8c980dea-daf6-422a-a07d-10a77aa0173e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_91e12df8-2f34-44e6-aec1-5f437a212f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_91e12df8-2f34-44e6-aec1-5f437a212f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_e2558acd-89ae-4de9-9349-ea5a6f31c858" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_e2558acd-89ae-4de9-9349-ea5a6f31c858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_eda227e9-f78b-4cf6-b234-22756d97e88c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:to="loc_us-gaap_Goodwill_eda227e9-f78b-4cf6-b234-22756d97e88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_153aeefb-ce03-4bf7-9b43-a087971a5906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_153aeefb-ce03-4bf7-9b43-a087971a5906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_a35cf22c-f721-4eb6-8f94-2c00cd97ed23" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_a35cf22c-f721-4eb6-8f94-2c00cd97ed23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_41317a60-8771-4a57-b9c9-7e7c09b3317c" xlink:href="rdnt-20230331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_61d4a4ca-6a53-4748-b298-bc0ca80caae8" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_41317a60-8771-4a57-b9c9-7e7c09b3317c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SEGMENTREPORTINGDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#SEGMENTREPORTINGDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SEGMENTREPORTINGDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b90c9310-abbf-460e-ad0a-8a63558c333a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9ca4caa2-f82d-466f-8892-6040d2a5478f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b90c9310-abbf-460e-ad0a-8a63558c333a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9ca4caa2-f82d-466f-8892-6040d2a5478f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ccdc72da-7032-4d86-8969-9e6e3d4f1a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9ca4caa2-f82d-466f-8892-6040d2a5478f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ccdc72da-7032-4d86-8969-9e6e3d4f1a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_251ea636-f5e7-448f-957f-e096fd076947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ccdc72da-7032-4d86-8969-9e6e3d4f1a33" xlink:to="loc_us-gaap_SegmentDomain_251ea636-f5e7-448f-957f-e096fd076947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_d813222f-1c82-40c0-baba-697dcd20fe1e" xlink:href="rdnt-20230331.xsd#rdnt_ImagingCentersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_251ea636-f5e7-448f-957f-e096fd076947" xlink:to="loc_rdnt_ImagingCentersMember_d813222f-1c82-40c0-baba-697dcd20fe1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_0a0ae6fd-5ba5-4775-997b-50a3ee3ed20d" xlink:href="rdnt-20230331.xsd#rdnt_AIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_251ea636-f5e7-448f-957f-e096fd076947" xlink:to="loc_rdnt_AIMember_0a0ae6fd-5ba5-4775-997b-50a3ee3ed20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b6ebaa4e-f916-4c9c-803f-5d8f0a819a45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9ca4caa2-f82d-466f-8892-6040d2a5478f" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_b6ebaa4e-f916-4c9c-803f-5d8f0a819a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9316a756-345d-48d6-8cfd-9b1720bbc955" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b6ebaa4e-f916-4c9c-803f-5d8f0a819a45" xlink:to="loc_us-gaap_Revenues_9316a756-345d-48d6-8cfd-9b1720bbc955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_ef34c1a4-4536-4482-9c72-bdc3c87975e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b6ebaa4e-f916-4c9c-803f-5d8f0a819a45" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_ef34c1a4-4536-4482-9c72-bdc3c87975e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1a743e32-d5aa-40ac-b239-39db0579e3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b6ebaa4e-f916-4c9c-803f-5d8f0a819a45" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1a743e32-d5aa-40ac-b239-39db0579e3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_aecf63a5-9632-40b7-b32d-b733f191d3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b6ebaa4e-f916-4c9c-803f-5d8f0a819a45" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_aecf63a5-9632-40b7-b32d-b733f191d3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_9cab03a3-5316-4429-8ced-dda3735beb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b6ebaa4e-f916-4c9c-803f-5d8f0a819a45" xlink:to="loc_us-gaap_SeveranceCosts1_9cab03a3-5316-4429-8ced-dda3735beb5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingIncomeLossExcludingReliefFunding_f4ed4627-7036-48e5-8511-a557e51623a2" xlink:href="rdnt-20230331.xsd#rdnt_OperatingIncomeLossExcludingReliefFunding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b6ebaa4e-f916-4c9c-803f-5d8f0a819a45" xlink:to="loc_rdnt_OperatingIncomeLossExcludingReliefFunding_f4ed4627-7036-48e5-8511-a557e51623a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f16469d5-7200-44d6-9a18-e814c93cad4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9ee1386b-1c18-428f-abdf-dc64e6781295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f16469d5-7200-44d6-9a18-e814c93cad4d" xlink:to="loc_us-gaap_DebtInstrumentTable_9ee1386b-1c18-428f-abdf-dc64e6781295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cb50170a-222a-44b0-9050-0f2db6215316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9ee1386b-1c18-428f-abdf-dc64e6781295" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cb50170a-222a-44b0-9050-0f2db6215316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_46f0a781-7736-4007-b21a-f1ecb20a1edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cb50170a-222a-44b0-9050-0f2db6215316" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_46f0a781-7736-4007-b21a-f1ecb20a1edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_eba6c9ba-74e6-4494-adf9-7dfacaf653d7" xlink:href="rdnt-20230331.xsd#rdnt_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_46f0a781-7736-4007-b21a-f1ecb20a1edb" xlink:to="loc_rdnt_TermLoanMember_eba6c9ba-74e6-4494-adf9-7dfacaf653d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b9b6c741-6fcb-48ca-890b-455278f2f9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9ee1386b-1c18-428f-abdf-dc64e6781295" xlink:to="loc_us-gaap_DebtInstrumentAxis_b9b6c741-6fcb-48ca-890b-455278f2f9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3bb49ddd-4767-4bb6-9b77-5bd2a5ccc8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b9b6c741-6fcb-48ca-890b-455278f2f9f2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3bb49ddd-4767-4bb6-9b77-5bd2a5ccc8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_bb90e23f-b903-492e-9b8b-16e61cd26a13" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3bb49ddd-4767-4bb6-9b77-5bd2a5ccc8ca" xlink:to="loc_rdnt_FirstLienTermLoanMember_bb90e23f-b903-492e-9b8b-16e61cd26a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_421c7aa7-a127-481d-ab7a-42dc92e77ccf" xlink:href="rdnt-20230331.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3bb49ddd-4767-4bb6-9b77-5bd2a5ccc8ca" xlink:to="loc_rdnt_RestatedAgreementMember_421c7aa7-a127-481d-ab7a-42dc92e77ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentNotesPayableMember_52ecaae2-2629-4401-a586-9beff99d19be" xlink:href="rdnt-20230331.xsd#rdnt_EquipmentNotesPayableMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3bb49ddd-4767-4bb6-9b77-5bd2a5ccc8ca" xlink:to="loc_rdnt_EquipmentNotesPayableMember_52ecaae2-2629-4401-a586-9beff99d19be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f9c7f506-9d54-4247-9f3b-7c939dc06caf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9ee1386b-1c18-428f-abdf-dc64e6781295" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f9c7f506-9d54-4247-9f3b-7c939dc06caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2e07a4cb-868f-41b0-ab19-5cc536f424b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9c7f506-9d54-4247-9f3b-7c939dc06caf" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2e07a4cb-868f-41b0-ab19-5cc536f424b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_268eb908-1abd-4db6-a4f4-682dd44985c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9c7f506-9d54-4247-9f3b-7c939dc06caf" xlink:to="loc_us-gaap_LongTermDebt_268eb908-1abd-4db6-a4f4-682dd44985c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_4be723a6-097e-43f9-92ae-712d10bb6fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9c7f506-9d54-4247-9f3b-7c939dc06caf" xlink:to="loc_us-gaap_LongTermDebtCurrent_4be723a6-097e-43f9-92ae-712d10bb6fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4b2dcde2-0070-4398-b03b-54d9d28b278c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9c7f506-9d54-4247-9f3b-7c939dc06caf" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4b2dcde2-0070-4398-b03b-54d9d28b278c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_73c79fa1-b8ba-47dc-bdc5-4b7b84ceb340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9c7f506-9d54-4247-9f3b-7c939dc06caf" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_73c79fa1-b8ba-47dc-bdc5-4b7b84ceb340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0a1000d1-39d3-48b7-8bb4-4169b354dab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0a1000d1-39d3-48b7-8bb4-4169b354dab9" xlink:to="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_639848b6-316a-4bab-8f86-fdcf530ee8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:to="loc_us-gaap_CreditFacilityAxis_639848b6-316a-4bab-8f86-fdcf530ee8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a0108fe6-d28f-405c-9ae0-d64ff55edc34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_639848b6-316a-4bab-8f86-fdcf530ee8ff" xlink:to="loc_us-gaap_CreditFacilityDomain_a0108fe6-d28f-405c-9ae0-d64ff55edc34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_f4f1771d-f2cd-4514-a4ec-7b0750488eed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a0108fe6-d28f-405c-9ae0-d64ff55edc34" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_f4f1771d-f2cd-4514-a4ec-7b0750488eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_ccbc92c6-dfb2-429d-b0c9-11186f119c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a0108fe6-d28f-405c-9ae0-d64ff55edc34" xlink:to="loc_us-gaap_LetterOfCreditMember_ccbc92c6-dfb2-429d-b0c9-11186f119c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0108aec5-79ef-497f-b7b0-b8b7bc322b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:to="loc_us-gaap_DebtInstrumentAxis_0108aec5-79ef-497f-b7b0-b8b7bc322b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1995afc7-360f-4a6a-9128-048e6bf64ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0108aec5-79ef-497f-b7b0-b8b7bc322b2d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1995afc7-360f-4a6a-9128-048e6bf64ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_a039ed2c-92dd-4cfd-8833-21c46fc00599" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1995afc7-360f-4a6a-9128-048e6bf64ed8" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_a039ed2c-92dd-4cfd-8833-21c46fc00599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_60075133-21d3-46ef-bcce-036aeb2412ec" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1995afc7-360f-4a6a-9128-048e6bf64ed8" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_60075133-21d3-46ef-bcce-036aeb2412ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_0c6b2b0f-dc8c-4198-a52c-625adc00ccca" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1995afc7-360f-4a6a-9128-048e6bf64ed8" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_0c6b2b0f-dc8c-4198-a52c-625adc00ccca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_d62fa24b-2553-4b50-8f47-b85fb5366c9f" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1995afc7-360f-4a6a-9128-048e6bf64ed8" xlink:to="loc_rdnt_FirstLienTermLoanMember_d62fa24b-2553-4b50-8f47-b85fb5366c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_3ec76a95-6573-4884-91db-2f2ddbb5f430" xlink:href="rdnt-20230331.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1995afc7-360f-4a6a-9128-048e6bf64ed8" xlink:to="loc_rdnt_RestatedAgreementMember_3ec76a95-6573-4884-91db-2f2ddbb5f430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_4d15eff2-f3c5-4497-98b2-a07dbe28c12f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_4d15eff2-f3c5-4497-98b2-a07dbe28c12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_4a181a5e-72ca-4d96-ad90-d3d89795a045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_4d15eff2-f3c5-4497-98b2-a07dbe28c12f" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_4a181a5e-72ca-4d96-ad90-d3d89795a045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_72479e13-0da7-42bc-a1ca-9a809e0d62da" xlink:href="rdnt-20230331.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_4a181a5e-72ca-4d96-ad90-d3d89795a045" xlink:to="loc_rdnt_BarclaysMember_72479e13-0da7-42bc-a1ca-9a809e0d62da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_15ba2e8c-6aa4-4ede-82ec-d003da6806bb" xlink:href="rdnt-20230331.xsd#rdnt_TruistMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_4a181a5e-72ca-4d96-ad90-d3d89795a045" xlink:to="loc_rdnt_TruistMember_15ba2e8c-6aa4-4ede-82ec-d003da6806bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_03156458-b2de-4713-838d-5af71fdc768d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_03156458-b2de-4713-838d-5af71fdc768d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0fdff532-5832-4f50-bdb3-9cdf67a713a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_03156458-b2de-4713-838d-5af71fdc768d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0fdff532-5832-4f50-bdb3-9cdf67a713a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_eaed57ec-335c-44ec-aa45-b0ad09e740b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0fdff532-5832-4f50-bdb3-9cdf67a713a7" xlink:to="loc_us-gaap_LineOfCreditMember_eaed57ec-335c-44ec-aa45-b0ad09e740b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_32cfe316-d60c-4d38-8f84-854a922353d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0fdff532-5832-4f50-bdb3-9cdf67a713a7" xlink:to="loc_us-gaap_MediumTermNotesMember_32cfe316-d60c-4d38-8f84-854a922353d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_71f45071-f661-4ef0-9abe-becf39bf92e3" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0fdff532-5832-4f50-bdb3-9cdf67a713a7" xlink:to="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_71f45071-f661-4ef0-9abe-becf39bf92e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_9217a2cb-5db6-47d6-b882-607b19f4a276" xlink:href="rdnt-20230331.xsd#rdnt_TermLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0fdff532-5832-4f50-bdb3-9cdf67a713a7" xlink:to="loc_rdnt_TermLoanMember_9217a2cb-5db6-47d6-b882-607b19f4a276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_d153f198-63bc-4c48-833d-3ca433299e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0fdff532-5832-4f50-bdb3-9cdf67a713a7" xlink:to="loc_us-gaap_LetterOfCreditMember_d153f198-63bc-4c48-833d-3ca433299e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_5d0186ce-5fb3-4976-b148-0127676e15ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:to="loc_us-gaap_VariableRateAxis_5d0186ce-5fb3-4976-b148-0127676e15ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8ecc61e5-d113-42aa-a614-63de08c9439f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_5d0186ce-5fb3-4976-b148-0127676e15ca" xlink:to="loc_us-gaap_VariableRateDomain_8ecc61e5-d113-42aa-a614-63de08c9439f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_fa871f76-1f43-4572-865b-c7d98da5c2db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8ecc61e5-d113-42aa-a614-63de08c9439f" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_fa871f76-1f43-4572-865b-c7d98da5c2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_74092077-99ef-4fc9-9ee5-4ef1c51175cd" xlink:href="rdnt-20230331.xsd#rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_fa871f76-1f43-4572-865b-c7d98da5c2db" xlink:to="loc_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_74092077-99ef-4fc9-9ee5-4ef1c51175cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember_5f938329-51e8-4bc3-a4b0-9c2f22392af6" xlink:href="rdnt-20230331.xsd#rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_fa871f76-1f43-4572-865b-c7d98da5c2db" xlink:to="loc_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember_5f938329-51e8-4bc3-a4b0-9c2f22392af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember_665217de-c276-492d-a059-f937d965a008" xlink:href="rdnt-20230331.xsd#rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_fa871f76-1f43-4572-865b-c7d98da5c2db" xlink:to="loc_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember_665217de-c276-492d-a059-f937d965a008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_c266cf19-7657-4098-abe2-3a4de4997d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8ecc61e5-d113-42aa-a614-63de08c9439f" xlink:to="loc_us-gaap_EurodollarMember_c266cf19-7657-4098-abe2-3a4de4997d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_fd778ca1-0ff1-41c5-8697-d51ab98b48ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8ecc61e5-d113-42aa-a614-63de08c9439f" xlink:to="loc_us-gaap_BaseRateMember_fd778ca1-0ff1-41c5-8697-d51ab98b48ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_b0a9b072-1fb5-436e-b6ff-74d7d3c35434" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:to="loc_rdnt_LeverageRatioAxis_b0a9b072-1fb5-436e-b6ff-74d7d3c35434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_c72d50cc-54ab-465d-afed-1f84b5254dcb" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_b0a9b072-1fb5-436e-b6ff-74d7d3c35434" xlink:to="loc_rdnt_LeverageRatioDomain_c72d50cc-54ab-465d-afed-1f84b5254dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_70181ceb-56e4-4c39-a5aa-6940e649246b" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_c72d50cc-54ab-465d-afed-1f84b5254dcb" xlink:to="loc_rdnt_LeverageRatioThreeMember_70181ceb-56e4-4c39-a5aa-6940e649246b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_511eba9a-9079-428e-9ab7-32e370cf23cc" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelIIIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_c72d50cc-54ab-465d-afed-1f84b5254dcb" xlink:to="loc_rdnt_PricingLevelIIIMember_511eba9a-9079-428e-9ab7-32e370cf23cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember_1e8c1265-cb8b-4277-8214-44923cadf1f2" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelIVMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_c72d50cc-54ab-465d-afed-1f84b5254dcb" xlink:to="loc_rdnt_PricingLevelIVMember_1e8c1265-cb8b-4277-8214-44923cadf1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e9b1a6c7-6ed2-4d9d-b346-9414c00a388b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_5f7acba2-2f4a-4727-be06-74649cf99aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_LineOfCredit_5f7acba2-2f4a-4727-be06-74649cf99aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_eef8cf4a-cb16-4390-864e-d9d89579ca57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_eef8cf4a-cb16-4390-864e-d9d89579ca57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_0836d788-5ea1-4328-b0d4-157c8b0063db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_0836d788-5ea1-4328-b0d4-157c8b0063db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_7f01daad-e692-4d49-9db9-633603380c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_7f01daad-e692-4d49-9db9-633603380c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b148be4f-7629-40bc-9b72-0ee3f5a053ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b148be4f-7629-40bc-9b72-0ee3f5a053ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_af2fe28e-ec9b-4b5a-a9fd-973bcc503dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_af2fe28e-ec9b-4b5a-a9fd-973bcc503dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_0f546512-d625-41a1-806d-eba92c2eba59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_0f546512-d625-41a1-806d-eba92c2eba59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_7390255a-810f-4c4e-baa0-e22528f1cdc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_7390255a-810f-4c4e-baa0-e22528f1cdc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d90f20c9-c1e3-46ce-a2d4-27d89f6598b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d90f20c9-c1e3-46ce-a2d4-27d89f6598b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges_655872e8-ef6f-44be-874e-1a1464dccbad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_AmortizationOfDeferredCharges_655872e8-ef6f-44be-874e-1a1464dccbad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d2156d12-4319-4b77-8977-d0b782e7ba04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d2156d12-4319-4b77-8977-d0b782e7ba04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_2743f23e-9690-4dfe-9a7b-18bdbdf3ae68" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_2743f23e-9690-4dfe-9a7b-18bdbdf3ae68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d27af323-ace4-4ec8-9466-1a9ad7f54d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d27af323-ace4-4ec8-9466-1a9ad7f54d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_6c8f36c0-9925-461c-abd4-c07b821511a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_6c8f36c0-9925-461c-abd4-c07b821511a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_99b7ba25-4a1b-40be-9819-1cc8009f2594" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_99b7ba25-4a1b-40be-9819-1cc8009f2594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_c86513ea-6553-4424-b4f9-8c8ed018bb9e" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_c86513ea-6553-4424-b4f9-8c8ed018bb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_dbbcddf0-1bc6-473f-bcd5-0900268d11ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_dbbcddf0-1bc6-473f-bcd5-0900268d11ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_f4f07837-0c2b-4b93-b788-24fb8858d749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_f4f07837-0c2b-4b93-b788-24fb8858d749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_80342e54-9d2e-41ae-beb3-022376f0bb91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_80342e54-9d2e-41ae-beb3-022376f0bb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a54baf27-c6b6-4920-bf44-cdefaf06e086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc68b432-7043-4740-be66-0a491293fe64" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a54baf27-c6b6-4920-bf44-cdefaf06e086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_15114e3e-ad87-4c2d-b46c-0186513f72de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c0bef3a3-2206-45d5-a396-32ee7a9b4f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_15114e3e-ad87-4c2d-b46c-0186513f72de" xlink:to="loc_us-gaap_DebtInstrumentTable_c0bef3a3-2206-45d5-a396-32ee7a9b4f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cc8d78df-3584-45dd-a866-def53f0ad4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c0bef3a3-2206-45d5-a396-32ee7a9b4f8a" xlink:to="loc_us-gaap_DebtInstrumentAxis_cc8d78df-3584-45dd-a866-def53f0ad4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3510e7a9-fb78-4e7d-8812-efcf8bb6fd52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cc8d78df-3584-45dd-a866-def53f0ad4f7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3510e7a9-fb78-4e7d-8812-efcf8bb6fd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_b07d46af-e9a8-4c5b-acd5-313920655aee" xlink:href="rdnt-20230331.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3510e7a9-fb78-4e7d-8812-efcf8bb6fd52" xlink:to="loc_rdnt_RestatedAgreementMember_b07d46af-e9a8-4c5b-acd5-313920655aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f0e09b8d-27cc-4051-b1fb-e3da1b5a09df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c0bef3a3-2206-45d5-a396-32ee7a9b4f8a" xlink:to="loc_us-gaap_CreditFacilityAxis_f0e09b8d-27cc-4051-b1fb-e3da1b5a09df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e1f5be2b-0436-47c2-a99d-61a2841c68a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f0e09b8d-27cc-4051-b1fb-e3da1b5a09df" xlink:to="loc_us-gaap_CreditFacilityDomain_e1f5be2b-0436-47c2-a99d-61a2841c68a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8326a677-dc63-4395-a954-c1541a962743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e1f5be2b-0436-47c2-a99d-61a2841c68a3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8326a677-dc63-4395-a954-c1541a962743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ebab47b9-7579-4640-b54d-a7a32e3a104b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c0bef3a3-2206-45d5-a396-32ee7a9b4f8a" xlink:to="loc_us-gaap_VariableRateAxis_ebab47b9-7579-4640-b54d-a7a32e3a104b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6d055b19-4773-449a-be81-6f5b6e2f71df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_ebab47b9-7579-4640-b54d-a7a32e3a104b" xlink:to="loc_us-gaap_VariableRateDomain_6d055b19-4773-449a-be81-6f5b6e2f71df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_337583fb-4cd7-495f-aff4-7247e8a0596f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_6d055b19-4773-449a-be81-6f5b6e2f71df" xlink:to="loc_us-gaap_EurodollarMember_337583fb-4cd7-495f-aff4-7247e8a0596f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_9b2763b2-d33f-4eb9-9d3c-6497ca1a8570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_6d055b19-4773-449a-be81-6f5b6e2f71df" xlink:to="loc_us-gaap_BaseRateMember_9b2763b2-d33f-4eb9-9d3c-6497ca1a8570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_214072f0-7fa8-41c5-abc5-83559754e500" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c0bef3a3-2206-45d5-a396-32ee7a9b4f8a" xlink:to="loc_rdnt_LeverageRatioAxis_214072f0-7fa8-41c5-abc5-83559754e500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_ac85a20f-5e44-4e77-9315-910ed5a9402f" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_214072f0-7fa8-41c5-abc5-83559754e500" xlink:to="loc_rdnt_LeverageRatioDomain_ac85a20f-5e44-4e77-9315-910ed5a9402f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember_d8c230d5-defd-4088-8825-8a8b8fa0a7f1" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_ac85a20f-5e44-4e77-9315-910ed5a9402f" xlink:to="loc_rdnt_PricingLevelIMember_d8c230d5-defd-4088-8825-8a8b8fa0a7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember_b279f75d-6562-4df4-bb04-7c66433639af" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelIIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_ac85a20f-5e44-4e77-9315-910ed5a9402f" xlink:to="loc_rdnt_PricingLevelIIMember_b279f75d-6562-4df4-bb04-7c66433639af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_ac2ec92f-3124-4866-8541-4f41bca58c36" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelIIIMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_ac85a20f-5e44-4e77-9315-910ed5a9402f" xlink:to="loc_rdnt_PricingLevelIIIMember_ac2ec92f-3124-4866-8541-4f41bca58c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember_5078e097-b31b-4fb2-87cc-2bd12fb6d9b8" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelIVMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_ac85a20f-5e44-4e77-9315-910ed5a9402f" xlink:to="loc_rdnt_PricingLevelIVMember_5078e097-b31b-4fb2-87cc-2bd12fb6d9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember_5cfce4d7-de21-4526-a924-f92a2d7d12e9" xlink:href="rdnt-20230331.xsd#rdnt_PricingLevelVMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_ac85a20f-5e44-4e77-9315-910ed5a9402f" xlink:to="loc_rdnt_PricingLevelVMember_5cfce4d7-de21-4526-a924-f92a2d7d12e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7075f75a-b127-45a0-9e3d-225b918523fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c0bef3a3-2206-45d5-a396-32ee7a9b4f8a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7075f75a-b127-45a0-9e3d-225b918523fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_bf3585a4-8109-46a7-a6c7-26608588465f" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7075f75a-b127-45a0-9e3d-225b918523fc" xlink:to="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_bf3585a4-8109-46a7-a6c7-26608588465f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_e06ae685-6856-443a-9f51-d4b83eef28fa" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7075f75a-b127-45a0-9e3d-225b918523fc" xlink:to="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_e06ae685-6856-443a-9f51-d4b83eef28fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f5652742-b544-4ee7-a052-838735132391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7075f75a-b127-45a0-9e3d-225b918523fc" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f5652742-b544-4ee7-a052-838735132391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_d15d4b5f-b4ce-47b0-b064-019f3ba82b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7075f75a-b127-45a0-9e3d-225b918523fc" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_d15d4b5f-b4ce-47b0-b064-019f3ba82b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_9ae4dcee-1847-45bb-aa79-a1de9d587a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7075f75a-b127-45a0-9e3d-225b918523fc" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_9ae4dcee-1847-45bb-aa79-a1de9d587a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_af32d6f4-9dd2-40a3-93e0-f8f10349c437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_af32d6f4-9dd2-40a3-93e0-f8f10349c437" xlink:to="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_261fbcf8-594e-4874-9101-b04c9afea43b" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:to="loc_rdnt_LeverageRatioAxis_261fbcf8-594e-4874-9101-b04c9afea43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_b75a557b-396e-49f5-aa54-00e55d77956a" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_261fbcf8-594e-4874-9101-b04c9afea43b" xlink:to="loc_rdnt_LeverageRatioDomain_b75a557b-396e-49f5-aa54-00e55d77956a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_3be8c792-c56b-4891-8af3-e2336ca7bd3c" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_b75a557b-396e-49f5-aa54-00e55d77956a" xlink:to="loc_rdnt_LeverageRatioOneMember_3be8c792-c56b-4891-8af3-e2336ca7bd3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember_b408f798-3092-4844-b8f8-e8edeaef32b6" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_b75a557b-396e-49f5-aa54-00e55d77956a" xlink:to="loc_rdnt_LeverageRatioTwoMember_b408f798-3092-4844-b8f8-e8edeaef32b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFourMember_020d1cfb-2956-4d34-acf0-1613cf31d969" xlink:href="rdnt-20230331.xsd#rdnt_LeverageRatioFourMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_b75a557b-396e-49f5-aa54-00e55d77956a" xlink:to="loc_rdnt_LeverageRatioFourMember_020d1cfb-2956-4d34-acf0-1613cf31d969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_cbaa4043-dacc-456c-a624-e18da5508263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:to="loc_us-gaap_CreditFacilityAxis_cbaa4043-dacc-456c-a624-e18da5508263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_dd0a612e-3966-4874-b43a-43a05042436a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_cbaa4043-dacc-456c-a624-e18da5508263" xlink:to="loc_us-gaap_CreditFacilityDomain_dd0a612e-3966-4874-b43a-43a05042436a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8e221803-b056-45d5-ab3f-64ae9e12cd68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_dd0a612e-3966-4874-b43a-43a05042436a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8e221803-b056-45d5-ab3f-64ae9e12cd68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_69f403fc-3c6c-4a73-bc89-af3eab1866b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:to="loc_us-gaap_DebtInstrumentAxis_69f403fc-3c6c-4a73-bc89-af3eab1866b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_35845b71-eb8a-4c8d-9f32-40e16b181413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_69f403fc-3c6c-4a73-bc89-af3eab1866b3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_35845b71-eb8a-4c8d-9f32-40e16b181413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_81d87089-3738-4598-8e5e-2911d4a88a46" xlink:href="rdnt-20230331.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35845b71-eb8a-4c8d-9f32-40e16b181413" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_81d87089-3738-4598-8e5e-2911d4a88a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e7c7625a-bf8a-473c-b679-5c5667650eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e7c7625a-bf8a-473c-b679-5c5667650eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0a8383a7-d430-47c7-8365-5c74474de737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e7c7625a-bf8a-473c-b679-5c5667650eff" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0a8383a7-d430-47c7-8365-5c74474de737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_6361b311-e2dc-4638-9c27-66abf32d96bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0a8383a7-d430-47c7-8365-5c74474de737" xlink:to="loc_us-gaap_LineOfCreditMember_6361b311-e2dc-4638-9c27-66abf32d96bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9a3f7c20-6493-46e5-b4cb-7ee33f241533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:to="loc_us-gaap_VariableRateAxis_9a3f7c20-6493-46e5-b4cb-7ee33f241533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3a589d3e-289d-4a5c-91d1-dff75cbb4528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_9a3f7c20-6493-46e5-b4cb-7ee33f241533" xlink:to="loc_us-gaap_VariableRateDomain_3a589d3e-289d-4a5c-91d1-dff75cbb4528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_ea9252a7-b42d-4e2d-816a-52cef4d6b6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_3a589d3e-289d-4a5c-91d1-dff75cbb4528" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_ea9252a7-b42d-4e2d-816a-52cef4d6b6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_67c6a4c6-70a5-4faf-a374-fc4be140597a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_3a589d3e-289d-4a5c-91d1-dff75cbb4528" xlink:to="loc_us-gaap_BaseRateMember_67c6a4c6-70a5-4faf-a374-fc4be140597a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f2e9ea25-2d2d-4f2b-bd0d-570f9e0b722b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:to="loc_srt_RangeAxis_f2e9ea25-2d2d-4f2b-bd0d-570f9e0b722b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_84ca7c00-b365-4165-926d-e0caf302b292" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f2e9ea25-2d2d-4f2b-bd0d-570f9e0b722b" xlink:to="loc_srt_RangeMember_84ca7c00-b365-4165-926d-e0caf302b292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ae136869-8789-4d2a-84bc-87c1f1c439ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_84ca7c00-b365-4165-926d-e0caf302b292" xlink:to="loc_srt_MaximumMember_ae136869-8789-4d2a-84bc-87c1f1c439ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_040b9bb7-fe1b-4e23-9d3f-5711ef85e018" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_84ca7c00-b365-4165-926d-e0caf302b292" xlink:to="loc_srt_MinimumMember_040b9bb7-fe1b-4e23-9d3f-5711ef85e018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e6298be2-79da-4f11-ae66-84ed43324abe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6d9af5e8-a79a-4c34-8f26-66ad04ddfeb9" xlink:to="loc_us-gaap_DebtInstrumentLineItems_e6298be2-79da-4f11-ae66-84ed43324abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_18108e4c-d6af-499a-b4a1-acb7cf559192" xlink:href="rdnt-20230331.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e6298be2-79da-4f11-ae66-84ed43324abe" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_18108e4c-d6af-499a-b4a1-acb7cf559192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_6024e698-6e2a-4d72-bd31-2e46e9c6480b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e6298be2-79da-4f11-ae66-84ed43324abe" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_6024e698-6e2a-4d72-bd31-2e46e9c6480b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_96b163bf-9a29-4145-a45f-594f97127bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a45917c-5b4b-4a18-905e-f68feb24958d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_96b163bf-9a29-4145-a45f-594f97127bf7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a45917c-5b4b-4a18-905e-f68feb24958d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_61c61895-6515-41dc-8f12-5265d08148e8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a45917c-5b4b-4a18-905e-f68feb24958d" xlink:to="loc_srt_RangeAxis_61c61895-6515-41dc-8f12-5265d08148e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b84a87a5-5dc4-4d77-ba98-70a29acd1bab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_61c61895-6515-41dc-8f12-5265d08148e8" xlink:to="loc_srt_RangeMember_b84a87a5-5dc4-4d77-ba98-70a29acd1bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c131d596-3390-4ffd-b74a-2c9f8bf1dff0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b84a87a5-5dc4-4d77-ba98-70a29acd1bab" xlink:to="loc_srt_MinimumMember_c131d596-3390-4ffd-b74a-2c9f8bf1dff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f65063cb-e303-46f2-9db3-51cea8f81eb3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b84a87a5-5dc4-4d77-ba98-70a29acd1bab" xlink:to="loc_srt_MaximumMember_f65063cb-e303-46f2-9db3-51cea8f81eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_17472c26-b72b-4bfa-ac29-e6e7066aa5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a45917c-5b4b-4a18-905e-f68feb24958d" xlink:to="loc_us-gaap_AwardTypeAxis_17472c26-b72b-4bfa-ac29-e6e7066aa5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f05500a6-965f-412e-a4d7-4b1fae2580d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_17472c26-b72b-4bfa-ac29-e6e7066aa5f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f05500a6-965f-412e-a4d7-4b1fae2580d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ab19dc79-bcd9-4f94-9ba4-97200f3ba45f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f05500a6-965f-412e-a4d7-4b1fae2580d3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ab19dc79-bcd9-4f94-9ba4-97200f3ba45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember_b3641cf7-dd16-4c83-a0b2-3137909d5d79" xlink:href="rdnt-20230331.xsd#rdnt_FutureServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f05500a6-965f-412e-a4d7-4b1fae2580d3" xlink:to="loc_rdnt_FutureServiceMember_b3641cf7-dd16-4c83-a0b2-3137909d5d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockUnitsMember_e153823d-f1c7-4c2f-846a-eae6acf67645" xlink:href="rdnt-20230331.xsd#rdnt_PerformanceBasedStockUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f05500a6-965f-412e-a4d7-4b1fae2580d3" xlink:to="loc_rdnt_PerformanceBasedStockUnitsMember_e153823d-f1c7-4c2f-846a-eae6acf67645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember_8c286a5a-4393-4bc2-b7d3-d2ab76b08257" xlink:href="rdnt-20230331.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f05500a6-965f-412e-a4d7-4b1fae2580d3" xlink:to="loc_rdnt_PerformanceBasedStockOptionsMember_8c286a5a-4393-4bc2-b7d3-d2ab76b08257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember_712cf069-02b1-4729-97b7-7669c93e2fca" xlink:href="rdnt-20230331.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f05500a6-965f-412e-a4d7-4b1fae2580d3" xlink:to="loc_rdnt_LongTermIncentivePlanSharesMember_712cf069-02b1-4729-97b7-7669c93e2fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c2a5488f-354a-4f2e-9440-966552ab42a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a45917c-5b4b-4a18-905e-f68feb24958d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c2a5488f-354a-4f2e-9440-966552ab42a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e51a44b-e53f-4812-a83a-0d05f0c14294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c2a5488f-354a-4f2e-9440-966552ab42a5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e51a44b-e53f-4812-a83a-0d05f0c14294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_08c3f954-1e02-4b42-911c-d4d736fd6943" xlink:href="rdnt-20230331.xsd#rdnt_DeepHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e51a44b-e53f-4812-a83a-0d05f0c14294" xlink:to="loc_rdnt_DeepHealthIncMember_08c3f954-1e02-4b42-911c-d4d736fd6943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_b6c15554-28a0-4268-964f-7c90fc01c092" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a45917c-5b4b-4a18-905e-f68feb24958d" xlink:to="loc_srt_TitleOfIndividualAxis_b6c15554-28a0-4268-964f-7c90fc01c092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32b055cb-6db2-45d0-a5f6-f93a6547ce36" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_b6c15554-28a0-4268-964f-7c90fc01c092" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32b055cb-6db2-45d0-a5f6-f93a6547ce36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_f1f5c478-2a7c-447d-a578-72628dcd9e42" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32b055cb-6db2-45d0-a5f6-f93a6547ce36" xlink:to="loc_srt_DirectorMember_f1f5c478-2a7c-447d-a578-72628dcd9e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a45917c-5b4b-4a18-905e-f68feb24958d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_8f06f4ae-b1d6-4463-9861-5c4aaedfd9b9" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_8f06f4ae-b1d6-4463-9861-5c4aaedfd9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a126fd82-1f2d-40c8-b75d-8451c3fadbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a126fd82-1f2d-40c8-b75d-8451c3fadbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c9f202bb-975c-4bca-b46b-76c66431849a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c9f202bb-975c-4bca-b46b-76c66431849a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c6928a8d-c3c7-419e-be46-9e456f66944d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c6928a8d-c3c7-419e-be46-9e456f66944d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8a887084-e1e5-4b94-985c-a4ab8e2e43d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8a887084-e1e5-4b94-985c-a4ab8e2e43d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8820c6ba-2396-4ec3-900d-b7497dc570d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8820c6ba-2396-4ec3-900d-b7497dc570d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0ac085a9-72b4-4ee7-b662-bb93c022baec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0ac085a9-72b4-4ee7-b662-bb93c022baec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e92b6aef-9b0e-4173-ac95-7ce670e4db9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e92b6aef-9b0e-4173-ac95-7ce670e4db9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_99bce166-3271-4342-afce-0b55ac9c4a40" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_99bce166-3271-4342-afce-0b55ac9c4a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_21a7a5a8-3517-47eb-a12e-f207e6c046ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_21a7a5a8-3517-47eb-a12e-f207e6c046ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_4e4e9334-a0ad-44e0-9b2b-79504852fc7d" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_4e4e9334-a0ad-44e0-9b2b-79504852fc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_46d09979-854d-4c7e-b303-a5979ad61695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_46d09979-854d-4c7e-b303-a5979ad61695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_e5671fd2-d326-481c-a299-7f959f16ae43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_SharesIssued_e5671fd2-d326-481c-a299-7f959f16ae43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_9215f8ff-cdac-4f3c-a615-3b2d04ba1cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_9215f8ff-cdac-4f3c-a615-3b2d04ba1cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_85e38891-8f88-454a-b54c-14f1128a5a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_85e38891-8f88-454a-b54c-14f1128a5a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_802dc245-b5a3-48ac-9248-a341425a28b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1443718d-a528-4e4a-8d40-33698f42c72a" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_802dc245-b5a3-48ac-9248-a341425a28b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1ebc6fe2-d52a-4aa0-85fc-358f0a05c575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6a10f2ec-084a-46c9-a789-7f87fe11ce29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1ebc6fe2-d52a-4aa0-85fc-358f0a05c575" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6a10f2ec-084a-46c9-a789-7f87fe11ce29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_185a8b6d-a6a5-4784-80ca-0c0a321f7213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6a10f2ec-084a-46c9-a789-7f87fe11ce29" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_185a8b6d-a6a5-4784-80ca-0c0a321f7213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0277fcc7-964b-4ccd-9782-e4bfe59b7a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_185a8b6d-a6a5-4784-80ca-0c0a321f7213" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0277fcc7-964b-4ccd-9782-e4bfe59b7a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_36fc14b1-6b1b-40c5-903c-3837e065957f" xlink:href="rdnt-20230331.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0277fcc7-964b-4ccd-9782-e4bfe59b7a4f" xlink:to="loc_rdnt_DeepHealthInc.Member_36fc14b1-6b1b-40c5-903c-3837e065957f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd407f93-b43c-496b-9af9-e9dd0fd08948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6a10f2ec-084a-46c9-a789-7f87fe11ce29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd407f93-b43c-496b-9af9-e9dd0fd08948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_28bd567b-dddc-48be-b314-95fd376abe54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd407f93-b43c-496b-9af9-e9dd0fd08948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_28bd567b-dddc-48be-b314-95fd376abe54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d1537fed-b068-4be6-92a5-5ec546b7942d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_28bd567b-dddc-48be-b314-95fd376abe54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d1537fed-b068-4be6-92a5-5ec546b7942d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a172e903-225a-4f47-80bf-2a694b582833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_28bd567b-dddc-48be-b314-95fd376abe54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a172e903-225a-4f47-80bf-2a694b582833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d3bc34f6-747a-43db-9473-1e680440661a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_28bd567b-dddc-48be-b314-95fd376abe54" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d3bc34f6-747a-43db-9473-1e680440661a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fc44c9ec-e2de-4251-af97-83bbc650673a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_28bd567b-dddc-48be-b314-95fd376abe54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fc44c9ec-e2de-4251-af97-83bbc650673a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a045d65e-ef6f-4ead-9155-5546e8c627c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd407f93-b43c-496b-9af9-e9dd0fd08948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a045d65e-ef6f-4ead-9155-5546e8c627c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a30b11de-b05c-49ea-b3fe-f267cf0749f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd407f93-b43c-496b-9af9-e9dd0fd08948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a30b11de-b05c-49ea-b3fe-f267cf0749f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_011e5ad5-b589-490a-8a99-0ec3c1c68080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a30b11de-b05c-49ea-b3fe-f267cf0749f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_011e5ad5-b589-490a-8a99-0ec3c1c68080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0568f8d5-2815-4df0-a254-83b1bc429e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a30b11de-b05c-49ea-b3fe-f267cf0749f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0568f8d5-2815-4df0-a254-83b1bc429e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8353ced3-c67b-497c-9926-50c5b2f15f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a30b11de-b05c-49ea-b3fe-f267cf0749f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8353ced3-c67b-497c-9926-50c5b2f15f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_64e115da-e485-452b-922f-deb878d72987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a30b11de-b05c-49ea-b3fe-f267cf0749f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_64e115da-e485-452b-922f-deb878d72987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_75c8232b-069f-42bf-b948-11a36ce706f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd407f93-b43c-496b-9af9-e9dd0fd08948" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_75c8232b-069f-42bf-b948-11a36ce706f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife_66a64abc-6b66-4fa8-afb9-fdceff7e7a8c" xlink:href="rdnt-20230331.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd407f93-b43c-496b-9af9-e9dd0fd08948" xlink:to="loc_rdnt_WeightedAverageRemainingContractualLife_66a64abc-6b66-4fa8-afb9-fdceff7e7a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_605d3265-c8e8-46fb-89ec-b166b46231bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_66a64abc-6b66-4fa8-afb9-fdceff7e7a8c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_605d3265-c8e8-46fb-89ec-b166b46231bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_b21ef353-cd2e-4eaa-b64e-a6cfe42182bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_66a64abc-6b66-4fa8-afb9-fdceff7e7a8c" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_b21ef353-cd2e-4eaa-b64e-a6cfe42182bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue_df6acaf1-8b0f-4b05-8e16-c7f78be66978" xlink:href="rdnt-20230331.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd407f93-b43c-496b-9af9-e9dd0fd08948" xlink:to="loc_rdnt_AggregateIntrinsicValue_df6acaf1-8b0f-4b05-8e16-c7f78be66978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_80762664-0d08-4f48-8e9b-f99611d85d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AggregateIntrinsicValue_df6acaf1-8b0f-4b05-8e16-c7f78be66978" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_80762664-0d08-4f48-8e9b-f99611d85d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4a865882-a7e1-47c8-adcc-7b5aa02a8fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AggregateIntrinsicValue_df6acaf1-8b0f-4b05-8e16-c7f78be66978" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4a865882-a7e1-47c8-adcc-7b5aa02a8fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5640b8f8-9955-43fb-ae3a-0dbeef054596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_548c139e-6305-4aa3-9361-20794d3f37b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5640b8f8-9955-43fb-ae3a-0dbeef054596" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_548c139e-6305-4aa3-9361-20794d3f37b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1ff2cebb-432a-4ad0-8d74-7fefee30ad4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_548c139e-6305-4aa3-9361-20794d3f37b2" xlink:to="loc_us-gaap_AwardTypeAxis_1ff2cebb-432a-4ad0-8d74-7fefee30ad4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c01d0a4f-eae5-414e-ab76-eeff9fba4d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1ff2cebb-432a-4ad0-8d74-7fefee30ad4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c01d0a4f-eae5-414e-ab76-eeff9fba4d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_96965714-7e91-483b-aa0d-7df2683d9ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c01d0a4f-eae5-414e-ab76-eeff9fba4d20" xlink:to="loc_us-gaap_RestrictedStockMember_96965714-7e91-483b-aa0d-7df2683d9ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9bd1c4d-85d3-4592-b91f-a3b23075fcee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_548c139e-6305-4aa3-9361-20794d3f37b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9bd1c4d-85d3-4592-b91f-a3b23075fcee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_f5ea7609-ae94-4dc7-a955-6bde9468da85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9bd1c4d-85d3-4592-b91f-a3b23075fcee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_f5ea7609-ae94-4dc7-a955-6bde9468da85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6880c82d-9eb9-4847-96d3-aa84a7479c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_f5ea7609-ae94-4dc7-a955-6bde9468da85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6880c82d-9eb9-4847-96d3-aa84a7479c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fabbe754-c7e3-474c-8233-903a2e739ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_f5ea7609-ae94-4dc7-a955-6bde9468da85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fabbe754-c7e3-474c-8233-903a2e739ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a82a4154-2d9d-40bf-a3f7-f1900362bf6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_f5ea7609-ae94-4dc7-a955-6bde9468da85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a82a4154-2d9d-40bf-a3f7-f1900362bf6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_8c373b86-8c72-44d8-b956-0f3dbe1fd06f" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_f5ea7609-ae94-4dc7-a955-6bde9468da85" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_8c373b86-8c72-44d8-b956-0f3dbe1fd06f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_09a4bc28-c4b5-40df-9811-8601f6028a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_f5ea7609-ae94-4dc7-a955-6bde9468da85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_09a4bc28-c4b5-40df-9811-8601f6028a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_16345a62-b296-412f-9a1c-5269130dee2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9bd1c4d-85d3-4592-b91f-a3b23075fcee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_16345a62-b296-412f-9a1c-5269130dee2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c721abe2-b482-46a0-a4f8-0e125380448b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9bd1c4d-85d3-4592-b91f-a3b23075fcee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c721abe2-b482-46a0-a4f8-0e125380448b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_850fee9a-8c64-468f-89ac-14850027570a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c721abe2-b482-46a0-a4f8-0e125380448b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_850fee9a-8c64-468f-89ac-14850027570a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dda0ba19-9abe-4d24-8d61-4bf626b05bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c721abe2-b482-46a0-a4f8-0e125380448b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dda0ba19-9abe-4d24-8d61-4bf626b05bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_70101a94-bdea-4ff8-8386-32095e314332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c721abe2-b482-46a0-a4f8-0e125380448b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_70101a94-bdea-4ff8-8386-32095e314332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_bdc43a16-743c-45b1-9219-330bd16ed95d" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c721abe2-b482-46a0-a4f8-0e125380448b" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_bdc43a16-743c-45b1-9219-330bd16ed95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5eccabff-ce98-4c85-be3a-7cf9685e5546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c721abe2-b482-46a0-a4f8-0e125380448b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5eccabff-ce98-4c85-be3a-7cf9685e5546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails" xlink:type="simple" xlink:href="rdnt-20230331.xsd#STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ea4b180d-50f6-406b-9db4-f569c6c06ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_133af644-dd09-4c7c-9852-74a1b3dfad01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ea4b180d-50f6-406b-9db4-f569c6c06ae0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_133af644-dd09-4c7c-9852-74a1b3dfad01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c78f9526-e69c-49f0-ab1e-2bee8a101845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_133af644-dd09-4c7c-9852-74a1b3dfad01" xlink:to="loc_us-gaap_AwardTypeAxis_c78f9526-e69c-49f0-ab1e-2bee8a101845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_40e21a25-db15-4aea-a059-6222d07172a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c78f9526-e69c-49f0-ab1e-2bee8a101845" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_40e21a25-db15-4aea-a059-6222d07172a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember_82a2f1f8-c281-41d4-8212-51232a73d94c" xlink:href="rdnt-20230331.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_40e21a25-db15-4aea-a059-6222d07172a9" xlink:to="loc_rdnt_LongTermIncentivePlanSharesMember_82a2f1f8-c281-41d4-8212-51232a73d94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02c36076-ca73-45b9-94f2-15df566218c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_133af644-dd09-4c7c-9852-74a1b3dfad01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02c36076-ca73-45b9-94f2-15df566218c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0975bc6f-9ef7-41f7-b593-df8cf84fa19c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02c36076-ca73-45b9-94f2-15df566218c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0975bc6f-9ef7-41f7-b593-df8cf84fa19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9964fda4-37e1-4bd2-aba4-c8cd4559c12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0975bc6f-9ef7-41f7-b593-df8cf84fa19c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9964fda4-37e1-4bd2-aba4-c8cd4559c12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_bd870af1-b5e1-4d36-8f66-6bb89d658013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0975bc6f-9ef7-41f7-b593-df8cf84fa19c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_bd870af1-b5e1-4d36-8f66-6bb89d658013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_02b9cc34-a873-421d-bad8-5e51ee7165ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0975bc6f-9ef7-41f7-b593-df8cf84fa19c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_02b9cc34-a873-421d-bad8-5e51ee7165ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_e3c80664-d220-4da4-a964-bc08b9e9b9a8" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0975bc6f-9ef7-41f7-b593-df8cf84fa19c" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_e3c80664-d220-4da4-a964-bc08b9e9b9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6ec2ee3f-b24a-43b2-a431-64f067628867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0975bc6f-9ef7-41f7-b593-df8cf84fa19c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6ec2ee3f-b24a-43b2-a431-64f067628867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_63a4e1b1-673f-4910-befd-12fda2497d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02c36076-ca73-45b9-94f2-15df566218c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_63a4e1b1-673f-4910-befd-12fda2497d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8bdd8eec-7760-43f2-8df2-a037ecae81d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02c36076-ca73-45b9-94f2-15df566218c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8bdd8eec-7760-43f2-8df2-a037ecae81d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_46d74c9b-827d-42d1-ada8-043fd5f43ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8bdd8eec-7760-43f2-8df2-a037ecae81d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_46d74c9b-827d-42d1-ada8-043fd5f43ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_72d3cf90-8fd3-4006-8889-d82cd50d6554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8bdd8eec-7760-43f2-8df2-a037ecae81d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_72d3cf90-8fd3-4006-8889-d82cd50d6554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8cf7ab2c-08d6-41f1-97fa-7fb2697b9194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8bdd8eec-7760-43f2-8df2-a037ecae81d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8cf7ab2c-08d6-41f1-97fa-7fb2697b9194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_5d4fa3eb-bea4-4461-85f3-7fff3e572153" xlink:href="rdnt-20230331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8bdd8eec-7760-43f2-8df2-a037ecae81d0" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_5d4fa3eb-bea4-4461-85f3-7fff3e572153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_860e7fd4-d59e-441e-94ff-0c6bf806a5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8bdd8eec-7760-43f2-8df2-a037ecae81d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_860e7fd4-d59e-441e-94ff-0c6bf806a5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480669262784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>May 04, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RadNet, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">478-7808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RDNT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,345,891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480662502832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 90,844<span></span>
</td>
<td class="nump">$ 127,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">176,354<span></span>
</td>
<td class="nump">166,357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from affiliates</a></td>
<td class="nump">20,387<span></span>
</td>
<td class="nump">18,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">55,100<span></span>
</td>
<td class="nump">54,022<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">342,685<span></span>
</td>
<td class="nump">367,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract', window );"><strong>PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">545,492<span></span>
</td>
<td class="nump">565,961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">623,309<span></span>
</td>
<td class="nump">603,524<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets', window );">Total property, equipment and right-of-use assets</a></td>
<td class="nump">1,168,801<span></span>
</td>
<td class="nump">1,169,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>OTHER ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">687,085<span></span>
</td>
<td class="nump">677,665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">103,003<span></span>
</td>
<td class="nump">106,228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Deferred financing costs</a></td>
<td class="nump">2,122<span></span>
</td>
<td class="nump">2,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="nump">59,321<span></span>
</td>
<td class="nump">57,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssets', window );">Deposits and other</a></td>
<td class="nump">51,052<span></span>
</td>
<td class="nump">53,172<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,414,069<span></span>
</td>
<td class="nump">2,433,907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable, accrued expenses and other</a></td>
<td class="nump">296,727<span></span>
</td>
<td class="nump">369,595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Due to affiliates</a></td>
<td class="nump">31,548<span></span>
</td>
<td class="nump">23,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">4,343<span></span>
</td>
<td class="nump">4,021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liability</a></td>
<td class="nump">58,590<span></span>
</td>
<td class="nump">57,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Current portion of notes payable</a></td>
<td class="nump">15,935<span></span>
</td>
<td class="nump">12,400<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">407,143<span></span>
</td>
<td class="nump">466,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG-TERM LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liability</a></td>
<td class="nump">623,538<span></span>
</td>
<td class="nump">604,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of current portion</a></td>
<td class="nump">852,354<span></span>
</td>
<td class="nump">839,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability, net</a></td>
<td class="nump">10,410<span></span>
</td>
<td class="nump">9,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">27,523<span></span>
</td>
<td class="nump">23,015<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,920,968<span></span>
</td>
<td class="nump">1,942,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock - $0.0001 par value, 200,000,000 shares authorized; 58,270,290 and 57,723,125 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">448,522<span></span>
</td>
<td class="nump">436,288<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(16,978)<span></span>
</td>
<td class="num">(20,677)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(103,628)<span></span>
</td>
<td class="num">(82,622)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total RadNet, Inc.'s stockholders' equity</a></td>
<td class="nump">327,922<span></span>
</td>
<td class="nump">332,995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">165,179<span></span>
</td>
<td class="nump">158,457<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">493,101<span></span>
</td>
<td class="nump">491,452<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 2,414,069<span></span>
</td>
<td class="nump">$ 2,433,907<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property Plant and Equipment Net Including Right of Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480669126288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock - par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock - shares authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock - shares issued (in shares)</a></td>
<td class="nump">58,270,290<span></span>
</td>
<td class="nump">57,723,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock - outstanding (in shares)</a></td>
<td class="nump">58,270,290<span></span>
</td>
<td class="nump">57,723,125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480669274960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total service revenue</a></td>
<td class="nump">$ 390,564<span></span>
</td>
<td class="nump">$ 341,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingExpensesExcludingDepreciationAndAmortization', window );">Cost of operations, excluding depreciation and amortization</a></td>
<td class="nump">351,865<span></span>
</td>
<td class="nump">315,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">31,315<span></span>
</td>
<td class="nump">27,118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on sale and disposal of equipment and other</a></td>
<td class="nump">579<span></span>
</td>
<td class="nump">1,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">201<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">383,893<span></span>
</td>
<td class="nump">343,486<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">INCOME (LOSS) FROM OPERATIONS</a></td>
<td class="nump">6,671<span></span>
</td>
<td class="num">(1,719)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>OTHER INCOME AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="nump">15,722<span></span>
</td>
<td class="nump">11,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of joint ventures</a></td>
<td class="num">(1,428)<span></span>
</td>
<td class="num">(2,517)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1', window );">Non-cash change in fair value of interest rate hedge</a></td>
<td class="nump">4,093<span></span>
</td>
<td class="num">(20,819)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expenses</a></td>
<td class="nump">1,432<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense (income)</a></td>
<td class="nump">19,819<span></span>
</td>
<td class="num">(11,578)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(LOSS) INCOME BEFORE INCOME TAXES</a></td>
<td class="num">(13,148)<span></span>
</td>
<td class="nump">9,859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(1,135)<span></span>
</td>
<td class="num">(1,496)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET (LOSS) INCOME</a></td>
<td class="num">(14,283)<span></span>
</td>
<td class="nump">8,363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">6,722<span></span>
</td>
<td class="nump">5,350<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</a></td>
<td class="num">$ (21,005)<span></span>
</td>
<td class="nump">$ 3,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</a></td>
<td class="num">$ (0.36)<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</a></td>
<td class="num">$ (0.36)<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EarningPerShareBasicAndDilutedAbstract', window );"><strong>WEIGHTED AVERAGE SHARES OUTSTANDING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">57,701,439<span></span>
</td>
<td class="nump">55,303,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">57,701,439<span></span>
</td>
<td class="nump">56,362,193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total service revenue</a></td>
<td class="nump">$ 352,420<span></span>
</td>
<td class="nump">$ 303,276<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember', window );">Revenue under capitation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total service revenue</a></td>
<td class="nump">$ 38,144<span></span>
</td>
<td class="nump">$ 38,491<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EarningPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earning Per Share, Basic and Diluted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EarningPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingExpensesExcludingDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses, Excluding Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingExpensesExcludingDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) included in earnings related to the fair value of the hedged item in an interest rate fair value hedge, offset by the gain (loss) on the hedging instrument to the extent that the fair value hedge is determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480666417200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET (LOSS) INCOME</a></td>
<td class="num">$ (14,283)<span></span>
</td>
<td class="nump">$ 8,363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">2,777<span></span>
</td>
<td class="num">(1,264)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</a></td>
<td class="nump">922<span></span>
</td>
<td class="nump">923<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">COMPREHENSIVE (LOSS) INCOME</a></td>
<td class="num">(10,584)<span></span>
</td>
<td class="nump">8,022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">6,722<span></span>
</td>
<td class="nump">5,350<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</a></td>
<td class="num">$ (17,306)<span></span>
</td>
<td class="nump">$ 2,672<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480662125888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>DeepHealth, Inc.</div></th>
<th class="th"><div>Total Radnet, Inc.'s Equity</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>DeepHealth, Inc.</div>
</th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,548,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 346,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 228,904<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 342,592<span></span>
</td>
<td class="num">$ (20,421)<span></span>
</td>
<td class="num">$ (93,272)<span></span>
</td>
<td class="nump">$ 117,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">530,188<span></span>
</td>
<td class="nump">13,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">10,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock for acquisitions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,106,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for acquisitions</a></td>
<td class="nump">56,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Change in cumulative foreign currency translation adjustment</a></td>
<td class="num">(1,264)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,264)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,264)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</a></td>
<td class="nump">923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="nump">8,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,013<span></span>
</td>
<td class="nump">5,350<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,197,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 421,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,847<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">409,863<span></span>
</td>
<td class="num">(20,761)<span></span>
</td>
<td class="num">(90,260)<span></span>
</td>
<td class="nump">122,603<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">57,723,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,723,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 491,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">332,995<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">436,288<span></span>
</td>
<td class="num">(20,677)<span></span>
</td>
<td class="num">(82,622)<span></span>
</td>
<td class="nump">158,457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">14,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">527,692<span></span>
</td>
<td class="nump">14,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">12,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Change in cumulative foreign currency translation adjustment</a></td>
<td class="nump">2,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</a></td>
<td class="nump">922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (14,283)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,005)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,005)<span></span>
</td>
<td class="nump">6,722<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="nump">58,270,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,270,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 493,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 327,922<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 448,522<span></span>
</td>
<td class="num">$ (16,978)<span></span>
</td>
<td class="num">$ (103,628)<span></span>
</td>
<td class="nump">$ 165,179<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480662391600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (14,283)<span></span>
</td>
<td class="nump">$ 8,363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">31,315<span></span>
</td>
<td class="nump">27,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease right-of-use assets</a></td>
<td class="nump">15,699<span></span>
</td>
<td class="nump">16,802<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Equity in earnings of joint ventures, net of dividends</a></td>
<td class="num">(1,835)<span></span>
</td>
<td class="num">(2,517)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs and loan discount</a></td>
<td class="nump">746<span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on sale and disposal of equipment and other</a></td>
<td class="nump">579<span></span>
</td>
<td class="nump">1,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredHedgeGains', window );">Amortization of cash flow hedge, net of taxes</a></td>
<td class="nump">922<span></span>
</td>
<td class="nump">923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Non-cash change in fair value of interest rate hedge</a></td>
<td class="nump">4,093<span></span>
</td>
<td class="num">(20,819)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">12,185<span></span>
</td>
<td class="nump">11,102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">2,335<span></span>
</td>
<td class="num">(501)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(9,997)<span></span>
</td>
<td class="num">(23,904)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other current assets</a></td>
<td class="num">(1,691)<span></span>
</td>
<td class="num">(4,065)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(2,726)<span></span>
</td>
<td class="num">(1,417)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="nump">942<span></span>
</td>
<td class="nump">1,387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(15,080)<span></span>
</td>
<td class="num">(15,859)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">335<span></span>
</td>
<td class="num">(4,519)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other</a></td>
<td class="nump">9,077<span></span>
</td>
<td class="nump">7,031<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">32,616<span></span>
</td>
<td class="nump">901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBuildings', window );">Purchase of imaging centers and other acquisitions</a></td>
<td class="num">(9,644)<span></span>
</td>
<td class="num">(25,123)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(55,915)<span></span>
</td>
<td class="num">(36,558)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of equipment</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(65,556)<span></span>
</td>
<td class="num">(61,564)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities', window );">Principal payments on notes and leases payable</a></td>
<td class="num">(184)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payments on term loan debt</a></td>
<td class="num">(3,688)<span></span>
</td>
<td class="num">(3,313)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock upon exercise of options</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(3,821)<span></span>
</td>
<td class="num">(3,313)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">EFFECT OF EXCHANGE RATE CHANGES ON CASH</a></td>
<td class="num">(229)<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET DECREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="num">(36,990)<span></span>
</td>
<td class="num">(63,893)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS, beginning of period</a></td>
<td class="nump">127,834<span></span>
</td>
<td class="nump">134,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS, end of period</a></td>
<td class="nump">90,844<span></span>
</td>
<td class="nump">70,713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the period for interest</a></td>
<td class="nump">21,471<span></span>
</td>
<td class="nump">7,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid during the period for income taxes</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredHedgeGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredHedgeGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of buildings (properties) whether for investment or use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a),(b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480662126192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 20, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Feb. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EquipmentAcquiredAndLeaseholdImprovements', window );">Equipment acquired and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.8<span></span>
</td>
<td class="nump">$ 42.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVMember', window );">Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">1,141,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Equity interest issued, value assigned</a></td>
<td class="nump">$ 30.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">965,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Equity interest issued, value assigned</a></td>
<td class="nump">$ 25.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquipmentAcquiredAndLeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquipmentAcquiredAndLeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480663815984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">NATURE OF BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text">NATURE OF BUSINESS AND BASIS OF PRESENTATION<div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At March&#160;31, 2023, we operated directly or indirectly through joint ventures with hospitals, 363 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  In addition to our center operations, we have certain other subsidiaries that develop Artificial Intelligence ("AI") products and solutions that are designed to enhance interpretation of radiographic images. Our operations comprise two segments for financial reporting purposes for this reporting period, Imaging Centers and Artificial Intelligence. For further financial information about these segments, see Note 5, Segment Reporting.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of RadNet, Inc as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#8220;RadNet&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221; in this report</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#8220;VIE&#8221;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#8217;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management and provide professional medical services for centers in Arizona, California, Delaware, Maryland, New Jersey and New York.  These VIEs are collectively referred to as the consolidated medical group ("the Group").  RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity.  Substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.  The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of the Group. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group on a combined basis recognized $48.8 million and $45.7 million of revenue, net of management services fees to RadNet, for the three months ended March&#160;31, 2023 and 2022, respectively and $48.8 million and $45.7 million of operating expenses for the three months ended March&#160;31, 2023 and 2022, respectively.  RadNet recognized $207.4 million and $191.0 million of total billed net service fee revenue for the three months ended March&#160;31, 2023, and 2022, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flows of the Group are included in the accompanying condensed consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022, we have included approximately $103.1 million and $100.4 million, respectively, of accounts receivable and approximately $18.8 million and $16.9 million of accounts payable and accrued liabilities related to the Group, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At all of our centers not serviced by the Group we have entered into long-term contracts with medical groups to provide professional services at those centers, including supervision and interpretation of diagnostic imaging procedures. The medical groups maintain full control over the physicians they employ. Through our management agreements, we make available to the medical groups the imaging centers, including all furniture, fixtures and medical equipment therein.  The medical groups are compensated for their services from the professional component of the global net service fee revenue and after deducting management service fees paid to us, we have no economic controlling interest in these medical groups. As such, the financial results of these groups are not consolidated in our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also own a 49% economic interest in ScriptSender, LLC, which provides secure data transmission services of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender, LLC is dependent on RadNet to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.  We have continued to finance ScriptSender during it's development phase and our maximum exposure to loss is $3.1&#160;million, which represents our receivable balance from the entity.  Maximum exposure to loss is the loss that we would absorb in the event that all of the assets of ScriptSender are deemed worthless.  We paid operating expenses for the venture of $0.5&#160;million and $0.4&#160;million for the three months ended March 31, 2023, and March&#160;31, 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended March&#160;31, 2023 and 2022 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480663898608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period covered in this report, there have been no material changes to the significant accounting policies we use and have explained, in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2022. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES  - Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service revenues during the three months ended March&#160;31, 2023 and 2022 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.707%"><tr><td style="width:1.0%"/><td style="width:65.631%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.781%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,209&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,465&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,153&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,087&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,745&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,123&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teleradiology and Software revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,333&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,399&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,144&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,491&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Center Segment Revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388,431&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,168&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI Segment Revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,133&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,564&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,767&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">GOVERNMENT ASSISTANCE: COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  To aid businesses and stimulate the national economy, Congress passed The Coronavirus Aid, Relief, and Economic Security ("CARES") Act, which was signed in to law on March 27, 2020.  As part of the CARES act, we received $39.6 million total of accelerated Medicare payments which were recorded to deferred revenue in our consolidated balance sheet and are being applied to revenue as services are performed.  Through the three months ended March 31, 2023, $38.6 million of the accelerated Medicare payments have been applied to revenue. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.  Amounts remaining to be collected on these agreements were $15.4 million and $15.4 million at March&#160;31, 2023 and December&#160;31, 2022, respectively. We do not utilize factoring arrangements as an integral part of our financing for working capital and assess the party's ability to pay upfront at the inception of the notes receivable and subsequently by reviewing their financial statements annually and reassessing any insolvency risk on a periodic basis.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEFERRED FINANCING COSTS - Costs of financing are deferred and amortized using the effective interest rate method and are related to our revolving credit facilities. Deferred financing costs, net of accumulated amortization, were $2.1 million and $2.3 million, as of March&#160;31, 2023 and December&#160;31, 2022, respectively.  See Note 6, Credit Facilities and Notes Payable for more information.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation of property and equipment is performed using the straight-line method over the estimated useful lives of the assets acquired, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BUSINESS COMBINATION  -  When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GOODWILL - Goodwill at March&#160;31, 2023 totaled $687.1 million.   Goodwill is recorded as a result of business combinations. When we determine the carrying value of reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  We tested goodwill and indefinite lived intangibles for impairment on October 1, 2022, noting no impairment.  Activity in goodwill for the three months ended March&#160;31, 2023 is provided below (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.531%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.225%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Center</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Artificial Intelligence</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606,483&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,182&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677,665&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill from acquisitions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,174&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,174&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614,836&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,249&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687,085&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INTANGIBLE ASSETS - The components of intangible assets, both finite and indefinite, along with annual amortization expense that will be recorded over the next five years at March&#160;31, 2023 and December&#160;31, 2022 are as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023:</span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,717&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,959&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,824&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,013&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">941&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,215&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.7</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer Relationships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">767&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,984&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,948&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patent and Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,931&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology &amp; Software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,810&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,657&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,657&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,617&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,083&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,392&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,216&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.5</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,952&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,494&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,114&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,666&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,649&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,128&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103,003&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Excluding the three months ended March 31, 2023</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,393&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,320&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer Relationships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,112&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,396&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,803&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patent and Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.4</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology &amp; Software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,297&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,297&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,297&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,257&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,722&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,196&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,066&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,032&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,032&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,750&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,094&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,713&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,266&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,272&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53,133&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106,228&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible asset amortization expense was $3.0 million and $2.1 million for the three months ended March&#160;31, 2023 and March&#160;31, 2022, respectively.  Intangible assets are amortized using the straight-line method over their useful life determined at acquisition. Management service agreements are amortized over 25 years using the straight line method.  Software development is capitalized and amortized over the useful life of the software when placed into service.  Trade names are reviewed annually for impairment.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INCOME TAXES -  Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a provision to income taxes of $1.1 million, or an effective tax rate of (8.6)%, for the three months ended March 31, 2023 and $1.5 million, or an effective tax rate of 15.2% for the three months ended March 31, 2022.  The income tax rates for the three months ended March&#160;31, 2023 diverge from the federal statutory rate due to (i) noncontrolling interests due to the controlled partnerships; (ii) effects of state income taxes (iii) effects of foreign income taxes; and (iv) excess tax benefits attributable to share-based compensation.  We believe no significant changes in the unrecognized tax benefits will occur within the next 12 months.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable.  We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tested for impairment if circumstances suggest that the carrying amount may not be recoverable.  Our ROU assets consist of facility and equipment assets on operating leases.  No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of March&#160;31, 2023.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities.  We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances.  Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we have amended and restated at various points in time: first on April 20, 2015, second on March 9, 2017, and currently as of April 15, 2021 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved 16,500,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric.  We evaluate performance-based awards to determine if it is probable that the vesting conditions will be met. We also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period.  Stock options generally vest over three years to five years and expire five years to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 7, Stock-Based Compensation, for more information.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPREHENSIVE (LOSS) INCOME - Accounting guidance establishes rules for reporting and displaying other comprehensive (loss) income and its components. Our foreign currency translation adjustments, changes in the fair value of cash flow hedges, and the amortization of balances associated with derivatives previously classified as cash flow hedges are included in other comprehensive (loss) income. The components of other comprehensive (loss) income for the twelve month periods ended March&#160;31, 2023 and March&#160;31, 2022 are included in the consolidated statements of comprehensive (loss) income.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DERIVATIVE INSTRUMENTS - In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 Swaps").  The 2019 Swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.  The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional. Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05% for the $400,000,000 notional.  As of the effective date, we are liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates are above the arranged rates.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive gain or loss in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $400,000,000 notional interest rate swap contract locked in at 2.05% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.96% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional are being recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $0.4 million per month and continuing at approximately $0.3 million through October 2025.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:36.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.229%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.217%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.534%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(15,201)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$922</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(14,279)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:36.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.229%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.217%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.534%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(18,887)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$924</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(17,963)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"/><td style="width:23.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.114%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ineffective interest rate swap</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,093)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjI1ZDk4ZTg3NTAxYTRkZWViMmE0ZTYyZGQzYTYzMjA3L3RhYmxlcmFuZ2U6MjVkOThlODc1MDFhNGRlZWIyYTRlNjJkZDNhNjMyMDdfMi00LTEtMS01NzA3Mw_82eff8fd-e435-416f-a669-f954d06a2aa7">Other income (expense)</span></span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"/><td style="width:23.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.114%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ineffective interest rate swap</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,819&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjllMGUxNjNhM2M3MDQ0NzA4ZGRmYzVhNDQyNjI2MmJlL3RhYmxlcmFuZ2U6OWUwZTE2M2EzYzcwNDQ3MDhkZGZjNWE0NDI2MjYyYmVfMi00LTEtMS04OTMxOA_468424d7-c562-4c21-a8d7-de7f7f9f175e">Other income (expense)</span></span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(923)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Fair Value Measurements section below for the fair value of the 2019 Swaps at March&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONTINGENT CONSIDERATION - </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Aidence Holding B.V.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise centered on lung cancer screening.  As part of the purchase agreement, we will pay up to $10.0 million consideration upon the completion of two identified milestones in RadNet common shares or cash at our election.  This </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contingency had a value of approximately $7.3 million on March&#160;31, 2023. The amount is reviewed quarterly and adjusted to fair value based on the yield rate of S&amp;P B-rated corporate bonds and the probability of FDA approval, which has been currently determined by management to be 80% for milestone one and 70% for milestone two.  In addition, there is a remaining general holdback of $4.0 million to be issued in shares of our common stock subject to adjustment for any indemnification claims.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantib B.V.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening.  As part of the purchase agreement, we will issue 18 months after acquisition, 113,303 shares of our common stock with an initial fair value at the date of close of $3.0 million subject to adjustment for any indemnification claims and will be adjusted to fair value in subsequent periods. This contingency had a value of approximately $2.8 million as of March&#160;31, 2023. In addition, there is a general holdback of $1.6 million to be issued in cash subject to adjustment for any indemnification claims.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Montclair</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2022, we completed our acquisition of Montclair Radiological Associates. As part of the purchase agreement, we recorded $1.2 million in contingent consideration to be determined by obtaining specific EBITDA targets within a defined time frame.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Heart and Lung Imaging Limited</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we completed our acquisition of 75% of the equity interests of Heart and Lung Imaging Limited. The purchase included $10.2 million in contingent milestone consideration and cash holdback of $0.6 million to be issued 24 months after acquisition subject to adjustment for any indemnification claims, which will be adjusted to fair value in subsequent periods.  The milestone contingency had a value of approximately $13.1 million as of March&#160;31, 2023.   The contingent consideration is determined by the achievement of a specific number of physician reads.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular rollforward of contingent consideration is as follows (amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.485%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issuance of contingent consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in valuation of Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023  Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,316&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,411&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Limited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,130&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Fair Value Measurements section below for the fair value of contingent consideration at March&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term assets</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Swaps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term assets</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Swaps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of contingencies and holdback relating to our Aidence Holding B.V. and Quantib B.V. acquisitions on January 20, 2022, the Montclair Radiological Associates acquisition on October 1, 2022 and the Heart and Lung Imaging Limited acquisition on November 1, 2022 that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence Holding B.V. milestone consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib B.V. holdback of 113,303 shares of RadNet common stock</span></div></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,411&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,411&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Imaging Limited</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,130&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,130&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these liabilities was determined using Level 3 inputs.  For Aidence Holding B.V., the  milestone contingent liability was adjusted to fair value based on the yield rate of S&amp;P B-rated corporate bonds and the probability of FDA approval.  For the Quantib B.V holdback shares, the fair value was determined by calculating the value of estimated shares issuable as of the reporting date (which was $25.03) at March&#160;31, 2023, the time period related to the contractual settlement term, and the probability of issuing the shares.  For Montclair Radiological Associates the contingent consideration is determined by obtaining specific EBITDA targets within a defined time frame.  For Heart Lung Imaging Limited the contingent consideration is determined by the achievement of a specific number of physician reads.  As significant </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">inputs for the contingent consideration of Aidence B.V., Quantib B.V., Montclair Radiological Associates and Heart Lung Imaging Limited are not observable and cannot be corroborated by observable market data they are classified as Level 3.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long Term Debt:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.651%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and Truist Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856,876&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856,876&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860,438&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.651%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and Truist Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,594&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,594&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,125&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and at December&#160;31, 2022 our Barclays revolving credit facility had no balance outstanding. Our Truist revolving credit facility relating to our consolidated subsidiary The New Jersey Imaging Network ("NJIN"), had no principal amount outstanding at March&#160;31, 2023 and at December&#160;31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our long-term debt, which is discussed in Note 6, Credit Facilities and Notes Payable, was determined using Level 2 inputs primarily related to comparable market prices.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.584%"><tr><td style="width:1.0%"/><td style="width:67.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.768%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income  attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,005)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,013&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,303,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.36)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,303,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,911&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and contingently issuable shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701,439&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,362,193&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value change for contingently issuable shares excluded from the computation of diluted per share amounts as its effect would be antidilutive</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750,075&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,912&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently issuable shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023  we excluded all outstanding options, restricted stock awards and other requisite shares in the calculation of diluted earnings per share because their effect would be antidilutive.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENTS IN EQUITY SECURITIES&#8211;Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we have three equity investments for which a fair value is not readily determinable and therefore the total amounts invested are recognized at cost as follows:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  Our investment of $1.2 million  represents a 14.21% equity interest in the company.  No observable price changes or impairment in our investment was identified as of March&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed.  On February 1, 2018, we purchased 2.1&#160;million preferred shares in Turner Imaging Systems for $2.0 million. On January 1, 2019 we funded a convertible promissory note in </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the amount of $0.1 million that converted to an additional 80,000 preferred shares on October 11, 2019.No observable price changes or impairment in our investment was identified as of March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million in support of its operations.  No observable price changes, impairment in our investment or impairment of the loan receivable was identified as of March&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENT IN JOINT VENTURES &#8211; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;Our investment in these joint ventures is accounted for under the equity method, since RadNet does not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of March&#160;31, 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment and financial information</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the three months ended March 31, 2023 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,893&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,321&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately $4.2 million and $5.5 million for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data for these joint ventures as of March&#160;31, 2023 and December&#160;31, 2022 and income statement data for the three months ended March 31, 2023 and 2022 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,091&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,304&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,995)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,588)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,872)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,952)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,368&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,458&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,754&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,564&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,321&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,893&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement data for the three months ended March 31,</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,086&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,411&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480663821936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT ACCOUNTING AND REPORTING STANDARD<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">RECENT ACCOUNTING AND REPORTING STANDARD</a></td>
<td class="text">RECENT ACCOUNTING AND REPORTING STANDARDS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor new accounting pronouncements issued by the FASB and do not believe any accounting pronouncements issued through the date of this report will have a material impact on our financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480666434848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS COMBINATIONS AND RELATED ACTIVITY</a></td>
<td class="text">BUSINESS COMBINATIONS AND RELATED ACTIVITY<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center Segment</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the California and New York markets.  These acquisitions are reported as part of our Imaging Center segment.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.678%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.973%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.286%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.267%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C.C.D.G.L.R. &amp; S Services Inc.</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,689</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,689)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southern California Diagnostic Imaging, Inc. </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,184)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inglewood Imaging Center, LLC</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,658</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,188)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ramapo Radiology Associates, P.C.</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2023</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,775)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,915</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,441</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,836</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,174</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">250</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,836)</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480666910528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT REPORTING</a></td>
<td class="text">SEGMENT REPORTING<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reportable segments are described below:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a strategy that diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  Included in the segment is our eRad subsidiary, which designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence ("AI")</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our chief operating decision maker ("CODM"), who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit and loss statements prepared on a basis not consistent with GAAP.  We do not report balance sheet information by segment since it is not reviewed by our CODM.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The table below presents segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.198%"><tr><td style="width:1.0%"/><td style="width:51.672%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.103%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.621%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.104%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2023</span></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">388,431&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">341,168&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">390,564&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">341,767&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cost of Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">344,580&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">310,110&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cost of operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">351,865&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">315,039&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Depreciation and Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">29,591&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">25,805&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31,315&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">27,118&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Loss on Disposal of Equipment:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">577&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,154&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total loss on disposal of equipment</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">579&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,128&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Severance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">122&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">201&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total severance</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">134&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">201&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;Income (Loss) from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,561&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,898&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,890)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(5,617)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total income (loss) from operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,671&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,719)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480664123808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">CREDIT FACILITIES AND NOTES PAYABLE</a></td>
<td class="text">CREDIT FACILITIES AND NOTES PAYABLE<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022 our term loan debt and other obligations are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:74.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.840%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.841%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712,313&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714,125&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,125&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on NJIN Term Loan Agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment notes payable at 6.0%, due 2028, collateralized by medical equipment</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,645&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868,289&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851,744&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,935)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,400)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term portion debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839,344&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no outstanding balance under our $195.0 million Barclays Revolving Credit Facility at March&#160;31, 2023 and have reserved $7.6 million for certain letters of credit. The remaining $187.4 million of our Barclays Revolving Credit Facility was available to draw upon as of March&#160;31, 2023.  We also had no balance under our $50.0 million Truist Revolving Credit Facility related to our consolidated subsidiary NJIN at March&#160;31, 2023, and with no letters of credit reserved against the facility, the full amount was available to draw upon.  At March&#160;31, 2023, we were in compliance with all covenants under our credit facilities.  On February 1, 2023, we issued a promissory note in the amount of $19.8 million to acquire radiology equipment previously leased under operating leases.</span></div><div style="margin-top:5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments to Credit Facilities</span></div><div style="margin-top:10pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays: First Amendment to Second Amended and Restated First Lien Credit and Guaranty Agreement</span></div><div style="margin-top:10pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2023, we entered into the First Amendment to Second Amended and Restated First Lien Credit and Guaranty Agreement (the &#8220;Amendment&#8221;). The Amendment replaces the interest rate benchmark, from the London Interbank Offered Rate (&#8220;LIBOR&#8221;) to the Secured Overnight Financing Rate (&#8220;SOFR&#8221;) and includes applicable credit spread adjustments of 0.11448%, 0.26161%, and 0.42826% for interest periods of one month, three months, and six months, respectively. The replacement of LIBOR with SOFR and the credit spread adjustments shall be effective as of March 31, 2023, which is the last day of the last-ending existing interest period of currently outstanding loans bearing interest at LIBOR. Other than the foregoing, the material terms of the Credit Agreement remain unchanged.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays: Second Amended and Restated First Lien Credit and Guaranty Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2021, we entered into the Second Amended and Restated First Lien Credit and Guaranty Agreement (the  "Restated Credit Agreement") which provides for $725.0 million of senior secured first lien term loans (the "First Lien Term Loans") and a $195.0 million senior secured revolving credit facility (the "Barclays Revolving Credit Facility"). The proceeds of the First Lien Term Loans were used to refinance loans outstanding under our prior first lien credit agreement and provide funding for current and future operations. Total costs of the Restated Credit Agreement amounted to approximately $14.9 million segregated as follows: $8.8 million capitalized to discount and deferred finance cost, $4.5 million expensed to debt restructuring costs, $1.5 million charged to loss on early extinguishment of debt and $0.1 million written off to interest expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist: Second Amended and Restated Revolving Credit and Term Loan Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 7, 2022, we entered into the Second Amended and Restated Revolving Credit and Term Loan Agreement (the "Restated Credit and Term Loan Agreement") which provides for a $150.0 million of a secured term loan (the "Truist Term Loan") and a $50.0 million secured revolving credit facility (the "Truist Revolving Credit Facility").  Both loans were secured by our simultaneous entry into the Second Amended and Restated Guaranty and Security Agreement on the same date.  The proceeds were were used to refinance the outstanding balance under our prior term loan agreement and provide funding for current and future operations. Total costs of the Restated Credit and Term Loan Agreement amounted to approximately $2.7 million segregated as follows: $2.0 million capitalized to discount and deferred finance cost and $0.7 million expensed to loss </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on extinguishment of debt and related expenses in other expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit and Term Loan Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All obligations under the Second Amended and Restated Credit and Term Loan Agreement bear interest at either a SOFR or a Base Rate (each as defined in the Restated Credit and Term Loan Agreement), plus an applicable margin according to the following schedule:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.099%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.099%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for SOFR Loans</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 3.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 3.00:1.00 but greater than or equal to 2.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.50:1.00 but greater than or equal to</span></div><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.00:1.00 but greater than or equal to 1.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Secured Credit Facilities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">First Lien Term Loans:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through March 31, 2023, the First Lien Term Loans under the Restated Credit Agreement bore interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement), plus an applicable margin.  The applicable margin for Eurodollar Rate and Alternate Base Rate First Lien Term Loans under the Restated Credit Agreement was 3.00% and 2.00%, respectively, with an effective Eurodollar Rate and the Alternate Base Rate of 4.63% and 8.00%, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amendment, effective March 31, 2023, the First Lien Term Loans under the Restated Credit Agreement will bear interest either at a SOFR or an Alternate Base Rate (in each case, as defined in the Amendment) plus an applicable margin.  The applicable margin for the SOFR and Alternate Base Rate First Lien Term Loans under the Amendment is 3.00% and 2.00%, respectively.  At March 31, 2023, we have an effective SOFR of 7.81% ,with an applicable credit spread adjustment of 0.11448%, and an Alternate Base Rate of 10%, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Credit Agreement provides for quarterly payments of principal for the First Lien Term Loan in the amount of approximately $1.8 million.  The  First Lien Term Loan will mature on April 23, 2028 unless otherwise accelerated under the terms of the Restated Credit Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist Term Loan:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Truist Term Loan currently bears interest at a three month SOFR election of 4.69% plus an applicable margin and fees based on Pricing Level III described above.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled amortization of the Truist Term Loan begins March 31, 2023 with quarterly payments of $1.9 million, representing 1.00% of the original principal balance. At scheduled intervals, the quarterly amortization increases by $0.9 million, with the remaining balance to be paid at maturity.  The Truist Term Loan will mature on October 10, 2027 unless otherwise accelerated under the terms of the  Credit Agreement.</span></div><div><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Credit Facilities</span></div><div style="padding-left:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Associated with both the Barclays and Truist Revolving Credit Facilities are deferred financing costs, net of accumulated amortization, of $2.1 million at March&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Revolving Credit Facility</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Barclays Revolving Credit Facility under the Restated Credit Agreement is a $195.0 million senior secured revolving credit facility. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a SOFR or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"><tr><td style="width:1.0%"/><td style="width:31.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Net Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term SOFR Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Alternate Base Rate Spread</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.50x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.00x but &#8804; 3.50x</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; 3.00x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the effective interest rate payable on revolving loans under the Barclays Revolving Credit Facility was 5.25%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for Eurodollar rate revolving loans which is currently 2.75% and fronting fees accrue at 0.125% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the Restated Credit Agreement. In addition, a commitment fee of 0.50% per annum accrues on the unused revolver commitments under the Barclays Revolving Credit Facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Barclays Revolving Credit Facility will terminate on April 23, 2026 unless otherwise accelerated in accordance with the terms of the Restated Credit Agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist Revolving Credit Facility:</span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Associated with the Truist Revolving Credit Facility of $50.0 million are deferred financing costs, net of accumulated amortization, of  $0.6 million at March&#160;31, 2023.  As of March&#160;31, 2023, NJIN had no borrowings under the Truist Revolving Credit Facility. </span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Truist Revolving Credit Facility bears interest with different margins based on types of borrowings at a Pricing Level III as noted in the pricing grid above.  The Truist Revolving Credit Facility terminates on the earliest of (i) October 7, 2027, (ii) the date on which the Revolving Commitments are terminated pursuant to Section 2.8 of the Truist Restated Credit Agreement, or (iii) the date on which all amounts outstanding under the Truist Restated Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  </span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent prior amendments to prior credit facilities:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">Truist Credit Facilities:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 31, 2018, under the Amended and Restated Revolving Credit and Term Loan Agreement, NJIN secured a term loan commitment of $60.0 million and established revolving credit facility of $30.0 million.  The agreement had a maturity date of August 31, 2023 and was refinanced on October 10, 2022 by the Second Amended and Restated Revolving Credit and Term Loan Agreement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480747801104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Incentive Plans</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have one long-term equity incentive plan, the RadNet, Inc. Equity Incentive Plan, which we first amended and restated April 20, 2015, again on March 9, 2017 and currently as of April 15, 2021  (the "Restated Plan&#8221;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved for issuance under the Restated Plan 16,500,000 shares of common stock. We can issue options (incentive and nonstatutory), </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance based options, stock awards (restricted or unrestricted), stock units, performance based stock units, and stock appreciation rights under the Restated Plan.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations.  Stock options generally vest over 3 to 5 years and expire 5 to 10 years from the date of grant.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes all of our option transactions for the three months ended March&#160;31, 2023:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678,914&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.72&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935,134&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.96</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,840,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2023</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672,538&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.70&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.98</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,568,342&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on March&#160;31, 2023 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on March&#160;31, 2023.  As of March&#160;31, 2023, total unrecognized stock-based compensation expense related to non-vested employee awards was $2.5 million, which is expected to be recognized over a weighted average period of approximately 2.11 years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">DeepHealth Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted options to acquire&#160;412,434&#160;shares at a grant date fair value of $16.93&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of March&#160;31, 2023, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $0.3 million, which is expected to be recognized over a weighted average period of approximately 0.60 years</span></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:48.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,982&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,473)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,509&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,565,800&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,537&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,940,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options issued in replacement of original DeepHealth options as a result of our acquisition are not included in the share count under the Restated Plan.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards ("RSAs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan permits the award of RSAs and the following summarizes all unvested RSA&#8217;s activities during the three months ended March&#160;31, 2023:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSAs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536,767&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.84&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694,324&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.77&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Canceled</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(667)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.80&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs unvested at March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526,405&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.51</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.77&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of all RSAs based on the closing price of our common stock on the award date.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other stock bonus awards</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan also permits share awards not subject to any future service period. These are valued and expensed based on the closing price of our common stock on the date of award. During the three months ended March&#160;31, 2023, 10,765 shares were issued with a value of $0.2 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance based stock units ("PSUs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we granted certain employees PSUs with a target award of 25,683 shares of our common stock. The PSUs will vest in two equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0% to 200% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022.  In January of 2023, based on the performance condition achieved, the board of directors issued 12,843 units with a fair value of $29.44 per unit.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, the we granted certain employees PSUs with a target award of 60,685 shares of our common stock. The PSUs will vest in two equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (&#8212;% to 200% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2023 through December 31, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance based stock options ("PSOs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we granted certain employees PSOs with a potential to option a maximum of 111,925 shares of our common stock. The PSOs will vest in three equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0 shares to 111,925 shares) depending upon the extent to which we achieve a performance condition as determined the board of directors over the period from January 1, 2022 through December 31, 2022.  In January of 2023, based on the performance condition achieved, the board of directors issued 27,981 options with a strike price of $29.44 per share.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, we granted certain employees PSOs with a potential to option a maximum of 235,227 shares of our common stock. The PSOs will vest in three equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0 shares to 235,227 shares) depending upon the extent to which we achieve a performance condition as determined the board of directors over the period from January 1, 2023 through December 31, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long Term Incentive Plan shares ("LTIPs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we issue stock-based compensation to certain employees in our AI segment in the form of Stock Units and Restricted Stock Awards, subject to certain restrictions. The awards represent a form of long term incentive and are reflective of a general practice within the software industry.  The units and shares vest ratably over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODE4OTk1_66873c0e-ef14-4872-a4e6-5ee1a266aa10">two</span> to four year period, conditioned on continued employment through the vesting periods. We determine the fair value of all LTIPs based on the closing price of our common stock on the award date.  The following summarizes all unvested LTIPs activities during the three months ended March 31, 2023:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LTIPs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,471&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.56&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,643&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.03&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,395)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Canceled</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,476)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.72&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317,243&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.43</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.87&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restated Plan summary</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, of the 16,500,000 shares of common stock reserved for issuance under the Restated Plan, at March&#160;31, 2023, there remain approximately 740,000 shares available under the Restated Plan for future issuance.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480660514032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">REVENUES</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES  - Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">ACCOUNTS RECEIVABLE</a></td>
<td class="text">ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.We do not utilize factoring arrangements as an integral part of our financing for working capital and assess the party's ability to pay upfront at the inception of the notes receivable and subsequently by reviewing their financial statements annually and reassessing any insolvency risk on a periodic basis.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">DEFERRED FINANCING COSTS</a></td>
<td class="text">DEFERRED FINANCING COSTS - Costs of financing are deferred and amortized using the effective interest rate method and are related to our revolving credit facilities.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text">PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation of property and equipment is performed using the straight-line method over the estimated useful lives of the assets acquired, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">BUSINESS COMBINATION</a></td>
<td class="text">BUSINESS COMBINATION  -  When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">GOODWILL</a></td>
<td class="text">GOODWILLGoodwill is recorded as a result of business combinations. When we determine the carrying value of reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  We tested goodwill and indefinite lived intangibles for impairment on October 1, 2022, noting no impairment.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES -  Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized.We believe no significant changes in the unrecognized tax benefits will occur within the next 12 months.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">LEASES</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable.  We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tested for impairment if circumstances suggest that the carrying amount may not be recoverable.  Our ROU assets consist of facility and equipment assets on operating leases.  No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of March&#160;31, 2023.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities.  We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances.  Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">EQUITY BASED COMPENSATION</a></td>
<td class="text">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we have amended and restated at various points in time: first on April 20, 2015, second on March 9, 2017, and currently as of April 15, 2021 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved 16,500,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric.  We evaluate performance-based awards to determine if it is probable that the vesting conditions will be met. We also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period.  Stock options generally vest over three years to five years and expire five years to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 7, Stock-Based Compensation, for more information.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">COMPREHENSIVE (LOSS) INCOME</a></td>
<td class="text">COMPREHENSIVE (LOSS) INCOME - Accounting guidance establishes rules for reporting and displaying other comprehensive (loss) income and its components. Our foreign currency translation adjustments, changes in the fair value of cash flow hedges, and the amortization of balances associated with derivatives previously classified as cash flow hedges are included in other comprehensive (loss) income. The components of other comprehensive (loss) income for the twelve month periods ended March&#160;31, 2023 and March&#160;31, 2022 are included in the consolidated statements of comprehensive (loss) income.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">DERIVATIVE INSTRUMENTS</a></td>
<td class="text">DERIVATIVE INSTRUMENTSThe 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional.As of the effective date, we are liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates are above the arranged rates.At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive gain or loss in the consolidated statement of equity.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div>The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our long-term debt, which is discussed in Note 6, Credit Facilities and Notes Payable, was determined using Level 2 inputs primarily related to comparable market prices.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">INVESTMENTS IN EQUITY SECURITIES</a></td>
<td class="text">INVESTMENTS IN EQUITY SECURITIES&#8211;Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">INVESTMENTS IN JOINT VENTURES</a></td>
<td class="text">INVESTMENT IN JOINT VENTURES &#8211; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;Our investment in these joint ventures is accounted for under the equity method, since RadNet does not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of March&#160;31, 2023.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">RECENT ACCOUNTING AND REPORTING STANDARDS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor new accounting pronouncements issued by the FASB and do not believe any accounting pronouncements issued through the date of this report will have a material impact on our financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480662071120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock', window );">Schedule of Service Fee Revenue</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service revenues during the three months ended March&#160;31, 2023 and 2022 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.707%"><tr><td style="width:1.0%"/><td style="width:65.631%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.781%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,209&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,465&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,153&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,087&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,745&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,123&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teleradiology and Software revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,333&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,399&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,144&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,491&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Center Segment Revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388,431&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,168&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI Segment Revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,133&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,564&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,767&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text">Activity in goodwill for the three months ended March&#160;31, 2023 is provided below (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.531%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.225%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Center</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Artificial Intelligence</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606,483&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,182&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677,665&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill from acquisitions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,174&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,174&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614,836&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,249&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687,085&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Annual Amortization Expense</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023:</span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,717&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,959&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,824&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,013&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">941&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,215&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.7</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer Relationships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">767&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,984&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,948&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patent and Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,931&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology &amp; Software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,810&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,657&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,657&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,617&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,083&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,392&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,216&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.5</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,952&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,494&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,114&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,666&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,649&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,128&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103,003&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Excluding the three months ended March 31, 2023</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,393&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,320&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer Relationships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,112&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,396&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,803&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patent and Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.4</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology &amp; Software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,297&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,297&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,297&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,257&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,722&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,196&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,066&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,032&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,032&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,750&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,094&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,713&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,266&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,272&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53,133&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106,228&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Effect of Derivative Instruments on Comprehensive Loss</a></td>
<td class="text">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:36.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.229%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.217%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.534%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(15,201)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$922</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(14,279)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:36.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.229%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.217%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.534%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(18,887)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$924</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(17,963)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"/><td style="width:23.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.114%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ineffective interest rate swap</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,093)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjI1ZDk4ZTg3NTAxYTRkZWViMmE0ZTYyZGQzYTYzMjA3L3RhYmxlcmFuZ2U6MjVkOThlODc1MDFhNGRlZWIyYTRlNjJkZDNhNjMyMDdfMi00LTEtMS01NzA3Mw_82eff8fd-e435-416f-a669-f954d06a2aa7">Other income (expense)</span></span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"/><td style="width:23.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.114%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ineffective interest rate swap</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,819&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjllMGUxNjNhM2M3MDQ0NzA4ZGRmYzVhNDQyNjI2MmJlL3RhYmxlcmFuZ2U6OWUwZTE2M2EzYzcwNDQ3MDhkZGZjNWE0NDI2MjYyYmVfMi00LTEtMS04OTMxOA_468424d7-c562-4c21-a8d7-de7f7f9f175e">Other income (expense)</span></span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(923)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular rollforward of contingent consideration is as follows (amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.485%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issuance of contingent consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in valuation of Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023  Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,316&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,411&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Limited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,130&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Fair Value of Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term assets</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Swaps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term assets</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Swaps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of contingencies and holdback relating to our Aidence Holding B.V. and Quantib B.V. acquisitions on January 20, 2022, the Montclair Radiological Associates acquisition on October 1, 2022 and the Heart and Lung Imaging Limited acquisition on November 1, 2022 that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence Holding B.V. milestone consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib B.V. holdback of 113,303 shares of RadNet common stock</span></div></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,411&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,411&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Imaging Limited</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,130&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,130&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.651%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and Truist Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856,876&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856,876&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860,438&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.651%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and Truist Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,594&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,594&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,125&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share</a></td>
<td class="text">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.584%"><tr><td style="width:1.0%"/><td style="width:67.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.768%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income  attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,005)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,013&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,303,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.36)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,303,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,911&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and contingently issuable shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701,439&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,362,193&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value change for contingently issuable shares excluded from the computation of diluted per share amounts as its effect would be antidilutive</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750,075&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,912&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently issuable shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023  we excluded all outstanding options, restricted stock awards and other requisite shares in the calculation of diluted earnings per share because their effect would be antidilutive.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Investment in Joint Ventures</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the three months ended March 31, 2023 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,893&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,321&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock', window );">Schedule of Joint Venture Investment and Financial Information</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data for these joint ventures as of March&#160;31, 2023 and December&#160;31, 2022 and income statement data for the three months ended March 31, 2023 and 2022 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,091&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,304&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,995)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,588)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,872)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,952)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,368&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,458&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,754&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,564&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,321&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,893&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement data for the three months ended March 31,</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,086&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,411&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Joint Venture Investment And Financial Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=35711157&amp;loc=d3e42567-110969<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480664012928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions</a></td>
<td class="text">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.678%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.973%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.286%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.267%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C.C.D.G.L.R. &amp; S Services Inc.</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,689</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,689)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southern California Diagnostic Imaging, Inc. </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,184)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inglewood Imaging Center, LLC</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,658</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,188)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ramapo Radiology Associates, P.C.</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2023</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,775)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,915</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,441</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,836</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,174</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">250</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,836)</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480667977072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text">The table below presents segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.198%"><tr><td style="width:1.0%"/><td style="width:51.672%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.103%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.621%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.104%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2023</span></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">388,431&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">341,168&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">390,564&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">341,767&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cost of Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">344,580&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">310,110&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cost of operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">351,865&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">315,039&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Depreciation and Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">29,591&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">25,805&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31,315&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">27,118&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Loss on Disposal of Equipment:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">577&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,154&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total loss on disposal of equipment</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">579&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,128&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Severance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">122&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">201&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total severance</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">134&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">201&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;Income (Loss) from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,561&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,898&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,890)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(5,617)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total income (loss) from operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,671&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,719)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480663894032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Term Loan Debt Obligations</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022 our term loan debt and other obligations are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:74.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.840%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.841%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712,313&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714,125&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,125&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on NJIN Term Loan Agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment notes payable at 6.0%, due 2028, collateralized by medical equipment</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,645&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868,289&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851,744&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,935)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,400)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term portion debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839,344&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ScheduleOfLeverageRatioTableTextBlock', window );">Schedule of Leverage Ratio</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All obligations under the Second Amended and Restated Credit and Term Loan Agreement bear interest at either a SOFR or a Base Rate (each as defined in the Restated Credit and Term Loan Agreement), plus an applicable margin according to the following schedule:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.099%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.099%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for SOFR Loans</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 3.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 3.00:1.00 but greater than or equal to 2.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.50:1.00 but greater than or equal to</span></div><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.00:1.00 but greater than or equal to 1.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></div>Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a SOFR or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"><tr><td style="width:1.0%"/><td style="width:31.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Net Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term SOFR Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Alternate Base Rate Spread</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.50x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.00x but &#8804; 3.50x</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; 3.00x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ScheduleOfLeverageRatioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Leverage Ratio [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ScheduleOfLeverageRatioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480662572960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Options Activity</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes all of our option transactions for the three months ended March&#160;31, 2023:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678,914&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.72&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935,134&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.96</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,840,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2023</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672,538&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.70&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.98</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,568,342&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:48.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,982&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,473)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,509&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,565,800&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,537&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,940,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of RSA Activity</a></td>
<td class="text">The Restated Plan permits the award of RSAs and the following summarizes all unvested RSA&#8217;s activities during the three months ended March&#160;31, 2023:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSAs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536,767&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.84&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694,324&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.77&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Canceled</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(667)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.80&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs unvested at March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526,405&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.51</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.77&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Schedule of LTIPs</a></td>
<td class="text">The following summarizes all unvested LTIPs activities during the three months ended March 31, 2023:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LTIPs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,471&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.56&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,643&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.03&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,395)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Canceled</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,476)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.72&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317,243&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.43</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.87&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480669385920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>center </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberOfCenters', window );">Number of centers | center</a></td>
<td class="nump">363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues', window );">BRMG and NY Groups revenues</a></td>
<td class="nump">$ 48,800<span></span>
</td>
<td class="nump">$ 45,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense', window );">BRMG and NY Groups operating expenses</a></td>
<td class="nump">48,800<span></span>
</td>
<td class="nump">45,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax', window );">Management services provided to BRMG and NY Groups</a></td>
<td class="nump">207,400<span></span>
</td>
<td class="nump">191,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">BRMG and NY Groups accounts receivable</a></td>
<td class="nump">2,414,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,433,907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">BRMG and NY Groups accounts payable</a></td>
<td class="nump">$ 1,920,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,942,455<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ScriptSenderLlcMember', window );">ScriptSender LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Book value of RadNet joint venture interests</a></td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ScriptSenderLlcMember', window );">ScriptSender LLC | Operating Expense | Equity Method Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses from transactions with related party</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">BRMG and NY Groups accounts receivable</a></td>
<td class="nump">103,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">BRMG and NY Groups accounts payable</a></td>
<td class="nump">$ 18,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Centers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense between the reporting entity and the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income between the reporting entity and the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ScriptSenderLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ScriptSenderLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_OperatingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_OperatingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480645847760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">24 Months Ended</th>
<th class="th" colspan="1">40 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 20, 2022 </div>
<div>USD ($) </div>
<div>loan </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 05, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 01, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>incentivePlan </div>
<div>jointVenture </div>
<div>security </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 10, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 15, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>agreement</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ContractsReceivableFactoringReceivable', window );">Contracts receivable, factoring receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">687,085,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">677,665,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,135,000<span></span>
</td>
<td class="nump">1,496,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans', window );">Number of plans | incentivePlan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Amount of loss recognized in income on derivative (current period ineffective portion)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 327,922,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">332,995,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities', window );">Number of securities without readily determinable fair value | security</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberofUnconsolidatedJointVentures', window );">Number of unconsolidated joint ventures | jointVenture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ManagementServiceFees', window );">Management service fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember', window );">Medic Vision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Total net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember', window );">Turner Imaging Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentSharesPurchased', window );">Number of shares purchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Preferred stock issued upon conversion (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember', window );">Turner Imaging Systems | Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbit.aiInc.Member', window );">WhiteRabbit.ai Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties', window );">Payments to fund loan to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Range of outcomes (upto)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones', window );">Number of identified milestones | loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Milestone contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,316,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,158,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne', window );">Percent of FDA approval and payout, milestone one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo', window );">Percent of FDA approval and payout, milestone two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Contingent Milestone Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Milestone contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Milestone contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Milestone contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,411,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,709,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod', window );">Contingent consideration, liability, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares', window );">Additional number of shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution', window );">Fair value of additional shares issued after execution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Contingent Milestone Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Milestone contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Milestone contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember', window );">Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Milestone contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart and Lung Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Milestone contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,656,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod', window );">Contingent consideration, liability, period</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business acquisition, percentage of voting interests acquired</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart and Lung Limited | Contingent Milestone Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Milestone contingent consideration</a></td>
<td class="nump">$ 10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart and Lung Limited | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Milestone contingent consideration</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains', window );">Monthly amortization of deferred hedge gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Accumulated Other Comprehensive Loss, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Amount of loss recognized in income on derivative (current period ineffective portion)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | 2019 Swaps - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | 2019 Swaps - Interest Rate Contracts | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.96%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | October 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | October 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member', window );">2019 SWAPS-1 | 2019 Swaps - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member', window );">2019 SWAPS-1 | 2019 Swaps - Interest Rate Contracts | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember', window );">Management Service Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Dignity Health | Joint Venture | Glendale Advanced Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Variable interest entity, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Amounts Returned to Property and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PPE estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PPE estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Dignity Health | Joint Venture | Glendale Advanced Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Variable interest entity, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Amounts Returned to Property and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PPE estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PPE estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember', window );">COVID-19 Pandemic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AdvanceMedicarePayments', window );">Advance medicare payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_RepaymentOfAdvanceMedicarePayments', window );">Repayment of advance medicare payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AdvanceMedicarePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advance Medicare Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AdvanceMedicarePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Number Of Identified Milestones</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ContractsReceivableFactoringReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contracts Receivable, Factoring Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ContractsReceivableFactoringReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Shares Purchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ManagementServiceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Management service fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ManagementServiceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Monthly Amortization Of Deferred Hedge Gains</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_MonthlyAmortizationOfDeferredHedgeGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberofUnconsolidatedJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Unconsolidated Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberofUnconsolidatedJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_RepaymentOfAdvanceMedicarePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayment Of Advance Medicare Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_RepaymentOfAdvanceMedicarePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular derivative asset or group of derivative assets held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToFundLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbit.aiInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbit.aiInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_ContingentMilestoneConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_ContingentMilestoneConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_CashHoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_CashHoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rdnt_RestatedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_DignityHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_DignityHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=rdnt_JointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=rdnt_JointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_GlendaleAdvancedImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_GlendaleAdvancedImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ProperyAndEquipmentNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ProperyAndEquipmentNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480759449632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Service Fee Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 390,564<span></span>
</td>
<td class="nump">$ 341,767<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_ImagingCenterSegmentRevenueMember', window );">Imaging Center Segment Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">388,431<span></span>
</td>
<td class="nump">341,168<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member', window );">Commercial insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">217,209<span></span>
</td>
<td class="nump">188,465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_Medicare1Member', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">86,624<span></span>
</td>
<td class="nump">70,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_Medicaid1Member', window );">Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">10,153<span></span>
</td>
<td class="nump">9,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member', window );">Workers' compensation/personal injury</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">12,675<span></span>
</td>
<td class="nump">12,449<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember', window );">Other patient revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">9,745<span></span>
</td>
<td class="nump">7,123<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember', window );">Management fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">4,248<span></span>
</td>
<td class="nump">5,508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_TeleradiologyandSoftwareMember', window );">Teleradiology and Software revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">4,333<span></span>
</td>
<td class="nump">3,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">5,300<span></span>
</td>
<td class="nump">5,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember', window );">Revenue under capitation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">38,144<span></span>
</td>
<td class="nump">38,491<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_AIMember', window );">AI Segment Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 2,133<span></span>
</td>
<td class="nump">$ 599<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_ImagingCenterSegmentRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_ImagingCenterSegmentRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_Medicare1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_Medicare1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_Medicaid1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_Medicaid1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_TeleradiologyandSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_TeleradiologyandSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_AIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_AIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480669495360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Goodwill (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 677,665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill from acquisitions</a></td>
<td class="nump">6,174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Valuation adjustment</a></td>
<td class="nump">1,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">1,643<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">687,085<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember', window );">Imaging Center</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">606,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill from acquisitions</a></td>
<td class="nump">6,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Valuation adjustment</a></td>
<td class="nump">1,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">614,836<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ArtificialIntelligenceMember', window );">Artificial Intelligence</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">71,182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill from acquisitions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Valuation adjustment</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">1,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 72,249<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ArtificialIntelligenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_ArtificialIntelligenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480661036192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Annual Amortization Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Reminder of fiscal amortization year</a></td>
<td class="nump">$ 9,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year one</a></td>
<td class="nump">11,494<span></span>
</td>
<td class="nump">$ 11,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year two</a></td>
<td class="nump">11,114<span></span>
</td>
<td class="nump">11,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year three</a></td>
<td class="nump">10,666<span></span>
</td>
<td class="nump">10,713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year four</a></td>
<td class="nump">9,649<span></span>
</td>
<td class="nump">10,266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">50,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">103,003<span></span>
</td>
<td class="nump">106,228<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names indefinite life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">7,100<span></span>
</td>
<td class="nump">7,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">IPR&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">17,164<span></span>
</td>
<td class="nump">17,032<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember', window );">Management Service Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Reminder of fiscal amortization year</a></td>
<td class="nump">1,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year one</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="nump">2,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year two</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="nump">2,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year three</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="nump">2,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year four</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="nump">2,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">8,959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,958<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 19,824<span></span>
</td>
<td class="nump">$ 20,393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">8 years 8 months 12 days<span></span>
</td>
<td class="text">8 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_CovenantNotToCompeteMember', window );">Covenant not to compete and other contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Reminder of fiscal amortization year</a></td>
<td class="nump">$ 1,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year one</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">$ 1,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year two</a></td>
<td class="nump">692<span></span>
</td>
<td class="nump">891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year three</a></td>
<td class="nump">406<span></span>
</td>
<td class="nump">642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year four</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 3,215<span></span>
</td>
<td class="nump">$ 3,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">3 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Reminder of fiscal amortization year</a></td>
<td class="nump">$ 924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year one</a></td>
<td class="nump">1,219<span></span>
</td>
<td class="nump">$ 1,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year two</a></td>
<td class="nump">1,088<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year three</a></td>
<td class="nump">966<span></span>
</td>
<td class="nump">1,112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year four</a></td>
<td class="nump">767<span></span>
</td>
<td class="nump">991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">816<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">10,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,396<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 15,948<span></span>
</td>
<td class="nump">$ 17,803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">18 years 1 month 6 days<span></span>
</td>
<td class="text">18 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_PatentAndTrademarksMember', window );">Patent and Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Reminder of fiscal amortization year</a></td>
<td class="nump">$ 280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year one</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year two</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year three</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year four</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 1,931<span></span>
</td>
<td class="nump">$ 1,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">6 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_DevelopedTechnologySoftwareMember', window );">Developed Technology &amp; Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Reminder of fiscal amortization year</a></td>
<td class="nump">$ 5,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year one</a></td>
<td class="nump">6,657<span></span>
</td>
<td class="nump">$ 6,297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year two</a></td>
<td class="nump">6,657<span></span>
</td>
<td class="nump">6,297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year three</a></td>
<td class="nump">6,617<span></span>
</td>
<td class="nump">6,297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year four</a></td>
<td class="nump">6,083<span></span>
</td>
<td class="nump">6,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">5,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,196<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 37,216<span></span>
</td>
<td class="nump">$ 38,066<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">6 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names indefinite life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Reminder of fiscal amortization year</a></td>
<td class="nump">$ 208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year one</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">$ 305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year two</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year three</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year four</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 605<span></span>
</td>
<td class="nump">$ 702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">4 years 7 months 6 days<span></span>
</td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_CovenantNotToCompeteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_CovenantNotToCompeteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_PatentAndTrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_PatentAndTrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_DevelopedTechnologySoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_DevelopedTechnologySoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480660519984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Effect of Derivative Instruments on Comprehensive Loss (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 491,452<span></span>
</td>
<td class="nump">$ 346,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</a></td>
<td class="nump">922<span></span>
</td>
<td class="nump">923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 493,101<span></span>
</td>
<td class="nump">$ 421,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Interest expense<span></span>
</td>
<td class="text">Interest expense<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Amount of comprehensive loss recognized on derivative net of taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</a></td>
<td class="nump">922<span></span>
</td>
<td class="nump">924<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of loss recognized in income on derivative (current period ineffective portion)</a></td>
<td class="num">(4,093)<span></span>
</td>
<td class="nump">20,819<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest Expense | Interest rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</a></td>
<td class="num">(922)<span></span>
</td>
<td class="num">(923)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Accumulated Other Comprehensive Loss, net of taxes | Interest rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(15,201)<span></span>
</td>
<td class="num">(18,887)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">$ (14,279)<span></span>
</td>
<td class="num">$ (17,963)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480666736736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Business Acquisitions by Acquisition, Contingent Consideration (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward', window );"><strong>Business Combination, Contingent Consideration, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in valuation of Contingent Consideration</a></td>
<td class="nump">$ 2,335<span></span>
</td>
<td class="num">$ (501)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward', window );"><strong>Business Combination, Contingent Consideration, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Accrued expenses at the beginning</a></td>
<td class="nump">11,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration', window );">Issuance of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in valuation of Contingent Consideration</a></td>
<td class="nump">158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation', window );">Currency Translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Accrued expenses at the end</a></td>
<td class="nump">11,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward', window );"><strong>Business Combination, Contingent Consideration, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Accrued expenses at the beginning</a></td>
<td class="nump">3,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration', window );">Issuance of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in valuation of Contingent Consideration</a></td>
<td class="nump">702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation', window );">Currency Translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Accrued expenses at the end</a></td>
<td class="nump">4,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember', window );">Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward', window );"><strong>Business Combination, Contingent Consideration, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Accrued expenses at the beginning</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration', window );">Issuance of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in valuation of Contingent Consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation', window );">Currency Translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Accrued expenses at the end</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart and Lung Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward', window );"><strong>Business Combination, Contingent Consideration, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Accrued expenses at the beginning</a></td>
<td class="nump">11,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration', window );">Issuance of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in valuation of Contingent Consideration</a></td>
<td class="nump">1,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation', window );">Currency Translation</a></td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Accrued expenses at the end</a></td>
<td class="nump">$ 13,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Arrangements Change In Currency Translation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Issuance Of Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480662149024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value of Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 20, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">First Lien Term Loans and Truist Term Loan</a></td>
<td class="nump">$ 860,438<span></span>
</td>
<td class="nump">$ 864,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares', window );">Additional number of shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,303<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">First Lien Term Loans and Truist Term Loan</a></td>
<td class="nump">856,876<span></span>
</td>
<td class="nump">843,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Quantib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">4,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">11,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Heart and Lung Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">13,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">First Lien Term Loans and Truist Term Loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Quantib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Heart and Lung Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">First Lien Term Loans and Truist Term Loan</a></td>
<td class="nump">856,876<span></span>
</td>
<td class="nump">843,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Quantib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Heart and Lung Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">First Lien Term Loans and Truist Term Loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Quantib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">4,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">11,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Heart and Lung Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">13,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 Swaps - Interest Rate Contracts | Estimate of Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Current and long term assets</a></td>
<td class="nump">19,209<span></span>
</td>
<td class="nump">23,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 Swaps - Interest Rate Contracts | Estimate of Fair Value Measurement | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Current and long term assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 Swaps - Interest Rate Contracts | Estimate of Fair Value Measurement | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Current and long term assets</a></td>
<td class="nump">19,209<span></span>
</td>
<td class="nump">23,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 Swaps - Interest Rate Contracts | Estimate of Fair Value Measurement | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Current and long term assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480666688208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to RadNet, Inc.'s common stockholders</a></td>
<td class="num">$ (21,005)<span></span>
</td>
<td class="nump">$ 3,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding during the period (in shares)</a></td>
<td class="nump">57,701,439<span></span>
</td>
<td class="nump">55,303,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)</a></td>
<td class="num">$ (0.36)<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Nonvested restricted stock subject only to service vesting (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">197,911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Add additional shares issuable upon exercise of stock options and contingently issuable shares (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">861,275<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of common shares used in calculating diluted net income per share (in shares)</a></td>
<td class="nump">57,701,439<span></span>
</td>
<td class="nump">56,362,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)</a></td>
<td class="num">$ (0.36)<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted', window );">Fair value change for contingently issuable shares excluded from the computation of diluted per share amounts as its effect would be antidilutive</a></td>
<td class="nump">$ 769<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Nonvested restricted stock subject to service vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</a></td>
<td class="nump">594,758<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Shares issuable upon the exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</a></td>
<td class="nump">750,075<span></span>
</td>
<td class="nump">46,912<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rdnt_ContingentSharesMember', window );">Contingently issuable shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</a></td>
<td class="nump">273,111<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Change for Contingently Available Shares Excluded From Computation Of Diluted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1828-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rdnt_ContingentSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rdnt_ContingentSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480666913120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Investment in Joint Ventures (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward', window );"><strong>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Beginning balance</a></td>
<td class="nump">$ 57,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings in these joint ventures</a></td>
<td class="nump">1,428<span></span>
</td>
<td class="nump">$ 2,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Ending balance</a></td>
<td class="nump">$ 59,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480669223168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Joint Venture Investment and Financial Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">$ 342,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 367,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="num">(407,143)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(466,723)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="nump">59,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">390,564<span></span>
</td>
<td class="nump">$ 341,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">(14,283)<span></span>
</td>
<td class="nump">8,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_JointVentureInterestMember', window );">Joint Venture Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Total net assets</a></td>
<td class="nump">109,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Book value of RadNet joint venture interests</a></td>
<td class="nump">50,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets', window );">Cost in excess of book value of acquired joint venture interests and other</a></td>
<td class="nump">8,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="nump">59,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,893<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember', window );">Equity Method Investment, Nonconsolidated Investee or Group of Investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">49,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Noncurrent assets</a></td>
<td class="nump">142,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="num">(32,995)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,588)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(48,872)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (37,952)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">42,086<span></span>
</td>
<td class="nump">34,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="nump">$ 2,909<span></span>
</td>
<td class="nump">$ 5,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the entity's ownership percentage in the investee multiplied by the investee's total equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_JointVentureInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_JointVentureInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480645674512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Feb. 01, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 687,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 677,665<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_BusinessAcquisitionsMember', window );">Business Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="nump">9,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="nump">3,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="nump">7,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">6,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="nump">250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other Assets</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="num">$ (7,836)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_CCDGLRSServicesIncMember', window );">C.C.D.G.L.R. &amp; S Services Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,689)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_SouthernCaliforniaDiagnosticImagingIncMember', window );">Southern California Diagnostic Imaging, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_InglewoodImagingCenterLLCMember', window );">Inglewood Imaging Center, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,188)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_RamapoRadiologyAssociatesPCMember', window );">Ramapo Radiology Associates, P.C.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,775)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets (Liabilities), Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_BusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_BusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_CCDGLRSServicesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_CCDGLRSServicesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_SouthernCaliforniaDiagnosticImagingIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_SouthernCaliforniaDiagnosticImagingIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_InglewoodImagingCenterLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_InglewoodImagingCenterLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_RamapoRadiologyAssociatesPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_RamapoRadiologyAssociatesPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480662355232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 390,564<span></span>
</td>
<td class="nump">$ 341,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of Operations</a></td>
<td class="nump">351,865<span></span>
</td>
<td class="nump">315,039<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="nump">31,315<span></span>
</td>
<td class="nump">27,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on Disposal of Equipment</a></td>
<td class="nump">579<span></span>
</td>
<td class="nump">1,128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingIncomeLossExcludingReliefFunding', window );">Income (Loss) from Operations</a></td>
<td class="nump">6,671<span></span>
</td>
<td class="num">(1,719)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember', window );">Imaging Centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">388,431<span></span>
</td>
<td class="nump">341,168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of Operations</a></td>
<td class="nump">344,580<span></span>
</td>
<td class="nump">310,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="nump">29,591<span></span>
</td>
<td class="nump">25,805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on Disposal of Equipment</a></td>
<td class="nump">577<span></span>
</td>
<td class="nump">1,154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingIncomeLossExcludingReliefFunding', window );">Income (Loss) from Operations</a></td>
<td class="nump">13,561<span></span>
</td>
<td class="nump">3,898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember', window );">AI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">2,133<span></span>
</td>
<td class="nump">599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of Operations</a></td>
<td class="nump">7,285<span></span>
</td>
<td class="nump">4,929<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="nump">1,724<span></span>
</td>
<td class="nump">1,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on Disposal of Equipment</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingIncomeLossExcludingReliefFunding', window );">Income (Loss) from Operations</a></td>
<td class="num">$ (6,890)<span></span>
</td>
<td class="num">$ (5,617)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingIncomeLossExcludingReliefFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Income (Loss) Excluding Relief Funding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingIncomeLossExcludingReliefFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480669304400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Term Loan Debt Obligations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">$ 868,289<span></span>
</td>
<td class="nump">$ 851,744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion</a></td>
<td class="num">(15,935)<span></span>
</td>
<td class="num">(12,400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term portion debt obligations</a></td>
<td class="nump">852,354<span></span>
</td>
<td class="nump">839,344<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_EquipmentNotesPayableMember', window );">Equipment notes payable at 6.0%, due 2028, collateralized by medical equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">$ 19,645<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loans | First Lien Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on First Lien Term Loans</a></td>
<td class="num">$ (10,606)<span></span>
</td>
<td class="num">(11,127)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">712,313<span></span>
</td>
<td class="nump">714,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loans | NJIN Term Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on First Lien Term Loans</a></td>
<td class="num">(1,188)<span></span>
</td>
<td class="num">(1,254)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">$ 148,125<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_EquipmentNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_EquipmentNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480643655696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Oct. 07, 2022</div></th>
<th class="th"><div>Apr. 23, 2021</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 27, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember', window );">Barclays | One Month SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.11448%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember', window );">Barclays | Three Months SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.26161%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember', window );">Barclays | Six Months SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.42826%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember', window );">Barclays | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 725,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember', window );">Barclays | First Lien Credit Agreement Seventh Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt restructuring and extinguishment expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredCharges', window );">Amortization of deferred issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember', window );">Truist | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentPeriodicPaymentPercent', window );">Periodic payment, percent</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease', window );">Periodic payment amortization increase</a></td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt instrument, periodic payment</a></td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember', window );">Truist | Term Loan | SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.69%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember', window );">Truist | First Lien Credit Agreement Seventh Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt restructuring and extinguishment expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember', window );">First Lien Term Loan | Barclays | Term Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="nump">$ 7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of credit facility, remaining borrowing capacity</a></td>
<td class="nump">$ 187,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 187,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Truist | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement | Truist | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement Eighth Amendment | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 195,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement Eighth Amendment | Truist | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement, Sixth Amendment | Line of Credit | Term SOFR Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">4.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement, Sixth Amendment | Line of Credit | Term SOFR Loans | Leverage Ratio Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement, Sixth Amendment | Line of Credit | Alternate Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement, Sixth Amendment | Line of Credit | Alternate Base Rate Spread | Leverage Ratio Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Term Loan | SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">7.81%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.81%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Term Loan | One Month SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">0.11448%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.11448%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Term Loan | Alternate Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Term Loan | Line of Credit | SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Term Loan | Line of Credit | Alternate Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Restated Agreement | Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Restated Agreement | Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Restated Agreement | Term SOFR Loans | Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Restated Agreement | Term SOFR Loans | Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Restated Agreement | Alternate Base Rate Spread | Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Restated Agreement | Alternate Base Rate Spread | Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Barclays | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | First Lien Credit Agreement, Sixth Amendment | Line of Credit | Term SOFR Loans | Leverage Ratio Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentPeriodicPaymentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentPeriodicPaymentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment Terms, Amortization Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of amortization of deferred charges applied against earnings during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480658415360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Leverage Ratio (Details) - Restated Agreement<br></strong></div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Pricing Level I</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage Ratio, greater than</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Pricing Level II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage Ratio, greater than</a></td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage Ratio, less than</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage Ratio, greater than</a></td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage Ratio, less than</a></td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage Ratio, greater than</a></td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage Ratio, less than</a></td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Pricing Level V</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage Ratio, less than</a></td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Revolving Credit Facility | Pricing Level I</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.45%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Revolving Credit Facility | Pricing Level II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Revolving Credit Facility | Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Revolving Credit Facility | Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Revolving Credit Facility | Pricing Level V</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Revolving Credit Facility | Term SOFR Loans | Pricing Level I</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Revolving Credit Facility | Term SOFR Loans | Pricing Level II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Revolving Credit Facility | Term SOFR Loans | Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Revolving Credit Facility | Term SOFR Loans | Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Revolving Credit Facility | Term SOFR Loans | Pricing Level V</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Revolving Credit Facility | Alternate Base Rate Spread | Pricing Level I</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Revolving Credit Facility | Alternate Base Rate Spread | Pricing Level II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Revolving Credit Facility | Alternate Base Rate Spread | Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Revolving Credit Facility | Alternate Base Rate Spread | Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Revolving Credit Facility | Alternate Base Rate Spread | Pricing Level V</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentCovenantLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480662352848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Margin Spread Based on Leverage Ratio (Details) - Revolving Credit Facility - First Lien Credit Agreement - Line of Credit<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember', window );">&gt; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Leverage ratio</a></td>
<td class="nump">3.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember', window );">&gt; 3.50x | Term SOFR Loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember', window );">&gt; 3.50x | Alternate Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember', window );">&gt; 3.00x but &#8804; 3.50x | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Leverage ratio</a></td>
<td class="nump">3.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember', window );">&gt; 3.00x but &#8804; 3.50x | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Leverage ratio</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember', window );">&gt; 3.00x but &#8804; 3.50x | Term SOFR Loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember', window );">&gt; 3.00x but &#8804; 3.50x | Alternate Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioFourMember', window );">&#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Leverage ratio</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioFourMember', window );">&#8804; 3.00x | Term SOFR Loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioFourMember', window );">&#8804; 3.00x | Alternate Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480661627984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>tranche </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>tranche </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>incentivePlan </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 10, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans', window );">Number of plans | incentivePlan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">261,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance', window );">Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">740,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember', window );">DeepHealth Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Shares Issuable Upon the Exercise of Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized expense weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 1 month 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Shares Issuable Upon the Exercise of Stock Options | DeepHealth Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized expense weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_FutureServiceMember', window );">Other Stock Bonus Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,765,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue', window );">Issuance of common stock upon exercise of options | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember', window );">Performance Based Stock Units ("PSUs")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">60,685<span></span>
</td>
<td class="nump">25,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches', window );">Number of vesting traches | tranche</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember', window );">Performance Based Stock Units ("PSUs") | Board of Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">12,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 29.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember', window );">Performance Based Stock Options ("PSOs")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="nump">235,227<span></span>
</td>
<td class="nump">111,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches', window );">Number of vesting traches | tranche</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember', window );">Performance Based Stock Options ("PSOs") | Board of Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">27,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 29.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember', window );">Long Term Incentive Plan Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Performance Based Stock Units ("PSUs")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Performance Based Stock Options ("PSOs")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available in grant (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Long Term Incentive Plan Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Performance Based Stock Units ("PSUs")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Performance Based Stock Options ("PSOs")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available in grant (in shares)</a></td>
<td class="nump">235,227<span></span>
</td>
<td class="nump">111,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Long Term Incentive Plan Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Vesting Tranches</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares reserved for future issuance related to deferred compensation arrangements with individuals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_FutureServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_FutureServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480668054176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Schedule of Options Activity (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">678,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">261,220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(5,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">935,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable Shares at the end (in shares) | shares</a></td>
<td class="nump">672,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise price Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 15.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">18.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">10.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">16.57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Per Common Share, Exercisable (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 14.70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingContractualLife', window );"><strong>Weighted Average Remaining Contractual Life (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance at end of period</a></td>
<td class="text">6 years 11 months 15 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Exercisable at the end</a></td>
<td class="text">5 years 11 months 23 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AggregateIntrinsicValue', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate value outstanding | $</a></td>
<td class="nump">$ 8,840,425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate value exercisable | $</a></td>
<td class="nump">$ 7,568,342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member', window );">DeepHealth, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">116,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(14,473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">102,509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable Shares at the end (in shares) | shares</a></td>
<td class="nump">77,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise price Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Per Common Share, Exercisable (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingContractualLife', window );"><strong>Weighted Average Remaining Contractual Life (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance at end of period</a></td>
<td class="text">6 years 6 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Exercisable at the end</a></td>
<td class="text">6 years 6 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AggregateIntrinsicValue', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate value outstanding | $</a></td>
<td class="nump">$ 2,565,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate value exercisable | $</a></td>
<td class="nump">$ 1,940,758<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_WeightedAverageRemainingContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life abstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_WeightedAverageRemainingContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480661926448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Schedule of RSA Activity (Details) - Restricted Stock Awards<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>RSAs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">536,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">694,324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(704,019)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod', window );">Forfeited or Canceled (in shares) | shares</a></td>
<td class="num">(667)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">526,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted-Average Remaining Contractual Term (Years)</a></td>
<td class="text">1 year 6 months 3 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 23.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">19.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">21.18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue', window );">Forfeited or Canceled (in dollars per share) | $ / shares</a></td>
<td class="nump">22.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 20.77<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited Or Cancelled In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited Or Cancelled Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140480660915728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Schedule of LTIPs (Details) - Long Term Incentive Plan Shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>LTIPs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">169,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">209,643<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(48,395)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod', window );">Forfeited or Canceled (in shares) | shares</a></td>
<td class="num">(13,476)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">317,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted-Average Remaining Contractual Term (Years)</a></td>
<td class="text">3 years 5 months 4 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 19.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">20.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">19.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue', window );">Forfeited or Canceled (in dollars per share) | $ / shares</a></td>
<td class="nump">19.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 19.87<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited Or Cancelled In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited Or Cancelled Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>rdnt-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rdnt="http://www.radnet.com/20230331"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rdnt-20230331.xsd" xlink:type="simple"/>
    <context id="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i49b54919f837402b828c88c2fb78a373_I20230504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2023-05-04</instant>
        </period>
    </context>
    <context id="ie931d8e47f25400f90b96046fd406a82_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6dc177faf452405fa2bf716f25f19919_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie6278308e0fe4e9e80559d07f63aa90e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iad3e3586af214825b747d44b00364a79_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia605a6d22e64439893da71566768e2e9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ieb7ff594ba1c456380fafa96528d1a70_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i91d4a0efd0134db0912cf424c9c05e57_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i95b93de2b17549f68c2d1d19032cb451_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9c5ed5063e474ba083fe5232406d387c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i468644d28f544537962de87ccfb1e608_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9479ea165b22465ab2af4cc1db0934bf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idb918f8d0aad4f99a42dbf93329537ec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7aad81709c2e40bfa6d50e57ba2978f8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7e0129316a1444a9a87a4f1035890d5e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3ca13f2a1d6242bdbe459e60b2e0745d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i913c1e2479954386a1891ed9fbce6745_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5adf124c49f04748907d0b7a789a6104_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib3adf6f8648e495e9006502147d4eae8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i48b53158259a45cf99350d972b519d34_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0079ed901cd348488a81abe9066a6c27_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia9f6f61fb6774fb88dfcd64fd07c4b8a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia1c7d6e31a0346089303a191fa0be906_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i32758e6d4de641c287fa2f616af42021_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifdf0d0a31a7d4bbeab91318c3504e0e3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib4127c96bf5a4ca98119ab44d3fb22df_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icd187a7758714339a38596e3b8703fda_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i03170300e04e4c6885da7ab306fe32fb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1c6492a471c24eb79e884f0d8d9e9ef5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idab5203b536348aeb1e033a60b58d92b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i78a4a63e76c7434296690fc94fa7d206_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b87a5ef08b949fd9eced9e15c7a255a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i385a0ecd81c14fc5b2842208e1659808_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie7430f7620cb4b499645b1c4db111fd3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibbbc7fc6774d480f8cf4ece72ee8d689_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i57c8687ae4a54bc7961fd12b87f8095c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie91409c4e3ca453ca3dfd68bcfbef870_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1051455c74414445a26e00de581866c1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibddc1d75b382422a8961f98fdde6c318_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic141cdf85619420ebcf66d35adb457ca_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idc0bf32b28e24d0aaab1535b72796e85_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9d8fc8460d0049568d657a5449e9ce3e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i622337df6b2342b8bcf81a0bbf78cfee_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i210a11d3d8e44324b361e34bb30b96fc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3c7ef23f5cc14489bb2ae2e8a17d5ac8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8ec1a7c8f9b74641a09c0fc25654b909_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i80882b4f5c6a453fa389846657050098_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7ae3cbf23e8046c887d676fc95010311_I20230201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-01</instant>
        </period>
    </context>
    <context id="i875e29b29f814b69a487f86dc63c58e7_D20220120-20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceHoldingBVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="i8e4e223d7eff48c4b6d57f718874ebf4_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceHoldingBVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="i06979ac32be0468ab90faae5f8a7fae6_D20220120-20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="i2a5b65acdc4a494dad73f5d762c4bff4_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="i4d24e08a1ed346ecadd8d502b2c5e3c9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i82df3264b09247118f927708d745a3e0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i780286e32ed648ff95b88393d95716a1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i52ba0462fc584809b69e0d06cebc198d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i193239544180470cbfa731378e7fcdf0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4ad85707f4d64ac6a9a8091c4223b351_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i574c4913311e49879ae8136ee2d28148_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibb9e5186dac3404d9c737b06211b3954_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0a4072ab0edd48c8a67ccfb8f51a6290_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i44ce173f477244e8b5b9d811a1911c07_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6ab20d39d79f4dc98599ce2f92baa5a6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibc4e3875a9e549a799c5a7ded655f868_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i00746cf82a884d0881fb0a193616659f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i49ac145dbb9f4ba0bc8a57932c917cba_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9fa4d806c58044f58518c1759a53deb2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3e3f72be824d49ff84df16d939b272c9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i10301ec9313f4145901cddf7c8e67034_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i67abe92a1c5140fc826b327cdcfeb0e3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:TeleradiologyandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibfcabd15dd704d3592f2fedf50542f92_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:TeleradiologyandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic85c070b82f34df996b2edd5c5a6f417_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1b8ceb76bd89449e9f1fdaa8aae701da_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if70ac0bb6794471fac30d72ea02c9975_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingCenterSegmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4ab2e2f3665f40458a4bcdf95423b45a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingCenterSegmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0acc5172ba1c4948b09055ace900fbac_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8aa11bdde454474a9b815f584cb69e06_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5aa3078177dd4a78b72f87d219634477_D20200401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i19b686e5617c4056bf4f5a81d0e86de8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i50b9260334df4b2f857a1e719c97d808_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ProperyAndEquipmentNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6f296060ae9f493f8defee2497cb5fc4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ProperyAndEquipmentNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9081293d8345436495fe616ab903e24b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i259ff7a14ab44385acf1d3dc8b32d84d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i25cc54b133f44bc6867c82ea3b1d00c2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6b60cc174bb1488b811b3f45e09bda82_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ArtificialIntelligenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i13c7509db64a4b76a1499e8339156036_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i369ccdd58842499284be59ca42e369de_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ArtificialIntelligenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if0cbe48174104f73982d4a0ca2a3857e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i82d4ebf817564c7681dcb7af65622412_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ArtificialIntelligenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iae3e6ed3102e4ceb8e24ea8985ea1e38_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if5905542a04540b09449e8b542c285c5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if58217de99e6462f8c2e57b616294439_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i93c4f1236b564f5bb1675e3e16faecef_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ida57b41fb8dc4945a8405b5de4684833_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iab8bcaf8f78f44d39aaba69d6770467c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie75b01796cbf464f8e6be437e129e127_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:PatentAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i11f4b30281c144d0ad846555d53b95ab_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:PatentAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0951dd5e901c4dca8d4d713eebf12539_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedTechnologySoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id515d4eb95a4477a9767fd98d4ee59a6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedTechnologySoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6f5ffc61061348a08dd5cb2414b976aa_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5bc3cf8be0c742bfadeb1994780ffa21_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i18f2154ea6514a0d9c02f237b9630268_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie29af3730fb445a08f77db24069ddaf2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5f27bb8d1da34982b392c9596891b7ea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icfc8d3dc08704d95ac2a3367f23db6ba_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia4f9799f448c40938b0f4799f0dab913_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i22f1eef02031411cac17b094592527ee_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia1117258b4fb43f699a2f7f3415be208_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i46bd0ff499564277b884f9a7be8f681c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i827b8872571a4f11aa439a07047d7c3a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:PatentAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1cbf83bd8a364fc4a600170db5d5f26c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:PatentAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i543e313dd7ca47d3adf0f80f8df4018c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedTechnologySoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9372083139794fde97d33c195ed380f7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedTechnologySoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie74daf4e113844e9a3ae6e83d17dac2f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie55468e7e99d494d912000e2264a206a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iac10bef62a4043318e0782f47e41f58d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1d21764379a54e939ddab4e98c95e66a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib9f162e3c0384b30924c94f3ad53ebae_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9099259394b94e1e889dc1476f075a27_I20210415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-15</instant>
        </period>
    </context>
    <context id="if7309a2667674a92a4cc3eeb4825b42f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7e2bb9a95d4d4802b2e4a3cc0aebe6ab_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if0db9c5249a94190ac881fc140ab7671_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i15eafbad7ffc4c0d940511464f11e6e8_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i2f647f27d1a94bd2971692b3e87ff615_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ifb12196c225347c6a543f74457559713_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i9ace4524b6974e138856ac8172419ae1_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ica6e378192f34ceb847f8a3feae3fc4d_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i965b8fc567f2478dba186b27fff59b4a_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ic22a4427ddba4a24b4b6ff3818dea43c_I20200701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-01</instant>
        </period>
    </context>
    <context id="i999c3e86ee8240ccb38c00170156728a_D20200701-20231031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="i1feee914475c47c19d03bc69138716ee_D20231101-20251031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2025-10-31</endDate>
        </period>
    </context>
    <context id="i973513e4e5fe46adadaacc2b2fd7052d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie8c2f246c0df4407bae5f83b9dea4895_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia1c807c6ae09463bb238f4f90ec7edfa_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3d0fb067263842908a465a961d0de307_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie7f7fa2072f04702b6070015044cc329_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i014cf416eb05406dbacef4beed33f8c4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8290c625ae1c431faf7a99cf4dcee8ab_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6d8e8b09e9574606ab6241afc0829c86_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icbba037786a84b888dd30f858c80bde1_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="iee8168439bff4dcc928d2f0538a23ea5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib6e9460c493149e6bd8bb71cb47a94dc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i31f77a27a2e24b72a13b080caab47d8e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie3d36b3137cf48c1b491cd5b202fbcdf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibd948f656ced403e875b56f896581911_I20221001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-01</instant>
        </period>
    </context>
    <context id="i0bdb93152d774671850e526671c6aec3_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="if10663cad4164b7d819dd600043b536c_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="i066eadbb98a54c6480345b29b400d31f_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="i0dd2d7518a4f46b4a60489e1be50cf79_D20221101-20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-01</endDate>
        </period>
    </context>
    <context id="iefc3e607700f46539886f8ce5ac3a6fe_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i173b6797abf9418b9ce2d7294d426b24_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2acb391edb584f9991ed018864e62fdf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibdfb2358240e4c36b0c1df5fddf49bd7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6697f341173242ddb3318ebb20797960_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie485aedb3f5a499890201c380e948451_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i35969f93dd244ab9975ff3d03ff35236_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i287bda58ab4a4749bc53627ff756795d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia76a78ff4e864951a5ad37cf84296e9a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i11045551fdb3449782344178a2ef73d6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i93c2f0e988bf4215ba9dd9160be1bc52_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i51f5b3ddf736445e83e7bbca68c313c4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i058ba722d17f465ca2784c234195b2cb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3d7f845cf42440e69575e47031da49f1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i53894f1fe8a84432ab52b5a5b819bc93_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3bb3938f8e9245c69f2103134c886ddc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6f3f9c5a69554b138e8af5ee50845912_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i17af87ec48d045ecb8769ad083958efe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8af6e51430bf454182807a0000e29d75_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia3bfe53a05d7443eaebd569b9c1fffbb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5fc55aa9a8f74f6e9d0a7f9ee6911a37_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3a1961ca97b748dd97f76e81cefd372a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib1cd387ced7b4e0ab675250e1043f341_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if254894b76e948059a1f851aac708545_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4d9c210824bd498595db6f8ea56f2975_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idab0c26ccbb3431a83faffea0666ec73_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5324382fed8640319b97df8ad78e78da_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib0f8ba61c5d04db397ce5b6e04306b7e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0eacec98a58d4cdda3f139bb7a0de027_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i22e2dd058697401197f55bd60a4150ee_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i333584db5d0c4718a15a9336dd0ec38b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5422c8baca9649c8971a2171b71a5b0e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8bc5a6bf23e24e448e14f910984a448e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i85f996450ac44be3a585f3df56209db0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if1418728f3764d51ae66362b3b005736_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7e1fc62ee042414286344a73cb1100ad_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8b566bef11524caba9939adb72309fb2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3e6a1bf96f13445c9ec8f1d1017b808f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8ddcffccfdaa4e738249bb0f26ff8fd0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6d7b50a32ec649b6bd1731fb1173bcf9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic0fffd4237ac4587a0961b2f15478644_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie5766c50c6d7461c835635f1c6343841_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7bb97ef0c9bf4fecbcdce0085a7cd336_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i040b12c6fad641ae884cad957f2cfe40_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6d6937e646b24c1c851fae386ba9607f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5ee8e2a0aedf4e16bfc1f00854be3504_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i74aaf1e8f24d470db2a98ecc203f2374_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0f8b6f8b3773411ea71c13b60855758a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic66c83d188f04d7dafa027910df93466_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id9fa9f6b4e3e40648840c75270131b86_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8091047fc1324ea98cd25d50961b4676_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic18ea46b2e144ce8bb4730330b274ca4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rdnt:ContingentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2f64f3acfb1b4f8d905cf0d5b3f16ff6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rdnt:ContingentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iadfab3b66cc3465da1facc6280643211_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7c812255b96e466a813bee1f44c493df_D20180201-20180201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2018-02-01</endDate>
        </period>
    </context>
    <context id="icff909ad5af946f582998f2b08a3332f_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i060d61245cc645109b4d1d8bb44ab6bf_I20191221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-21</instant>
        </period>
    </context>
    <context id="ib78892651f964e84abae349ff967869b_D20191105-20191105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:WhiteRabbit.aiInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-05</startDate>
            <endDate>2019-11-05</endDate>
        </period>
    </context>
    <context id="i976bed9367284ed1a85563a07d391884_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i22cb4964ff984901bd7110c2d6eecce4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i97bd8c7f570042a88fd03a8a7dca61be_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0a7007c50a3b4e91aede5d39ed591d0d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9ec59367bdfc4e95acaca6780a70c7b4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:JointVentureInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iafd6cdf3d5ab422fae40a0ba5aedb8eb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:JointVentureInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i370e4f75f34c4628af09b09b3f73bf92_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie0a61645bc4e4f3e9911510a2c98ef50_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i788654bdc6144e84b022463f3c939653_I20230101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:CCDGLRSServicesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="idf90602139824e3f84f725fcb7a55b86_I20230101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:SouthernCaliforniaDiagnosticImagingIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="iaf3a349f994e4b7c8b647f364de53930_I20230201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:InglewoodImagingCenterLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-01</instant>
        </period>
    </context>
    <context id="if677eedf1e8441f48af5d0ec930fda69_I20230201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RamapoRadiologyAssociatesPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-01</instant>
        </period>
    </context>
    <context id="ibd669e75c1d64607a8a4a42d825b5372_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0df0cc0c59df4b2f96629acaa138268c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2afa7782c90e43af8a9291b388ae0a30_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id46e5c5dde784886904adce4e0b992aa_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9ac0a47d40fa44da84be66fbe8b675c2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if935da71de9445f7a64decc4aa12e4d7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if2ee49b2f311482e92604c71016505c9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3c3b439894a24feb9d3346baa502e442_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i62f2d5d6e38947cebfe0535e07397150_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:EquipmentNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6ec02cff0bb7403d93c06ed1115db776_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:EquipmentNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iff74038af72140fba140e6ea501d015f_I20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="iafa7ca073c27455da1ef23c17f9d1eaf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i27e434031da1489c8d9bbda89a5969c6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic21b3f13e434406ba1275f4ac33a277e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5bdf271a43584924822139b8fb9380b0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idfa89e509e1e48328e0d64bb2910a9ae_I20230327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:OneMonthSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-27</instant>
        </period>
    </context>
    <context id="i96f81a7f32d64009b629b9ef4859f993_I20230327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:ThreeMonthsSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-27</instant>
        </period>
    </context>
    <context id="i42b5a1db32b749cc972364acdd9c9644_I20230327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:SixMonthsSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-27</instant>
        </period>
    </context>
    <context id="ie71f440e2c7643508c28e8a01a00242c_I20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="icc1ca11c511b475ca49c7b77c92736bc_I20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="if7ec32e42eb944bb9330cd1cb04f945c_D20210423-20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-23</startDate>
            <endDate>2021-04-23</endDate>
        </period>
    </context>
    <context id="i3bc539faeadf438fbd7d4d1552f9881b_I20221007">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-07</instant>
        </period>
    </context>
    <context id="i8827e76d9d944f0c83ab889ff9b40970_I20221007">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-07</instant>
        </period>
    </context>
    <context id="i2949ad265aae416b895dc287e1c90a56_I20221007">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-07</instant>
        </period>
    </context>
    <context id="i4a4b8e05477244e69f17430f41440f40_D20221007-20221007">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-07</startDate>
            <endDate>2022-10-07</endDate>
        </period>
    </context>
    <context id="i6f4de3e0b12c4ce99436f199560d928d_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="icc503ebed81d4c76998b856dfa54a9b5_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ie5832838df87478bba175d9f9ab09d12_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="idb58ba96caad4ba7bb0c8651dbcd3083_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i489017a84c394ba39520152a49aa8cda_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="icb4c174e094d423b95626eb584086fe6_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i84d7aa7a0eb0454e91b9f2219e820140_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ie5a73f30657642bda3a4e7fae521a479_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ib440cff642614ebfb76342cdb0207f49_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="id7d124de1ada45beacf97bc0d67b1168_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i5fd2d5ebfa4446888fa605822721f229_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ifb2039ca234941c2af241afaa4dd085a_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="icaaf8454b0ae42a5825cbd6024216629_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="ia8045fe5cfc84ac08c6a0c898079bdde_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i2d3c803e6a4b4fa7b9264589b4154b82_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ia4c088461a3c4c95a93abef9e3f00c29_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i3de3948a63bb469ba713d1ada7005b41_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="ia8335fa556c04b78865bee76634b9ff7_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i324536b68eb244a7b90b0a3ba932bb6a_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i55a8765735c14513a443454a717b1110_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i3ba2dd225829444a8f3c676b6fd16f76_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id30c357b819f411f883897ece82a2ee9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i60ee747f054f4a7fa53e6ca0d30f6fac_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ida485f8e22d14a529a4301403a5a90a4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i61d0d3aa77e94d1e8d2fddb57f6be350_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i58b95ffabd8f4ce5a478e21bfbc7b17d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7dfe80ca8754497ba1f5422326933310_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifd37700473c648cbbf786d4b1f0c907d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:OneMonthSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i771d845d28a0407987c7a78f55f3c8ac_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia7a1589942bf4d659b4c2a4bbeb48cb0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1f1da3a1ad334f35988ca6282aa57b99_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idfd92754a11641c3b9f84f0578f4bc74_D20230331-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifbe38301ce1249c88966ffa550df3678_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i24c9c233e2a54c57a8964647449f94d6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7d5747c3ac914bc7a1e6aa46bd3d149e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i903948a537d64b37b67178fb25e84ed9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i10cefc40b0c44d8cbc4372fcfb77562b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i07e3281e1e824c3d97f67f8ac8a57bd4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i48658f8cfbcf4487bc406a287ad83c2d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icb9196414c2f47f29fa015cf40d76abc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if01c31d758364150a9bb3ce7cd850ca4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibf860e6898d344c0a7a4962ee596f36d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i44d10d8940d34f76ab949ea9ed5bbdc3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic4bd4668c12145b1bdf1773fe1c0b99e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iaaae0769addc4e53bad052090529ee90_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie97a081dfdc74b2dac6dc6743edad186_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iee7b9274694a4e7fbfba10c74d1e9f2b_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i97202989895048c6b3682a076c3a5dc3_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i034e56b7f7854922a502eefa5771dc2a_I20210610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2021-06-10</instant>
        </period>
    </context>
    <context id="if953ce5e5d654143a5f27fbf0c7a8bcf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i552d69a649564205922349013a84c526_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i26ed0c3bb3bc4dfca4136d54d21385d7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8ced063bc27e4d249a4e8c5f2627065c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i603724082df64ed1a5f7a54cc923b37e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iebc09a78aa3040b9b0079b356035fa32_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i75c6b8d0c0664a95a8cd0428ddf549df_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i16e7a48c2cb34748acb734708003ddda_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1b2d16ac66924839910f548784911842_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idca80d4271d24fc3a40ba5927cee3bbe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8816a5b45bc14eeba46c2e754bf6809a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6a719cbef35d464180bcd3fa66af85f8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic4df50bb1eea438187c006139af9358d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:FutureServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3baed7f4af1344d989545d489662cec2_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="if430b6d648944e90a7a4d909825414d6_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ic141fc5027bd4033a301df773b032bc0_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i20728da098554c3492944bc24dc7bedd_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ib7d7b27aecc643be998969b03dbed528_D20230101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i29265dd33e844d5a8bbc1d746f6353ac_D20230101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i375bf56db89c40ecb67521134911bf52_D20230101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="ia74217dd8ba14406bfc31c3b148192a3_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ie6809d4048aa4a35b513b76bacbff9df_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i78302aa8284649589fadb30185381e93_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i3fb7ffda1bf04655ba1b20ddc4c4aab0_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i4a2bf0a508d6442ca467b195bdef4273_D20230101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i50a36f080a554744add73eda4ce89019_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i52e51b40e55a4447973325a56d0ca1aa_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ibac46b5931104d75a9811d327fb9c53d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i78c12519a4964a51b7deba80b2e9ae56_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1cfa0f61545742ee999c634dad4b4b76_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i041f68f3d9614026814745b94c47b8c7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia5b043dd93d14bad91a507a5b7da5817_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="center">
        <measure>rdnt:center</measure>
    </unit>
    <unit id="segment">
        <measure>rdnt:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="incentiveplan">
        <measure>rdnt:incentivePlan</measure>
    </unit>
    <unit id="agreement">
        <measure>rdnt:agreement</measure>
    </unit>
    <unit id="loan">
        <measure>rdnt:loan</measure>
    </unit>
    <unit id="security">
        <measure>rdnt:security</measure>
    </unit>
    <unit id="jointventure">
        <measure>rdnt:jointVenture</measure>
    </unit>
    <unit id="tranche">
        <measure>rdnt:tranche</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80L2ZyYWc6YmFlNDI0NzYxMzJkNGQ0ZTllNGI0MDI0ZGY4OGVkZTYvdGFibGU6NTcyMDEwZmM5MjZmNDA0MzlmZWZjYjkyNTA1ZGRkNDYvdGFibGVyYW5nZTo1NzIwMTBmYzkyNmY0MDQzOWZlZmNiOTI1MDVkZGQ0Nl8xLTEtMS0xLTU3MDcz_887a8092-6339-4b10-ade9-9472e9cccca3">0000790526</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80L2ZyYWc6YmFlNDI0NzYxMzJkNGQ0ZTllNGI0MDI0ZGY4OGVkZTYvdGFibGU6NTcyMDEwZmM5MjZmNDA0MzlmZWZjYjkyNTA1ZGRkNDYvdGFibGVyYW5nZTo1NzIwMTBmYzkyNmY0MDQzOWZlZmNiOTI1MDVkZGQ0Nl8yLTEtMS0xLTU3MDcz_ba787b22-e9eb-4974-a360-7af1a550251c">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80L2ZyYWc6YmFlNDI0NzYxMzJkNGQ0ZTllNGI0MDI0ZGY4OGVkZTYvdGFibGU6NTcyMDEwZmM5MjZmNDA0MzlmZWZjYjkyNTA1ZGRkNDYvdGFibGVyYW5nZTo1NzIwMTBmYzkyNmY0MDQzOWZlZmNiOTI1MDVkZGQ0Nl8zLTEtMS0xLTU3MDcz_9b4d48e7-bbf8-4f48-918f-dd2e9241834a">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80L2ZyYWc6YmFlNDI0NzYxMzJkNGQ0ZTllNGI0MDI0ZGY4OGVkZTYvdGFibGU6NTcyMDEwZmM5MjZmNDA0MzlmZWZjYjkyNTA1ZGRkNDYvdGFibGVyYW5nZTo1NzIwMTBmYzkyNmY0MDQzOWZlZmNiOTI1MDVkZGQ0Nl80LTEtMS0xLTU3MDcz_0d61e601-1ae0-4cf6-b9aa-a98848f1620b">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80L2ZyYWc6YmFlNDI0NzYxMzJkNGQ0ZTllNGI0MDI0ZGY4OGVkZTYvdGFibGU6NTcyMDEwZmM5MjZmNDA0MzlmZWZjYjkyNTA1ZGRkNDYvdGFibGVyYW5nZTo1NzIwMTBmYzkyNmY0MDQzOWZlZmNiOTI1MDVkZGQ0Nl81LTEtMS0xLTU3MDcz_6351cb84-54e9-43af-b6ec-5d484d68c519">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjI1ZDk4ZTg3NTAxYTRkZWViMmE0ZTYyZGQzYTYzMjA3L3RhYmxlcmFuZ2U6MjVkOThlODc1MDFhNGRlZWIyYTRlNjJkZDNhNjMyMDdfMi00LTEtMS01NzA3Mw_82eff8fd-e435-416f-a669-f954d06a2aa7">http://fasb.org/us-gaap/2022#InterestExpenseDebt</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjllMGUxNjNhM2M3MDQ0NzA4ZGRmYzVhNDQyNjI2MmJlL3RhYmxlcmFuZ2U6OWUwZTE2M2EzYzcwNDQ3MDhkZGZjNWE0NDI2MjYyYmVfMi00LTEtMS04OTMxOA_468424d7-c562-4c21-a8d7-de7f7f9f175e">http://fasb.org/us-gaap/2022#InterestExpenseDebt</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ibac46b5931104d75a9811d327fb9c53d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODE4OTk1_66873c0e-ef14-4872-a4e6-5ee1a266aa10">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQw_7cea45bf-859e-453b-b12a-1a6a5db99cd2">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQ3_c00d5dde-a915-4d81-bd93-3807822f35fa">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQ_ef335a64-5003-4281-81f9-13999e835d9e">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQx_ba65a21e-17ad-406a-bb07-f1e5620fde1d">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQy_a112aef3-36f0-4068-a187-1ed3de94e7f6">001-33307</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjM5_fa9edf49-f013-49c2-90b4-85f05e6ac125">RadNet, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6N2QzYzdkOTBmZDJiNDAyNjhlZDIwMmQzZjA4NzNiODAvdGFibGVyYW5nZTo3ZDNjN2Q5MGZkMmI0MDI2OGVkMjAyZDNmMDg3M2I4MF8wLTAtMS0xLTU3MDcz_7fa5dc69-3c5e-4594-b125-49c7349fc0ef">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6N2QzYzdkOTBmZDJiNDAyNjhlZDIwMmQzZjA4NzNiODAvdGFibGVyYW5nZTo3ZDNjN2Q5MGZkMmI0MDI2OGVkMjAyZDNmMDg3M2I4MF8wLTItMS0xLTU3MDcz_48eb6980-64cf-43d5-8d17-a174b7f9deda">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6N2QzYzdkOTBmZDJiNDAyNjhlZDIwMmQzZjA4NzNiODAvdGFibGVyYW5nZTo3ZDNjN2Q5MGZkMmI0MDI2OGVkMjAyZDNmMDg3M2I4MF8zLTAtMS0xLTU3MDcz_4ffe3ffd-8264-426d-bf3a-611c9a8b7722">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6N2QzYzdkOTBmZDJiNDAyNjhlZDIwMmQzZjA4NzNiODAvdGFibGVyYW5nZTo3ZDNjN2Q5MGZkMmI0MDI2OGVkMjAyZDNmMDg3M2I4MF80LTAtMS0xLTU3MDcz_adabd29d-fd49-48a2-a7cd-7fa8f10d3eb7">Los Angeles,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6N2QzYzdkOTBmZDJiNDAyNjhlZDIwMmQzZjA4NzNiODAvdGFibGVyYW5nZTo3ZDNjN2Q5MGZkMmI0MDI2OGVkMjAyZDNmMDg3M2I4MF80LTEtMS0xLTU3MDcz_a341c96c-9697-496e-b52c-bf91f97573c9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6N2QzYzdkOTBmZDJiNDAyNjhlZDIwMmQzZjA4NzNiODAvdGFibGVyYW5nZTo3ZDNjN2Q5MGZkMmI0MDI2OGVkMjAyZDNmMDg3M2I4MF80LTItMS0xLTU3MDcz_3702e269-d644-49ef-9f0b-2c3df85c9eb2">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQz_283adce0-6f6b-4ea4-88b1-ed78703dadea">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQ0_5006d701-1c1d-455a-9144-7ef6fda89a1d">478-7808</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6MDhkZTFlYWU1ZTM0NDVlN2FkMTViYTFkMzU3OWU3NDgvdGFibGVyYW5nZTowOGRlMWVhZTVlMzQ0NWU3YWQxNWJhMWQzNTc5ZTc0OF8xLTAtMS0xLTU3MDcz_565c424d-9197-47f2-baa0-de00980edd3a">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6MDhkZTFlYWU1ZTM0NDVlN2FkMTViYTFkMzU3OWU3NDgvdGFibGVyYW5nZTowOGRlMWVhZTVlMzQ0NWU3YWQxNWJhMWQzNTc5ZTc0OF8xLTItMS0xLTU3MDcz_5cc08ffd-cf59-42ef-81d3-bd5ac798aff9">RDNT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6MDhkZTFlYWU1ZTM0NDVlN2FkMTViYTFkMzU3OWU3NDgvdGFibGVyYW5nZTowOGRlMWVhZTVlMzQ0NWU3YWQxNWJhMWQzNTc5ZTc0OF8xLTQtMS0xLTU3MDcz_97fb3bd3-ca91-41ac-aba9-477c64bac39a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQ1_e7ed9400-cde6-472b-b786-67a6c063ae11">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjQ2_7dc4b746-7daa-4cb4-8e5d-da6dc08d2197">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6YmQ1MzMwOWJkODYzNGE5YTk1ZTQxNmU2NTE0ZjI0ZjYvdGFibGVyYW5nZTpiZDUzMzA5YmQ4NjM0YTlhOTVlNDE2ZTY1MTRmMjRmNl8wLTAtMS0xLTU3MDcz_dff21e54-9d16-4158-8060-5cf70aff04dd">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6YmQ1MzMwOWJkODYzNGE5YTk1ZTQxNmU2NTE0ZjI0ZjYvdGFibGVyYW5nZTpiZDUzMzA5YmQ4NjM0YTlhOTVlNDE2ZTY1MTRmMjRmNl8xLTMtMS0xLTU3MDcz_77363525-789f-4fef-ba85-bb09ead3add7">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGFibGU6YmQ1MzMwOWJkODYzNGE5YTk1ZTQxNmU2NTE0ZjI0ZjYvdGFibGVyYW5nZTpiZDUzMzA5YmQ4NjM0YTlhOTVlNDE2ZTY1MTRmMjRmNl8yLTMtMS0xLTU3MDcz_cab58244-eb4c-4eda-9410-9f03771769d7">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8zODQ4MjkwNjk5NDY1_29313771-3b69-4c77-88d8-c5d24c8ac151">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i49b54919f837402b828c88c2fb78a373_I20230504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xL2ZyYWc6MWMxNjQ0YWM4YjdiNDMwZGFkZGU5NjdjNjMyMWUxNTgvdGV4dHJlZ2lvbjoxYzE2NDRhYzhiN2I0MzBkYWRkZTk2N2M2MzIxZTE1OF8yMjMw_edad0482-64b0-4d94-809f-00a8f9ef2e26"
      unitRef="shares">58345891</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNC0xLTEtMS01NzA3Mw_2cc9dd1e-ad12-41cb-80b7-46e723e37ba3"
      unitRef="usd">90844000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNC0zLTEtMS01NzA3Mw_919b18e4-3a52-494e-9bc6-61cb9b993fb0"
      unitRef="usd">127834000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNS0xLTEtMS01NzA3Mw_a3c5b070-11f2-46ac-98e1-606876777b16"
      unitRef="usd">176354000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNS0zLTEtMS01NzA3Mw_53243e01-a6fb-4e7e-ba0e-565698a12522"
      unitRef="usd">166357000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNi0xLTEtMS01NzA3Mw_ec10ad6b-c718-482d-a727-dca1a55488e3"
      unitRef="usd">20387000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNi0zLTEtMS01NzA3Mw_4de7004f-2dcd-4d87-852f-501024c0ea43"
      unitRef="usd">18971000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNy0xLTEtMS01NzA3Mw_64ff3379-6c98-4491-99ed-ab2a0dc7472a"
      unitRef="usd">55100000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNy0zLTEtMS01NzA3Mw_15869f87-80aa-4a0d-b092-6fb12196c3e2"
      unitRef="usd">54022000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfOS0xLTEtMS01NzA3Mw_a929d5d0-15b9-4e6f-833a-1a0f553b7e29"
      unitRef="usd">342685000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfOS0zLTEtMS01NzA3Mw_5b9372f5-d6cb-4f21-9e2f-e8b70412107d"
      unitRef="usd">367184000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTEtMS0xLTEtNTcwNzM_a83c8b75-ce77-4c7c-84eb-d2669c2865f8"
      unitRef="usd">545492000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTEtMy0xLTEtNTcwNzM_cf3d45a2-4fec-4bbd-90e8-4256b349e14a"
      unitRef="usd">565961000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTItMS0xLTEtNTcwNzM_87cc9eaf-0564-4f22-afcd-a2a091fc025b"
      unitRef="usd">623309000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTItMy0xLTEtNTcwNzM_6964f3e6-0ba6-477c-8a81-f09be14d8958"
      unitRef="usd">603524000</us-gaap:OperatingLeaseRightOfUseAsset>
    <rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTMtMS0xLTEtNTcwNzM_007fe57a-4c44-4285-a02e-3cc299a1742f"
      unitRef="usd">1168801000</rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets>
    <rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTMtMy0xLTEtNTcwNzM_9b04f39a-5472-4253-bbbe-147cd98647dc"
      unitRef="usd">1169485000</rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets>
    <us-gaap:Goodwill
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTUtMS0xLTEtNTcwNzM_5e5df33f-4db7-4403-a972-4df33b0fe2b5"
      unitRef="usd">687085000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTUtMy0xLTEtNTcwNzM_f8358bc4-b91d-4dd7-bf23-d9d11fc98534"
      unitRef="usd">677665000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTYtMS0xLTEtNTcwNzM_2ac58116-4526-4cef-8395-195252fd8fa9"
      unitRef="usd">103003000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTYtMy0xLTEtNTcwNzM_593e1c38-6b2e-4ba8-904b-e162b2a9c29d"
      unitRef="usd">106228000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTctMS0xLTEtNTcwNzM_9e847b10-ccd7-4525-9864-e2660ebc8573"
      unitRef="usd">2122000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTctMy0xLTEtNTcwNzM_d51ef516-ccde-4078-83c7-2ab670e96c42"
      unitRef="usd">2280000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTgtMS0xLTEtNTcwNzM_7830bd2d-c825-4715-9870-866862cff27c"
      unitRef="usd">59321000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMTgtMy0xLTEtNTcwNzM_6a9c2863-c2b3-401d-bbdd-416280767f12"
      unitRef="usd">57893000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:DepositsAssets
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjAtMS0xLTEtNTcwNzM_fe10e992-c907-48f4-a8f5-757f539eba00"
      unitRef="usd">51052000</us-gaap:DepositsAssets>
    <us-gaap:DepositsAssets
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjAtMy0xLTEtNTcwNzM_7d87b27a-cc78-4951-bf1a-7b4755ff4434"
      unitRef="usd">53172000</us-gaap:DepositsAssets>
    <us-gaap:Assets
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjEtMS0xLTEtNTcwNzM_d8302c8b-982f-4bcd-bced-586454043290"
      unitRef="usd">2414069000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjEtMy0xLTEtNTcwNzM_56fe9b92-ffd4-46d0-8e12-3eb973514d99"
      unitRef="usd">2433907000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjQtMS0xLTEtNTcwNzM_6ea57cf6-abb4-4736-b393-cc1c1aa111e0"
      unitRef="usd">296727000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjQtMy0xLTEtNTcwNzM_7db3b826-1a31-4b06-9259-40d3886c51a6"
      unitRef="usd">369595000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjUtMS0xLTEtNTcwNzM_5e09d495-c425-49a6-bc82-12ce114af436"
      unitRef="usd">31548000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjUtMy0xLTEtNTcwNzM_bffd112d-47c6-44a4-9e78-22f2a94d12eb"
      unitRef="usd">23100000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjYtMS0xLTEtNTcwNzM_f029e480-ab21-46aa-9695-54d13b09b160"
      unitRef="usd">4343000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjYtMy0xLTEtNTcwNzM_7523dc39-cc7a-4265-89c8-f836141abe96"
      unitRef="usd">4021000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjgtMS0xLTEtNTcwNzM_5fac224e-272d-4786-9156-3f750baa407d"
      unitRef="usd">58590000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjgtMy0xLTEtNTcwNzM_4d96139b-ed0c-4bb4-a1e0-5343eff518bf"
      unitRef="usd">57607000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjktMS0xLTEtNTcwNzM_50bcf879-1555-4b58-b3a0-23ffc222f6a9"
      unitRef="usd">15935000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMjktMy0xLTEtNTcwNzM_ab38e699-948b-467e-9ac4-f52e75f1aeb9"
      unitRef="usd">12400000</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzAtMS0xLTEtNTcwNzM_c4f981c5-f869-4209-8bee-223e386d7145"
      unitRef="usd">407143000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzAtMy0xLTEtNTcwNzM_8c44aa8a-48f2-429d-9bbc-8177c24a25d3"
      unitRef="usd">466723000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzMtMS0xLTEtNTcwNzM_abacd9a5-0a63-4933-8732-707d8d405add"
      unitRef="usd">623538000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzMtMy0xLTEtNTcwNzM_6626b9c5-d479-4c31-a4aa-9ab4f201e29d"
      unitRef="usd">604117000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzQtMS0xLTEtNTcwNzM_264d6339-5bbe-49ca-8c4a-dbd3b72b5af9"
      unitRef="usd">852354000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzQtMy0xLTEtNTcwNzM_9fd17a19-a62d-4c93-8c1d-d106ff3f122a"
      unitRef="usd">839344000</us-gaap:LongTermNotesPayable>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzUtMS0xLTEtODAzMzc_cc15e556-132e-41b0-a8bc-2a2787cfa2db"
      unitRef="usd">10410000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzUtMy0xLTEtODAzMzc_6d96c18b-1c3a-4abd-aa0c-2bc5026956d3"
      unitRef="usd">9256000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzUtMS0xLTEtNTcwNzM_de04fc86-9ec7-4638-a721-e5ececcf8cad"
      unitRef="usd">27523000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzUtMy0xLTEtNTcwNzM_2956f1f0-12f9-4a51-9e28-b6fc2c776d9a"
      unitRef="usd">23015000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzYtMS0xLTEtNTcwNzM_34870be8-3631-4c00-a0e6-c07ed732fe73"
      unitRef="usd">1920968000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzYtMy0xLTEtNTcwNzM_b97bd0b6-a654-4fa0-8022-6cdf2a2a23a6"
      unitRef="usd">1942455000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMC0xLTEtNTcwNzMvdGV4dHJlZ2lvbjowODFlMTI0MWU0M2E0OTdmYTI2YTExMTFhMjE3M2NhM18xOQ_691553cb-7732-4231-b3b9-eceb4a84700b"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMC0xLTEtNTcwNzMvdGV4dHJlZ2lvbjowODFlMTI0MWU0M2E0OTdmYTI2YTExMTFhMjE3M2NhM18xOQ_bf7dc29a-c3fc-4306-a7c9-fdf6c69c9ca8"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMC0xLTEtNTcwNzMvdGV4dHJlZ2lvbjowODFlMTI0MWU0M2E0OTdmYTI2YTExMTFhMjE3M2NhM18zMw_56b69b52-a43d-48b6-bcc7-912357f2f77d"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMC0xLTEtNTcwNzMvdGV4dHJlZ2lvbjowODFlMTI0MWU0M2E0OTdmYTI2YTExMTFhMjE3M2NhM18zMw_663c734b-5a6d-4c5d-95b8-5f40777a0b4c"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMC0xLTEtNTcwNzMvdGV4dHJlZ2lvbjowODFlMTI0MWU0M2E0OTdmYTI2YTExMTFhMjE3M2NhM181NQ_9924a4dc-3ce1-4718-adda-a2a53f962537"
      unitRef="shares">58270290</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMC0xLTEtNTcwNzMvdGV4dHJlZ2lvbjowODFlMTI0MWU0M2E0OTdmYTI2YTExMTFhMjE3M2NhM181NQ_acdb9aba-0395-4f84-9b68-c545eede61f9"
      unitRef="shares">58270290</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMC0xLTEtNTcwNzMvdGV4dHJlZ2lvbjowODFlMTI0MWU0M2E0OTdmYTI2YTExMTFhMjE3M2NhM182Mg_3c9acd77-5a39-4027-9374-68a4bc5ec842"
      unitRef="shares">57723125</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMC0xLTEtNTcwNzMvdGV4dHJlZ2lvbjowODFlMTI0MWU0M2E0OTdmYTI2YTExMTFhMjE3M2NhM182Mg_f42b97bf-04b2-499a-a9a6-c7401b2ec2ea"
      unitRef="shares">57723125</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMS0xLTEtNTcwNzM_a5c36b0b-d395-4d77-96f1-b9a0c319c231"
      unitRef="usd">6000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzgtMy0xLTEtNTcwNzM_97e58089-5a10-4ab5-871d-73fae792df58"
      unitRef="usd">6000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzktMS0xLTEtNTcwNzM_54b0d90c-450e-40f2-8ce2-f2a45d71d31c"
      unitRef="usd">448522000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfMzktMy0xLTEtNTcwNzM_8069d9a1-a33c-4193-9869-2cd63ad4b862"
      unitRef="usd">436288000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDAtMS0xLTEtNTcwNzM_555dac9d-5a04-49cd-844b-84f8e3a0f5e3"
      unitRef="usd">-16978000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDAtMy0xLTEtNTcwNzM_9005680d-f2af-4526-95ec-7ee5b6080129"
      unitRef="usd">-20677000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDEtMS0xLTEtNTcwNzM_86faeeec-ce44-459d-9c0f-4282c8b78f2c"
      unitRef="usd">-103628000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDEtMy0xLTEtNTcwNzM_1a22bc68-2129-4ef9-b69e-c2719d2d6f2d"
      unitRef="usd">-82622000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDItMS0xLTEtNTcwNzM_b77ff2ec-1a40-487a-936b-11ae731f7a21"
      unitRef="usd">327922000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDItMy0xLTEtNTcwNzM_5ded9e9a-c45c-4e2c-b4d2-4ef0ad06dc72"
      unitRef="usd">332995000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDMtMS0xLTEtNTcwNzM_faff1971-1811-403b-ba65-1f32c804245a"
      unitRef="usd">165179000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDMtMy0xLTEtNTcwNzM_b7c9da44-c439-4a93-ab7d-09887e5548ae"
      unitRef="usd">158457000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDQtMS0xLTEtNTcwNzM_5d448d4a-12b3-4f36-900c-eb0e92ffda9f"
      unitRef="usd">493101000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDQtMy0xLTEtNTcwNzM_25250923-be78-48c7-bd4c-b7ed3fa9d298"
      unitRef="usd">491452000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDUtMS0xLTEtNTcwNzM_f91d4e90-6954-4455-af26-86562ed85e40"
      unitRef="usd">2414069000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xNi9mcmFnOmE3NjdkZDYzM2YzYzRjOTliNjU2YjRiODUxY2QwNDg1L3RhYmxlOmNmM2I3YTZiYjg3MDQ3MGM4OGU5MjAzNjM4YjQ1NDE1L3RhYmxlcmFuZ2U6Y2YzYjdhNmJiODcwNDcwYzg4ZTkyMDM2MzhiNDU0MTVfNDUtMy0xLTEtNTcwNzM_1482a19f-2318-4896-87db-f8abc116ed95"
      unitRef="usd">2433907000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6278308e0fe4e9e80559d07f63aa90e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMy0xLTEtMS01NzA3Mw_73ed309e-71b2-42e3-9bcb-21b14ae6870c"
      unitRef="usd">352420000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad3e3586af214825b747d44b00364a79_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMy0zLTEtMS01NzA3Mw_8865b6ed-03ce-476a-a613-2e8e6e7aaf9e"
      unitRef="usd">303276000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia605a6d22e64439893da71566768e2e9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfNC0xLTEtMS01NzA3Mw_aef52ab1-b0bb-4521-8fd2-48e06edd5ae8"
      unitRef="usd">38144000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb7ff594ba1c456380fafa96528d1a70_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfNC0zLTEtMS01NzA3Mw_c640f261-1819-4c80-8b07-4df899b90092"
      unitRef="usd">38491000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfNS0xLTEtMS01NzA3Mw_f0745dce-620a-46e8-8b21-08e5ca26a5bc"
      unitRef="usd">390564000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfNS0zLTEtMS01NzA3Mw_55ebc513-9368-4491-9282-6fb98ed37667"
      unitRef="usd">341767000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <rdnt:OperatingExpensesExcludingDepreciationAndAmortization
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfOC0xLTEtMS01NzA3Mw_8a4ed7b0-9a8f-46e0-9e62-cf6548b976dd"
      unitRef="usd">351865000</rdnt:OperatingExpensesExcludingDepreciationAndAmortization>
    <rdnt:OperatingExpensesExcludingDepreciationAndAmortization
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfOC0zLTEtMS01NzA3Mw_eb315de5-f8cb-4d3c-9899-5defeba926ce"
      unitRef="usd">315039000</rdnt:OperatingExpensesExcludingDepreciationAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfOS0xLTEtMS01NzA3Mw_adab325c-84c5-4874-8fe0-b1766d5468ef"
      unitRef="usd">31315000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfOS0zLTEtMS01NzA3Mw_dfe2acd7-6c9b-4632-ab36-06104a097091"
      unitRef="usd">27118000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTAtMS0xLTEtNTcwNzM_f518c1b1-672f-4333-80b1-52af33157315"
      unitRef="usd">-579000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTAtMy0xLTEtNTcwNzM_258f9e77-a485-494f-9fff-510a4e385363"
      unitRef="usd">-1128000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:SeveranceCosts1
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTEtMS0xLTEtNTcwNzM_2539df92-633c-4f1e-8b5f-561aeec51daf"
      unitRef="usd">134000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTEtMy0xLTEtNTcwNzM_392122a3-afd1-4d86-8bbe-ed4da965ac9f"
      unitRef="usd">201000</us-gaap:SeveranceCosts1>
    <us-gaap:OperatingExpenses
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTItMS0xLTEtNTcwNzM_dc77313a-8a53-4dc3-8559-dc3760cafbb8"
      unitRef="usd">383893000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTItMy0xLTEtNTcwNzM_3373f9af-c20e-48b1-9a39-a55476fad2a6"
      unitRef="usd">343486000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTMtMS0xLTEtNTcwNzM_676aadf2-e4e3-4bc7-aa38-9737ffce3ebe"
      unitRef="usd">6671000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTMtMy0xLTEtNTcwNzM_0972d1fd-013f-4ed9-95d4-35fa313ef9c6"
      unitRef="usd">-1719000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpenseDebt
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTYtMS0xLTEtNTcwNzM_b188af0d-79af-40f2-9c38-ee4a7d89db22"
      unitRef="usd">15722000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTYtMy0xLTEtNTcwNzM_8246996d-d091-4d93-8222-ccd2eeda4213"
      unitRef="usd">11593000</us-gaap:InterestExpenseDebt>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTctMS0xLTEtNTcwNzM_7f569d6d-7452-405e-ba5e-2a4c6ee070d2"
      unitRef="usd">1428000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTctMy0xLTEtNTcwNzM_26a3fa49-651d-43de-ac75-3e0a10ee4ba1"
      unitRef="usd">2517000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTgtMS0xLTEtNTcwNzM_09bfc23e-5c0b-4141-a777-b9749774bb77"
      unitRef="usd">-4093000</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMTgtMy0xLTEtNTcwNzM_419be03b-d64e-42cb-b3ab-5a4a0a65ae38"
      unitRef="usd">20819000</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjAtMS0xLTEtNTcwNzM_ab177296-883e-4333-8e8d-2ded1e44453e"
      unitRef="usd">-1432000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjAtMy0xLTEtNTcwNzM_5d2a67ab-7f1b-421f-a48c-2f4284677452"
      unitRef="usd">-165000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjEtMS0xLTEtNTcwNzM_6329c906-d47b-49c9-ad26-eefdb69a442f"
      unitRef="usd">-19819000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjEtMy0xLTEtNTcwNzM_328bf53e-bea5-4173-a9bf-7d2cfb09d8fc"
      unitRef="usd">11578000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjItMS0xLTEtNTcwNzM_b98d10e9-e389-49a5-9328-82777c9232da"
      unitRef="usd">-13148000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjItMy0xLTEtNTcwNzM_077a7574-e96e-43da-aa23-13d34f49db8a"
      unitRef="usd">9859000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjMtMS0xLTEtNTcwNzM_868847ea-de4b-41d7-8af8-94676e25ddbb"
      unitRef="usd">1135000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjMtMy0xLTEtNTcwNzM_f5816733-bf2f-4bda-a821-19d240058909"
      unitRef="usd">1496000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjQtMS0xLTEtNTcwNzM_7eddd20c-3ad3-46b8-8dc3-a84bdee4c359"
      unitRef="usd">-14283000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjQtMy0xLTEtNTcwNzM_ac0873e6-e864-4b35-af93-23c53f27c3dc"
      unitRef="usd">8363000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjUtMS0xLTEtNTcwNzM_8fedd0f0-1544-4a5a-bd02-f53e642a9e0b"
      unitRef="usd">6722000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjUtMy0xLTEtNTcwNzM_a8d6b28c-18a2-4fac-8fc0-d30da80487c6"
      unitRef="usd">5350000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjYtMS0xLTEtNTcwNzM_7652df12-08b0-4235-af04-4033c6a0776f"
      unitRef="usd">-21005000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjYtMy0xLTEtNTcwNzM_1e6abe0e-c0d4-4e58-a01b-7600c0c72030"
      unitRef="usd">3013000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjgtMS0xLTEtNTcwNzM_8f9748b8-4c46-4eb1-86d4-4e0d6cd0fdd2"
      unitRef="usdPerShare">-0.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMjgtMy0xLTEtNTcwNzM_7779acd1-5afa-43e9-8047-f6519e834879"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMzAtMS0xLTEtNTcwNzM_f1bdc465-3372-47c4-8177-f9880c464a14"
      unitRef="usdPerShare">-0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMzAtMy0xLTEtNTcwNzM_9c515850-056f-47fd-bfc6-2a06eb847a68"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMzItMS0xLTEtNTcwNzM_9a4895d3-645d-4f61-b48d-e159533c22c8"
      unitRef="shares">57701439</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMzItMy0xLTEtNTcwNzM_aa8a4049-48c1-4839-abd7-97952bf83f3a"
      unitRef="shares">55303007</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMzMtMS0xLTEtNTcwNzM_ae8d27aa-8b95-4010-9619-81ced9ca506f"
      unitRef="shares">57701439</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8xOS9mcmFnOjk0MjZhNGE0Y2Y4YTQwMzhiYzIzNTNiMzFlYTc0NmI5L3RhYmxlOjYxZDE1NjlhMmUwZTRhOWJhYzAwZDEyZDMzZjBiZTIzL3RhYmxlcmFuZ2U6NjFkMTU2OWEyZTBlNGE5YmFjMDBkMTJkMzNmMGJlMjNfMzMtMy0xLTEtNTcwNzM_da8085fe-3484-4028-bef8-06e1582443af"
      unitRef="shares">56362193</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfMi0xLTEtMS01NzA3Mw_74622a58-1c04-42ba-888c-2a6a56543ed5"
      unitRef="usd">-14283000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfMi0zLTEtMS01NzA3Mw_d327628e-fdf1-4a80-9116-3dc6307f2906"
      unitRef="usd">8363000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfMy0xLTEtMS01NzA3Mw_9a95495e-a48f-4580-afc2-e07355eed176"
      unitRef="usd">2777000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfMy0zLTEtMS01NzA3Mw_75e89b97-a8de-4da8-8569-69604d1690b1"
      unitRef="usd">-1264000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfNS0xLTEtMS01NzA3Mw_ceb09a19-aec8-4df4-a233-1a510bd41b53"
      unitRef="usd">-922000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfNS0zLTEtMS01NzA3Mw_57d0f977-07e2-44af-a373-71e3159c897c"
      unitRef="usd">-923000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfNi0xLTEtMS01NzA3Mw_5ed6ca93-a200-4ac5-8df6-6beec0c1b5ad"
      unitRef="usd">-10584000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfNi0zLTEtMS01NzA3Mw_0915ad55-6e22-4ae2-b53e-7b700bfae505"
      unitRef="usd">8022000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfNy0xLTEtMS01NzA3Mw_57d5c249-1760-4751-aa5e-c18e583bcabc"
      unitRef="usd">6722000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfNy0zLTEtMS01NzA3Mw_cd492cf4-df9c-4be8-8562-6d47956c3e0f"
      unitRef="usd">5350000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfOS0xLTEtMS01NzA3Mw_50e545bb-b203-409e-8fd8-5ee9bfe24018"
      unitRef="usd">-17306000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yMi9mcmFnOjQxYTI3MTk4ODg0ZDQzNDc5OTdmMzA2MGNmNzVjMzc0L3RhYmxlOmY1MWY5M2ZmZmVlMzQ3ZjE5Njc3NWExNDc1NmM5MzA5L3RhYmxlcmFuZ2U6ZjUxZjkzZmZmZWUzNDdmMTk2Nzc1YTE0NzU2YzkzMDlfOS0zLTEtMS01NzA3Mw_9582a636-d117-4f7c-977b-5330e59efc4b"
      unitRef="usd">2672000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i91d4a0efd0134db0912cf424c9c05e57_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMi0xLTEtMS01NzA3Mw_d288a3ba-378f-4649-a832-b330aab807e3"
      unitRef="shares">57723125</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i91d4a0efd0134db0912cf424c9c05e57_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMi0zLTEtMS01NzA3Mw_605f163a-7331-478f-a54c-95fdc5e08b0b"
      unitRef="usd">6000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95b93de2b17549f68c2d1d19032cb451_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMi01LTEtMS01NzA3Mw_f52cbec6-dd99-4f87-8686-f0c68fef56d1"
      unitRef="usd">436288000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9c5ed5063e474ba083fe5232406d387c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMi03LTEtMS01NzA3Mw_c1c9c9ac-7bc0-4f54-a237-ed2da95d2eac"
      unitRef="usd">-20677000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i468644d28f544537962de87ccfb1e608_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMi05LTEtMS01NzA3Mw_f988179d-e22d-43a3-b8ad-f54adbc72f94"
      unitRef="usd">-82622000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9479ea165b22465ab2af4cc1db0934bf_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMi0xMS0xLTEtNTcwNzM_a74c37d4-c739-49f8-90b7-dff7919b05ba"
      unitRef="usd">332995000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idb918f8d0aad4f99a42dbf93329537ec_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMi0xMy0xLTEtNTcwNzM_85eb6a27-4d37-4b5a-b4ce-dd56df369e50"
      unitRef="usd">158457000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMi0xNS0xLTEtNTcwNzM_713ecb95-0aa9-4dd1-ba60-7f8810e57798"
      unitRef="usd">491452000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i7aad81709c2e40bfa6d50e57ba2978f8_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNC0xLTEtMS01NzA3Mw_ba2f800f-c7f7-44d7-a049-a876e5956aad"
      unitRef="shares">5000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7e0129316a1444a9a87a4f1035890d5e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNC01LTEtMS01NzA3Mw_5db16ba1-67fc-4df1-b28b-b033177f431f"
      unitRef="usd">51000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3ca13f2a1d6242bdbe459e60b2e0745d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNC0xMS0xLTEtNTcwNzM_b6ae02a7-53cf-47eb-b5c1-0dba44266da2"
      unitRef="usd">51000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNC0xNS0xLTEtNTcwNzM_1715f181-1872-4ef5-943c-4c29808c2df8"
      unitRef="usd">51000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i7aad81709c2e40bfa6d50e57ba2978f8_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNS0xLTEtMS01NzA3Mw_11ea695e-62c7-443a-8718-146dc663114a"
      unitRef="shares">527692</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i913c1e2479954386a1891ed9fbce6745_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNi0xLTEtMS01NzA3Mw_6022174f-cd11-48c1-ae83-9eee00d2d7eb"
      unitRef="shares">14473</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7e0129316a1444a9a87a4f1035890d5e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNy01LTEtMS01NzA3Mw_09898e5e-678d-4c2e-b963-a6d22ba53802"
      unitRef="usd">12185000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3ca13f2a1d6242bdbe459e60b2e0745d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNy0xMS0xLTEtNTcwNzM_ecf958f5-213f-480a-9989-98b31b06651d"
      unitRef="usd">12185000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfNy0xNS0xLTEtNTcwNzM_593c4724-3072-41f3-9dce-4fbea966b8f9"
      unitRef="usd">12185000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i5adf124c49f04748907d0b7a789a6104_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMTctNy0xLTEtNTcwNzM_8c8d9c14-4110-4d73-87ce-b5b756532cb4"
      unitRef="usd">2777000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i3ca13f2a1d6242bdbe459e60b2e0745d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMTctMTEtMS0xLTU3MDcz_b3ba4db8-de7b-4750-b49f-0d2eb568a792"
      unitRef="usd">2777000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMTctMTUtMS0xLTU3MDcz_2d576f71-62c9-4d47-afd0-a2e1e1ce2561"
      unitRef="usd">2777000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i5adf124c49f04748907d0b7a789a6104_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMTktNy0xLTEtNTcwNzM_27eea0c9-be65-4b3a-8766-52248260d3aa"
      unitRef="usd">-922000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i3ca13f2a1d6242bdbe459e60b2e0745d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMTktMTEtMS0xLTU3MDcz_1633853d-2bb1-4a28-b24d-3b6dc038f8d4"
      unitRef="usd">-922000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMTktMTUtMS0xLTU3MDcz_da0a0630-a1f2-4e36-90f8-98a2cc3f76a2"
      unitRef="usd">-922000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquityOther
      contextRef="i7e0129316a1444a9a87a4f1035890d5e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjAtNS0xLTEtNTcwNzM_627334f8-4c98-4a9f-9141-5f2fa6916299"
      unitRef="usd">2000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ib3adf6f8648e495e9006502147d4eae8_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjAtOS0xLTEtNTcwNzM_71b76cc5-03a8-4118-a2d8-f19acaf201c5"
      unitRef="usd">1000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i3ca13f2a1d6242bdbe459e60b2e0745d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjAtMTEtMS0xLTU3MDcz_09fb8e50-ea28-400b-bf95-8cc317236e2f"
      unitRef="usd">3000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjAtMTUtMS0xLTU3MDcz_afa609c2-317d-447d-a43d-5ed079897925"
      unitRef="usd">3000</us-gaap:StockholdersEquityOther>
    <us-gaap:ProfitLoss
      contextRef="ib3adf6f8648e495e9006502147d4eae8_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjEtOS0xLTEtNTcwNzM_7cbf1038-5094-41fe-be1e-71e8d4288ba9"
      unitRef="usd">-21005000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3ca13f2a1d6242bdbe459e60b2e0745d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjEtMTEtMS0xLTU3MDcz_d1bececd-33c8-49c5-a51e-13d399cc5c19"
      unitRef="usd">-21005000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i48b53158259a45cf99350d972b519d34_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjEtMTMtMS0xLTU3MDcz_4def42ea-6d82-4d95-b3ec-34a52488e08a"
      unitRef="usd">6722000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjEtMTUtMS0xLTU3MDcz_fcaa6826-e0f7-48ed-9621-2fea8824ac8c"
      unitRef="usd">-14283000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0079ed901cd348488a81abe9066a6c27_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjItMS0xLTEtNTcwNzM_8e01aa0b-a9a3-420e-a7f2-74e31dafe3e3"
      unitRef="shares">58270290</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0079ed901cd348488a81abe9066a6c27_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjItMy0xLTEtNTcwNzM_4734d8b2-1b5d-4701-bcf9-a6e245e22596"
      unitRef="usd">6000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia9f6f61fb6774fb88dfcd64fd07c4b8a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjItNS0xLTEtNTcwNzM_93816d7e-2106-45bc-acb9-77f7e656a047"
      unitRef="usd">448522000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1c7d6e31a0346089303a191fa0be906_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjItNy0xLTEtNTcwNzM_b8c82857-354d-4fdf-8ba2-d5b5a09c0b68"
      unitRef="usd">-16978000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i32758e6d4de641c287fa2f616af42021_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjItOS0xLTEtNTcwNzM_4e6419b0-2710-4815-8878-dc5ea62336b1"
      unitRef="usd">-103628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifdf0d0a31a7d4bbeab91318c3504e0e3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjItMTEtMS0xLTU3MDcz_aad57889-6c2d-4c05-b3f9-85f9b062f340"
      unitRef="usd">327922000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib4127c96bf5a4ca98119ab44d3fb22df_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjItMTMtMS0xLTU3MDcz_2faabb96-6092-4780-94c7-2a31b57db502"
      unitRef="usd">165179000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjItMTUtMS0xLTU3MDcz_fcea62f2-13c5-4096-bb7c-d7098b2453dd"
      unitRef="usd">493101000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="icd187a7758714339a38596e3b8703fda_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjQtMS0xLTEtNTcwNzM_c053b8f9-5916-4f8a-b492-65febdb11190"
      unitRef="shares">53548227</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icd187a7758714339a38596e3b8703fda_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjQtMy0xLTEtNTcwNzM_78a369f1-bed4-4408-9a1f-d0d3207bbc76"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03170300e04e4c6885da7ab306fe32fb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjQtNS0xLTEtNTcwNzM_939e4dc0-e4e4-41e5-a583-029b2fe15a72"
      unitRef="usd">342592000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1c6492a471c24eb79e884f0d8d9e9ef5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjQtNy0xLTEtNTcwNzM_44444bd6-14d3-4d4f-bd16-5d193ba581e4"
      unitRef="usd">-20421000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idab5203b536348aeb1e033a60b58d92b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjQtOS0xLTEtNTcwNzM_c1eee391-6294-4354-aba5-bd047e380bf3"
      unitRef="usd">-93272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i78a4a63e76c7434296690fc94fa7d206_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjQtMTEtMS0xLTU3MDcz_8cc6cd87-e477-4113-8472-d282fa8603b8"
      unitRef="usd">228904000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4b87a5ef08b949fd9eced9e15c7a255a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjQtMTMtMS0xLTU3MDcz_d1a0f0da-7d59-4207-b0ed-7ddca72e9e02"
      unitRef="usd">117253000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i385a0ecd81c14fc5b2842208e1659808_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjQtMTUtMS0xLTU3MDcz_36e74b1c-1adc-4fff-acc8-02ba0924f9dd"
      unitRef="usd">346157000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ie7430f7620cb4b499645b1c4db111fd3_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjYtMS0xLTEtNTcwNzM_81a0531e-632f-49cf-ac67-ec0f5439de28"
      unitRef="shares">530188</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ibbbc7fc6774d480f8cf4ece72ee8d689_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjctMS0xLTEtNTcwNzM_74a9b0c9-52a5-4b5a-adca-84a1b8bd3db8"
      unitRef="shares">13119</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i57c8687ae4a54bc7961fd12b87f8095c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjgtNS0xLTEtNTcwNzM_7085cd73-3c0f-4a29-bead-31ed2136be87"
      unitRef="usd">10801000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie91409c4e3ca453ca3dfd68bcfbef870_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjgtMTEtMS0xLTU3MDcz_79f8b490-6463-4d16-bee7-74740b339698"
      unitRef="usd">10801000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjgtMTUtMS0xLTU3MDcz_2efb7dad-ff6b-4b10-b177-3e116c1ae295"
      unitRef="usd">10801000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="ie7430f7620cb4b499645b1c4db111fd3_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjktMS0xLTEtNTcwNzM_3a19915b-93aa-44e0-b9a1-aa0d6181ce57"
      unitRef="shares">2106292</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i57c8687ae4a54bc7961fd12b87f8095c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjktNS0xLTEtNTcwNzM_736d193b-3b2f-4856-a61c-b525791b5aff"
      unitRef="usd">56470000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ie91409c4e3ca453ca3dfd68bcfbef870_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjktMTEtMS0xLTU3MDcz_ea86e2dd-9ca5-41bd-bda8-9f706f49e534"
      unitRef="usd">56470000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMjktMTUtMS0xLTU3MDcz_bdb017a1-7130-4c25-969e-afd8a1b7e052"
      unitRef="usd">56470000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i1051455c74414445a26e00de581866c1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzQtNy0xLTEtNTcwNzM_dc7a2f9f-d562-4130-81fa-4de9e8fab4d3"
      unitRef="usd">-1264000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="ie91409c4e3ca453ca3dfd68bcfbef870_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzQtMTEtMS0xLTU3MDcz_85c14c41-89ac-4de5-86d5-2f1f53846ca8"
      unitRef="usd">-1264000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzQtMTUtMS0xLTU3MDcz_30c0e9da-1f0e-451f-8c01-29050c0a1750"
      unitRef="usd">-1264000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i1051455c74414445a26e00de581866c1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzYtNy0xLTEtNTcwNzM_a778b517-21d2-4d31-92cb-28686a65a0e3"
      unitRef="usd">-923000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ie91409c4e3ca453ca3dfd68bcfbef870_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzYtMTEtMS0xLTU3MDcz_1e880271-6f36-4588-bb53-58d2550164fa"
      unitRef="usd">-923000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzYtMTUtMS0xLTU3MDcz_b4f16907-39ba-453a-8191-3e8f023c1de9"
      unitRef="usd">-923000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquityOther
      contextRef="i1051455c74414445a26e00de581866c1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzctNy0xLTEtNTcwNzM_2976eec6-42a0-40c3-93e9-fb9e0818ab55"
      unitRef="usd">-1000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ibddc1d75b382422a8961f98fdde6c318_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzctOS0xLTEtNTcwNzM_4d449fb4-8284-429e-85c9-56f1b242a1fc"
      unitRef="usd">1000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ie91409c4e3ca453ca3dfd68bcfbef870_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzctMTEtMS0xLTU3MDcz_85403b7c-adb3-4a65-9c67-9a6e07120faa"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzctMTUtMS0xLTU3MDcz_85cb1163-b7b2-46b0-a84d-1147981ac5b5"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:ProfitLoss
      contextRef="ibddc1d75b382422a8961f98fdde6c318_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzgtOS0xLTEtNTcwNzM_ac52d9b6-3e37-433f-baf8-bc23e31bc7a8"
      unitRef="usd">3013000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie91409c4e3ca453ca3dfd68bcfbef870_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzgtMTEtMS0xLTU3MDcz_87b01e86-aae7-440d-9e94-916c9fae7b20"
      unitRef="usd">3013000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic141cdf85619420ebcf66d35adb457ca_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzgtMTMtMS0xLTU3MDcz_77143f66-b5ef-433a-b290-1b58b271802b"
      unitRef="usd">5350000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzgtMTUtMS0xLTU3MDcz_7452029e-077c-4370-b080-ba6e8a29679d"
      unitRef="usd">8363000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="idc0bf32b28e24d0aaab1535b72796e85_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzktMS0xLTEtNTcwNzM_c086254f-43f1-4550-9fca-20223de8f746"
      unitRef="shares">56197826</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idc0bf32b28e24d0aaab1535b72796e85_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzktMy0xLTEtNTcwNzM_2f967b59-9c1c-4fae-8e4b-7a63fa869caa"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9d8fc8460d0049568d657a5449e9ce3e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzktNS0xLTEtNTcwNzM_71c13ac5-e3c6-4792-8854-60cdf9ea498b"
      unitRef="usd">409863000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i622337df6b2342b8bcf81a0bbf78cfee_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzktNy0xLTEtNTcwNzM_8f168e64-8be5-4285-ba4d-8f6abc6e7aba"
      unitRef="usd">-20761000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i210a11d3d8e44324b361e34bb30b96fc_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzktOS0xLTEtNTcwNzM_28c2f8ef-a13f-4db1-bea3-2d179e00695e"
      unitRef="usd">-90260000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c7ef23f5cc14489bb2ae2e8a17d5ac8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzktMTEtMS0xLTU3MDcz_97d2284d-ed2d-4107-bcaa-337af5eaf57a"
      unitRef="usd">298847000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8ec1a7c8f9b74641a09c0fc25654b909_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzktMTMtMS0xLTU3MDcz_f2d8ffe7-474d-40a7-8ac7-3b495dbf9e07"
      unitRef="usd">122603000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80882b4f5c6a453fa389846657050098_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8yNS9mcmFnOmM3ODQ1ZDE3YjJjMDRhN2E4YTYyNDhhNzA1Njg1MjE4L3RhYmxlOjhhMzUyNDM2YzQ5MzQ3OGViMDU4MzBlYWQxYjQzNDRmL3RhYmxlcmFuZ2U6OGEzNTI0MzZjNDkzNDc4ZWIwNTgzMGVhZDFiNDM0NGZfMzktMTUtMS0xLTU3MDcz_1dbdcda6-d174-4264-84bd-e874cd231492"
      unitRef="usd">421450000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMy0xLTEtMS01NzA3Mw_42d381ef-13c0-4a50-a075-502df63ccd10"
      unitRef="usd">-14283000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMy0zLTEtMS01NzA3Mw_0e892015-0a67-412f-9452-a14a44254d64"
      unitRef="usd">8363000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNS0xLTEtMS01NzA3Mw_a0ddd216-4c3c-405f-8189-a9cf8d8c0a88"
      unitRef="usd">31315000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNS0zLTEtMS01NzA3Mw_a71dd938-b0dc-435a-94df-3bfc6839a223"
      unitRef="usd">27118000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNi0xLTEtMS01NzA3Mw_7df9202e-21cd-4b72-be56-04d4db26692f"
      unitRef="usd">15699000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNi0zLTEtMS01NzA3Mw_dbc9fee8-df4b-4d2e-a9d1-a56784431a83"
      unitRef="usd">16802000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNy0xLTEtMS01NzA3Mw_9ca22123-0987-4e58-b9bf-a51d6884dc03"
      unitRef="usd">1835000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNy0zLTEtMS01NzA3Mw_c29edb9a-14d3-4b33-831f-ca75cd5aaede"
      unitRef="usd">2517000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfOS0xLTEtMS01NzA3Mw_e1f21564-3e10-489e-bfc8-954a88ff2bca"
      unitRef="usd">746000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfOS0zLTEtMS01NzA3Mw_97e8ca3c-2b6f-4a18-be2b-cd575df2c77b"
      unitRef="usd">648000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTAtMS0xLTEtNTcwNzM_f12ce7e6-806d-4205-ba0e-c86c13333cc6"
      unitRef="usd">-579000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTAtMy0xLTEtNTcwNzM_8f27e1b7-066a-4e79-bec1-2826cce44c11"
      unitRef="usd">-1128000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTItMS0xLTEtNTcwNzM_a924267e-0156-40f1-a09e-3c156c36be01"
      unitRef="usd">922000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTItMy0xLTEtNTcwNzM_10e09b41-1b28-48c3-a508-07a737fb0d40"
      unitRef="usd">923000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTMtMS0xLTEtNTcwNzM_a66f1429-ad99-4d1b-bccf-df809234641e"
      unitRef="usd">-4093000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTMtMy0xLTEtNTcwNzM_6d3cc379-6ac2-4e17-a562-44bd2b5decbd"
      unitRef="usd">20819000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:ShareBasedCompensation
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTQtMS0xLTEtNTcwNzM_5bdde31b-e8eb-402e-b31c-c7d173535afa"
      unitRef="usd">12185000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTQtMy0xLTEtNTcwNzM_dc530ec8-9e29-48fe-bd83-8859e654bd80"
      unitRef="usd">11102000</us-gaap:ShareBasedCompensation>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTYtMS0xLTEtNTcwNzM_8e9db33b-8d7d-4f3c-b1e0-ec9fdc529ba9"
      unitRef="usd">2335000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTYtMy0xLTEtNTcwNzM_fae2950e-3919-447e-809b-bda8ccface8b"
      unitRef="usd">-501000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTgtMS0xLTEtNTcwNzM_419c52b8-8514-44e0-aedf-d1e1cac27d44"
      unitRef="usd">9997000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTgtMy0xLTEtNTcwNzM_146b17dc-9a35-42e2-91c3-39a03540f38a"
      unitRef="usd">23904000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTktMS0xLTEtNTcwNzM_8f075d8c-3023-4ffa-874f-fc65898da9a6"
      unitRef="usd">1691000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMTktMy0xLTEtNTcwNzM_1ea5e45c-328b-4ef2-b085-8e4f3eb9f98f"
      unitRef="usd">4065000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjAtMS0xLTEtNTcwNzM_18456ba3-1a64-4825-aba7-09eedbf82342"
      unitRef="usd">2726000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjAtMy0xLTEtNTcwNzM_d55b61f8-cea1-48f7-89fa-855a157fcc62"
      unitRef="usd">1417000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjEtMS0xLTEtNTcwNzM_ba332966-1ee6-454e-b624-3c41b9b9ade2"
      unitRef="usd">-942000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjEtMy0xLTEtNTcwNzM_051700fb-903d-43da-a726-5ae1d48b592f"
      unitRef="usd">-1387000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjItMS0xLTEtNTcwNzM_f499e08c-83db-4e95-abec-ae11623d19ce"
      unitRef="usd">-15080000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjItMy0xLTEtNTcwNzM_b39c7652-9150-40bf-86eb-0825e8a9486d"
      unitRef="usd">-15859000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjMtMS0xLTEtNTcwNzM_1794adda-76c4-4e4f-a1af-6036393e31e5"
      unitRef="usd">335000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjMtMy0xLTEtNTcwNzM_5e38f59a-0177-4fc3-a7d5-6b41ae695f38"
      unitRef="usd">-4519000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjQtMS0xLTEtNTcwNzM_42426260-90ec-47ca-b058-c4fe9bef6c34"
      unitRef="usd">9077000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjQtMy0xLTEtNTcwNzM_5e899d98-3dfd-425e-963f-9313a1ed417c"
      unitRef="usd">7031000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjUtMS0xLTEtNTcwNzM_236b1678-faa3-4890-a337-534a4ac28319"
      unitRef="usd">32616000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjUtMy0xLTEtNTcwNzM_02986aa6-65a4-424f-beb0-f128b942053c"
      unitRef="usd">901000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjctMS0xLTEtNTcwNzM_a1258b01-39d2-47cc-985d-abfaab350ce7"
      unitRef="usd">9644000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjctMy0xLTEtNTcwNzM_2fa05887-3c29-414d-bf36-911636ca3c53"
      unitRef="usd">25123000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjktMS0xLTEtNTcwNzM_7e2c1646-dbcf-44f4-9852-d8dd2374079d"
      unitRef="usd">55915000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMjktMy0xLTEtNTcwNzM_95843963-fb45-4e76-af7e-a6d24edbb9be"
      unitRef="usd">36558000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMzAtMS0xLTEtNTcwNzM_f360544b-94fd-4418-af26-0c8048949b26"
      unitRef="usd">3000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMzAtMy0xLTEtNTcwNzM_7be47a5c-cf5f-4828-8957-40c4a81881df"
      unitRef="usd">117000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMzQtMS0xLTEtNTcwNzM_9539c72f-b0b9-4cd6-a744-5a11a6a11c07"
      unitRef="usd">-65556000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMzQtMy0xLTEtNTcwNzM_838395dd-9976-46dd-992d-c5016b26b0ca"
      unitRef="usd">-61564000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMzYtMS0xLTEtNTcwNzM_48a36a82-7057-4a1d-8459-68771e467eb1"
      unitRef="usd">184000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMzYtMy0xLTEtNTcwNzM_3214b62b-31e1-49d9-aa47-5cc0c5fad797"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfDebt
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMzctMS0xLTEtNTcwNzM_57fd9484-ded0-4df3-8de3-28eefa4debe2"
      unitRef="usd">3688000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfMzctMy0xLTEtNTcwNzM_5dfa6c8b-252c-4ae9-a2d9-5fd02db34afa"
      unitRef="usd">3313000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNDctMS0xLTEtNTcwNzM_557defb3-507b-438c-8f8f-8f1324854b81"
      unitRef="usd">51000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNDctMy0xLTEtNTcwNzM_ee3af9c9-5206-4c53-acfd-f17f41c373a8"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNDgtMS0xLTEtNTcwNzM_46ec427e-10bf-4d14-ab6b-4056d7ad4d59"
      unitRef="usd">-3821000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNDgtMy0xLTEtNTcwNzM_41c7cf8b-4b7a-4255-b03c-e38a5f37292b"
      unitRef="usd">-3313000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNDktMS0xLTEtNTcwNzM_e3cc8acd-c8c6-4866-8181-6a6b5a0d6cfe"
      unitRef="usd">-229000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNDktMy0xLTEtNTcwNzM_a6a02731-5ae7-4c26-96ec-ba8285c65f87"
      unitRef="usd">83000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTAtMS0xLTEtNTcwNzM_364dfe5f-aeb7-49d6-b4be-24cb00f331af"
      unitRef="usd">-36990000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTAtMy0xLTEtNTcwNzM_63429bd2-4585-4a93-ba68-995a76c4d358"
      unitRef="usd">-63893000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTEtMS0xLTEtNTcwNzM_5df9b6ae-bb40-4949-8cc0-a2e70a6d31b2"
      unitRef="usd">127834000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i385a0ecd81c14fc5b2842208e1659808_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTEtMy0xLTEtNTcwNzM_88ed137b-7e2e-4e39-99f6-c4a466b04f80"
      unitRef="usd">134606000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTItMS0xLTEtNTcwNzM_dbe1199f-9bbf-4003-bd34-03aaaddda5ab"
      unitRef="usd">90844000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i80882b4f5c6a453fa389846657050098_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTItMy0xLTEtNTcwNzM_90878777-898c-4252-a5ae-e32c86a479f1"
      unitRef="usd">70713000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTUtMS0xLTEtNTcwNzM_3e3c9c0a-ad0f-408f-96a6-ae9c97359a8c"
      unitRef="usd">21471000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTUtMy0xLTEtNTcwNzM_c4637d05-296b-4d51-aa64-765991201ccc"
      unitRef="usd">7448000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTYtMS0xLTEtNTcwNzM_2c86db76-e7e0-4166-b262-3ab3951a7c62"
      unitRef="usd">40000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RhYmxlOjUyMmIwODcyYjdjNDQyMzJiYjA3NGNkN2UwYzkxNDAzL3RhYmxlcmFuZ2U6NTIyYjA4NzJiN2M0NDIzMmJiMDc0Y2Q3ZTBjOTE0MDNfNTYtMy0xLTEtNTcwNzM_317d7a99-617e-4e09-ab47-25e9f49e9343"
      unitRef="usd">34000</us-gaap:IncomeTaxesPaidNet>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RleHRyZWdpb246NWUwNDRjY2ExZGM1NDMyZjhhMjg2MjEyZDgxZWFmMDZfNDMz_156afbc5-0d53-4c2e-bfcb-bdb9a7008339"
      unitRef="usd">40800000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RleHRyZWdpb246NWUwNDRjY2ExZGM1NDMyZjhhMjg2MjEyZDgxZWFmMDZfNDQw_5a46d6d4-f041-43ca-8bff-01312e381ffb"
      unitRef="usd">42200000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7ae3cbf23e8046c887d676fc95010311_I20230201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RleHRyZWdpb246NWUwNDRjY2ExZGM1NDMyZjhhMjg2MjEyZDgxZWFmMDZfNTQ5NzU1ODE1ODM3_083dfb92-e0af-4cc0-bbed-024900e71583"
      unitRef="usd">19800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i875e29b29f814b69a487f86dc63c58e7_D20220120-20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RleHRyZWdpb246NWUwNDRjY2ExZGM1NDMyZjhhMjg2MjEyZDgxZWFmMDZfNzE4_e9350570-06e1-4cce-ba7e-0fe03750584d"
      unitRef="shares">1141234</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i8e4e223d7eff48c4b6d57f718874ebf4_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RleHRyZWdpb246NWUwNDRjY2ExZGM1NDMyZjhhMjg2MjEyZDgxZWFmMDZfODMz_65838e77-9c67-49fe-a078-3c7fe41f5b61"
      unitRef="usd">30600000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i06979ac32be0468ab90faae5f8a7fae6_D20220120-20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RleHRyZWdpb246NWUwNDRjY2ExZGM1NDMyZjhhMjg2MjEyZDgxZWFmMDZfODY4_0a598e9d-737b-40f9-b684-52a240dc43f9"
      unitRef="shares">965058</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i2a5b65acdc4a494dad73f5d762c4bff4_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zMS9mcmFnOjVlMDQ0Y2NhMWRjNTQzMmY4YTI4NjIxMmQ4MWVhZjA2L3RleHRyZWdpb246NWUwNDRjY2ExZGM1NDMyZjhhMjg2MjEyZDgxZWFmMDZfOTU3_c5b99c97-8fb7-4680-b615-4815e41a94a0"
      unitRef="usd">25900000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfODIxOA_43ec0ef8-4bd0-4dd4-97df-fcb58b2cbb13">NATURE OF BUSINESS AND BASIS OF PRESENTATION&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At March&#160;31, 2023, we operated directly or indirectly through joint ventures with hospitals, 363 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  In addition to our center operations, we have certain other subsidiaries that develop Artificial Intelligence ("AI") products and solutions that are designed to enhance interpretation of radiographic images. Our operations comprise two segments for financial reporting purposes for this reporting period, Imaging Centers and Artificial Intelligence. For further financial information about these segments, see Note 5, Segment Reporting.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of RadNet, Inc as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#x201c;RadNet&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d; or the &#x201c;Company&#x201d; in this report&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#x201c;VIE&#x201d;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#x2019;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management and provide professional medical services for centers in Arizona, California, Delaware, Maryland, New Jersey and New York.  These VIEs are collectively referred to as the consolidated medical group ("the Group").  RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity.  Substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.  The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of the Group. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Group on a combined basis recognized $48.8 million and $45.7 million of revenue, net of management services fees to RadNet, for the three months ended March&#160;31, 2023 and 2022, respectively and $48.8 million and $45.7 million of operating expenses for the three months ended March&#160;31, 2023 and 2022, respectively.  RadNet recognized $207.4 million and $191.0 million of total billed net service fee revenue for the three months ended March&#160;31, 2023, and 2022, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cash flows of the Group are included in the accompanying condensed consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022, we have included approximately $103.1 million and $100.4 million, respectively, of accounts receivable and approximately $18.8 million and $16.9 million of accounts payable and accrued liabilities related to the Group, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At all of our centers not serviced by the Group we have entered into long-term contracts with medical groups to provide professional services at those centers, including supervision and interpretation of diagnostic imaging procedures. The medical groups maintain full control over the physicians they employ. Through our management agreements, we make available to the medical groups the imaging centers, including all furniture, fixtures and medical equipment therein.  The medical groups are compensated for their services from the professional component of the global net service fee revenue and after deducting management service fees paid to us, we have no economic controlling interest in these medical groups. As such, the financial results of these groups are not consolidated in our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also own a 49% economic interest in ScriptSender, LLC, which provides secure data transmission services of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender, LLC is dependent on RadNet to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#x2019;s economic performance.  We have continued to finance ScriptSender during it's development phase and our maximum exposure to loss is $3.1&#160;million, which represents our receivable balance from the entity.  Maximum exposure to loss is the loss that we would absorb in the event that all of the assets of ScriptSender are deemed worthless.  We paid operating expenses for the venture of $0.5&#160;million and $0.4&#160;million for the three months ended March 31, 2023, and March&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended March&#160;31, 2023 and 2022 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <rdnt:NumberOfCenters
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfMjU2_c588018a-2adb-48c5-873c-09862abd3659"
      unitRef="center">363</rdnt:NumberOfCenters>
    <us-gaap:NumberOfReportableSegments
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfMTIxOQ_f119ec67-82f8-47ec-9ea3-9ab053f45fee"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNDY3MA_72bac9b6-dbff-4748-9d1f-220b95688040"
      unitRef="usd">48800000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNDY3Nw_5bd3f972-f2b8-46b7-a580-2740c0672480"
      unitRef="usd">45700000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNDc5MA_a492d6ee-55d1-46b1-8c9b-65ca6cc045c2"
      unitRef="usd">48800000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNDc5Nw_9312aced-9048-4f3e-8152-22e5b6f1a00f"
      unitRef="usd">45700000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNDg5Mw_4d1c12b3-28fc-4afd-bff7-57062e8ed903"
      unitRef="usd">207400000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNDkwMA_4b2ca43d-03e7-4a93-ba2e-0bca0e1f3fcf"
      unitRef="usd">191000000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:Assets
      contextRef="i4d24e08a1ed346ecadd8d502b2c5e3c9_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNTM4OA_56c61090-b614-482b-80b2-e075c505be60"
      unitRef="usd">103100000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i82df3264b09247118f927708d745a3e0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNTM5NQ_9f419f6c-d048-4fef-8b93-c596c982ce31"
      unitRef="usd">100400000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="i4d24e08a1ed346ecadd8d502b2c5e3c9_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNTQ1NA_6c67a264-b6b1-4c20-9292-d5e3458848a8"
      unitRef="usd">18800000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i82df3264b09247118f927708d745a3e0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNTQ2MQ_f2c8eca4-a17e-43e8-b6c9-028ab31ee3d5"
      unitRef="usd">16900000</us-gaap:Liabilities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i780286e32ed648ff95b88393d95716a1_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNjM3NA_49c49538-1a41-4679-bbaa-bfca91f38bce"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i780286e32ed648ff95b88393d95716a1_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNzAwMw_df6b89fa-6860-4c28-964e-29159da8b8a8"
      unitRef="usd">3100000</us-gaap:EquityMethodInvestments>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i52ba0462fc584809b69e0d06cebc198d_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNzI0NA_3352c7cf-0cc4-4fe3-92f4-62a404585ff5"
      unitRef="usd">500000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i193239544180470cbfa731378e7fcdf0_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV8zNy9mcmFnOmJmZGM1M2I2M2Y2ZjQ2ZjJhYmFlZTBlMDM0ZDhkMzVmL3RleHRyZWdpb246YmZkYzUzYjYzZjZmNDZmMmFiYWVlMGUwMzRkOGQzNWZfNzI1MQ_c41c0f13-e176-48aa-b698-7b86c3207481"
      unitRef="usd">400000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMTE_b13739a6-c927-4be4-b7bc-d52b2ab2f7b2">SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the period covered in this report, there have been no material changes to the significant accounting policies we use and have explained, in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2022. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;REVENUES  - Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total service revenues during the three months ended March&#160;31, 2023 and 2022 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.781%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers' compensation/personal injury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other patient revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Teleradiology and Software revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue under capitation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging Center Segment Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AI Segment Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total service revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;GOVERNMENT ASSISTANCE: COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  To aid businesses and stimulate the national economy, Congress passed The Coronavirus Aid, Relief, and Economic Security ("CARES") Act, which was signed in to law on March 27, 2020.  As part of the CARES act, we received $39.6 million total of accelerated Medicare payments which were recorded to deferred revenue in our consolidated balance sheet and are being applied to revenue as services are performed.  Through the three months ended March 31, 2023, $38.6 million of the accelerated Medicare payments have been applied to revenue. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.  Amounts remaining to be collected on these agreements were $15.4 million and $15.4 million at March&#160;31, 2023 and December&#160;31, 2022, respectively. We do not utilize factoring arrangements as an integral part of our financing for working capital and assess the party's ability to pay upfront at the inception of the notes receivable and subsequently by reviewing their financial statements annually and reassessing any insolvency risk on a periodic basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DEFERRED FINANCING COSTS - Costs of financing are deferred and amortized using the effective interest rate method and are related to our revolving credit facilities. Deferred financing costs, net of accumulated amortization, were $2.1 million and $2.3 million, as of March&#160;31, 2023 and December&#160;31, 2022, respectively.  See Note 6, Credit Facilities and Notes Payable for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation of property and equipment is performed using the straight-line method over the estimated useful lives of the assets acquired, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BUSINESS COMBINATION  -  When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;GOODWILL - Goodwill at March&#160;31, 2023 totaled $687.1 million.   Goodwill is recorded as a result of business combinations. When we determine the carrying value of reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  We tested goodwill and indefinite lived intangibles for impairment on October 1, 2022, noting no impairment.  Activity in goodwill for the three months ended March&#160;31, 2023 is provided below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Artificial Intelligence&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill from acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;614,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INTANGIBLE ASSETS - The components of intangible assets, both finite and indefinite, along with annual amortization expense that will be recorded over the next five years at March&#160;31, 2023 and December&#160;31, 2022 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average amortization period remaining in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Management Service Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Covenant not to compete and other contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Patent and Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed Technology &amp;amp; Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names indefinite life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Annual Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;103,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Excluding the three months ended March 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average amortization period remaining in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Management Service Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Covenant not to compete and other contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Patent and Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed Technology &amp;amp; Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names indefinite life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Annual Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;106,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intangible asset amortization expense was $3.0 million and $2.1 million for the three months ended March&#160;31, 2023 and March&#160;31, 2022, respectively.  Intangible assets are amortized using the straight-line method over their useful life determined at acquisition. Management service agreements are amortized over 25 years using the straight line method.  Software development is capitalized and amortized over the useful life of the software when placed into service.  Trade names are reviewed annually for impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INCOME TAXES -  Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded a provision to income taxes of $1.1 million, or an effective tax rate of (8.6)%, for the three months ended March 31, 2023 and $1.5 million, or an effective tax rate of 15.2% for the three months ended March 31, 2022.  The income tax rates for the three months ended March&#160;31, 2023 diverge from the federal statutory rate due to (i) noncontrolling interests due to the controlled partnerships; (ii) effects of state income taxes (iii) effects of foreign income taxes; and (iv) excess tax benefits attributable to share-based compensation.  We believe no significant changes in the unrecognized tax benefits will occur within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable.  We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ROU assets are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; tested for impairment if circumstances suggest that the carrying amount may not be recoverable.  Our ROU assets consist of facility and equipment assets on operating leases.  No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of March&#160;31, 2023.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities.  We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances.  Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EQUITY BASED COMPENSATION &#x2013; We have one long-term incentive plan that we adopted in 2006 and which we have amended and restated at various points in time: first on April 20, 2015, second on March 9, 2017, and currently as of April 15, 2021 (the &#x201c;Restated Plan&#x201d;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved 16,500,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric.  We evaluate performance-based awards to determine if it is probable that the vesting conditions will be met. We also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period.  Stock options generally vest over three years to five years and expire five years to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#x2019; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 7, Stock-Based Compensation, for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COMPREHENSIVE (LOSS) INCOME - Accounting guidance establishes rules for reporting and displaying other comprehensive (loss) income and its components. Our foreign currency translation adjustments, changes in the fair value of cash flow hedges, and the amortization of balances associated with derivatives previously classified as cash flow hedges are included in other comprehensive (loss) income. The components of other comprehensive (loss) income for the twelve month periods ended March&#160;31, 2023 and March&#160;31, 2022 are included in the consolidated statements of comprehensive (loss) income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DERIVATIVE INSTRUMENTS - In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 Swaps").  The 2019 Swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.  The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional. Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05% for the $400,000,000 notional.  As of the effective date, we are liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates are above the arranged rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive gain or loss in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $400,000,000 notional interest rate swap contract locked in at 2.05% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.96% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional are being recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $0.4 million per month and continuing at approximately $0.3 million through October 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.217%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive loss recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(15,201)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$922&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(14,279)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.217%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive loss recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(18,887)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$924&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(17,963)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ineffective interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of loss recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjI1ZDk4ZTg3NTAxYTRkZWViMmE0ZTYyZGQzYTYzMjA3L3RhYmxlcmFuZ2U6MjVkOThlODc1MDFhNGRlZWIyYTRlNjJkZDNhNjMyMDdfMi00LTEtMS01NzA3Mw_82eff8fd-e435-416f-a669-f954d06a2aa7"&gt;Other income (expense)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(922)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ineffective interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of gain recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjllMGUxNjNhM2M3MDQ0NzA4ZGRmYzVhNDQyNjI2MmJlL3RhYmxlcmFuZ2U6OWUwZTE2M2EzYzcwNDQ3MDhkZGZjNWE0NDI2MjYyYmVfMi00LTEtMS04OTMxOA_468424d7-c562-4c21-a8d7-de7f7f9f175e"&gt;Other income (expense)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(923)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Fair Value Measurements section below for the fair value of the 2019 Swaps at March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CONTINGENT CONSIDERATION - &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Aidence Holding B.V.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise centered on lung cancer screening.  As part of the purchase agreement, we will pay up to $10.0 million consideration upon the completion of two identified milestones in RadNet common shares or cash at our election.  This &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;contingency had a value of approximately $7.3 million on March&#160;31, 2023. The amount is reviewed quarterly and adjusted to fair value based on the yield rate of S&amp;amp;P B-rated corporate bonds and the probability of FDA approval, which has been currently determined by management to be 80% for milestone one and 70% for milestone two.  In addition, there is a remaining general holdback of $4.0 million to be issued in shares of our common stock subject to adjustment for any indemnification claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Quantib B.V.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening.  As part of the purchase agreement, we will issue 18 months after acquisition, 113,303 shares of our common stock with an initial fair value at the date of close of $3.0 million subject to adjustment for any indemnification claims and will be adjusted to fair value in subsequent periods. This contingency had a value of approximately $2.8 million as of March&#160;31, 2023. In addition, there is a general holdback of $1.6 million to be issued in cash subject to adjustment for any indemnification claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Montclair&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 1, 2022, we completed our acquisition of Montclair Radiological Associates. As part of the purchase agreement, we recorded $1.2 million in contingent consideration to be determined by obtaining specific EBITDA targets within a defined time frame.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Heart and Lung Imaging Limited&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2022, we completed our acquisition of 75% of the equity interests of Heart and Lung Imaging Limited. The purchase included $10.2 million in contingent milestone consideration and cash holdback of $0.6 million to be issued 24 months after acquisition subject to adjustment for any indemnification claims, which will be adjusted to fair value in subsequent periods.  The milestone contingency had a value of approximately $13.1 million as of March&#160;31, 2023.   The contingent consideration is determined by the achievement of a specific number of physician reads.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular rollforward of contingent consideration is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1, 2023 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issuance of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Change in valuation of Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023  Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aidence&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quantib&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses &amp;amp; Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart and Lung Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses &amp;amp; Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Fair Value Measurements section below for the fair value of contingent consideration at March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FAIR VALUE MEASUREMENTS &#x2013; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Swaps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Swaps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#x2019;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Consideration:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair values of contingencies and holdback relating to our Aidence Holding B.V. and Quantib B.V. acquisitions on January 20, 2022, the Montclair Radiological Associates acquisition on October 1, 2022 and the Heart and Lung Imaging Limited acquisition on November 1, 2022 that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aidence Holding B.V. milestone consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quantib B.V. holdback of 113,303 shares of RadNet common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair Radiological Associates&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart and Lung Imaging Limited&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these liabilities was determined using Level 3 inputs.  For Aidence Holding B.V., the  milestone contingent liability was adjusted to fair value based on the yield rate of S&amp;amp;P B-rated corporate bonds and the probability of FDA approval.  For the Quantib B.V holdback shares, the fair value was determined by calculating the value of estimated shares issuable as of the reporting date (which was $25.03) at March&#160;31, 2023, the time period related to the contractual settlement term, and the probability of issuing the shares.  For Montclair Radiological Associates the contingent consideration is determined by obtaining specific EBITDA targets within a defined time frame.  For Heart Lung Imaging Limited the contingent consideration is determined by the achievement of a specific number of physician reads.  As significant &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;inputs for the contingent consideration of Aidence B.V., Quantib B.V., Montclair Radiological Associates and Heart Lung Imaging Limited are not observable and cannot be corroborated by observable market data they are classified as Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long Term Debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans and Truist Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans and Truist Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023 and at December&#160;31, 2022 our Barclays revolving credit facility had no balance outstanding. Our Truist revolving credit facility relating to our consolidated subsidiary The New Jersey Imaging Network ("NJIN"), had no principal amount outstanding at March&#160;31, 2023 and at December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of our long-term debt, which is discussed in Note 6, Credit Facilities and Notes Payable, was determined using Level 2 inputs primarily related to comparable market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.584%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income  attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,303,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income per share attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,303,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add nonvested restricted stock subject only to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add additional shares issuable upon exercise of stock options and contingently issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares used in calculating diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,362,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value change for contingently issuable shares excluded from the computation of diluted per share amounts as its effect would be antidilutive&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested restricted stock subject to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingently issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023  we excluded all outstanding options, restricted stock awards and other requisite shares in the calculation of diluted earnings per share because their effect would be antidilutive.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INVESTMENTS IN EQUITY SECURITIES&#x2013;Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, we have three equity investments for which a fair value is not readily determinable and therefore the total amounts invested are recognized at cost as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  Our investment of $1.2 million  represents a 14.21% equity interest in the company.  No observable price changes or impairment in our investment was identified as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed.  On February 1, 2018, we purchased 2.1&#160;million preferred shares in Turner Imaging Systems for $2.0 million. On January 1, 2019 we funded a convertible promissory note in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the amount of $0.1 million that converted to an additional 80,000 preferred shares on October 11, 2019.No observable price changes or impairment in our investment was identified as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million in support of its operations.  No observable price changes, impairment in our investment or impairment of the loan receivable was identified as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INVESTMENT IN JOINT VENTURES &#x2013; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;Our investment in these joint ventures is accounted for under the equity method, since RadNet does not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture investment and financial information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our investment in joint ventures during the three months ended March 31, 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We charged management service fees from the centers underlying these joint ventures of approximately $4.2 million and $5.5 million for the three months ended March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of key balance sheet data for these joint ventures as of March&#160;31, 2023 and December&#160;31, 2022 and income statement data for the three months ended March 31, 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost in excess of book value of acquired joint venture interests and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income statement data for the three months ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMTI_14c61b80-40b8-44ff-be9c-37976dbd99f8">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;REVENUES  - Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwODQ_8450e587-be9a-4d50-89f5-36c9ab7c0854">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total service revenues during the three months ended March&#160;31, 2023 and 2022 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.781%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers' compensation/personal injury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other patient revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Teleradiology and Software revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue under capitation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging Center Segment Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AI Segment Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total service revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ad85707f4d64ac6a9a8091c4223b351_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMi0xLTEtMS01NzA3Mw_6e3fd41b-5097-4411-ad51-a47046791748"
      unitRef="usd">217209000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i574c4913311e49879ae8136ee2d28148_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMi0zLTEtMS01NzA3Mw_fc85a281-fbfe-4007-a24a-01e7414ae639"
      unitRef="usd">188465000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb9e5186dac3404d9c737b06211b3954_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMy0xLTEtMS01NzA3Mw_7fa6a431-57be-49e7-b0ad-f38251507616"
      unitRef="usd">86624000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a4072ab0edd48c8a67ccfb8f51a6290_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMy0zLTEtMS01NzA3Mw_9e9a7e89-cc64-486d-b685-dc2162e289f0"
      unitRef="usd">70999000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44ce173f477244e8b5b9d811a1911c07_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfNC0xLTEtMS01NzA3Mw_5a616eb4-49f8-44e4-aeb7-45bcfd18244d"
      unitRef="usd">10153000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ab20d39d79f4dc98599ce2f92baa5a6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfNC0zLTEtMS01NzA3Mw_0c9631e5-d9ee-48dd-a4da-f5e74c221058"
      unitRef="usd">9087000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc4e3875a9e549a799c5a7ded655f868_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfNS0xLTEtMS01NzA3Mw_4b182cf9-464e-41a3-a9e1-bda8207417c2"
      unitRef="usd">12675000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00746cf82a884d0881fb0a193616659f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfNS0zLTEtMS01NzA3Mw_2eda7c0e-271f-446f-934d-1e2e2ffa8939"
      unitRef="usd">12449000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i49ac145dbb9f4ba0bc8a57932c917cba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfNi0xLTEtMS01NzA3Mw_d5f012fb-882b-40ab-896b-df7541aa0536"
      unitRef="usd">9745000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9fa4d806c58044f58518c1759a53deb2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfNi0zLTEtMS01NzA3Mw_918cdd2e-0074-4968-b1cc-4cb8bc77a654"
      unitRef="usd">7123000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e3f72be824d49ff84df16d939b272c9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfNy0xLTEtMS01NzA3Mw_19df1694-cb04-4957-a20c-10cc7acfd77a"
      unitRef="usd">4248000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10301ec9313f4145901cddf7c8e67034_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfNy0zLTEtMS01NzA3Mw_79ba4e85-4ccb-4f08-9d4a-1f80c0cee19a"
      unitRef="usd">5508000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67abe92a1c5140fc826b327cdcfeb0e3_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfOC0xLTEtMS01NzA3Mw_be47d98f-d8c8-4597-add1-8f143785b0db"
      unitRef="usd">4333000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibfcabd15dd704d3592f2fedf50542f92_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfOC0zLTEtMS01NzA3Mw_3db6156c-4beb-47e5-ae87-528366f1d75a"
      unitRef="usd">3399000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic85c070b82f34df996b2edd5c5a6f417_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfOS0xLTEtMS01NzA3Mw_ad0579fb-cb6a-4e77-b448-ccd26e712b64"
      unitRef="usd">5300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b8ceb76bd89449e9f1fdaa8aae701da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfOS0zLTEtMS01NzA3Mw_5eadf0de-9645-4c1d-aa48-785d28be8a95"
      unitRef="usd">5647000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia605a6d22e64439893da71566768e2e9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMTAtMS0xLTEtNTcwNzM_6183171d-59e8-4eb1-8d52-f8a378292423"
      unitRef="usd">38144000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb7ff594ba1c456380fafa96528d1a70_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMTAtMy0xLTEtNTcwNzM_0d12aa03-bcd2-46e8-839d-0a5292cb685c"
      unitRef="usd">38491000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if70ac0bb6794471fac30d72ea02c9975_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMTEtMS0xLTEtNTcwNzM_2e67808a-46bc-4331-9f9b-2aa00ecb4af9"
      unitRef="usd">388431000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ab2e2f3665f40458a4bcdf95423b45a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMTEtMy0xLTEtNTcwNzM_7d35861a-fce1-4019-adfe-0dd88d53ba7f"
      unitRef="usd">341168000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0acc5172ba1c4948b09055ace900fbac_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMTItMS0xLTEtNTcwNzM_0389fee4-f416-492b-8b73-f759f5687929"
      unitRef="usd">2133000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8aa11bdde454474a9b815f584cb69e06_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMTItMy0xLTEtNTcwNzM_888f71f5-333e-4cdc-971e-6970f0f91834"
      unitRef="usd">599000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMTMtMS0xLTEtNTcwNzM_f251ef97-bc12-40d3-aa34-6d4b8cf54283"
      unitRef="usd">390564000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmU1NGUxMjkwOWRmZjQ3OTRhMTYyNmMyOWY4NGQ2NTVmL3RhYmxlcmFuZ2U6ZTU0ZTEyOTA5ZGZmNDc5NGExNjI2YzI5Zjg0ZDY1NWZfMTMtMy0xLTEtNTcwNzM_33001949-3ba0-402f-84d2-d16c2049ab87"
      unitRef="usd">341767000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <rdnt:AdvanceMedicarePayments
      contextRef="i5aa3078177dd4a78b72f87d219634477_D20200401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNDQwNw_d2d190ce-34a1-42ed-a8f9-5789e520a475"
      unitRef="usd">39600000</rdnt:AdvanceMedicarePayments>
    <rdnt:RepaymentOfAdvanceMedicarePayments
      contextRef="i19b686e5617c4056bf4f5a81d0e86de8_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTA4NA_1d8a9072-3984-4073-bf2a-be9f004cc3e1"
      unitRef="usd">38600000</rdnt:RepaymentOfAdvanceMedicarePayments>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNjY_9a93121e-1764-47c6-a636-ec881f864de5">ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.We do not utilize factoring arrangements as an integral part of our financing for working capital and assess the party's ability to pay upfront at the inception of the notes receivable and subsequently by reviewing their financial statements annually and reassessing any insolvency risk on a periodic basis.</us-gaap:ReceivablesPolicyTextBlock>
    <rdnt:ContractsReceivableFactoringReceivable
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNzM3Mw_9fb61f4c-1566-4e3b-ba3c-dab1dce9bc87"
      unitRef="usd">15400000</rdnt:ContractsReceivableFactoringReceivable>
    <rdnt:ContractsReceivableFactoringReceivable
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNzM4MA_e329e285-af33-4873-a4e5-643e92013133"
      unitRef="usd">15400000</rdnt:ContractsReceivableFactoringReceivable>
    <us-gaap:DeferredChargesPolicyTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwOTk_746c7f8e-2661-415c-99e1-ee99bfa77a30">DEFERRED FINANCING COSTS - Costs of financing are deferred and amortized using the effective interest rate method and are related to our revolving credit facilities.</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNzg5OA_6a1fc5a4-b44c-40e9-9294-8f829245241d"
      unitRef="usd">2100000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNzkwNQ_2f099931-9072-4240-8ed4-ddd2184c3813"
      unitRef="usd">2300000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMTc_166ad8aa-28e3-4486-9fb9-3ecca2e8cdb3">PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation of property and equipment is performed using the straight-line method over the estimated useful lives of the assets acquired, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i50b9260334df4b2f857a1e719c97d808_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfODMzNw_02bcc413-965e-4110-9d94-047952c87f6e">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i6f296060ae9f493f8defee2497cb5fc4_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfODM0Mw_20127ff9-c7ad-426b-abf5-5100fe9e43b8">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9081293d8345436495fe616ab903e24b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfODQ2Mg_eb3db0de-7acc-42bc-b7d8-a76fa35fb42c">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i259ff7a14ab44385acf1d3dc8b32d84d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfODQ2OA_3e5fe1d3-e164-4eeb-a44d-7ab25515ec18">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNjE_61d5a1da-90fa-4821-a29b-f57e378bf305">BUSINESS COMBINATION  -  When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNjg_27b25dc8-0e08-49c5-80ab-51d27ac03ac2">GOODWILLGoodwill is recorded as a result of business combinations. When we determine the carrying value of reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  We tested goodwill and indefinite lived intangibles for impairment on October 1, 2022, noting no impairment.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:Goodwill
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfOTY4MA_0cd14def-15c2-4db6-ad60-5c80d792fe4a"
      unitRef="usd">687100000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNzQ_50b749c0-b196-4267-b629-f3121f0880cd">Activity in goodwill for the three months ended March&#160;31, 2023 is provided below (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Artificial Intelligence&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill from acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;614,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i25cc54b133f44bc6867c82ea3b1d00c2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMS0xLTEtMS04MTAxNA_e794b7d6-881b-4681-a865-1d248eee6407"
      unitRef="usd">606483000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6b60cc174bb1488b811b3f45e09bda82_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMS0zLTEtMS04MTAxOA_2e7a6d9c-6b72-4b97-ab4d-15ee8ccc40d9"
      unitRef="usd">71182000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMC0xLTEtMS01NzA3Mw_7b027977-1d8b-4334-81a0-6b5a0c76ddf7"
      unitRef="usd">677665000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMi0xLTEtMS04MTAyOQ_a77f0abf-db25-425c-9e3a-6ede7293e755"
      unitRef="usd">6174000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i369ccdd58842499284be59ca42e369de_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMi0zLTEtMS04MTAzOQ_d9d15d8f-cec6-4b47-be04-339600216ac3"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMS0xLTEtMS01NzA3Mw_7f89fe42-b0f4-4fb4-91d1-b10e6b3e8452"
      unitRef="usd">6174000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMy0xLTEtMS04MTAyOQ_6fe91c47-041c-47b4-aa2b-dff2f13e113a"
      unitRef="usd">1603000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i369ccdd58842499284be59ca42e369de_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMy0zLTEtMS04MTAzOQ_4623f7d7-661e-4e8a-9d4f-8e5044546eef"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMi0xLTEtMS01NzA3Mw_0bbfa6f8-08cb-4966-8c62-db932f45ad2b"
      unitRef="usd">1603000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfNC0xLTEtMS04MTAyOQ_493db7b6-29d6-4dda-8f31-6b62aae78714"
      unitRef="usd">576000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i369ccdd58842499284be59ca42e369de_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfNC0zLTEtMS04MTAzOQ_fd6c3f43-7b23-47c3-8385-73efae820cb4"
      unitRef="usd">1067000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMy0xLTEtMS01NzA3Mw_47f95ba8-9814-435f-b8d3-3dd9f29a94bd"
      unitRef="usd">1643000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="if0cbe48174104f73982d4a0ca2a3857e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMTUtMS0xLTEtODEwMzM_8c9a304c-32f8-48fe-870b-6839750370be"
      unitRef="usd">614836000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i82d4ebf817564c7681dcb7af65622412_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMTUtMy0xLTEtODEwNDc_9db94213-fe24-4f0f-8906-c6134a69afbb"
      unitRef="usd">72249000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdhNzFjZmJjNmUyMzQwMzU4Zjc4MGI1MzAwMjZlYjMwL3RhYmxlcmFuZ2U6N2E3MWNmYmM2ZTIzNDAzNThmNzgwYjUzMDAyNmViMzBfMTQtMS0xLTEtNTcwNzM_3b7cfdcd-7b62-4871-85cd-eaa34ed1c22c"
      unitRef="usd">687085000</us-gaap:Goodwill>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMzg0ODI5MDc0MzQ4OQ_42ba37c6-e922-45d5-84b8-27d6c42bc467">&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average amortization period remaining in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Management Service Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Covenant not to compete and other contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Patent and Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed Technology &amp;amp; Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names indefinite life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Annual Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;103,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Excluding the three months ended March 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average amortization period remaining in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Management Service Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Covenant not to compete and other contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Patent and Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed Technology &amp;amp; Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names indefinite life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Annual Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;106,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="iae3e6ed3102e4ceb8e24ea8985ea1e38_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMS0xLTEtMS04NzgyNA_9b3048c8-6635-4346-9258-58c4a4aa0f71"
      unitRef="usd">1717000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="iae3e6ed3102e4ceb8e24ea8985ea1e38_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMS0zLTEtMS04NzgyNA_bd6605bc-f748-429b-bc99-c80170a8e18e"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="iae3e6ed3102e4ceb8e24ea8985ea1e38_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMS01LTEtMS04NzgyNA_01b11ed2-af2f-42ba-a4bd-a0c4f3cac91c"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="iae3e6ed3102e4ceb8e24ea8985ea1e38_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMS03LTEtMS04NzgyNA_a1a4f997-6d25-49fa-97cd-088778db2966"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="iae3e6ed3102e4ceb8e24ea8985ea1e38_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMS05LTEtMS04NzgyNA_dadbf4b6-89de-4309-a952-fe2889a9262c"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="iae3e6ed3102e4ceb8e24ea8985ea1e38_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMS0xMS0xLTEtODc4MjQ_07e225a1-0b67-4d90-a7a8-3106ae889fe1"
      unitRef="usd">8959000</rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iae3e6ed3102e4ceb8e24ea8985ea1e38_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMS0xMy0xLTEtODc4MjQ_6afd11da-5bca-4931-a241-e487b23c829c"
      unitRef="usd">19824000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="if5905542a04540b09449e8b542c285c5_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMS0xNS0xLTEtODc4MjQ_defe8a1a-8690-4931-aae9-91b52fa30a34">P8Y8M12D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="if58217de99e6462f8c2e57b616294439_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMi0xLTEtMS04NzgyNA_c83bf82d-a87e-4f41-8f99-87f061091e6b"
      unitRef="usd">1013000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="if58217de99e6462f8c2e57b616294439_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMi0zLTEtMS04NzgyNA_31967218-9e0e-426b-9271-fb62c59d2389"
      unitRef="usd">941000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="if58217de99e6462f8c2e57b616294439_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMi01LTEtMS04NzgyNA_1eb0a9d5-ea37-42c9-822f-19e4228ec32b"
      unitRef="usd">692000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="if58217de99e6462f8c2e57b616294439_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMi03LTEtMS04NzgyNA_9e71b696-af5c-4960-b4cb-62896eb5f47b"
      unitRef="usd">406000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="if58217de99e6462f8c2e57b616294439_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMi05LTEtMS04NzgyNA_9b771b35-866d-4061-a19f-834cbb23c154"
      unitRef="usd">122000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="if58217de99e6462f8c2e57b616294439_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMi0xMS0xLTEtODc4MjQ_49b1443a-685b-44cd-89b3-a1d1560bfb57"
      unitRef="usd">41000</rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if58217de99e6462f8c2e57b616294439_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMi0xMy0xLTEtODc4MjQ_6e04896e-4d3c-4534-be09-f8a07f7d0008"
      unitRef="usd">3215000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i93c4f1236b564f5bb1675e3e16faecef_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMi0xNS0xLTEtODc4MjQ_344715e0-9ed4-44c7-9ad7-6937743e28fe">P3Y8M12D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ida57b41fb8dc4945a8405b5de4684833_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMy0xLTEtMS04NzgyNA_e6c9a8e4-0546-4739-ae78-bc06e686360c"
      unitRef="usd">924000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ida57b41fb8dc4945a8405b5de4684833_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMy0zLTEtMS04NzgyNA_78e49eec-ff0b-401a-a698-22772853d30f"
      unitRef="usd">1219000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ida57b41fb8dc4945a8405b5de4684833_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMy01LTEtMS04NzgyNA_e0597db6-c752-4d44-aaeb-196e2630bc7f"
      unitRef="usd">1088000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ida57b41fb8dc4945a8405b5de4684833_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMy03LTEtMS04NzgyNA_6f46e65f-4da8-4395-846a-6026ba5dd5b0"
      unitRef="usd">966000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ida57b41fb8dc4945a8405b5de4684833_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMy05LTEtMS04NzgyNA_58044f41-956e-4d6a-812b-81d8ba555c8f"
      unitRef="usd">767000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="ida57b41fb8dc4945a8405b5de4684833_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMy0xMS0xLTEtODc4MjQ_fe5ab6d1-ac58-46a1-b656-104382936fb6"
      unitRef="usd">10984000</rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ida57b41fb8dc4945a8405b5de4684833_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMy0xMy0xLTEtODc4MjQ_1d7e3687-1ba5-402c-89db-20d6bb4325fb"
      unitRef="usd">15948000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="iab8bcaf8f78f44d39aaba69d6770467c_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfMy0xNS0xLTEtODc4MjQ_8e150473-9593-4ff4-9786-0840c453a380">P18Y1M6D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ie75b01796cbf464f8e6be437e129e127_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNC0xLTEtMS04NzgyNA_efc5d741-8c6c-4423-82b9-3a114a99ad34"
      unitRef="usd">280000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ie75b01796cbf464f8e6be437e129e127_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNC0zLTEtMS04NzgyNA_5f697f8a-52b6-47aa-a6e0-657d58c40877"
      unitRef="usd">313000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ie75b01796cbf464f8e6be437e129e127_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNC01LTEtMS04NzgyNA_355c6f74-4885-42ea-a6b7-86b56a76dbcd"
      unitRef="usd">313000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ie75b01796cbf464f8e6be437e129e127_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNC03LTEtMS04NzgyNA_10f6d826-4dca-4ecb-bc12-e13a9169cd2b"
      unitRef="usd">313000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ie75b01796cbf464f8e6be437e129e127_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNC05LTEtMS04NzgyNA_f9f52a6f-6808-4468-93fb-c9c31e66c4cc"
      unitRef="usd">313000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="ie75b01796cbf464f8e6be437e129e127_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNC0xMS0xLTEtODc4MjQ_eddbe744-17d6-4d06-a119-a050d01ba936"
      unitRef="usd">399000</rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie75b01796cbf464f8e6be437e129e127_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNC0xMy0xLTEtODc4MjQ_9ee951ba-01e3-4368-9e44-aa32397da3cc"
      unitRef="usd">1931000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i11f4b30281c144d0ad846555d53b95ab_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNC0xNS0xLTEtODc4MjQ_1c4766af-08c1-47b5-9b08-a18ac2d6eb72">P6Y3M18D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i0951dd5e901c4dca8d4d713eebf12539_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNS0xLTEtMS04NzgyNA_3e29099d-ab14-4c4a-bc25-7df684b56382"
      unitRef="usd">5810000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i0951dd5e901c4dca8d4d713eebf12539_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNS0zLTEtMS04NzgyNA_f7e80f2d-2a72-463a-8b8f-d1f88daa5d4a"
      unitRef="usd">6657000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i0951dd5e901c4dca8d4d713eebf12539_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNS01LTEtMS04NzgyNA_bac0a61f-df58-46fd-86f6-a3b7102308e9"
      unitRef="usd">6657000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i0951dd5e901c4dca8d4d713eebf12539_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNS03LTEtMS04NzgyNA_d9d4520d-1bd3-4932-9dcb-eb60a158ad4f"
      unitRef="usd">6617000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i0951dd5e901c4dca8d4d713eebf12539_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNS05LTEtMS04NzgyNA_d270c677-44dd-4f25-9f9c-88f643ce751d"
      unitRef="usd">6083000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="i0951dd5e901c4dca8d4d713eebf12539_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNS0xMS0xLTEtODc4MjQ_1be0ac00-884f-4b2d-a58e-ff86c2cb3c03"
      unitRef="usd">5392000</rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0951dd5e901c4dca8d4d713eebf12539_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNS0xMy0xLTEtODc4MjQ_633fa7c5-ff90-4d50-a549-dff9b4adba98"
      unitRef="usd">37216000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="id515d4eb95a4477a9767fd98d4ee59a6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNS0xNS0xLTEtODc4MjQ_88c32a1b-dc89-4ed3-bc0e-017e1f94484b">P6Y6M</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i6f5ffc61061348a08dd5cb2414b976aa_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNi0xLTEtMS04NzgyNA_0889be76-571f-4f9e-9daf-25b88e3b9b27"
      unitRef="usd">208000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i6f5ffc61061348a08dd5cb2414b976aa_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNi0zLTEtMS04NzgyNA_e191dda9-a8d1-4d4c-b2e7-d968a0b0d8c1"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i6f5ffc61061348a08dd5cb2414b976aa_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNi01LTEtMS04NzgyNA_9b8acdee-6eb3-4df5-bae8-16496bcde155"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i6f5ffc61061348a08dd5cb2414b976aa_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNi03LTEtMS04NzgyNA_4e6ef73f-4fa1-45f2-948d-f390c3509369"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i6f5ffc61061348a08dd5cb2414b976aa_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNi05LTEtMS04NzgyNA_6c37b8e4-b81e-490e-a89c-2a6ff0d827d4"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="i6f5ffc61061348a08dd5cb2414b976aa_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNi0xMS0xLTEtODc4MjQ_b0d1237a-8123-474b-a44e-7555fa7da3e8"
      unitRef="usd">89000</rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6f5ffc61061348a08dd5cb2414b976aa_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNi0xMy0xLTEtODc4MjQ_53408469-41bc-4962-9041-b8d3e296955c"
      unitRef="usd">605000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i5bc3cf8be0c742bfadeb1994780ffa21_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNi0xNS0xLTEtODc4MjQ_41c06222-0dc2-4272-9e02-25a05668cabf">P4Y7M6D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i18f2154ea6514a0d9c02f237b9630268_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNy0xMS0xLTEtODc4MjQ_5125d2d5-34c3-4173-ab26-0e35a0abeb2b"
      unitRef="usd">7100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i18f2154ea6514a0d9c02f237b9630268_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfNy0xMy0xLTEtODc4MjQ_840cac81-6e36-4053-9487-3591bab92193"
      unitRef="usd">7100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie29af3730fb445a08f77db24069ddaf2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOC0xMS0xLTEtODc4MjQ_967675bf-cf78-4122-a1a3-88f0bdc75f5f"
      unitRef="usd">17164000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie29af3730fb445a08f77db24069ddaf2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOC0xMy0xLTEtODc4MjQ_0a7872bd-6121-4548-bf2f-b8902fd1b6bf"
      unitRef="usd">17164000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOS0xLTEtMS04NzgyNA_325379a4-4130-4f3d-8dc7-8ec0bb120968"
      unitRef="usd">9952000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOS0zLTEtMS04NzgyNA_67825113-2805-4988-bca4-9e0123e94ad6"
      unitRef="usd">11494000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOS01LTEtMS04NzgyNA_cd995e2c-6ed6-4895-bea0-0ecad40d3b75"
      unitRef="usd">11114000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOS03LTEtMS04NzgyNA_b03a7c71-bf59-4e0c-9dc6-4709d915fd47"
      unitRef="usd">10666000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOS05LTEtMS04NzgyNA_c60d77d3-c5e0-43be-9631-558ecb878d98"
      unitRef="usd">9649000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOS0xMS0xLTEtODc4MjQ_ac070538-1c55-4bdc-8471-ed61f627e495"
      unitRef="usd">50128000</rdnt:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjFhZDQ4ZDc4ZGRmOTQ0NmE5YTQ2YWRmN2I1N2IyZTc0L3RhYmxlcmFuZ2U6MWFkNDhkNzhkZGY5NDQ2YTlhNDZhZGY3YjU3YjJlNzRfOS0xMy0xLTEtODc4MjQ_1324e028-e013-4d0b-9fee-087de7e38ca6"
      unitRef="usd">103003000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i5f27bb8d1da34982b392c9596891b7ea_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMS0xLTEtMS04NzY4Mw_fe588d01-13a2-42c2-8f18-5fc5d65ad741"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i5f27bb8d1da34982b392c9596891b7ea_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMS0zLTEtMS04NzY4Mw_62cd29c3-36a0-4a54-b624-afde996e9c54"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i5f27bb8d1da34982b392c9596891b7ea_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMS01LTEtMS04NzY4Mw_6f644be0-6af4-4e9f-a3aa-0358698548ef"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i5f27bb8d1da34982b392c9596891b7ea_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMS03LTEtMS04NzY4Mw_683956ed-568d-4803-9412-bb0bc651bed1"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i5f27bb8d1da34982b392c9596891b7ea_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMS05LTEtMS04NzY4Mw_0e57f400-d182-46f1-9746-8e4944007619"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i5f27bb8d1da34982b392c9596891b7ea_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMS0xMS0xLTEtODc2ODM_3416909e-0570-4512-857b-a66050f790a8"
      unitRef="usd">8958000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5f27bb8d1da34982b392c9596891b7ea_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMS0xMy0xLTEtODc2ODM_4a06242b-9a98-4930-a299-0603d32d50ee"
      unitRef="usd">20393000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="icfc8d3dc08704d95ac2a3367f23db6ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMS0xNS0xLTEtODc2ODM_c6a6edb0-f25a-4150-8039-cc29eaff70b7">P8Y10M24D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ia4f9799f448c40938b0f4799f0dab913_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMi0xLTEtMS04NzY4Mw_aec19933-09f4-4335-8ba0-b4c8b8af3a4f"
      unitRef="usd">1319000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ia4f9799f448c40938b0f4799f0dab913_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMi0zLTEtMS04NzY4Mw_2d7f34d6-bc00-405f-8a7f-72e1502594ab"
      unitRef="usd">891000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ia4f9799f448c40938b0f4799f0dab913_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMi01LTEtMS04NzY4Mw_17d049c8-9934-4447-bde1-11270aa2c82d"
      unitRef="usd">642000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ia4f9799f448c40938b0f4799f0dab913_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMi03LTEtMS04NzY4Mw_81959a83-7dd3-4bb8-9ed5-f29ba519f703"
      unitRef="usd">356000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ia4f9799f448c40938b0f4799f0dab913_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMi05LTEtMS04NzY4Mw_229e0f4c-ae14-4d66-b010-781c50776cbc"
      unitRef="usd">72000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="ia4f9799f448c40938b0f4799f0dab913_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMi0xMS0xLTEtODc2ODM_31ca812f-0a9c-4a5e-855e-5ceaa53b1e2d"
      unitRef="usd">40000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia4f9799f448c40938b0f4799f0dab913_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMi0xMy0xLTEtODc2ODM_6615174f-d0ce-4985-9fd7-51509ac2fe01"
      unitRef="usd">3320000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i22f1eef02031411cac17b094592527ee_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMi0xNS0xLTEtODc2ODM_96103d0b-f4dd-41d4-9f9d-51c63655095d">P3Y1M6D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ia1117258b4fb43f699a2f7f3415be208_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMy0xLTEtMS04NzY4Mw_69303be7-956a-4265-a8ea-67cabe4c79ca"
      unitRef="usd">1244000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ia1117258b4fb43f699a2f7f3415be208_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMy0zLTEtMS04NzY4Mw_ace87b67-e9b7-46db-9433-690104bf8010"
      unitRef="usd">1244000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ia1117258b4fb43f699a2f7f3415be208_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMy01LTEtMS04NzY4Mw_d64631a4-1e1d-4916-a84d-0e261a5c77ee"
      unitRef="usd">1112000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ia1117258b4fb43f699a2f7f3415be208_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMy03LTEtMS04NzY4Mw_1af0c7cf-7c01-4bee-85d4-c2b636697546"
      unitRef="usd">991000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ia1117258b4fb43f699a2f7f3415be208_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMy05LTEtMS04NzY4Mw_12216279-175b-451f-8ada-c03d5595a9c7"
      unitRef="usd">816000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="ia1117258b4fb43f699a2f7f3415be208_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMy0xMS0xLTEtODc2ODM_678c337c-7596-4a60-a99e-3478a289ccf0"
      unitRef="usd">12396000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia1117258b4fb43f699a2f7f3415be208_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMy0xMy0xLTEtODc2ODM_4ae3c10c-07e2-45b7-ae71-04e80cfedbf7"
      unitRef="usd">17803000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i46bd0ff499564277b884f9a7be8f681c_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfMy0xNS0xLTEtODc2ODM_7b98149d-ea74-4b49-8779-ace9b4644d4b">P18Y7M6D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i827b8872571a4f11aa439a07047d7c3a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNC0xLTEtMS04NzY4Mw_fa3c0b26-8c24-45fe-9bdb-ffdbeda93495"
      unitRef="usd">298000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i827b8872571a4f11aa439a07047d7c3a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNC0zLTEtMS04NzY4Mw_84248e6c-b59b-4055-9e78-9e5a0c8ed941"
      unitRef="usd">298000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i827b8872571a4f11aa439a07047d7c3a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNC01LTEtMS04NzY4Mw_a656ce3a-7cb2-406a-b8e8-e1a755a4f84d"
      unitRef="usd">298000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i827b8872571a4f11aa439a07047d7c3a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNC03LTEtMS04NzY4Mw_58ad9fd0-5ff2-40ff-9a7a-b2675c8c16e1"
      unitRef="usd">298000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i827b8872571a4f11aa439a07047d7c3a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNC05LTEtMS04NzY4Mw_31a49ebf-cb18-4094-96a8-4fcb5eba6a2f"
      unitRef="usd">298000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i827b8872571a4f11aa439a07047d7c3a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNC0xMS0xLTEtODc2ODM_d1fb0251-9c76-43ab-9c49-fedfa9b483bd"
      unitRef="usd">322000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i827b8872571a4f11aa439a07047d7c3a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNC0xMy0xLTEtODc2ODM_4983493f-6e1f-4179-9de6-dd0c0a2fb5d0"
      unitRef="usd">1812000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i1cbf83bd8a364fc4a600170db5d5f26c_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNC0xNS0xLTEtODc2ODM_336a7c6c-adb3-4126-8dae-b439b55a522b">P6Y4M24D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i543e313dd7ca47d3adf0f80f8df4018c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNS0xLTEtMS04NzY4Mw_1230c018-6091-4413-975c-117ba9273b18"
      unitRef="usd">6297000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i543e313dd7ca47d3adf0f80f8df4018c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNS0zLTEtMS04NzY4Mw_79a1a6d0-652f-4768-952e-ce25952e5a71"
      unitRef="usd">6297000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i543e313dd7ca47d3adf0f80f8df4018c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNS01LTEtMS04NzY4Mw_c42a50fe-a724-48dd-8d5a-31f9289fee94"
      unitRef="usd">6297000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i543e313dd7ca47d3adf0f80f8df4018c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNS03LTEtMS04NzY4Mw_465a2a3e-007a-4cfe-a15d-0315de081290"
      unitRef="usd">6257000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i543e313dd7ca47d3adf0f80f8df4018c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNS05LTEtMS04NzY4Mw_9a2e4ba7-a334-4b10-91eb-7236ad5c2d8a"
      unitRef="usd">5722000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i543e313dd7ca47d3adf0f80f8df4018c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNS0xMS0xLTEtODc2ODM_67129d06-f0af-46b5-9409-35cb240fc71d"
      unitRef="usd">7196000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i543e313dd7ca47d3adf0f80f8df4018c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNS0xMy0xLTEtODc2ODM_66f04797-6956-48fd-9203-2d7f279707e9"
      unitRef="usd">38066000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i9372083139794fde97d33c195ed380f7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNS0xNS0xLTEtODc2ODM_23f46b07-5e2a-400b-ab97-523b6e48f4ba">P6Y8M12D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ie74daf4e113844e9a3ae6e83d17dac2f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNi0xLTEtMS04NzY4Mw_a79aadc0-0897-429f-84e1-699de1d6c4d9"
      unitRef="usd">305000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ie74daf4e113844e9a3ae6e83d17dac2f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNi0zLTEtMS04NzY4Mw_994c4c50-55b6-4753-81bf-a6172b4aa19f"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ie74daf4e113844e9a3ae6e83d17dac2f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNi01LTEtMS04NzY4Mw_d85daa88-ae7a-4a01-944a-eba9f8a905cd"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ie74daf4e113844e9a3ae6e83d17dac2f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNi03LTEtMS04NzY4Mw_6a6892b5-ea5c-43c3-b5d4-2a2991a5ccba"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ie74daf4e113844e9a3ae6e83d17dac2f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNi05LTEtMS04NzY4Mw_709dc4c2-85b5-4084-b46f-7f18290a58bb"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="ie74daf4e113844e9a3ae6e83d17dac2f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNi0xMS0xLTEtODc2ODM_87ce8670-d0c7-4c25-b9a6-98ee75cb21f3"
      unitRef="usd">89000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie74daf4e113844e9a3ae6e83d17dac2f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNi0xMy0xLTEtODc2ODM_68492968-cd3c-4fa7-bcd2-c1672bd65ebf"
      unitRef="usd">702000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="ie55468e7e99d494d912000e2264a206a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNi0xNS0xLTEtODc2ODM_eddd56fc-45d4-45f9-9c43-dd9b678e63ab">P4Y6M</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iac10bef62a4043318e0782f47e41f58d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNy0xMS0xLTEtODc2ODM_f3905514-157f-4cb9-9e25-5e380a9df17b"
      unitRef="usd">7100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iac10bef62a4043318e0782f47e41f58d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfNy0xMy0xLTEtODc2ODM_40affe34-6d12-487e-958c-b2d9005aae39"
      unitRef="usd">7100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i1d21764379a54e939ddab4e98c95e66a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOC0xMS0xLTEtODc2ODM_0e973fb4-bde6-4719-8ae8-3c42e223fcd8"
      unitRef="usd">17032000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i1d21764379a54e939ddab4e98c95e66a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOC0xMy0xLTEtODc2ODM_b9ce9f93-af14-4298-9a9f-85415fa3b46e"
      unitRef="usd">17032000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOS0xLTEtMS04NzY4Mw_d75efbc8-cd91-4f6f-bace-7bbfe60e0eb9"
      unitRef="usd">11750000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOS0zLTEtMS04NzY4Mw_da2ded4e-e4a5-48d0-bf84-8c8bfbb30259"
      unitRef="usd">11094000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOS01LTEtMS04NzY4Mw_e103c8c7-2777-4c3a-8f95-2beff408f73f"
      unitRef="usd">10713000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOS03LTEtMS04NzY4Mw_d8882800-0da1-43ac-8aee-549098226e92"
      unitRef="usd">10266000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOS05LTEtMS04NzY4Mw_917ba9cb-f44b-4a65-9806-2e798d757ea9"
      unitRef="usd">9272000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOS0xMS0xLTEtODc2ODM_399b02be-940a-40d2-ae53-0bbfb8fc5dd4"
      unitRef="usd">53133000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjcxYWMzZTA5YmMyNjRhMGM5NDMxNzE1MDlkY2ZhMGFmL3RhYmxlcmFuZ2U6NzFhYzNlMDliYzI2NGEwYzk0MzE3MTUwOWRjZmEwYWZfOS0xMy0xLTEtODc2ODM_0f932791-2ec5-4bc9-9c4d-b065e18953e3"
      unitRef="usd">106228000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODYyMTA4_71ae9c40-1f7a-4c81-9e39-33ec7f41681d"
      unitRef="usd">3000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODYyMTE2_2fa707d8-b1a1-4912-bd21-fb1bb30f00c8"
      unitRef="usd">2100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if5905542a04540b09449e8b542c285c5_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODY0MDI3_093c5cdb-4e34-46ca-b9ec-5c7e9c8c5d12">P25Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMTM_57b0ed4f-c993-4280-ac96-7c862d894330">INCOME TAXES -  Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized.We believe no significant changes in the unrecognized tax benefits will occur within the next 12 months.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTE1NTk_d8ded35d-9780-4b0e-873e-1472cbb1bf3a"
      unitRef="usd">1100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTE1OTE_b26ce420-aee2-416d-b350-787d30f1768c"
      unitRef="number">-0.086</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib9f162e3c0384b30924c94f3ad53ebae_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTE2NDA_688f003a-a35b-43c2-8325-73eef72d451a"
      unitRef="usd">1500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib9f162e3c0384b30924c94f3ad53ebae_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTE2NzI_9cef98c4-994c-4a9b-b4b6-1c5ed1b0041b"
      unitRef="number">0.152</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMTU_52d73107-6e0b-41a5-b06c-55fc79a4e355">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable.  We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ROU assets are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; tested for impairment if circumstances suggest that the carrying amount may not be recoverable.  Our ROU assets consist of facility and equipment assets on operating leases.  No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of March&#160;31, 2023.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities.  We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances.  Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.&lt;/span&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMDg_13915843-0bcd-46fa-a663-ca9d9db41737">EQUITY BASED COMPENSATION &#x2013; We have one long-term incentive plan that we adopted in 2006 and which we have amended and restated at various points in time: first on April 20, 2015, second on March 9, 2017, and currently as of April 15, 2021 (the &#x201c;Restated Plan&#x201d;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved 16,500,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric.  We evaluate performance-based awards to determine if it is probable that the vesting conditions will be met. We also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period.  Stock options generally vest over three years to five years and expire five years to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#x2019; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 7, Stock-Based Compensation, for more information.</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTQ1MTI_59a98dfb-8b7f-4156-b5bc-2fdf0eec3709"
      unitRef="incentiveplan">1</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i9099259394b94e1e889dc1476f075a27_I20210415"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTQ4NTk_6bc5c9bf-fcb7-4539-8f16-00f130815ce5"
      unitRef="shares">16500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if7309a2667674a92a4cc3eeb4825b42f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTU1NDk_2e060629-248f-47d7-acc2-58a52942b14d">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i7e2bb9a95d4d4802b2e4a3cc0aebe6ab_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTU1NTU_a7261e27-1b73-4233-9c51-fbdf52154938">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="if7309a2667674a92a4cc3eeb4825b42f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTU1Njk_53c2c32d-cf24-4aca-afdf-314adb0ee6c0">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i7e2bb9a95d4d4802b2e4a3cc0aebe6ab_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTU1NzU_230e1db4-f802-42db-83a6-d257ebdbb909">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwODk_d7990858-c22d-4eaf-90fd-7ecef313fa84">COMPREHENSIVE (LOSS) INCOME - Accounting guidance establishes rules for reporting and displaying other comprehensive (loss) income and its components. Our foreign currency translation adjustments, changes in the fair value of cash flow hedges, and the amortization of balances associated with derivatives previously classified as cash flow hedges are included in other comprehensive (loss) income. The components of other comprehensive (loss) income for the twelve month periods ended March&#160;31, 2023 and March&#160;31, 2022 are included in the consolidated statements of comprehensive (loss) income.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNTc_492f7847-834d-4750-9c78-6c0c36b39dc3">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNTg_84f4abb0-55b7-40a0-92ad-53c72e9ae410">DERIVATIVE INSTRUMENTSThe 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional.As of the effective date, we are liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates are above the arranged rates.At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive gain or loss in the consolidated statement of equity.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="if0db9c5249a94190ac881fc140ab7671_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTgwMDA_203065b5-e91c-4b65-af81-e890df526eb8"
      unitRef="agreement">4</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="if0db9c5249a94190ac881fc140ab7671_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTgwOTk_260b36c9-2900-48a4-88c8-b143422ab954"
      unitRef="usd">500000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="i15eafbad7ffc4c0d940511464f11e6e8_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTgxMTc_d42bdee4-a5af-4a0c-8a8a-e64c0c348701"
      unitRef="agreement">2</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i15eafbad7ffc4c0d940511464f11e6e8_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTgxMzQ_a1120eeb-b400-450d-ac5e-2342be423c65"
      unitRef="usd">50000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="i2f647f27d1a94bd2971692b3e87ff615_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTgxNDY_10c2b381-9bf4-4a3e-998f-25bf8dba2c28"
      unitRef="agreement">2</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i2f647f27d1a94bd2971692b3e87ff615_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTgxNjQ_252f88c7-bc86-41dc-85e5-9451261ca310"
      unitRef="usd">200000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="ifb12196c225347c6a543f74457559713_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTg1MjE_cb5593e6-6198-43b3-825a-83168f8b8864"
      unitRef="number">0.0196</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i9ace4524b6974e138856ac8172419ae1_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTg1MzI_43c4edce-cd15-443e-9570-060789bf13f2"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="ica6e378192f34ceb847f8a3feae3fc4d_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTg1NTE_94b17eff-37eb-40a0-994d-050872dac6fa"
      unitRef="number">0.0205</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i965b8fc567f2478dba186b27fff59b4a_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTg1NjI_c8fe0cdc-3792-4232-861f-01c76fb5e3cc"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i965b8fc567f2478dba186b27fff59b4a_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTkyODI_c8fe0cdc-3792-4232-861f-01c76fb5e3cc"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="ica6e378192f34ceb847f8a3feae3fc4d_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTkzMzU_94b17eff-37eb-40a0-994d-050872dac6fa"
      unitRef="number">0.0205</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i9ace4524b6974e138856ac8172419ae1_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTkzNjM_43c4edce-cd15-443e-9570-060789bf13f2"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="ifb12196c225347c6a543f74457559713_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTk0MTY_cb5593e6-6198-43b3-825a-83168f8b8864"
      unitRef="number">0.0196</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i965b8fc567f2478dba186b27fff59b4a_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTk2MzU_c8fe0cdc-3792-4232-861f-01c76fb5e3cc"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i9ace4524b6974e138856ac8172419ae1_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTk2Nzg_43c4edce-cd15-443e-9570-060789bf13f2"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:StockholdersEquity
      contextRef="ic22a4427ddba4a24b4b6ff3818dea43c_I20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTk4NTA_560bb138-f93d-430a-aeb6-2062aad047dd"
      unitRef="usd">24400000</us-gaap:StockholdersEquity>
    <rdnt:MonthlyAmortizationOfDeferredHedgeGains
      contextRef="i999c3e86ee8240ccb38c00170156728a_D20200701-20231031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMTk5NTc_041ad0b6-23cc-4e11-a713-c7f45175258e"
      unitRef="usd">400000</rdnt:MonthlyAmortizationOfDeferredHedgeGains>
    <rdnt:MonthlyAmortizationOfDeferredHedgeGains
      contextRef="i1feee914475c47c19d03bc69138716ee_D20231101-20251031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjAwMDI_9e6c1c09-a2ae-4959-82bb-6e5ae80e03d0"
      unitRef="usd">300000</rdnt:MonthlyAmortizationOfDeferredHedgeGains>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNjc_0ebe75ee-3bf3-4cda-b836-14f10eecdcd3">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.217%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive loss recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(15,201)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$922&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(14,279)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.217%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive loss recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(18,887)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$924&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(17,963)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ineffective interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of loss recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjI1ZDk4ZTg3NTAxYTRkZWViMmE0ZTYyZGQzYTYzMjA3L3RhYmxlcmFuZ2U6MjVkOThlODc1MDFhNGRlZWIyYTRlNjJkZDNhNjMyMDdfMi00LTEtMS01NzA3Mw_82eff8fd-e435-416f-a669-f954d06a2aa7"&gt;Other income (expense)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(922)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ineffective interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of gain recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjllMGUxNjNhM2M3MDQ0NzA4ZGRmYzVhNDQyNjI2MmJlL3RhYmxlcmFuZ2U6OWUwZTE2M2EzYzcwNDQ3MDhkZGZjNWE0NDI2MjYyYmVfMi00LTEtMS04OTMxOA_468424d7-c562-4c21-a8d7-de7f7f9f175e"&gt;Other income (expense)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(923)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i973513e4e5fe46adadaacc2b2fd7052d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjhiMjU3YzM1Yzk3NTQ4NTRhNTdmNTdhZjA1MzYyMjYzL3RhYmxlcmFuZ2U6OGIyNTdjMzVjOTc1NDg1NGE1N2Y1N2FmMDUzNjIyNjNfMi0yLTEtMS01NzA3Mw_33943de7-2f60-427f-9573-770e92824af9"
      unitRef="usd">-15201000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ie8c2f246c0df4407bae5f83b9dea4895_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjhiMjU3YzM1Yzk3NTQ4NTRhNTdmNTdhZjA1MzYyMjYzL3RhYmxlcmFuZ2U6OGIyNTdjMzVjOTc1NDg1NGE1N2Y1N2FmMDUzNjIyNjNfMi00LTEtMS01NzA3Mw_4fa8ffeb-83fe-4148-876f-7989b6b9031b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ie8c2f246c0df4407bae5f83b9dea4895_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjhiMjU3YzM1Yzk3NTQ4NTRhNTdmNTdhZjA1MzYyMjYzL3RhYmxlcmFuZ2U6OGIyNTdjMzVjOTc1NDg1NGE1N2Y1N2FmMDUzNjIyNjNfMi02LTEtMS01NzA3Mw_92bd4fe8-f968-4014-8d48-58b466a8a2bf"
      unitRef="usd">-922000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1c807c6ae09463bb238f4f90ec7edfa_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjhiMjU3YzM1Yzk3NTQ4NTRhNTdmNTdhZjA1MzYyMjYzL3RhYmxlcmFuZ2U6OGIyNTdjMzVjOTc1NDg1NGE1N2Y1N2FmMDUzNjIyNjNfMi04LTEtMS01NzA3Mw_14b49962-ad26-4e9a-9854-a6d9f021c712"
      unitRef="usd">-14279000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d0fb067263842908a465a961d0de307_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmI2YzVhNTgxODMyYjQyMTY4NmJhMDRhMjc1ZDUwOGUxL3RhYmxlcmFuZ2U6YjZjNWE1ODE4MzJiNDIxNjg2YmEwNGEyNzVkNTA4ZTFfMi0yLTEtMS04OTU4NA_bcdfe8ba-e388-4ac0-ba2a-a82335c3073b"
      unitRef="usd">-18887000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ie7f7fa2072f04702b6070015044cc329_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmI2YzVhNTgxODMyYjQyMTY4NmJhMDRhMjc1ZDUwOGUxL3RhYmxlcmFuZ2U6YjZjNWE1ODE4MzJiNDIxNjg2YmEwNGEyNzVkNTA4ZTFfMi00LTEtMS04OTY0Mw_2bc242a3-e29b-4cd3-8e01-31b82b4fa764"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ie7f7fa2072f04702b6070015044cc329_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmI2YzVhNTgxODMyYjQyMTY4NmJhMDRhMjc1ZDUwOGUxL3RhYmxlcmFuZ2U6YjZjNWE1ODE4MzJiNDIxNjg2YmEwNGEyNzVkNTA4ZTFfMi02LTEtMS04OTYwMA_3596ea41-e3cd-41e0-aa4a-d48cec149e3d"
      unitRef="usd">-924000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i014cf416eb05406dbacef4beed33f8c4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmI2YzVhNTgxODMyYjQyMTY4NmJhMDRhMjc1ZDUwOGUxL3RhYmxlcmFuZ2U6YjZjNWE1ODE4MzJiNDIxNjg2YmEwNGEyNzVkNTA4ZTFfMi04LTEtMS04OTYwNg_cf9adf19-fa6d-4146-a3f9-7e98085fed29"
      unitRef="usd">-17963000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ie8c2f246c0df4407bae5f83b9dea4895_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjI1ZDk4ZTg3NTAxYTRkZWViMmE0ZTYyZGQzYTYzMjA3L3RhYmxlcmFuZ2U6MjVkOThlODc1MDFhNGRlZWIyYTRlNjJkZDNhNjMyMDdfMi0yLTEtMS01NzA3Mw_7b564b29-e4b2-4887-af36-c43edcdc2349"
      unitRef="usd">4093000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i8290c625ae1c431faf7a99cf4dcee8ab_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjI1ZDk4ZTg3NTAxYTRkZWViMmE0ZTYyZGQzYTYzMjA3L3RhYmxlcmFuZ2U6MjVkOThlODc1MDFhNGRlZWIyYTRlNjJkZDNhNjMyMDdfMi02LTEtMS01NzA3Mw_1a581119-ef78-4cf2-8147-009f614864d1"
      unitRef="usd">922000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ie7f7fa2072f04702b6070015044cc329_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjllMGUxNjNhM2M3MDQ0NzA4ZGRmYzVhNDQyNjI2MmJlL3RhYmxlcmFuZ2U6OWUwZTE2M2EzYzcwNDQ3MDhkZGZjNWE0NDI2MjYyYmVfMi0yLTEtMS04OTMwMg_6667482f-9c38-411b-af7e-8af1b156951b"
      unitRef="usd">-20819000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i6d8e8b09e9574606ab6241afc0829c86_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjllMGUxNjNhM2M3MDQ0NzA4ZGRmYzVhNDQyNjI2MmJlL3RhYmxlcmFuZ2U6OWUwZTE2M2EzYzcwNDQ3MDhkZGZjNWE0NDI2MjYyYmVfMi02LTEtMS04OTMxMA_91b7e446-f5d6-4593-97bb-3641867d7faf"
      unitRef="usd">923000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="icbba037786a84b888dd30f858c80bde1_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUxMTgx_026a49dd-1dc7-48f5-b4a8-d9909190d8e4"
      unitRef="usd">10000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <rdnt:BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones
      contextRef="icbba037786a84b888dd30f858c80bde1_I20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUxMTg3_fd8873ec-c0d5-4486-9c9b-d245c941e258"
      unitRef="loan">2000</rdnt:BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iee8168439bff4dcc928d2f0538a23ea5_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUxMTky_d794a12a-14c6-4cf0-92bc-3cc24c777d5a"
      unitRef="usd">7300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne
      contextRef="icbba037786a84b888dd30f858c80bde1_I20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMDUy_90d9d163-3e0f-476d-ba37-0522e0bd86de"
      unitRef="number">0.80</rdnt:BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne>
    <rdnt:BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo
      contextRef="icbba037786a84b888dd30f858c80bde1_I20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMDU2_988aff8f-ded0-46d8-85ac-80573c4b307e"
      unitRef="number">0.70</rdnt:BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib6e9460c493149e6bd8bb71cb47a94dc_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMDYw_d7d3fc1f-0790-457b-b03c-8ac7940c36e1"
      unitRef="usd">4000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod
      contextRef="i06979ac32be0468ab90faae5f8a7fae6_D20220120-20220120"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMDcy_645acb7e-d3ee-4488-b113-6bf94fd55d6e">P18M</rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod>
    <rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares
      contextRef="i2a5b65acdc4a494dad73f5d762c4bff4_I20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMDc2_06979715-8fef-4dee-a84d-9f95072065aa"
      unitRef="shares">113303</rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares>
    <rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution
      contextRef="i2a5b65acdc4a494dad73f5d762c4bff4_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMDgw_17b25050-54b5-4d81-aa4e-09996819b39a"
      unitRef="usd">3000000</rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i31f77a27a2e24b72a13b080caab47d8e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMDg3_6120a800-8080-450e-a46a-95f0badafa8c"
      unitRef="usd">2800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie3d36b3137cf48c1b491cd5b202fbcdf_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMDk5_772e2b7a-636d-49dc-9355-8b559c337888"
      unitRef="usd">1600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ibd948f656ced403e875b56f896581911_I20221001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMTA2_acd33478-f20c-4241-badd-a9c32c0c5efd"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i0bdb93152d774671850e526671c6aec3_I20221101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMTEz_be14074d-a9a3-4eb3-88a2-9a690f6f4b4c"
      unitRef="number">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if10663cad4164b7d819dd600043b536c_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMTE3_aac189c5-5226-47ac-9bc2-a1a9402e76c4"
      unitRef="usd">10200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i066eadbb98a54c6480345b29b400d31f_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMTI0_6efcae21-c439-4800-b59b-aaf695d03803"
      unitRef="usd">600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod
      contextRef="i0dd2d7518a4f46b4a60489e1be50cf79_D20221101-20221101"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMTMx_d9dd7412-0464-4f96-89df-efd2f28a7a84">P24M</rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iefc3e607700f46539886f8ce5ac3a6fe_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODUyMTM1_d75c5f03-ba01-4b79-8862-179fef3166a6"
      unitRef="usd">13100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMzg0ODI5MDczMjEwMA_c3573792-e043-4faf-bef6-80d3c0ffae19">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular rollforward of contingent consideration is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1, 2023 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issuance of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Change in valuation of Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023  Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aidence&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quantib&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses &amp;amp; Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart and Lung Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses &amp;amp; Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i173b6797abf9418b9ce2d7294d426b24_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfMi00LTEtMS04MDgzOQ_84df4d6a-2b8d-4f15-bfca-5f3b924aaf4a"
      unitRef="usd">11158000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration
      contextRef="i2acb391edb584f9991ed018864e62fdf_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfMi02LTEtMS04MDgzOQ_f2c918f1-60f9-45a7-973e-928e8334359b"
      unitRef="usd">0</rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i2acb391edb584f9991ed018864e62fdf_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfMi04LTEtMS04MDgzOQ_9c1c66f4-fb2c-4bb9-9189-f2e0e8273ab6"
      unitRef="usd">158000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation
      contextRef="i2acb391edb584f9991ed018864e62fdf_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfMi0xMC0xLTEtODA4Mzk_7c5b91dc-76bc-4d28-a077-0de6b0941b70"
      unitRef="usd">0</rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ibdfb2358240e4c36b0c1df5fddf49bd7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfMi0xMi0xLTEtODA4Mzk_31bd98d3-5474-464c-94a4-0689758280ac"
      unitRef="usd">11316000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6697f341173242ddb3318ebb20797960_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNC00LTEtMS04MDgzOQ_8726de3f-38a7-4917-86cc-e5d1f54ca55a"
      unitRef="usd">3709000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration
      contextRef="ie485aedb3f5a499890201c380e948451_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNC02LTEtMS04MDgzOQ_33e8e094-490e-4bb9-b8ea-7c70c5ab675d"
      unitRef="usd">0</rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ie485aedb3f5a499890201c380e948451_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNC04LTEtMS04MDgzOQ_3390abb1-c3fc-4e4c-8c09-fcfcd2f61765"
      unitRef="usd">702000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation
      contextRef="ie485aedb3f5a499890201c380e948451_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNC0xMC0xLTEtODA4Mzk_95f2ca79-0b37-46cf-a027-1a570c40cb5a"
      unitRef="usd">0</rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i35969f93dd244ab9975ff3d03ff35236_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNC0xMi0xLTEtODA4Mzk_3335d43a-20bc-4a04-a3e2-df119a06edfa"
      unitRef="usd">4411000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i287bda58ab4a4749bc53627ff756795d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNi00LTEtMS04MDgzOQ_c2ccb510-0498-48b8-84c5-a2ad90f6119f"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration
      contextRef="ia76a78ff4e864951a5ad37cf84296e9a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNi02LTEtMS04MDgzOQ_15f9b992-8f30-4fd9-a385-e7f993e524a7"
      unitRef="usd">0</rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ia76a78ff4e864951a5ad37cf84296e9a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNi04LTEtMS04MDgzOQ_669a634e-63ee-44ca-9ffd-7c11bbbf7231"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation
      contextRef="ia76a78ff4e864951a5ad37cf84296e9a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNi0xMC0xLTEtODA4Mzk_1ca430be-7dc1-47a2-a2bc-0874f367da49"
      unitRef="usd">0</rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i11045551fdb3449782344178a2ef73d6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNi0xMi0xLTEtODA4Mzk_286c3d12-715e-41b5-8974-c9b4cbcd1d4d"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i93c2f0e988bf4215ba9dd9160be1bc52_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNy00LTEtMS04MDgzOQ_8a580348-e0cb-42e2-b092-1b2983aaa53a"
      unitRef="usd">11656000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration
      contextRef="i51f5b3ddf736445e83e7bbca68c313c4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNy02LTEtMS04MDgzOQ_5f5a77b1-03ff-4022-a7fe-20b75fbbfc89"
      unitRef="usd">0</rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i51f5b3ddf736445e83e7bbca68c313c4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNy04LTEtMS04MDgzOQ_c75a8d42-ca2e-4fe9-b6cd-fcbf188bb5db"
      unitRef="usd">1124000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation
      contextRef="i51f5b3ddf736445e83e7bbca68c313c4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNy0xMC0xLTEtODA4Mzk_c2859cf2-f301-42ec-a494-a4a82a8ec7a0"
      unitRef="usd">350000</rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i058ba722d17f465ca2784c234195b2cb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmY1NTdiOGI0ZjUyYjQ0YWJhOThmOTE4MGFmYzUyMWViL3RhYmxlcmFuZ2U6ZjU1N2I4YjRmNTJiNDRhYmE5OGY5MTgwYWZjNTIxZWJfNy0xMi0xLTEtODA4Mzk_a9ac0830-96c6-4384-8f39-be45a8e11def"
      unitRef="usd">13130000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMDY_42510688-7dfd-497a-8c3b-8c5328ea89d2">FAIR VALUE MEASUREMENTS &#x2013; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair &lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.&lt;/span&gt;&lt;/div&gt;The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#x2019;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of our long-term debt, which is discussed in Note 6, Credit Facilities and Notes Payable, was determined using Level 2 inputs primarily related to comparable market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwODY_b0f45d45-1e5c-4f75-a28d-7903ea607c04">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Swaps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Swaps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair values of contingencies and holdback relating to our Aidence Holding B.V. and Quantib B.V. acquisitions on January 20, 2022, the Montclair Radiological Associates acquisition on October 1, 2022 and the Heart and Lung Imaging Limited acquisition on November 1, 2022 that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aidence Holding B.V. milestone consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quantib B.V. holdback of 113,303 shares of RadNet common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair Radiological Associates&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart and Lung Imaging Limited&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans and Truist Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans and Truist Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeAssets
      contextRef="i3d7f845cf42440e69575e47031da49f1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmM3YmE1NWUwZWVmODQwYTRiNmU2MzFlZmQ0MzhhMzZjL3RhYmxlcmFuZ2U6YzdiYTU1ZTBlZWY4NDBhNGI2ZTYzMWVmZDQzOGEzNmNfNC0xLTEtMS01NzA3Mw_ee6f3bc7-db9a-4307-b078-46ac83712b20"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i53894f1fe8a84432ab52b5a5b819bc93_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmM3YmE1NWUwZWVmODQwYTRiNmU2MzFlZmQ0MzhhMzZjL3RhYmxlcmFuZ2U6YzdiYTU1ZTBlZWY4NDBhNGI2ZTYzMWVmZDQzOGEzNmNfNC0zLTEtMS01NzA3Mw_73f2bb8d-a747-4d0e-97f3-a312226142f1"
      unitRef="usd">19209000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i3bb3938f8e9245c69f2103134c886ddc_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmM3YmE1NWUwZWVmODQwYTRiNmU2MzFlZmQ0MzhhMzZjL3RhYmxlcmFuZ2U6YzdiYTU1ZTBlZWY4NDBhNGI2ZTYzMWVmZDQzOGEzNmNfNC01LTEtMS01NzA3Mw_8e06a831-cf2e-4b45-a227-43640b85736d"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i6f3f9c5a69554b138e8af5ee50845912_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmM3YmE1NWUwZWVmODQwYTRiNmU2MzFlZmQ0MzhhMzZjL3RhYmxlcmFuZ2U6YzdiYTU1ZTBlZWY4NDBhNGI2ZTYzMWVmZDQzOGEzNmNfNC03LTEtMS01NzA3Mw_56e80780-7c25-42f5-9386-bb7338cdae32"
      unitRef="usd">19209000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i17af87ec48d045ecb8769ad083958efe_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmMzZjFkMDY4YTVmNTQ1YmE5NGVhNmQxNDU5N2QzNjg2L3RhYmxlcmFuZ2U6YzNmMWQwNjhhNWY1NDViYTk0ZWE2ZDE0NTk3ZDM2ODZfNC0xLTEtMS01NzA3Mw_21a67260-85e5-4db9-9d64-9e0c2c6f58fc"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i8af6e51430bf454182807a0000e29d75_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmMzZjFkMDY4YTVmNTQ1YmE5NGVhNmQxNDU5N2QzNjg2L3RhYmxlcmFuZ2U6YzNmMWQwNjhhNWY1NDViYTk0ZWE2ZDE0NTk3ZDM2ODZfNC0zLTEtMS01NzA3Mw_7c346562-1b48-4072-9cc4-575487279661"
      unitRef="usd">23302000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ia3bfe53a05d7443eaebd569b9c1fffbb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmMzZjFkMDY4YTVmNTQ1YmE5NGVhNmQxNDU5N2QzNjg2L3RhYmxlcmFuZ2U6YzNmMWQwNjhhNWY1NDViYTk0ZWE2ZDE0NTk3ZDM2ODZfNC01LTEtMS01NzA3Mw_fbf2c339-ef17-47d6-bfa7-7700a33b5d36"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i5fc55aa9a8f74f6e9d0a7f9ee6911a37_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmMzZjFkMDY4YTVmNTQ1YmE5NGVhNmQxNDU5N2QzNjg2L3RhYmxlcmFuZ2U6YzNmMWQwNjhhNWY1NDViYTk0ZWE2ZDE0NTk3ZDM2ODZfNC03LTEtMS01NzA3Mw_8328ba9d-595f-459e-a314-2d39a84f2061"
      unitRef="usd">23302000</us-gaap:DerivativeAssets>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i3a1961ca97b748dd97f76e81cefd372a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfMy0xLTEtMS04MDg0Nw_0ff65fee-c3b1-4cab-be4a-dadcb13a0dcc"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ib1cd387ced7b4e0ab675250e1043f341_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfMy0zLTEtMS04MDg0Nw_8b294ae3-262f-4ef4-9883-4a1fa20eaea3"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="if254894b76e948059a1f851aac708545_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfMy01LTEtMS04MDg0Nw_bd57a15f-7ed3-495b-8bd3-95bf0607c16a"
      unitRef="usd">11316000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i4d9c210824bd498595db6f8ea56f2975_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfMy03LTEtMS04MDg0Nw_f3584c9b-ff63-4a8f-9b9c-b6de63d6bbb4"
      unitRef="usd">11316000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares
      contextRef="i2a5b65acdc4a494dad73f5d762c4bff4_I20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNC0wLTEtMS04MDg0Ny90ZXh0cmVnaW9uOmZiYTA0NTYxMmZkNzQ3NWVhMjQ3MTg1YjdmNTY4ZTNkXzMw_380da2c7-9b49-43a7-b762-e7897980a6b6"
      unitRef="shares">113303</rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="idab0c26ccbb3431a83faffea0666ec73_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNC0xLTEtMS04MDg0Nw_978b934d-4613-4148-97ef-7a9bfedf7bef"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i5324382fed8640319b97df8ad78e78da_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNC0zLTEtMS04MDg0Nw_c4594b85-ec31-4c92-8cb8-c09580fec29f"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ib0f8ba61c5d04db397ce5b6e04306b7e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNC01LTEtMS04MDg0Nw_1ca862a8-a6da-4c3e-ab7f-cfdcd74f3b7b"
      unitRef="usd">4411000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i0eacec98a58d4cdda3f139bb7a0de027_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNC03LTEtMS04MDg0Nw_13d82772-b40e-470d-b207-43dd949a0b94"
      unitRef="usd">4411000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i22e2dd058697401197f55bd60a4150ee_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNS0xLTEtMS04MDg0Nw_17362d70-0686-458c-ab21-7c7d53647598"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i333584db5d0c4718a15a9336dd0ec38b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNS0zLTEtMS04MDg0Nw_4aa0ecd0-917e-49b4-8e9e-ae47a354dc7f"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i5422c8baca9649c8971a2171b71a5b0e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNS01LTEtMS04MDg0Nw_be6bdd4d-cb27-43a8-a4d4-9a278a899211"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i8bc5a6bf23e24e448e14f910984a448e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNS03LTEtMS04MDg0Nw_ca35cd28-32a7-47b7-ac9a-32b877534096"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i85f996450ac44be3a585f3df56209db0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNi0xLTEtMS04MDg0Nw_80ffaa50-1a9a-412e-8c5a-a5b3dc24a3c1"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="if1418728f3764d51ae66362b3b005736_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNi0zLTEtMS04MDg0Nw_22ce3448-3b44-4af2-a013-08a4af5ae567"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i7e1fc62ee042414286344a73cb1100ad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNi01LTEtMS04MDg0Nw_2062bbb1-ffed-48f6-b673-a9c2df300da9"
      unitRef="usd">13130000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i8b566bef11524caba9939adb72309fb2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjA3YzA1ZDAyZGE1NDQ1YjQ5YTU4MWZhZTFhYmY3NzJiL3RhYmxlcmFuZ2U6MDdjMDVkMDJkYTU0NDViNDlhNTgxZmFlMWFiZjc3MmJfNi03LTEtMS04MDg0Nw_b67cb8f2-0994-4a2e-b47e-ac6ebfd59e3d"
      unitRef="usd">13130000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:SharePrice
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODU2NDcz_a62c7555-4b5e-4403-a900-a0decb09de2d"
      unitRef="usdPerShare">25.03</us-gaap:SharePrice>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3e6a1bf96f13445c9ec8f1d1017b808f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjRjMjM4Y2Q2OGU5MjRiZmRhNWY2ZmU5MzM2YzUyNWU3L3RhYmxlcmFuZ2U6NGMyMzhjZDY4ZTkyNGJmZGE1ZjZmZTkzMzZjNTI1ZTdfMi0xLTEtMS01NzA3Mw_d079ad6e-b73c-4cf0-be56-cabd669e7ef0"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i8ddcffccfdaa4e738249bb0f26ff8fd0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjRjMjM4Y2Q2OGU5MjRiZmRhNWY2ZmU5MzM2YzUyNWU3L3RhYmxlcmFuZ2U6NGMyMzhjZDY4ZTkyNGJmZGE1ZjZmZTkzMzZjNTI1ZTdfMi0zLTEtMS01NzA3Mw_2308e843-da0d-4b70-8bd9-00e78a25dda5"
      unitRef="usd">856876000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6d7b50a32ec649b6bd1731fb1173bcf9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjRjMjM4Y2Q2OGU5MjRiZmRhNWY2ZmU5MzM2YzUyNWU3L3RhYmxlcmFuZ2U6NGMyMzhjZDY4ZTkyNGJmZGE1ZjZmZTkzMzZjNTI1ZTdfMi01LTEtMS01NzA3Mw_d4ae14a9-5ab5-4dab-8eb9-02abd0912cb3"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic0fffd4237ac4587a0961b2f15478644_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjRjMjM4Y2Q2OGU5MjRiZmRhNWY2ZmU5MzM2YzUyNWU3L3RhYmxlcmFuZ2U6NGMyMzhjZDY4ZTkyNGJmZGE1ZjZmZTkzMzZjNTI1ZTdfMi03LTEtMS01NzA3Mw_5379b560-df27-41c2-a50b-e02f8535441a"
      unitRef="usd">856876000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjRjMjM4Y2Q2OGU5MjRiZmRhNWY2ZmU5MzM2YzUyNWU3L3RhYmxlcmFuZ2U6NGMyMzhjZDY4ZTkyNGJmZGE1ZjZmZTkzMzZjNTI1ZTdfMi05LTEtMS01NzA3Mw_11de9004-66c2-48a8-81f5-3faf0f440596"
      unitRef="usd">860438000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie5766c50c6d7461c835635f1c6343841_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdiOTA1YmM5YjNlYTRmMmM4NGM2YjE1YTVjZmEzZjg5L3RhYmxlcmFuZ2U6N2I5MDViYzliM2VhNGYyYzg0YzZiMTVhNWNmYTNmODlfMi0xLTEtMS01NzA3Mw_f3f6ecee-044f-4a5c-9b9b-b3811af3288b"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i7bb97ef0c9bf4fecbcdce0085a7cd336_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdiOTA1YmM5YjNlYTRmMmM4NGM2YjE1YTVjZmEzZjg5L3RhYmxlcmFuZ2U6N2I5MDViYzliM2VhNGYyYzg0YzZiMTVhNWNmYTNmODlfMi0zLTEtMS01NzA3Mw_e2716d1a-f98e-456e-9800-00a7ca83e517"
      unitRef="usd">843594000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i040b12c6fad641ae884cad957f2cfe40_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdiOTA1YmM5YjNlYTRmMmM4NGM2YjE1YTVjZmEzZjg5L3RhYmxlcmFuZ2U6N2I5MDViYzliM2VhNGYyYzg0YzZiMTVhNWNmYTNmODlfMi01LTEtMS01NzA3Mw_d9d736f4-cd8a-4222-93d4-4c52e823f040"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6d6937e646b24c1c851fae386ba9607f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdiOTA1YmM5YjNlYTRmMmM4NGM2YjE1YTVjZmEzZjg5L3RhYmxlcmFuZ2U6N2I5MDViYzliM2VhNGYyYzg0YzZiMTVhNWNmYTNmODlfMi03LTEtMS01NzA3Mw_6ee42494-7205-4e9f-b853-e025dcbc2d25"
      unitRef="usd">843594000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjdiOTA1YmM5YjNlYTRmMmM4NGM2YjE1YTVjZmEzZjg5L3RhYmxlcmFuZ2U6N2I5MDViYzliM2VhNGYyYzg0YzZiMTVhNWNmYTNmODlfMi05LTEtMS01NzA3Mw_7cf8e027-0634-4f40-85a2-28bfd0d2e063"
      unitRef="usd">864125000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LineOfCredit
      contextRef="i5ee8e2a0aedf4e16bfc1f00854be3504_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjQzNjQ_097f275a-4147-4081-a140-88fa280d0cf8"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i74aaf1e8f24d470db2a98ecc203f2374_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjQzNjQ_fa8c1588-64de-4109-9606-65fd9bb89e8b"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjQ1MTI_a2bf9b56-43b8-4ccd-8eea-26f49e2dc786"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjQ1MTI_b032d066-9449-488e-8b5b-488ec2c39277"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMTk_c0886962-9438-48c6-8be5-94706ee0c7fc">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNzE_9dcc4004-624a-4cac-a428-aeadad28bc63">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.584%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income  attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,303,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income per share attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,303,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add nonvested restricted stock subject only to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add additional shares issuable upon exercise of stock options and contingently issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares used in calculating diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,362,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value change for contingently issuable shares excluded from the computation of diluted per share amounts as its effect would be antidilutive&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested restricted stock subject to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingently issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023  we excluded all outstanding options, restricted stock awards and other requisite shares in the calculation of diluted earnings per share because their effect would be antidilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMi0xLTEtMS01NzA3Mw_a9faa0e4-972f-485d-8850-79c6c009c078"
      unitRef="usd">-21005000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMi0zLTEtMS01NzA3Mw_cb85e7ca-cbf5-487e-81b5-c5aaa3fc75f6"
      unitRef="usd">3013000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfNS0xLTEtMS01NzA3Mw_882f42d9-62e2-42b2-b720-2fd9a6de51c9"
      unitRef="shares">57701439</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfNS0zLTEtMS01NzA3Mw_efd42770-7080-4f29-bdb2-c60af3c9b773"
      unitRef="shares">55303007</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfNi0xLTEtMS01NzA3Mw_e9ce6493-045e-49f3-b5f5-b27b6b3feb16"
      unitRef="usdPerShare">-0.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfNi0zLTEtMS01NzA3Mw_e6f08b19-e5fa-4f75-9a9d-f5749c752a7b"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfOS0xLTEtMS01NzA3Mw_38e7b4c1-157b-4295-a325-dc23087aa171"
      unitRef="shares">57701439</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfOS0zLTEtMS01NzA3Mw_acda0f3f-9f68-49f2-86b7-1177afad695e"
      unitRef="shares">55303007</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTAtMS0xLTEtNTcwNzM_3449dc90-9c5f-4f1f-b279-5dd21114ffab"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTAtMy0xLTEtNTcwNzM_9319ad07-e08c-47bf-ae34-6dfc13c1ec0b"
      unitRef="shares">197911</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTEtMS0xLTEtNTcwNzM_9bbad6a3-9648-404c-975a-5329fd22a64c"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTEtMy0xLTEtNTcwNzM_be33a43a-41f5-42f4-b5cc-f396b014214e"
      unitRef="shares">861275</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTItMS0xLTEtNTcwNzM_0ef6828e-85f4-4fdf-ba4c-9c836aae4e4a"
      unitRef="shares">57701439</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTItMy0xLTEtNTcwNzM_d3672d54-c046-43cd-a6c8-4075b2a4ac09"
      unitRef="shares">56362193</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTMtMS0xLTEtNTcwNzM_29491451-dfb7-4c4f-9c87-b96a906c49be"
      unitRef="usdPerShare">-0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTMtMy0xLTEtNTcwNzM_4ad84d28-ae73-4cc2-ad2f-f906dfdf9f0f"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareDiluted>
    <rdnt:FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTUtMS0xLTEtODgxODg_9a7c7884-e38d-4842-b919-065a2fc2c8e8"
      unitRef="usd">769000</rdnt:FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted>
    <rdnt:FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTUtMy0xLTEtODgyMzI_e9d0f0c8-a731-4e41-b92e-9e8deb3934d3"
      unitRef="usd">0</rdnt:FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0f8b6f8b3773411ea71c13b60855758a_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTYtMS0xLTEtNTcwNzM_64f72dc9-6bf3-4f48-b964-8a5811dae4c7"
      unitRef="shares">594758</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic66c83d188f04d7dafa027910df93466_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTYtMy0xLTEtNTcwNzM_ece392aa-e738-4953-b4cc-4e5ac1c85d18"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id9fa9f6b4e3e40648840c75270131b86_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTctMS0xLTEtNTcwNzM_db3bde55-ea55-455b-8e51-f7d7fc7f122a"
      unitRef="shares">750075</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8091047fc1324ea98cd25d50961b4676_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTctMy0xLTEtNTcwNzM_d53b4d82-95a9-419f-acb5-da32c7634cdd"
      unitRef="shares">46912</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic18ea46b2e144ce8bb4730330b274ca4_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTgtMS0xLTEtODczMjk_9b7eb0e7-6eef-41c4-a08e-fe2d515e7fb0"
      unitRef="shares">273111</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2f64f3acfb1b4f8d905cf0d5b3f16ff6_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjU2ODkwZWEyY2YzNDQxMGE4OTAxZmEwY2E0YWQzYzEwL3RhYmxlcmFuZ2U6NTY4OTBlYTJjZjM0NDEwYTg5MDFmYTBjYTRhZDNjMTBfMTgtMy0xLTEtODczMzc_30543e12-7322-4a12-aee0-bd58a3f4bcd0"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwODg_22e72f2b-2ec7-4059-9134-ceedcac328b7">INVESTMENTS IN EQUITY SECURITIES&#x2013;Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income.</us-gaap:EquityMethodInvestmentsPolicy>
    <rdnt:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjU5NTQ_93130d09-3757-4c49-ad53-28b4f9a65e4f"
      unitRef="security">3</rdnt:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="iadfab3b66cc3465da1facc6280643211_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjYzMTY_ce9fecd6-50fd-44ed-b752-1bb08dc7340c"
      unitRef="usd">1200000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="iadfab3b66cc3465da1facc6280643211_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjYzMzM_e9f818f9-e50a-4bc6-b35a-27fdf26e999f"
      unitRef="number">0.1421</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <rdnt:EquityMethodInvestmentSharesPurchased
      contextRef="i7c812255b96e466a813bee1f44c493df_D20180201-20180201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODU4MjE4_595e62a6-7ba5-4e5b-97a5-07a3c3dd7ac2"
      unitRef="shares">2100000</rdnt:EquityMethodInvestmentSharesPurchased>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i7c812255b96e466a813bee1f44c493df_D20180201-20180201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODU4MjIy_c78275c9-e9fd-4ecb-8a7e-b0d3e74c738d"
      unitRef="usd">2000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ShortTermBorrowings
      contextRef="icff909ad5af946f582998f2b08a3332f_I20190101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODU4MjQy_1a73bab7-107d-4053-aca7-37761489f67c"
      unitRef="usd">100000</us-gaap:ShortTermBorrowings>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="i060d61245cc645109b4d1d8bb44ab6bf_I20191221"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfNTQ5NzU1ODU4MjYy_63785148-705e-4f56-a899-e3c9cfa496f7"
      unitRef="shares">80000</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ib78892651f964e84abae349ff967869b_D20191105-20191105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjcwMDA_0a30dc79-41cc-40ca-9dac-f48db35eab7b"
      unitRef="usd">1000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="ib78892651f964e84abae349ff967869b_D20191105-20191105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjcwMzE_e15af5d1-5310-400a-a818-0645ad7e841f"
      unitRef="usd">2500000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkxMDQ_b41e3fa7-70a0-49ab-b186-f98c78beb70f">INVESTMENT IN JOINT VENTURES &#x2013; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;Our investment in these joint ventures is accounted for under the equity method, since RadNet does not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of March&#160;31, 2023.</us-gaap:InvestmentPolicyTextBlock>
    <rdnt:NumberofUnconsolidatedJointVentures
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjcyMjQ_cae394fc-9f5a-4921-b13b-b69f01513cab"
      unitRef="jointventure">13</rdnt:NumberofUnconsolidatedJointVentures>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i976bed9367284ed1a85563a07d391884_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjcyOTU_aa9ce8fc-df2b-4385-bcb3-25334ebc63bf"
      unitRef="number">0.35</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i22cb4964ff984901bd7110c2d6eecce4_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjczMDE_358377c5-7db8-4c87-8615-8a4148a1a3dd"
      unitRef="number">0.55</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNjQ_d15dfb7b-060a-426b-91b1-5e2fe75dd22f">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our investment in joint ventures during the three months ended March 31, 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmRkM2Y4N2UzYmQ0ZjRmNzg5MmNlMjc3ZjNlYmExMjE1L3RhYmxlcmFuZ2U6ZGQzZjg3ZTNiZDRmNGY3ODkyY2UyNzdmM2ViYTEyMTVfMC0xLTEtMS01NzA3Mw_bd62b305-53da-4450-80d7-19dac528a83d"
      unitRef="usd">57893000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmRkM2Y4N2UzYmQ0ZjRmNzg5MmNlMjc3ZjNlYmExMjE1L3RhYmxlcmFuZ2U6ZGQzZjg3ZTNiZDRmNGY3ODkyY2UyNzdmM2ViYTEyMTVfMS0xLTEtMS01NzA3Mw_64fbf57e-0ee0-45e2-8a73-405c2a0654b2"
      unitRef="usd">1428000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmRkM2Y4N2UzYmQ0ZjRmNzg5MmNlMjc3ZjNlYmExMjE1L3RhYmxlcmFuZ2U6ZGQzZjg3ZTNiZDRmNGY3ODkyY2UyNzdmM2ViYTEyMTVfNy0xLTEtMS01NzA3Mw_4b5922c4-07b8-4fc3-affc-6234defa3485"
      unitRef="usd">59321000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <rdnt:ManagementServiceFees
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjg4MzE_b86b1b59-5b1c-48d1-8703-1f6d7c058a11"
      unitRef="usd">4200000</rdnt:ManagementServiceFees>
    <rdnt:ManagementServiceFees
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjg4Mzg_ef820130-6aca-4d0f-97ea-49ef929f6562"
      unitRef="usd">5500000</rdnt:ManagementServiceFees>
    <rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RleHRyZWdpb246YjNhZjI4MWU1OTBlNDk1ZTkzMjMxNjVlYjFhODBmYWFfMjkwNjM_9126db1a-cbc6-4819-bf94-31298980f362">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of key balance sheet data for these joint ventures as of March&#160;31, 2023 and December&#160;31, 2022 and income statement data for the three months ended March 31, 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost in excess of book value of acquired joint venture interests and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income statement data for the three months ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock>
    <us-gaap:AssetsCurrent
      contextRef="i97bd8c7f570042a88fd03a8a7dca61be_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfMS0xLTEtMS01NzA3Mw_125bbcc0-9852-4849-949f-a5c14544431c"
      unitRef="usd">49091000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0a7007c50a3b4e91aede5d39ed591d0d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfMS0zLTEtMS01NzA3Mw_06eea465-7e01-4877-b0ca-1b79924fe799"
      unitRef="usd">39304000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i97bd8c7f570042a88fd03a8a7dca61be_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfMi0xLTEtMS01NzA3Mw_4f99c516-6634-4950-86aa-f8cf6c6f8e20"
      unitRef="usd">142144000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i0a7007c50a3b4e91aede5d39ed591d0d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfMi0zLTEtMS01NzA3Mw_b7dcedaa-41de-42f6-a976-d803df470c12"
      unitRef="usd">134694000</us-gaap:AssetsNoncurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i97bd8c7f570042a88fd03a8a7dca61be_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfMy0xLTEtMS01NzA3Mw_32e93139-d6e2-41e3-a301-0846a89fd767"
      unitRef="usd">32995000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0a7007c50a3b4e91aede5d39ed591d0d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfMy0zLTEtMS01NzA3Mw_8a8db139-4678-4a86-a2f4-42668adc1f1a"
      unitRef="usd">29588000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i97bd8c7f570042a88fd03a8a7dca61be_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfNC0xLTEtMS01NzA3Mw_616da740-1bd4-4d08-9572-59de32fa1c90"
      unitRef="usd">48872000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i0a7007c50a3b4e91aede5d39ed591d0d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfNC0zLTEtMS01NzA3Mw_3fe6bc4c-040c-4ec6-98dd-f315060d22e6"
      unitRef="usd">37952000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="i9ec59367bdfc4e95acaca6780a70c7b4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfNS0xLTEtMS01NzA3Mw_299351b8-0d60-4ca1-a500-8b0bb3c7518c"
      unitRef="usd">109368000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="iafd6cdf3d5ab422fae40a0ba5aedb8eb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfNS0zLTEtMS01NzA3Mw_e6aaae2e-885b-4525-b2ab-15612198ed1a"
      unitRef="usd">106458000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestments
      contextRef="i9ec59367bdfc4e95acaca6780a70c7b4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfNy0xLTEtMS01NzA3Mw_d38590fb-2c72-414f-8725-d64c30e9bfde"
      unitRef="usd">50754000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="iafd6cdf3d5ab422fae40a0ba5aedb8eb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfNy0zLTEtMS01NzA3Mw_1e5ad868-bbd5-4be9-8d45-643fcafd5091"
      unitRef="usd">49564000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets
      contextRef="i9ec59367bdfc4e95acaca6780a70c7b4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfOC0xLTEtMS01NzA3Mw_12c7f235-13df-49b2-aa08-ff02a8f0f6bd"
      unitRef="usd">8567000</us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets>
    <us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets
      contextRef="iafd6cdf3d5ab422fae40a0ba5aedb8eb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfOC0zLTEtMS01NzA3Mw_c62c4900-7f40-47dc-b483-85489b8c7a9a"
      unitRef="usd">8329000</us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i9ec59367bdfc4e95acaca6780a70c7b4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfOS0xLTEtMS01NzA3Mw_cdf28c4e-eb59-4274-99b5-311d44c7e51c"
      unitRef="usd">59321000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="iafd6cdf3d5ab422fae40a0ba5aedb8eb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOjYwNDFmZGNlZDFkMjQ5MWM5NTRjZGM5NTJiNTI0OGI2L3RhYmxlcmFuZ2U6NjA0MWZkY2VkMWQyNDkxYzk1NGNkYzk1MmI1MjQ4YjZfOS0zLTEtMS01NzA3Mw_42b8c7fd-beda-4658-81ab-795325c1cc8c"
      unitRef="usd">57893000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:Revenues
      contextRef="i370e4f75f34c4628af09b09b3f73bf92_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmMzNTZmMjk5Y2NjOTQyZWJhMjhkZGY5ZDY2Y2JjODljL3RhYmxlcmFuZ2U6YzM1NmYyOTljY2M5NDJlYmEyOGRkZjlkNjZjYmM4OWNfMS0xLTEtMS01NzA3Mw_36328d30-798a-41bc-a914-9a89f0bcb304"
      unitRef="usd">42086000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie0a61645bc4e4f3e9911510a2c98ef50_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmMzNTZmMjk5Y2NjOTQyZWJhMjhkZGY5ZDY2Y2JjODljL3RhYmxlcmFuZ2U6YzM1NmYyOTljY2M5NDJlYmEyOGRkZjlkNjZjYmM4OWNfMS0zLTEtMS01NzA3Mw_a679a288-3676-49b3-b006-e8bbef7da02f"
      unitRef="usd">34411000</us-gaap:Revenues>
    <us-gaap:ProfitLoss
      contextRef="i370e4f75f34c4628af09b09b3f73bf92_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmMzNTZmMjk5Y2NjOTQyZWJhMjhkZGY5ZDY2Y2JjODljL3RhYmxlcmFuZ2U6YzM1NmYyOTljY2M5NDJlYmEyOGRkZjlkNjZjYmM4OWNfMi0xLTEtMS01NzA3Mw_a0a1be58-b94a-42f0-9d56-4503f5e8bdaf"
      unitRef="usd">2909000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie0a61645bc4e4f3e9911510a2c98ef50_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80MC9mcmFnOmIzYWYyODFlNTkwZTQ5NWU5MzIzMTY1ZWIxYTgwZmFhL3RhYmxlOmMzNTZmMjk5Y2NjOTQyZWJhMjhkZGY5ZDY2Y2JjODljL3RhYmxlcmFuZ2U6YzM1NmYyOTljY2M5NDJlYmEyOGRkZjlkNjZjYmM4OWNfMi0zLTEtMS01NzA3Mw_72749eb4-7c5f-4cf0-ad73-63aac9ca9f56"
      unitRef="usd">5035000</us-gaap:ProfitLoss>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80My9mcmFnOmNlMDI2OTEwYTZiZjRmYWE4ZGM3NjhjMWM2YWIwMjlkL3RleHRyZWdpb246Y2UwMjY5MTBhNmJmNGZhYThkYzc2OGMxYzZhYjAyOWRfMjcyNw_6dbf0f81-2919-4519-8d0a-4955afd33083">RECENT ACCOUNTING AND REPORTING STANDARDS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We monitor new accounting pronouncements issued by the FASB and do not believe any accounting pronouncements issued through the date of this report will have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80My9mcmFnOmNlMDI2OTEwYTZiZjRmYWE4ZGM3NjhjMWM2YWIwMjlkL3RleHRyZWdpb246Y2UwMjY5MTBhNmJmNGZhYThkYzc2OGMxYzZhYjAyOWRfMjcyNg_1a614777-17fa-455c-aee4-a6ddb9a2a5b1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We monitor new accounting pronouncements issued by the FASB and do not believe any accounting pronouncements issued through the date of this report will have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RleHRyZWdpb246NWQ1YzBlNDQyMDU3NGFjMTkwYTZmODAzMTJhNThkMGZfMzY0NA_4971f8a2-c1ba-4a5e-9b6b-4587bd0313ef">BUSINESS COMBINATIONS AND RELATED ACTIVITY&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Imaging Center Segment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2023, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the California and New York markets.  These acquisitions are reported as part of our Imaging Center segment.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.678%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.286%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C.C.D.G.L.R. &amp;amp; S Services Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,689&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,689)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Southern California Diagnostic Imaging, Inc. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inglewood Imaging Center, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,600&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,188&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,658&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,188)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ramapo Radiology Associates, P.C.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,915&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,441&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,836&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,174&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;250&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,836)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RleHRyZWdpb246NWQ1YzBlNDQyMDU3NGFjMTkwYTZmODAzMTJhNThkMGZfMzY0Nw_c428affe-e7e8-4328-b6dc-af33732db2d2">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.678%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.286%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C.C.D.G.L.R. &amp;amp; S Services Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,689&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,689)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Southern California Diagnostic Imaging, Inc. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inglewood Imaging Center, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,600&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,188&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,658&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,188)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ramapo Radiology Associates, P.C.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,915&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,441&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,836&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,174&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;250&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,836)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i788654bdc6144e84b022463f3c939653_I20230101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMS0yLTEtMS01NzA3Mw_c75ea00e-887b-434c-8b66-3115e9206407"
      unitRef="usd">3500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i788654bdc6144e84b022463f3c939653_I20230101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMS0zLTEtMS01NzA3Mw_4501f442-2e80-4dd7-a389-dc847c0d04b1"
      unitRef="usd">435000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i788654bdc6144e84b022463f3c939653_I20230101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMS00LTEtMS01NzA3Mw_902f680a-b9e4-4fe0-ac7e-4ecca83725e9"
      unitRef="usd">1689000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i788654bdc6144e84b022463f3c939653_I20230101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMS01LTEtMS01NzA3Mw_26fac19d-9ea9-44a7-82fb-1bba5d5b3645"
      unitRef="usd">3015000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i788654bdc6144e84b022463f3c939653_I20230101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMS02LTEtMS01NzA3Mw_7da56d30-f689-4040-893d-237d5164aa93"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i788654bdc6144e84b022463f3c939653_I20230101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMS03LTEtMS01NzA3Mw_8f0c24e8-639b-4e18-b800-1e1b26b8c9df"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i788654bdc6144e84b022463f3c939653_I20230101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMS04LTEtMS01NzA3Mw_d4fc0470-ccc3-4c80-9e2b-afd68fbd6281"
      unitRef="usd">1689000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="idf90602139824e3f84f725fcb7a55b86_I20230101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi0yLTEtMS04MjExNg_76fa2022-92e7-48e1-9e01-1f36495074c0"
      unitRef="usd">1815000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="idf90602139824e3f84f725fcb7a55b86_I20230101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi0zLTEtMS04MjExNg_2018a461-b293-414a-8a77-83d2c97fc029"
      unitRef="usd">466000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="idf90602139824e3f84f725fcb7a55b86_I20230101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi00LTEtMS04MjExNg_f10ec512-69a9-4f62-bc58-022ea9573885"
      unitRef="usd">1184000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="idf90602139824e3f84f725fcb7a55b86_I20230101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi01LTEtMS04MjExNg_00b50735-6526-4960-88b9-8ef487d81393"
      unitRef="usd">1272000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="idf90602139824e3f84f725fcb7a55b86_I20230101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi02LTEtMS04MjExNg_2706fbdc-e580-4ff4-9139-21f659fccf92"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="idf90602139824e3f84f725fcb7a55b86_I20230101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi03LTEtMS04MjExNg_89d06bb5-555b-44e2-a99d-0bd353a1b079"
      unitRef="usd">27000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="idf90602139824e3f84f725fcb7a55b86_I20230101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi04LTEtMS04MjExNg_19eb9f06-50d8-4034-bda3-10881562631d"
      unitRef="usd">1184000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="iaf3a349f994e4b7c8b647f364de53930_I20230201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi0yLTEtMS01NzA3Mw_3f1bf62b-a199-48da-b6c2-bda430fe6b83"
      unitRef="usd">2600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="iaf3a349f994e4b7c8b647f364de53930_I20230201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi0zLTEtMS01NzA3Mw_f95302f9-2b4d-4325-bc0e-d6ea2c4e00df"
      unitRef="usd">877000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="iaf3a349f994e4b7c8b647f364de53930_I20230201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi00LTEtMS01NzA3Mw_dd942e78-9dfb-4ec8-86c9-d41f93b3b13a"
      unitRef="usd">1188000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="iaf3a349f994e4b7c8b647f364de53930_I20230201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi01LTEtMS01NzA3Mw_0ddab062-5efe-4df3-bae0-4d9bf23e513d"
      unitRef="usd">1658000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="iaf3a349f994e4b7c8b647f364de53930_I20230201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi02LTEtMS01NzA3Mw_f625fe66-069b-4a5c-b4cc-c2841a80fc2c"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="iaf3a349f994e4b7c8b647f364de53930_I20230201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi03LTEtMS01NzA3Mw_631caf65-b8ee-4944-8b9f-da0e2b0ecd7d"
      unitRef="usd">15000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="iaf3a349f994e4b7c8b647f364de53930_I20230201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMi04LTEtMS01NzA3Mw_b39423c9-5974-4362-b53d-8ad0c6431aa1"
      unitRef="usd">1188000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="if677eedf1e8441f48af5d0ec930fda69_I20230201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfNC0yLTEtMS04MjEzMw_8de7d36e-06ff-4e55-ba87-9e30c36fc8d9"
      unitRef="usd">2000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="if677eedf1e8441f48af5d0ec930fda69_I20230201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfNC0zLTEtMS04MjEzMw_80307b71-17dc-45a6-8482-fe6f4f61aa7a"
      unitRef="usd">1663000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="if677eedf1e8441f48af5d0ec930fda69_I20230201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfNC00LTEtMS04MjEzMw_88ec6329-b14d-48f4-952d-3d878320c4de"
      unitRef="usd">3775000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="if677eedf1e8441f48af5d0ec930fda69_I20230201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfNC01LTEtMS04MjEzMw_afccfb76-63f0-445a-a7ce-a95482e4611c"
      unitRef="usd">229000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="if677eedf1e8441f48af5d0ec930fda69_I20230201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfNC02LTEtMS04MjEzMw_00681db9-47cf-4f3e-9c83-b74a04b97fef"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="if677eedf1e8441f48af5d0ec930fda69_I20230201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfNC03LTEtMS04MjEzMw_77aa9743-62ac-4e95-a105-abfaa12fb41f"
      unitRef="usd">8000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="if677eedf1e8441f48af5d0ec930fda69_I20230201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfNC04LTEtMS04MjEzMw_48027b5e-ca3c-49d1-8395-e2a9d8d0416f"
      unitRef="usd">3775000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ibd669e75c1d64607a8a4a42d825b5372_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMy0yLTEtMS01NzA3Mw_0d106d97-ce99-45d8-b730-10f33c081aaf"
      unitRef="usd">9915000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ibd669e75c1d64607a8a4a42d825b5372_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMy0zLTEtMS01NzA3Mw_9ca4dae6-616a-4bf5-85c6-d4f9b9989a06"
      unitRef="usd">3441000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="ibd669e75c1d64607a8a4a42d825b5372_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMy00LTEtMS01NzA3Mw_9fbee11b-6abc-4c28-ac5f-aa923a08f12b"
      unitRef="usd">7836000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ibd669e75c1d64607a8a4a42d825b5372_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMy01LTEtMS01NzA3Mw_cf39cfc6-0040-49c8-a499-c8995053b12f"
      unitRef="usd">6174000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ibd669e75c1d64607a8a4a42d825b5372_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMy02LTEtMS01NzA3Mw_541bead3-49aa-49b7-a051-2cb5b1641c97"
      unitRef="usd">250000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="ibd669e75c1d64607a8a4a42d825b5372_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMy03LTEtMS01NzA3Mw_7343d327-2cd8-41c3-a2f9-aff93ae36e0c"
      unitRef="usd">50000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="ibd669e75c1d64607a8a4a42d825b5372_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80Ni9mcmFnOjVkNWMwZTQ0MjA1NzRhYzE5MGE2ZjgwMzEyYTU4ZDBmL3RhYmxlOjM4ODVlMWQ1MjNhZDRmY2FiMWI2NTdjZTk4NDY5OTFlL3RhYmxlcmFuZ2U6Mzg4NWUxZDUyM2FkNGZjYWIxYjY1N2NlOTg0Njk5MWVfMy04LTEtMS01NzA3Mw_d2153471-f6ce-4822-b64b-8bfc2d7c8d70"
      unitRef="usd">7836000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RleHRyZWdpb246OWIyMzQ5YmVjNTJmNGFmNjk4YTc5ZDgwMmVlZDQ0NmJfMTkzNw_f0eb28a8-91c2-404b-a636-f6591eb7504a">SEGMENT REPORTING&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our reportable segments are described below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Imaging Center&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a strategy that diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  Included in the segment is our eRad subsidiary, which designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Artificial Intelligence ("AI")&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our chief operating decision maker ("CODM"), who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit and loss statements prepared on a basis not consistent with GAAP.  We do not report balance sheet information by segment since it is not reviewed by our CODM.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The table below presents segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.103%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;388,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;341,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;390,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;341,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Cost of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;344,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;310,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total cost of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;351,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;315,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Depreciation and Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;29,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;25,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;31,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;27,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Loss on Disposal of Equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total loss on disposal of equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total severance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;&#160;Income (Loss) from Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,890)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(5,617)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,719)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RleHRyZWdpb246OWIyMzQ5YmVjNTJmNGFmNjk4YTc5ZDgwMmVlZDQ0NmJfMTkzNg_476b00ed-4c0d-4175-aad4-e03059034681">The table below presents segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.103%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;388,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;341,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;390,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;341,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Cost of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;344,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;310,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total cost of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;351,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;315,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Depreciation and Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;29,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;25,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;31,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;27,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Loss on Disposal of Equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total loss on disposal of equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total severance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;&#160;Income (Loss) from Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,890)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(5,617)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,719)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMy0xLTEtMS01NzA3Mw_39186d0e-ed4f-48c5-aa3b-50ff08469443"
      unitRef="usd">388431000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0df0cc0c59df4b2f96629acaa138268c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMy0zLTEtMS01NzA3Mw_d155283b-8365-4212-b50a-cbbbebd76eb9"
      unitRef="usd">341168000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2afa7782c90e43af8a9291b388ae0a30_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfNC0xLTEtMS01NzA3Mw_9516d27f-9afb-49d5-b855-87066a046b15"
      unitRef="usd">2133000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id46e5c5dde784886904adce4e0b992aa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfNC0zLTEtMS01NzA3Mw_bf320fb0-e832-40ec-8163-bff4e87d3af3"
      unitRef="usd">599000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfNS0xLTEtMS01NzA3Mw_eb23c5af-9b73-40fc-8830-814c27af3f9e"
      unitRef="usd">390564000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfNS0zLTEtMS01NzA3Mw_ba73d841-56fd-47df-86de-116681f45996"
      unitRef="usd">341767000</us-gaap:Revenues>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfOC0xLTEtMS01NzA3Mw_c1d339b5-abb7-4997-ba16-098e7d78c98b"
      unitRef="usd">344580000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i0df0cc0c59df4b2f96629acaa138268c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfOC0zLTEtMS01NzA3Mw_4ad255de-1917-4a5a-b56f-a01880b9a8ca"
      unitRef="usd">310110000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i2afa7782c90e43af8a9291b388ae0a30_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfOS0xLTEtMS01NzA3Mw_1d6165e7-c3e6-4100-bc78-28163b29a0a2"
      unitRef="usd">7285000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="id46e5c5dde784886904adce4e0b992aa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfOS0zLTEtMS01NzA3Mw_8b95de97-9bce-4d58-985a-abf1ac6bd53d"
      unitRef="usd">4929000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTAtMS0xLTEtNTcwNzM_a90ce823-8ff6-4943-896d-a17b0bef7a94"
      unitRef="usd">351865000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTAtMy0xLTEtNTcwNzM_13caebae-4e22-4e98-8537-8de6eb5ea16f"
      unitRef="usd">315039000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTMtMS0xLTEtNTcwNzM_9514653e-dde6-45a9-894f-68380459d87e"
      unitRef="usd">29591000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0df0cc0c59df4b2f96629acaa138268c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTMtMy0xLTEtNTcwNzM_cb411d05-91e9-49f6-864c-d5d54a194ae6"
      unitRef="usd">25805000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2afa7782c90e43af8a9291b388ae0a30_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTQtMS0xLTEtNTcwNzM_4ebc247a-b817-46c4-ba9f-4f4721cb0627"
      unitRef="usd">1724000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id46e5c5dde784886904adce4e0b992aa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTQtMy0xLTEtNTcwNzM_f06f1b39-ef2d-4e34-a158-b6614a156d18"
      unitRef="usd">1313000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTUtMS0xLTEtNTcwNzM_f09122f8-d041-435b-8c51-561ce8f82ca4"
      unitRef="usd">31315000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTUtMy0xLTEtNTcwNzM_8b85cacd-f79f-49cd-bbc0-e09a19a02d2e"
      unitRef="usd">27118000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTgtMS0xLTEtNTcwNzM_2cf98561-cb0c-4667-9c31-a436b4c33c29"
      unitRef="usd">-577000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i0df0cc0c59df4b2f96629acaa138268c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTgtMy0xLTEtNTcwNzM_d2b7097e-12f1-4220-8d0a-79566d5f7e47"
      unitRef="usd">-1154000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i2afa7782c90e43af8a9291b388ae0a30_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTktMS0xLTEtNTcwNzM_4a4c5aa4-5706-4ccd-9739-9602a36c687c"
      unitRef="usd">-2000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="id46e5c5dde784886904adce4e0b992aa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMTktMy0xLTEtNTcwNzM_3f7a5035-7cff-460d-a76a-952391e0b169"
      unitRef="usd">26000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjAtMS0xLTEtNTcwNzM_3a2e277e-c039-4af0-add1-94fb9075901d"
      unitRef="usd">-579000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjAtMy0xLTEtNTcwNzM_bc010214-ea48-441f-8237-368101186f20"
      unitRef="usd">-1128000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:SeveranceCosts1
      contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjMtMS0xLTEtNTcwNzM_59c46b8b-4bad-4b82-8fe9-2bdaeeef10d6"
      unitRef="usd">122000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i0df0cc0c59df4b2f96629acaa138268c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjMtMy0xLTEtNTcwNzM_52ee0597-cba7-4df8-9dff-c70f03d03c18"
      unitRef="usd">201000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i2afa7782c90e43af8a9291b388ae0a30_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjQtMS0xLTEtNTcwNzM_32153614-713d-4cb2-ab3d-3ff23bac44b4"
      unitRef="usd">12000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="id46e5c5dde784886904adce4e0b992aa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjQtMy0xLTEtNTcwNzM_2dfc4c93-2300-4ba1-bca7-a8433d634ce6"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjUtMS0xLTEtNTcwNzM_56d05b7f-ccdf-4b51-bc90-5e469b6f806f"
      unitRef="usd">134000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjUtMy0xLTEtNTcwNzM_753170f5-cdcc-44c7-b981-6594131df15e"
      unitRef="usd">201000</us-gaap:SeveranceCosts1>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="i13c7509db64a4b76a1499e8339156036_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjgtMS0xLTEtNTcwNzM_9120541e-d3a8-46e6-8e86-54235e4ec44b"
      unitRef="usd">13561000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="i0df0cc0c59df4b2f96629acaa138268c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjgtMy0xLTEtNTcwNzM_d69f217c-8ccf-4bdb-a352-30ba2daf2ada"
      unitRef="usd">3898000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="i2afa7782c90e43af8a9291b388ae0a30_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjktMS0xLTEtNTcwNzM_d47fd23c-6b04-4db2-9fdc-21e3dc944ccc"
      unitRef="usd">-6890000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="id46e5c5dde784886904adce4e0b992aa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMjktMy0xLTEtNTcwNzM_45c2b1a6-7dcb-4c7d-acd0-c82df721485d"
      unitRef="usd">-5617000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMzAtMS0xLTEtNTcwNzM_02718a3b-5c87-494d-8714-5c1604ab02db"
      unitRef="usd">6671000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="i5646ca82fa5f4bc2b8fc534476ed4bed_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV80OS9mcmFnOjliMjM0OWJlYzUyZjRhZjY5OGE3OWQ4MDJlZWQ0NDZiL3RhYmxlOmZjMTJiZWM0MmQzYTRmOGU5YzI0ZmIzOThhMjg5ZDkzL3RhYmxlcmFuZ2U6ZmMxMmJlYzQyZDNhNGY4ZTljMjRmYjM5OGEyODlkOTNfMzAtMy0xLTEtNTcwNzM_c0e4e659-07bc-44b7-9f16-6fc82a9fe420"
      unitRef="usd">-1719000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfODE0NQ_708ab15b-cebe-45f4-8bf3-45d909ec7aab">CREDIT FACILITIES AND NOTES PAYABLE&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 and December&#160;31, 2022 our term loan debt and other obligations are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="12" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans collateralized by RadNet's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement collateralized by NJIN's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on NJIN Term Loan Agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment notes payable at 6.0%, due 2028, collateralized by medical equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term portion debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no outstanding balance under our $195.0 million Barclays Revolving Credit Facility at March&#160;31, 2023 and have reserved $7.6 million for certain letters of credit. The remaining $187.4 million of our Barclays Revolving Credit Facility was available to draw upon as of March&#160;31, 2023.  We also had no balance under our $50.0 million Truist Revolving Credit Facility related to our consolidated subsidiary NJIN at March&#160;31, 2023, and with no letters of credit reserved against the facility, the full amount was available to draw upon.  At March&#160;31, 2023, we were in compliance with all covenants under our credit facilities.  On February 1, 2023, we issued a promissory note in the amount of $19.8 million to acquire radiology equipment previously leased under operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Amendments to Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays: First Amendment to Second Amended and Restated First Lien Credit and Guaranty Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2023, we entered into the First Amendment to Second Amended and Restated First Lien Credit and Guaranty Agreement (the &#x201c;Amendment&#x201d;). The Amendment replaces the interest rate benchmark, from the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;) to the Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;) and includes applicable credit spread adjustments of 0.11448%, 0.26161%, and 0.42826% for interest periods of one month, three months, and six months, respectively. The replacement of LIBOR with SOFR and the credit spread adjustments shall be effective as of March 31, 2023, which is the last day of the last-ending existing interest period of currently outstanding loans bearing interest at LIBOR. Other than the foregoing, the material terms of the Credit Agreement remain unchanged.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays: Second Amended and Restated First Lien Credit and Guaranty Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 23, 2021, we entered into the Second Amended and Restated First Lien Credit and Guaranty Agreement (the  "Restated Credit Agreement") which provides for $725.0 million of senior secured first lien term loans (the "First Lien Term Loans") and a $195.0 million senior secured revolving credit facility (the "Barclays Revolving Credit Facility"). The proceeds of the First Lien Term Loans were used to refinance loans outstanding under our prior first lien credit agreement and provide funding for current and future operations. Total costs of the Restated Credit Agreement amounted to approximately $14.9 million segregated as follows: $8.8 million capitalized to discount and deferred finance cost, $4.5 million expensed to debt restructuring costs, $1.5 million charged to loss on early extinguishment of debt and $0.1 million written off to interest expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Truist: Second Amended and Restated Revolving Credit and Term Loan Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 7, 2022, we entered into the Second Amended and Restated Revolving Credit and Term Loan Agreement (the "Restated Credit and Term Loan Agreement") which provides for a $150.0 million of a secured term loan (the "Truist Term Loan") and a $50.0 million secured revolving credit facility (the "Truist Revolving Credit Facility").  Both loans were secured by our simultaneous entry into the Second Amended and Restated Guaranty and Security Agreement on the same date.  The proceeds were were used to refinance the outstanding balance under our prior term loan agreement and provide funding for current and future operations. Total costs of the Restated Credit and Term Loan Agreement amounted to approximately $2.7 million segregated as follows: $2.0 million capitalized to discount and deferred finance cost and $0.7 million expensed to loss &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on extinguishment of debt and related expenses in other expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit and Term Loan Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All obligations under the Second Amended and Restated Credit and Term Loan Agreement bear interest at either a SOFR or a Base Rate (each as defined in the Restated Credit and Term Loan Agreement), plus an applicable margin according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pricing Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Letter of Credit Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Percentage for Commitment Fee&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 3.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.45%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 3.00:1.00 but greater than or equal to 2.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.50:1.00 but greater than or equal to&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.00:1.00 but greater than or equal to 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;V&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Senior Secured Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline"&gt;First Lien Term Loans:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through March 31, 2023, the First Lien Term Loans under the Restated Credit Agreement bore interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement), plus an applicable margin.  The applicable margin for Eurodollar Rate and Alternate Base Rate First Lien Term Loans under the Restated Credit Agreement was 3.00% and 2.00%, respectively, with an effective Eurodollar Rate and the Alternate Base Rate of 4.63% and 8.00%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Amendment, effective March 31, 2023, the First Lien Term Loans under the Restated Credit Agreement will bear interest either at a SOFR or an Alternate Base Rate (in each case, as defined in the Amendment) plus an applicable margin.  The applicable margin for the SOFR and Alternate Base Rate First Lien Term Loans under the Amendment is 3.00% and 2.00%, respectively.  At March 31, 2023, we have an effective SOFR of 7.81% ,with an applicable credit spread adjustment of 0.11448%, and an Alternate Base Rate of 10%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Credit Agreement provides for quarterly payments of principal for the First Lien Term Loan in the amount of approximately $1.8 million.  The  First Lien Term Loan will mature on April 23, 2028 unless otherwise accelerated under the terms of the Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Truist Term Loan:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Truist Term Loan currently bears interest at a three month SOFR election of 4.69% plus an applicable margin and fees based on Pricing Level III described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The scheduled amortization of the Truist Term Loan begins March 31, 2023 with quarterly payments of $1.9 million, representing 1.00% of the original principal balance. At scheduled intervals, the quarterly amortization increases by $0.9 million, with the remaining balance to be paid at maturity.  The Truist Term Loan will mature on October 10, 2027 unless otherwise accelerated under the terms of the  Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Revolving Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Associated with both the Barclays and Truist Revolving Credit Facilities are deferred financing costs, net of accumulated amortization, of $2.1 million at March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays Revolving Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Barclays Revolving Credit Facility under the Restated Credit Agreement is a $195.0 million senior secured revolving credit facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a SOFR or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.342%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;First Lien Net Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Term SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Alternate Base Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.00x but &#x2264; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2264; 3.00x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the effective interest rate payable on revolving loans under the Barclays Revolving Credit Facility was 5.25%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for Eurodollar rate revolving loans which is currently 2.75% and fronting fees accrue at 0.125% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the Restated Credit Agreement. In addition, a commitment fee of 0.50% per annum accrues on the unused revolver commitments under the Barclays Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Barclays Revolving Credit Facility will terminate on April 23, 2026 unless otherwise accelerated in accordance with the terms of the Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Truist Revolving Credit Facility:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Associated with the Truist Revolving Credit Facility of $50.0 million are deferred financing costs, net of accumulated amortization, of  $0.6 million at March&#160;31, 2023.  As of March&#160;31, 2023, NJIN had no borrowings under the Truist Revolving Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Truist Revolving Credit Facility bears interest with different margins based on types of borrowings at a Pricing Level III as noted in the pricing grid above.  The Truist Revolving Credit Facility terminates on the earliest of (i) October 7, 2027, (ii) the date on which the Revolving Commitments are terminated pursuant to Section 2.8 of the Truist Restated Credit Agreement, or (iii) the date on which all amounts outstanding under the Truist Restated Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Recent prior amendments to prior credit facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline"&gt;Truist Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On August 31, 2018, under the Amended and Restated Revolving Credit and Term Loan Agreement, NJIN secured a term loan commitment of $60.0 million and established revolving credit facility of $30.0 million.  The agreement had a maturity date of August 31, 2023 and was refinanced on October 10, 2022 by the Second Amended and Restated Revolving Credit and Term Loan Agreement.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfODE0Ng_b21ed4e5-7710-4c7c-8a23-4f6f8134fc03">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 and December&#160;31, 2022 our term loan debt and other obligations are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="12" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans collateralized by RadNet's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement collateralized by NJIN's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on NJIN Term Loan Agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment notes payable at 6.0%, due 2028, collateralized by medical equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term portion debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i9ac0a47d40fa44da84be66fbe8b675c2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfMi0xLTEtMS01NzA3Mw_e2d9eb79-0ba3-4fa0-b03a-dd16b73af35f"
      unitRef="usd">712313000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if935da71de9445f7a64decc4aa12e4d7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfMi0zLTEtMS01NzA3Mw_52939de4-ab53-4a43-991d-eb14975c85f5"
      unitRef="usd">714125000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i9ac0a47d40fa44da84be66fbe8b675c2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfMy0xLTEtMS01NzA3Mw_a6bdcb91-95e0-4946-ad29-b467b06f4fb4"
      unitRef="usd">10606000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="if935da71de9445f7a64decc4aa12e4d7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfMy0zLTEtMS01NzA3Mw_70e43cb6-da40-4e16-a9ea-0bcdad1515e6"
      unitRef="usd">11127000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="if2ee49b2f311482e92604c71016505c9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfNC0xLTEtMS01NzA3Mw_f95b24ff-3c67-4b5e-8ca4-df00508a1469"
      unitRef="usd">148125000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3c3b439894a24feb9d3346baa502e442_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfNC0zLTEtMS01NzA3Mw_35456db9-7626-4936-9411-b8189e1dc213"
      unitRef="usd">150000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="if2ee49b2f311482e92604c71016505c9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfNS0xLTEtMS04MTY1OA_b995ecc5-4c68-4f4b-afbe-e3dd3f6ed361"
      unitRef="usd">1188000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i3c3b439894a24feb9d3346baa502e442_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfNS0zLTEtMS04MTY2Ng_b26a62be-1c72-44c1-847b-90f24db98174"
      unitRef="usd">1254000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i62f2d5d6e38947cebfe0535e07397150_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfNy0wLTEtMS01NzA3My90ZXh0cmVnaW9uOjc1MDA0NmQ2MjQ4ZDQ0MDU5MDExYTA4Y2EzYmFlMDNiXzE2NDkyNjc0NDE3NTg_705f69c6-27d0-4e83-83da-56638adc0806"
      unitRef="number">0.060</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i62f2d5d6e38947cebfe0535e07397150_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfNy0xLTEtMS04MTY3NA_1bbf9029-074e-45cd-92c2-64404348cc9c"
      unitRef="usd">19645000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6ec02cff0bb7403d93c06ed1115db776_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfNy0zLTEtMS04MTY3NA_9de01fff-09e1-408f-955b-2c2c3f6c0106"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfOC0xLTEtMS01NzA3Mw_2c93b2cb-5f9d-41c5-a5a2-3f5531040ee7"
      unitRef="usd">868289000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfOC0zLTEtMS01NzA3Mw_bb247c59-ecef-4f4b-beea-8d721eda1453"
      unitRef="usd">851744000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfOS0xLTEtMS01NzA3Mw_fb7faa46-8ac3-4888-9568-687c762a1332"
      unitRef="usd">15935000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfOS0zLTEtMS01NzA3Mw_51548384-3c6e-422a-86b5-73e0983dfa0d"
      unitRef="usd">12400000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfMTAtMS0xLTEtNTcwNzM_31fd693c-6529-4c3d-8d21-e22128b21130"
      unitRef="usd">852354000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjI5YTFiMzg4ZDdhNDRlZGI5MzFmYjg4NGJjMTgyOTE0L3RhYmxlcmFuZ2U6MjlhMWIzODhkN2E0NGVkYjkzMWZiODg0YmMxODI5MTRfMTAtMy0xLTEtNTcwNzM_cc15fd79-7a1b-48de-910b-ecec42cea585"
      unitRef="usd">839344000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LineOfCredit
      contextRef="i5ee8e2a0aedf4e16bfc1f00854be3504_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMTM3_097f275a-4147-4081-a140-88fa280d0cf8"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i74aaf1e8f24d470db2a98ecc203f2374_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMTM3_fa8c1588-64de-4109-9606-65fd9bb89e8b"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iff74038af72140fba140e6ea501d015f_I20210423"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMTcw_2214944d-f71d-443a-960d-d2ec2dbed877"
      unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="iafa7ca073c27455da1ef23c17f9d1eaf_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMjMy_bb42b153-f194-4104-b534-7a012888253f"
      unitRef="usd">7600000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i27e434031da1489c8d9bbda89a5969c6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMjgw_60638824-c522-400c-9bb4-4a02144e484e"
      unitRef="usd">187400000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="ic21b3f13e434406ba1275f4ac33a277e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMzcw_a72522ec-f0ec-416c-955a-0cc2bd2e0677"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5bdf271a43584924822139b8fb9380b0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNDAz_7226fb1f-e455-4f2d-85c0-d4ae78452461"
      unitRef="usd">50000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7ae3cbf23e8046c887d676fc95010311_I20230201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQyOTE4_083dfb92-e0af-4cc0-bbed-024900e71583"
      unitRef="usd">19800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idfa89e509e1e48328e0d64bb2910a9ae_I20230327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxNzMw_ce8d5d85-a10a-4b32-b2bb-4fbb5ed9a7ea"
      unitRef="number">0.0011448</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i96f81a7f32d64009b629b9ef4859f993_I20230327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxNzM0_3211cf21-aedf-4a9e-bba1-d6f548687088"
      unitRef="number">0.0026161</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i42b5a1db32b749cc972364acdd9c9644_I20230327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxNzM4_7de905da-c1c8-40b7-a734-b260ec27d275"
      unitRef="number">0.0042826</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCredit
      contextRef="ie71f440e2c7643508c28e8a01a00242c_I20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNzYw_a80b8eac-0690-438a-abfe-d13b36340f65"
      unitRef="usd">725000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iff74038af72140fba140e6ea501d015f_I20210423"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfODM5_2214944d-f71d-443a-960d-d2ec2dbed877"
      unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="icc1ca11c511b475ca49c7b77c92736bc_I20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMTE4MA_70d31960-392e-4d42-8ecd-4374625e9f15"
      unitRef="usd">14900000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="icc1ca11c511b475ca49c7b77c92736bc_I20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMTIwNg_40da806a-04d4-4dc9-8b09-1fb6d445b5c0"
      unitRef="usd">8800000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="icc1ca11c511b475ca49c7b77c92736bc_I20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMTI2MA_ce9135f1-1499-4f53-8254-ad9dac17fea4"
      unitRef="usd">4500000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if7ec32e42eb944bb9330cd1cb04f945c_D20210423-20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMTMwMg_96a4a443-57eb-4332-a0f4-d6fc9060c12c"
      unitRef="usd">-1500000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:AmortizationOfDeferredCharges
      contextRef="if7ec32e42eb944bb9330cd1cb04f945c_D20210423-20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMTM1Nw_283a8d1c-1876-4f3c-8fc8-0361f209ec8e"
      unitRef="usd">100000</us-gaap:AmortizationOfDeferredCharges>
    <us-gaap:LineOfCredit
      contextRef="i3bc539faeadf438fbd7d4d1552f9881b_I20221007"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODM1_d2d000cf-887a-47ab-8860-1da8e1313515"
      unitRef="usd">150000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i8827e76d9d944f0c83ab889ff9b40970_I20221007"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODQy_79e87fca-d7cb-4f17-9d5e-68413e071c71"
      unitRef="usd">50000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i2949ad265aae416b895dc287e1c90a56_I20221007"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODQ3_f2f2fdaa-949c-48a2-97ec-5a693393808c"
      unitRef="usd">2700000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="i2949ad265aae416b895dc287e1c90a56_I20221007"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODU0_46d4ff77-41c2-4a6a-b7e7-c537819642b6"
      unitRef="usd">2000000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i4a4b8e05477244e69f17430f41440f40_D20221007-20221007"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODYx_4e3ab33e-f2d2-4fcc-90e3-fcdb988f46a4"
      unitRef="usd">-700000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <rdnt:ScheduleOfLeverageRatioTableTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMzg0ODI5MDcyMjEyMg_94ef51f8-0aca-4106-8cfc-ee50080f08bd">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All obligations under the Second Amended and Restated Credit and Term Loan Agreement bear interest at either a SOFR or a Base Rate (each as defined in the Restated Credit and Term Loan Agreement), plus an applicable margin according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pricing Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Letter of Credit Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Percentage for Commitment Fee&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 3.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.45%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 3.00:1.00 but greater than or equal to 2.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.50:1.00 but greater than or equal to&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.00:1.00 but greater than or equal to 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;V&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a SOFR or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.342%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;First Lien Net Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Term SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Alternate Base Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.00x but &#x2264; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2264; 3.00x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</rdnt:ScheduleOfLeverageRatioTableTextBlock>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="i6f4de3e0b12c4ce99436f199560d928d_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMS0xLTEtMS04MTc1OC90ZXh0cmVnaW9uOmY2MmE1YTM5OTMxYzQ0ODY4YjBjOGE0MDE0OGYyNzkzXzI5_5ce8faab-d4b8-43da-afad-874843bc7997"
      unitRef="number">3.00</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="icc503ebed81d4c76998b856dfa54a9b5_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMS0yLTEtMS04MTc1OC90ZXh0cmVnaW9uOjNhNmQ3NWNiMzk4ZjQ5MzFhZTNlMDY4Y2IyZGE1ZmU0XzU_0df3dbef-4dfc-4834-8779-2502293c9b3a"
      unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ie5832838df87478bba175d9f9ab09d12_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMS0zLTEtMS04MTc1OC90ZXh0cmVnaW9uOmRmNDAyMWVlZDRiMDQ4YjQ5MjRiODZhZmExN2FjMmRkXzU_0942dd05-e7d8-4da7-86fc-854f0ee71592"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="idb58ba96caad4ba7bb0c8651dbcd3083_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMS00LTEtMS04MTc1OC90ZXh0cmVnaW9uOmQ3ZDYwZmI3OWVjMTQ3N2Q5ZjRlYTdlY2JmYjYyODU5XzU_d56a12fe-6e46-432b-b8cd-a38285b14f1a"
      unitRef="number">0.0250</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="idb58ba96caad4ba7bb0c8651dbcd3083_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMS01LTEtMS04MTc1OC90ZXh0cmVnaW9uOjc2Mjg1YmQyNWQ0ZDQwNTQ5NTU2YzY4N2IzZWZiNTQ0XzU_7450925d-b8b8-4b94-8bd0-3d6c9daeed8f"
      unitRef="number">0.0045</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="i489017a84c394ba39520152a49aa8cda_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMi0xLTEtMS04MTc1OC90ZXh0cmVnaW9uOmQxZGE0Njk4MmQ2OTRkZTZhZTNkNjRjNTcwYjM3MGExXzE0_fba54fce-6d33-4781-b27d-f6034f78ec06"
      unitRef="number">3.00</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="i489017a84c394ba39520152a49aa8cda_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMi0xLTEtMS04MTc1OC90ZXh0cmVnaW9uOmQxZGE0Njk4MmQ2OTRkZTZhZTNkNjRjNTcwYjM3MGExXzUx_a5194395-fcb5-409f-a5e0-0853d50c82b0"
      unitRef="number">2.50</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="icb4c174e094d423b95626eb584086fe6_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMi0yLTEtMS04MTc1OC90ZXh0cmVnaW9uOmQ3YjZkMTBlZDRhYzQ2Yzc4MzEyMGQ5NzhhNDcxZjU5XzU_6937795d-3c00-42c9-8bcf-e289b24e8f81"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i84d7aa7a0eb0454e91b9f2219e820140_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMi0zLTEtMS04MTc1OC90ZXh0cmVnaW9uOjdhOWVmZDk1ZDYxYTRmMjNiYjhlODM5Y2VhNTBlYjE0XzU_cd158ceb-132f-4672-be7f-88534befd83c"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ie5a73f30657642bda3a4e7fae521a479_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMi00LTEtMS04MTc1OC90ZXh0cmVnaW9uOmNkYmQwYTQwYWUxNDQ2NTY5NmY1MDcwYWE3OGIxNThhXzU_37091c8e-2212-44a5-bdde-473aa3122214"
      unitRef="number">0.0225</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="ie5a73f30657642bda3a4e7fae521a479_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMi01LTEtMS04MTc1OC90ZXh0cmVnaW9uOmM0ZGQzYzRhMTg2MTRkOTVhNDZkNzVhZGQzNmNkNGRkXzU_021f9fe1-d416-4df9-99be-bb7fc27463a7"
      unitRef="number">0.0040</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="ib440cff642614ebfb76342cdb0207f49_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMy0xLTEtMS04MTc1OC90ZXh0cmVnaW9uOmI2MThlYWZmZjMwNTQ2ZTE4N2UxM2VmZjQyY2QxMmYxXzE1_6cea3405-0aee-4763-9777-ac3d46a39918"
      unitRef="number">2.50</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="ib440cff642614ebfb76342cdb0207f49_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMy0xLTEtMS04MTc1OC90ZXh0cmVnaW9uOmI2MThlYWZmZjMwNTQ2ZTE4N2UxM2VmZjQyY2QxMmYxXzUy_0d730a0e-984f-4637-b9b6-bb920724cf50"
      unitRef="number">2.00</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id7d124de1ada45beacf97bc0d67b1168_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMy0yLTEtMS04MTc1OC90ZXh0cmVnaW9uOmFjMDQwODk4MjQxZjRkMmRiODI3MmI0ODBlMjA1ZWM5XzU_8d8ea284-5b8e-4bf9-aa5c-eb673116dfa3"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i5fd2d5ebfa4446888fa605822721f229_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMy0zLTEtMS04MTc1OC90ZXh0cmVnaW9uOjJiYTBhYjM0ZDk4YzRiYmQ5ODlmYjFiYTE5MWEyMjA3XzU_331f017a-b4ff-43a7-80b7-6422b1e28e40"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ifb2039ca234941c2af241afaa4dd085a_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMy00LTEtMS04MTc1OC90ZXh0cmVnaW9uOjFmNDRmNzYzMjAyYzQ1ZWQ4OWE5ZmNhNjQyNTUyYTA4XzU_e3d01780-0b56-47ea-8ab9-824aa448119c"
      unitRef="number">0.0200</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="ifb2039ca234941c2af241afaa4dd085a_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfMy01LTEtMS04MTc1OC90ZXh0cmVnaW9uOjJkYjM2Yjg3YTk0NzQ3OTZiNTBhMjM1NzA0ZmQyZDUzXzU_fd6c5323-072c-40de-b13a-4a88aef62129"
      unitRef="number">0.0035</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="icaaf8454b0ae42a5825cbd6024216629_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNC0xLTEtMS04MTc1OC90ZXh0cmVnaW9uOjk1OTk5MTFmNWQ1MjQ2MWRiNGU4NTgzYTEwNTIxOWExXzE0_18b2b243-953c-443e-bf2e-8622fcf8d0df"
      unitRef="number">2.00</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="icaaf8454b0ae42a5825cbd6024216629_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNC0xLTEtMS04MTc1OC90ZXh0cmVnaW9uOjk1OTk5MTFmNWQ1MjQ2MWRiNGU4NTgzYTEwNTIxOWExXzUx_43ab5146-afbe-470c-972a-d6e1c53aaa52"
      unitRef="number">1.50</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ia8045fe5cfc84ac08c6a0c898079bdde_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNC0yLTEtMS04MTc1OC90ZXh0cmVnaW9uOmIyODAwYTFkM2M0NzQxMzFhMGU3YjM2N2M4NTk0ZjkzXzU_5bca1d7b-35a6-4a78-9e55-66a6f3c674ae"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2d3c803e6a4b4fa7b9264589b4154b82_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNC0zLTEtMS04MTc1OC90ZXh0cmVnaW9uOmU4NmE0MDU4YWRmYTRiOGJhZTI1MjVhNTI2NjRiNzgxXzU_834fe680-fe15-4132-99d1-c215bd809113"
      unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ia4c088461a3c4c95a93abef9e3f00c29_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNC00LTEtMS04MTc1OC90ZXh0cmVnaW9uOmYxZTBjODBkZmE1ZDRmZjFhMzc0ZDcyZGVmYWMzYWMwXzU_20dfbaf9-952c-464e-8f25-58d8a459f537"
      unitRef="number">0.0175</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="ia4c088461a3c4c95a93abef9e3f00c29_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNC01LTEtMS04MTc1OC90ZXh0cmVnaW9uOjYyY2VjZjBhZTZjYjQxYzdhZWNiOWQ5NWFlNTQyOTM1XzU_98444397-aed2-4662-9a3a-e3ecc8f72064"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="i3de3948a63bb469ba713d1ada7005b41_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNS0xLTEtMS04MTc1OC90ZXh0cmVnaW9uOjZkYjdhZjkzODE5OTRiYjhiOTU3MmNmYWMwZDg0NDBlXzE0_641f85ef-103d-4ef3-9d09-463289ff29c0"
      unitRef="number">1.50</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ia8335fa556c04b78865bee76634b9ff7_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNS0yLTEtMS04MTc1OC90ZXh0cmVnaW9uOjk3NTJkMjE0ZDJjNjQ3ZTNhMzQyY2M3YTJiZTA4NGRlXzU_9b763439-e160-4935-a282-ea95606ecdad"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i324536b68eb244a7b90b0a3ba932bb6a_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNS0zLTEtMS04MTc1OC90ZXh0cmVnaW9uOjZiYWMwOGI2ZGExMzQyOGNhMWI4MmIyZTI0YWQ3Y2ZhXzU_c6478d42-0b08-420d-8e85-82addb186cdd"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i55a8765735c14513a443454a717b1110_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNS00LTEtMS04MTc1OC90ZXh0cmVnaW9uOmYwZTUyYzIyZTdkZDRhZjE4NjdjN2Q0ODc4YTAyODFiXzU_b5a85d35-a03a-4bff-8c45-2c0278755b8b"
      unitRef="number">0.0150</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i55a8765735c14513a443454a717b1110_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOjQ0ZjE1ZTY2ZTE2YTRiMGNiZTlkMWQ2ZjU0ZTE2YjQyL3RhYmxlcmFuZ2U6NDRmMTVlNjZlMTZhNGIwY2JlOWQxZDZmNTRlMTZiNDJfNS01LTEtMS04MTc1OC90ZXh0cmVnaW9uOjAyMzI0MzAwODljYTQ0OWY5YTllNjBiNzc4ZmQ0YzNhXzU_e8738c88-8ae2-4c63-83c0-9129c05667e0"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i3ba2dd225829444a8f3c676b6fd16f76_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM3MzAw_68350ed2-19a5-4848-802c-50c99ca57f4a"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id30c357b819f411f883897ece82a2ee9_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM3MzA4_0d0650f2-cd36-4c84-8d9e-123f97f9eb16"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i60ee747f054f4a7fa53e6ca0d30f6fac_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMjI3OQ_dfe413b2-be9b-4f00-beb1-59cbf4681252"
      unitRef="number">0.0463</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ida485f8e22d14a529a4301403a5a90a4_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMjI4Ng_96863042-3b99-45c8-9049-f81a785556e8"
      unitRef="number">0.0800</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i61d0d3aa77e94d1e8d2fddb57f6be350_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxNzU5_a35b601c-f7e9-4f8c-977b-f79d3b6876aa"
      unitRef="number">0.0300</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i58b95ffabd8f4ce5a478e21bfbc7b17d_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxNzYz_5aff89bb-0629-4317-be69-0b6c8b416012"
      unitRef="number">0.0200</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i7dfe80ca8754497ba1f5422326933310_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxNzUx_3263fd4e-b946-4eb9-99e1-0d35e026ea1d"
      unitRef="number">0.0781</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifd37700473c648cbbf786d4b1f0c907d_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxNzU1_a0bb0e7a-9aab-4ee4-895f-486eb7846d52"
      unitRef="number">0.0011448</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i771d845d28a0407987c7a78f55f3c8ac_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxNzY3_dc4d295d-c1ab-402e-a674-7f15453601f8"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="ia7a1589942bf4d659b4c2a4bbeb48cb0_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfMjYwMA_71ed41ad-2017-4d87-8b44-58337ee4193e"
      unitRef="usd">1800000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i1f1da3a1ad334f35988ca6282aa57b99_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODkx_b933c934-7343-4ad9-a545-8aab4131a83a"
      unitRef="number">0.0469</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="idfd92754a11641c3b9f84f0578f4bc74_D20230331-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODcy_b03cf41b-0d6a-484c-a4c9-667fe256f923"
      unitRef="usd">1900000</us-gaap:DebtInstrumentPeriodicPayment>
    <rdnt:DebtInstrumentPeriodicPaymentPercent
      contextRef="idfd92754a11641c3b9f84f0578f4bc74_D20230331-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODgw_03a10b11-a47c-479d-961d-96a85749bd4f"
      unitRef="number">0.0100</rdnt:DebtInstrumentPeriodicPaymentPercent>
    <rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease
      contextRef="ifbe38301ce1249c88966ffa550df3678_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODM4ODg0_a0c4faa9-e3e5-46ee-9774-8d4fc96ee055"
      unitRef="usd">900000</rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i27e434031da1489c8d9bbda89a5969c6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQzMjQ5_ab896daf-148e-40c8-8497-3623dc60e083"
      unitRef="usd">2100000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iff74038af72140fba140e6ea501d015f_I20210423"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNDQwNA_2214944d-f71d-443a-960d-d2ec2dbed877"
      unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="i24c9c233e2a54c57a8964647449f94d6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMS0wLTEtMS01NzA3My90ZXh0cmVnaW9uOmUxMGRhZmU3YTg5ZDQyZmNiM2E0MTgxZjE1NDEzNjBhXzY_a3ecc5c2-02c2-4738-8191-621edd6fb173"
      unitRef="number">3.50</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7d5747c3ac914bc7a1e6aa46bd3d149e_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMS0xLTEtMS01NzA3Mw_aeeff00c-894d-4a44-8ecb-52d1a171314a"
      unitRef="number">0.0325</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i903948a537d64b37b67178fb25e84ed9_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMS0yLTEtMS01NzA3Mw_30dcd8e7-2b00-4d9f-b9ae-4e9deb28d818"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="i10cefc40b0c44d8cbc4372fcfb77562b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMi0wLTEtMS01NzA3My90ZXh0cmVnaW9uOjM3MmU0OGFkZjA5YzQyZTE4NmMxZmQwN2Q1ZjVkZTE5XzY_dce67bfe-ef2b-4cd1-8c26-b80ccfeec6ab"
      unitRef="number">3.00</rdnt:DebtInstrumentLeverageRatio>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="i07e3281e1e824c3d97f67f8ac8a57bd4_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMi0wLTEtMS01NzA3My90ZXh0cmVnaW9uOjM3MmU0OGFkZjA5YzQyZTE4NmMxZmQwN2Q1ZjVkZTE5XzE2_d956eb06-8c54-44d2-b2ef-0aeda57f8058"
      unitRef="number">3.50</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i48658f8cfbcf4487bc406a287ad83c2d_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMi0xLTEtMS01NzA3Mw_eefc6ccb-3311-4067-b35f-0974eda155f0"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="icb9196414c2f47f29fa015cf40d76abc_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMi0yLTEtMS01NzA3Mw_1bc82936-ef3d-49ff-84e6-be07989fa216"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="if01c31d758364150a9bb3ce7cd850ca4_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMy0wLTEtMS01NzA3My90ZXh0cmVnaW9uOjFmNzQ2ODgzMjIwYjQ5OGZiZTQ4NjBmYTk1YjI4NmZmXzY_b164a027-f255-460e-89de-186c206502b3"
      unitRef="number">3.00</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ibf860e6898d344c0a7a4962ee596f36d_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMy0xLTEtMS01NzA3Mw_e14edd37-0316-4ce9-bc3f-759b13581796"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i44d10d8940d34f76ab949ea9ed5bbdc3_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RhYmxlOmM3MjY0YTMyZWM5ZTQzOTY5YmYzZTQzZTEzNmVhM2QwL3RhYmxlcmFuZ2U6YzcyNjRhMzJlYzllNDM5NjliZjNlNDNlMTM2ZWEzZDBfMy0yLTEtMS01NzA3Mw_b3cc33a9-b8d3-41f6-ba17-111dd3562e84"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="iafa7ca073c27455da1ef23c17f9d1eaf_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTAyMg_9d0ff1bb-41df-4701-8f82-71d8a706820d"
      unitRef="number">0.0525</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic4bd4668c12145b1bdf1773fe1c0b99e_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTIxMQ_6336e8b5-88c6-472f-9c8c-98af7949173a"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="iaaae0769addc4e53bad052090529ee90_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTI0Mg_09b42e1c-bac9-4f21-a232-818ccebff557"
      unitRef="number">0.00125</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="iaaae0769addc4e53bad052090529ee90_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ0Mg_0eba1e16-74d4-4d86-9522-1d27bc03b5c8"
      unitRef="number">0.0050</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i8827e76d9d944f0c83ab889ff9b40970_I20221007"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQwNDc2_911c570c-f791-49ef-9985-bb2484f0f0e6"
      unitRef="usd">50000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ie97a081dfdc74b2dac6dc6743edad186_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQwNDgz_6d105f3e-fa9f-41e5-beea-b3a0e2d2877f"
      unitRef="usd">600000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iee7b9274694a4e7fbfba10c74d1e9f2b_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxMzE5_ef631c0f-a766-4e7b-8b94-af8eba2566bf"
      unitRef="usd">60000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i97202989895048c6b3682a076c3a5dc3_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81Mi9mcmFnOjljZmE2ZDI1ZWY1NDQ4NjU4YTgxNDk1NTgwMzM1ZWMxL3RleHRyZWdpb246OWNmYTZkMjVlZjU0NDg2NThhODE0OTU1ODAzMzVlYzFfNTQ5NzU1ODQxMzI2_19222527-899c-4bce-bee3-1cadf8825044"
      unitRef="usd">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNDQzNg_97ed5616-f22c-4a88-855b-7f1da83e7712">STOCK-BASED COMPENSATION&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have one long-term equity incentive plan, the RadNet, Inc. Equity Incentive Plan, which we first amended and restated April 20, 2015, again on March 9, 2017 and currently as of April 15, 2021  (the "Restated Plan&#x201d;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved for issuance under the Restated Plan 16,500,000 shares of common stock. We can issue options (incentive and nonstatutory), &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;performance based options, stock awards (restricted or unrestricted), stock units, performance based stock units, and stock appreciation rights under the Restated Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations.  Stock options generally vest over 3 to 5 years and expire 5 to 10 years from the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes all of our option transactions for the three months ended March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the 2006 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;935,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.96&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,840,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;672,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,568,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on March&#160;31, 2023 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on March&#160;31, 2023.  As of March&#160;31, 2023, total unrecognized stock-based compensation expense related to non-vested employee awards was $2.5 million, which is expected to be recognized over a weighted average period of approximately 2.11 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%"&gt;DeepHealth Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted options to acquire&#160;412,434&#160;shares at a grant date fair value of $16.93&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of March&#160;31, 2023, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $0.3 million, which is expected to be recognized over a weighted average period of approximately 0.60 years&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the Deep Health Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,565,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,940,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options issued in replacement of original DeepHealth options as a result of our acquisition are not included in the share count under the Restated Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Awards ("RSAs")&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Plan permits the award of RSAs and the following summarizes all unvested RSA&#x2019;s activities during the three months ended March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;RSAs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSAs unvested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(704,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSAs unvested at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.51&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the fair value of all RSAs based on the closing price of our common stock on the award date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other stock bonus awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Plan also permits share awards not subject to any future service period. These are valued and expensed based on the closing price of our common stock on the date of award. During the three months ended March&#160;31, 2023, 10,765 shares were issued with a value of $0.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance based stock units ("PSUs")&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, we granted certain employees PSUs with a target award of 25,683 shares of our common stock. The PSUs will vest in two equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0% to 200% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022.  In January of 2023, based on the performance condition achieved, the board of directors issued 12,843 units with a fair value of $29.44 per unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2023, the we granted certain employees PSUs with a target award of 60,685 shares of our common stock. The PSUs will vest in two equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (&#x2014;% to 200% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2023 through December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance based stock options ("PSOs")&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, we granted certain employees PSOs with a potential to option a maximum of 111,925 shares of our common stock. The PSOs will vest in three equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0 shares to 111,925 shares) depending upon the extent to which we achieve a performance condition as determined the board of directors over the period from January 1, 2022 through December 31, 2022.  In January of 2023, based on the performance condition achieved, the board of directors issued 27,981 options with a strike price of $29.44 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2023, we granted certain employees PSOs with a potential to option a maximum of 235,227 shares of our common stock. The PSOs will vest in three equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0 shares to 235,227 shares) depending upon the extent to which we achieve a performance condition as determined the board of directors over the period from January 1, 2023 through December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long Term Incentive Plan shares ("LTIPs")&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we issue stock-based compensation to certain employees in our AI segment in the form of Stock Units and Restricted Stock Awards, subject to certain restrictions. The awards represent a form of long term incentive and are reflective of a general practice within the software industry.  The units and shares vest ratably over a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODE4OTk1_66873c0e-ef14-4872-a4e6-5ee1a266aa10"&gt;two&lt;/span&gt; to four year period, conditioned on continued employment through the vesting periods. We determine the fair value of all LTIPs based on the closing price of our common stock on the award date.  The following summarizes all unvested LTIPs activities during the three months ended March 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;LTIPs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LTIPs unvested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LTIPs unvested at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.43&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restated Plan summary&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In summary, of the 16,500,000 shares of common stock reserved for issuance under the Restated Plan, at March&#160;31, 2023, there remain approximately 740,000 shares available under the Restated Plan for future issuance.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNjk_4b84adf9-c59f-4d63-b285-f1be0e7b8f7c"
      unitRef="incentiveplan">1</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i034e56b7f7854922a502eefa5771dc2a_I20210610"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNDUx_f3d0368c-9b73-463b-8de1-2de2d7a09aac"
      unitRef="shares">16500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if7309a2667674a92a4cc3eeb4825b42f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNzgy_d6c99485-5905-48e9-8c21-5a5d78ba2d0d">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i7e2bb9a95d4d4802b2e4a3cc0aebe6ab_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNzg4_9dfe42fc-759f-41de-8ed0-3d18987a484e">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="if7309a2667674a92a4cc3eeb4825b42f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfODA4_b564b912-7337-40b3-a096-2e56eafcb795">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i7e2bb9a95d4d4802b2e4a3cc0aebe6ab_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfODE0_30602ca9-f384-41bf-8aa3-87607150cbb1">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNDQzMw_327ce299-ca81-48f3-bd5a-5a1ef9ddda85">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes all of our option transactions for the three months ended March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the 2006 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;935,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.96&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,840,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;672,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,568,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the Deep Health Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,565,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,940,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfMS0yLTEtMS01NzA3Mw_96071d04-a59c-467c-8dbc-1909246347dd"
      unitRef="shares">678914</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i6dc177faf452405fa2bf716f25f19919_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfMS00LTEtMS01NzA3Mw_b3b85013-eb78-4bb2-a9bb-eb3425bf7d86"
      unitRef="usdPerShare">15.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfMi0yLTEtMS01NzA3Mw_d1046536-ef4c-4a04-bcc9-de2da526f62e"
      unitRef="shares">261220</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfMi00LTEtMS01NzA3Mw_ede86d22-ca21-4886-a9bc-a001190bf55c"
      unitRef="usdPerShare">18.64</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfMy0yLTEtMS01NzA3Mw_86188b86-231a-4064-8913-3e1c65c4ca0e"
      unitRef="shares">5000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfMy00LTEtMS01NzA3Mw_1b1b68a5-86d7-445a-9c4d-956d417309db"
      unitRef="usdPerShare">10.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfNS0yLTEtMS01NzA3Mw_27191567-f936-4da7-8f6f-1d57bd4c2412"
      unitRef="shares">935134</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfNS00LTEtMS01NzA3Mw_ab2d5591-69ed-443e-86f1-cfff9fdf61f3"
      unitRef="usdPerShare">16.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfNS02LTEtMS01NzA3Mw_e93e03c1-1471-49db-bab7-21a4cab4f71b">P6Y11M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfNS04LTEtMS01NzA3Mw_933b193f-8f17-4943-b68e-0ce71121a4fe"
      unitRef="usd">8840425000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfNi0yLTEtMS01NzA3Mw_e28dc79b-0a83-4179-9612-75812077fc68"
      unitRef="shares">672538</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfNi00LTEtMS01NzA3Mw_340014a7-ddbc-406a-813a-bbb586b750db"
      unitRef="usdPerShare">14.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfNi02LTEtMS01NzA3Mw_e79ca1a4-87b8-4421-a4cb-7d0004d7312c">P5Y11M23D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjlmNjg3ZDcwNjM3YzQzZWE5ZDQzMDQzZjgzNjQyZTg3L3RhYmxlcmFuZ2U6OWY2ODdkNzA2MzdjNDNlYTlkNDMwNDNmODM2NDJlODdfNi04LTEtMS01NzA3Mw_3c6edc2e-2040-4a60-99a5-b0823c1f6274"
      unitRef="usd">7568342000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="if953ce5e5d654143a5f27fbf0c7a8bcf_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMTgwMA_645d49dc-0e20-49f4-8911-342083284648"
      unitRef="usd">2500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i552d69a649564205922349013a84c526_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMTg4Nw_83c722da-2107-47d3-bbb5-de0649c19acf">P2Y1M9D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i26ed0c3bb3bc4dfca4136d54d21385d7_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMjA0Nw_3b369f31-653c-4025-8dc7-40e70756e52f"
      unitRef="shares">412434</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8ced063bc27e4d249a4e8c5f2627065c_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMjA4Nw_6abce8ae-1bd0-4627-8d01-1171f458e438"
      unitRef="usdPerShare">16.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i603724082df64ed1a5f7a54cc923b37e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMjMzNQ_bca4f629-f794-4c21-8c89-6940716fb32e"
      unitRef="usd">300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="iebc09a78aa3040b9b0079b356035fa32_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMjQyMg_c2f15b22-8928-449c-8ba9-a96014a1cb99">P0Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i75c6b8d0c0664a95a8cd0428ddf549df_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfMS0yLTEtMS01NzA3Mw_e8c46b1b-35ed-4f42-85b9-cf98d501e616"
      unitRef="shares">116982</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i75c6b8d0c0664a95a8cd0428ddf549df_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfMS00LTEtMS01NzA3Mw_8502e9e9-7af6-48a5-8786-a59bb9010ad3"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i16e7a48c2cb34748acb734708003ddda_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfMi0yLTEtMS01NzA3Mw_2cc7cb07-71c1-4514-84e6-0db2bd31470d"
      unitRef="shares">14473</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i16e7a48c2cb34748acb734708003ddda_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfMi00LTEtMS01NzA3Mw_969c07a0-e19f-4ea0-b037-b46ae42913f1"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i1b2d16ac66924839910f548784911842_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfMy0yLTEtMS01NzA3Mw_f89fbbdf-5bc7-4a74-b6b9-6748a8d75bcd"
      unitRef="shares">102509</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i1b2d16ac66924839910f548784911842_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfMy00LTEtMS01NzA3Mw_8d4d0302-90ae-43df-836b-bba801efbede"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i16e7a48c2cb34748acb734708003ddda_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfMy02LTEtMS01NzA3Mw_a22ff3bb-2b68-4ab9-8866-fd4501dd026b">P6Y6M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i1b2d16ac66924839910f548784911842_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfMy04LTEtMS01NzA3Mw_2238241d-913b-4ed4-8693-6eb1e5ac393e"
      unitRef="usd">2565800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i1b2d16ac66924839910f548784911842_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfNC0yLTEtMS01NzA3Mw_4df9ec8c-5086-4efa-8d86-748a68daa2c3"
      unitRef="shares">77537</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i1b2d16ac66924839910f548784911842_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfNC00LTEtMS01NzA3Mw_8e96a14e-e875-4d3e-b89d-d9ea55d153e2"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i16e7a48c2cb34748acb734708003ddda_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfNC02LTEtMS01NzA3Mw_3538a15a-0593-4b05-9f0e-c817dfb3f729">P6Y6M18D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i1b2d16ac66924839910f548784911842_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOjNiMGI5YjIzNjgzZTQyNDg4YTM5MmJkZTFkMzVjMGUyL3RhYmxlcmFuZ2U6M2IwYjliMjM2ODNlNDI0ODhhMzkyYmRlMWQzNWMwZTJfNC04LTEtMS01NzA3Mw_1d2f5e98-e161-42ba-b031-37c9d4eaa7cb"
      unitRef="usd">1940758000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNDQzNA_0408449e-84c9-4eeb-a968-f3d1b6b45c2e">The Restated Plan permits the award of RSAs and the following summarizes all unvested RSA&#x2019;s activities during the three months ended March&#160;31, 2023:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;RSAs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSAs unvested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(704,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSAs unvested at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.51&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="idca80d4271d24fc3a40ba5927cee3bbe_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfMS0xLTEtMS01NzA3Mw_b1218a40-55e3-4d33-8154-fddf98888b3c"
      unitRef="shares">536767</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="idca80d4271d24fc3a40ba5927cee3bbe_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfMS01LTEtMS01NzA3Mw_2f984b6c-b4ac-418e-ad79-85057e8fc68d"
      unitRef="usdPerShare">23.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8816a5b45bc14eeba46c2e754bf6809a_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfMy0xLTEtMS01NzA3Mw_a800f8f6-29fd-4383-a81e-01493b97ab74"
      unitRef="shares">694324</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8816a5b45bc14eeba46c2e754bf6809a_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfMy01LTEtMS01NzA3Mw_201419bc-061b-4cd0-8271-15988af09993"
      unitRef="usdPerShare">19.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i8816a5b45bc14eeba46c2e754bf6809a_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfNC0xLTEtMS01NzA3Mw_e09e5e76-601c-4547-ae4f-1a08d96be9fd"
      unitRef="shares">704019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8816a5b45bc14eeba46c2e754bf6809a_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfNC01LTEtMS01NzA3Mw_8bc75fe8-ffe5-4c9b-afe3-8b3440ab5fb8"
      unitRef="usdPerShare">21.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod
      contextRef="i8816a5b45bc14eeba46c2e754bf6809a_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfNS0xLTEtMS01NzA3Mw_261888b5-b27c-4c8b-8927-1c6cbd6e5ea7"
      unitRef="shares">667</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue
      contextRef="i8816a5b45bc14eeba46c2e754bf6809a_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfNS01LTEtMS01NzA3Mw_185f779c-073a-4437-bc6c-66f536fdeb99"
      unitRef="usdPerShare">22.80</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i6a719cbef35d464180bcd3fa66af85f8_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfNi0xLTEtMS01NzA3Mw_85554af2-b76b-4120-a649-01d296988d0d"
      unitRef="shares">526405</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i8816a5b45bc14eeba46c2e754bf6809a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfNi0zLTEtMS01NzA3Mw_ad1f6804-6f48-430a-917d-b124d228deeb">P1Y6M3D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i6a719cbef35d464180bcd3fa66af85f8_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmM5NDhkNGY2ZTA0YjQ5YzA5OTQxNzZiNTFlY2Q2MjE5L3RhYmxlcmFuZ2U6Yzk0OGQ0ZjZlMDRiNDljMDk5NDE3NmI1MWVjZDYyMTlfNi01LTEtMS01NzA3Mw_12adb4f6-1805-4ead-b648-568fffae0d57"
      unitRef="usdPerShare">20.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ic4df50bb1eea438187c006139af9358d_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIwOTkx_1fe9f83e-833e-4f60-ac23-3a16d42d5a2f"
      unitRef="shares">10765000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="ic4df50bb1eea438187c006139af9358d_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIxMDU2_1fe54f08-4cc4-4e83-9abd-fae72f239bd8"
      unitRef="usd">200000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i3baed7f4af1344d989545d489662cec2_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMzM0Mw_d1c0d8a6-93e4-4233-8531-23f8cc6a9bb2"
      unitRef="shares">25683</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches
      contextRef="i3baed7f4af1344d989545d489662cec2_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIzNzYw_99be3500-5bc2-4409-a034-0c5c050ede32"
      unitRef="tranche">2</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i3baed7f4af1344d989545d489662cec2_D20220101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIzNzgx_27320cc7-2e94-4b3f-8bf5-da861e19086b">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="if430b6d648944e90a7a4d909825414d6_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMzUxNw_70bc2835-46e1-4bf0-ba82-592ca7111059"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ic141fc5027bd4033a301df773b032bc0_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMzUyMw_bc57aff6-cc68-4c6e-8121-4b64553dea12"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharesIssued
      contextRef="i20728da098554c3492944bc24dc7bedd_I20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODE5NDU0_834577a7-a8b5-47e3-a451-5c990a75c1d4"
      unitRef="shares">12843</us-gaap:SharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i20728da098554c3492944bc24dc7bedd_I20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODE5NDU3_d90ce0c2-2ab0-4e20-aca3-e7fd85733c0e"
      unitRef="usdPerShare">29.44</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib7d7b27aecc643be998969b03dbed528_D20230101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIwODIz_5d76f440-5e39-4824-97bb-265a714aeb7e"
      unitRef="shares">60685</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches
      contextRef="ib7d7b27aecc643be998969b03dbed528_D20230101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIzNzg4_f9d6d941-0aab-4e0b-bce2-685811b297e8"
      unitRef="tranche">2</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib7d7b27aecc643be998969b03dbed528_D20230101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODI0Njc5_84b1cae2-192b-4152-bf76-4c0eaa833dda">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i29265dd33e844d5a8bbc1d746f6353ac_D20230101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIwODI3_5e78ae0b-7acb-464d-9f8e-b999f175b78b"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i375bf56db89c40ecb67521134911bf52_D20230101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIwODMx_233d81c8-a5c0-4465-ad31-1b8439b087e8"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ia74217dd8ba14406bfc31c3b148192a3_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMzg2Mg_9a0d9728-f361-44b8-bf9b-dee8f433eb30"
      unitRef="shares">111925</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches
      contextRef="ia74217dd8ba14406bfc31c3b148192a3_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODI0NzEy_7d51b0ba-e27f-488e-994f-ab1fea78faa3"
      unitRef="tranche">3</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia74217dd8ba14406bfc31c3b148192a3_D20220101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODI0NzI4_a562f1e4-fe6f-4f50-9cdf-0c55461f8c38">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ie6809d4048aa4a35b513b76bacbff9df_I20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNDAzOA_628210d2-02f6-4550-b955-5c4e04d4e4c5"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i78302aa8284649589fadb30185381e93_I20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNDA1MQ_74a59cc3-5a1a-4230-8817-b523efec74e8"
      unitRef="shares">111925</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharesIssued
      contextRef="i3fb7ffda1bf04655ba1b20ddc4c4aab0_I20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODE5NzAw_44558586-8018-40ea-bcc2-20bf3dd15030"
      unitRef="shares">27981</us-gaap:SharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i3fb7ffda1bf04655ba1b20ddc4c4aab0_I20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODE5NzQ3_8f818157-da8c-4d44-8c10-51dfbd125a3c"
      unitRef="usdPerShare">29.44</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i4a2bf0a508d6442ca467b195bdef4273_D20230101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIwODEx_9dbf2a5b-5201-4ff8-a3a3-adbfc4920bd2"
      unitRef="shares">235227</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches
      contextRef="i4a2bf0a508d6442ca467b195bdef4273_D20230101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODI0NzU1_61f4675b-d5b9-4cbc-b878-709fcd127aa8"
      unitRef="tranche">3</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i4a2bf0a508d6442ca467b195bdef4273_D20230101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODI0NzU5_d9af1859-2693-4818-b2aa-26e8a71d0f3b">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i50a36f080a554744add73eda4ce89019_I20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIwODE5_68492b1d-8db9-4811-bee9-b672b454a94a"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i52e51b40e55a4447973325a56d0ca1aa_I20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNTQ5NzU1ODIwODE1_a98d3076-0f5a-409f-a1cd-848563ff12e9"
      unitRef="shares">235227</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i78c12519a4964a51b7deba80b2e9ae56_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMzg0ODI5MDcwMjUyNw_b496d805-9bc9-405e-b985-faae78d39c88">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock
      contextRef="i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfMzg0ODI5MDcwMjUyMQ_d7422a2b-4670-4ff1-883a-023724a81280">The following summarizes all unvested LTIPs activities during the three months ended March 31, 2023:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;LTIPs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LTIPs unvested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LTIPs unvested at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.43&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i1cfa0f61545742ee999c634dad4b4b76_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfMS0xLTEtMS04MDEyNQ_8ab0c34e-fa5a-440f-a1e9-39604e3cebfd"
      unitRef="shares">169471</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1cfa0f61545742ee999c634dad4b4b76_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfMS01LTEtMS04MDE3Ng_bb287f14-a56f-45a7-a0ee-a317f0923860"
      unitRef="usdPerShare">19.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i041f68f3d9614026814745b94c47b8c7_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfMy0xLTEtMS04MDEzMw_081b8105-d8f7-499a-bd52-2830f47566e4"
      unitRef="shares">209643</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i041f68f3d9614026814745b94c47b8c7_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfMy01LTEtMS04MDE3Ng_f6cc7eab-ba37-4fa5-8244-586ce1ee1a7e"
      unitRef="usdPerShare">20.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i041f68f3d9614026814745b94c47b8c7_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfNC0xLTEtMS04MDEzMw_65b19fbc-aaf1-4a26-9cd1-40d04f75c28e"
      unitRef="shares">48395</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i041f68f3d9614026814745b94c47b8c7_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfNC01LTEtMS04MDE3Ng_eb56dcd8-bc0b-4788-b36d-34e6b8b08ea7"
      unitRef="usdPerShare">19.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod
      contextRef="i041f68f3d9614026814745b94c47b8c7_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfNS0xLTEtMS04MDEzMw_a46add22-f520-4b3f-a46a-7b51bc4dfef1"
      unitRef="shares">13476</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue
      contextRef="i041f68f3d9614026814745b94c47b8c7_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfNS01LTEtMS04MDE3Ng_78b579bc-9924-44a5-8343-cef18bf617cf"
      unitRef="usdPerShare">19.72</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia5b043dd93d14bad91a507a5b7da5817_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfNi0xLTEtMS04MDE0MQ_c4116acf-074d-48f6-8d7f-2773485575ae"
      unitRef="shares">317243</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i041f68f3d9614026814745b94c47b8c7_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfNi0zLTEtMS04MDE2MQ_04d6dc63-553e-45ed-aa0b-29b6f2bc1b17">P3Y5M4D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia5b043dd93d14bad91a507a5b7da5817_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RhYmxlOmJiY2ZlMWU3NjdhZTQ0YjBhYTdhNTcwZGZjZTUyZDE5L3RhYmxlcmFuZ2U6YmJjZmUxZTc2N2FlNDRiMGFhN2E1NzBkZmNlNTJkMTlfNi01LTEtMS04MDE3Ng_9b1b3521-6d2f-453d-91f5-68d11ef7eca9"
      unitRef="usdPerShare">19.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i034e56b7f7854922a502eefa5771dc2a_I20210610"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNDI3NA_f3d0368c-9b73-463b-8de1-2de2d7a09aac"
      unitRef="shares">16500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
      contextRef="ie931d8e47f25400f90b96046fd406a82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzMThhNTczZjk1ZTRlMDdhZGRiYmJmYjk1NDNkMWM1L3NlYzpmMzE4YTU3M2Y5NWU0ZTA3YWRkYmJiZmI5NTQzZDFjNV81NS9mcmFnOjA5ZmQ0YzBkZTMxOTQ5NDFhNDgzNGU2YjI2MTJiNmI5L3RleHRyZWdpb246MDlmZDRjMGRlMzE5NDk0MWE0ODM0ZTZiMjYxMmI2YjlfNDM2Nw_b3b5f196-562e-4ba2-9417-cbed90efa94b"
      unitRef="shares">740000</us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>54
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M&=I.2& L<"8/5RJZ766_0^-/Y.P6G-TC6Z;B,(WDLT!U'G&M&8^U,Y%HV(F
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M4GOK665'Q;_7F]S9>M)V4TGT#K;23ELLI*X'@V4U7[(SG6=9;V<R&[PQC!E
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M0FD,:'TEA'X?F!\4K[?.?U!+ P04    " #NA:I6._?*EQH)  #G3   &
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MAX1Y>YC9PIJK\=.UJ9N&0XA].7TZG0"040-(6 @)BR!A,1"L-P/TPPS01\Z
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M5T51?W_2_"33X;?-KO\#4$L#!!0    ( .Z%JE;66#U(*@@  (TA   8
M>&PO=V]R:W-H965T<R]S:&5E=#<N>&ULK9IM<^(X$H#_BHK;NMJM&@9+LHV=
M2ZABP-FA*@$VD-G[ZM@B> =;K&SR<K_^6C:QP9:T256^)'YIM;LE=3\MB<MG
M+G[F6\8*])+NLORJMRV*_<5@D$=;EH;Y5[YG&;S9<)&&!=R*QT&^%RR,RT;I
M;D LRQVD89+U1I?ELZ487?)#L4LRMA0H/Z1I*%Z_L1U_ONKAWMN#N^1Q6\@'
M@]'E/GQD*U;<[Y<"[@:UECA)698G/$.";:YZ8WPQL2W9H)3XD;#G_.0:25<>
M./\I;V;Q5<^2%K$=BPJI(H1_3VS"=CNI">SX^ZBT5W]3-CR]?M-^73H/SCR$
M.9OPW9])7&RO>EX/Q6P3'G;%'7_^SHX..5)?Q'=Y^1<]'V6M'HH.><'38V.P
M($VRZG_X<NR(DP:@1]V '!N0=@-;TX >&]#2T<JRTJUI6(2C2\&?D9#2H$U>
ME'U3M@9ODDP.XZH0\#:!=L5HLIA/@_DJF"*X6BUN9M/Q&FY6:_AW&\S7*[2X
M1I/QZCNZOEG\N4)]=+^:HE]_^0W]@I(,K;?\D(=9G%\."K!&ZAQ$QR]_J[Y,
M-%^FZ)9GQ39'01:S^+S] +RH72%OKGPC1H6WH?B**/Z"B$6HPI[)^YL3@SFT
M[EE:ZJ.ZGFTZ[?IN<8L6R^!NO)[-?T?CR7KV8[:>!2M5KU5:;;56&=47^3Z,
MV%4/PC9GXHGU1O_^%W:M_ZA<_B1E9QU@UQU@F[2/YI"$?MWQ//\-9DK$4Z;R
MME+AEBIDRGD:];%-/!B_IU,_NF(>=1NA,_N<VC['.$#C^"^(+TA)18X*#CDI
MXEF4[!C*VH;+U_)A%.9;M!?\*8$9BQY>$613$19)]EBEHZ1(6'ZA<M/YS$']
M)&5GG>;6G>8:!W7*0&F4A%4.SF(4IEP4R?_*!RK/*W7.R<A13+'3&M^N%!EB
M[*D'>%C;.C3:.CXQ#?'-R6CM&&1^)&2*[_--_P W89ZS0IG&AAW;L./Z?LL#
MA93K643M@5=[X!D]"/X^),6K3+0L%!E8GDL__N))5J GF+@'&. OY=2$QW$B
MYZ4F%WL=\_K8H^UA4$@1!P_53OBU$_Z'A@$@RX2  -HD60@1!^,1\1R"4$ZG
M'0\S\"2/^"$K5([X'1.'MMMRHROCVIJYA*T&E);1C1M(" @\R$-($=)4L'+/
MX4[ZQ&"@]C*5E&]XL65"242K8YDS;,\DA1#&1&?_">CQAX:A3&8;*./0EL6/
MK)Y&1?C"U#C'';M\0MK&JX0TB1J3QG9B1@G/^J6]T3;,'ID,B$V8"/04[@Y,
M&@T!P2 6"@0!SBJ'E"Z0CG6VY;=AHY#J$\O#OL:-IB+ 1MZ.5@6/?O9EU1G#
ME$^A%,^U>?.HZFP6$.RU(U8EAK$N[^"&W=@,[XFFHX&1,H/*F0Z7.20<H7?!
M[F9UVLDY"JF^8V&- PW<L9GNE0.Y]."$TF62KQ)-$CXDNY+8]=1_>QU!-,L$
MU9*3[P\I/ >=^X. N0C<*$0(HUBN2=3HQY_*_L_2=MZK#?VQ&?_CJ$S,N:R6
M6/(4/NS4<=;E>=_W_6%[Z!5BA/J6K1G\!OS83/Z%3,"P? +,R)2L13ON4KN/
M71^W[52(V9;K:,QLZ([->*_,-)BGXO&0M'&G$L.V#MNXX38V@WOZ!FH]$KJD
M]>T.$KI"F'H:ZTC#8V+F\:)5S;T%ZJO*4-)E:A\[EF>U;%7+>8XF]9.&OL1,
MW[HO!8/"[:",&M)E9S==*H3ZMJ-C$VD02\R(K2-['[[*L/X":3 2!["8O4A0
ML=Q<VI N-'UKV(YXA=30HIID3QJP$C-8Y^]=G"DM[R*4$A>WHTPAYNLP11K.
M$OM#NP2S^8]@]8Y= F+$]T>I\EG:SCNA834Q4FNT?(.IK.32\+%<$C!9TIU,
MN@K+>5*25MDEC@(ZKFVWQU$A!HL<79%*&C82,QM/O8!Y"+,/EF[2_'IQH+1:
MP4#'\3LK9)4<=1U'LRX@#2N)F95+P2/&XAQM!$^KU<WI@D9I<Y>'[1I:(8)U
M1"(-,(D9F'6<'_*J#$NR)ZCZWQ'C"D1"YSF=(%?)P7)?4Y&0AJ7$_U"<7\_F
MX_GD'7%N1/2'X_R3M)UOB#;(IF9D+T4"Z_T]+)D!,M7&&ZQ%,UX<X5*"O":0
M<G-4Q6>O'>(**4L]@+0!.#4#?'EB,22F]+A3P1Z4$4(5E*:NY[4-58E1K$E%
MM($Y-</\/*836+:$671<OZ6IW,20*U%TV,,E>V$B2JJTQ??:[$J[Y';:=;)"
M1M?O)[OH[T3[6\@WNT;FD*==7O>I1SHVJ\3T0]" G9H7T,'U=3!9R].3X+^3
M[^/Y[P&Z&Z\#5%VOT&)>'JLH+5>LB EI;Q,II#R=U0V)J9G$\V"-IL'D+ABO
M JA%JI.?\7Q:701_W,]^C&_DL9#2;@59J>O[[2);)>=2S]=9WQ"8F@FLM?8+
M>F!05<@=U)+.3"0\5KK0I2PF0X]V,HQ"CMJNY6I<:&A,S30VN,!D)60TOLM<
MW_(Z!9!";&@-M3.^@3/UC(A;W2^7-^6AX?@&36>KR<UB=7\7G!T@PIRZ7MS=
MCM>SQ5SI@I'_'S[]^B1MYQW2,)^:U\^3<D42)C&*#T)./2ACC\.'-ES4FY;*
MCN@NF@FVAYWLI=H.U^UUVPVH;3.H_]GRZEA,MR]P5']Z7F>WLX!"AK;+K,')
MP7;*Q&-YWI^C<J5:'0S73^O?%(S+D_36\V_X8E+],J!14_U0X384D!ERJ#TV
MH-+Z.H2^%-79?W53\'UY?/[ BX*GY>66A3$34@#>;SC4+\<;^8'Z%QBC_P-0
M2P,$%     @ [H6J5N(^<:O\ P  L1,  !@   !X;"]W;W)K<VAE971S+W-H
M965T."YX;6RUF%USFS@4AO^*ANUTDIFN^;*=.+4]XQ@\[4[SL2797G3V0@;9
M: K(E83=_OL]"$+ )6P\HUXDEH3>1])[T $T/3#^3<2$2/0C33(Q,V(I=U>F
M*<*8I%@,V(YD<&7#>(HE5/G6%#M.<*1$:6(ZEC4V4TPS8SY5;?=\/F6Y3&A&
M[CD2>9IB_O.:).PP,VSCJ>$SW<:R:##GTQW>DH#(Q]T]AYI94R*:DDQ0EB%.
M-C-C85_YME,(5(]_*#F(1AD52UDS]JVH?(QFAE7,B"0DE 4"P\^>+$F2%"28
MQ_<*:M1C%L)F^8F^4HN'Q:RQ($N6?*&1C&?&I8$BLL%Y(C^SPP=2+6A4\$*6
M"/4?':J^EH'"7$B65F*804JS\A?_J(QH".SA"P*G$CC'@M$+ K<2N*\=85@)
MAJ\5C"J!6KI9KET9YV&)YU/.#H@7O8%6%)3[2@U^T:RX40+)X2H%G9PO[VX]
M_S;P/02EX.[31V_Q )7@ 7YN_-N' -VMT'(1?$"K3W=? G1VCSG)9$PD#7%R
MCOY$CX&'SMZ<HS>(9NB&)@G$7TQ-"9,KAC##:B++<B+."Q-QT0T#KD!^%I&H
MK3=A4?7*G*>573N]P+]P-D".]0[^'*=K/OWR&\P'R+65W.V0>Z^7=XWN]\M7
M9#U 5N?H+3/<.LRNXKDO\ *))8']+1';H"46,5I!BA#HZV(M)(?=^F_''*]+
MYK";6:2P*['#(9D9D*,$X7MBS-_^88^M]UUVZX1Y.F&^)E@K,,,Z,,,^^MS_
MGM.="@P.H<A)A' 6H81 \HM9$B&:[CC;J]AU[:KK7ORI,2IA$P4K'C'[^= :
M7$[-?=/[CD[.P&EW\C5-J^7IJ/9TU.OI8R9(F!=6>F0MNTSKU9]JFDZ8IQ/F
M:X*U@C"N@S#N#4)A/3P1(+ODZO;>P$!HCY.<= 6DEW5J0'3"/)TP?_S+UK$G
MC?W5,OJB-OJBU^@%C4@6=KK:*SS559TP3R?,UP1KN7]9NW_9ZWX0P_N00%2(
M'/+-&;P""=5RWA6/$C5JAM\>VHX[;"?/9>^0IUJM$^9K@K6LGM163_[W42E_
M0DZ1!."R\OQ=F500%H)NL^,WQ]+WR2_;SK4&XR/3>P<_U72=,%\3K&6Z;3U_
M(%B]MO^=XTS2=9>O_<I3$XQ6FJ>5YNNBM6/0^$BS]669BM5,,Y/QR!H=O<<M
M^\<\V6^=-%\7K>VW\^RW\YM2305NYAIG-)@<6]\[_,G6ZZ3YNFBE]6;C:"(E
M?*O.A 0*69[)\EN^;JW/G1;JM.6H?6E?>>7IT3.F/,R"3^TMO&C"-],&D-;@
M NY\7IX/E17)=NH 9,VD9*DJQ@1'A!<=X/J&,?E4*0:H3^GF_P%02P,$%
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MC*<'<)\2,'V@ [I?FKW\'U!+ P04    " #NA:I63WZHA. I  !8A@  &0
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M4E]2$.Q9_@\R<W62$[@O68G12K^7L*M.-QB.!OBKWY^H2[(>S$Z-YIX$H_Y
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M&5#L>Q*, =IQ:P33W*&A59 4H!S/=J?E8,2CM0L!W71Z:M+OJ.&DJ_IMH"1
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M$"Q027SVD]O\G8,*:^I5$8C"O,V2;>EXS53&$FM0*2B$IV.Q$5HI%,B2)T;
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MP_E6CPC/$;Y%9HJ#.Y?*.@>6'!FT_EO\-VG79=H;]),#,@80K9E0],R2 LE
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MX5E12&[HN2'Z;(]9[[-K9\Z5:+3!@KN>(X%IU3&W:<7$<E6IC8#'X#; 5EO
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MOUKIS_,@\8)P<D*B0C\<,PS9,R%=?WE%R*MH79;E9DWDCX.'&AY@*XTR+PF
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M\OSG5Q=G^ (]\<'HC4O^K? H<VL_X1_3XK>3,Z1(ESIO<8D,_O.HKW19XDI
MQY^RZ$G8$U],_^U7?T.'A\/,,Z>O;/G1%.WJMY,?3U2A%UE7MG=V\[N6 [W
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M(#KY\9)'1,W4B4Y^^@3[2/!XN]':)ZAFV1\8)LDG\(%S0[S>X ?L9%K-VX7
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M+TYXQL;_T=HU_4#GW+:MK>B?X.' ZO !^'YA 7K+'[A!^,G6E_\/4$L#!!0
M   ( .Z%JE:FVUPVWPX  $\S   9    >&PO=V]R:W-H965T<R]S:&5E=#$W
M+GAM;.U;:7/;1A+]*U.**[%2B(3[4&Q5491D,RM+6HEV/FSM!Q <BHA!@,$
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MT*Q89E2NED56[*9*H5;P'D[]P W]T(XBUP]BFW]1%1KHE#AL[\3WW+[7[]#
M)Y733B,%XZ5$I&-*'V!U__OD_N><_&A@>?BQYWJ>M\?'(!PT=D)$!@/#R WB
MJ .WWZJLM#N%T*B@9#^8M:&AW_4^N)!6:#(V< _PS#'-$L8!MR#^F=N/8OCX
M;A#XP3D\"4W;-KO-G [Z S<8G,$@]MW3*((I*C6D8TM*@U$*:4_>$S]VS\+8
M< W<R/,ZY$NQK*MF(_,_Z/<$2HF*(S,*S]R0X(^T4;QMH_C-;33%9PK"$JEX
MR.:AUCF.->9\CW)%AQPUPPIAAHF@5(\IE'3NV;0_HM(4]!2N)06[;I)#>9TC
MDZ9&D)I1F^QA9EN)P>SSW2,(,[JB:\B01CA!1EU#;447$;$SU64)O-%:QX62
M5]2;=#V6):<:,"5#M_,R,Q=F(F2:F4P)"UJWKEE0ZR@.X4%FB5DQL>2MB,)X
MA_FIQJ171.U'W5>'!7;N'9.:HM;FB%EL?+Q#W)-]0)F0CX:.D;\6>9YI&V.2
MA G\2H\8;1-&[I, %3_5./D:=CUOZ-,'@F[L?8#2A+\HJAS\UKR][W6CN#F?
M3&Q+U"9VL/-*P_(UZP9S8SV(]ZWOS]O[9-W;M]XTO\/]B?F=\U[+>:_EO-=R
M/MQW_LN>]3<Y[V])^MW3EG.GK6"T]\,]-DWC3=1VPHXGN(W:N![HNFG7N^VP
M9GES<K(PA;PKZ9E].\/'I3ZGBHB][_0U::R3N5[V:-G$B8[?@1?M!$W Z[#O
M=HQL8(-A0W+HC.PUWH<YRJ5]!9M;E"Z9^JFX7=T^M,?U^W(G7K_2ZP94P'%!
MJB8I#LCZY5M/M"CM:W,N-+U=[7!%#J,T K2_$'0]K2?&P/;OQ^@_4$L#!!0
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M7A^RF?>:A:Y7=L::U1HG-ON8X8@LI#' ]XNZUKN%"= .W8/_ %!+ P04
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M=,2#H>G92'K#292<%KP0SDF07&X1%/9&5A"_KPGAAQO90'Y"-?@/4$L#!!0
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M5$LIK1_U76VU>:CZ(>!3MBI6VJJQLUG;3[W+JB+[,L\WUT(.IKO2.SC=2<U
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M8#F3Y2R6LUG.83G!<B[+>2SGLUS <B'+12PG62YFN83E4HS;>R/8*>".CEK
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M*HZ)^I1#?2/YICHH\(5+U>?J<DV)&J!+ _7YDG/Y=%-^07O69/H_4$L#!!0
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M O+OBRPK7SY4'>Q>IW7Q-U!+ P04    " #NA:I6[J.R4Z0$  #/$P  &0
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MI^PF%G=Q$I>Q+-@++DL1)\5+5?G3F+,7W[YDW[(X91\?LT6A2A?GW5)UO>I
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M8"]D[ AZ,X7>K+(^F,&X\D*;!@1A(9BWC@1>0\4)BI;8@;?7:!K:];<<@4P
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MEXCR@I-M\6[^CG!.DN+G!@<AIGD#\?R>$/Y\D2>HOP<M_P=02P,$%     @
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MCW&</=\IOK]E_XU H_\ 4$L#!!0    ( .Z%JE:&>LPBD@0  (,4   9
M>&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;+5876_;-A3]*X16# FP1"+UG=D&
M$MOM##1MX*3;P[ 'Q:9MH9*HDG3<[=>/E!3)DB@N'MP76Z+N/3SWZO(>BJ,#
MH5_9#F,.OJ=)QL;&CO/\QC39:H?3B%V3'&?BR8;0-.+BEFY-EE,<K0NG-#&1
M97EF&L69,1D58P]T,B)[GL09?J" [=,THG_?X80<Q@8T7@>6\7;'Y8 Y&>71
M%C]B_B5_H.+.K%'6<8HS%I,,4+P9&[?P9HI<Z5!8_![C SNZ!C*49T*^RIO%
M>FQ8DA%.\(I+B$C\O> I3A*))'A\JT"->D[I>'S]BOZ^"%X$\QPQ/"7)'_&:
M[\9&8( UWD3[A"_)X3=<!5007)&$%;_@4-JZM@%6>\9)6CD+!FF<E?_1]RH1
M1PX"1^V *@?4=7 &'.S*P2X"+9D58<TB'DU&E!P E=8"35X4N2F\131Q)E_C
M(Z?B:2S\^.1Q_N%^_ND)+.</GY=/BT\?P,4,\RA.V"6X E\>9^#BW25X!^(,
M/.W(GD79FHU,+F:6_N:JFN6NG 4-S&*#>Y+Q'0/S;(W7;7]3,*YIHU?:=T@+
M>!_1:V##7P"RD*W@,WV[.]+0L>LLV@6>/91%O!6ES<$2YX3R.-N"158N,5FJ
M?WX4YF#!<<K^4N6NQ';4V'(=W[ \6N&Q(18JP_0%&Y.??X*>]:LJ\#.!M=+@
MU&EP=.B3)7[!V1ZK8BP=O<)1MI:7B1U:KN>,S)=C]@HS!_J>7YNU>+DU+U?+
M:TH8!V0#/N>8%J]$6<(EAGL\MPL#S^U05)A!U[)#-46OINAI*<ZP>!^KN"P8
ML<C ;2HKZ9]B0,764] 01#ID^U;(AS!0<_5KKKZ6ZT?"&! T9S'+"8L2F=KY
MMWV<RS6@XNKW6+A^V&':MX$0#1 -:J*!ENBCJ$<:92ME10;]">UN.?9MD 75
MG,*:4ZCEM,A6),7@0B;Q$FPH2?^C+,,>!\_S88=HW^@*^G"@)J'5B(.E)YM&
M6]G-IN+%8JIN_%J$4[O7N=#:\1Z)(?R!?;P"/U<JSH363@5J4H'^;R^O/%N]
M)P@<NUN4*CL'0F]@5<-&;:%6Q=[8SRN0]O2.&UA=F@H[:$%H#=!LU!#JY?#D
MGE[AM?I-Z(:]O"K,1%CN -]&):%>)D_NZ["OA:[O=]GVC2!TG0&RC5Y"O6!J
M>SOLZQZ4&[TV,84X#G5WV&@CU(OCR?T=*I3/=KW>2^^;V4$XM)0:A81ZB;Q=
M*#EIG4[N9&=":X?8""X,?V13U\KYR:DX$UK[HZG1<Z37<TU3KSQ;JP':=J<*
M%59N.+#-0(WL(JV6O;&?5R#'<_LHZ.YX%59.B(8H-G*(]')X<B]'??&#/NIN
M,%568A\_P+812*07R),[.>IK8+==*DRND#? M-%(I-=(;1M'?:&#/5I]FP'A
M1HT0(KT0GMS#*[SC[]8K+PB[.PV5F>CTW:];\^@X)\5T6YQR,; B^XR71R3U
M:'V2=EN<'W7&[^#-M#P/:V#*X[G[B(J-/0,)W@A(Z]H7S&AYXE7><)(7AT;/
MA'.2%I<['*TQE0;B^880_GHC)ZC/'2?_ E!+ P04    " #NA:I6^W@;\" $
M  #S$   &0   'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6RM6&UOXD80_BLK
M]UK=24GL]0N8%) ()#HJFHL2KE55]<."![#.]OIVEW"I^N,[:QQC@[$N)W_!
M:WOFV>>9G?'.TM]Q\45N !3Y%D>)'!@;I=)KTY3+#<1,7O$4$GRSXB)F"F_%
MVI2I !9D3G%DVI;5,6,6)L:PGSU[$,,^WZHH3.!!$+F-8R9>;B#BNX%!C=<'
MC^%ZH_0#<]A/V1J>0'U.'P3>F05*$,:0R) G1,!J8(SH]9AVM4-F\4<(.UD:
M$RUEP?D7?3,-!H:E&4$$2Z4A&%Z>80Q1I)&0Q]<<U"CFU([E\2OZ728>Q2R8
MA#&/_@P#M1D8OD$"6+%MI![Y[B/D@CR-M^21S'[)+K>U#++<2L7CW!D9Q&&R
MO[)O>2!*#M0]XV#G#O;W.CBY@Y,)W3/+9$V88L.^X#LBM#6BZ4$6F\P;U82)
M7L8G)?!MB'YJ.'Z\G4SGY&XTGLZF\^GM$QG=3\C]ISF.'D9_C6YFM^22/&'V
M!-L("%^1.8B8S#A+R 06BGQ:1.&:Z261Y/T$% LC^0%=/C]-R/MW'\@[$B9D
MON%;R9) ]DV%I/74YC(G>+,G:)\A^#L35\2A%\2V;*?&?=SL/H%EX6Y7W4T,
M51$ONXB7G>$Y9_%0\S212FPQF17Y>X8&9*H@EO_4B=NCN?5HND:O9<J6,#"P
M""6(9S"&O_Q$.]:O=5); JL(=PKA3A/Z<,X5B[! 4#X_+'F=Y#U.)\/17Y'G
MH=_Q;;_7-Y_+8FK,/-IUW<*L0M,M:+J--&<@Y346CA!Z=5(N-,TZEGL8KS3]
M)?5ZCG?$LL[,=BVKGJ57L/2:6?)D390NI)SA=P76.^'B>[;CN4>4:\R<GG,N
ML)V"<J>1\NW7;9AF*9]P!9*D[(4M\(O %.E<63]?D& +NLC\"X+?I(BA.A:%
M_T) %B\DAB!<8OK *TB=O,;YWUHJ+8%50M4M0M5M]1O1;5-X2V 5X7XAW&_I
M&^&?%#_M==SCXO-/,OE,W?4*@KU&@M,$TQ*D(@+S\X)(A9> I""6N$[8M=11
MW2-2J\SBRNH<46V<]P?#3JW#)FXU!_YU3Y;D/W(7"E0X"R$Y[-6U^VXCYEOS
MKBVT:@1*;0QMM>9RN+;$MX16%7_H26CCSC^<A'+)MZ@:-Y*ZU:]ON^R3&KRD
M5N<DLW.[ZA9(J=VM+T5Z:"AH6QU%#E2FT*6V0YUCJG5V+K6],U0/305M[BHJ
M]77_V_2^U 6/U@+@W)[6C/OF-&L)K1J%0]-"O79KK+$)>K/XEM"JX@_M#VWN
M?WZLQCIUM>/[QWE;9V9[9SHV>NA#:.-N_Y8*ZYYNR*Y?KIR<:8V=9UDG_;!9
M.I'JOP/P%+<.L7HB6*&C==5%K6)_PM[?*)YFA]0%5WCDS88;8 $(;8#O5QR[
MSOQ&GWN+_SF&_P-02P,$%     @ [H6J5F$4B3%+$P  ;"H! !D   !X;"]W
M;W)K<VAE971S+W-H965T,S8N>&ULQ=UK;]M*8L;QKT*X1;$+9&.1NI\F!AS/
MS4!R$L0Y6Q1%7S R;0M'%R]%.TG1#[^D3'DX%#TBE7^P^V*/DYB_H>4'')(/
M+V^^K=,_-W=)D@7?EXO5YNW)79;=_W9ZNIG=)<MX\WI]GZSR?[E9I\LXR_^8
MWIYN[M,DOMXNM%R<1KW>Z'09SU<G9V^V?_<I/7NS?L@6\U7R*0TV#\MEG/YX
MERS6W]Z>A">[O_@\O[W+BK\X/7MS']\F5TGVQ_VG-/_3Z;-R/5\FJ\U\O0K2
MY.;MR7GXFPFC7K'$]EO^/D^^;2I?!\7/\G6]_K/XP^7UVY->L4K)(IEEA1'G
M_WE,+I+%HJ#R%?E'J9X\#UHL6/UZIZOM3Y__-%_C37*Q7OS7_#J[>WLR.0FN
MDYOX89%]7G\S2?D3#0MOMEYLMO\??"N_MW<2S!XVV7I9+IROP7*^>OIO_+W\
M)"H+A(,7%HC*!:*V"_3+!?IM%QB4"PS:+C L%QC6%QB^L,"H7&#4=H1QN<"X
M[0*3<H')]K?[].O8_BY%G,5G;]+UMR MOCO7BB^V@=@NG?\*YZLBO%=9FO_K
M/%\N.[OX+,7EET"=7UR^O_QR*:^"\]]%\/O'+_E7G\[_^_S=>QG\+?@]3M.X
M"%GP%Y%D\7RQ^6O^MW]<B> O__[7-Z=9OB(%=SHK!U5/@T8O#-H//JQ7V=TF
MD*OKY-I=_C3_ 9Y_BFCW4[R+O."'.'T=],-70=2+^@WK<^%?_.,L>QWTQMO%
MHX;%A7_Q\_M\]*B_73QL6%P>6/SA=K?RX:3IP_RYGUVW6#P:O[BX\2\NDMGS
MZ)'G-]E_SF-_Z_5?]+YFP>5JDZ4/^28R"_[G??X-P666+#?_V[!V[YZT0;-6
M;/E_V]S'L^3M2;YIWR3I8W)R]A__%HYZ_]F4$A(3)"9)3)&8)C$#84[R!L_)
M&_CTLR_K+%X$LS2YGF?!33R;+^;9/-D$^8R_R>+5]7QUVQ3 )W2T18L]A<>S
MWIO3QVJJO,-V316)21)3!S\(30YG?,,YO__A\^]_Z/W]B^0F2?/??G S7\6K
M6?[K#F;K3;9Y%:SR?<CU3;Z;-7M8/BSB+/^>>+E.L_G_Q<7^5U,JAGMK%X6]
MXG^U;'A7J6LV2$R2F'K"AH<^#DT.:AH&[;N#.CD9/>=DY,W)NSB=+>(?F^#_
M@X_YU+3=DPFN/JK/33GP4EVG)Q(3)"9)3)&8)C$#84[LQL^Q&Z,[1F,R>20F
M2$R2F"(Q36(&PISD39Z3-_%N\"Y769*K69 ? B:O@GQGJ)@![Y-TEN<PODV:
MTN<5NZ:/Q 2)21)3)*:?L#"J[A^][O7"<#"8N).N@<9ULC5]SM:T[63ZY2Y-
MDMV)@9?F4Z_6-5<D)DA,DI@B,4UB!L*<Y(4]>^:KA\ZH)0>%#]4$JDE44ZBF
M4<U0FAO!RLG7$)]:_63G&)*:0#6):@K5=*GM3;#1*!R%M0F6&MD-661#%K6=
M8Z_FWP_-L'ZL<[Q(3:":1#6%:AK5#*6Y ;2G]$/VG'Z(GM1'-8%J$M44JFE4
M,Y3F1M">VP_])_>/FFC)\]47J"903:*:0C5=:GL3[2":1*/Z1 N-[(;,%@BA
MOT&H'LPFZ3)XOXX;RP$_TSE8:(> :A+5%*II5#.4YD;/=A+AB)UBT6("U02J
M2513J*91S5":&T';3X3>D]#']N=^M7,2T::BU*HU[C@:]AJ:2XD.K%!-HYJA
M-#=FMHP(_6U$99)5\S3?HWL_3U;!Q5/LSF_3)-EN *^2QZ0H9L_S/UT7?].8
M/;2F0#6!:A+5%*II5#.4YL;3]AGAE)V(T48#U02J2513J*91S5":>RFL[34B
M[TGKIPC.-YN'>#5+GJYA:DJ>7^F:/%03I5:]=B<<3)OF771<A6H:U0REN:FR
M547DKRJVJ;J>;V;KA^;)U+]\YSRAO42I5?,TF33&":T<4$VCFJ$T-TZVE(C\
MI01ZM:5_K,[10SN+4JM&;S!LC!Y:1Z":1C5#:6[T;!T1><\U/VW)BI/!Z<,L
M>TB+Z.6'IT'R/<N_?)AO[K8[;LGW^V2U29JG3K2@0#51:L[4V9PWM'M -8UJ
MAM+<O-GN(?)W#^>5K5>Q9;O>;?I:[*.A%02JB5)S@M:8,[1<0#6-:H;2W)S9
M^B'RUP]?TGSCE1TJ'_Q(YTBAY0.J2513J*91S5":&SQ;/D1L^1"AY0.J"523
MJ*903:.:H30W@K9\B'Y)^>!7.R=QORXH=[WJDZ) !Y:HIE!-HYJA-#=FMGR(
M_.7#IR2=KZ_GL^ ^_E%LZE[M+B%I#%=Y#7[/O7*A=G7@A7_(SMLOM#9 -85J
M&M4,I;G!LK5!Y+\/HAXLYY1',%_E6[9XTWB54@E7-SI-)THO_"O0.69H-8!J
MJN4GHM%1#:6Y3TVP)_W[;4[Z/^^#;3=,3J*:LM-O.,W>&![_X%W#@VH2U12J
M:50SE.9&S#8 _18-@(U8L9N5!(_QXJ%QN^3'NNY:H9I -5EJU>W-J'&O3Z'C
M:E0SE.:&R_8!?7\?L'_RHKA=X85[%/Q6YVRAY_M13:*:0C6-:H;2W/Q5'CL$
M/W>(?? 0^^0A]M%#[+.'V(</L4\?^A4]0=_V!'U_3_ NWLPWP=,S"(-\K_\Q
M3N?QUT6RO6>A,8-H.X!J M4DJJE2"T/WP'PPFM:.$-!A#:6Y\;+U0+]E/?#3
METWZ!^J<.[1"0#6):@K5-*H92G/#:2N$/ELA]-$* =4$JDE44ZBF4<U0FAM!
M6R'T_15"R\LF_4KGY(WWSL!$XZ;" !U6HII"-8UJAM+<4-G"H.\O# Y>->E?
MOG.<)OMQ:NR?T&$EJBE4TZAF*,V-DZT)^OZ:X.<O7?,/T#EOT[V\-6^]T+H
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MU*U%9*>JV4#Q=7J2.>5*\3B]7.F$0)@']/R"<_4Z, L49]O=_P!02P,$%
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MYV"M/'1'XXZKWVYU1]!R,!1-5UD9:;[92#.HS%]F2;YH"PP20WTS*(WNN/3
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M!/'WARPK7S_(#)ZS_'MU.?W_ 5!+ P04    " #NA:I6TG7(O5$%  "^&0
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MKJ$@LL<WP/3(DHN"*-T5*U=N!)#,&A74]3VO[Q8D9TXRLM_F(AGQK:(Y@[E
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ME"1N!#"W@RC"$'@:<01S !XP)(K,>W#G?12LWE/!^K^UPV=02P,$%     @
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MD%1,B*0SP0][5CTVPZBGL+7':.-P.AZ#>"7^)XQ\NV4YG?#\4-)*'N,H:-$
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M#YOY)U!+ 0(4 Q0    ( .Z%JE8'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ [H6J5CX3.7?O
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ [H6J5IE<G",0!@  G"<  !,              ( !S0$  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " #NA:I6 '!:Z+4%  "L'@  &
M            @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ [H6J5O"D]CN>!P  &2   !@              ("!^0T  'AL+W=O
M<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( .Z%JE9@.)/+M0(  '$'
M   8              " @<T5  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q0
M2P$"% ,4    " #NA:I6C_LC+9\&   R'   &               @(&X&
M>&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ [H6J5J>BWJ2B
M P  R0D  !@              ("!C1\  'AL+W=O<FMS:&5E=',O<VAE970U
M+GAM;%!+ 0(4 Q0    ( .Z%JE8[]\J7&@D  .=,   8              "
M@64C  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #NA:I6
MUE@]2"H(  "-(0  &               @(&U+   >&PO=V]R:W-H965T<R]S
M:&5E=#<N>&UL4$L! A0#%     @ [H6J5N(^<:O\ P  L1,  !@
M     ("!%34  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    (
M .Z%JE:A?2G*2PX  '4F   8              " @4<Y  !X;"]W;W)K<VAE
M971S+W-H965T.2YX;6Q02P$"% ,4    " #NA:I63WZHA. I  !8A@  &0
M            @('(1P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4
M Q0    ( .Z%JE8I0[_(H0(   <&   9              " @=]Q  !X;"]W
M;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ [H6J5LK+(M-9!
M, D  !D              ("!MW0  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX
M;6Q02P$"% ,4    " #NA:I64F&!59L&   K#@  &0              @(%'
M>0  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( .Z%JE99
MYSP'J T  #,N   9              " @1F   !X;"]W;W)K<VAE971S+W-H
M965T,30N>&UL4$L! A0#%     @ [H6J5D]>Z,)1"@  <Q\  !D
M     ("!^(T  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .Z%JE;LK,JO\ 0  (H,   9              "
M@8C,  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ [H6J
M5E B)A59!   @ L  !D              ("!K]$  'AL+W=O<FMS:&5E=',O
M<VAE970R,2YX;6Q02P$"% ,4    " #NA:I6 S:D03X%  "M&@  &0
M        @($_U@  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0
M   ( .Z%JE95=84/Z"D  /M) P 9              " @;3;  !X;"]W;W)K
M<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ [H6J5O\O;+UZ!0  =R(
M !D              ("!TP4! 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q0
M2P$"% ,4    " #NA:I6MV:MFJD#  ! #@  &0              @(&$"P$
M>&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( .Z%JE8 >A3!
M:0H  %I+   9              " @60/ 0!X;"]W;W)K<VAE971S+W-H965T
M,C8N>&UL4$L! A0#%     @ [H6J5NZCLE.D!   SQ,  !D
M ("!!!H! 'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " #N
MA:I6/M7)^A8%  !L'P  &0              @('?'@$ >&PO=V]R:W-H965T
M<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( .Z%JE8DS$,&70D  $EJ   9
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M970S,RYX;6Q02P$"% ,4    " #NA:I6AGK,(I($  "#%   &0
M    @($S1 $ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    (
M .Z%JE;[>!OP( 0  /,0   9              " @?Q( 0!X;"]W;W)K<VAE
M971S+W-H965T,S4N>&UL4$L! A0#%     @ [H6J5F$4B3%+$P  ;"H! !D
M             ("!4TT! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"
M% ,4    " #NA:I6.):(A!<&   2+P  &0              @('58 $ >&PO
M=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( .Z%JE8(@H$I4 0
M .<6   9              " @2-G 0!X;"]W;W)K<VAE971S+W-H965T,S@N
M>&UL4$L! A0#%     @ [H6J5M&6KO0$#   3(@  !D              ("!
MJFL! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " #NA:I6
MTG7(O5$%  "^&0  &0              @('E=P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0P+GAM;%!+ 0(4 Q0    ( .Z%JE8>/'*3? ,  ($+   9
M      " @6U] 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%
M  @ [H6J5J@O XMY P  A@L  !D              ("!(($! 'AL+W=O<FMS
M:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " #NA:I62M?*X5,#  "Z%0
M#0              @ '0A $ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( .Z%
MJE:7BKL<P    !,"   +              "  4Z( 0!?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( .Z%JE8?#8WJD0,  +@<   /              "  3>) 0!X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #NA:I6OLLS09D!  !U&0  &@
M            @ 'UC $ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " #NA:I6(]5N#:@!  "X&0  $P              @ '&C@$ 6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     ,@ R )4-  "?D $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>327</ContextCount>
  <ElementCount>309</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>116</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION</Role>
      <ShortName>NATURE OF BUSINESS AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - RECENT ACCOUNTING AND REPORTING STANDARD</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARD</Role>
      <ShortName>RECENT ACCOUNTING AND REPORTING STANDARD</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - SEGMENT REPORTING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SEGMENTREPORTING</Role>
      <ShortName>SEGMENT REPORTING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - SEGMENT REPORTING (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SEGMENTREPORTINGTables</Role>
      <ShortName>SEGMENT REPORTING (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SEGMENTREPORTING</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails</Role>
      <ShortName>NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Service Fee Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Service Fee Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Annual Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Annual Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Effect of Derivative Instruments on Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Effect of Derivative Instruments on Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Business Acquisitions by Acquisition, Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Business Acquisitions by Acquisition, Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value of Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value of Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Investment in Joint Ventures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofInvestmentinJointVenturesDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Investment in Joint Ventures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Joint Venture Investment and Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Joint Venture Investment and Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - SEGMENT REPORTING (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SEGMENTREPORTINGDetails</Role>
      <ShortName>SEGMENT REPORTING (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SEGMENTREPORTINGTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Term Loan Debt Obligations (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Term Loan Debt Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Leverage Ratio (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Leverage Ratio (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Margin Spread Based on Leverage Ratio (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Margin Spread Based on Leverage Ratio (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Schedule of Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - STOCK-BASED COMPENSATION - Schedule of RSA Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Schedule of RSA Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="rdnt-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - STOCK-BASED COMPENSATION - Schedule of LTIPs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Schedule of LTIPs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept DueFromRelatedPartiesCurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. rdnt-20230331.htm 4</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept DueToAffiliateCurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. rdnt-20230331.htm 4</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. rdnt-20230331.htm 4</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept LondonInterbankOfferedRateLIBORMember in us-gaap/2022 used in 4 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. rdnt-20230331.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 -  rdnt-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="rdnt-20230331.htm">rdnt-20230331.htm</File>
    <File>q12023exhibit311.htm</File>
    <File>q12023exhibit312.htm</File>
    <File>q12023exhibit321.htm</File>
    <File>q12023exhibit322.htm</File>
    <File>rdnt-20230331.xsd</File>
    <File>rdnt-20230331_cal.xml</File>
    <File>rdnt-20230331_def.xml</File>
    <File>rdnt-20230331_lab.xml</File>
    <File>rdnt-20230331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="861">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>60
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "rdnt-20230331.htm": {
   "axisCustom": 1,
   "axisStandard": 35,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 861,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 327,
   "dts": {
    "calculationLink": {
     "local": [
      "rdnt-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rdnt-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "rdnt-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 564,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 3,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 8
   },
   "keyCustom": 38,
   "keyStandard": 271,
   "memberCustom": 72,
   "memberStandard": 39,
   "nsprefix": "rdnt",
   "nsuri": "http://www.radnet.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.radnet.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - RECENT ACCOUNTING AND REPORTING STANDARD",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARD",
     "shortName": "RECENT ACCOUNTING AND REPORTING STANDARD",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - SEGMENT REPORTING",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.radnet.com/role/SEGMENTREPORTING",
     "shortName": "SEGMENT REPORTING",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - STOCK-BASED COMPENSATION",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRecognitionPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "16",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRecognitionPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "menuCat": "Tables",
     "order": "17",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)",
     "menuCat": "Tables",
     "order": "18",
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - SEGMENT REPORTING (Tables)",
     "menuCat": "Tables",
     "order": "19",
     "role": "http://www.radnet.com/role/SEGMENTREPORTINGTables",
     "shortName": "SEGMENT REPORTING (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Tables)",
     "menuCat": "Tables",
     "order": "20",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfCenters",
      "reportCount": 1,
      "unique": true,
      "unitRef": "center",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details)",
     "menuCat": "Details",
     "order": "22",
     "role": "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails",
     "shortName": "NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfCenters",
      "reportCount": 1,
      "unique": true,
      "unitRef": "center",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:ContractsReceivableFactoringReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)",
     "menuCat": "Details",
     "order": "23",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:ContractsReceivableFactoringReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Service Fee Revenue (Details)",
     "menuCat": "Details",
     "order": "24",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Schedule of Service Fee Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "if70ac0bb6794471fac30d72ea02c9975_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i6dc177faf452405fa2bf716f25f19919_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Goodwill (Details)",
     "menuCat": "Details",
     "order": "25",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Schedule of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Annual Amortization Expense (Details)",
     "menuCat": "Details",
     "order": "26",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Schedule of Annual Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i6dc177faf452405fa2bf716f25f19919_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Effect of Derivative Instruments on Comprehensive Loss (Details)",
     "menuCat": "Details",
     "order": "27",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Schedule of Effect of Derivative Instruments on Comprehensive Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie8c2f246c0df4407bae5f83b9dea4895_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Business Acquisitions by Acquisition, Contingent Consideration (Details)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Schedule of Business Acquisitions by Acquisition, Contingent Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i2acb391edb584f9991ed018864e62fdf_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value of Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value of Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Earnings Per Share (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Schedule of Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesRestrictedStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i6dc177faf452405fa2bf716f25f19919_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Investment in Joint Ventures (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofInvestmentinJointVenturesDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Schedule of Investment in Joint Ventures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Joint Venture Investment and Financial Information (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Schedule of Joint Venture Investment and Financial Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i9ec59367bdfc4e95acaca6780a70c7b4_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentAggregateCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ibd669e75c1d64607a8a4a42d825b5372_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - SEGMENT REPORTING (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
     "shortName": "SEGMENT REPORTING (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingCostsAndExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Term Loan Debt Obligations (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Term Loan Debt Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Narrative (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "idfa89e509e1e48328e0d64bb2910a9ae_I20230327",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:ScheduleOfLeverageRatioTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i6f4de3e0b12c4ce99436f199560d928d_I20180831",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Leverage Ratio (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Leverage Ratio (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:ScheduleOfLeverageRatioTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i6f4de3e0b12c4ce99436f199560d928d_I20180831",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i24c9c233e2a54c57a8964647449f94d6_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Margin Spread Based on Leverage Ratio (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Margin Spread Based on Leverage Ratio (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i24c9c233e2a54c57a8964647449f94d6_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CompensationRelatedCostsPolicyTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans",
      "reportCount": 1,
      "unitRef": "incentiveplan",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
     "shortName": "STOCK-BASED COMPENSATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "ie931d8e47f25400f90b96046fd406a82_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "rdnt:OperatingExpensesExcludingDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i6dc177faf452405fa2bf716f25f19919_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Options Activity (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails",
     "shortName": "STOCK-BASED COMPENSATION - Schedule of Options Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i6dc177faf452405fa2bf716f25f19919_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "idca80d4271d24fc3a40ba5927cee3bbe_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - STOCK-BASED COMPENSATION - Schedule of RSA Activity (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails",
     "shortName": "STOCK-BASED COMPENSATION - Schedule of RSA Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "idca80d4271d24fc3a40ba5927cee3bbe_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i1cfa0f61545742ee999c634dad4b4b76_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - STOCK-BASED COMPENSATION - Schedule of LTIPs (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails",
     "shortName": "STOCK-BASED COMPENSATION - Schedule of LTIPs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i1cfa0f61545742ee999c634dad4b4b76_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "icd187a7758714339a38596e3b8703fda_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "icd187a7758714339a38596e3b8703fda_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:EquipmentAcquiredAndLeaseholdImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:EquipmentAcquiredAndLeaseholdImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION",
     "shortName": "NATURE OF BUSINESS AND BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20230331.htm",
      "contextRef": "i02a061cc075e43208a904aa1dd6ff29f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 116,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Current"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "rdnt_A2019SWAPS1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 SWAPS1 [Member]",
        "label": "2019 SWAPS1 [Member]",
        "terseLabel": "2019 SWAPS-1"
       }
      }
     },
     "localname": "A2019SWAPS1Member",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_A2019SWAPSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 SWAPS [Member]",
        "label": "2019 SWAPS [Member]",
        "terseLabel": "2019 SWAPS"
       }
      }
     },
     "localname": "A2019SWAPSMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AI",
        "label": "AI [Member]",
        "terseLabel": "AI",
        "verboseLabel": "AI Segment Revenue"
       }
      }
     },
     "localname": "AIMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AdvanceMedicarePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advance Medicare Payments",
        "label": "Advance Medicare Payments",
        "terseLabel": "Advance medicare payments"
       }
      }
     },
     "localname": "AdvanceMedicarePayments",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_AggregateIntrinsicValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Intrinsic Value",
        "label": "Aggregate Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "AggregateIntrinsicValue",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_AidenceHoldingBVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aidence Holding B.V.",
        "label": "Aidence Holding B.V. [Member]",
        "terseLabel": "Aidence"
       }
      }
     },
     "localname": "AidenceHoldingBVMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AidenceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aidence",
        "label": "Aidence [Member]",
        "terseLabel": "Aidence"
       }
      }
     },
     "localname": "AidenceMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ArtificialIntelligenceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Artificial Intelligence",
        "label": "Artificial Intelligence [Member]",
        "terseLabel": "Artificial Intelligence"
       }
      }
     },
     "localname": "ArtificialIntelligenceMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BarclaysMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Barclays [Member]",
        "label": "Barclays [Member]",
        "terseLabel": "Barclays"
       }
      }
     },
     "localname": "BarclaysMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares",
        "terseLabel": "Additional number of shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution",
        "terseLabel": "Fair value of additional shares issued after execution"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisitions",
        "label": "Business Acquisitions [Member]",
        "terseLabel": "Business Acquisitions"
       }
      }
     },
     "localname": "BusinessAcquisitionsMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Contingent Consideration Arrangements Change In Currency Translation",
        "label": "Business Combination Contingent Consideration Arrangements Change In Currency Translation",
        "terseLabel": "Currency Translation"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Issuance Of Contingent Consideration",
        "label": "Business Combination, Contingent Consideration Arrangements, Issuance Of Contingent Consideration",
        "terseLabel": "Issuance of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone One",
        "label": "Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone One",
        "terseLabel": "Percent of FDA approval and payout, milestone one"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone Two",
        "label": "Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone Two",
        "terseLabel": "Percent of FDA approval and payout, milestone two"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Period",
        "label": "Business Combination, Contingent Consideration, Liability, Period",
        "terseLabel": "Contingent consideration, liability, period"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPeriod",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability",
        "label": "Business Combination, Contingent Consideration, Liability [Roll Forward]",
        "terseLabel": "Business Combination, Contingent Consideration, Liability [Roll Forward]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityRollForward",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Number Of Identified Milestones",
        "label": "Business Combination, Contingent Consideration, Number Of Identified Milestones",
        "terseLabel": "Number of identified milestones"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets (Liabilities), Other",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets (Liabilities), Other",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities",
        "negatedTerseLabel": "Right of Use Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset",
        "terseLabel": "Right of Use Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_CCDGLRSServicesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "C.C.D.G.L.R. &amp; S Services Inc.",
        "label": "C.C.D.G.L.R. &amp; S Services Inc. [Member]",
        "terseLabel": "C.C.D.G.L.R. &amp; S Services Inc."
       }
      }
     },
     "localname": "CCDGLRSServicesIncMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_COVID19PandemicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19 Pandemic [Member]",
        "label": "COVID-19 Pandemic [Member]",
        "terseLabel": "COVID-19 Pandemic"
       }
      }
     },
     "localname": "COVID19PandemicMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CapitationArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitation Arrangements [Member]",
        "label": "Capitation Arrangements [Member]",
        "terseLabel": "Revenue under capitation arrangements",
        "verboseLabel": "Revenue under capitation arrangements"
       }
      }
     },
     "localname": "CapitationArrangementsMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CashHoldbackMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Holdback",
        "label": "Cash Holdback [Member]",
        "terseLabel": "Cash Holdback"
       }
      }
     },
     "localname": "CashHoldbackMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CommercialInsurance1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Insurance1 [Member]",
        "label": "Commercial Insurance1 [Member]",
        "terseLabel": "Commercial insurance"
       }
      }
     },
     "localname": "CommercialInsurance1Member",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ContingentMilestoneConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Milestone Consideration",
        "label": "Contingent Milestone Consideration [Member]",
        "terseLabel": "Contingent Milestone Consideration"
       }
      }
     },
     "localname": "ContingentMilestoneConsiderationMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ContingentSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Shares",
        "label": "Contingent Shares [Member]",
        "terseLabel": "Contingently issuable shares"
       }
      }
     },
     "localname": "ContingentSharesMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ContractsReceivableFactoringReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts Receivable, Factoring Receivable",
        "label": "Contracts Receivable, Factoring Receivable",
        "terseLabel": "Contracts receivable, factoring receivable"
       }
      }
     },
     "localname": "ContractsReceivableFactoringReceivable",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_CovenantNotToCompeteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Covenant Not To Compete [Member]",
        "terseLabel": "Covenant not to compete and other contracts"
       }
      }
     },
     "localname": "CovenantNotToCompeteMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DebtInstrumentCovenantLeverageRatioMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "terseLabel": "Leverage Ratio, less than"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLeverageRatioMaximum",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Liquidity Ratio Required, Minimum",
        "label": "Debt Instrument, Covenant, Liquidity Ratio Required, Minimum",
        "terseLabel": "Leverage Ratio, greater than"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "rdnt_DebtInstrumentLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Leverage Ratio",
        "label": "Debt Instrument, Leverage Ratio",
        "terseLabel": "Leverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentLeverageRatio",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "rdnt_DebtInstrumentPeriodicPaymentPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment, Percent",
        "label": "Debt Instrument, Periodic Payment, Percent",
        "terseLabel": "Periodic payment, percent"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPercent",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment Terms, Amortization Increase",
        "label": "Debt Instrument, Periodic Payment Terms, Amortization Increase",
        "terseLabel": "Periodic payment amortization increase"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentTermsAmortizationIncrease",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DeepHealthInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DeepHealth, Inc. [Member]",
        "label": "DeepHealth, Inc. [Member]",
        "terseLabel": "DeepHealth, Inc."
       }
      }
     },
     "localname": "DeepHealthInc.Member",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DeepHealthIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deep Health, Inc. [Member]",
        "label": "Deep Health Inc [Member]",
        "terseLabel": "DeepHealth Inc."
       }
      }
     },
     "localname": "DeepHealthIncMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DevelopedTechnologySoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed technology [Member]",
        "label": "Developed Technology &amp; Software [Member]",
        "terseLabel": "Developed Technology &amp; Software"
       }
      }
     },
     "localname": "DevelopedTechnologySoftwareMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DignityHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dignity Health [Member]",
        "terseLabel": "Dignity Health"
       }
      }
     },
     "localname": "DignityHealthMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_EarningPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earning Per Share, Basic and Diluted",
        "label": "Earning Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "WEIGHTED AVERAGE SHARES OUTSTANDING"
       }
      }
     },
     "localname": "EarningPerShareBasicAndDilutedAbstract",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_EquipmentAcquiredAndLeaseholdImprovements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment Acquired and Leasehold Improvements",
        "terseLabel": "Equipment acquired and leasehold improvements"
       }
      }
     },
     "localname": "EquipmentAcquiredAndLeaseholdImprovements",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquipmentNotesPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment Notes Payable",
        "label": "Equipment Notes Payable [Member]",
        "terseLabel": "Equipment notes payable at 6.0%, due 2028, collateralized by medical equipment"
       }
      }
     },
     "localname": "EquipmentNotesPayableMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_EquityMethodInvestmentSharesPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Shares Purchased",
        "label": "Equity Method Investment, Shares Purchased",
        "terseLabel": "Number of shares purchased (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentSharesPurchased",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Securities",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Securities",
        "terseLabel": "Number of securities without readily determinable fair value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Change for Contingently Available Shares Excluded From Computation Of Diluted",
        "label": "Fair Value Change for Contingently Available Shares Excluded From Computation Of Diluted",
        "terseLabel": "Fair value change for contingently issuable shares excluded from the computation of diluted per share amounts as its effect would be antidilutive"
       }
      }
     },
     "localname": "FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_FirstLienCreditAgreementEighthAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Credit Agreement Eighth Amendment",
        "label": "First Lien Credit Agreement Eighth Amendment [Member]",
        "terseLabel": "First Lien Credit Agreement Eighth Amendment"
       }
      }
     },
     "localname": "FirstLienCreditAgreementEighthAmendmentMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Lien Credit Agreement [Member]",
        "terseLabel": "First Lien Credit Agreement"
       }
      }
     },
     "localname": "FirstLienCreditAgreementMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementSeventhAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Credit Agreement Seventh Amendment [Member]",
        "label": "First Lien Credit Agreement Seventh Amendment [Member]",
        "terseLabel": "First Lien Credit Agreement Seventh Amendment"
       }
      }
     },
     "localname": "FirstLienCreditAgreementSeventhAmendmentMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementSixthAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Credit Agreement Sixth Amendment [Member]",
        "label": "First Lien Credit Agreement Sixth Amendment [Member]",
        "terseLabel": "First Lien Credit Agreement, Sixth Amendment"
       }
      }
     },
     "localname": "FirstLienCreditAgreementSixthAmendmentMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Lien Term Loan [Member]",
        "terseLabel": "First Lien Term Loan"
       }
      }
     },
     "localname": "FirstLienTermLoanMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FutureServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future Services [Member]",
        "label": "Future Service [Member]",
        "terseLabel": "Other Stock Bonus Awards"
       }
      }
     },
     "localname": "FutureServiceMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_GlendaleAdvancedImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Glendale Advanced Imaging [Member]",
        "terseLabel": "Glendale Advanced Imaging"
       }
      }
     },
     "localname": "GlendaleAdvancedImagingMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HealthCareManagementServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care, Management Service [Member]",
        "label": "Health Care, Management Service [Member]",
        "terseLabel": "Management fee revenue"
       }
      }
     },
     "localname": "HealthCareManagementServiceMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HealthCarePatientServiceOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care, Patient Service Other [Member]",
        "label": "Health Care, Patient Service Other [Member]",
        "terseLabel": "Other patient revenue"
       }
      }
     },
     "localname": "HealthCarePatientServiceOtherMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HeartAndLungImagingLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Heart and Lung Imaging Limited",
        "label": "Heart and Lung Imaging Limited [Member]",
        "terseLabel": "Heart and Lung Limited"
       }
      }
     },
     "localname": "HeartAndLungImagingLimitedMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ImagingCenterSegmentRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Imaging Center Segment Revenue",
        "label": "Imaging Center Segment Revenue [Member]",
        "terseLabel": "Imaging Center Segment Revenue"
       }
      }
     },
     "localname": "ImagingCenterSegmentRevenueMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ImagingCentersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Imaging Centers",
        "label": "Imaging Centers [Member]",
        "terseLabel": "Imaging Centers",
        "verboseLabel": "Imaging Center"
       }
      }
     },
     "localname": "ImagingCentersMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_InglewoodImagingCenterLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inglewood Imaging Center, LLC",
        "label": "Inglewood Imaging Center, LLC [Member]",
        "terseLabel": "Inglewood Imaging Center, LLC"
       }
      }
     },
     "localname": "InglewoodImagingCenterLLCMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]",
        "terseLabel": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]"
       }
      }
     },
     "localname": "InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofInvestmentinJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_JointVentureInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Joint Venture Interest",
        "label": "Joint Venture Interest [Member]",
        "terseLabel": "Joint Venture Interest"
       }
      }
     },
     "localname": "JointVentureInterestMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Joint Venture Investment And Financial Information",
        "label": "Joint Venture Investment And Financial Information [Table Text Block]",
        "terseLabel": "Schedule of Joint Venture Investment and Financial Information"
       }
      }
     },
     "localname": "JointVentureInvestmentAndFinancialInformationTableTextBlock",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_JointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Joint Venture [Member]",
        "terseLabel": "Joint Venture"
       }
      }
     },
     "localname": "JointVentureMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio [Axis]",
        "label": "Leverage Ratio [Axis]",
        "terseLabel": "Leverage Ratio [Axis]"
       }
      }
     },
     "localname": "LeverageRatioAxis",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_LeverageRatioDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Leverage Ratio [Axis]",
        "label": "Leverage Ratio [Domain]",
        "terseLabel": "Leverage Ratio [Domain]"
       }
      }
     },
     "localname": "LeverageRatioDomain",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Four [Member]",
        "label": "Leverage Ratio Four [Member]",
        "terseLabel": "\u2264 3.00x"
       }
      }
     },
     "localname": "LeverageRatioFourMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio One [Member]",
        "label": "Leverage Ratio One [Member]",
        "terseLabel": "> 3.50x"
       }
      }
     },
     "localname": "LeverageRatioOneMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Three [Member]",
        "label": "Leverage Ratio Three [Member]",
        "terseLabel": "Leverage Ratio Three"
       }
      }
     },
     "localname": "LeverageRatioThreeMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Two [Member]",
        "label": "Leverage Ratio Two [Member]",
        "terseLabel": "> 3.00x but \u2264 3.50x"
       }
      }
     },
     "localname": "LeverageRatioTwoMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LongTermIncentivePlanSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Incentive Plan Shares",
        "label": "Long Term Incentive Plan Shares [Member]",
        "terseLabel": "Long Term Incentive Plan Shares"
       }
      }
     },
     "localname": "LongTermIncentivePlanSharesMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ManagementServiceContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Service Contracts [Member]",
        "terseLabel": "Management Service Contracts"
       }
      }
     },
     "localname": "ManagementServiceContractsMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ManagementServiceFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management service fees.",
        "label": "Management Service Fees",
        "terseLabel": "Management service fees"
       }
      }
     },
     "localname": "ManagementServiceFees",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_MedicVisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medic Vision [Member]",
        "terseLabel": "Medic Vision"
       }
      }
     },
     "localname": "MedicVisionMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_Medicaid1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid1 [Member]",
        "label": "Medicaid1 [Member]",
        "terseLabel": "Medicaid"
       }
      }
     },
     "localname": "Medicaid1Member",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_Medicare1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare1 [Member]",
        "label": "Medicare1 [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "Medicare1Member",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MontclairMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Montclair",
        "label": "Montclair [Member]",
        "terseLabel": "Montclair"
       }
      }
     },
     "localname": "MontclairMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MonthlyAmortizationOfDeferredHedgeGains": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monthly Amortization Of Deferred Hedge Gains",
        "label": "Monthly Amortization Of Deferred Hedge Gains",
        "terseLabel": "Monthly amortization of deferred hedge gains"
       }
      }
     },
     "localname": "MonthlyAmortizationOfDeferredHedgeGains",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_NumberOfCenters": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Centers",
        "label": "Number Of Centers",
        "terseLabel": "Number of centers"
       }
      }
     },
     "localname": "NumberOfCenters",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_NumberofUnconsolidatedJointVentures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Unconsolidated Joint Ventures",
        "label": "Number of Unconsolidated Joint Ventures",
        "terseLabel": "Number of unconsolidated joint ventures"
       }
      }
     },
     "localname": "NumberofUnconsolidatedJointVentures",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_October2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2023 [Member]",
        "label": "October 2023 [Member]",
        "terseLabel": "October 2023"
       }
      }
     },
     "localname": "October2023Member",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_October2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2025 [Member]",
        "label": "October 2025 [Member]",
        "terseLabel": "October 2025"
       }
      }
     },
     "localname": "October2025Member",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Month Secured Overnight Financing Rate (SOFR)",
        "label": "One Month Secured Overnight Financing Rate (SOFR) [Member]",
        "terseLabel": "One Month SOFR"
       }
      }
     },
     "localname": "OneMonthSecuredOvernightFinancingRateSOFRMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_OperatingExpensesExcludingDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Expenses, Excluding Depreciation And Amortization",
        "label": "Operating Expenses, Excluding Depreciation And Amortization",
        "terseLabel": "Cost of operations, excluding depreciation and amortization"
       }
      }
     },
     "localname": "OperatingExpensesExcludingDepreciationAndAmortization",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_OperatingIncomeLossExcludingReliefFunding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income (Loss) Excluding Relief Funding",
        "label": "Operating Income (Loss) Excluding Relief Funding",
        "terseLabel": "Income (Loss) from Operations"
       }
      }
     },
     "localname": "OperatingIncomeLossExcludingReliefFunding",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_PatentAndTrademarksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patent and Trademarks",
        "label": "Patent and Trademarks [Member]",
        "terseLabel": "Patent and Trademarks"
       }
      }
     },
     "localname": "PatentAndTrademarksMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PerformanceBasedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Based Stock Options",
        "label": "Performance Based Stock Options [Member]",
        "terseLabel": "Performance Based Stock Options (\"PSOs\")"
       }
      }
     },
     "localname": "PerformanceBasedStockOptionsMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PerformanceBasedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Based Stock Units",
        "label": "Performance Based Stock Units [Member]",
        "terseLabel": "Performance Based Stock Units (\"PSUs\")"
       }
      }
     },
     "localname": "PerformanceBasedStockUnitsMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIIIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level III [Member]",
        "label": "Pricing Level III [Member]",
        "terseLabel": "Pricing Level III"
       }
      }
     },
     "localname": "PricingLevelIIIMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level II [Member]",
        "label": "Pricing Level II [Member]",
        "terseLabel": "Pricing Level II"
       }
      }
     },
     "localname": "PricingLevelIIMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level I [Member]",
        "label": "Pricing Level I [Member]",
        "terseLabel": "Pricing Level I"
       }
      }
     },
     "localname": "PricingLevelIMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level IV [Member]",
        "label": "Pricing Level IV [Member]",
        "terseLabel": "Pricing Level IV"
       }
      }
     },
     "localname": "PricingLevelIVMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level V [Member]",
        "label": "Pricing Level V [Member]",
        "terseLabel": "Pricing Level V"
       }
      }
     },
     "localname": "PricingLevelVMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property Plant and Equipment Net Including Right of Use Assets",
        "label": "Property Plant and Equipment Net Including Right of Use Assets",
        "totalLabel": "Total property, equipment and right-of-use assets"
       }
      }
     },
     "localname": "PropertyPlantandEquipmentNetIncludingRightofUseAssets",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ProperyAndEquipmentNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Propery and Equipment, Net [Member]",
        "terseLabel": "Amounts Returned to Property and Equipment"
       }
      }
     },
     "localname": "ProperyAndEquipmentNetMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_QuantibMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quantib",
        "label": "Quantib [Member]",
        "terseLabel": "Quantib"
       }
      }
     },
     "localname": "QuantibMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RamapoRadiologyAssociatesPCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ramapo Radiology Associates, P.C.",
        "label": "Ramapo Radiology Associates, P.C. [Member]",
        "terseLabel": "Ramapo Radiology Associates, P.C."
       }
      }
     },
     "localname": "RamapoRadiologyAssociatesPCMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RepaymentOfAdvanceMedicarePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment Of Advance Medicare Payments",
        "label": "Repayment Of Advance Medicare Payments",
        "terseLabel": "Repayment of advance medicare payments"
       }
      }
     },
     "localname": "RepaymentOfAdvanceMedicarePayments",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_RestatedAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restated Agreement [Member]",
        "label": "Restated Agreement [Member]",
        "terseLabel": "Restated Agreement",
        "verboseLabel": "NJIN Term Loan Agreement"
       }
      }
     },
     "localname": "RestatedAgreementMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RestatedPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restated Plan [Member]",
        "terseLabel": "Restated Plan"
       }
      }
     },
     "localname": "RestatedPlanMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ScheduleOfLeverageRatioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Leverage Ratio [Table Text Block]",
        "label": "Schedule Of Leverage Ratio [Table Text Block]",
        "terseLabel": "Schedule of Leverage Ratio"
       }
      }
     },
     "localname": "ScheduleOfLeverageRatioTableTextBlock",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_ScriptSenderLlcMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScriptSender LLC [Member]",
        "terseLabel": "ScriptSender LLC"
       }
      }
     },
     "localname": "ScriptSenderLlcMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited Or Cancelled In Period",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited Or Cancelled In Period",
        "negatedTerseLabel": "Forfeited or Canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited Or Cancelled Weighted Average Grant Date Fair Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited Or Cancelled Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited or Canceled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans",
        "terseLabel": "Number of plans"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Vesting Tranches",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Vesting Tranches",
        "terseLabel": "Number of vesting traches"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value",
        "terseLabel": "Issuance of common stock upon exercise of options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Six Months Secured Overnight Financing Rate (SOFR)",
        "label": "Six Months Secured Overnight Financing Rate (SOFR) [Member]",
        "terseLabel": "Six Months SOFR"
       }
      }
     },
     "localname": "SixMonthsSecuredOvernightFinancingRateSOFRMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_SouthernCaliforniaDiagnosticImagingIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Southern California Diagnostic Imaging, Inc.",
        "label": "Southern California Diagnostic Imaging, Inc. [Member]",
        "terseLabel": "Southern California Diagnostic Imaging, Inc."
       }
      }
     },
     "localname": "SouthernCaliforniaDiagnosticImagingIncMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TeleradiologyandSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Teleradiology and Software [Member]",
        "label": "Teleradiology and Software [Member]",
        "terseLabel": "Teleradiology and Software revenue"
       }
      }
     },
     "localname": "TeleradiologyandSoftwareMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loans"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Months Secured Overnight Financing Rate (SOFR)",
        "label": "Three Months Secured Overnight Financing Rate (SOFR) [Member]",
        "terseLabel": "Three Months SOFR"
       }
      }
     },
     "localname": "ThreeMonthsSecuredOvernightFinancingRateSOFRMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TruistMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Truist",
        "label": "Truist [Member]",
        "terseLabel": "Truist"
       }
      }
     },
     "localname": "TruistMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TurnerImagingSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Turner Imaging Systems",
        "label": "Turner Imaging Systems [Member]",
        "terseLabel": "Turner Imaging Systems"
       }
      }
     },
     "localname": "TurnerImagingSystemsMember",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_WeightedAverageRemainingContractualLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Contractual Life abstract",
        "label": "Weighted Average Remaining Contractual Life",
        "terseLabel": "Weighted Average Remaining Contractual Life (in years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLife",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_WhiteRabbit.aiInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "WhiteRabbit.ai Inc. [Member]",
        "label": "WhiteRabbit.ai Inc. [Member]",
        "terseLabel": "WhiteRabbit.ai Inc."
       }
      }
     },
     "localname": "WhiteRabbit.aiInc.Member",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_WorkersCompensationPersonalInjury1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Workers' Compensation/Personal Injury1 [Member]",
        "label": "Workers' Compensation/Personal Injury1 [Member]",
        "terseLabel": "Workers' compensation/personal injury"
       }
      }
     },
     "localname": "WorkersCompensationPersonalInjury1Member",
     "nsuri": "http://www.radnet.com/20230331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r244",
      "r468",
      "r469",
      "r473",
      "r474",
      "r508",
      "r557",
      "r638",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r244",
      "r468",
      "r469",
      "r473",
      "r474",
      "r508",
      "r557",
      "r638",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r241",
      "r242",
      "r363",
      "r390",
      "r562",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Board of Directors"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r345",
      "r346",
      "r347",
      "r348",
      "r406",
      "r513",
      "r545",
      "r558",
      "r559",
      "r578",
      "r585",
      "r594",
      "r643",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r345",
      "r346",
      "r347",
      "r348",
      "r406",
      "r513",
      "r545",
      "r558",
      "r559",
      "r578",
      "r585",
      "r594",
      "r643",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r306",
      "r514",
      "r579",
      "r593",
      "r636",
      "r637",
      "r645",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r306",
      "r514",
      "r579",
      "r593",
      "r636",
      "r637",
      "r645",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r345",
      "r346",
      "r347",
      "r348",
      "r398",
      "r406",
      "r434",
      "r435",
      "r436",
      "r512",
      "r513",
      "r545",
      "r558",
      "r559",
      "r578",
      "r585",
      "r594",
      "r635",
      "r643",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r345",
      "r346",
      "r347",
      "r348",
      "r398",
      "r406",
      "r434",
      "r435",
      "r436",
      "r512",
      "r513",
      "r545",
      "r558",
      "r559",
      "r578",
      "r585",
      "r594",
      "r635",
      "r643",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r241",
      "r242",
      "r363",
      "r390",
      "r563",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r407",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r262",
      "r407",
      "r601",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r262",
      "r407",
      "r601",
      "r602",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r624",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable, accrued expenses and other"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r311",
      "r312"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r217",
      "r225",
      "r226",
      "r472",
      "r565",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss, net of taxes"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r34",
      "r35",
      "r36",
      "r211",
      "r539",
      "r550",
      "r553"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r33",
      "r36",
      "r138",
      "r504",
      "r546",
      "r547",
      "r608",
      "r609",
      "r610",
      "r618",
      "r619",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r13",
      "r592"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r442",
      "r443",
      "r444",
      "r618",
      "r619",
      "r620",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r114",
      "r115",
      "r409"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net (loss) income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfDeferredCharges": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of amortization of deferred charges applied against earnings during the period.",
        "label": "Amortization of Deferred Charges",
        "terseLabel": "Amortization of deferred issuance costs"
       }
      }
     },
     "localname": "AmortizationOfDeferredCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredHedgeGains": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth.",
        "label": "Amortization of Deferred Hedge Gains",
        "verboseLabel": "Amortization of cash flow hedge, net of taxes"
       }
      }
     },
     "localname": "AmortizationOfDeferredHedgeGains",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r41",
      "r382",
      "r496",
      "r614"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of deferred financing costs and loan discount"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r56",
      "r80",
      "r86"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Intangible asset amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r175",
      "r186",
      "r208",
      "r239",
      "r290",
      "r296",
      "r302",
      "r317",
      "r349",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r468",
      "r473",
      "r485",
      "r592",
      "r639",
      "r640",
      "r685"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "BRMG and NY Groups accounts receivable",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r203",
      "r212",
      "r239",
      "r317",
      "r349",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r468",
      "r473",
      "r485",
      "r592",
      "r639",
      "r640",
      "r685"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "CURRENT ASSETS"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r239",
      "r317",
      "r349",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r468",
      "r473",
      "r485",
      "r639",
      "r640",
      "r685"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "terseLabel": "Noncurrent assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Alternate Base Rate Spread"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r463",
      "r583",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r120",
      "r121",
      "r463",
      "r583",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "terseLabel": "Equity interest issued, value assigned"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails",
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Business acquisition, percentage of voting interests acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r466",
      "r613"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in fair value of contingent consideration",
        "verboseLabel": "Change in valuation of Contingent Consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Range of outcomes (upto)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r126",
      "r127",
      "r465"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "periodEndLabel": "Accrued expenses at the end",
        "periodStartLabel": "Accrued expenses at the beginning",
        "terseLabel": "Milestone contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r126",
      "r128"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Milestone contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r131",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS COMBINATIONS AND RELATED ACTIVITY"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r122",
      "r123"
     ],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property &amp; Equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total Consideration"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures related to transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination by type of transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Axis]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Axis]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of transaction that is recognized separately from the acquisition of assets and assumptions of liabilities in a business combination by transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Domain]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Domain]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "BUSINESS COMBINATION"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r0",
      "r61",
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "NATURE OF BUSINESS AND BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r58",
      "r205",
      "r560"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r53",
      "r58",
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS, end of period",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r53",
      "r165"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "NET DECREASE IN CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Promissory Note"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r92",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r618",
      "r619",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock - par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock - shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock - shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r12",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock - outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r12",
      "r592"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock - $0.0001 par value, 200,000,000 shares authorized; 58,270,290 and 57,723,125 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "EQUITY BASED COMPENSATION"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r37",
      "r220",
      "r222",
      "r230",
      "r535",
      "r542"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r135",
      "r136",
      "r144",
      "r220",
      "r222",
      "r229",
      "r534",
      "r541"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r134",
      "r144",
      "r220",
      "r222",
      "r228",
      "r533",
      "r540"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "COMPREHENSIVE (LOSS) INCOME"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "COMPREHENSIVE (LOSS) INCOME"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r393",
      "r394",
      "r397"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r10",
      "r11",
      "r99",
      "r100",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Preferred stock issued upon conversion (in shares)"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CreditDerivativesByContractTypeAxis": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type of contract of credit derivatives.",
        "label": "Credit Derivatives Contract Type [Axis]",
        "terseLabel": "Credit Derivatives Contract Type [Axis]"
       }
      }
     },
     "localname": "CreditDerivativesByContractTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditDerivativesContractTypeDomain": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents major types of credit derivative contracts.",
        "label": "Credit Derivatives Contract Type [Domain]",
        "terseLabel": "Credit Derivatives Contract Type [Domain]"
       }
      }
     },
     "localname": "CreditDerivativesContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r97",
      "r238",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r376",
      "r383",
      "r384",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "CREDIT FACILITIES AND NOTES PAYABLE"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r176",
      "r177",
      "r185",
      "r244",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r372",
      "r373",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r497",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r167",
      "r169",
      "r360",
      "r497",
      "r574",
      "r575"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument face value"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r374",
      "r484",
      "r574",
      "r575"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "First Lien Term Loans and Truist Term Loan"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r25",
      "r167",
      "r388",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r25",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r26",
      "r244",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r372",
      "r373",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r497",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "auth_ref": [
      "r26",
      "r183"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments including both interest and principal payments.",
        "label": "Debt Instrument, Periodic Payment",
        "terseLabel": "Debt instrument, periodic payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r26"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Periodic payment, principal"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r26",
      "r99",
      "r101",
      "r102",
      "r103",
      "r166",
      "r167",
      "r169",
      "r184",
      "r244",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r372",
      "r373",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r385",
      "r497",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r166",
      "r169",
      "r644"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Discount on First Lien Term Loans"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": {
     "auth_ref": [
      "r166",
      "r169"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.",
        "label": "Debt Instrument, Unamortized Discount, Current",
        "terseLabel": "Debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "DEFERRED FINANCING COSTS"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares reserved for future issuance related to deferred compensation arrangements with individuals.",
        "label": "Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance",
        "terseLabel": "Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r168"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r168",
      "r644"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Deferred financing costs, net of accumulated amortization"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r168"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "terseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r448",
      "r449"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssets": {
     "auth_ref": [
      "r605"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.",
        "label": "Deposits Assets",
        "terseLabel": "Deposits and other"
       }
      }
     },
     "localname": "DepositsAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r56",
      "r285"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "netLabel": "Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r674",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional amounts"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r146",
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative instruments of a particular derivative asset or group of derivative assets held by the entity.",
        "label": "Derivative Asset, Number of Instruments Held",
        "terseLabel": "Number of forward interest rate cap agreements"
       }
      }
     },
     "localname": "DerivativeAssetNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r213",
      "r214",
      "r484",
      "r564"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Current and long term assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeBasisSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.",
        "label": "Derivative, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DerivativeBasisSpreadOnVariableRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r677"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "negatedLabel": "Amount of loss recognized in income on derivative (current period ineffective portion)"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "auth_ref": [
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative.",
        "label": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r151",
      "r152",
      "r155",
      "r157",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r145",
      "r147",
      "r149",
      "r150",
      "r159",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "DERIVATIVE INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r411",
      "r438",
      "r439",
      "r441",
      "r445",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r210",
      "r351",
      "r352",
      "r353",
      "r357",
      "r358",
      "r359",
      "r507",
      "r561",
      "r617"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).",
        "label": "Due from Related Parties, Current",
        "terseLabel": "Due from affiliates"
       }
      }
     },
     "localname": "DueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToAffiliateCurrent": {
     "auth_ref": [
      "r4",
      "r171",
      "r196",
      "r617"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Affiliate, Current",
        "terseLabel": "Due to affiliates"
       }
      }
     },
     "localname": "DueToAffiliateCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r231",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r265",
      "r267",
      "r272",
      "r273",
      "r274",
      "r276",
      "r477",
      "r478",
      "r536",
      "r543",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)",
        "verboseLabel": "BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r231",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r267",
      "r272",
      "r273",
      "r274",
      "r276",
      "r477",
      "r478",
      "r536",
      "r543",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)",
        "verboseLabel": "Diluted net income per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted, Other Disclosure [Abstract]",
        "terseLabel": "Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r63",
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r489"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "EFFECT OF EXCHANGE RATE CHANGES ON CASH"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized expense weighted average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r673"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Shares issuable upon the exercise of stock options",
        "verboseLabel": "Shares Issuable Upon the Exercise of Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r98",
      "r198",
      "r224",
      "r225",
      "r226",
      "r245",
      "r246",
      "r247",
      "r251",
      "r259",
      "r261",
      "r277",
      "r318",
      "r392",
      "r442",
      "r443",
      "r444",
      "r456",
      "r457",
      "r476",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r504",
      "r546",
      "r547",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvesteeMember": {
     "auth_ref": [
      "r71",
      "r521",
      "r523",
      "r525",
      "r527",
      "r529",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor.",
        "label": "Equity Method Investee [Member]",
        "terseLabel": "Equity Method Investee"
       }
      }
     },
     "localname": "EquityMethodInvesteeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Aggregate Cost",
        "terseLabel": "Total net assets",
        "totalLabel": "Total net assets"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r202",
      "r239",
      "r317",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r202",
      "r239",
      "r317",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember": {
     "auth_ref": [
      "r603",
      "r616",
      "r629",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee or group of nonconsolidated investees. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee or Group of Investees"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the entity's ownership percentage in the investee multiplied by the investee's total equity.",
        "label": "Equity Method Investment, Underlying Equity in Net Assets",
        "terseLabel": "Cost in excess of book value of acquired joint venture interests and other"
       }
      }
     },
     "localname": "EquityMethodInvestmentUnderlyingEquityInNetAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r72",
      "r291",
      "r604"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Book value of RadNet joint venture interests"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r52",
      "r74",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "INVESTMENTS IN EQUITY SECURITIES"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "verboseLabel": "Schedule of Investment in Joint Ventures"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r374",
      "r484",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimate of Fair Value Measurement"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EurodollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.",
        "label": "Eurodollar [Member]",
        "terseLabel": "Term SOFR Loans"
       }
      }
     },
     "localname": "EurodollarMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r160",
      "r162",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r160",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Assets and Liabilities"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r374",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r482",
      "r509",
      "r510",
      "r511",
      "r574",
      "r575",
      "r580",
      "r581",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r160",
      "r161",
      "r374",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r374",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r374",
      "r399",
      "r404",
      "r482",
      "r509",
      "r580",
      "r581",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r374",
      "r399",
      "r404",
      "r482",
      "r510",
      "r574",
      "r575",
      "r580",
      "r581",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r374",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r482",
      "r511",
      "r574",
      "r575",
      "r580",
      "r581",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r374",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r509",
      "r510",
      "r511",
      "r574",
      "r575",
      "r580",
      "r581",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Amortization year one"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Reminder of fiscal amortization year"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Amortization year five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Amortization year four"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Amortization year three"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Amortization year two"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r334",
      "r336",
      "r337",
      "r339",
      "r515",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r81",
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r85",
      "r515"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Amortiztion total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted average amortization period remaining in years"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r614",
      "r633",
      "r634"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedLabel": "Loss on sale and disposal of equipment and other",
        "negatedTerseLabel": "Loss on sale and disposal of equipment and other"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r56"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedNetLabel": "Loss on Disposal of Equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r56",
      "r95",
      "r96"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Debt restructuring and extinguishment expenses"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r206",
      "r321",
      "r532",
      "r572",
      "r592",
      "r630",
      "r632"
     ],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r323",
      "r572"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill from acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r332",
      "r333",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "GOODWILL"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r117",
      "r631"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Valuation adjustment"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOtherMember": {
     "auth_ref": [
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service provided for maintenance, diagnosis and treatment of physical and mental health, classified as other.",
        "label": "Health Care, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "HealthCareOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HealthCarePatientServiceMember": {
     "auth_ref": [
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service provided to patient for maintenance, diagnosis and treatment of physical and mental health. Excludes service to resident in health care facility.",
        "label": "Health Care, Patient Service [Member]",
        "verboseLabel": "Service fee revenue"
       }
      }
     },
     "localname": "HealthCarePatientServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r38",
      "r173",
      "r181",
      "r195",
      "r290",
      "r295",
      "r301",
      "r304",
      "r537",
      "r571"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "(LOSS) INCOME BEFORE INCOME TAXES"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r39",
      "r56",
      "r72",
      "r180",
      "r193",
      "r287"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity in earnings of joint ventures",
        "terseLabel": "Equity in earnings in these joint ventures"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofInvestmentinJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.",
        "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions",
        "negatedLabel": "Equity in earnings of joint ventures, net of dividends"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r340",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r240",
      "r260",
      "r261",
      "r288",
      "r450",
      "r461",
      "r462",
      "r544"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for income taxes",
        "terseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r223",
      "r446",
      "r447",
      "r452",
      "r453",
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid during the period for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accounts payable, accrued expenses and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r566"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1": {
     "auth_ref": [
      "r151",
      "r153"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) included in earnings related to the fair value of the hedged item in an interest rate fair value hedge, offset by the gain (loss) on the hedging instrument to the extent that the fair value hedge is determined to be effective.",
        "label": "Increase (Decrease) in Fair Value of Hedged Item in Interest Rate Fair Value Hedge",
        "negatedTerseLabel": "Non-cash change in fair value of interest rate hedge"
       }
      }
     },
     "localname": "IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r613",
      "r681"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r613"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedLabel": "Other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r613"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "auth_ref": [
      "r268",
      "r269",
      "r270",
      "r274"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "terseLabel": "Add additional shares issuable upon exercise of stock options and contingently issuable shares (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r335",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-Lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r82",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r79",
      "r83"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets",
        "totalLabel": "Other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r44",
      "r380",
      "r389",
      "r576",
      "r577"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r232",
      "r235",
      "r236"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid during the period for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "2019 Swaps - Interest Rate Contracts",
        "verboseLabel": "Interest rate contracts"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r316",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "INVESTMENTS IN JOINT VENTURES"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r606"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Investment in joint ventures"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofInvestmentinJointVenturesDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r23",
      "r239",
      "r317",
      "r349",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r469",
      "r473",
      "r474",
      "r485",
      "r570",
      "r639",
      "r685",
      "r686"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "BRMG and NY Groups accounts payable",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r17",
      "r179",
      "r191",
      "r592",
      "r616",
      "r629",
      "r680"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r24",
      "r204",
      "r239",
      "r317",
      "r349",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r469",
      "r473",
      "r474",
      "r485",
      "r592",
      "r639",
      "r685",
      "r686"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "negatedLabel": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r8",
      "r9",
      "r239",
      "r317",
      "r349",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r469",
      "r473",
      "r474",
      "r485",
      "r639",
      "r685",
      "r686"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "negatedLabel": "Noncurrent liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "LONG-TERM LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r8",
      "r177",
      "r185"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Total credit facilities outstanding",
        "verboseLabel": "Credit facilities outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r20",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r20",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of credit facility, remaining borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Unused capacity, commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r8",
      "r177",
      "r188",
      "r373",
      "r387",
      "r574",
      "r575"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Total debt obligations"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "negatedLabel": "Less: current portion"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r209"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long term portion debt obligations"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "terseLabel": "Notes payable, net of current portion"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r26",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofTermLoanDebtObligationsDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MediumTermNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instruments with maturities ranging from five to ten years.",
        "label": "Medium-term Notes [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "MediumTermNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r29",
      "r178",
      "r190",
      "r239",
      "r317",
      "r349",
      "r352",
      "r353",
      "r354",
      "r358",
      "r359",
      "r485"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r234"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r234"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r53",
      "r54",
      "r57"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r40",
      "r57",
      "r182",
      "r194",
      "r202",
      "r219",
      "r221",
      "r226",
      "r239",
      "r250",
      "r254",
      "r255",
      "r256",
      "r257",
      "r260",
      "r261",
      "r271",
      "r290",
      "r295",
      "r301",
      "r304",
      "r317",
      "r349",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r478",
      "r485",
      "r571",
      "r639"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income attributable to RadNet, Inc.'s common stockholders",
        "totalLabel": "NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r137",
      "r143",
      "r219",
      "r221",
      "r260",
      "r261",
      "r610"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r200",
      "r248",
      "r249",
      "r252",
      "r253",
      "r262",
      "r263",
      "r264",
      "r313",
      "r314",
      "r319",
      "r320",
      "r458",
      "r459",
      "r460",
      "r475",
      "r479",
      "r480",
      "r481",
      "r486",
      "r487",
      "r488",
      "r498",
      "r499",
      "r503",
      "r505",
      "r516",
      "r517",
      "r518",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "RECENT ACCOUNTING AND REPORTING STANDARD"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARD"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "RECENT ACCOUNTING AND REPORTING STANDARDS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r132",
      "r392",
      "r618",
      "r619",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "negatedTotalLabel": "Total other expense (income)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Notes Payable, Current",
        "terseLabel": "Current portion of notes payable"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Offsetting Assets [Line Items]",
        "terseLabel": "Offsetting Assets [Line Items]"
       }
      }
     },
     "localname": "OffsettingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OffsettingAssetsTable": {
     "auth_ref": [
      "r30",
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.",
        "label": "Offsetting Assets [Table]",
        "terseLabel": "Offsetting Assets [Table]"
       }
      }
     },
     "localname": "OffsettingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "verboseLabel": "Cost of Operations"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenseMember": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.",
        "label": "Operating Expense [Member]",
        "terseLabel": "Operating Expense"
       }
      }
     },
     "localname": "OperatingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "OPERATING EXPENSES"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r290",
      "r295",
      "r301",
      "r304",
      "r571"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "INCOME (LOSS) FROM OPERATIONS"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r501"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r501"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r500"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Amortization of operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets [Abstract]",
        "terseLabel": "OTHER ASSETS"
       }
      }
     },
     "localname": "OtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r215",
      "r216"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "netLabel": "Amount of comprehensive loss recognized on derivative net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r216",
      "r218"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedLabel": "Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes",
        "negatedNetLabel": "Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes",
        "negatedTerseLabel": "Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "auth_ref": [
      "r32",
      "r34"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "terseLabel": "Change in cumulative foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses [Abstract]",
        "terseLabel": "OTHER INCOME AND EXPENSES"
       }
      }
     },
     "localname": "OtherExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other expenses"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Radnet, Inc.'s Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsToAcquireBuildings": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for acquisition of buildings (properties) whether for investment or use.",
        "label": "Payments to Acquire Buildings",
        "negatedTerseLabel": "Purchase of imaging centers and other acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBuildings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Payments to acquire equity method investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.",
        "label": "Payments to Acquire Other Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": {
     "auth_ref": [
      "r611",
      "r682"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.",
        "label": "Payments to Fund Long-Term Loans to Related Parties",
        "terseLabel": "Payments to fund loan to related parties"
       }
      }
     },
     "localname": "PaymentsToFundLongtermLoansToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r607"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r50",
      "r113"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from issuance of common stock upon exercise of options"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r202",
      "r219",
      "r221",
      "r233",
      "r239",
      "r250",
      "r260",
      "r261",
      "r290",
      "r295",
      "r301",
      "r304",
      "r317",
      "r349",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r467",
      "r470",
      "r471",
      "r478",
      "r485",
      "r537",
      "r571",
      "r589",
      "r590",
      "r610",
      "r639"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "netLabel": "Net (loss) income",
        "terseLabel": "Net (loss) income",
        "totalLabel": "NET (LOSS) INCOME",
        "verboseLabel": "NET (LOSS) INCOME"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r91",
      "r192",
      "r538",
      "r592"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net, Including and Excluding Capital Leased Asset [Abstract]",
        "terseLabel": "PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r91",
      "r555",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "PPE estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r625",
      "r626",
      "r627",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "ACCOUNTS RECEIVABLE"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r405",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r197",
      "r506",
      "r507",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r170"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Expenses from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r405",
      "r506",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r612"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedLabel": "Payments on term loan debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.",
        "label": "Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security",
        "negatedLabel": "Principal payments on notes and leases payable"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Nonvested restricted stock subject to service vesting",
        "verboseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r14",
      "r104",
      "r189",
      "r549",
      "r553",
      "r592"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r198",
      "r245",
      "r246",
      "r247",
      "r251",
      "r259",
      "r261",
      "r318",
      "r442",
      "r443",
      "r444",
      "r456",
      "r457",
      "r476",
      "r546",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r281",
      "r282",
      "r294",
      "r299",
      "r300",
      "r306",
      "r307",
      "r309",
      "r395",
      "r396",
      "r514"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "verboseLabel": "Total service revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "REVENUES"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r227",
      "r239",
      "r281",
      "r282",
      "r294",
      "r299",
      "r300",
      "r306",
      "r307",
      "r309",
      "r317",
      "r349",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r485",
      "r537",
      "r639"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "netLabel": "Revenue",
        "terseLabel": "Net revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "REVENUE"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r120",
      "r121",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetails",
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofBusinessAcquisitionsbyAcquisitionContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r120",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Effect of Derivative Instruments on Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Term Loan Debt Obligations"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofServiceFeeRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r76",
      "r202",
      "r239",
      "r317",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofJointVentureInvestmentandFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r81",
      "r84",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r88",
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of RSA Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "terseLabel": "Schedule of LTIPs"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.",
        "label": "Schedule of Principal Transactions Revenue [Table Text Block]",
        "terseLabel": "Schedule of Service Fee Revenue"
       }
      }
     },
     "localname": "ScheduleOfPrincipalTransactionsRevenueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r66",
      "r67",
      "r68",
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r66",
      "r67",
      "r68",
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r408",
      "r410",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r106",
      "r108",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Options Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Annual Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "Term SOFR Loans",
        "verboseLabel": "SOFR"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionAxis": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of securities financing transactions, including, but not limited to those measured at fair value or cost.",
        "label": "Securities Financing Transaction [Axis]",
        "terseLabel": "Securities Financing Transaction [Axis]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionTypeDomain": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement of financing transaction securities held.",
        "label": "Securities Financing Transaction [Domain]",
        "terseLabel": "Securities Financing Transaction [Domain]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r278",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r309",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r343",
      "r344",
      "r572",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r278",
      "r279",
      "r280",
      "r290",
      "r293",
      "r298",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT REPORTING"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTING"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance costs",
        "verboseLabel": "Severance"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Share-based payment award, award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r423",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r423",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Weighted-Average Remaining Contractual Term (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "RSAs",
        "verboseLabel": "LTIPs"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available in grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "periodEndLabel": "Exercisable Shares at the end (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Exercise Price Per Common Share, Exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Issuance of common stock upon exercise of options (in shares)",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Aggregate value outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending Balance (in dollars per share)",
        "periodStartLabel": "Beginning Balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise price Per Common Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofLTIPsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSAActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Award vesting rights, percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Share-based payment award, expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "periodEndLabel": "Aggregate value exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Balance at end of period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable at the end"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Shares issued per share (in dollars per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r5",
      "r176",
      "r187",
      "r592"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r61",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "IPR&amp;D"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r201",
      "r278",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r309",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r341",
      "r343",
      "r344",
      "r572",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r28",
      "r98",
      "r198",
      "r224",
      "r225",
      "r226",
      "r245",
      "r246",
      "r247",
      "r251",
      "r259",
      "r261",
      "r277",
      "r318",
      "r392",
      "r442",
      "r443",
      "r444",
      "r456",
      "r457",
      "r476",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r504",
      "r546",
      "r547",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r245",
      "r246",
      "r247",
      "r277",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r11",
      "r12",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issuance of common stock for acquisitions (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r11",
      "r12",
      "r98",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under the equity compensation plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r11",
      "r12",
      "r98",
      "r104",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)",
        "terseLabel": "Issuance of common stock upon exercise of options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONScheduleofOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r28",
      "r98",
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of common stock for acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r28",
      "r98",
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon exercise of options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r12",
      "r15",
      "r16",
      "r70",
      "r592",
      "r616",
      "r629",
      "r680"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "terseLabel": "Amount of loss recognized in income on derivative (current period ineffective portion)",
        "totalLabel": "Total RadNet, Inc.'s stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r132",
      "r133",
      "r142",
      "r198",
      "r199",
      "r225",
      "r245",
      "r246",
      "r247",
      "r251",
      "r259",
      "r318",
      "r392",
      "r442",
      "r443",
      "r444",
      "r456",
      "r457",
      "r476",
      "r490",
      "r491",
      "r495",
      "r504",
      "r547",
      "r548",
      "r616",
      "r629",
      "r680"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEffectofDerivativeInstrumentsonComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names amortized",
        "verboseLabel": "Trade Names indefinite life"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "negatedLabel": "Non-cash change in fair value of interest rate hedge"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured Debt"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense between the reporting entity and the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Expense",
        "terseLabel": "BRMG and NY Groups operating expenses"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Income or Loss before Tax",
        "terseLabel": "Management services provided to BRMG and NY Groups"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income between the reporting entity and the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Revenues",
        "terseLabel": "BRMG and NY Groups revenues"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityRevenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "terseLabel": "Variable interest entity, ownership percentage"
       }
      }
     },
     "localname": "VariableInterestEntityOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r139",
      "r468",
      "r469",
      "r473",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLENarrativeDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r266",
      "r274"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average number of common shares used in calculating diluted net income per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r265",
      "r274"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding during the period (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.",
        "label": "Weighted Average Number of Shares, Restricted Stock",
        "terseLabel": "Nonvested restricted stock subject only to service vesting (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "d",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=35711157&loc=d3e42567-110969",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1828-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r595": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r596": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r597": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r598": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r599": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=126960272&loc=d3e32014-111567",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>61
<FILENAME>0000790526-23-000010-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000790526-23-000010-xbrl.zip
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MWM>5K,V"/X%!8RY%A6&F$;66$A=K>HV5L? <3RA 7P9FBOR140U#D=>/-(D
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M'-:"XWIM?^"Y5F_\7/#</\#S/L+SH_GU"DH_GID_&JP!X$>"(093HQ('3-0
M?F/P X&9:C8%28!M0?M""CM!/W1=LV@R')XZJ/1HOY1U(7CB/)UO>8?23*<
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MD6N=%($A,&WMG.I!CAJ?B[AN^:O*4]0;5<W_$)YS^+;^BYA(B;S$_;D6>:_
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M,:!+R XB*0>F;INCHG22KH0L"1M0^7KZX)L7OZ$<@:XG'+-4P(?D<XB1H_F
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M&F06;@X7O=:FH#$V"8B3@X<BD;-60PREN ;8J@:CH-D^?+'IK59@M(W64U0
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MV-D:Z_?RIW6RD<;YG;.=SO9W?Z=['SY^[GWXR'J[[]#?6!&4+&I #%> 6B&
ME$X"RQRF5FJ+&/IIS^[&[!/]HXOR>@D=ID=ZXJ<7.#%9KLEGYX5)IJDP23$^
MG95HG6 [OKBGO\[!A,Z[)Y<)?N=K^D6951<O.AT-YBMZ?JNM'U<Y5891A520
M1%"(C<322FEQ,$)J(LC?W7)Q,TBW(L39P7%<L/_O5K?WXHJ\YW*D9065P_)6
M^]]'^^/:CX\/W+CL69F^,+(!JY,(X-/2A-2L[O/?WFD'J<2 4P,!=8H""54
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M0SV:M4>N<S'_/9\WJLHVJKWY)E4RU#@/GWMG>W]K26S<E!BP7@A K;! 4F^
MPYPKBR5G029G &M1=6]O0#Y>K*\J5^?=RZK\0*K\]4=5MH$XRC2.?--;0(UQ
M0$$O <6,&T*51S3YZ3EK*9X/&!^;;YPWW!Z]+X9>3WU13A08!W :_\A'BP_#
M.[X)X762P4$:S'YX._6EI9S1JCJTZBX1#RFL55X' !FGR43&0 ?K@,8:*A0L
MQ,QL;7-,6@2J&AU#Y&/%FA*/K,L/I\L+S(,K3@/Q'$"C.: B&1%:(A"@,I%U
M.*E8-"(X)*THXAKI\M/T=%QW0G=RSMQ;W]T?I3.D*F:2'?GWI2T3-YK]:&#I
M'PVL[L@.3],$EO W_@9_TXQ_U>'?WA*7@5 $SX0&U-+(9;!D0$/L ;$6*Z61
MH#AL;:,6XK(E856V5S[EVRAPN"\/RN!0$W!8($?*P$B.E :,"IR<,0088SQ
M5%BG)*?"V3DXJ!9M3@C 9GEMKCX-W.^_ZASDX[Y-),$OQV/W>3 <YK.]=?O8
M+F8Z[S+5[3)OER@H\\P%0@*@+I5OHI  K=)^DUXU,'AL6#3!I6C!RO:8AG+,
MS5;;JMQI66W7HK8+Y#!(PJ2Q%!B%4DZ@$\ $3(!3#J%@E62$1K45HL5YG=1V
ML]C?RF=V9?[?(%E6[P>I#4$^IWL8#M']-N5SBS5:LYTOY]9L!JKJ@>K=$K_
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M "H#!5H&!@03@1'EC88PHB=J09:=-QNLN]4Y;[+NKDUW%YB/<%(8+#2P5DA
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M)0Y0:5)U>BN BCC#XJH((A5 N]VB6@>0Y475H$7%.;&"4 .8YBD$C3F@F)&
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M[/JZ:<'WN7\3I[X[VIE/? X;J0Z>KJ@>3@UT*K4W8-!'>R]@(*W'(&!-F8M
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M<&TH<&E'/&&2ZX#3828S@@I'J8&0<*J%*H$+7P 7SL!5=^ Z6P N*3DSW#L
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M'I1890A8+P0L\BZ22N?K "R&'E!I$%":** 9BS(,VF'-4Z(+:5%95<V8QD%
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M=,3_ *7X]V='?K(S/CZ9^",_F@X^^4N-@^=2V3D72C_)9#[$]LCUOTNH_4U
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MMU='0Q$JBT'$3@=H9*5 4^( \PX*)950F-4&39] K&O/SXI?AN/I]-=B4)Z
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M+K>V$6\I(>\?09K!,8-C?9[[5L$$6##IN:/.<XHLEB)H''DDUX%&6$09'#<
M'!>#B&B2M3(08)&Z"TG$@)1" F>9UQP3P@V*X A)B^.,CAD=-PH=;P&.D35
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M;IIZI+&6B!L+7G3..4H5(2J#OV#MMW:R%+SH%32%O)T>;5  [:D"P\/5.C;
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M#_(% C@K3V4XN#1G/QX; %)_,L :P+_ ?6-DI[Y:$DZ!'ET;RV5)PF/MZ0"
M;7"5:-=S4?3AYS]@C-;5P7/XUGD_0C=<OPL?[/8O_P12#0\<,CD'DY%7!15
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MQL9NX/3B:T*NXUG7^07A+>7VUR,:7G*8R?P\R=L\5.E<_IK'$C_*=L%E=EY
MX,,2@?<# L?ZITFVXHW/RQ:>%R?ELJ]$A A=)D(U)BKS.92(]2RJILG'__[:
MJ*D/INT6T_O#A[W%O#^:":,/+X\/").W7QX7__O>\JP=/NXN"8?.K]:/GK<B
M.Y'?7HR2F/^8U$.?G0R<;,*4_.?#/?_L<\?3/];JP>_2ZD99D0(!]=QF7)E,
M226P)(93RC1+R8^*:=@-64FA'F*W<IM#+<0N^$=]$-#]KU5:0.B7!/_;6[?]
M8YOIM)Z]/__:/3I_2SI_O_T:'=%W;\X_?'K-CD[>G,'GKSKGAU='[][SSM^O
M:><DUE/$[\"]QA_HV^S#21C7_M7123O]\'>HIS!IY^]]<'(/Z/MO!^F'3Z?X
MP]Y[$H_K*_#7ER?[H\-C3#K?VNSP\F/FF+><:)1BF2/."4'*IO 7SW$H?"4Y
M%X#M)&]1O%CONIQUK4R/PKMWU*<[F=DY')\W20T>-G@X7UR8<\,E 9@CCDN1
M2^4$89ESU%)!N/A1W5B#AVN&A]_F\- ;D2I82N2U=PCD)4>*<H4P<3DG86.&
MR=!K3+1X=E-1XF/%PTVBZ#_VH-8.?^NDPQN=*'JWYUUJ=38:?;66+B4BL\HP
MCKF5)F>YQADE1(=JWH:-;A3Z7BVPT=RK3'%&4)IK0%_I<J2QLL@S05.2XCPC
MV=:.R%H9O:G8]];@NQPA'A1?;QL:>O**CA7'.54:.VNY,$)EN3%>"Y\2E5'Y
MP_+\1M'73-'G:99T4N5.2&1,%GHY9Q;I3*3(&DHRZJB0'F_MY+@EY;V]SC56
M] T@4AL8ZZP+-GZ*2"UYWL>'KYP;1W+F>9Y3SIW0J996$**(),3@O"%2FX2O
MG=T%(I4J8$I. [1*'XH<'4?*Z1SQ5!MOB8!5MZ&7>HND;$5>[#HZJD]>T3.E
M*;9,VEQZ;HT4J93&42^I5@J$I"%2&Z;H\T0*&YDQXH Y20<>D[ 6*6X5\JG+
MN:&4X%1L[<@6%HN'ECT>/=\ 'K6! :EW_<%G-QC^GVG?8Y":?Y757'$?^=-X
M<-5$JVZ,5AGNF,A3)5W*P=T!Y$U5;IW-TM2+3#0D:Z.P]WB!9'$-1,IXB7CH
MX,F)8@C6FB!ME0A=Z4@>3A(EM)7E]]XJ6&,G]LDK.H:USHP75 G!+1:">(W!
ME6+ P;.T2M!O2-;F*/H\R:+.JMQ@AVA./'A3F4>2<8N(H\"EO1(R;@K2%E_2
M$_SQ*/H&L*P-C%8=Q<8#=>U"58?1A*YN#%U)90A/K=;@T6J%M0D5H))1(\'>
M:M6PJHT"V\6,-)MZ3*C72(03'CE6\)/,-+(^3X%C*9RR+'BT.5]5_L4Z>K1/
M7L^E5]P*G)E48,Y]*E(B#,E3J5)FG:8-J=HP/5_8 H3UM#:<4 WT&7&9":2)
M,8@;+;3)<Y6E?&LG;Q'ZF"/4&\"I-C!R=7BM^]*]2-63\&"98SZGV@G*+9?>
M@QOK26;!K=$T!V;5D*J- MO%Q"HBPX)*CHS& 6S3D-:*#2+8F%P9;P%OMW9X
MB_+%,W0?CP/[Y/6<8%!B9R0CS'/PHB0F8(-];H3+<LQX0ZHV3,_G254NM>).
MI,"B##A/'@LD+5>(>($--LX1"7J>ME+\F/5\ TC5!@:J3ES7#90MX':G5['K
MQW'?CR[+7LI-U.K[>1BYTDY214Q*./9&T$PSFAMKO-/8L89@;1+P'BTF7&G'
M<RN%1U88@<"R L&REB#A"6>Y2#6V.A LQAZS-_OD]3R<$*LM2:W-,;<LE=13
M[ZQ/<<I#UE5#L#9,S^<)%K,Z(VEFPJDW0+!RER+E1(Y2*EB6>6+S% @6:['[
MYZVOL9YO ,':P*A5W EL@E0W8:L1J<$YUH)ZQJV7,M/469N:5&7@S39)ZYN%
MK8OY5,KB-)=>(Z,SA;C+<Z0Y%\@82S.7$ZHS'IQ7AO$C=EZ?O)X3+8S3>::M
MD)Q+)SWQ5BFAE,LQL:KA4!NFY_,<*G7*>FQ=./D\1*J(14J!GH.;9*G03BB9
M!CW/^+USUM=8SS> 0VU@D.I6/:&;.-5-V*LR#&S*4NHRSID4DEF5@[^3Y9EP
MU#4;@1N%O8<G[8"[D6?!/%QVOAU^S(A@) ?(3:430+(T0<*F%'FA6"ZHI)PR
M<&!%B_![MUA88P_VR6LZ,"SO4\FU(H:G&1/8*Z]DEE)AB<J;%@N;I^E7US4=
M6T*5P@QI\)\0ST#=!9,6896"FIO0;\%$3>>2/&)-WP">M8&QJH/J$(_=V(<X
M.7:G,=OJS?TSK>[757&C,=GG6!FL=9:#XYL3KPS#-J=.86JDS-.&?6T6)N\O
ML"_@U;G 0@$<:X,X+""27FH4@!H[H[GR,F R@#*[-RC?5:'6Q3-N0.+[+9EU
MJ#IC699ZCGDJ% <#[V4:CBCC:1,>VSR0F"-NN66IR(A"WCB"."82*>L=PM8*
M\-685KD'D."D1;)5I7%M'$AL *W;P/!9^V E5.Y)>-# U4Q*<AH]:,F%QA*G
MJ3).8NQA3AJVMEE ?+# UC 3TCO'D><D0UQ2C83.&?)Y*GV:B5Q28&NT19JD
MKL>LZ$(I0K2UCJ?@EG$EM2"I3P4W.I,._Z(F6HTNWTV7YTB5$,*#2YTBQIA#
MW%B#9$X<RF2./?:2"!:2"YJTK284=M>\^&4':?XD_ZZ.AF0@,+8_#@=-UN-_
MLH>-K'Z"'HUA^JF3@1L&NK96ZW"!@7J:$N=ECK0A%'%L&5**<919KH7Q*:<B
M[-9*W$JS577$7YVF_>9808.Y#>:N_@2HC&=&">I5ZKDV5 MO4@9^0>9 )YUM
MPJ\;A[ESG@)C&!/))6):8<!<ZI'@EB)+,D,QETJ+O R_YMFJ$A0?#>;^;E_C
M7_&D]9WJ'/=J<3IC4*3"Q'/=2X#9B><HWWCH^\S4?0(]+/Q5.9M%S[K>Z!G+
MXC.O]$*_$O+">?)_'_VS_Z9SN-\Y2=K'QP?')^W.[OZS9/?HGX,]1&3RJMW9
MVS\\V$W@WV2W_6;_.&GOGB0OWG;V#CI_)RA)CGI)>1 U(:T$L XGHS.7O.L/
MNC;YMU/=T5ER-#A5O>);F8'YQ[M_'_T)4#B$V5 C9Z?W4L-$):?=O@8_"J;"
MNO/";"?)23]1(.5Z/(31!_2+1<<PB^?C+EP@WJX7KPW?<X#2_?.K5@(@>CJ
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ML(P<L+SN)/04,-@7/<#@\(V D9?]P>?P<UD4W2W# W%3(<)G))W_!RZFX79
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M0<UR_]1R?[[LO/Y(/992AN+"$-GE,/](.,N1M982P0T3A(7E7DQ;KY>[%5U
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MCK6.M8ZUCO5+8]5KC-$;W?4K:< EFE-_:V+P>QY"KV_D><^G!^_T\6*-WF
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MBQA)AFJ38C2\(KPBO!XS_40 OIC+Y5)8:EE$&"N+N,]0)R(@S.#OB#6A!A>
MBPKP"O!Z@O*C!_ABUMA8&KFS"EF6CQ!P!"-#HD.*,FF#\#1HN[(N5M6RJ:L*
M\ KPNM?VH2)ME_?:@J8.6**$+;CBT@ED.#:(">\HQ\DK$E;6U2JI6VTKS&NR
M^S$A^5(WZ(2Y,@I)(R2XW"D@0S%#^0PN"K_'*IJ5=:97L7S.4'Y!6VT-4Q1K
MP*U1AJ<0#2"7>6)$# S JVKB_+%B=S%Q3ED"U8L5$I&"-XVQ0]8!E 5E3D;
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MUR3EUWZ,U\@W?B:X_J9O?FFP9HU2\T3&FL_7(^J)#-:L"?IM=ZUC_<I8V<W
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M:AF*U+B\EXLA'6&1&7&:.IZLROU):E;T<4.O9D4?%\KH',K.=C;VF3 R6DY
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M=RVF^Z#OQK*0O_;;YD8CR/" U7&[#;#LP?&.8),U!1\PI@#^R0#(&F[LSEN
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M4>L=,R0&)S1/QN0?,=%:\BAI"E=GGJXBJ263^O/-YB:NTFZZYN*++)8ZGV)
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MWN*:.8QJ7<8H1EPP.C DN.*(2^Z1X98C++51,-\:6U_N<3$R?:I@GB#J<;Q
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MH)Q;9XP2*;& &?P4E,G:K34O8#+IUF),!,XLJ(CL>K>8(\LB12$18BR6,20
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MTCV8[KQ,QDW4;14>^*/DY?T);?-,9NV[X:A^\^>]& <?>]WC(U@);]BJ/=D
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MIP7+ 38B *6E@8J:"-4P-!<PY(E2R28N*,<B6>H2L/Q$12+&$%/#T.S T&2
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MWR:W#"T F_("6^9X-,3&$$5@)@9A2,#AKD%/-;X]%;Z=3N ;EC$7D1)(14P
MWY1"+A^E)DX90WF*\,_",C.+#/-YP;>W4#6MV>WX&]EG';ST-*3K?.!K7'HT
M7&I-NS63,5X0B:1D/%<$QTA+:U'2/DDODXX4YP2I=)'P7P:F&:YW].:E]W$I
M12V]3R*]DZS" ;;& .+*28B(TR21-4JBH#$+B2OL20XN9'Q1FEF2WK>T:=5N
M5:F(6P\,?)[?>M?_? 'R\-?Y:-=FS6,#T'14%*,Y\HT9%&2D*"<Z09:!@8,U
MEU:;%)148-;016.F/>G_>@W%JFO1?2SF4(ONDXKN)'?05@>719=+I1&W&K@#
M33R?=I;:!D\2L0O+U"P*/7TRX45$]XWM-_PJ<9A?L^6%B4-MO#P^ #6GSW5*
M(H-5'"/B L\A>!H9H2@2)D1&DR7>X(5EKA>UFHZ\O#L U9L.,RR]3\ =:NE]
M$NF=I \L1>D\]PAS['.I"XF,#@$E1D3.+4YIE,#\U:(1,R*]C[3I,#<'LK?*
MVH*YH&<=-U/[E>]&IJ(7.?NC"\D#' OKX;]@'F28]LKQNY*I1RM46(/S'<!Y
M.IJ&&L,$<1KA(#'BWA)D!<9(.^P<\TH0G>L<8K/(Y"\?.Z_#:6K8FV_8LRE(
M'Q(+PCI.P?2('%OLK  ZZG1T=V6A->P]+^Q-<M(HK;611J2U<(@+*I"CUB$B
M)*'$Z)S1.,.>7.1B;F!O1%O'#1FO<5Z=5'EDB_0.S[C0X2N.)#_&&UZHE8]I
M'U!1%82;9<WP[CSI:S>-D]+N3Z0K'245K]/IO9%T>D]K ;R%%!7/I?ZFG;&!
M:6%P<HAZE9VQ/"&M0 <&R3W#T;@4XL*RP(M*/%:,Z1SQ^AJ29JEO,\/.:TAZ
M3$B:9.0D"ANTU,BY(!!WT2 =N$"2L^1A8@4VI#S6(^0L0=)CYNZ<!RKX_J:*
M #FYS;CJWS7TL"H',=B+O3?FJ9X99O7E+$-1]?UZ!]A\%8M; ]QC =S&M!.;
M -=*E E$6$B(&T>1M5BCE#"U.N$D75A8UH!O:H;B;VM']EQQE%JXGT>X)]F+
ME]1S@S%2B6/$5?#(<<V0%EP;I[VRQF;A9M3,D' _YCX64S/.7"HG]Q/M8M6N
MH#?G"GHLEE8G<IT-4)_VC8.:IAKF%L6<\I%3Q9$Q3B!&2.#<JRARIHFG2.1:
MN\9G"Q9J/'P^8EOCX:S@X23)Y30SV120B[F\CA0::6(=4D8P*CSQ/L<*/6IY
MG=IG_JI\YI=SA)<_Z@R:=0;-NRO_<LF\A")<?W"JV<O)9%]+JLDWGFGSJ9)K
M5FS8S#@=SALGO?@C=HYCO5%2&P:W& 9,X<B3$HEQSR75-F'CX'\L*>:2H?<N
M5;=9+;VW0/;A3<VMG</&_H'8ILW]C:U/PYUO?^XU]O<.=CYNBYW5;;I-_]S?
M6&WO3Y)]Z!5I'L+[MMK[VQ0,@]4_<\6;X<;'S8.=_?9!<W]G?_NPP3>^-:]*
ML\DDHSHP#.Q>YZPQSB-K"$<F)VO SCN&^<(RIXM8RWDA^_7F1XUQ3U35"UM)
M)!?.<\ Z%HTA1!!LJ3<Z)H%OJ])28]QS8-SDAH:5REBJ-6)2R>R29\AA+%'4
MSL6D@L4T+2PSOLC)W&SP/FHQX7D@HE41D%]QG[XV&+ZJBZ\&:1^=3?[=ZZ;6
M(!<^KK'VT;!V.GVHQ9:X*#1RAMN<@! C$P2@KL L"4#<8 %KZ:+!LQ0A\4A[
MJS4:O5(T>G3>5Z/1DZ#1)/-35'$3'4?*BX2X!S2R03$DF;7>>&N2D O+8A&S
MZ62$+QRO=7.=U?QW7J&MSG%9GN]EMLS+4G$3XW162ZU<KXD1;85BR8C((U8P
M.LZYY(S@+! OOG.VL'QC ;;<BB<'B*G=W[)GS8VMM8(5__,/30GYHWBB6HQC
M2(!&KW@/2PHF=1?PH0._^M()D=W?[_=L9S=F5_F%:X 3MX[:L3\S=1F'8Y1H
MPG/7*8S?R?;63BM79=[^ML9W/C98<W]O'YY/M[^MGS1 @J?J,M(O\/FV:&R]
MVVM"FYH?=_:VM_8.MD\]W?C8^+E]"G_OKPPWOFVFQKX?-D^^R^ 23AJ&UA #
M3(/D,R4XE^X4PJ; &-:L G00EQA6,M8R%J(&PR_J2'FBSFJ"N1-:::PC3E-E
M'#?7WJ\UMXJ5]^\WOC2WUIL?BY7F:K&Y]O?&9OG7YRWX>V5S]?.TJ$X*QHUK
M?/G?KO?;Q$T3LE[-\:T=>*K:H7=8KW^#N>N'U<\WO39WOQ,@#EPIA8A*L"*%
M\,C&R)&5@(3&4BL<N:EDZ'2)T*<#P_*)O[<&\#I_!WC<C-EAUQX6Z_T^B%5Q
MOAJ*R\OA6A&XMG-72<'D?2]?)/5;Z0MN#;J]H@-/M.?]/[K4_Z)5#9 ;EE[D
M#RN?WY7GHT*WZ'0'A8OM5OP1X:/A[<\8[ 'KV-TK'Q3LH(QQ'NRU^D4O'G5[
M@^*DU6X7>S8_KLBEQWLMVRY:AT= :@J CNYQKTCC\K[G;N[^1-7A.]&-B6 :
M3JMC;4?=?BM?\WLOMFVN:?S'.*J@)-T7;AQ%=.#S6ZSK=]O'@^MOF?(6O]#4
M$STQ8!=^[IV%&1W9W8A<+]H#9!,T]G?;/K'#_L)OEQ4!:(&),9SL_K6=3.G)
M.EF15C!$NKURSG^O:M[#5= F.S-M*?9Z6:/]XW:J24$GEF6LL\R\S]JPQ":[
M?-54WHA2UU5IO@ZV[DB%Y>Q2X:+DPORYN/"[XSXTH=]_WSUT@%9YRE=;?=_N
M]H][,U.%O-D:,8K]KP?-;XUL"^/&_@K8GF##GJZ)QL<UNK._>P+/',(S^<[J
MN\-)1M'\]HELG^;JXY^&C=4OK/GQPWX#[&I@)H<;JRO0_C^A_7L'C8\[J7&Z
MC9LKW[E1)&E+D2<.&(45$1DG<W8CK5S C+"8IM@NMM@0:QA-FG/B\ZNY(X%)
M$KB(89*!O/OR>;VY]OES\7ZC\6Z]N;*UOM'\/&*\?ZULK:T"$=Y:_[J^M7UG
MNOMK4G0U!;ZM5_/"I%;R:>I*!3X167JF?M_8R_5#NYN)S?M2<1>?XVZF'D^T
M8![TH.=F$:O'O3P@F<NE5J\_*/Y[;'MY;$!!96A<+$XB2/(AV/B#DOO%ZN!]
MM53R53[V!K;5&25TK<@@/*S;;G=/\J.A@V4.9'C27LOO%;&5S^3#Q[M 38K0
MZD6?&3P\(=]W5.Y]^5)!]FQHP3#L#@N@MW8<B0\D=@3-L;]4%%OE32W044,@
MH+8/C1K%2O8O-;5?G-A^,>C" /?@W?!]146/>G!A+EL^:L![F"9X0*=E2X*<
MAWF[VSL )ML[@/Y5;YQ\M.W%$?N%YL%KCF ,<P_R"R;67+]:<_"<)U9@G_U>
M#,?MN)'&JNRBC+\;7OCK3:NSD^^>9^=>BBBJJ!$,MT9.!K"2$V.*T>!HH)/J
MC#@F,,.:6\FXQ-A%2A+!<+V)1&(QJ<ZRH69#-HF2;?5&AT,#R%3O<,0NQI)S
MEM=B)%!Y%<*OL$K"Q?(+Y>>7)>TDELO09\=_*/Y9+NCN,:!#Z/_K]V?2DK>A
M_I5:]-;!?.[@?3![EG!E^MPW>I_0):GT4P3$$_JP"/U;6BO8DYPU,.H)3@60
M)8X?=H3AQ@,72YS21W^J7N)$/?I3Y1+53S)?5-ZML;=%_52BF;W($V%'UP<D
MW50,YSD#\F\GD>7B6\N$9EC<X4S"&QB,U;P!N#)26?60G*=_R-L[_19TJ-1S
M]<CDD?F[USV"Y@R+_[&'1W\4.7',T24#[$V/SF;^/;/ +V!>K-Q<V/M-#<S'
M;C=DIT(]&M7YP('M[+8R':X7R?FP;)2["H\X(KWJX8\P6B\9=W8'J/GKFII^
M]X[O#B[_]X]7M=BNR4VY]'YI=>GCTE]+FTLC9?:Y^!Q[/UH>7K+>\4MW68+/
M-8"S%_=(?B._W?%<[QL>I7M$ARJMI> N>$DXCYH[3"F7+#%OF)&"C5)$$7Q+
M4.@57J_-Z+N['6AV6,\;0*W4RKLJ%=".B?]80Z]TP@4T6:EVK9IQ3BJ,/'#[
M<90LI<$W5K^V&]\^D<9^<V]G=?-PFWYH-;ZMT^96V-_9.N#-U6VQL?6A/1EA
MVCC=Y="VGSNK7X8-^N&@^7%G?SM'L>YODR9MMC>V=G%S_T TOGW-9XN&D\FC
ME(@6XUQA1#G$&?=(.RES\B@1#<62XUSO>E%@/!5A6@O@ZQ# *P5O;&[]W;:=
M 5QQ9F_5$G<_B9M*3R0P29Q31*/&B(>@D&7:H. U5QX'S%W.('Y%1'<M;S,B
M;[W0&3Q4V.Q5PE92ZHT$A+J\N-9XCRA_>$+^#*9):FR1,Y$CGB)&UJN8*[YZ
MJYFBH/> 9"Y*/7W"JY; &9' L<8;<\=:8AY18LAD\4V9K"<F(!.M09Q;A31-
M#A'GK C",<E%YHB8U#IKYB7F,3GB^6YB=7&YC;:U9SOG8EE+WGTDCTZ>_PM6
MR)S=!C062![F&&G# J),!4$DM]:P7 "K%KM9%;M?H8I7REQUR87/2Z&[K/]2
MZV<,Z#3VNK4 WD\ V80 ZH0]A7E'DAD'%)%HY#3&B$3BJ'3:FY#R$5)-"?WC
MF:7P=?@8KI;0?\Z)B%YIS6T<E8[[SNY?T?;CA>]KEOJ(HLHGBT7RY#%7&'GO
M&>)>8^"KU*&<\%LG%R35Y#J[[E^_YKNZG&[X*I%]:"+9EY"]S]WCK%(Z%Z.9
M5UMVM]/M0QO'(<F+I:?J3H%,CSM>LP=6USFD'JG_=::5E^[;/9112 9+3 DS
M&G@#2YHG147R3EDAG):U+^VU:*#6F2^--_;7?C9WORN9;$Z?@PR-"G$="6@@
M3!!)3'(CL.(>9PVDK]@GF8W<47<H>_<KH%5+=NVDFTU1/IT098J)MEP2Y*AA
MN?*X1=HJA30+U!L%3).:A64N?SFG<"W(<R?(M?=OC@0;3PAV(CAZ02B2)OLR
MDJ3(>:$1J.UHC5!,:Y%U--&_7+Z[%NVY$^W:K?B$HD@F1!%C!YR8"20%S6FM
M)49:.X-T3%RKH&$6619%JF@MBF]6%&M_Y0R+-)VDS0K+Y()'4>38MI0X,K "
M$"5)"I.\3X9>Z:^LY?FUR_.S.4)K";Z/!+,)"=8F8.F<0 )F%7$>*;+&!(1=
M8()9XK "PY>J6H)G0X+OXRB=.<.W=I0^AXCS"1$G)CJ3L$0"!XTX9ARY8!DB
M6&LB))6,A.M,X'\]T,=U9:S"B]21N3V\X@;?XSBGS2PAP'IGMQU/@,!.)(M:
M+/[ZZ_T31:#,E7N6/NUYP;D:BWL52F>6<9.,X9$[Y;637&5/5H@"+',\TA:T
M]F3.OXJ8/!7($G%)YN 98@SB.ECDI*=93W"&4Y1.LUP%1S[?J<!:S&JWXMS)
MU>39OV0$3&4RB#H><K) @9S'$049+?4\8IS#2;6:-J]JJ7I6J:I]?',D99,G
M_$(PG$:ED0DI!VU[C;3T!@5.DF&..<)L9>#H6LYF0WO5#K<G=+B-Y0*'8!V6
M%(F8(N(A,>1LS&?0C4N414%8:?A+4<O%C,A%[?V:8?F:/*T'%I, VT@B+/-A
M(2L\<MQ[Y*GFQ&J<//6/?EJOEJ#:WS1',C-YP$XRXFV28 ?I"#K)<(ZT,PD%
MBR-U./J@LDYZ[H/E=]FOGFU1NX]C:.:LI=HQ])R.H;$L.@9V$P-#21C%$6<Y
M-E*P@+0-V$O.B+7D.KOI)4_0S:)79M,>VJ-NL7E6A61E7(*DOUC\O?3^83D>
M7]G!N>L\,_7!N;=W<"Y)I6(,B<1<"RMQ;9,(H/]!_:1@I:G=3:]$\33?7SHX
M=YJS+(2H I,1#*>4$(\"Z*#5"IG(L&<R>1URT-$BOL+=5,<=U9+]J!ZN6LX?
M3<Y/)^4<,ZR<(HBHX!$75B+--44IRL23!'ZIRHUY*5DMYV].SFN?VQR)-IX4
M;1V]9-0@1[)G6^?(?T$#8D$KS2CV/,2<(U"I^NS[VQ/M:3=?+6WWD38R(6TV
M'Z5Q2B+)$D8<-"FRRD=DC0!]&KDDQ -AIM.9CFI9>RNR5KL.9UB@Z81 8RPU
M"<X@KCQ8P(E%9+QFR"EN,7=&I9B &=?V[QL4Z-J3.9,BS"9$6"EKC>(,26K!
MN(U&($LP_'#)6D*3@[E?6)[VG-0"///^T9FS;&O_Z'-(.)^0<*XQ54Y$Y"T#
M"3>!(,U S".U)NB .9'I.AOWM1V<&Q5$OSIZXE6D#K^A/N\CQ)X\P?CA/'I7
M87L]J[?-ZCUT@0M2FJB$)T%RB975EEM.@Z;"":;H2!<P5OLIYUL!-(93Q^)P
M(%@&HY"/^5B<"!H,-(81P8DQCS6Q%A2 631/$Z]62^>L2V?M:WPQ69T\:F>\
MY<%&B221%G&7!-+"2Q1X,LX8;2R6F:P!H:]E=2YEM?87SI%X3E7A2RY&0AR2
MUH$MY:E&UHN$K#646:P3H6YA62UJ-IUBMQ;/>1#/^FC?$XK3Y-$^GYCQ"=0;
MSC7"N/$@3APXJM?&""R8(Q28J5PD:CJG3RU.\R1.M5MOAL5R\D2@X,1%&QA(
MI 42:IQ"%@N"J'?"$<F)-VIAF3Y- ;]:*&>:@M:NN2<3P\E#AHIQ%AA5('<Y
MXQWQ#-F<A<6F9)B-3$;\^ =S?U$*7T=UOZLE]#Z^MYFS$FO?VW.(\%1U/TH$
MXXJ@)'U$7%.*G.0.:9<\#<KKH/!U]N(59Q-_&^397BXOS<NMU3FV(XD/K1]7
M?0X?C\5D^NCA2(Z6_^UZOYV#1OFD7[FO7"B)$6V%8LF(R",(0 C.N>2, % C
M7GSG9N&*EQW:WFZK4T$%+OU"SRSI-$MZT=S86BM$459()7\4(\%O@B#U6OZR
MI&-JL23>8P4=911K:S"WEH0@4Z(F?5\=IZ=%YR)_F1Q_CKMY8W4S'G5[6417
M6WW?[O:/>W$+7O.NW?4'+RQ^&Y_'XM=N-?8;>./;G_",+\.=_<T]$ BQ\7&-
M;7S[Q!NK?[9WOGW"S=6=%HA2._YG<[CS+1PYRN7&M_5AX_23V#[\NM_<^O.P
M^?'#(8@.M,&+G540W<.O[9U5N/?PS]38.CAMGGQ/.#JJK4:&>)H+23MD)9,H
MIV4GT2D!(UT!+ZQXH"$9Q'#@DE/\_[/WIDUM)%G;\%^IX'[F?KLC2";WQ3WA
M"&RP'_IIB<'&[8$O1*X@T,)(PBR__CU9)38A%AD!PM3T- V2JI25><YUKK/D
M22D$IYP$[*A1'*21:.8)UVFAB(!IAUFP^T=QX?W7U<^-U>9F\67UW^M?-M>:
MG\\5<;3:-P7\=ND?4[]JS>X?T/4'(,DK:8*W& MNJ=>2L(BE"BD:22Q?N#*(
M)U",\H[O6D/0>/\ 55D_ZA?]4G S-!6#2I0'A>U',&P#WV^Y& H7V[WC=U/,
MY%,^X9W/<[T;[?2@^(P%082.YO_ZF,_7H#CL]WZT8 V*P[W30<NWX%N*X]9P
MKVB-/@]J<$$#BF&O2-;GO^PP%L#?BU"=GMJ"Q>R&8MB/=EC>MY?@K4&F$=4[
M\$=)\ 9+Q=?8_]'R\'JKZ]M'(1;P3=V8SU_MQT&O:[L^7GS[;XTO:[\O@O!W
M#H^&("- ['J[?0N#+7[[N GO',)W#_N@1K'3&@RR/EW]R+]7\V>Z1[X=;;\
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M7?LS'Z.<6X%X"T[9Y-J?E?'NH<M7NH<^JE_/O$CO&Y//N@ZH3K3_$I1WYG5
M5Z$.?F_'_ LPWZN(5[/?V;'?Q@W7WPC"I6 1A9#31<(:</UY0E(SC;DP02M
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M ,] MN'>V_M B\X\WE[QI]N?_^YL?6^<P;_'&8PH>,[.YB)\D<.<DH-3G:A
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M7'A/)5FD]&:%[Y3&9C(2/:D]J=%@2J;Y2$B8GG(.ID*$FG;.#@O&:6<,4<M
M*?*6YG2WEIEV>F0Q)N"?NR1$+OC72_+1GOD<(\%KO\?/1GQ?$S\\5_N?8X@S
MC.&^0IOPVXM3Q%QMM%:V]ETYZE^4F%:)Q*NE2!>K7#/ F:'^S4-&M"1:.\!Z
MRHC-1T!RI UAB$7BI?#<6YR+62?N\+J1AYL29.8BE/!KJOFO0/W. :!F?T^
M ^/LCSCBI+8" 0=4B'-AD?$\("-DX"07HP>7RUR7R*/]P#D&@]=^CWO8WWD!
M)"Q>O/MKZT_^["??0H#VHJJB:H'P_[/WK<UM&\G:?P6E=<YQW@(87 8W>X^K
M%$O.:D\D)9:\.<D7UP 82+!)@@% R?*O?[MG!B!X%4F1$@EBM\J11 (8]/3T
M;7J>IVS8?>F"[=QJ>J,\^,PX_<F()VT_Q<Y[[8OI?@K3-7S#=EPM1N)I$E%7
M\V(GUHS(=H.(A"8QS*-WOF6KAK6IJLURJVQ7ZCEM9?=)%J+M(=@/PS 9SM/
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M5R2Y750(P8BK=),87AN4DO/=U86"2'6"M4()Q3@Y;062NXS==3@0%&IG_:1
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M*T%#,Q&7GX^B(^'6A](\W27L/I<L)Z-U(=V,4)>4=[B"=- 7)Y&D,,**9#9
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M9;T.^8%?R7L2^*6B$P2;4WA?"/R2*0^,9JKL-\EXJQ7CWX#'#@?YO3@F4?6
MS.W2263M$U2:#I)"_)V?M:"AP*[%-AW%A110R9*<=\C47P=N6X DJO:@ZL5$
M/T_]JS2ZHUPR&8T2F).;A_JW<3_Z6E7./YZIRF^GU_SJBV'8A==4SK$'"9\"
M\H6_XW."!\70.]8/'44I?:U">[#ZBAQ>.N:"KMZ>OP]VX_ ^HQDM,%+"O!,&
M[S[1*()C&>\$45'F Q9B;T?W057B+.W-:"<:[_+!QB?X.6#%/6-]Y=^T/Z09
MO(=L+BGG:/SAG<6=9--J/Z?_;%?:<BXK(MK32=#'\:'N;1_=/,+=1WNO1@HW
M6I5T &OD&ZRN O1,>66Y'4>!,7=!DU74*L/H&#](_<,DL6.5'R_].!.7"MR9
M=/R5K[4ZO#LM3KO=E-L<V03""OZZQ>U8AYILU4/N>/YSU1;*5UBQKMSF]*PA
M*!WVW8G-]1_?3#0\+^ACJ\[1C2O3\S:X^&;'LYQU&EQ@)HD__^.U>SOTCFO,
MOW31;1=_9GO+=8RL/%AS$XTH^Y1V/D($YB_S4CNX63W=[,%]PUH-'PV:SJF]
MZ"8T]JS6HK'XC9<A &R4Y,R-E.[V:8E<T2Z%C$M$$! JQ8PWR4,@ 5$'C^5C
MABD,XTD"_IX7:?A5"T3.D_8PQN!!R-9.0LT\$K9S@GRUO???[1-@IN&HMF'N
MWG&X39YU;)7Y,)39\!W5=W95F3>$=[+3JG>UI'M9ZO3Q'D-1&*IMKGK&>#-H
M%"U@R/*SI*N6_3*8,@<3H?X\3+H\\.3G,/\>)@-^;C:#?VCWP AO3$_U[559
M$6;/^4M&4TV?)5]U3.OE9ND0PH1S>:P^'PX&W>3@D(Q-736LER'S;L.#Y<,#
M6[4/*3S8YC;I0D$+%KP96U^EU%^BGOC_)LZ$'X;S<UR5V"]#R]>&*,MS:[FJ
M8[Q@('D((<K[J6WZEMUM)!V+$-7VUF2XWIFR\0;CF\9-L $QJK&K$RP-4#F0
M<N02B67#/F3?[W$(UOJ$#3(6)J*!DT.!]5(8W?=#+#Z;OFK[:Y)O[JGUW<=9
MLE5/?QG ZH,I/O^:YKF28LMV5P !"JQ![+.,1\7H ZM"V^ZJ-8TVOWONRI-J
MO&02?@@!PQ7#TRG]D/%^[$,K0!OFJDT2;7SP['L$+QC"'4)P,.^@RII]0_)P
M@P42C](A'I58&7>PV=UEFQ#0;B]9RR6JYZY:,]FXE/:CV;)=+^UZL5S5=-?<
MQWCY];(T#07'1!</%$?=\43=V!$[[5D.;,X^DCJ/D.[_/<_NZ^Q3I&=]?JHY
M5X)$D-Z)<PQI'"<0LI=M(W@.>4"33)Q_Z%%DQNMC4*\J23\?9N+'8)C#_?,<
M2;/Y%[MP#_#T<+MAD2<1'MC,[N!O<+^"=5F8]E1E6"3=I.#/@)G\RC!$@(\S
M>L>Z_"8IW[0N@X;YYY0GJ#UVYICN+%:% 5*-H]1160MQD*3.+#'.L=!70HZ!
MF7/>B&&FW-$L28?Y%@^Q+L?#\'(,*IL[CR/P \HD=<8A\6?'FW<,LB;>O.DN
M=Q1U1:AU3]\*@ON>W=98[JCSX0"!;QMIOF'(-"W _.9.8/Y6M_@?V(*^UH9B
MC+>X\RWN?(L[OT6QM;CSJY=X2Q/=0H4_ C@ICH*W8EHL)GG(N!738V)2;5MO
M@>?7EJ#?XLZO@3O_)&._)8'MH'*],G5+-7W2BNDQ*V:I1BNF1\6DJ_!3"SR_
M?E->"SS? L_OA@Q?&> 9C!9X_DE\):J[$6JJ@Y5@"SS_[.+=%/#\/B)7<ZS<
MJX+U>GR/%N&D<;?Z%CZ%G&(2KCY7^BE"F=,@O>-=!'@0C<8Q7MME=ZR;2_SS
M"-^0(;8S;UE(LX+?-NG'W>$W/(,PH$6"'.1*SMA7O'P6.'Q'4:X2>%_*4=U%
MWT'9TX";R?>X#9QTNTI,0W%SL8.<]!76&W33!R::G!6*XQ*[S 436_*TBV@\
M$EI?-#H,NG";A<#R^5*[W(U!FI=*0LR.RSMYTISW1KS)& KZCKTM,9?Y3FSM
M0FEZ]-$E- "3,2SF7S)E-EZH/<2RQL51__>V.G<YH#=,XP#G&HUAL&]H]YX^
MY$<_C;=F)'UM0H:3KS_W)>-X:R\IS$[$PE2<[WX#+H1E^"T8$]V9L2BP>N+_
M.?I'$EN&1VW7BGV;$::[X'""((@#WR969(3V9],\>G?-NT*032+%7B@\V$#?
MS9K*W6N=>0PY\&D$$#OM?A8*0,G2G"FOC(XY27U@_8#6>((C ?YNKTYDP)](
M,^&K()WOD(E[/$*BT%&.N]BG!685GQ?3!-O!ND.NB[S'2:'W-./N!(R\M-#2
M[\1)!M[I;S#26,&#"_B([L%===-[I$[)QX;WV.WJ##$U+R[<&!_/+47.E9N,
M]O&RY=AFE'PPS/@(N <7.Y:=76](6PY^[_&QM]UF>]86UG:;M=UF.YB.MMUF
MFT%3_2_:&[Q53BN#_G$QGFI#6XO:=K.VW:QM-VO;S79$6KS=K.T+>J3Q@(-@
MMU)Z1$H<A+J5TF(IO79<<RDKWK:8S13@:[-C_=@VF:W<9-:V SUBO6S5]=>S
M7H<D)4\UG59*C]EX4R6NOIZ5;WO+N)7W.NY3K7S;75;K+E.NDF(CQTD.MKWG
ME:4:=ML@]:0N/=5R-G&\XF EV+:8M2UFS[W'SU%79/D1MYB#1=NS)7J*PAN-
M8!!%"C]&PY#-^*YH1H([88M8A;_2Y0\*85P9#8M<N;]-PENY@9]FHG<JP%W[
M K%PE&B8X55B0W]^_]?B43>E[6LW-O#G,F6U2#![NXG>[LVW>_,[Z,?;O?F-
M<!I>24L-#I2[[T/;@&TWY=M-^793OMV4WQ%IM9ORRVQ%<$+:5DJ/E-PX(6PK
MI<52(JKM;EE(C3;OIM\A[9[\JGOR[3;J([;+4SVCQ3%YW,*ONR]U0%*R5,=V
MV@WY]2T\Z1CM?GR['[\[DL3=9+/=37Z24?3]5G[M;OP>B7>)W?AF;+US=)?K
MVK%MW'KO36RL5KOM>.X\RI([UE>"APH"1@"U2  8/(X>P!,BY3[!W>TL"4<W
M%\ G8L\]Y[OP](9CO QS<4:=1G?(Z1'- 7LYZU?T*QS;Y99&"N7C$*0TWR4J
M "WXX7JJX$9Y0KO%@Y+D*6@J4W[[\]?CCV<?_I3[_<GHV8A5\]O5^3%(?Q@]
M< B:+,T+O%>(@\I4/GIQ'3R<9DP9=HL272!C22\89G@SI"@1L#*#[C!7Q$ZR
M$E"DAN$[].Q;R%B4\T<F?7B?6D=#.BRZ]&$AR,S<^6EH?\';Z:7S0BT'EQQA
M: $QX@NV'KB.OF;K@>7;V]AU=]VM;.;OVVW=MO6@;3UH6P]>*+H3%ONRLMBG
M<ZALF[[-W+8>M*T';>M!VWJP(])J6P^66(B.JQ*[;3UX1$JVJSI&BYKPB)1\
MU2-;!DUHM'DWW"=O3+6M!^UV\:2%-]>V70<D)=M6O37YL@Y(2H[J.EM6I69;
M>+-M/6A;#W9)DJ_(AH*VPY6@L;91;"78-A_L;//!K+W0?6P_J$[^9XEH/4CG
M;+#RU@/\)4L8;Q"@89;FN4*[7=RIQXWT'OV"S06T8#<IIV"9HI89=3B49#6T
MD*0P+!*M"N-P^H\BWR_<II_[+DW9IC](]A<R+HZ6_:5E?WFRQO$[ODD*T.]P
MB2Z48]D#A2U [(8#C(RL#)J*?MJ?87?>E*_[O*TIGM71R5JM*<3K&-MH33$Z
M]C::/?;OMFUK2MN:TLS6%!T%=31CGAJZE=^V=[3M'6U[1]O>L2/2.F&###OO
M>3L^1J20',/HOH_3%K9;]?,(#FR_;6AX'$C=T]<[:GM 4K)4U[/;MH_U-P5)
MQVW;/I82U:]8CP5SCW6#-*>\+CM"0$4GP NB[3;^8^ULZR'$')"(#-58LRWR
M@(3T&A2II8987X#]7AOJ+R.GB[2OA32_54*>'^$>V3C%=8)3R_)"',N]9='-
M4KB?AQRU$55?DR/H<(3T&I'Y/,/?,LG9WLO))*IO+%7[:E. K3B"0XG_Q4G+
MJ1/Q;7@VT\2[5MO0_%A#\[;;F1L@HO6 E=H(?_,1_H%V>U\Q& W"X[1-MD^I
M:"RW.]G*;RY(=]OD_:1BD;N1/*IM\9XA7 18FK&%,+?!N]YU^&(]V?W>_RC]
MM%!ZC/9!U/%P=%A_7[HDS\JZ$YL@FWDQC"ZKXWAKT8,1H^/:RS7KK0A/97A;
M@?[:M]MZ;2-DVPC9R$;(W=*KV1ZRLM0M+5C;O-DV;[;-FVWSYHMC<RGK&.7G
M$AE7UIV2&=*CN!LIXC1:2(;J;*12TV0A$=4PY\O(? 89Z<I>2,JR._9__<-P
M]"ET@B4E]#2?QX6D[[:(-MJZ>J ['.^QN>DW"D/'<_NE6]S OMOSR'/WE/*5
M::C$W<3>[L%*T%4)V007V\$*T"#JHO1ZD9=]%@GNB0LV/*]CK>B#5Y#?03KH
MPT#^J8B'2N2?@F>=R<2F#1+TT*+(DF H-FN*5#+^(+0.MAYTNTHWI4BOT\4V
MA!SO)3B(Q.E#3D-48O]$RAW-$GZCL;;D7!F@@T\1WR>%IU8W6Q$-"%]HU ?-
MVZ('9>0P>B#"XPA\HB+I(4+'5)<TZR*R3]K/5866-$'R\P%]X =JY-/C)(,_
M_CVD&7R.[RG B*JOPVBR&S%^O W\M3<M+RRPS8?Y65Y_]E813X89S@-'0;IG
M".$$ZL-QIE!HU]DP 5&.9"<XH,#:(.S3B),*]/>5H7L=78$A=E'Y$-$J@!?F
MJIB7DR!%K^2WC(TF$CX!394SV5%^II)**F.AF.^20PLNN.FF06VUY$*).2<6
M+IQ0(%ZQ.!8 49/*G@JVJYSU477AOC!^):9ATH7WP/OPTUKP#:&JT=2R5/%5
MD,<KZ0_YFJQ6,3RV#TN!"ZNC7#&F(,29J;_]-?E[F,!S'OC-W],!;N0J'UD.
MSP$UY-\RWBH!ZZ;W?+WTTHPI$2MHTJU&/#740]5: 9R6@J(5J%V,2R<>%L.,
M3=M0^&^:XR><,@W4@5=HQ;3"-(([I$E_P@+E]W2@T)N,,;0V>4=1Y!J9 "[C
MB&7ESI:(!$K@,%4LI9"!!D:E,>3&*Q=P95P'QY_#:=L&@RS]5O*JO;)&ZTF5
M*P_D=2=L&KS%,!1O7WJ#R=>'H:,:XKA/0,YW')H,\KB\R(;BF;DPMOCLBQ3>
MW525*YCN)(8H 5;><1@BLAN^_&\0;(1\A4A_ &L@PH=@[-CGH0A?+\)\(*T;
M)Y 3CZD99[@V0:0X#DXW3]FCT6B+#-2$"I?04?905>>/>5?;1T[!7"%O8%\!
M<X8],%)IA_VQF?Z2)LA]".)%BL(G,-KMRDQ]F 8G'%OC(U!"L;I36"C?X4.V
MCKQ*ER&P$W$!OC(ZI'*?Z"D$6.+BL9@;&0L^W>S8(V,#PH_D)IL<FE$-#49%
MK([U U@7#/JJ[R%.90_,*6>$%,Y3FHH9@ZJ,8V4.Y6!*]#8,&OY_>U?>W39R
MY+\*GN-)-'D01("WG/@]6;8SVO78CJ3)[/Z5UP2:)"(0X."0S/WT6U7=N'B)
MI$@1 )&7D242Z*.ZKNZN^A6\<.7;_P?N18W$F$-B;.?)42,QG@P28[S3%P<L
MJ"QSVO/\5=3G"FS&&_ V").Q K9 ^08J"684HTQ:_!'<\VE BMGB4\>;P189
MWJ-RM RKT9KI5H>[8]KFD$,V]<&YB;VLN( M^'@C+EJS)^#T@:<35Q/VHA#V
MW@C\B_MWF#J?3,=401>:&/B@854%Q3H(U:1.K]BW3",'+ 7BVEHV&[GPE6VB
M__J[*-DKYT#;[OSL9"5>T-PQ$"ZAYPJ]J*#W]0@*7"I\4BF6]T3S\:%-W AA
M]PG*+WQ.)P:R]26@OVM\9VJ*+!N.F2%FL ,;HQ3#<T]<]<I0H!U-U_5=(F"-
MGF9T5P=X[AS\V=':APBL+5^SFT7 +K]EB-G#]<@PG5A,XUYC92L2AO7"@-AB
ML%F-(5J'H=9AJ,O#4)?$4]:1IYM&GNY/O9U C.IR6;R+CU71S?Z6');L(;3P
MA0:APJWO7X8W&-1>I.)4(%ANQ3ZT2*@9QPRY6*XZWAJJWMP-7>MT:-3N'QA9
MI/04TM5V<S4(Y>8!9!6*$5OA-K<[6A+L>0RM^*+XM"J%H"U?GY]JW_00_+;J
MYQUS&)6GPQ/>W_'\N\Z'6;O7;(.YKG.&GH-Y-WJ[(2*?#HUTM==:#:U=YU4E
ME )[;=1Y55N$;1]UYUHARQAZYH-R[4WP G7W2C$O(EGQ6*W3WDUI;4>&DJBF
M;FO;C$])AA?JF)KR9[W> M!$3?1#$UW7M>W)OLX*U[;V)6Y>=6SMMWQM\@.Y
MQ244.5UM];N[>;^OJ>XJ2?M^HU%3_CA;OIKGC^7>=[9.H-Y@LUV;^7I+C3]S
M=5C_S";3=\H55F+5ZITUFOJN<:@;O!)J(EUMZCMB.=0;O1?2OJ7K->6/ R*F
MOQ# I+:_]39[TVVVXF"-W+,1L]W5J*TGYP+O>-E4;SU>>KIH=#8_6ZR)OB=F
M[]7<?J2S]$976ZR(7.^RZUWVBR^N7U0#K6J[ZM4Y4B>WN4!0*]UX5V_MCL2)
M->'+Q_:UP:VCJ]<15%2G2+?4+RHX7<'HU^5!_OV=X8XK&_RZG% =U= [)<I6
MV3@!M!@;QTKQBJ'V&MV:5VI>V8!76FW-*"VK5"F@_\A)<*>2BOX%;SH(UO*%
MZ PGDU%\UE%[_<9N9;A/ATAMM:,OGN+61,H?=:M&M[G;#>.I):<;6ID\N#HW
MO3X]>1&_B8"$N## F>TBR.INZO1DSDZZC=W08DZ&0&?M1JOFH;4D HO<J)//
M-S'(S;[6+I%%KC?*]4;Y1?QV0R98&? AEH )V8\=KS).9W?35=O]-;N;FDAB
MGZSK-9&>(9*AMGIK3ESJ?7)Z?-TKE56N]\GU/GD?5GEW<WPR.QL9[%,3:?W9
M?F?'0^N3(1%0J-X?;W*VWVAHBSY+O3\][O[T0&7@BVXF9:DSQ>4AY;;MP94^
M$"7+(M[+-[?[H-TKQ/L435X*N+YO6VJKM9AW5Y-P"Q(V5;VUQIVJ=<VF]UI:
MK[1[^K5+5[LY:]V<"RK@^+[,E4EEI9. RFKF:GB*.LP6E8.G@IM3WX9G9ISY
M6$<3:WY^DH5)/U"9^&OFPI,?>2BKP$]];^2SB3+UGK@/#0UF\"6?_L*9$XZQ
MKS$T,^#<Q<*FOH?UYZVXCO5GF+UM,96F^5_<#_B,<-[QS__U_ <%*/S 0RQ'
M>A50T6HVF2K15-2#CWL6U56I3*F"K(G#8@Y^#9V%8LX>7>2'LZFH-&KBA/Q
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MOH; X<R=T7ED]QVH&[Q/37DML[H*0P068 >A1$4WR[10Z9;D=ZQO#7/F2P1
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M!F*[80\HJD_8(C!1W!?V:WG@OR?2 _\"<W$QSRB,?!!_<%)QH"!0+DD6MAK
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M"/3)))09S0;!HLS#L<9HJO ,38EE9C)##T< [DVQ ;1>!($&3HOE$48D384
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MXPY=5H8#<J?C55]""5DLS8MOZ(F]\/GGIR904%)[RE(;ZUKQKV+E":K%CT$
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MJ*ZJ"(RU)ZE08@UD+-J:=3>%H":.YV9R>N'YF3@^*;2'R(AXJ81W"B[A1D[
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M8L$:2-9BT2=G*,?IP?/L9^(XA_"!;=Y"Z/-9F5K0)_).>)=CHKMNB!Q]X=&
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M)FU21'+!FK>*7QK=VG/_ROZ<3G;2?U\,27,7PU%5T:Q>!LBLM@IX210_$$_
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M6+]GG>U"5P^%35OC7E1EG4U*=Y^;YG0LV&PX $'?$HA,(6),X2+)QFFJ2UF
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M&3!NC*0A$L,"1L#X)?$X4N)U9DRK5(YE#ZM41/DOI?;"YQJE[KRKWF%DY3!
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MIR28TK@D5V;Y]O./CN>=C;N&Z6X;]XL%\!Q7L,G\=H1R_Q:&C^_ I^'HRPO
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M2$9S)35CK7R'KS]W_[Y"7:,W=2S6AX_0C"]F,+DLOM'UD:>W)0W'"\)#\5M
M*.++MQ*2TMFDP&AU_V -CN/V#;H:?LV;W+D-]EU0JP*9%K#Z\@;6(CJ0#]"9
MLD<TT,'<_?2O68<N!Y^#R8KDK%V9^"AQ@'^89*(*DCDN:F?][U,$CZWP>]+
M-E;NV>-;W>U@7+3*2&*TL25(]L0+%TF*P'QR)J?J-^C=1W$ 1Z "/P\X=#L8
MMW8/@.O5;M$*X3>8?6C2Z?@33&<WK31N_Q3@^DY!;V*PQAHB'$.]>Z])P"&@
M%P0\,6J%#ZU$\6C]Z.X8C]*+V"MQ:^:7G9LH%^";@*V6OQ;0*G8?>!C- 5H0
M[(W6IE=**A>P/X:0!AI2E@3GRY*E6;9:HZ=$Y*B=D9YB>/F-BN6AQ@5/42M;
M,%&]0 J7U/C'<'J36:G \H((';+2R =2)$Y&2YCQ,7(5<8SM;O2Z]]'[[5Y0
MT^A--8O5SD5]?S49PV19PG/^!0=Y>;U/(I4/,91;RBPE,DI+O$Z"L)A#5!"B
M4[(5D9N?<1R,5K)A[5?S'Q^&,WCG0QC._N:'I^/XMU5M%E54)Y\(M8P1:7 N
MLL@98:)4P6JI;&Z7;+SI"<=!:Q7[5:QG+&-]WER5]JH?/3JWU\N*IB@N6X(B
MPS/.'Q[EYKPE5'$(@DG%?:N&MH^LQ.N>?;2N?F=#KWF;=VYD7@"]@X]7D_C!
M3^'ZS/LNQNNS]<=15O3F6P/;OV/?G<1F7P14]MW;@\U19IN\(C&7:S\@<>*5
M$L1;,!D=DLQ2C=9C!U;) Q[]@42RC=UK>P8OAA=HU"^_@A_-/BP7-<:$9M1[
M@D\.Z*E8C$U 2\(5Z.0TC\&TJSE;\^'[]0=ZXJ"I:, >FY ];R[#<#PON#H'
M'+"?P>C+.X@-(OX?2+<N)%ZTZ/7<4.,%)U1;7_KT*N+*;7XN)BD9\X[KVMWP
M=X1ZE+[&/NE;XXL>0G8KO[P%\IZ;GVT-^K!-T7K51G<]=N"UQV9JVP\@<Z,B
MOKB$<UGNP+62..X$P?G;1BM,TJZO)FM/1) MFZ]]&WK<AL[:CM9_-FCE/W"!
MN)JL&I'A2,&H8@069/$Y$G$AL?*5LU[9+&EHY6?=_^S#=1CJF96FGDDK>EX)
MAH/7<.%'+\>S5=:AM"X9;0+1412)S]6M+$%U:V:"L<X^5/H]A?BWB^;33_C1
MBVD#O[B9+=8\\"A]HJZ&7>/G[/P:%RP+&*N662V M'!;'F?Z]E/WZW=TMG]3
MT785I^1[>+2/28#S!,4(1&9FB;4ZD*BIIY)2JOE#*_U3X'##4MT;A=N8K/9J
M^LL(QLF/X"1]\N,(:7GBLMJ5QRF?J^A(RF6?'[@G(:;YKKQ++#*>(;=:6!]\
MS/[6V&ZF;WJQ6P_[%N<?FLGL_=W\/AJB",DYA"(-D=J46^D%8O0R4R<8I]5O
M?E\+Y"C7UWJF7[/2=FZ;?@_5JM-;"UP][1=L@'2@N]>ZL_:8#CI8O(=(?A.\
M+*+R'CA1/N)ZEJ@BI>,3HC6!.\ZM3K7;+.U5"(_=O+8W'6QCZ%YZ*UY>XLPY
M]*.W'J?"U9T?43"@9:#"X,27#1#K<#6T"A*C2DF,_2JSOQ;(_H/N*C3=:YO8
MU<8;78-__^F.95[CM_._F/^\C/P=Y!_*?W]_=WIMI<^?/_]MXM,89G^+S>5/
M<P.=G_[RYO35Z?.3-^]/GC\_^_W-^],WO[P]>WWZ_/3E^6K);/(Y3#X-([P"
M_.!/,+Z"%S#SP]'T:ZC3X>7'$3SF$79]Y$\W(_W: LOG?J6,WL<,?\U*15WZ
M\8=A^OG'H?5!.!%4X-9(&7DHUS1&%VEP03*,Q;H^O.-UFW/O]Q_#!*?CW$PN
MY_M+RR>\PM?B)8YF,O:CYU?368/R1;/":4F^&FATDX$;340L=PSG+(C55I/(
M8V09&(9!M;=P=P9;H?_4ZAFE\>+$Q]D_AK,/J^>\_"N.KA*Z^R?3*>#_TWO_
MUP#?ZM),/Z%5/"\]$SWQW)?[E[)@*C.1JE]9N@/, UQ-N1?%K6EHU2N#?41M
M-VG06YIL^NP+AC3I*LZF&,TL9X[I(IBQD>ND 4-:YUFYI(.3X+P@1DMA!(:I
M0L?:'ET? ZDH7#\:/36Y'I[[=4[F#\6$:?;W.&KP%?GYQ]GD"FY^B*\5KGTO
M1_-L$%S[X:)\T27#:CF0L\ER&(NF YIQKFVY><A;?"LC1N."4Y(S9&9QH073
MJHS[D62J=<\^_$[%P=305&2E<A[>F@&N&HVT %4Q2W,CD/UG97;GZ#[AE0R\
M-_99UL&IQ(F#DF0(#N??Y#-Q/C 9@$<E6T6O3XOU![(L]T3Z-G:M?3RQW%9_
M#B75\'RQPBRGOU4U2.0T4!QJGM=_"9:)Y0@6("<%0&D.[0HO'GW4?C,N*_'1
M]&;,ZAW\K[=+3L?3JTDY56&K=O34I)1]) K#Z)(^[(A/.A-#(U4Q6P?.M.)X
M\S/V1VX?5#3U[=A+4:.?7&,1*B2AA2%,V((%9RPOO2$B&V&0-QI;YD;?^>#C
M(;*+Q2J62-W",DPK+" SA)0S2;Q<-J%Q/)8K1P3CS&<E%%6/;@.N^^!C8V\W
MB]UG;^=[N!95=\WD3XP-<&;XB&[%/(9XB]\WXS)'_/?5Y,LU2),TLUP3%B,N
M+3+@JJ( _]#<<2V4MRTO[FO[Q./ANQ<;WQ?"SG=JK*X8',T^/,=)Y2TBQ,$O
M78NSV8?K XH<5?+1H$9SN1HTT]+DCQD"SAN:<<9)H=UBV^)AQT-_;<O>9W[G
M]NEW\/WFQ_YBOF>SA+A$YY.E(C)-@C.E/"L+$G321$A.=4Y.L=!N07[T4<?(
M>@VKWN=\YQ:YBQIZ&,'$IV$S:BZ^>(PCFCS[[*]3?)5#ER\*5KIYBG)-%! [
MO[.+*HG0DL1)JA7A#S_G>-BN:,_[5'?N>GBCQ=MSCK5.*G"!Q%@2W!PN.=9I
M2R "I\HPD6WM4K2U0(Y"!?5,?9__G7M1+>]P^SB<^85!,>1;S$2KAADN<T/Q
M'Y!8[B&6/..ZPY,C3)N(3&B(=Q/H-UZ$M_DI1T%P75O>)WGG;@5S8">GJXL6
M 3!<</.6)ZZ L,258%Z*$&VF(45/6Q&Z^L1O?FMK)]-LW.+8?WK-+TV3/@]'
MH_ZS:NX^:5_)- ^.\$X.#0_)*)$-!0F2">F!12^\5IKFI'UNFT-S]YG=%MC5
MI[V^/O$-N*H[@$AB9BBQS $7>ZN)E=;C3) ,A-JWT-T#T=5M6'W@NV8T>M5,
MT)]) _1:LN(1ERZ7(Y%6EX0WRXBPOG1JX(R)VIVSU\#8?ZI*-X;O>@E=+=M#
MBLD*TH!),$'11'!.E#A-NM*@06NBO!/)4^.-KWV%WNK9AZ-U9R(V$+N5%7M(
MXEWA.(G_O!I.(+VXFJ!+]!8FPP8'Z%&W0B LRM ;Q2F5>"[16[%9.L27G:]]
M0]Y#>(Z']<[6KK@W?Q?;VU63EAA+=Y:2WY;^^VK117,Z<)3&+$6Y BR6BYS0
M!)8&31"?A,!8DG>OQ*HFB0>!'8\VZMF_XA' 79 X8!A>C)]?328PCE_FA>2C
M>;SS"]KN=3-%I%[G8"EZWR&45"$:2' (/%MTK35UG-/:N;[MT1V/7"HS4?&T
MX-Y2)WUBDBE*V+RM$W4EKDJ2I$"#X1%#+%G[1L7U#D.7O-K5)R[RX7 @@9<C
MN)R3(3+Z0+S)OC 8!<\TVE3;>]\ 95^YK77]VQIV/736Z?589GXV_\15]XWE
MEM*BR4I2-%"!CATKMI& 5@HN.P*4*<<\,]FDVDIY"-#A\U([,'Y71=4LWT>9
MY ++<G>J#9B^JF5O SE0C6P]HNY*H+.5>Z=>4=# N"045" R&56Z&E)"*4Z3
M)C E[K9W_A8H?ZP:=D^,;V/<7A-,5YO\&,1ES;TB20I.I&*6^& H >U!Q908
M9>V.PM=]^@&*6W>W]L;TT5U,53MC]&0R&^;A(M-Q!J/1\ *]Z-7Q#Y-1,H<.
M.<OH+DL&FJ OG4K=@[0F!W1MVIUN/_24;Y;+:J9[0F<H)^/QE1^=7#8XMO^9
M1U$O_RJY6'LH57[TT?LZ9=G.!G>.7:**4F?0(60O92E6UE%98Z3- !1XVV.7
M1T%T6YE?%?/!Z^$G2"A>/[X8H@]:ZCAGTYO )IE8BIM"Z<F$JY--Y88"2TGR
MGCDJE;>N]A%&&UQ=O9('GK'&WN^@S!+X5I[E5\-I]*/_"WXRB)'G1$L[ Q/P
M#^TD\3AGEYO?' ?!(Q6U^P!5@+W_J;:ZSNYZ0?LFLX<#I>V&\ 8GG/>?8?0)
M?L,P_L,4T0.5209">;)$.C1<\#Z11#DN8<;1Z&H?0W5#_-VKL!.%/81IVZ$O
MK\S[S\T@"A4]=XI8)]%>!I%;4_),P,60(D"BM7LU[ 3TNY?;+H3U<+ZV VB4
M#0R8UIQ&])\Q(L;H**1 0K*1*/ 8'5L!7M<^1]D1ZK^4MA-I/1S3;0_[57,U
M&2B?70I<$Z\YHI8^$JM8(MY&845.H'CM':K=D/Y+:;M0UL/9W@ZH\7<'WI>6
MMS$1="_14#Y08BTU)$87C)80%:W=4&8WI/\2VBZ4U2X\V@RYH(PS2+>1G^09
M3*Y?D.2YC2 %"31C<,-9((X)1Q3-#*=A2;6X([4->W@=0!R1BO;*1\5BIMW4
M?P.]O (8I.1H620Y28;0DR!.HA>I)149> (M:N<^=8![1*+;-WD]5%8] /T-
MS 8VN:RT5?@NE+8KP;K20UP1G%R3RM+8>W?Z]BDM1/1]J6=;"BJ67K5 M]BU
M*XF MT2^2!IE ^FE,N6,)3B(1*I8+ED1BJ3L@L_4%\OL3SD/0?V^)%6-M(H5
M8/=S<!X8P"(MQV2J+<?E6F>*TR:UAGC#'.'6A)"D5,Y7;^;=&MV^<MYZUU%/
MA#R5S+@'!O7LRV_^OYO)\Y&?+E)"."[/D2M#N/$X#6N.GJ(0Y0(,E@U7T>;J
M+7"W@'?XK+FZ FD_GW4B:K^;]C= ;]TIVP9N3XEW6T(]3&I>;]2WEU@UWIZ
MW#($#8 ^I-+S1@Y.DL"#(#0&D<O%=ZEZ^>.3D-DCZ8!/567;T%6]J]W=MB^K
M9N.K_#AAP(14ZD)X.;CRFA$+5A.:M4I62Y'NMM_>U"CMD2<]*0^].T]-7T:N
MW[;R$XS]>/:FF;UOYMV_9M<=*(2*E.=(1,8@07KOB<WE(DV(-$+RF<MVW&]^
MQA&S7LFP?5R>LVRV_0X6Q5K3#\./*RE2'7,J55I2E!OK&5#TX'"X7AE%(5B=
MJU^R]@"<XY1';1YJ-\M\ZV<POU?N_<0GN/23/U>H%&CO@V0$E$#_/DE' DN4
M&&>HBA)H\*K5C+#Q$<?)>$6SUNZM^0(^P:CY".D]Q _C>6NPNWW!DJ$(AZ$?
MGTI+&I.)<]P1*Z@MMW9S;MHM X\^ZHC)KVOF'D[3YZ(L([WN%,4A*Z]+/83-
MI1N[(P[I)$SJR'#T",E57@GN8CA./52Q>,5C[A6>T_'2PH_'2+=V'IVBFIN$
M#FOI"4"C0LP^D,R5U#92(ZM7VN^"LV?;7%_'=%UOGHQW+.([3*5#862,(H/A
MG*"7CQ2KI(0R^[7+/8S[?[MZ5]C=5ZQ7VGJ]0NL1Y(OMUJ0-<T -21Q*/D/(
M:"1'B9-2:NEYB'=;WE8\(&F#<%^')'L75H]$K?/F#W%PLH5-YUMFQBN+_R_I
M\Z6]O\H!ET(M";6&@2[-85+MP^ M(1[^ *6^6+:;\#J1UL-.Q"-PU[I<;2#W
M=)BR ]S#'*CT*H/M)%>-PR<B/\9+!F&I*^8TH<<?!0D*EP[-C+92:^]X[0VR
M)R.[1PY8GKKJMJ&N![7=B_=4D)+)E(F.I>U,X)(X,+$TW#90^A=Y5CMV.GR$
MW3MQCT79VUB]#Q=_N>NSW! JGMJJ]7/*@2IPQ')6@,E(;'08>U";@S#,!U';
M@=H(YOAU48>')]0^XF7.$&=-?@&3X2<_0R.>CJ<8*,P[WC3C<@(U@0]E*O\$
MI35?_UTE=D6TKV8352QVIP<%R]Y;)DURADF1DA76F 0>D@XN"-&V!\6NV+I-
M3F<YX\LV6]XK?CO#,,AD.*699*<8D2YK8K-S).C %65<9%T[IV0CF.[-\IKX
MYX=FA._K].4_KX:S+Z?CY4;0VY(OB]/<;#89AJM9B<?>-V^:<8FQ45KXB1>E
MX<P$IK,!8]*'7$) FJ"T0TVEIM>B24RFW*0D[M[<6:&K7@WD^Y_<Z^CJ?NN]
MO?/8@T,POX+EJ_<91]%<SM_JYW[ZX=6H^?PKI M8]51]!KF9X.H1RVI8NB#=
M5#J]]W\-G#%E.>3$EUX&$B@0IY(GE**WK84.+-:69>4A'(L^#\EL#_'+UL/9
M.!#+@O-&).(IAGL2I"*6:4N<4,G$\O+%VB6XU<!_M^*LPF8/O2TJK0*!2HX^
MFB(8,^ J(/S\ZAY%C. L)DXA*?H-K.;;V^_&PUPQ?3:^^=F\.DT!)"<-L5KC
MO).5)T'B'S:*XMKZ[*HWW'H4U+&\AG6MWT->R'V UVU5RWE&F3+.ULTC+TM<
M-"T!_,LQ1BV3^9PQ8,YKSVD@&!KA6V8M+F8X21!N?8PZ@<4UK'<I=1C \<IN
M7ZSVD+ARUT2+8S3OJ&.,:I(-+Y?;9)S0H\:U*3)!HPHNR=K%7&N![.L,O"<W
MH;-MGTHAX+7 %TMM$7<SONX&S;4UFH$@.*"RGPB)!&I+1B85(4=NE*Z]QCT(
MZ%!GU17XWM0@O[/=>XAI[F!:U7VU -73$?-:0 =NF-^=N*8OJ^]/$BY$+7%A
M T8-+G&@2<BN-):6T28;G$VU[R'>HQ3:-M+?EQ*V,'8/"CB)\>KR:H1C3BOO
M"!WQKX+BMWYR<V"D(E>,*<3G#"<R!4F"9:4]5: <+9%H]3X%6T+<O]M:@=AF
M?ZSTL*V[\)>OWYS7S7+7I+PQ4DAALU6$.E4N889 G**21##2\:245[4/4QZ
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M;M?8DT$R'LEYO$G3]:UX!ZI&>GM83]%^'B&&:^P1" P0]^[ H$P=M^0XV-5
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M*3G&?!':=YN<T&6UP];].$)=H_9AK2H?I+ FH"UO.LPG9VE1AU*>)F<TEQB
M'&99NVLJB*K4%IL.,R/[&'VW'*'MUC]V:+01_!JP#+X 7??6\W+^]>OLO-+]
M.]XR?C&FG L#'I,AV=34Q91U'1#$A'&9SK/FS[3=R3ML#(VMCS78&7P5NH[6
MO\XNEA1^7[T-;J*\J,*LDQ98$O76WTN(]15:J!*=TRY;-6:"4"]BCQ=7[76U
M!F6#;UP?/%A/'9-*H%;@L\#Z&H DDRB!U"^M*8S.S]:WK0\2=!QH:2?S-8@8
M?,UZFSI",UYELP2M8J@SJY*)IF;4$\M%D<-=JV,*,\A<ZR+R3;0<(PZVE/0:
M"#2^6+VLOT,?>3#)@L%<\U!\ABB5H0"=J\18D,ZU=D\FV&&BG;K[2W4J'29N
MF[E519:1WBE'6*V#B\B*A0BNSLHN.14M&:(KK=OOW:=B2M6JO?0Z;RK?$5),
M;U-T50G2A::1*E77T;.?*M6ANGI0]0,$O2L0!,:9HT,/<BW(5DPG\ $99*-*
MT1ISDJU?UG:G_$<J4W>A^S[R'4'G[_'[_,OWFHYZ.Q7^LFR+8A=N+<]01,J@
M-%<0%":PD5G-E'.(K9_<'R1H]U[A<)W='P'82.!CU*FL\MVOX]SK0=8I)B\2
M<5LB63I1+5W-$>&<.U,X]TFW?@Q91\<1Z'ZP>$=O2[ ZXRJ' 9,&ZY%8]+9
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MX^*LYF)==D6=G7U:==:>E\7/GYR<9?S[P[_"M_J3ZZJ,X,AY) F0!TG$:RO
M&1TAV>Q=#CJ)YO,5!A&\>]]@J,;G^U)7ZZ>9=V?XQYR"CX<Y>/?[^^N@1#$O
MF+7@5_G$)7GP2$*C\(0GS;G5=WNE;X@$>BZ\>XCL4*?S'2FD]<7!1]+P);7+
MKN3JXB7YW1XT1P<J)@EA->(ZB2*$]"*4CI%D[[6?#(1&5DOKNX8/L[_[$6N,
MIC@[(R0R[;4918; M ?B@41C=&"L6V?4OBL_&02-JI(1+CY>7RSF>?[E2UA<
M%RD*8Q(%Y6"-MD!'I /Z5P)D4!F5]S;+UH[Q71H.WJD9)-01?.+?PA)O@CM;
MZU+@P$KAH,C8$;B]A:QYB-Y%Y9JW5[]-P<$K>(! 6]N 6WV;+T=JL^ CHQ.+
METC>C#0(T90"5F7"69):W>WCL.&0O_?1AWXYU4!@#>>DW*?F>HQ]!WK67TQU
M4>0^[IM:"'ZC#@=(K;5;OXZN9$76+"70*D101I.!+YB)3*>B%EKEU"UK;V=:
MW'"!M LE]A'6J,J[C 2N D7&'4\809O:RCQ)#T&3N3!>,33DLBFSA09OK+ [
M>]A&\!NUN*W46M_-_+F855>[TO;EY.3D.E3CO(Z^"N"9]63Q71UJ$"U(@=*R
M5(1,W:I=UW[\(2MQN+Q:;\9;%/WS.J47:QJ^T9"B(_Y$G3@BR&53A":90BZ\
MB/X*_.>1Z6\;:6WT2O_'O]T1QQOZZZ_Y]97=]UC^:_W_7^]/ADRM_Y ^8[[X
M@O-R6S3K9M@O9U^_?7FTS?JP!?_M%Y>WN;]:]1841N87_SZO"?(41,SR__QO
MLY1MW7W9D785A8Z!92:ML4$%],'GTV%+M^PQ\N9GNTW+K"Y6!XA<4 RL P./
M,H,0.GKNM)#ESNG;N,7(3U(:C@UX.?^.9Z%^]G]<S'*=_EL%^1[I;PO,?Q!J
MOEY\/8U%:J>#JI/XZ" UP<(J=!'&,*>=HYW>K;9ZB\7W7:>['0 >&!C07N2M
MO8\-]-[<:E<#Z$^1F3I*20/]9^ADEF1LB^:05702L0A7NE5C=5_S> $Q5,"C
M-UQZ8)A:T48+JP1$K6JU$MIZ#2QJ$KR5FDLA1^[.?@AC[;8!S*B:&*%GVYL^
M8RVX)ASK E&E6C11NU,QHX!Q7V0,3D3>O)SL$,>,#,'-6/K84<^ ;I,K?$"*
M+1"!.U4%%".$0#%?X!E]ULZ&NUG*SU-&VL.JO:Y&2)I==Q>?6,0B@R3.&1E9
MG34$Z4V]*$ ;?%3%M<Z;G> \@7;6J;]4IS)/8$T?Q91<MBX7((=<538R!&=,
M?2S0LK"051EW..?47JYZZ?7Q'K-]Y+O+EJ)=Z'JJ/69[Z:QK;]%M!+Y+0)#S
MS"K H43KR+&VM2TF%X E%1>C*5F+@P9"_QZSH^"@CYQ;7]MOZJ@6F<W*A +H
M ]&4-#DM=0"?Y-+3*:AUP&Y3,Z??C:Z7^+MTH^LCNQ$*F]?T2BH,F8^.7!N;
M4NV,S\GG*1'(VPD\DN/C\],:$33$I ^4[PA7$&NG(72AZ2F.".JEJRYC8K81
M]*Y&!"$O.J*(P)2L5;I)0/ ^@^%!.,63<<VGI4]Y1%!SW?>1[\Y'!#DI3##6
M0DY&@I*>#CFO%22N%0_>"*M:*_\01@3UTEFO$4%]!#Z"X;]7*(@Q1&6C!ZMK
M/HBI Q.U(I?5AIH2$CA3K8OCIEP>/<3H#Y+M"%?':_*CNU#TU,JC>VGI\5+9
M;42\F_)HDYG6D1-1ULJ:,10@HN-@Z*PS*(KES3W\J99'-]9Y'\F.H.M[I2E2
M6NTD.2TJ90O*ZP*A% 6UZRFZ6HIDGD2]3R^]/%;OTT>H(UCN.^4I/@IK9!20
MI2R@D+#LLTQ@E+<I\."T98U5/,%ZGR$*'B#04;/45P>4X(I941C84N^':O51
MB+4$26KMK5:H6;=)#Y.N]]G&VVH@L(8OJ!O3?KO0<Q3U/KT$_UBIR#92VT6]
M3TA.!\$*:%SE#]4& Y)K\)QAUL$K=G=(Q[ZUV*_>IZD2^PAKU!*#ZXYD+I$:
MZ&PAV690S#EP3A!SP457 @NV\$[*6_/A$R@PZ"7NC04&6\AJW *?ZX<287VQ
M.H/1II:$DL,5(R.O*QFCI#32AVX[;]VG'XWVMI'6J%OO)T4A"4Q>%)!<$'_U
M(=1IQ4$5Q6,*VB79K</)5.NS&BEP&WFU+CM?6W&DF77(O(4H.<4^=<JUJS?C
M(F8N2C39QV[M129:G]5&?]M(J^&5WSV"?M*32D)%\6I&02#2PD#P!*SB11#9
M$E'8;0#LF@\_%N5M(ZN-(<0^:NO^"(M/L[/+S/<:U69:==?E=EUIV%T%WE92
MN5.4EY7247.39!%*<$]8LQ@9UA&OW"#K7I37E9IQZO30".]J<QKK<Z!CB7,(
M6$V+PER[\BKZJ%'3M-Z,4*=W2WZGW''F4"7(-:U&^7H5I +QF:)-A<(8[KO5
M$3^PR+XSDK93Z -E5MN+<(0;SL[5/(8)A::VF$919TE9 3%+#@*509^,<JSU
MF^7AU55M@Y!1-3%Z6NKEG2*Y6*%H=! LX5<EJ< 5,N7&A,Q4S@6C'Q4<DZA;
M:*?]_E+==]W"ICLNPTM,Q8'V"BFRLG4 ,.- \7$BYC HN47'EZE=J?=2U"-7
MZCT$MHM+V"[T',>5>A_!/WJEOH74=J'-:'70VD:0WA!=OF@(02M@#+7.UGIM
MNE7)3_5*O:42^PAK5.75?LQ7S^$17;)>0-(F$G^>@PM% @HI30J6_(!NC9?6
M?_X$+A=Z"7VC!K>36.N[]=L=O?XUO[XO5LP52_Z;9$27<DI!=(19=)@Q8)$B
M=KN=7?_Y1Z/$[20VZD[\?7YQG9G"!,L\E0C"UWX8F6Q^2(4!-URF(GGVIMLE
MWX8%CD:-6\IL]'*,R[JQ&()B2D(.-?%<FP3!" 7(:W-JS9PPX^;A'X,KVTB^
MNRK Z4+34RS Z:6K+D48VPAZ5P4X.;-@N,!ZMIE+3S'6GD;T']-,"27O>L('
MI/S^!3C-==]'OKLOP$$AN&.2X@)]G0(790%3V_XA%RD;UUCYAU" TTMG_0IP
M>@A\]$ON%>"-+XK)DD FPKH*EFA+S@/%!A@B=\8TGR ][68:0PS_0/F.4(:S
ML:B\"UU/M9E&+YUU;:*PC<!WVTS#*1TM!XRNXMYE\*5.967(#=''%1_W()A>
M,XU1<-!'SJUC^$U3KZ^M$\_.,F)06NG(.GD'#C52E,IY5L&YH+I=R#R\SKZ?
M*;=51I?YX5M(<@0[?W?<\F79F4W6B-I-K%1>K4P0C?6@DS;&&LVPM*[+6D?'
ML=CZP3(>H97>AC';7:@:R=:OIV@_EGZXQAZ!P !QCV#I-\U<#TXZ&2QD)5GM
M+F#!2:.).JN451FM;-T];Y<@>,3*[PH#?:0\ANYO- .]'@LH#8^2DZD3F9P9
M0W;))V'K61?)Y&5O8NN\I?M4[-[TM]#/ YU6MQ#N+AIK^""+38+5 E))]*"N
M'80C6$19LTFYEJV=^2DWUAABYP?)]KZN]0B]%;I0]-0::_32TN--%K81\6X:
M:\B@G<^28@OZ'P6I.H'GF4,NQ>H4H]*B]1WN5!MK--9Y'\F.H.MA\X8Q>*$%
M&;BH!!%/=@D<-P&T2%A4-I&DTQ@6@PB>1$>'7AJ?[TM=X_?W,#:9H)(!RX(&
M54*!(*V"DE1$KICVMO6CX 3[>PQ!PP"!-CQ*EHOST_?A[-/E\5@$>@Q"@\@5
M8T5$B)EET)85CRQ:(3I% /2I-S1*?_NES5L+'KH'N+WT[JMPZYF^/XFXG@S=
M@8P^OEX79;;?DX\[=@.$?U=] R0WQEZ\OB)6*=C$&,0:=RI.7[PP&9"E4"03
M4=PM&9NF C<X:>WUUT=@C?5V-?OKNDH>N33.>'#6>5!9!' JIEIKS0M/2OK0
MJ9[Q$<W=6G1W!G&0V.<M9-;0OUD1<CG [SKU4K'H8[10L-;(HY"UTU8A)'*.
MQ6EDO%.X])CR;BYZ@,K;6F8;=U[#VO0/']^]_#^_O?CP^M7+=W_\^?KMAQ<?
M3]Z]?1L6BW ^^XX#*LX[?O+@.O)M.+A3'6ZR]8H9'941RC$?C='&N!(PV.AB
M.NVXQL @]7-8X*JD_.7\ZS>R">$2V(L*PE7]YH]?O_)G^+%Z6_]76.0W/ZL%
MN5+2<I<AD#]-Z%)T-&3%0$KC75$B6=$ZV!A.]:!G^*V7?WM1]^.[\N>7<+8\
M=869H@)"Y+E.HC2T+9WAH),* 7/)_FZQZ8;G^C;T[#YFVS'X;B4 [$&'(\3]
M@[E8_73YXN+\\WPQ^T_,IX$+4[(3P$OU]%AR$&M/**<T3[*$'&/KF3S-F7@R
M2)X&#,:X.]V6H=67?^+R?';VZ4]<S.:9GR9?"',Q@K<Z 7FMM3.%B6#-JK$9
M=\I/QD"MH?\9S;M2_@B%.RM"X^.\Q+N\O/[[VVRQ^N5+3DZ3\<(%DFB2R5(H
MX,GFH#+@46E3C/%*M1[MVXSXIPGAG:M]A/SSUQ1US7\@?L#%]UG"]6)].S_[
M3KL.+S?@\N/\/'RY^?.7\^7YV_GYO^/Y>TSS3V?5PGPXGZ?_]^Y;_3%Y4<'5
M=,M:IH,4YD:OR(NB[1I4B X%*IE;ISOLA+$GA_OIP66$+,W1F+S<\K_/%U??
MJK_'3YT3+)D80-3NY@H3A1B,9?+'E+<Y:<LR/Y3-L9;#YUTR'0"-D/"TM;"O
MMOL_Z!?/ER=7!O$?B_ER><I"8DX'#U;$VKH3+41C!,3H92(TQX!I*B[]9C:>
M'/#W#86&[[KCL/1_L2:8T)Z_[#NQ^N&K<(Z_A]GBG^'+!9ZB%]$$+. C0_('
MK820O :;T%B&*D??N@IDQRP^[XH)0>C^CK$[N3J_%QAM/@$NF?(^)N2FCG^Q
M')14 D))""QJ3=PE%52WF3=C4?AD8#T=/=\'K]O;<?_Z/RYFYS]^I34MWYU_
MQL7'S^%L+<>G@@<;=' @-:>XWV*$4%L:E-I$VB2F3/-JOUWQ]F1VPJ1!<W]S
M^/T^BEY=W'ZD?Y ^X_*49(Q>UM9:+&10"AD9+!'!>LV4TZ(DFYN>Z%TI>S+X
MW;]>USPMM7DSW>9N]N;SPOOJ9"UIVR7Z*;E9I\IDYKWU=> *<94L0B0<DKCI
MFR$;;GSS?/TQ&'DRX)X.'-: O,T#ZO)DN;S ?(K:6%YRG4XI:C\DGB (3Q%S
M\=H73K% \SGM-]=_FI#:1OAKD-#F!?**F#JX!@FEJ^^=>L%U<:5 RB&!*K+V
M2N,:9!29J1AX2JTKR3<2\Z0QLKU:U@!F\)-?JV22[V'VI=9N_#Y?K-S44Z=1
MNE7CXN)J4Q425]0J :\3!H0CQY6-\H(] B]/$Z[[!L4:M ]^S'N%!1>+C6S]
MW]GYYY.S//L^RQ>K]Y>O\[/56^1[7.+B.];'EM\OSB\66+<R>;AXZIC(22A-
M? 1)!SYM8B^4@R 55T('X:)J#//F3#PY?.\7!FN /?S9[6IZV-76>TBTRTVR
MO:R]<T%ISVT"'54$%;@#SS1",:Y@%,IKU_S<;D7\KD;I[/MXWHNR]SVKYW:-
MFN')<.<U&,UKK4Q.9%.X "V,SLQQY;!%9=#>RV/WI.NU1;5]9#YB+687,HZO
MJ+:7\#<496XCN1$5&9T*S@8-.B=51\)9B,&[6G8O?$B9Q]"LQ'WO1;4M]-='
M8*V+:F_5&"8N>=;>D+GRC*+6LLHO"B"2+RX6GDMA#30WD;K,7F+?6)?91V:M
MBVIO5?<6HYF1*0+6.TIEB@"?HP3-$P8*S#AV:R)^&!716RMO:YF-4"%S:<:O
M.R!RJZQ(PA!^!%GR6 *$)#R@0<N,"4%WVWT]7/1;!#Q-7VBX+L:J.-E*$+_8
M.,NUNO%&G^4N/(W4H6X,?O;3XVX 3/K>QNU*Q_LH_=N&M\*T9BP8\$87<K4$
M0J"#G[CD):#0CC4O,#D<W#[2IF_BL.VCVA'@^C.7_U>!RG7+E,A]3M9#3-F3
M=U>K5&*@+U8P5B3]4;?.X-I(S 3O<T?7]::BBT&*:CU:\_+2^*H0Y-H_E4;Q
M5"SDS$T=:B AL"A <FD]\UEGVZTOQ)H/?\) :"+OUA,]_L1%F2^^UA>#%?\K
M=/Y%.EE>-Y;D6CHA,Q1>ZS^3*."4"8 !34C%6*-T)S \MM)31T93333TZS<3
M=Y4#>MTJ*@EG@JY3SFKSW)@$F>@L(8L0K8G,"6VW!\JMM9ZATE0;#<NV+Z?6
MSL\^?<3%UY.SFHTV^XZ5[\OW]ROJ+!>I,..!B<B!'#I/QBY:L,;XY"6*DCJ.
M3W]LJ:<.E;:Z&*&8^;>+Y>P,E\L7Z3\N9LM+W:P&:8J@E7,%9$W)4(4X]DHQ
M$H#1FD"LZ.>-O=<-I#SMNZ46^AFA+\0ZLNH?%WB]9;H0.-*5T:/$[>?^IXDJ
M.\!CN!Y&B),?)]2@YD'1!D$M2TV4%1"<#, RTX4EKH1OG3>U)Z \<N&R'YST
M$7_K*.@5XK?_C>%+3;)*UTU+79+%:P4<F2!#JP1XSA-DLKO2E&S\W:3U#3[*
MF@_?O5?26/[SAL)K_++X<79>;>:O;+D5=J-)7&LB2+C 0 E#)M"H C9Y5A+C
MB37IEKUV\:?I0+3114./<RU!-;'R/7Y9R6/Y>?;MX_PUN<D_)WEW(;5A8D]/
M\G:?_-- H0_!8P1M-$XZZ4NR%)%"MQ3!Y"CJP'8&01<#Q<M@M+()I3D6X#R0
M=+1?W/110F.\O"(+F^C'UTD;O.BDK ,1Z#15RM9L6_JK%4:XG+)'U<(,W5YU
MMYDNHRIGWD2R&SV.T7O,7YOD>;FZKGN1SDE,)(S6/><?76FD'O3].+S3DYY)
M+6+)-DIR177*(3#G=>(^2Y5+5!MZTC^ZYMY[U*>LF"5$0U22T.E-!!^*!_0Y
MLY*)2]5ZR-YPJO?=FNK=Q?GR/- Y<O;I_?S+E]_GB_K#4^%BUL9&R+G.2G6Q
MEC9S!5Z7+*TA.G3K.'T<3B9X-]T6R:T;334 Q)1ZX-_GZK)8\31S+6W!#)&1
M2Z0B&O"BYHMBTLI$ZY683*'J)B8."-P-T34>X+> QI3ZXC_00#%P*] S":*.
M4%=%67 L%G+DC%=1.^&:SYH>@8UGO$\ 'F.D,]>W]<LV":\N%C\;^U\^H=Y\
M>'_]-R[2C/@ZS3(FJ2B$L<K6!_A,)E)9"1R-8THQ8WCS>0^]J7S&Z_C*'>'=
ML[U%*4FIY#$!BHR@A.9 _AQM,AECJC4F5DYF.DDW9V/W4KV"1[TKOY)J8$IG
MHQ&PF (*0P;/-=EILM+HDA$VC=*.JR43!W1$3",^&0:#";IK-S;:G;:^UP?B
MJG50/8[+U7$<)(N<TTD269UWXS'0<5QJ"TAC4V%6^3(U;ZX_E\\[8UI VD<9
M6QN.3QGGJ$.N;5KJ8%O/ KC@/3!,,O%$3H5K73FY(]8.:)/L"*7[V52](#:I
M@KHN_>7OL*J-*XY8%:ZV-,B%01!:56>6QZ2$1S=*2\'=L/>\HX;NJ#U!;5)E
MUG="VF[<.JEEPBPAU5!;>9O >V% LZ2C*%P7N_-V\$TY?-Y;8^^M\0 W[7N6
M!]DT"CG7.0 J1Z>(%N24"U$@8W3692O\[@W6&.[?7N]D'M2 U<D)27)GQE.(
M+F*!2)$0<!ZD2;6HO'GKDAVQ=D!'VC2BU#$@T[JX[@YA[[$JAK;BR_G9^2*D
M\XOPY<VLT,%B@E$A)C#1&% E. @E>B@Y82D6;7!W)M1M2%_ON."3 =MH6ABA
MN&[%?WQ<1+'W4;^.XUIG*$X-T[73O(;DT-6^5!%<?5Z(W)BHC)#D'8]QGNZ6
MS=W!?3R\M1I$L2.PC'4U<8_ER^>_%Q?GG^>+.M7TKS-:[<9K8"VA7=[VL:N(
M;EB/*XET%D,4' LYO)"RP/I,0'XY>8803"JH!'=B1WMFYZP_F7TT;5"U[A?Q
MXM.G!7X*YWA"1,W.EK-T.3TO%Q-2*!Q<9.0Y41@*#KF!9(MU$8WQUG7R2C8L
M\+2\D!92GN# Y1N&Y YCCEDCC%&U*-'57"!'C/D(Q7O#>79D3":<J[ OJ+;#
MRG@/& ,4O3._H+LK=./4OLT8/U7!&>V<@&"QMMM(9%ER2F"C#H&)X$H<Y<)G
M%&Z.!</[5_48+P3-RG]-X*P(<LN9JX7_)GEBR=418LX6Y#RA\*TQ^P0'< RZ
M^MJ+LO<]@..QCA7<Z>"BR>3S!DT[T"EP+ 5@B04I>+&"MTY&.MHF0KUPT;&)
M4!_][*4G3!<"GYL(]59E[^8PV^AA+X!APMJ2DJV%[!%42AG(^1" *A;4/MJ@
M6K^3'U83H7%QTD?\HS81^N]79>G2E,15Y& B)X)8TN 967?II$5FM-=W\R:Z
M=!'Z[]-M(]1+ QO;"&TCOBE4];__\&('%?UK5AF]FO\QSNY4\GMC8DRQ".^+
M2@&=BCZP1%YL8E&@>+22?\UZ>Z_BCSYFGE2&>O\ 2GL!T?,"04;2GM4E(;:.
M@PZWBO_M_.PR1GY-!\3YCY.S)84"*T=S0R57T1BL8>17HJ]S<>@0"5YKVON9
MOF%<#FXR-3-]F3O(B^D^>&\WL'=,V$RI_/\^?^>?<?'Q<[CB?TF2^([+<[R:
M87QJ''E*3I!!Q>A!.56-+"DF!(K(K+(^N<D</WV9.Z#],2Y 6VVC4=$UI5*U
M1QF]G=-]6D*,:+6"9)$.-:L2."%E]2N#0"M]B)TZLDUB%]WF[7D3[7H3#<#6
ME&K6'N7SGZN3XB>?P8F@>&W<EWVFL"Q6GZ!8*-PS)HV(Q70:DSJ)/72;M^<]
MM.L]- !;K9-KQV.25%!P1GR^6[RL<SN^?+G!LDO2RN@,N&0%*)4=^=G: "LR
M1^04-)MNET3[H?]YRZRYSCH *(V5<+P3=Y7Y4*?:.$@J:CHF<@'O. =G&"^&
M"1=LITZJDS!!#P9#4])"_QS?Y2DW4NE@!$3A39U=0YH*/-4QXYY+EA'%9)*V
MQA#  1V/>[[ZV3O\#BJN_7EHW!'%*B9Y%<[Q]S!;K%*1;AHT,@N<J"1Q*$<&
MP@0&014'#+G0LK:P<H?CNF\E@N?]>$ 0/*@HN;LX3IUF!=$'\M,,^97&%7 ^
M)."*?L*$U98=CE'LSO<![;TI@'^"&[D7<@_*GC[8^V.-('(.+ ;NR9V(2*&A
M4."RX74FN1$F,AWSX5C2GLP_[^-I[N,Q,7Q0IOCVI>+C@K",,QZ\@IBQ=ADF
M33KI#$C!O$;)E92'<YW0D_GGS3S-S3PFA@_[YOQQ6<2<E R\MFFNM10Z<O""
MSCDI&052!K/7>8)7ZL][=92].D5-]H+H85[5/RX#C2F%6 HD] Y4<AHBR@ V
M%6^<QMHG^6#,[K9A\#Y+^[1RB4N/8"33H$*0X"4Y@()9K[(LTL;F?L\3+.T;
M='VW%V5/I;3ODGSZY<OJD5)$PAA!24$N3LB,XA6KP!8LB)*%K%I?F]TBX/#+
M^'IA8-Y*%Y-J*_R+C;-<VZZ\#5]_UIEUX&FD>K\Q^-E/B>  F#3K.=I8QX>"
MW\1X9N0. P:DW<UKNY]H#2"6XDL,*HN=-[.<#&X?J5B<.&S[J'8$N+XGSW8Q
M2^35KII67=7G>>.-MIS$@IZ#<C)"""R#S448)[/'YM,^UA(RP;!X=!W/6RMH
M"@64;SZ>_+D<L73RUN>/7C2YF9L[Y9(8G U55\+4^XL0$Q=6,'04#2<G'Q]\
M?&NEO1=*,I&D803<%&P-=Z('KXH KG/1Q@CNTF2Z6K\YO$))YJV.R12@W6OI
MF* O47L)N;A4G"J!^U':13X72C; ^_X*)?O YJ +);TWJN2@0*X:;\4LR(S2
M7Y-+66GMZ7!]+I2<8+)]+X#NK5"R#[H.. 'F-&9G6>VJ%W7E,TL#KA@#)D;G
ML]&.-6^>]5PH>:R;: "V#CCOA!R#Z%.2"LB_)\= \ PQ9 <:-4>TW&B<C*?V
M7"@Y\3TT %N'G>[QD^4:#+/:%C@+P>C8(*M+4;."F)B+'GWTH5O[\.="R2EL
MF4.!TF%F7USW]< D$&6!*&K?3AG)7562 SFQS%@CG#.3N8MYVH621@:%O#:[
MLZ0NY3F#B"4#%Q1N".5MEH>34/Y4"B7W<O6S=_@=5%R[79ZABSD[Q 36&C(0
MDG3J,GT)C.+^VM&0Y\G,!7PNE)SX?AP?@@<5)??($%4F6Y5\!"=LIB@G<P@Y
M.& DCJR+DF$Z3TG/A9+[ O\$-W(OY!Z4/>U;9&9%EJEX!J[4Y%?&##CG/&0G
M4M8L&ZW5P6SAYT+)H]C'8V+XH$QQWR(SEXH-4=0Q(+FV4RD<O"T!;(G">!L]
M]X>SF9\+)8]B,X^)X<.^.>]0@955"1(CQ?I!@5*&@]-%DBQ*D:BMX%I.\$K]
M>:^.LE>GJ,E>$#W,J_H.1Y9A:$M6D+5'D@''>JU1@"43BV,FZ-)\!-\$^)Y.
MH227,A2C2 &9>5#))O!."[ J\"AS"9GQYT+)_5[?[479TRR43-85KX4!-+[.
MDBP,0J1#0T1$%SCC3K6>I7)DA9*],/!@H60?71Q,H5D'GIX+)7L52O:"R4XJ
MSK;0\:'@5S$4/ @-.?):!HV!_&+MP0@A,K/<BK!S?VHRN.U5*#DYV/91;>L9
MD&_F9Y_J:_H)!3=GY[/O6&E;<;"\*LAS(HC"BX,D' ?%R:5W@@O07$A!/D_V
M*G6*MQ]=:H(1\.CJG(^FB];%D?=.D)6@$?/7?WM=:P.7,W)"7I]1 +4(EY^Z
M/.]0$=GCE*H++G\=4W7I?A61#5CX608YS$20BN=?\<,YA8XK2,7E*K6E\0&^
M:96!]NV$P@'"Y/GKO^N6P5<8VQ-^?X6='PZ/Z.BN:7A *AL/[0U;\>K;]4ND
M@^=__9?_#U!+ P04    " #NA:I6>OEC1)L/ 0"F(0L %0   ')D;G0M,C R
M,S S,S%?;&%B+GAM;.2]:7/D.)(V^/W]%=@:LYDJ,Z&+!TB"/<=K2J6R6K-*
M22.IJF:V;"T,I\3I4% =#.4QOWX!'G$' T"0%/O=#UVME$C _0'QP.%PN/_+
M__[V,@5?Q+S(\MF__N#_R?L!B!G+>39[^M<??GW\!/$/__O?_M?_^I?_"\+_
M_'!_#3[F[.U%S!;@8B[(0G#P-5L\@]^Y*/X*Y#Q_ ;_G\[]F7PB$_U:^=)&_
M?I]G3\\+$'A!N/W7^9]I$"2^CP/H>0F!R L22'&"]$^<"D09#:*SIS_[(HY3
MWR<P)%P])B("*>(>Y%&,11B3"#-1-CK-9G_]L_X/)84 2KE94?[S7W]X7BQ>
M__SSSU^_?OW3-SJ?_BF?/_T<>%[X<_/T#_7CWW:>_QJ63_MIFOY<_G7Y:)'M
M>U UZ__\GY^O']BS>"$PFQ4+,F.Z@R+[<U'^\CIG9%%B?E0N</ )_2_8/ ;U
MKZ ?P-#_T[>"__!O_PN "HYY/A7W0@+]_[_>7QWL,OU9/_'S3#SID;T3\RSG
M#PLR7UP3*J9*^K*UQ?=7\:\_%-G+ZU0TOWN>"[F_V>E\OM&JEC+54OJQEO(?
M#G7V\PGB=R3O8E?6#H0KU;WI2L8V3&\Z$_=1\8/H7^"U;DX6N?J@+F=\J&]W
MV=7)HO<O<5>?1;X@TP$^BU4W:R)/]2^NU4]U-[JA%C(M^ZFI>TU4\6TA9EQ4
M;+G1-,CXO_Z@?IJ\%?")D-?)A[<BFXFB.&=_>\N*3)/W^;>LF)#8DS*,(AAR
M*M6ZY7D0AT$*(TZHCXA/1.!/%LM/>R)F\->'1HJR*Z-^?K#0<W%@OLY%D;_-
MV6JE>YGN6[[4RJ77.OSSC+R(XI74+RAAM5%0R?]OC9A@34[PAY;T__V7GU>Z
MN>,Z'0JMZ?B RMF&.%-M+.3S;1AR9@K#:@X62H,2 TD*6BI1-Z$ "8*?Q711
M-+^!^C?E1#S6R\\[HWP^;S0@<W9D$.HG?F:YLI%>%W!C/+1-::7J(K?Z0"J
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M'M-E2,A$4);R,)"0,X$@"@+%L9*&,!$^ER1*(BR8N]MTV<_8N',MP>:CF+^
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MUI^>I''H!\B'D= YS*(P@<136Z)(^(C'$4M2CYG=X6OKQN8+'>;>WLV_7]V
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M,\.X'X1[7F8TN.6-_[LU<'_4DJOU_">P%!Z<'X?9VERV1ZPCN]FBXT$-:'M
MMBUIAQ8<*QPT+5YK7FPR%WV_J+-@B80*CT6Z3K DBKXH@C0F& J*/<(1DGYD
M5;&OO;NQ&<JU6&LL-=5B+U.-?;>L?=".M1D]=8=@SY2TXIQ2TC.PE/4,7'2=
MALP,E:X*)+1W-FRE!"/%=THFF+UU:A[R\Z(0BV)"J<0DC3DD@2<A"B2"*?(I
M%$D:10+%7.W#W7*/5QV,E3;T_89IKB; 0N>1(*6LKOG&:RC-..(4@'K?#R_S
MBI>R]9%+?%/ISO.'U\V_4\[P3>4.YPG?>L[!X78>>'[Z\/OYW4-]&*RV+-Q+
MU<25B2[?&T5J'L<IAA&.4IJB*):2&[O2MEL?VR36XH%2/@LGS YD!BZN4X#H
M>;*N,' )*=@!P\+7= HH WF1;,"Q<PT=4K[5Z;/STG#NG$/R;CAJ#C[D9F3\
M1N;*:IF*JYDB U$LZHPBU;;H^P>Q^"K$[+>KR_,9K_YT-6/YB[B=7^=%\4'(
M?"X>R;<)36/L>8K2:!(+B#@/E)'B)U RX:5AX/O,+MM7-V*-C0L_DQFIKPD5
M8OXE8Z)8>7$6.?AP__F7TMJY^2_PRSQ_>[4T<SH:3#/C:/@AZIFE&X5 HQ&H
MY#X#GY5U_S8OLY<U^I5EBI4Z.L615@C04B.@5.K.%.L6XHX,N(Z$&M3LZQ;(
M;6.QX];=B/Q>3'6>^#LR7WQ_G)-9H1W!^:R.9?"8)Z,$$R@CJ>._? DQQP%,
MDIAQ@=)4I$9%:(QZ&QOMUL*"4EJP)JYCZ$@[U&;LV1F /9/B"=A9TYT1)AVQ
M6'M?@Y*3D=K;G&/VDN/-2?8L^-M4W,IS15<\F[[IC?"#8&_STE5^^8U-WY3)
M\DFIHF^#OBWJX/U+,M<7.8OF.M:C9L4)PJF?$))"0OU8;W=]2"(>0K4#3ED@
M121#*]]WM^*-C:P:[4IC8TT_L%(0-!H"_3&!-1WU2XV6JXN)X(]24]M\W]U^
M!6:T^'YCVS./OL>PVM\[[07]KBZK=BO<L#=<>P%VYUIL/[TXN#P_O!793!2%
MZH5FL[*7 S&-RS,3U3<KL[M_^GA^_JIWQ62J#.8[\CU_6WS.ILJNSF?B\6L^
M(<A+$JZ6DH3''D1Q&$*"F("<Q2D/DB!(J%%1A]XE'=O24@NNV42)#D@M>^EQ
M>"VE/P,OC?Q@\36W<%+V.N(&WM^QC&//RTBC)EC3\PP<BNO>."MN1O^V&OU&
M8[4:E5EJRM%?:JUO<XUE]"W<W6/Y"@9RG8_B:[#SR0\Q0JW^_5X%&.ZL8 @<
M-\X=!NGP]/HMGZKJ&]_+NWL!07$<1AR&89KJY*0Q3%&20$Y#P0/"A8RMBK4?
MZFAL"_VUF"GTZC*D#C<@#P)JMHGK J:>UU$+A$XJ2+)/_1Z*DVQT\VZ%2O8I
MVU:T9._SIV9Y*+]3%*<>3R6%,D0A1(D((8TD@U$LO$"JOTEBE.%K?_/CF^X;
M%_%M9OP!_ P,[I-0Z7UV=PV(:_X&6V#>)W5#5PS8KK]YOH;A:*Q=XL-9&CJX
M][WRUES^[4VQX&>Q>,[YU>R+,HOT)U!<+XNK1MR+">4(>I@)B$(>01SHHDPA
M"3W?YXP$5M$5YEV/C>K6W:B5[* 2'JQ)?T)A6XM!L75H=PGU@,[J$U$^P0=M
M"ECG_N6C';^3[]@4D,-^8>,6W"AMSQ[Q7K#\:9;]C^!77'65R3)2H@JJ/6=*
M'&4)ZK3JJU+?ZF]J">1W<WU;1&TBU9>I$Z]KT5^UM),4(3^5<0A)$G.(:))"
M2@6'L0SB@%'$/6&UJQM$ZK$1:2,H^$?R\OK/8"FG'5T.,^!F3#NZ87P75_!*
M9;"N<W5)H "-UE7-B)7>H%9<)[6M5%<_:>7/RB>/?Q[6/#_H<'6T1 PC\Z"K
MRZ##L+TP#=NY?6G4:_%$IG4TG]X%ADD4Q+&?P#05@3YY]"%A"8,D9I[TO1 '
MB=')XYZVQ[8^E.+5 ;!6&^A]N+43^(EH].Y+, ?"JI3I 96=JI=NMS58P=(#
M2JS7*#WTB*.O/Y\]Z704.E_%C9*OOO,K>:P B2*8,)E")&(?IK$0T!><L10E
M7$JKE/[[NQG=)%U>BGS5N3GR&> Z)4M.I]E3R::6]P<.@&OH]3\9LKYG\K(4
MN1;QK ZW*HNLU!=-/Y-%'2K3X6E *RQ=G07L[V38DX!617?. =J?[C7F:*UJ
M27'QK'^\FE6? *MB::>5FY>%(6$^BJ%/&5&D$G%(O1#!@%/D!Y&(A&]4RK0?
M\<9&1HV(8$W&7D)(3(?/X!#C70?E'?:'!V-#UDM8J3=*!<'5#(QN4'L)!NIA
M<-\Q JC?0>XKW,=R##J*\3'M=8R!/9:(.4;SV/;B&L*SW,]/ N21("$!]'RL
MEEV2AC#5-T<BG_M"Q&%*O-0FU=M:VU9KY@"YW!YU'\LT2-8YV]91B\*(X3AF
M,$QP"%'D24AX$L-4TBA*(\$YL;KAYXK:$%4V=ZY) \)8_J99[95\UPXC=QP-
M-SMNZ/2]PS'XD!S"F794[2R":=7RP$%+.RKMQBGM/G)"'<(/QRLG?MBNG+@Z
M:A8B9:D.9XH33-7<QFHCPKP(1DP0P9-$^+%5XJ?311H;)50E5ZEA:5:Z6YKU
ME)B!TP?8,)9@T&'K.\;@U&*Z?<4?= 9RET4:3Q-H^&J.G0"XM^QC-RV[4?DO
M><Z_9M/IG9H$SZJ3\\KJT'E$^7^_U<$4DTC(P&,)AI0&3.?Z5(23H 1&8>J%
M*$I3CHU.B:QZ'1LA_T:F;]5\)DLA[6C5#&PSYNP<PI[)L9'W##02@Y7(8$WF
M[GC/"J*.J,VLST'9RPJ&;8*R>[G3G.E5--=&1N-S6I3UM"=!$&!/;:IA%# ,
MD1='D 21@ $FNOB7QYE/; C)7H2QL=/%^<-?P*?KV]\?P*?[V\_@ZN:WRX?'
MJYM?P/G%X]5O5X]7EX;I"D\8%C/JZA?LGGGL2#KUI1)KZ=3!'XT>'1IU[B#V
MFV&]38 Q9%HW ,@PX[I)2PZ'?LXF814)NZIX4=PNGL7\\9G,;E_+D_-/^5R*
M;"'X[?R"* RG4\%_%]G3L_K5>743X!?5R^(C68A/))MK@T=,0I:&F%$/1D0J
MJ@V1#XGGQ[#T7$KIIY2;5Y8=F7)C(_&E$CH'7Z6&^OG'; 9X/IV2>0%>Q1P4
M&J&?+,ZL1H:ZR3'FR$0>T0)4)<HYXF7X4'L9P#XO0WW_80TC4(($-$J@A@FL
MOL7;YEO4'V,#%:BQ B580*,%-%R@Q.OO^..T.(X=F>@C/,S]^_Y8[0Z&1_HU
MM!XKCTWFX0ZEQZ;YOB/ML<IXVE6J,N:]R+0<=3H-U=NM_"W7MG23<'89&3_Q
M/!(C% 204X8@\A,&:409C'W.:9(F4L16=;[=Q!B;I;B,DB$K-<ZT=5@KHN\Y
M?BE54=O26I?J6:6,VXTHRW$S\P7T/QI#Q:2=KP_$W<9 5%HLDW"O[BQU?_?(
M#<>.+Q-9"O$NMX/<@#ITW<>Q-9?2*U=UR0R)1)H0+F#L>0(BZ?LPE2* TO,2
MC] T9(D_451.<[.B*U?VY3366^]OAIU?@0?Q5)J$]^*+F%GM+I9PA52FDF*%
M3QBI982R$*:$!KIF713@-) LLJA0XP#6$*O"^94+- ;;<1>%>R9>]5FX5)ZY
M<J@XXZ#\0/NKE@&W+"QS95-0YFKX0C)7;05DMO_HP*MWRM(M;UD^SA6IOI#Y
M7XOZ2XF)2!(<,HAI$D/$B2):+Q'0CP.?I 'RH]3HK*F]F[%1225H&9.X$M5B
MHAW&TX!N.D&I9_[9"Y +)1U&RH*C.D%L(-*R^[3L>.PH#JW$=OCMX9CNJ 8;
MU'?\:?L[XI?ES=:+_.4EGSTL<O;7TLE0W+XMBH4:-&713H(@3H4?!3 , IV^
M*980QS2"@DF*0B^B06(4FFW6W=BXL9(85"*#4N:SRH59@#6QS6^7&R#>SIK=
MX]@S>YX*H=6]='-DG*ZJ&S0_V.UU<U77+[1;O.7F^UOZ$.NZ8Z53<OG+OV1B
MKII\_E[7&Q(QEM@7&/I^0A6[^#&D*,)0(!)&/);42ZVNOEOU/C:R69U3@*6D
MU561\]\<JSW9C8:9(Z\WC'LFHM/@M?;3.<'4D7O.KN]!O7).L&P[X]P:<:U-
M]R6??E'$N)GWM_'-12P.$Y)"'U,,42H93&4J((L(P02A@&"K^E"MO8V-L);"
M@DI:T(AK6Y*N#6$S4NH,MYY)Z"!D'=8/ML*DLY)T;7T-7)+.0.W=DG0F+[E&
M/7]=!5/?S?.9^I%5G*6V<]6]Y.)JMOY,-F/9ZW0MWI9P2KPX1) SSI2A%(60
M<(8@DSSQ0^;%ZF]V8= GRS0V-E(JK5\TV%2J7.AKM4 VVWRPT<PD?+>W$3;C
MN8''K6_/_FH4'O3V@\QY 7Y]Y3IJ9S5@A\:KIVCKS@#N+/SZ=(D&CL?N#,+=
M .WNFK9WEWVLO::/ZM6)" 7':<2@CP)E^25) &D@& Q)2(.(1PHYH[SFVPV/
MC58;V8 6SMS1M8'5<9>6*P(]$Y29\E8NJGV:.CFC-AH:S.VT3_QU!]/>OP^<
M?* .?5MS:FU%O%U^$W.6%4*Q Q/W^70J\[E^<8(8$DS'5G@!2R'""$&"/0HC
M'F*6>@ECGE4BDN%5&!M][ 3F-H*#5RUY61&V\0UK) 9*7^#^B9C9:>,>^)Y9
M\^3T"&=-N/?9^A'!V6Z4]_)C*M'HQ2!\OY%\[QP,[@K\?>1L.'F .LOQ<+HD
MCBNL+J\L^*WJ9*;[^Y3-B#*79T_W:@?VD,OY\B]7,RZ^/7PEK_HO2]]G0 (O
M#:&DH8"(Q1QBRA,H$4$^IH'B"<.XQ$[DL2' 8>(9'VX_W5NN9R<-"%-B,'U#
MGD>I5 .BBXLD40"%'Z3*K$$<,:OD'8,-QQ"&2)D\68\(N,Z);7+IT\;%T&08
M"NV^5_]*#[ 4%RPUT27;!/A1C\)/:W\O]0%:H>J![EWAG6#;U7I\DBS#+JU=
MP+:S2G;2J-N"=[#0QJ^%D&_3ZTR*2<"]T/>B$/(TX1 E4L+4"R)(@P2I?\5)
M2JTRCACT.3:NO+N[!#KCP0O1QO9;*2>89E]L<WR:P&U&CAV#V#,%;M4AVBQ#
M= 8JF8$6NCN*LT"H(R(SZ7%0NK* 8)N4;%YUHYXJ\NKWC(NKF;+>7^J*0>4U
MET]*E<MO:F;/R/3BK5CD+V)^O4RPZ/LB3+THA21"/D0I\2 6.D =*;-.^&'$
M0RM"<I9D;#15RPSTEP :J4$C]@E9,=W'RHS-!AF!_B,93@;?FN1.!JXCZG.7
M8U!"/!FN;9H\O<%>BZ,TB8^_UU<S;^6GC^?GKZ_S_ N9*E:_(]_SM\7G;*J,
MFWPF;F=BXC/?(S0)H!]21:Z8Z\K$<0R]E/LA\Q7W)D8!7+U+.C;RK077MYZ5
MZ(#4LI>VSFLI_1EX:>0'ZG^]E-YP&/%VBA[5./9,X?NK<!ZJP'&VK+GY?7GM
M'=Q6H]]H#)3*X*X>_:76X'8\H]]+#99^OX)W+,<R^-?05X46]Q'JJ%B+@P!C
MK-OBCJ-C"9<3.G0P-6Y?RVYG3Y??]/F-*)9U]CZ*U[E@676B,^/G+[IHX?]4
M+")30D@2,^AQ*B *,($DP3X,!4JP)#Y+N7G& 2<1QF8<7.1%:1GDK_4P%F=
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M'".PMXNQS>Q:2%!*"928%N?@^S%LG]O=(-/SU-X!Q25*8#\Z%G$")Z,T4*2
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MW)KA7B35EC^"L:")HJU0PE1R!EDLL2]2F7K,*JWOX:[&9E"M) 6-J,Y7DEH
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MI8^Q<4,=85'+>0:TI#JAM9;5-OID%]!V9N@(IIX9P0DAATB4@QB<$(RRV^;
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MA5; 3[S,U5>?O^0SN4[P^FK.QN<SUZSLAP-AN9J^B-ZN5\X[+VBU=MZO*_M
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M/NG?:;,Q#)G(XA2R*-/:$2-M-HJ8PA IDB9I$B?<2CL:6QF:9M1 08FTL@I
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MSTRY*[.H+A$YGD->-(0RBD6FB( XU&L99$(ELB@,]6>69$3P5$B9N2YH>A[
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M?OZ5%;,)UD*F""<P8TQ C,MS>28$2CCB*F?<5@YUU;KR;'ML@6=IOHUR-@Z
M/RM3/:2P?#N@G:QZAK5GPNJ$J)>(5D=L+M#7\FUQ,.FMCE!LJW)U?42PG:8J
M[^ZS(4+SMV4AZ]2[K1AZ^63_]J ?7E=B;MZ\/]CT5?W=S,PGL5"4B$A#D:L4
M8JD3R.*L+']I"$Y%A"ETX0;4!>:-C>Q*.^VG.:\M!;^\?EO-/:4D G=AYWVH
M@3KF3;:G-KZ!'>>V9Y8VR;7IT,;#*U#Z> 6LE[UN705 O[\=K4N,>^N-K@#
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M:1-'J#B)=60E>A).S1PWI9"8. WF.A$:1XF,<Z=,I ML&!M9-B[8.6YCL6<
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M-7$GRV0"<23MADV>0:4054+R*%?.Z2C'&A@;[30V@L9(8*UT3T@Y"F([OX2
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M!W8\Z2"^*/DZ579UCZ_*.CXOZL?JW=26 ."9HIK@!"8XI1#G(H<T$1PJPDS
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M3Y(TSI.<$<BE$K8Z0@(I)@+F#/%,YLKJ8TY6]A2OV]!_KD&O;WO=;'_O<W5
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M$Q0V'<%6F5Z6%GO$F2< =0C@+X>I9Z;;& @J"[O$X2?P\0BW+\=IH*CZ *]
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M->%+.L]A(7Z@+NF9WD_VP/6I'@!_ELXXY4N'[12/=?N!.F>@97S_3@JTB!\
MQM8U_4N>/]P2?P 4=E;\0SROX\2GYMX'?3^?595UR^'R6JR*[^5T:^>#2[!"
M3 L)L5!V5D-B2)A*8)SGG"!&E$J<\F&[-3_F@>OCR]VCIUZ$)_:.,X_>$.U[
M6K$%YMKT:GX &N-]1AK_^4(GY$)-!OP:'S;2[P3,01C?[2DAB]?M3P1^GYDG
MED7&J\7F1_-"+F]_6*'5I7I<%$(]V3E&_1-K7[TH_0]EA>J5O*Y3=1IY'YOF
M:.L:O[*I/20>3R(IHPAI!B,9FY!?&[[D*D=04IP)FJ6Y(<[+2]\-[M?8B'C+
M$\!6Y5$"-0M2(F_X5\9C@>GMK1W3^'%LN6FS2'!5[XG:(GR5_Z $ )0(K']:
MU81NW ?737+C6IEM"P%@(>B[@M^;=6FO]?^&]VH$U0/?K"O=:@^^G7D=UN&J
MQ%BO8DA:QE2AF$,SZ>1F+%899!AE,***Q"A'N<B8\_*;?_MC&S.K3.UNU;\Z
MH.^P?M8OICT//[MP]E<#K /T'JMD_7;!0(MC7;HBT/)8=_Q:5\4Z/':XQ;#N
M/N^L@5WPF&YSQ ^E)-+'XKM-+UJ9%Z@P0]CU<JE6R^M*>:I\3V]_V!&R'L6D
MW4_Z4"P%F_Y3L<4D0KG5D&)08<DK:2FN50)Y3!$1,1%8.=4/"VC3V,898V1I
MHUW7T:65C;!7M7GPT]CL-U,+T7%NLZR!NZ/G(:KR!I;N@(T_H'2H+$ZN1#GI
MV7*M$:6N.[#R"_RSK<^\)SX!40XT:0EAT: 3CH 0[D\60C[:OU"'F3,LY]-"
MVK3Z,@&L4,OW<]O&),-,:11KF"0,0XR%@)1%&40JTT2G*8^RQ+5<Q^EFQD:G
MVY:"QE3P9V6L1^&.%F#;N3$<7#W374>DO IYG ?B@G(>+0\?K*C'>0>W2WLX
M7-TM5ON#+0J[PF 82)EW9%7E@C[\-3-?W)?BVZ:6^"0F-%.:4(C-YP\QB0@D
M.=>0B4S%&4VTS(5/1.;<\MB(HC$<%+7E0)6F7X%Y8[P5UJFM]XO W+O#+<[J
M!>2>Z66-;V-TQ3$&W_]Z9=/"3G*_*_.2VW_:7U3_WMK'OP)K!\'C^8[P#JN\
M00T4/+FW.VB(Y W'?B#D_X".RH1L^<7^OST:\YU-[:&8)]/<HK#!N?W%]4SN
M_F#KRNJ8S-U,+*SZ^'M5_6G^/7V59@)]^Z,2Y[(3Z=M2/&L2&R/,)!9!R8B"
M6"0)9"@V_^0ZHDF.>!23R6J^8E,WPAS6?"_673O1'RO<W[Z ][<W3[?7S[=6
MD/7F^OGOX/K^??47*\_ZQ_5'J];J*;(X[#OAQMKC[>F^(TOCRA6P_P5;'MFI
M<N,LJ"ZQ2:M[/]R]HT(!-#" 7QH@?KT":RQ  T:U8%G!$5"*\DVZ,93,Y;#&
M#RNA^28=<R#/^3967*+J^]ZT^KV,MY;O?C:[CB_FB:4Z;:PH3LQ,  H<FVF"
MC 0D2D00Z5S3E,7,C'S^,K^M;8YM;E!+?VS9O,YK -;F"X2 V[%W'%C"(MKW
M:' AF!VU@YW@"2HFW-[B&Z@+.T%P7&[8[=:.)+0NUO[(S R[23_(J:"8"LAT
M9A50< 8YP0CF"4ZQCK-<X,R+=HZU,C:B>30]5RR7\\5/<#]?>:XR',?1D4(N
M1:?WQ<G&/E :V$,EDE8(0A'#T3:&I8(V-P\^_M:+A]A'MOLA'\RU$XVC'&<(
M080R!K%F''))&$PRGF>"FC]2WM_6<6/&V CC>G]K&&AG+>\+.Z2/+>$N,(]R
M%]@Z CZT=47/V[[[2+[)3N_:B!%O[NX#==E^[L'3N@KOW"@;8TWO9E+]^-_J
MYR3""551K*#D*H68Y0@21A'DB/.(12JB*/43W-EK86S,5LO&U%:"TDQ@[/05
MV-D'LIVV@L#3,R-Y(]-!2.>$]Q<(Z.P_<6#AG!,.'0KFG+JP6[!SO55A8U/U
MTI9ZJY,'-$]9KI,41H(AB!6AD&0XA3*W$R"<:(F=LJQ=&QS;9[YM+]@8?%46
M'/3,TW &W2UT"0EESY1P(8K>L8@K-(&BCK/-#1I?N#J_'TDXW]?A?,<3^\J^
MS9^8+.;3^>>?)CZ9FUG;2BT?;^IU ,X2)HB9.@D42XAQGD*:)PA2DF9(Q(9L
MW,H^NC4W-IJI# 9KB\'&Y"OP^+>;OWD<*3B/=3N_A$>P9W8Y"UZ7@QGG4?0X
MAQ$4S8&.771_)?W.6#ACTWJDXOQ3ACM!X>S1SH$)][O&I@V^%@#8.RGXFWGT
MZKUQ85U Z&D^G7Z8+^Q3)Q'->919FB<D@9CR'-)(QY!$..9,ZICF>!!%Q7[\
M&]L(T]@.FS/0FP)@8Y$;[_8>N07+([-Z1*/G<.+E:Z2.G,@OT0(6KJT7$_QY
MS9?E5EY(79AQO@EOK4+9DW?_&1J6_7;M<.KJEYD9?+_LW<]/[%_SQ<V4+9=E
MODB&"8DYSB%37$.<(@%)+A64*9=11*-<Q%ZK21YMCVT\;MVW65K"+>T'I0.=
M$GA\.N;BS;)+X'[+'3)?I$-NBYW"K/^]L(.6Q[(!=@H2CUVODX^X5%'Q+&TO
M3_%VJ84V000)%2,"(YQG$$<\@32E$4P(3?)<T40HIRVRX):-C1JWI0.KJ).W
M1J?+37C*#\/36F30DSS#=;OC_.0M.K/OF<5!/[;/,I:MTXRS_7B!0F0@S(.+
M1UYJUQOI2@:"\[3D9*@&NF8_-$?6DTP1+B*(161S0&,&>:1SF*990J.,H(0Z
M'4[=?_#8"+G>T??;[3Q RS6S872[EZ[N=\AC.+L=Z9J^,.1&XRGS#Y,5+M\X
MM,)TQ>RSK:(\_:/>>%$:1X1+ A-,S+>'60H990I&,2=IG/"48.*\57BD@;%]
M?K6)H+01_.&QB74,/8?-OPLQZ?ESW(.CR^;>,5P\MO,NQ&>@#3QOG/SV[5I
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M^1_7C\^HSN%+J)9<)@K&E!@:%$D*J8$#HC@7,<[S.$_<E94/'C\VCK/V@=)
MB'Q."1W UDY!EX/1,[]L<$"=3DT=X.%S8.H27 ;*__3"Q_.LU"GWVX])'=PU
MX FI4Q;O'HXZ>56WB.X/MBALY88G$R66!:L0$SE%*8&"ZA1B)!@DC"20*9&3
M1&4<4Z_MXOT&QL95C7W &MBI'-@!A&Z!TR7 ],Q;7IAXASRG' \4T1P\?M"
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M\J/YV__Z'\U/S'^LBN'_^A__'U!+ P04    " #NA:I6[+,L:Y:K  #1MP<
M%0   ')D;G0M,C R,S S,S%?<')E+GAM;-R]:7=;.9(F_+U_1;XU7U]D8E_J
M=/4<698SU:VTW)(R:WJ^\& )R)RB2 ]).=/UZR? 13LEBL35A;L6FUI\;RP/
M A% +/_Z/_^\&OWP%::SX63\M[^P'^E??H!QG*3A^/)O?_GMX@.Q?_F?__8O
M__*O_Q\A_^O=V<D/[R?Q^@K&\Q\.I^#GD'[X8SC__,/?$\S^\4.>3JY^^/MD
M^H_A5T_(ORW^T>'DR[?I\/+S_ =.N7CXT^E? ^>&,<L)I<832;DAP1I9/J4
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MG211AGY>P87_\ZZX2HJ$CIR[2$E@%NTWR@3W\%!ZY&8OF%0,_',M?/9)4]E
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MFN9T_'XX^[*Z CS-JV;G(H)S O=R(P5#:1E&?+2".%!@/:/!R-IUF,\2U//
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MH!"L#\[6CD6ZX*/?5- W!G#O0&C <KX'?',<+E2,GT>P.K\_N"K.\#^7V2^
M05OR#H@U((C,"3<?:R31V=GLO<?MIW:N_39T]6MM^T?/I&-5MC'382VMDQ(9
MGI4Y/*<9!7DPF\'\+FNK*<\#ZBA#X2GB0BHIKT805W*U<P@8KV45F:[=N?NU
M-/9K99L#;J<J;L#&WKDR164L#QU^A?GG"<KT*ZQ4L>BI^WY8!#Y.L]/I^^%L
M>0RQ2"%P-O$8)?I6F=N2)AN(%=D2+=#]UYJ*E&J'3_M3W6]F?G,P?V,8-#&6
MX>[J/<T?AF./6AA?'DYF\]G :.6,LHF8K'@IP8XDV,5L-N,S\^!-]?X7S]'3
M;YI^<W"MIKH&+/#ZEOYTC.OIRV29F'6:%QO,;*"4TX+B@M*^9 E"4B1H6>IP
M8^F;;I*K7DKZ+$']IN(W!\1ZRFOG$OS^XGJ_HN4FHV0VX"BCH#P0CQ)"<T\3
M"0D_X4J#:)-0JOK I9=HZC=!OCE85E5A$Z'6;^,I^-'PGY#N+#F8#K\BC^B@
M#))B7 E:^DCR8NHCQHY1).)4 ) *EUO*E3'Y DG]YKPW!\F:"FS"?=Q0C64T
ME=POYI?0TF4@HQOLLB/&H(.L* H.JF>A[5XTUUFR>W/XJZ"N)@SANG$4<A'0
M[RU,'$[&16 H:_PT0V%.5VJ>>OSN0@>'G\O'XS%N#->+2[RG_\G)T(?A"&,_
M-F!<T)AT(IZ7) );BE\C?@K&NM(^-;A4NUW.&['6;X9\<PNC14 U$)8]SOM9
M)+;>:F'AXA^,TYI%U =J\48EUCC):%9$>2=P/W.1>.<U"=+9P$RIN:G=5WQ/
MDGM.H6]N8;PE IH$_$&,97&7^@% /ZVTG*-6@P C">- B4RAC%W%3YY%_(_T
MSKKNFZ@]IJNU#E<= N5%D.ZIM29\ZPT2799SS5>G*]0EQYVAQ 0-1'IJ20 I
MB&54QJAYT*%VAOXV=+76L:I/+.ZIM9:Q6')O[S$FI7&*&D&RLAC )D%)F51-
M?,P4 U@49_5N/UN2UEH7JMX1N9?N&@7E^I!OZ2U=^#^AW(1 XDI98F)$[\?@
MJ@L2/7 JDU*,1J]8[8/:K0AKK>E4GX#<5V^-PO%^WL1-&#B0'JSW-A&N39E?
M;FV9'>5)DH;YZ+F4;P#)#<2UUF:J5SM907]-!C7K]78&7V%\#0,;7*8",@:'
M&=>:#9P$GR2A*@9%K>0R=A^G/R"JM79/+=C'7?35Q('MY@CMD_]6PK.2!AGC
M]!KN"G0030(74&PQ:%Z&[&F4(FX$CG)E\0<\0.V+_]TH;:VW4PNQ=S7--H'@
M[5/?T9&66HF4B%08T^'VH(DUB1$=A!9!,&"T=C'9]M3U&P>]<0%!1TK;?4^?
MS/VH2S@N$Q6?%J2P7@<?(U&&T<(FD""X)BH+)RS-/KO:LT->3V4C@Z[>J,*O
MEKH:<#+1VJ\;5BY'^+R[1E&7V8*#$"A-62+I,9HR[301%[0AF4F1M01F=&WO
M<C,U358 5L/!HWG659323EK>(X86C@Z*$RWZ_-NGD1_/T=\HJ=M?RN\-;(Z0
M:%1$0)D.I*TKF0V*\,!DRL8IQ6O7FKR2Q"8+^MX,CQ75UQ!(IY,(D!95!.=^
M!*=Y,X?>)2E,&<]KC"=2H%R=X+@6P009,D?WHX,.2]N2UZ2SV!DX.U); YOS
M]I(<8#@FP9=T;= 9O9QLB,_)$^JLTRHSRZOGD&Y/7;]GYF^,QXZ4UF[P<E/"
M\H0@E?,YFRR)T@G=%<,T<=$:HI1U+A>VY1O!\ADJ&QF,^$;!2RUU-6 ?S^#+
MRC,YS2>3\27Z E?O(12;OVZW#_%ZNEQLPIIL12G)#F6*:$JEN)4'HC,5.@D*
M"6J',Z^AK\D IQI6'LVQ[TAQ3=PHWN6N<#4PS@8362+<ZTBD,YQXQ@7Q(95.
M^5$'6SN<>4A#D_'*6\#KU0IH D)WG=K2"A_%A([MLB?D;V-4UC%^8URJ3W#)
M/%T>4+S?V4T/OKM3H@9&2@<^)A(DRD0*7%;6.TVRYD9FZP*WM:O>.V6HR7BG
M*W"W XT&/(#M93^(.?I<FJ8RSTJ15H@EAQ]]>N.B\!'EK]_H'/T)ZIJ,D+I"
M<$=*:R!".LH9(CKR1W_&18W)&6X(I^/";/E_.8?XZD>P2' N[2<B;A?E![A0
M[W_CSF\.G/<,C+$DX@HD,CI* NXY1&AA&=.<,E5[LD$';/0+\,YBK+X5WH )
MWHO9Y6B?Q\D(JZWIKEB7HD;IQ!ABF?<3T"Q(9@P)*04B?8@BNN0BA<K+X6TY
M[#>3K[.5TC!,&M@X]K,85@@E(;$R%S!CA(P<^\ H$<HF+FWD3-?.7.E^,^@L
M1[!-B+]*B<T,/]^/91"12<<"0=;0NXNXYX7 #<%ORA1QN493^URD>]QVEB[8
M*&Y?H\16QE)<?_DR6HC2C]:B/![GR?1JJ<RU4*447D>I23"IY.LJ#')"!&)1
MHL: ABAJ5XQN25J_#3(Z0V(7BFG 15Y/MRB3@#'X+5.OK6<\X$)Q9<EXC&I+
MNT&:M,=-P%$OZG>=O$="SQWYNU#SHP3GW67>!&1N2JK6''BFN$U6D61EJ:P"
M3;S.C"0NC**&!E5]1MQC*GI.]'P3X.PE^6K8Z6D@S:>%(C[#?!C]Z#Y3M:?3
MW'_5FXZJ>8;+MYA;8ZE2F0M!>"BCO))(Z.LC7#/58#$TM4[6+I#I8FY-4?[@
M)KMJE1N82L%*"<_+,*CCJR_3R==EVYV!,AB2>UP\08>(D7C"9<0%$%_LL@(P
M.KN7T/6Z5S8\>.8U$%B;J [EW<"6=R.NBV7CC^2=I@PEXHH--QAA>(=N9>96
ME[$H%GQG:^1BZ\8L_=0T[ *>"F)N "3KCE]W!L$?_#F<#;33I?R,$[[8\7%/
M)C84 1G#C-21QNH=+#:0THC-V4&[&YJK[2/J1A&SM)SP?G+EA^,!.&^-D9:D
M178($X98:=%EI,DE<(R*6'NTU8M$]8NB*JK? DZ[ZZ%'8"UVX8,R2"#"+Y-%
M7<Z[WW^%JP#3@1.9.S""L!(?2".!.)<XH4()9@3(3-56+L[3SV\/%7MH<%)7
MG'TCXC^O_7@^#"O*1?9!Y01$4%I.P6(F0<9 C/2:6NY0+'$K(-Q[;+\N28?Z
MWUUX#>PP)8-UOLI@O<!_LS"5H$H_<A6(#A9%(50D+G!)-)66&9!)5^^E_!0=
MC3BQ^WLC>PNY0:"L5DTPRDK</XDH-28R>$>"SYY0Y:@6E#%1_9KA:4KZW5[V
MU_ +D-E!W V YK?QK.3"0RILK QDE$%%ZP+!#Q:EDDLKXB2)CZXT*,PLB]H3
M?IX@HRVX[*+=1WW^]Q-U VBYL;@GN%4?X\?9P"949G&BDDF"2%]2-35Z4CIZ
M:D%)W%1KUV ]IJ*1&JO]]Z$]!=P 1 JXC\>S^?2ZL/'!1U@V0A\81JE&2!.O
MHB1H7QWQ("*)24K\ON"<U0;*)EH:.4394<>/!HA6$'@#P'G"_U].VUO?M<Y*
M/0*DT^FB+@%7VL?K8D/7U0G+GPZ,USIHF] XEV-IFQ7QA@?"@RAY)!$$J^T9
MUZ&\$5^Z#BA[4.;W .&'3/_N1]=E8.KP<HS<1FNEL=00&E'J,BE'G%""**>$
MME&I:&IW -V/XD:VW3>";#WEM7F+__'@XK>SH],/[WX[/_YX='Y^\/']NX/S
MX_/3#Y_.CLZ//EX<7!R??MSETG[+)U>XH]^%ATI7\J?32S]>398KDUXFHV'R
MJV'>G^ZP<S.5TX]N$'Q[]P;*4R>])!"*\TC+N&0A Y%<4^"&Y9QJU^-4(;R6
MZ7P/LS@=?EF]_IV?#6>EY<HM%1>HKG?X+_\QT%Q$CO\E45%%).14^@!I4LIQ
MF<S 9:A=J_%Z*OMU-=\>DYNL:D=Z;=.2GA___/'XP_'A =J;P\/3WSY>''_\
M^=/IR?'A\='Y+@;T^0=6L)NOH+B2N5PUA!V.+S\A*N/=ZD\#(DD51.F>9' K
M]9'8I#6AC$5FN+$@JT]1W4C-WD<FZ!X,\S"69E&/7G(+>D'!JY0SX=F52PF-
MH%>>$2:23XH)GD3M^N'M*.O7@%5"R:-CEOI*:=,2G1T='MU=TN@/G1U].CTK
MG\\O\*N#L_>[&*2MGEO!+KV>_DKFZ2/\<0<9T\D8/\;5OCA.RQE_LYNVUHO?
M&>+^B:*[1:CFS%K++,$-U&(TDLN(-2M)=CQ0%IP 6]M!J4#V_DT3=B;A=N4!
M&"N4I"2 ST1&SH@'BW$5]5*5.;B&U6ZG5(/NOMLLO2UF'W=>>&/-MVESU['G
MX>FO[XX_+@+.\X7=.BD)XP>'%\>_'U_\URY6=\LG5["[N_!0R?(^,76U3 LH
MTPKNIH;<)*MF(7TRAGA+,231E!+O328@A8/$5*".=A0%;D=A!V.-WP]G<329
M74_A=MW8A.%18@8]E(P+-SM+<!TY$AG+,<K,N:E]:;L=96UDE76 IBW&!>^K
MJ#8-W/G1SZ7BY<81VRFB??B,&D'LLW35JKR!R[*CG<&7R731<'4-G:R#TQ@6
M$,T-1[V6U  3/('HJ90LN>QJ1ZV;:-D[9GWPW*=@G+2+)8^.&%J:V$;.B75*
M$"%%A%(?9W+U HJ7R>KY9K<&-A[%JI65T:9-.3P[>G]\\>'@\/CD^.+XJ#@;
M'T\OCLX_'?S7P;N3HUU,S$N/K%$2^!JJ*QF@<M]_BX';B3@1$%RVN.L"MQ6
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M4%^#FT?5B1VJJ8$-]):]A[?T!^.TOJA?K/8[MV1.6>6D)URZ7.8YIC(8S9"
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M[R!/IF58]@!#F6PX ,F6 9$I1(*A3239.$VU!Z:JCR6O0WF_ 40[\-U?K0V
M>=G5>R"9BKIDT>E,2W&OSR1 CL1'J[EBP;GJO4Z6;^ZWN6EG8-I!K V X007
MP'"T2( ;"&Y47A",@":2<8^D>P0S %AN!'?;Y6F] A%W7M]OD]'.8+&K@!O
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MUR??2[7R*+K$%6<69#)H^ N3P!B9P'FK@U/2<E'[+>9%@@9N1GUDA.VOBZ:
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MK1>KA>$=*>T&[;?VKM2>DAL*03R0QZT=Y$H8\,]IN9+6LEG]%A(Y<L(1+Y@
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MV22F_-K+7%2:VH3&<&2IV"4^@TF6X$$OA!*.^5"]8=]N% X;;N^]P*.ZDAJ
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M2"!3"$QDXG0\>J3FTTX9J[WE5!_!6>Y)40U <-7<_?UM-VSM'4J(66 \E4F
M>% ;1TM=N#8<CVO'7.T.(8\(:#SJLJ>6GZ;0[2WR9O#RH(&ZPB/79TE+?PE:
MQM-ZW%&907",<*JD4K3V=,2G-#1N@]=$S9Z";P XZ^;[XW0/?<J9U4R#B\61
M]MJ6N% $HEWDZ-IF96J'+)Y3T?C=50<\!PI_=_C8%7PFZ:H$-&H#Z,$NL%I(
MX6W)'PYEJ!LG8-!PA"0HE[9$'5GMU*^-A S;3NWX,-I3!4T@:;.,3JZN9LM%
MWD_GBV(M*N)5 IH$BLD0@WZKCY <=T3J$&6JWGKY=;*&[8]V))355D\+#=*V
M9(9Q&Q(1(0'77($0QH$U4>*WPBKG P^\=L[!(5E]O35(&Q19NZFA 5-J,QM_
M3%!'U[_&DZOU<(_/:7$[NRN[)(4VL335TBBTTH4U$@'2LI@]M]0_'1?<$\Y>
M('+8!FF#(K"6ZAK YF$IA-PDB8YO0MN!H&A)\("^,(7,DO,^*JJJ#\CH/WG4
MO'','D^E#>#W:_J9)C=(-Y[[#+<<AQ03^D>V= HJ7?=C8DZ8Y)")V@'7]=J=
M4&7?.*KV$G0# /DRF^;Q8CEK!D]>HM!7ALQCZ=4A/1BC./ R*#,H=(MR;>OM
M?O5NH5+RQE&RI[3;K!E^]\?%V>?3BXOWY[^_._M\<GEV_OGBY/.'KZ>?3BY/
M/YR\OSS[\^SRWP](%M]M@0KIWP=P5"FA>\/TSU))46RGAV/#U^F[S@8=(PL0
MG$!KBA -)G*#UI0)/LAD>:Q=5+4;A?6>%#=,_9N_^_7@N]6SF-<QH'OC0:F(
MNS,;!2:)\@SK3$A.6L5JQ^]WI7'85Z$>$;;]F;$'Y35P=V[@:M6:,;J8N2:@
M.#&EW3W!HYU*H)SY9<62U;6#;5M(:>4!L@_];YF;?(@R&L54^7)VEZ_)+...
M!@Z!:F0H&F2(<P99$>T,,X*KVA6)KQ+5QI%VD.H[P&E_/0R=L[5I_ZT[ZA&3
MHDD!:(@E(.,RLH%VJ)(6MYX4D>AN.5O;UV@/'0=H\I5)Q/N(=6ATO'__X;=/
M7R\NTNSG.*3YV22L\\^H9CR6\6J6E+Y&!B]_6I["%/&)2$(%C9VPL6V% 3M'
MU-+=M+8@AT;#Q?2F=-J:O'?7XSR=3<;NP]A=3:;SQ3B<?7=7X\G5/6.&6>>]
M#D!(**G[48+UG(#7C#BFHP@B=$+(+JL.V+*A#]3T)O"AD70VN;I.?TVG\9:+
M]ZFDMW[Z]/Z6%Y(I\31(*%X$FGLE>R.I#%D2*VAF,5+1"3RO+#1@3X0^\%)3
MK$-#Y*O[[GY,O[HXGEY/KW[=!]Z_K+D1*@>=(P>?;'DU4@&Y,0ZX3=XHJRGG
MLA-(7EUJF)R7WF!25[1MND;W45E%HW B.%!.<A!:&/#,XA^!!&?P_\A9_U[1
M'3VMY' .XWCOIY:&(/8@./8UA>G59/R?*9Y%%/TXCXO$5J_9MWY$_ T/X[_&
MU]<GD_@@IPQ_Y^9[BI_38F2"-20F!]%EA9XH<^"(CD")T]HY0C6O'97LB97F
M?+D]L;8%Q$,JOH'$KCW%L)']+[/ICS1;_/IR[28+_(WRL/;C^S+#DB;*8C;
M,A=X[R2%]TZ@(+/@VC'*LJF=%G$4QH8]]%O;&SV"8FBK=4^)N$T2^5I&Z9[G
M/^:K7QXE)J5Q(8*Q#AV\F"Q8+BS@+>Q4YC08:3K9NST2.6R1076@-Z73!JR@
M]:TV0O88TTAMUL:7&6,*A8F[$_]2JFAU,M5'P*_7'K8 H;>S="_1-@")FG?
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MO#8L:>](OZ\WVVGKAK$W%:[O12U#/PL_$=3#=],1TX)GQA-890F(F,OSMO9
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MXO6#H0 !FP'MBL1%9#3G8:;&O#\U6H)]PH #K_V:T3[YJK4*WJ5,#4)M7MR
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M,S$Q+FAT;5!+ 0(4 Q0    ( .Z%JE;"9W).\P@  !!"   4
M  "  0,)  !Q,3(P,C-E>&AI8FET,S$R+FAT;5!+ 0(4 Q0    ( .Z%JE;V
M9YMX,@4  +X:   4              "  2@2  !Q,3(P,C-E>&AI8FET,S(Q
M+FAT;5!+ 0(4 Q0    ( .Z%JE:&W<B#$04  ,,9   4              "
M 8P7  !Q,3(P,C-E>&AI8FET,S(R+FAT;5!+ 0(4 Q0    ( .Z%JE::3SJ9
M^5D" %L@'  1              "  <\<  !R9&YT+3(P,C,P,S,Q+FAT;5!+
M 0(4 Q0    ( .Z%JE:\Q9K&NA(  +G%   1              "  ?=V @!R
M9&YT+3(P,C,P,S,Q+GAS9%!+ 0(4 Q0    ( .Z%JE91OJKW4!T  &D: 0 5
M              "  >") @!R9&YT+3(P,C,P,S,Q7V-A;"YX;6Q02P$"% ,4
M    " #NA:I6[O%K.HV$  !=R@4 %0              @ %CIP( <F1N="TR
M,#(S,#,S,5]D968N>&UL4$L! A0#%     @ [H6J5GKY8T2;#P$ IB$+ !4
M             ( !(RP# ')D;G0M,C R,S S,S%?;&%B+GAM;%!+ 0(4 Q0
M   ( .Z%JE;LLRQKEJL  -&W!P 5              "  ?$[! !R9&YT+3(P
D,C,P,S,Q7W!R92YX;6Q02P4&      H "@"2 @  NN<$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
